https://atc.digitellinc.com/p/s/joint-plenary-i-8
https://atc.digitellinc.com/p/s/joint-award-session-11
https://atc.digitellinc.com/p/s/asts-pioneer-award-13
https://atc.digitellinc.com/p/s/ast-lifetime-achievement-awards-15
https://atc.digitellinc.com/p/s/state-of-the-art-address-the-tortuous-path-to-allograft-specific-therapies-16
https://atc.digitellinc.com/p/s/midday-symposium-chronic-antibody-mediated-rejection-when-should-we-intervene-and-does-it-matter-18
https://atc.digitellinc.com/p/s/joint-plenary-ii-21
https://atc.digitellinc.com/p/s/asts-awards-24
https://atc.digitellinc.com/p/s/asts-presidential-address-26
https://atc.digitellinc.com/p/s/state-of-the-art-address-immune-checkpoint-inhibitors-emerging-targets-for-induction-of-anti-tumor-immunity-and-transplantation-tolerance-27
https://atc.digitellinc.com/p/s/midday-symposium-delayed-allograft-function-what-is-the-impact-and-what-therapeutics-are-the-most-promising-30
https://atc.digitellinc.com/p/s/joint-plenary-iii-32
https://atc.digitellinc.com/p/s/ast-awards-33
https://atc.digitellinc.com/p/s/ast-presidential-address-34
https://atc.digitellinc.com/p/s/controversies-in-transplantation-clinical-using-the-hepatitis-c-infected-donor-organ-in-the-era-of-direct-acting-antivirals-access-for-all-or-only-for-some-35
https://atc.digitellinc.com/p/s/joint-plenary-iv-40
https://atc.digitellinc.com/p/s/whats-hot-whats-new-42
https://atc.digitellinc.com/p/s/wednesday-may-3-2017-59
https://atc.digitellinc.com/p/s/defining-high-risk-in-solid-organ-transplant-preoperative-and-postoperative-strategies-70
https://atc.digitellinc.com/p/s/state-of-the-art-assays-to-assess-rejection-risk-75
https://atc.digitellinc.com/p/s/the-preoperative-plan-management-of-immunosuppression-in-the-transplant-recipient-with-a-prior-history-of-cancer-80
https://atc.digitellinc.com/p/s/novel-ways-to-manage-polypharmacy-post-transplantation-85
https://atc.digitellinc.com/p/s/preoperative-evaluation-and-plan-for-the-hiv-positive-liver-organ-candidate-90
https://atc.digitellinc.com/p/s/peritransplant-anticoagulation-what-is-the-data-95
https://atc.digitellinc.com/p/s/the-high-risk-cardiovascular-recipient-100
https://atc.digitellinc.com/p/s/the-diabetic-recipient-management-of-perioperative-glucose-does-it-matter-105
https://atc.digitellinc.com/p/s/postoperative-monitoring-of-high-pras-110
https://atc.digitellinc.com/p/s/basic-science-morning-program-molecular-sensors-of-injuryinnate-reactivity-to-cell-death-and-injury-115
https://atc.digitellinc.com/p/s/tam-receptors-and-tlrs-regulating-adaptive-immune-responses-120
https://atc.digitellinc.com/p/s/nlrx1-regulation-of-innate-immunity-125
https://atc.digitellinc.com/p/s/nod-signaling-130
https://atc.digitellinc.com/p/s/detecting-pathogen-associated-signals-135
https://atc.digitellinc.com/p/s/overview-of-cell-death-pathways-140
https://atc.digitellinc.com/p/s/autophagy-not-recorded-145
https://atc.digitellinc.com/p/s/pyroptosis-150
https://atc.digitellinc.com/p/s/cell-death-and-sterile-inflammation-155
https://atc.digitellinc.com/p/s/2nd-annual-leadership-resilience-in-transplantation-administrator-boot-camp-160
https://atc.digitellinc.com/p/s/transplants-financial-nuances-medicare-cost-report-basics-165
https://atc.digitellinc.com/p/s/matching-revenue-to-effort-documentation-for-optimal-reimbursement-not-recorded-170
https://atc.digitellinc.com/p/s/overview-of-healthcare-reform-175
https://atc.digitellinc.com/p/s/healthcare-reform-and-transplant-centers-180
https://atc.digitellinc.com/p/s/unos-by-laws-and-policies-185
https://atc.digitellinc.com/p/s/unos-membership-and-professional-standards-committee-overview-requirements-for-medical-and-surgical-directors-key-personnel-requirements-190
https://atc.digitellinc.com/p/s/case-report-site-survey-preparation-and-process-195
https://atc.digitellinc.com/p/s/case-report-maintaining-compliance-200
https://atc.digitellinc.com/p/s/overview-of-cms-regulations-for-certification-of-transplant-programs-205
https://atc.digitellinc.com/p/s/site-survey-process-and-follow-up-requirements-210
https://atc.digitellinc.com/p/s/mitigating-factors-and-service-improvement-agreements-215
https://atc.digitellinc.com/p/s/expectations-for-quality-improvement-plans-and-observed-best-practices-220
https://atc.digitellinc.com/p/s/the-program-director-and-transplant-administrator-do-you-have-what-it-takes-to-support-the-mutlidisciplinary-approach-to-transplantation-225
https://atc.digitellinc.com/p/s/round-table-1-quality-assurance-plans-outcomes-staffing-models-230
https://atc.digitellinc.com/p/s/essential-immunology-for-the-transplant-community-235
https://atc.digitellinc.com/p/s/how-does-rejection-occur-240
https://atc.digitellinc.com/p/s/overview-of-innate-immunity-and-its-clinical-applications-245
https://atc.digitellinc.com/p/s/why-t-cell-activation-matters-applications-to-human-transplant-recipients-250
https://atc.digitellinc.com/p/s/b-cells-and-plasma-cells-the-biology-behind-the-new-therapies-255
https://atc.digitellinc.com/p/s/injury-to-the-epithelium-fundamental-mechanisms-and-clinical-applications-260
https://atc.digitellinc.com/p/s/allograft-fibrosis-an-ends-to-the-means-of-injury-265
https://atc.digitellinc.com/p/s/identifying-functioning-mechanisms-of-allograft-injury-in-man-by-immune-monitoring-270
https://atc.digitellinc.com/p/s/regulating-the-immune-response-does-this-really-happen-in-people-275
https://atc.digitellinc.com/p/s/update-in-histocompatiblity-and-antibody-detection-280
https://atc.digitellinc.com/p/s/transplant-tolerance-fact-or-fiction-285
https://atc.digitellinc.com/p/s/gene-expression-the-technique-molecules-and-their-application-to-transplantation-290
https://atc.digitellinc.com/p/s/responding-to-viral-infection-mechanisms-and-consequences-on-recipient-immunity-and-allograft-injury-295
https://atc.digitellinc.com/p/s/controversies-in-kidney-transplantation-300
https://atc.digitellinc.com/p/s/induction-therapy-which-agent-for-which-patient-305
https://atc.digitellinc.com/p/s/belatacept-approved-now-what-310
https://atc.digitellinc.com/p/s/steroid-free-immunosuppression-is-this-standard-of-care-in-2012-315
https://atc.digitellinc.com/p/s/moving-immunosuppression-forward-three-critical-trials-that-must-be-performed-in-kidney-transplantation-320
https://atc.digitellinc.com/p/s/obesity-when-is-big-too-big-for-kidney-transplantation-325
https://atc.digitellinc.com/p/s/transplantation-in-the-elderly-should-this-be-routinely-offered-to-70-and-80-year-olds-330
https://atc.digitellinc.com/p/s/beyond-preoperative-clearance-what-long-term-cardiac-prognosis-is-acceptable-for-kidney-transplantation-335
https://atc.digitellinc.com/p/s/wait-list-management-do-all-these-tests-really-need-to-be-repeated-340
https://atc.digitellinc.com/p/s/hot-topics-in-liver-transplantation-viral-infections-and-malignancy-345
https://atc.digitellinc.com/p/s/treatment-of-hcv-in-the-liver-transplant-candidate-and-recipient-safe-or-sorry-350
https://atc.digitellinc.com/p/s/update-on-hcv-infection-current-and-future-antiviral-therapies-and-management-strategies-355
https://atc.digitellinc.com/p/s/update-on-hepatitis-b-infection-the-success-of-antivirals-360
https://atc.digitellinc.com/p/s/viral-hepatitis-in-non-hepatic-organ-transplantation-365
https://atc.digitellinc.com/p/s/hepatocellular-carcinoma-keeping-patients-within-unos-criteria-370
https://atc.digitellinc.com/p/s/hepatocellular-carcinoma-downstaging-patients-into-unos-criteria-375
https://atc.digitellinc.com/p/s/cholangiocarcinoma-friend-or-foe-380
https://atc.digitellinc.com/p/s/liver-transplantation-for-non-hepatocellular-cancer-385
https://atc.digitellinc.com/p/s/giving-life-maintaining-life-transplant-from-beginning-to-end-390
https://atc.digitellinc.com/p/s/whats-age-got-to-do-with-it-pushing-the-age-barrier-395
https://atc.digitellinc.com/p/s/how-much-is-too-much-is-bmi-really-an-issue-in-transplantation-400
https://atc.digitellinc.com/p/s/real-time-programmatic-decision-making-405
https://atc.digitellinc.com/p/s/wait-list-management-delisting-patients-410
https://atc.digitellinc.com/p/s/who-cares-for-the-donor-the-donor-win-program-415
https://atc.digitellinc.com/p/s/escaping-the-coffin-managing-long-term-issues-420
https://atc.digitellinc.com/p/s/let-the-patient-grow-up-pediatric-transition-to-adult-care-425
https://atc.digitellinc.com/p/s/outlier-clinics-innovative-strategies-to-avoid-loss-to-follow-up-430
https://atc.digitellinc.com/p/s/controversies-in-transplant-infections-point-counterpoint-influenza-435
https://atc.digitellinc.com/p/s/biomarkers-and-beyond-applying-omic-technology-to-patient-care-440
https://atc.digitellinc.com/p/s/malignancy-transmission-in-solid-organ-transplantation-case-studies-with-us-and-international-perspectives-445
https://atc.digitellinc.com/p/s/update-on-clinical-pharmacology-450
https://atc.digitellinc.com/p/s/antiviral-therapy-for-hcv-one-year-later-455
https://atc.digitellinc.com/p/s/great-cases-in-transplant-infectious-diseases-460
https://atc.digitellinc.com/p/s/management-of-the-kidney-transplant-patient-with-a-failingfailed-renal-allograft-465
https://atc.digitellinc.com/p/s/the-virtual-crossmatch-understanding-its-role-in-wait-list-management-470
https://atc.digitellinc.com/p/s/meet-the-experts-novel-strategies-in-lung-transplantation-ex-vivo-lung-repair-immunosuppression-in-the-current-era-475
https://atc.digitellinc.com/p/s/controversies-in-transplant-immunology-i-do-il-17-andor-th17-cells-play-a-role-in-allograft-rejection-480
https://atc.digitellinc.com/p/s/controversies-in-transplant-immunology-ii-future-of-islet-485
https://atc.digitellinc.com/p/s/achieving-clinical-transplantation-tolerance-where-do-we-stand-490
https://atc.digitellinc.com/p/s/tolerance-induction-strategies-in-liver-transplantation-an-update-495
https://atc.digitellinc.com/p/s/identifying-the-tolerant-organ-transplant-recipient-500
https://atc.digitellinc.com/p/s/tolerance-induction-strategies-in-kidney-transplantation-a-review-505
https://atc.digitellinc.com/p/s/acute-and-chronic-rejection-in-vascularized-composite-allografts-vca-510
https://atc.digitellinc.com/p/s/immunology-of-vca-515
https://atc.digitellinc.com/p/s/rejection-in-skin-containing-vca-the-banff-update-520
https://atc.digitellinc.com/p/s/tolerance-protocols-for-vascularized-composite-tissue-allotransplantation-preclinical-data-525
https://atc.digitellinc.com/p/s/marginal-kidneys-connecting-the-kidney-recipient-and-center-530
https://atc.digitellinc.com/p/s/the-right-kidney-biopsy-pump-and-discard-535
https://atc.digitellinc.com/p/s/the-right-recipient-update-on-the-eurotransplant-senior-program-540
https://atc.digitellinc.com/p/s/the-right-center-policy-challenges-to-efficient-distribution-545
https://atc.digitellinc.com/p/s/lung-transplantation-challenges-progress-and-clinical-therapeutics-550
https://atc.digitellinc.com/p/s/avoiding-primary-graft-dysfunction-biomarkers-and-new-therapies-555
https://atc.digitellinc.com/p/s/emerging-infections-in-lung-transplant-recipients-560
https://atc.digitellinc.com/p/s/the-latest-in-the-understanding-and-treatment-of-bos-565
https://atc.digitellinc.com/p/s/maximizing-transplant-center-organ-utilization-in-an-era-of-regulatory-oversight-570
https://atc.digitellinc.com/p/s/transplant-outcomes-assessment-and-center-behavior-575
https://atc.digitellinc.com/p/s/loss-aversion-and-organ-utilization-decisions-580
https://atc.digitellinc.com/p/s/transplant-center-oversight-and-quality-improvement-the-cms-perspective-585
https://atc.digitellinc.com/p/s/minimizing-the-impact-of-immunosuppression-in-liver-transplant-recipients-590
https://atc.digitellinc.com/p/s/overview-of-current-and-future-immunosuppression-strategies-in-liver-recipients-595
https://atc.digitellinc.com/p/s/minimizing-the-toll-of-long-term-immunosuppression-not-recorded-600
https://atc.digitellinc.com/p/s/liver-transplant-tolerance-holy-grail-or-fail-605
https://atc.digitellinc.com/p/s/risk-evaluation-and-mitigation-strategies-rems-in-transplantation-610
https://atc.digitellinc.com/p/s/what-are-risk-evaluation-and-mitigation-strategies-rems-615
https://atc.digitellinc.com/p/s/rems-in-transplantation-620
https://atc.digitellinc.com/p/s/implications-of-rems-for-healthcare-providers-625
https://atc.digitellinc.com/p/s/the-microbiome-effects-of-commensal-microbes-on-health-and-disease-630
https://atc.digitellinc.com/p/s/gut-microbiota-drives-autoimmunity-not-recorded-635
https://atc.digitellinc.com/p/s/effect-of-the-microbiota-on-the-tcr-repertoire-of-tregs-not-recorded-640
https://atc.digitellinc.com/p/s/microbiota-effects-on-small-bowel-transplants-645
https://atc.digitellinc.com/p/s/state-of-the-art-address-immune-checkpoint-blockade-in-cancer-therapy-new-insights-and-opportunities-650
https://atc.digitellinc.com/p/s/hepatitis-c-virus-the-new-era-655
https://atc.digitellinc.com/p/s/new-antivirals-for-hcv-current-and-future-agents-660
https://atc.digitellinc.com/p/s/predictors-of-hcv-disease-progression-and-treatment-response-il28b-and-beyond-665
https://atc.digitellinc.com/p/s/treatment-of-hcv-in-liver-transplant-candidates-and-recipients-what-now-670
https://atc.digitellinc.com/p/s/living-kidney-donation-outcomes-research-lessons-learned-from-four-multi-site-studies-675
https://atc.digitellinc.com/p/s/kidney-donor-outcomes-cohort-kdoc-study-680
https://atc.digitellinc.com/p/s/renal-and-lung-living-donors-evaluation-relive-study-685
https://atc.digitellinc.com/p/s/assessing-long-term-outcomes-after-living-kidney-donation-altold-study-690
https://atc.digitellinc.com/p/s/donor-nephrectomy-outcomes-research-donor-network-695
https://atc.digitellinc.com/p/s/microvasculature-injury-and-repair-consequences-and-therapeutic-targets-in-lung-transplantation-700
https://atc.digitellinc.com/p/s/role-of-microvascular-injury-in-airway-fibrosis-705
https://atc.digitellinc.com/p/s/bronchial-artery-revascularization-technique-and-outcomes-710
https://atc.digitellinc.com/p/s/hif1-alpha-dependent-mechanism-of-vascularization-and-vascular-remodeling-715
https://atc.digitellinc.com/p/s/new-insights-in-dendritic-cell-functions-during-initiation-of-adaptive-immune-responses-720
https://atc.digitellinc.com/p/s/directing-dendritic-cells-out-of-peripheral-tissues-725
https://atc.digitellinc.com/p/s/chemokine-control-of-cd8-t-cell-dendritic-cell-interactions-during-responses-to-viruses-730
https://atc.digitellinc.com/p/s/handing-antigens-off-from-fdc-to-resident-dc-in-lymph-nodes-735
https://atc.digitellinc.com/p/s/vascularized-composite-allografts-clinical-lessons-learned-from-the-past-10-years-and-challenges-for-the-next-10-years-740
https://atc.digitellinc.com/p/s/the-nonimmune-concept-of-self-psychosocial-issues-in-the-evaluation-and-long-term-outcome-of-hand-and-face-allograft-recipients-745
https://atc.digitellinc.com/p/s/infectious-complications-in-vca-treatment-strategies-now-and-future-prevention-750
https://atc.digitellinc.com/p/s/technical-evolution-of-hand-transplantation-and-improving-long-term-outcomes-755
https://atc.digitellinc.com/p/s/delayed-renal-allograft-function-pathogenesis-prevention-and-management-760
https://atc.digitellinc.com/p/s/risk-factors-for-dgf-and-the-impact-on-transplant-outcomes-765
https://atc.digitellinc.com/p/s/pre-transplant-assessment-and-management-of-the-donor-kidney-770
https://atc.digitellinc.com/p/s/the-financial-implications-of-dgf-hospitalization-dialysis-and-pumping-775
https://atc.digitellinc.com/p/s/treatment-strategies-to-mitigate-dgf-780
https://atc.digitellinc.com/p/s/clinical-trials-in-dgf-issues-in-design-and-human-subjects-protection-not-recorded-785
https://atc.digitellinc.com/p/s/the-primary-and-essential-care-of-transplant-recipients-staying-alive-790
https://atc.digitellinc.com/p/s/tailoring-treatment-in-management-of-hypertension-795
https://atc.digitellinc.com/p/s/diabetes-management-in-transplantation-how-tight-for-how-long-800
https://atc.digitellinc.com/p/s/avoiding-infection-vaccines-and-lifestyle-after-transplantation-805
https://atc.digitellinc.com/p/s/cancer-prevention-and-screening-how-big-is-the-risk-810
https://atc.digitellinc.com/p/s/the-science-the-art-and-the-allure-of-transplantation-815
https://atc.digitellinc.com/p/s/part-1-fundamental-concepts-of-transplantation-in-the-beginning-historical-anecdotes-820
https://atc.digitellinc.com/p/s/part-1-fundamental-concepts-of-transplantation-immunosuppression-because-we-havent-quite-figured-out-tolerance-825
https://atc.digitellinc.com/p/s/part-1-fundamental-concepts-of-transplantation-transplant-surgery-the-most-invasive-thing-you-can-do-to-someone-830
https://atc.digitellinc.com/p/s/part-1-fundamental-concepts-of-transplantation-transplant-nephrology-urine-is-golden-835
https://atc.digitellinc.com/p/s/part-1-fundamental-concepts-of-transplantation-transplant-hepatology-no-other-option-840
https://atc.digitellinc.com/p/s/part-1-fundamental-concepts-of-transplantation-transplant-id-immunosuppression-brings-out-the-strange-infections-845
https://atc.digitellinc.com/p/s/part-1-fundamental-concepts-of-transplantation-live-donation-when-you-dont-need-an-operation-but-want-one-anyway-850
https://atc.digitellinc.com/p/s/part-1-fundamental-concepts-of-transplantation-transplant-immunology-research-from-past-to-future-855
https://atc.digitellinc.com/p/s/part-1-fundamental-concepts-of-transplantation-clinical-research-opportunities-so-many-databases-so-little-time-860
https://atc.digitellinc.com/p/s/part-2-why-i-love-it-surgery-865
https://atc.digitellinc.com/p/s/part-2-why-i-love-it-medicine-870
https://atc.digitellinc.com/p/s/part-2-why-i-love-it-basic-science-875
https://atc.digitellinc.com/p/s/part-2-why-i-love-it-pharmacy-880
https://atc.digitellinc.com/p/s/how-to-prepare-and-give-a-talk-885
https://atc.digitellinc.com/p/s/grant-writing-basic-science-890
https://atc.digitellinc.com/p/s/manuscript-writing-basic-science-895
https://atc.digitellinc.com/p/s/grant-writing-clinical-900
https://atc.digitellinc.com/p/s/contemporary-trends-in-immunosuppression-after-heart-transplantation-905
https://atc.digitellinc.com/p/s/monotherapy-with-cni-is-too-little-too-much-910
https://atc.digitellinc.com/p/s/induction-therapy-revisited-has-alemtuzumab-made-a-difference-915
https://atc.digitellinc.com/p/s/where-do-the-mtor-inhibitors-fit-in-920
https://atc.digitellinc.com/p/s/critical-care-issues-in-liver-transplant-candidates-925
https://atc.digitellinc.com/p/s/acute-on-chronic-liver-failure-keeping-patients-alive-before-transplantation-930
https://atc.digitellinc.com/p/s/controversies-in-the-management-of-acute-liver-failure-935
https://atc.digitellinc.com/p/s/intraoperative-management-protecting-the-vital-organs-940
https://atc.digitellinc.com/p/s/hiv-and-transplantation-experience-and-hurdles-945
https://atc.digitellinc.com/p/s/hiv-positive-donors-the-south-african-experience-950
https://atc.digitellinc.com/p/s/solid-organ-transplantation-in-hiv-the-european-experience-955
https://atc.digitellinc.com/p/s/antiretroviral-therapy-in-solid-organ-transplant-recipients-current-options-anti-rejection-activity-and-drug-drug-interactions-960
https://atc.digitellinc.com/p/s/kinases-in-transplantation-from-outside-to-cellside-965
https://atc.digitellinc.com/p/s/gsk-3beta-treg-function-and-allografts-970
https://atc.digitellinc.com/p/s/kinase-inhibitors-of-cardiac-allograft-rejection-975
https://atc.digitellinc.com/p/s/clinical-use-of-jak-3-inhibitors-in-transplantation-not-recorded-980
https://atc.digitellinc.com/p/s/update-in-intestinal-transplantation-985
https://atc.digitellinc.com/p/s/which-pathway-to-take-autologous-reconstruction-or-intestinal-transplantation-990
https://atc.digitellinc.com/p/s/long-term-functional-outcomes-why-do-grafts-fail-and-can-anything-be-done-995
https://atc.digitellinc.com/p/s/predicting-the-future-of-intestinal-transplantation-1000
https://atc.digitellinc.com/p/s/updates-in-transplant-psychiatry-1005
https://atc.digitellinc.com/p/s/psychiatric-evaluation-for-patients-with-acute-liver-failure-requiring-liver-transplantation-1010
https://atc.digitellinc.com/p/s/addiction-and-liver-transplantation-review-of-current-evidence-1015
https://atc.digitellinc.com/p/s/to-give-or-not-to-give-reflections-of-a-transplant-psychiatrist-on-the-evaluation-and-care-of-adult-living-liver-donors-1020
https://atc.digitellinc.com/p/s/kidney-paired-donation-lessons-finances-and-progress-1025
https://atc.digitellinc.com/p/s/the-best-and-worst-aspects-of-our-program-1030
https://atc.digitellinc.com/p/s/the-best-and-worst-aspects-of-our-program-1035
https://atc.digitellinc.com/p/s/the-best-and-worst-aspects-of-our-program-1040
https://atc.digitellinc.com/p/s/the-best-and-worst-aspects-of-our-program-1045
https://atc.digitellinc.com/p/s/the-best-and-worst-aspects-of-our-program-1050
https://atc.digitellinc.com/p/s/the-best-and-worst-aspects-of-our-program-1055
https://atc.digitellinc.com/p/s/financing-kidney-paired-donation-1060
https://atc.digitellinc.com/p/s/state-of-the-art-address-mechanisms-of-antibody-action-the-role-of-the-fc-domain-1065
https://atc.digitellinc.com/p/s/antibodies-in-kidney-transplantation-1070
https://atc.digitellinc.com/p/s/novel-methods-to-diagnose-antibody-mediated-rejection-in-kidney-transplantation-not-recorded-1075
https://atc.digitellinc.com/p/s/the-utility-of-antibody-monitoring-in-sensitized-and-unsensitized-renal-transplant-recipients-1080
https://atc.digitellinc.com/p/s/treatment-of-detected-antibody-and-antibody-mediated-rejection-whats-new-1085
https://atc.digitellinc.com/p/s/consensus-conference-results-in-antibody-mediated-rejection-after-heart-transplantation-state-of-the-art-1090
https://atc.digitellinc.com/p/s/assays-to-detect-circulating-antibodies-1095
https://atc.digitellinc.com/p/s/new-pathology-criteria-for-antibody-mediated-rejection-1100
https://atc.digitellinc.com/p/s/clinical-aspects-of-antibody-mediated-rejection-the-ishlt-consensus-conference-1105
https://atc.digitellinc.com/p/s/liver-transplantation-in-the-extreme-1110
https://atc.digitellinc.com/p/s/the-extreme-donor-steatotic-dcd-old-challenges-and-results-1115
https://atc.digitellinc.com/p/s/the-extreme-recipient-when-is-sick-too-sick-techniques-for-maximizing-outcomes-in-marginal-patients-liver-transplants-in-association-with-other-nonintestinal-organs-not-recorded-1120
https://atc.digitellinc.com/p/s/extreme-surgery-techniques-for-difficult-technical-hurdles-1125
https://atc.digitellinc.com/p/s/molecular-signals-directing-t-cell-differentiation-1130
https://atc.digitellinc.com/p/s/t-bet-regulation-of-th1-and-th17-differentiation-not-recorded-1135
https://atc.digitellinc.com/p/s/molecular-signals-directing-t-follicular-helper-cell-differentiation-1140
https://atc.digitellinc.com/p/s/crel-and-treg-development-1145
https://atc.digitellinc.com/p/s/return-of-the-macrophage-new-insights-into-the-functions-of-an-old-leukocyte-1150
https://atc.digitellinc.com/p/s/functional-populations-of-macrophages-1155
https://atc.digitellinc.com/p/s/klf4-and-macrophage-polarization-1160
https://atc.digitellinc.com/p/s/nlrs-and-macrophages-and-meyloids-cells-1165
https://atc.digitellinc.com/p/s/the-wild-world-of-regulatory-cells-from-bench-to-bedside-1170
https://atc.digitellinc.com/p/s/overview-of-peripheral-regulation-1175
https://atc.digitellinc.com/p/s/foxp3-regulatory-t-cells-ntregs-vs-itregs-1180
https://atc.digitellinc.com/p/s/b-regulatory-cells-1185
https://atc.digitellinc.com/p/s/myeloid-derived-suppressor-cells-1190
https://atc.digitellinc.com/p/s/tolerance-vs-inflammation-1195
https://atc.digitellinc.com/p/s/bringing-tregs-to-the-clinic-not-recorded-1200
https://atc.digitellinc.com/p/s/the-art-and-science-of-transition-nuts-and-bolts-1205
https://atc.digitellinc.com/p/s/setting-the-scene-does-crossing-the-street-really-impact-outcomes-in-pediatric-solid-organ-transplantation-not-recorded-1210
https://atc.digitellinc.com/p/s/transition-a-pediatric-practitioners-perspective-orthey-cantwont-take-care-of-my-patient-the-same-way-1215
https://atc.digitellinc.com/p/s/transition-an-adult-practitioners-perspective-or-who-is-this-dropped-at-our-doorstep-1220
https://atc.digitellinc.com/p/s/the-adolescent-perspective-or-whats-the-big-deal-its-just-across-the-street-1225
https://atc.digitellinc.com/p/s/the-art-and-science-of-transition-collaboration-consensus-and-measuring-success-1230
https://atc.digitellinc.com/p/s/working-together-to-build-consensus-on-transition-from-pediatrics-to-adults-the-uk-experience-1235
https://atc.digitellinc.com/p/s/operationalizing-the-key-components-to-a-successful-transition-program-or-i-know-what-to-do-but-how-do-i-do-it-1240
https://atc.digitellinc.com/p/s/technology-based-transition-tools-1245
https://atc.digitellinc.com/p/s/studying-the-science-of-transition-and-measuring-outcomes-1250
https://atc.digitellinc.com/p/s/managing-infections-in-transplantation-challenges-and-opportunities-1255
https://atc.digitellinc.com/p/s/bk-polyomavirus-have-we-made-progress-not-recorded-1260
https://atc.digitellinc.com/p/s/advances-in-prevention-and-treatment-of-fungal-infection-1265
https://atc.digitellinc.com/p/s/managing-hiv-transplantation-the-basics-1270
https://atc.digitellinc.com/p/s/controversies-in-cmv-prevention-and-management-pro-and-con-not-recorded-1275
https://atc.digitellinc.com/p/s/new-diagnostic-strategies-in-liver-transplantation-1280
https://atc.digitellinc.com/p/s/diagnostic-testing-in-transplant-infectious-disease-international-standards-and-new-assays-1285
https://atc.digitellinc.com/p/s/interpretation-of-donor-specific-antibody-testing-and-cross-match-techniques-1290
https://atc.digitellinc.com/p/s/single-port-donor-nephrectomy-techniques-and-outcomes-1295
https://atc.digitellinc.com/p/s/extended-criteria-liver-donors-dcd-and-beyond-1300
https://atc.digitellinc.com/p/s/meet-the-experts-practical-approach-to-circulating-antibodies-for-patients-awaiting-heart-transplantation-or-making-sense-of-the-sensitized-patient-1305
https://atc.digitellinc.com/p/s/unossrtr-registry-analysis-the-devil-is-in-the-details-1310
https://atc.digitellinc.com/p/s/controversies-in-transplant-immunology-ii-depletional-vs-non-depletional-induction-which-is-the-more-efficacious-strategy-for-the-induction-of-robust-long-term-tolerance-in-transplantation-1315
https://atc.digitellinc.com/p/s/controversies-in-transplant-immunology-iv-does-neolymphorganogenesis-in-allografts-impact-graft-injury-and-outcome-1320
https://atc.digitellinc.com/p/s/antibody-mediated-rejection-of-the-pancreas-allograft-diagnosis-treatment-and-prognosis-1325
https://atc.digitellinc.com/p/s/pancreas-transplant-state-of-the-art-1330
https://atc.digitellinc.com/p/s/diagnosis-of-antibody-mediated-rejection-of-the-pancreas-allograft-morphologic-and-immunologic-criteria-1335
https://atc.digitellinc.com/p/s/management-and-prognosis-of-antibody-mediated-rejection-of-the-pancreas-allograft-1340
https://atc.digitellinc.com/p/s/donor-screening-for-infection-new-guidelines-and-the-higher-risk-donor-1345
https://atc.digitellinc.com/p/s/new-phs-guidelines-for-donor-screening-what-have-we-learned-1350
https://atc.digitellinc.com/p/s/new-rules-for-donor-testing-what-do-we-really-need-1355
https://atc.digitellinc.com/p/s/transplantation-from-hbv-and-hcv-positive-donors-experience-and-challenges-1360
https://atc.digitellinc.com/p/s/liver-transplantation-for-hepatocellular-carcinoma-novel-biomarkers-and-therapies-1365
https://atc.digitellinc.com/p/s/biomarkers-and-tissue-assays-for-predicting-aggressive-vs-nonaggressive-tumors-with-high-or-low-likelihood-of-recurrence-prepost-transplant-1370
https://atc.digitellinc.com/p/s/managing-hcc-patients-on-the-wait-list-is-there-consensus-1375
https://atc.digitellinc.com/p/s/post-transplant-strategies-to-avoid-recurrent-hcc-monitoring-and-modifying-therapy-1380
https://atc.digitellinc.com/p/s/non-hla-antibodies-in-transplantation-what-why-and-when-1385
https://atc.digitellinc.com/p/s/overview-of-non-hla-antigenic-targets-in-acute-rejection-and-chronic-alligraft-dysfunction-1390
https://atc.digitellinc.com/p/s/when-does-antibody-develop-1395
https://atc.digitellinc.com/p/s/why-do-we-care-1400
https://atc.digitellinc.com/p/s/novel-mechanisms-of-organ-graft-fibrosis-1405
https://atc.digitellinc.com/p/s/innate-immune-mechanisms-in-bronchiolitis-obliterans-1410
https://atc.digitellinc.com/p/s/new-insights-into-hepatic-fibrosis-1415
https://atc.digitellinc.com/p/s/fibrotic-mechanisms-in-the-kidney-1420
https://atc.digitellinc.com/p/s/optimizing-medical-adherence-an-ongoing-opportunity-to-improve-outcomes-after-solid-organ-transplantation-1425
https://atc.digitellinc.com/p/s/adherence-and-non-adherence-in-the-pediatric-solid-organ-transplant-recipient-definitions-classifications-and-outcome-measures-in-2012-1430
https://atc.digitellinc.com/p/s/virtual-communities-an-actual-tool-to-identify-and-address-non-adherence-1435
https://atc.digitellinc.com/p/s/the-new-frontier-in-electronic-patient-monitoring-1440
https://atc.digitellinc.com/p/s/overcoming-hurdles-to-transplantation-tolerance-1445
https://atc.digitellinc.com/p/s/consequences-of-ischemiareperfusion-injury-brain-death-and-senescence-on-tolerance-induction-1450
https://atc.digitellinc.com/p/s/genetic-barriers-to-tolerance-induction-1455
https://atc.digitellinc.com/p/s/prr-signaling-and-tolerance-induction-1460
https://atc.digitellinc.com/p/s/desensitization-state-of-the-art-1465
https://atc.digitellinc.com/p/s/the-role-of-eculizumab-in-desensitization-1470
https://atc.digitellinc.com/p/s/bortezomib-and-desensitization-not-recorded-1475
https://atc.digitellinc.com/p/s/desensitization-in-the-context-of-kidney-exchange-1480
https://atc.digitellinc.com/p/s/molecular-diagnostics-1485
https://atc.digitellinc.com/p/s/molecular-diagnostics-pro-1490
https://atc.digitellinc.com/p/s/molecular-diagnostics-con-1495
https://atc.digitellinc.com/p/s/molecular-diagnostics-pro-rebuttal-1500
https://atc.digitellinc.com/p/s/molecular-diagnostics-con-rebuttal-1505
https://atc.digitellinc.com/p/s/regulatory-environment-autonomy-vs-regulation-1510
https://atc.digitellinc.com/p/s/regulatory-environment-autonomy-vs-regulation-con-1515
https://atc.digitellinc.com/p/s/regulatory-environment-autonomy-vs-regulation-pro-1520
https://atc.digitellinc.com/p/s/regulatory-environment-autonomy-vs-regulation-pro-rebuttal-1525
https://atc.digitellinc.com/p/s/regulatory-environment-autonomy-vs-regulation-con-rebuttal-1530
https://atc.digitellinc.com/p/s/report-of-the-scientific-registry-of-tranplant-recipients-1535
https://atc.digitellinc.com/p/s/srtr-year-in-review-1540
https://atc.digitellinc.com/p/s/directions-in-liver-allocation-1545
https://atc.digitellinc.com/p/s/directions-in-reporting-center-specfic-results-1550
https://atc.digitellinc.com/p/s/allotransplants-cellular-transplants-organ-repair-and-xenotransplants-a-debate-about-the-future-of-organ-transplantation-1555
https://atc.digitellinc.com/p/s/next-generation-transplantation-ips-cells-for-tissue-engineering-1560
https://atc.digitellinc.com/p/s/xenotransplantation-of-hepatocyles-1565
https://atc.digitellinc.com/p/s/discussion-when-will-new-technologies-supplant-allotransplants-1570
https://atc.digitellinc.com/p/s/mtor-signaling-and-memory-t-cell-differentiation-1575
https://atc.digitellinc.com/p/s/the-role-of-mtor-in-memory-t-cell-differentiation-1580
https://atc.digitellinc.com/p/s/mtor-regulation-of-helper-t-cell-differentiation-1585
https://atc.digitellinc.com/p/s/mtor-regulation-of-homeostatic-proliferation-induced-memory-cd8-t-cells-1590
https://atc.digitellinc.com/p/s/protecting-the-kidney-after-liver-transplantation-1595
https://atc.digitellinc.com/p/s/perioperative-measures-to-preserve-kidney-function-1600
https://atc.digitellinc.com/p/s/is-chronic-kidney-disease-avoidable-1605
https://atc.digitellinc.com/p/s/kidney-injury-biomarkers-in-liver-transplantation-ready-for-prime-time-1610
https://atc.digitellinc.com/p/s/recent-fda-approved-immunosuppression-for-kidney-transplantation-and-new-agents-in-phase-iii-trials-1615
https://atc.digitellinc.com/p/s/everolimus-in-kidney-transplantation-1620
https://atc.digitellinc.com/p/s/belatacept-in-kidney-transplantation-1625
https://atc.digitellinc.com/p/s/update-on-tofacitinib-1630
https://atc.digitellinc.com/p/s/new-phase-iii-agents-in-development-for-kidney-transplantation-1635
https://atc.digitellinc.com/p/s/fda-session-meeting-the-challenges-of-drug-development-in-transplantation-1640
https://atc.digitellinc.com/p/s/orphan-drug-act-history-perspective-and-challenges-for-the-future-1645
https://atc.digitellinc.com/p/s/clinical-trial-design-from-superiority-to-non-inferiority-1650
https://atc.digitellinc.com/p/s/evolution-from-fixed-dosing-to-therapeutic-drug-monitoring-not-recorded-1655
https://atc.digitellinc.com/p/s/update-in-transplantation-from-the-division-of-transplant-and-ophthalmology-products-dtop-1660
https://atc.digitellinc.com/p/s/the-complexity-of-transplant-care-partnering-with-the-medical-community-1665
https://atc.digitellinc.com/p/s/pain-management-who-is-prescribing-1670
https://atc.digitellinc.com/p/s/fraction-prevention-and-t-scores-the-pill-box-1675
https://atc.digitellinc.com/p/s/promoting-health-literacy-to-improve-post-transplant-outcomes-1680
https://atc.digitellinc.com/p/s/advances-in-cellular-xenotransplantation-1685
https://atc.digitellinc.com/p/s/treatment-of-parkinsons-disease-in-monkeys-with-transplanted-pig-cells-not-recorded-1690
https://atc.digitellinc.com/p/s/transplantation-of-mesenchymal-stem-cells-from-genetically-engineered-swine-1695
https://atc.digitellinc.com/p/s/pancreatic-islet-xenotransplantation-1700
https://atc.digitellinc.com/p/s/advances-in-islet-transplantation-1705
https://atc.digitellinc.com/p/s/results-of-the-clinical-islet-transplantation-cit-consortium-1710
https://atc.digitellinc.com/p/s/progress-and-challenges-in-islet-transplantation-1715
https://atc.digitellinc.com/p/s/testing-of-novel-islet-transplantation-protocols-in-non-human-primates-1720
https://atc.digitellinc.com/p/s/maximizing-organ-donation-in-the-hispanic-community-1725
https://atc.digitellinc.com/p/s/the-current-state-of-organ-donation-in-the-hispanic-community-1730
https://atc.digitellinc.com/p/s/enhancing-cultural-competency-in-hispanic-organ-donation-1735
https://atc.digitellinc.com/p/s/increasing-organ-donation-and-enhancing-transplant-outcomes-in-the-hispanic-population-a-transplant-center-based-approach-1740
https://atc.digitellinc.com/p/s/protective-genes-and-transplant-ischemia-reperfusion-injury-1745
https://atc.digitellinc.com/p/s/protective-genes-in-liver-ischemiareperfusion-injury-1750
https://atc.digitellinc.com/p/s/cd39-and-purinergic-signaling-in-ischemia-reperfusion-injury-1755
https://atc.digitellinc.com/p/s/micrornas-in-tissue-injury-and-repair-1760
https://atc.digitellinc.com/p/s/they-supply-them-and-you-buy-them-where-are-we-with-transplant-tourism-1765
https://atc.digitellinc.com/p/s/where-is-it-today-1770
https://atc.digitellinc.com/p/s/sold-to-the-highest-bidder-1775
https://atc.digitellinc.com/p/s/sentenced-to-donation-1780
https://atc.digitellinc.com/p/s/clinico-pathological-conference-diagnostic-challenges-in-transplantation-1785
https://atc.digitellinc.com/p/s/case-1-a-kidney-transplant-patient-with-rising-serum-creatinine-bk-viremia-and-severe-tubulitis-at-allograft-biopsy-how-should-i-treat-this-patient-clinical-case-presentation-1790
https://atc.digitellinc.com/p/s/case-1-a-kidney-transplant-patient-with-rising-serum-creatinine-bk-viremia-and-severe-tubulitis-at-allograft-biopsy-how-should-i-treat-this-patient-diagnostician-discussion-monitoring-and-therapy-1795
https://atc.digitellinc.com/p/s/case-1-a-kidney-transplant-patient-with-rising-serum-creatinine-bk-viremia-and-severe-tubulitis-at-allograft-biopsy-how-should-i-treat-this-patient-diagnostician-discussion-pathology-slides-1800
https://atc.digitellinc.com/p/s/case-2-a-difficult-case-of-antibody-mediated-rejection-clinical-case-presentation-1805
https://atc.digitellinc.com/p/s/case-2-a-difficult-case-of-antibody-mediated-rejection-diagnostician-discussion-histocombatibility-1810
https://atc.digitellinc.com/p/s/case-2-a-difficult-case-of-antibody-mediated-rejection-diagnostician-discussion-pathlogy-1815
https://atc.digitellinc.com/p/s/case-3-rejection-or-accommodation-in-an-infant-after-heart-transplantation-clinical-case-presentation-1820
https://atc.digitellinc.com/p/s/case-3-rejection-or-accommodation-in-an-infant-after-heart-transplantation-diagnostician-discussion-histocombatibility-1825
https://atc.digitellinc.com/p/s/case-3-rejection-or-accommodation-in-an-infant-after-heart-transplantation-diagnostician-discussion-pathlogy-1830
https://atc.digitellinc.com/p/s/transplant-finance-avoiding-lost-opportunities-1835
https://atc.digitellinc.com/p/s/transplant-center-development-and-maximizing-revenue-streams-1840
https://atc.digitellinc.com/p/s/transplant-administrators-perspective-1845
https://atc.digitellinc.com/p/s/clinical-trials-and-transplant-finance-1850
https://atc.digitellinc.com/p/s/whats-hot-whats-new-1855
https://atc.digitellinc.com/p/s/clinical-1860
https://atc.digitellinc.com/p/s/basic-1865
https://atc.digitellinc.com/p/s/joint-plenary-session-i-1870
https://atc.digitellinc.com/p/s/a-phase-2-clinical-trial-of-donor-specific-tolerance-induction-in-recipients-of-hla-disparate-living-donor-kidney-allografts-by-donor-stem-cell-infusion-abstract-1-1875
https://atc.digitellinc.com/p/s/b-cell-derived-il-10-is-required-for-co-stimulatory-blockade-induced-tolerance-abstract-2-1880
https://atc.digitellinc.com/p/s/sotrastaurin-and-reduced-exposure-tacrolimus-prevents-acute-rejection-and-preserves-renal-function-after-de-novo-kidney-transplantation-6-month-results-abstract-3-1885
https://atc.digitellinc.com/p/s/discordant-serology-and-nucleic-acid-testing-nat-results-for-hiv-hbv-and-hcv-in-2010-abstract-4-1890
https://atc.digitellinc.com/p/s/everolimus-with-early-reduction-or-elimination-of-tacrolimus-in-719-de-novo-liver-transplant-recipients-12-month-efficacy-and-safety-results-from-h2304-study-abstract-5-1895
https://atc.digitellinc.com/p/s/joint-plenary-session-ii-1900
https://atc.digitellinc.com/p/s/effect-of-everolimus-based-immunosuppression-on-de-novo-heart-transplant-recipients-24-months-efficacy-and-safety-results-from-a2310-study-abstract-140-1905
https://atc.digitellinc.com/p/s/high-mfi-de-novo-mhc-class-ii-donor-specific-antibody-formation-impairs-patient-survival-after-liver-transplantation-abstract-141-1910
https://atc.digitellinc.com/p/s/expression-of-endothelial-indoleamine-23-dioxygenase-prevents-transplant-vasculopathy-abstract-142-1915
https://atc.digitellinc.com/p/s/joint-plenary-session-iii-1920
https://atc.digitellinc.com/p/s/high-pre-transplant-insulin-requirements-correlates-with-pancreas-failure-risk-in-spk-abstract-298-1925
https://atc.digitellinc.com/p/s/identification-of-alloreactive-macrophages-in-vivo-that-recognize-and-reject-allogeneic-non-self-abstract-299-1930
https://atc.digitellinc.com/p/s/joint-plenary-session-iv-1935
https://atc.digitellinc.com/p/s/2011-update-from-the-collaborative-islet-transplant-registry-citr-abstract-448-1940
https://atc.digitellinc.com/p/s/adoptive-immunotherapy-with-donor-derived-liver-natural-killer-cells-prevents-hcc-recurrence-after-liver-transplantation-in-recipients-exceeding-the-milan-criteria-abstract-449-1945
https://atc.digitellinc.com/p/s/reduced-cutaneous-squamous-cell-carcinoma-after-conversion-to-sirolimus-a-2-year-prospective-open-label-multicenter-trial-abstract-450-1950
https://atc.digitellinc.com/p/s/anti-il-1223-synergizes-with-costimulatory-blockade-to-suppress-intragraft-il-17-and-prolong-transplant-survival-in-mice-and-non-human-primates-abstract-451-1955
https://atc.digitellinc.com/p/s/cognate-antigen-is-necessary-and-sufficient-for-the-migration-of-effector-and-memory-t-cells-to-vascularized-allografts-abstract-452-1960
https://atc.digitellinc.com/p/s/modulation-of-il-10-specific-b-cell-micrornas-by-latent-membrane-protein-1-and-epstein-barr-virus-abstract-453-1965
https://atc.digitellinc.com/p/s/development-of-neoplasia-following-liver-lt-and-kidney-kt-transplantation-in-the-hiv-infected-recipient-abstract-454-1970
https://atc.digitellinc.com/p/s/disparities-in-provision-of-transplant-education-to-patients-with-end-stage-renal-disease-affect-access-to-kidney-transplant-abstract-455-1975
https://atc.digitellinc.com/p/s/waiting-list-functional-status-is-a-potent-predictor-of-mortality-among-adult-kidney-transplant-recipients-regardless-of-age-abstract-143-1980
https://atc.digitellinc.com/p/s/the-attenuation-of-national-kidney-transplant-volume-is-strongly-associated-with-center-performance-evaluations-abstract-300-1985
https://atc.digitellinc.com/p/s/panel-discussion-where-do-we-go-from-here-1990
https://atc.digitellinc.com/p/s/medical-care-of-the-kidney-transplant-recipient-breakout-1-physician-keeping-the-kidney-allograft-alive-2000
https://atc.digitellinc.com/p/s/medical-care-of-the-kidney-transplant-recipient-2005
https://atc.digitellinc.com/p/s/should-we-screen-for-common-cancers-post-transplant-2010
https://atc.digitellinc.com/p/s/post-transplantation-obesity-is-surgical-management-preferred-over-medical-therapy-2015
https://atc.digitellinc.com/p/s/post-transplant-hypertension-should-ace-inhibitors-be-the-treatment-of-choice-2020
https://atc.digitellinc.com/p/s/hyperuricemia-post-transplantation-should-everyone-be-treated-2025
https://atc.digitellinc.com/p/s/immunization-post-transplantation-what-is-necessary-and-what-is-safe-2030
https://atc.digitellinc.com/p/s/dsa-late-post-transplant-should-we-measure-it-and-do-we-need-to-treat-it-2035
https://atc.digitellinc.com/p/s/fsgs-how-to-prevent-and-manage-recurrence-post-transplantation-2040
https://atc.digitellinc.com/p/s/bk-monitoring-has-it-improved-post-transplant-graft-outcome-2045
https://atc.digitellinc.com/p/s/cni-toxicity-is-this-really-a-significant-cause-of-graft-loss-2050
https://atc.digitellinc.com/p/s/medical-care-of-the-kidney-transplant-recipient-breakout-2-allied-health-clinical-management-in-transplant-for-the-allied-health-professional-2055
https://atc.digitellinc.com/p/s/living-renal-donors-preoperative-evaluation-with-mri-2060
https://atc.digitellinc.com/p/s/diagnostic-labs-why-basic-labs-require-advanced-interpretation-in-transplant-patients-2065
https://atc.digitellinc.com/p/s/identifying-and-preventing-early-medication-errors-and-adverse-drug-events-in-transplant-recipients-2070
https://atc.digitellinc.com/p/s/transplant-dermatology-assessing-and-diagnosing-skin-cancers-post-transplant-2075
https://atc.digitellinc.com/p/s/medical-care-of-the-kidney-transplant-recipient-breakout-3-pharmacy-primary-care-issues-in-transplantation-what-makes-the-transplant-patient-unique-2080
https://atc.digitellinc.com/p/s/hyperlipidemia-best-practices-for-managing-the-transplant-recipients-cardiovascular-risk-2085
https://atc.digitellinc.com/p/s/diabetes-in-the-transplant-recipient-2090
https://atc.digitellinc.com/p/s/nutritional-supplements-and-vitamins-post-transplant-are-they-needed-or-safe-2095
https://atc.digitellinc.com/p/s/strategies-to-reduce-medications-cost-a-focus-on-the-purse-2100
https://atc.digitellinc.com/p/s/clinical-research-basics-and-beyond-research-using-secondary-data-not-as-simple-as-you-might-think-2105
https://atc.digitellinc.com/p/s/a-look-inside-the-srtr-data-2110
https://atc.digitellinc.com/p/s/usrds-and-medicare-claims-data-2115
https://atc.digitellinc.com/p/s/pharmacy-claims-and-other-novel-data-sources-2120
https://atc.digitellinc.com/p/s/statistical-pitfalls-in-transplant-registry-studies-2125
https://atc.digitellinc.com/p/s/designing-randomized-and-nonrandomized-human-subjects-studies-2130
https://atc.digitellinc.com/p/s/feasibility-recruitment-retention-and-logistics-2135
https://atc.digitellinc.com/p/s/getting-funding-for-human-subjects-research-2140
https://atc.digitellinc.com/p/s/getting-your-research-published-2145
https://atc.digitellinc.com/p/s/transplant-infectious-disease-an-overview-of-the-transplant-clinician-2150
https://atc.digitellinc.com/p/s/ebv-and-ptld-2155
https://atc.digitellinc.com/p/s/optimizing-pediatric-vaccination-2160
https://atc.digitellinc.com/p/s/the-impact-of-respiratory-viral-infections-in-lung-recipients-2165
https://atc.digitellinc.com/p/s/infection-control-and-solid-organ-transplantation-2170
https://atc.digitellinc.com/p/s/preparing-your-patient-for-transplantation-id-perspectives-2175
https://atc.digitellinc.com/p/s/gastrointestinal-infections-post-transplant-2180
https://atc.digitellinc.com/p/s/management-of-utis-in-transplant-patients-2185
https://atc.digitellinc.com/p/s/polyoma-infections-in-transplantation-bkvn-and-pml-2190
https://atc.digitellinc.com/p/s/basic-immunology-and-transplant-immunology-for-the-clinician-2195
https://atc.digitellinc.com/p/s/overview-what-does-an-immune-response-look-like-start-to-finish-2200
https://atc.digitellinc.com/p/s/ischemia-reperfusion-injury-clinical-impact-and-mechanisms-of-injury-2205
https://atc.digitellinc.com/p/s/innate-immunity-and-its-role-in-allograft-rejection-2210
https://atc.digitellinc.com/p/s/development-of-donor-reactive-t-cell-responses-2215
https://atc.digitellinc.com/p/s/cell-mediated-rejection-effector-mechanisms-injury-and-consequence-2220
https://atc.digitellinc.com/p/s/antibody-mediated-effector-mechanisms-and-rejection-2225
https://atc.digitellinc.com/p/s/memory-and-consequences-in-graft-outcome-2230
https://atc.digitellinc.com/p/s/cell-mediated-regulation-in-allograft-recipients-2235
https://atc.digitellinc.com/p/s/tolerance-strategies-go-into-the-patient-2240
https://atc.digitellinc.com/p/s/advanced-immunology-updates-for-basic-and-clinical-scientists-2245
https://atc.digitellinc.com/p/s/damps-2250
https://atc.digitellinc.com/p/s/functional-development-of-th1-2-9-and-17-2255
https://atc.digitellinc.com/p/s/update-on-tregs-2260
https://atc.digitellinc.com/p/s/update-on-b-cell-populations-and-activation-2265
https://atc.digitellinc.com/p/s/update-on-positive-and-negative-costimulatory-pathways-2270
https://atc.digitellinc.com/p/s/update-on-t-cell-signaling-pathways-and-new-intracellular-targets-for-drugs-in-transplantation-2275
https://atc.digitellinc.com/p/s/kidney-paired-donation-2280
https://atc.digitellinc.com/p/s/update-on-the-unos-kpd-program-2285
https://atc.digitellinc.com/p/s/findings-from-a-national-consensus-conference-2290
https://atc.digitellinc.com/p/s/evolution-of-a-single-center-kpd-program-2295
https://atc.digitellinc.com/p/s/progress-towards-a-financial-model-for-kpd-2300
https://atc.digitellinc.com/p/s/development-of-validated-lab-protocols-in-the-ctot-2305
https://atc.digitellinc.com/p/s/introduction-2310
https://atc.digitellinc.com/p/s/hla-ab-monitoring-2315
https://atc.digitellinc.com/p/s/digital-image-analysiscross-validation-of-pathology-2320
https://atc.digitellinc.com/p/s/flow-cytometry-2325
https://atc.digitellinc.com/p/s/q-rtpcr-analysis-of-urine-and-blood-2330
https://atc.digitellinc.com/p/s/personalized-immunosuppression-in-liver-transplant-recipients-2335
https://atc.digitellinc.com/p/s/the-past-present-and-future-of-immunosuppression-in-liver-transplantation-2340
https://atc.digitellinc.com/p/s/tailoring-immunosuppressive-strategies-to-minimize-liver-transplant-complications-2345
https://atc.digitellinc.com/p/s/identifying-candidates-for-immunosuppression-minimization-or-withdrawal-closing-in-on-tolerance-2350
https://atc.digitellinc.com/p/s/bench-to-the-bedside-epstein-barr-virus-2355
https://atc.digitellinc.com/p/s/pathogenesis-of-ptld-2360
https://atc.digitellinc.com/p/s/novel-biomarkers-to-predict-ptld-beyond-viral-load-2365
https://atc.digitellinc.com/p/s/state-of-the-art-therapy-for-ptld-2370
https://atc.digitellinc.com/p/s/apol1myh9-in-kidney-transplantation-2375
https://atc.digitellinc.com/p/s/apol1-and-myh9-associated-end-stage-renal-disease-in-african-americans-2380
https://atc.digitellinc.com/p/s/apol1-gene-variants-in-african-american-kidney-transplant-recipients-and-the-impact-on-kidney-transplant-outcomes-2385
https://atc.digitellinc.com/p/s/apol1-gene-variants-in-african-american-kidney-donors-2390
https://atc.digitellinc.com/p/s/cultural-competency-in-transplantation-2395
https://atc.digitellinc.com/p/s/community-based-approach-mottep-results-in-african-americans-hispanic-americans-and-asians-2400
https://atc.digitellinc.com/p/s/transplant-center-based-approach-northwestern-experience-in-hispanic-americans-2405
https://atc.digitellinc.com/p/s/cultural-competency-clinical-2410
https://atc.digitellinc.com/p/s/heart-donor-trends-new-revelations-2415
https://atc.digitellinc.com/p/s/selection-of-donor-hearts-does-a-marginal-heart-exist-2420
https://atc.digitellinc.com/p/s/hormonal-therapy-in-thoracic-organ-transplantation-does-it-work-2425
https://atc.digitellinc.com/p/s/use-of-the-transmedics-heart-in-a-box-for-donor-transport-a-new-beginning-2430
https://atc.digitellinc.com/p/s/cellular-xenotransplantation-2435
https://atc.digitellinc.com/p/s/minimizing-immunosuppression-in-preclinical-islet-xenotransplantation-2440
https://atc.digitellinc.com/p/s/xenotransplantation-of-encapsulated-hepatocytes-2445
https://atc.digitellinc.com/p/s/local-immunosuppression-for-protection-of-intracerebral-neural-cell-xenotransplants-2450
https://atc.digitellinc.com/p/s/sunday-plenary-session-2455
https://atc.digitellinc.com/p/s/complement-fixing-hla-antibodies-predict-outcome-in-hla-incompatible-renal-transplantation-2460
https://atc.digitellinc.com/p/s/donor-specific-hla-antibodies-prediction-of-pancreas-graft-outcome-2465
https://atc.digitellinc.com/p/s/immune-tolerance-across-a-full-mhc-barrier-in-a-swine-hind-limb-transplantation-model-using-a-combined-co-stimulatory-blockade-and-donor-bone-marrow-cells-approach-2470
https://atc.digitellinc.com/p/s/anti-tim-4-mediates-long-term-engraftment-of-islet-allografts-by-promoting-il-10-expression-by-tim-1-plus-bregs-and-inhibiting-ifngamma-expression-by-proinflammatory-be1-b-cells-2475
https://atc.digitellinc.com/p/s/a-high-rate-of-ervr-with-protease-inhibitor-triple-hcv-therapy-in-liver-transplant-recipients-a-multicenter-study-from-crush-c-2480
https://atc.digitellinc.com/p/s/ast-lifetime-achievement-award-2485
https://atc.digitellinc.com/p/s/asts-lifetime-achievement-award-2490
https://atc.digitellinc.com/p/s/toward-a-genetic-theory-of-infectious-diseases-2495
https://atc.digitellinc.com/p/s/recognition-of-self-dna-as-an-instigator-of-tissue-pathology-2500
https://atc.digitellinc.com/p/s/tlr9-signaling-by-mitochondrial-dna-mediates-myocarditis-and-heart-failure-2505
https://atc.digitellinc.com/p/s/fatal-inflammation-through-tlr9-signaling-2510
https://atc.digitellinc.com/p/s/sensing-tissue-damage-and-ischemia-through-toll-like-receptors-2515
https://atc.digitellinc.com/p/s/transcription-factors-in-the-development-of-tolerance-2520
https://atc.digitellinc.com/p/s/sirtuin-regulation-of-peripheral-t-cell-tolerance-2525
https://atc.digitellinc.com/p/s/c3a-receptor-and-c5a-receptor-signaling-modulate-regulatory-t-cell-induction-function-and-stability-2530
https://atc.digitellinc.com/p/s/novel-mechanisms-controlling-treg-function-and-stability-2535
https://atc.digitellinc.com/p/s/successful-approaches-to-expanding-live-donation-2540
https://atc.digitellinc.com/p/s/the-house-calls-trial-2545
https://atc.digitellinc.com/p/s/exploring-transplant-expanding-live-donor-transplantation-through-education-2550
https://atc.digitellinc.com/p/s/the-live-donor-champion-program-separating-the-patient-from-the-advocate-2555
https://atc.digitellinc.com/p/s/update-on-kidney-paired-donation-as-expansion-of-live-donor-transplantation-2560
https://atc.digitellinc.com/p/s/how-i-do-it-technical-challenges-in-liver-transplantation-2565
https://atc.digitellinc.com/p/s/techniques-in-reoperative-liver-transplantation-2570
https://atc.digitellinc.com/p/s/techniques-in-vascular-reconstruction-2575
https://atc.digitellinc.com/p/s/complex-biliary-reconstructions-in-liver-transplantation-2580
https://atc.digitellinc.com/p/s/improving-deceased-donor-kidney-allocation-2585
https://atc.digitellinc.com/p/s/an-update-on-the-unos-kidney-allocation-policy-proposal-2590
https://atc.digitellinc.com/p/s/an-equity-based-approach-to-kidney-allocation-2595
https://atc.digitellinc.com/p/s/gaining-extra-life-years-through-kidney-allocation-2600
https://atc.digitellinc.com/p/s/advances-in-costimulation-targeting-in-transplantation-from-the-bench-to-the-clinic-2605
https://atc.digitellinc.com/p/s/blocking-costimulatory-signals-2610
https://atc.digitellinc.com/p/s/enhancing-inhibitory-signals-2615
https://atc.digitellinc.com/p/s/promises-and-challenges-of-costimulation-targeting-in-the-clinic-2620
https://atc.digitellinc.com/p/s/bench-to-the-bedside-cytomegalovirus-2625
https://atc.digitellinc.com/p/s/cmv-immunology-evasion-and-latency-2630
https://atc.digitellinc.com/p/s/immunologic-tools-to-predict-cmv-risk-2635
https://atc.digitellinc.com/p/s/novel-prevention-and-treatment-strategies-for-cmv-2640
https://atc.digitellinc.com/p/s/cardiovascular-disease-in-transplant-recipients-selection-management-and-risk-reduction-2645
https://atc.digitellinc.com/p/s/cardiovascular-assessment-of-patients-prior-to-transplant-2650
https://atc.digitellinc.com/p/s/post-transplant-follow-up-and-management-of-patients-with-cardiac-disease-2655
https://atc.digitellinc.com/p/s/exercise-intervention-to-improve-cardiovascular-health-2660
https://atc.digitellinc.com/p/s/advances-in-cardiac-transplantation-2665
https://atc.digitellinc.com/p/s/advances-in-cardiothoracic-transplantation-tolerance-induction-2670
https://atc.digitellinc.com/p/s/genomic-and-proteomic-biomarkers-in-cardiac-transplantation-2675
https://atc.digitellinc.com/p/s/advances-in-immunosuppression-after-cardiac-transplantation-2680
https://atc.digitellinc.com/p/s/part-1-fundamental-concepts-of-transplantation-2685
https://atc.digitellinc.com/p/s/old-school-my-heroes-in-solid-organ-transplantation-2690
https://atc.digitellinc.com/p/s/immunosuppression-how-it-works-why-we-need-it-and-when-we-wont-2695
https://atc.digitellinc.com/p/s/liver-transplantation-big-operations-big-wins-2700
https://atc.digitellinc.com/p/s/kidney-transplantation-antibodies-are-barriers-or-are-they-2705
https://atc.digitellinc.com/p/s/thoracic-transplantation-the-vital-side-of-the-diaphragm-2710
https://atc.digitellinc.com/p/s/transplant-id-a-journey-through-bizarre-transplant-infections-2715
https://atc.digitellinc.com/p/s/live-donation-perspective-of-a-donorphysician-2720
https://atc.digitellinc.com/p/s/basic-science-research-lessons-from-the-laboratory-2725
https://atc.digitellinc.com/p/s/clinical-research-the-whole-field-is-your-laboratory-2730
https://atc.digitellinc.com/p/s/transplantation-in-depth-clinical-2735
https://atc.digitellinc.com/p/s/liver-transplantation-at-asan-medical-center-2740
https://atc.digitellinc.com/p/s/liver-transplantation-in-japan-2745
https://atc.digitellinc.com/p/s/liver-transplantation-in-hong-kong-2750
https://atc.digitellinc.com/p/s/allied-health-symposium-i-living-donation-practice-guidelines-for-the-advanced-transplant-practitioner-2755
https://atc.digitellinc.com/p/s/donor-consent-what-do-potential-living-donors-want-and-need-to-know-2760
https://atc.digitellinc.com/p/s/the-living-donor-evaluation-optimal-assessment-for-improved-outcomes-2765
https://atc.digitellinc.com/p/s/expanding-the-criteria-for-living-donors-what-are-the-limits-2770
https://atc.digitellinc.com/p/s/the-impact-of-patient-education-on-outcomes-after-living-donor-transplant-2775
https://atc.digitellinc.com/p/s/maximizing-live-donation-an-algorithm-for-program-process-improvement-2780
https://atc.digitellinc.com/p/s/kidney-exchange-an-economists-perspective-2785
https://atc.digitellinc.com/p/s/nk-cell-and-nk-t-cell-mediated-inflammation-2790
https://atc.digitellinc.com/p/s/nk-cell-memory-2795
https://atc.digitellinc.com/p/s/inkt-cell-activation-by-self-lipids-generated-during-microbial-infections-2800
https://atc.digitellinc.com/p/s/emerging-topics-in-nk-cell-biology-2805
https://atc.digitellinc.com/p/s/notch-directed-t-cell-development-2810
https://atc.digitellinc.com/p/s/notch-activation-and-th-cell-subset-differentiation-2815
https://atc.digitellinc.com/p/s/tor-notch-interactions-during-thymocyte-differentiation-2820
https://atc.digitellinc.com/p/s/notch-signaling-in-alloimmune-responses-2825
https://atc.digitellinc.com/p/s/growing-up-too-fast-strategies-for-transitioning-adolescents-to-adult-transplant-care-2830
https://atc.digitellinc.com/p/s/continuity-of-care-from-adolescent-to-adult-programs-strategies-to-overcome-the-challenges-in-transition-2835
https://atc.digitellinc.com/p/s/resource-utilization-during-the-transfertransition-process-to-adult-care-2840
https://atc.digitellinc.com/p/s/assessing-transition-the-development-of-the-unc-trxansition-scale-2845
https://atc.digitellinc.com/p/s/treatment-of-antibody-mediated-rejection-2850
https://atc.digitellinc.com/p/s/dominant-role-of-amr-in-kidney-transplant-failure-2855
https://atc.digitellinc.com/p/s/the-role-for-plasmapheresis-in-treatment-of-amr-2860
https://atc.digitellinc.com/p/s/the-role-for-complement-inhibition-in-treatment-of-amr-2865
https://atc.digitellinc.com/p/s/subclinical-amr-2870
https://atc.digitellinc.com/p/s/omics-and-transplantation-how-new-technologies-may-improve-outcomes-in-the-clinic-2875
https://atc.digitellinc.com/p/s/metabolomics-in-transplant-2880
https://atc.digitellinc.com/p/s/proteogenomic-profiling-and-chronic-allograft-nephropathy-2885
https://atc.digitellinc.com/p/s/pharmacogenomics-from-research-to-the-clinic-2890
https://atc.digitellinc.com/p/s/update-on-tuberculosis-in-transplant-recipients-and-candidates-2895
https://atc.digitellinc.com/p/s/interferon-g-release-assays-igras-and-other-immune-assays-for-tb-in-transplant-patients-2900
https://atc.digitellinc.com/p/s/novel-therapies-and-the-role-of-vitamin-d-in-tuberculosis-2905
https://atc.digitellinc.com/p/s/update-on-management-of-tuberculosis-in-transplant-recipients-and-candidates-2910
https://atc.digitellinc.com/p/s/incentives-for-donors-beyond-pro-and-con-2915
https://atc.digitellinc.com/p/s/a-framework-for-discussing-incentives-for-donors-2920
https://atc.digitellinc.com/p/s/pro-argument-2925
https://atc.digitellinc.com/p/s/con-argument-2930
https://atc.digitellinc.com/p/s/improving-transplant-outcomes-through-teaching-and-technology-2935
https://atc.digitellinc.com/p/s/health-literacy-the-impact-of-patient-education-on-outcomes-2940
https://atc.digitellinc.com/p/s/text4health-texting-as-a-strategy-to-improve-outcomes-post-transplant-2945
https://atc.digitellinc.com/p/s/is-there-an-app-for-that-designing-and-implementing-apps-to-improve-patient-outcomes-2950
https://atc.digitellinc.com/p/s/maximizing-outcomes-from-dcd-livers-2955
https://atc.digitellinc.com/p/s/whom-if-anyone-might-benefit-from-a-dcd-liver-transplant-2960
https://atc.digitellinc.com/p/s/which-dcd-livers-should-be-used-and-how-can-they-be-optimized-2965
https://atc.digitellinc.com/p/s/is-anyone-in-the-world-doing-better-using-dcd-livers-2970
https://atc.digitellinc.com/p/s/monday-plenary-session-2975
https://atc.digitellinc.com/p/s/blocking-c3ac5a-receptor-signaling-promotes-induction-and-stability-of-murine-and-human-alloreactive-regulatory-t-cells-2980
https://atc.digitellinc.com/p/s/results-of-a-phase-2-safety-efficacy-and-pharmacokinetic-study-of-tol-101-an-anti-tcr-monoclonal-antibody-for-the-prophylaxis-of-acute-rejection-in-kidney-transplantation-2985
https://atc.digitellinc.com/p/s/prolonged-cold-ischemia-increases-the-early-infiltration-and-effector-functions-of-memory-cd8-t-lymphocytes-in-cardiac-allografts-2990
https://atc.digitellinc.com/p/s/a-common-rejection-module-crm-across-multiple-transplant-organs-identifies-novel-therapeutics-for-treatment-of-acute-rejection-in-solid-organ-transplantation-2995
https://atc.digitellinc.com/p/s/ast-awards-3000
https://atc.digitellinc.com/p/s/ast-presidential-address-3005
https://atc.digitellinc.com/p/s/the-future-of-transplantation-personalized-medicine-for-the-organ-3010
https://atc.digitellinc.com/p/s/losing-control-of-cd8-t-cell-tolerance-3015
https://atc.digitellinc.com/p/s/molecular-signal-directing-cd8-t-cells-to-exhaustion-3020
https://atc.digitellinc.com/p/s/losing-control-of-cd8-plus-t-cells-are-cytokines-the-key-3025
https://atc.digitellinc.com/p/s/mechanisms-regulating-fate-commitment-and-plasticity-of-self-tolerant-cd8-t-cells-3030
https://atc.digitellinc.com/p/s/how-i-do-it-technical-challenges-in-kidney-and-pancreas-transplantation-3035
https://atc.digitellinc.com/p/s/how-many-kidneys-can-fit-into-an-abdomen-techniques-in-reoperative-kidney-transplantation-3040
https://atc.digitellinc.com/p/s/difficult-ureters-and-bladders-advanced-techniques-to-obtain-urinary-drainage-in-kidney-transplantation-3045
https://atc.digitellinc.com/p/s/technical-challenges-in-pancreas-transplantation-3050
https://atc.digitellinc.com/p/s/long-term-risks-after-living-kidney-donation-3055
https://atc.digitellinc.com/p/s/lessons-from-secondary-data-3060
https://atc.digitellinc.com/p/s/lessons-from-the-donor-donor-nephrectomy-outcomes-research-network-3065
https://atc.digitellinc.com/p/s/update-on-relive-renal-and-lung-living-donors-evaluation-robert-gaston-3070
https://atc.digitellinc.com/p/s/update-on-altold-3075
https://atc.digitellinc.com/p/s/focused-studies-of-risk-in-african-american-donors-3080
https://atc.digitellinc.com/p/s/treatment-of-diabetes-with-transplantation-3085
https://atc.digitellinc.com/p/s/state-of-the-art-medical-treatment-for-diabetes-3090
https://atc.digitellinc.com/p/s/current-status-of-islet-cell-transplantation-for-diabetes-3095
https://atc.digitellinc.com/p/s/current-status-of-whole-organ-pancreas-transplant-for-diabetes-3100
https://atc.digitellinc.com/p/s/update-on-hepatitis-c-in-transplantation-3105
https://atc.digitellinc.com/p/s/treatment-of-hepatitis-c-in-the-pre-transplant-setting-3110
https://atc.digitellinc.com/p/s/treatment-of-hepatitis-c-in-the-post-transplant-setting-3115
https://atc.digitellinc.com/p/s/new-agents-for-hepatitis-c-the-potential-for-non-interferon-approaches-3120
https://atc.digitellinc.com/p/s/srtr-allocation-and-program-specific-reports-3125
https://atc.digitellinc.com/p/s/whats-new-in-organ-specific-allocation-3130
https://atc.digitellinc.com/p/s/addressing-geographic-disparities-in-organ-availability-3135
https://atc.digitellinc.com/p/s/limitations-of-the-program-specific-reports-3140
https://atc.digitellinc.com/p/s/how-to-systematically-and-objectively-quantify-post-transplant-risk-a-centers-experience-3145
https://atc.digitellinc.com/p/s/autophagy-new-insights-into-an-old-pathway-3150
https://atc.digitellinc.com/p/s/autophagy-in-the-kidney-in-normal-physiology-and-under-stress-3155
https://atc.digitellinc.com/p/s/autophagy-in-the-liver-fueling-tissue-fibrogenesis-and-metabolic-stress-3160
https://atc.digitellinc.com/p/s/autophagy-in-immune-cells-its-role-in-tolerance-3165
https://atc.digitellinc.com/p/s/vca-clinical-experience-update-3170
https://atc.digitellinc.com/p/s/immunology-and-optimizing-immunosuppression-for-vca-3175
https://atc.digitellinc.com/p/s/patient-selection-when-is-the-right-time-for-vca-3180
https://atc.digitellinc.com/p/s/role-of-the-initial-injury-in-vca-outcomes-3185
https://atc.digitellinc.com/p/s/mechanical-circulatory-support-in-thoracic-transplantation-update-and-controversies-3190
https://atc.digitellinc.com/p/s/machine-or-biology-what-device-for-which-patient-with-a-failing-heart-3195
https://atc.digitellinc.com/p/s/management-of-right-heart-failure-after-vad-implantation-3200
https://atc.digitellinc.com/p/s/early-experience-with-the-total-artificial-heart-indications-and-outcomes-3205
https://atc.digitellinc.com/p/s/transplantation-in-depth-basic-science-bone-marrow-transplantation-niches-and-regulation-3210
https://atc.digitellinc.com/p/s/hematopoietic-stem-cell-niches-in-bone-marrow-3215
https://atc.digitellinc.com/p/s/strategies-to-promote-immune-reconstitution-following-bmtx-3220
https://atc.digitellinc.com/p/s/microbiota-regulation-of-inflammation-following-bmtx-3225
https://atc.digitellinc.com/p/s/bone-marrow-induced-microchimerism-and-donor-tolerance-3230
https://atc.digitellinc.com/p/s/bone-marrow-transplant-to-promote-solid-organ-transplantation-3235
https://atc.digitellinc.com/p/s/incorporation-of-facilitating-cells-into-hsc-regimens-to-promote-tolerance-in-transplant-patients-3240
https://atc.digitellinc.com/p/s/new-challengesnew-opportunities-3245
https://atc.digitellinc.com/p/s/controversies-in-pediatric-end-of-life-decision-making-3250
https://atc.digitellinc.com/p/s/cni-minimization-or-steroid-minimization-which-is-optimal-for-children-3255
https://atc.digitellinc.com/p/s/first-dsa-now-what-non-hla-antibodies-in-pediatric-solid-organ-transplantation-3260
https://atc.digitellinc.com/p/s/new-long-term-complications-in-pediatric-transplantation-3265
https://atc.digitellinc.com/p/s/resistant-organisms-3270
https://atc.digitellinc.com/p/s/metabolic-syndrome-3275
https://atc.digitellinc.com/p/s/bone-disease-3280
https://atc.digitellinc.com/p/s/allied-health-symposium-ii-improving-your-practice-clinical-updates-for-transplant-coordinators-and-mid-level-practitioners-3285
https://atc.digitellinc.com/p/s/immunosuppression-in-with-the-new-out-with-the-old-3290
https://atc.digitellinc.com/p/s/transplant-infectious-diseases-surveillance-treatment-and-outcomes-3295
https://atc.digitellinc.com/p/s/hypertension-best-practices-for-management-post-transplant-3300
https://atc.digitellinc.com/p/s/substance-use-in-the-transplant-recipient-3305
https://atc.digitellinc.com/p/s/primary-prevention-screening-protocols-for-transplant-recipients-3310
https://atc.digitellinc.com/p/s/transplantation-across-the-age-spectrum-prediction-and-intervention-3315
https://atc.digitellinc.com/p/s/frailty-in-kidney-transplantation-3320
https://atc.digitellinc.com/p/s/sarcopenia-3325
https://atc.digitellinc.com/p/s/rehabilitation-and-prehabilitation-in-transplantation-3330
https://atc.digitellinc.com/p/s/dealing-with-de-novo-donor-specific-hla-antibodies-3335
https://atc.digitellinc.com/p/s/dsa-and-transplant-outcomes-3340
https://atc.digitellinc.com/p/s/pathology-associated-with-posttransplant-antibodies-3345
https://atc.digitellinc.com/p/s/how-would-we-treat-asymptomatic-patients-having-dsa-3350
https://atc.digitellinc.com/p/s/danger-will-robinson-laparoscopic-and-robotic-kidney-transplantation-3355
https://atc.digitellinc.com/p/s/minimally-invasive-open-surgery-for-kidney-recipient-3360
https://atc.digitellinc.com/p/s/laparoscopic-kidney-transplantation-3365
https://atc.digitellinc.com/p/s/robotic-assisted-kidney-and-pancreas-transplantation-3370
https://atc.digitellinc.com/p/s/molecular-and-cellular-biomarkers-of-clinical-transplant-tolerance-3375
https://atc.digitellinc.com/p/s/a-need-for-biomarkers-of-operational-tolerance-in-liver-and-kidney-transplantation-3380
https://atc.digitellinc.com/p/s/discovering-validating-and-prioritizing-biomarkers-of-tolerance-3385
https://atc.digitellinc.com/p/s/functional-assessment-for-clinical-transplant-tolerance-3390
https://atc.digitellinc.com/p/s/lung-transplantation-clinical-practice-considerations-3395
https://atc.digitellinc.com/p/s/re-evaluation-of-donor-criteria-myth-vs-reality-3400
https://atc.digitellinc.com/p/s/early-mechanical-support-vs-maximal-pharmacological-therapy-for-right-ventricular-support-after-lung-transplant-3405
https://atc.digitellinc.com/p/s/the-role-of-de-novo-donor-specific-antibody-post-lung-transplant-3410
https://atc.digitellinc.com/p/s/puberty-through-pregnancy-after-transplant-clinical-and-ethical-considerations-3415
https://atc.digitellinc.com/p/s/optimal-family-planning-post-transplant-3420
https://atc.digitellinc.com/p/s/transplant-and-puberty-discussing-the-birds-and-the-bees-with-adolescent-transplant-recipients-3425
https://atc.digitellinc.com/p/s/pregnancy-as-an-endpoint-of-quality-ethical-considerations-in-family-planning-after-transplantation-3430
https://atc.digitellinc.com/p/s/the-pediatric-immune-system-and-transplantation-obstacle-or-opportunity-3435
https://atc.digitellinc.com/p/s/the-developing-immune-system-a-target-for-tolerance-3440
https://atc.digitellinc.com/p/s/personalized-immunosuppression-dream-or-reality-3445
https://atc.digitellinc.com/p/s/bad-to-be-nave-minimizing-risk-for-infections-in-pediatric-transplantation-3450
https://atc.digitellinc.com/p/s/apps-web-and-wifi-pill-bottles-emerging-technologies-in-transplantation-3455
https://atc.digitellinc.com/p/s/emerging-technologies-in-transplantation-apps-3460
https://atc.digitellinc.com/p/s/emerging-technologies-in-transplantation-web-3465
https://atc.digitellinc.com/p/s/novel-strategies-to-improve-behavioral-health-after-transplant-using-wireless-technology-3470
https://atc.digitellinc.com/p/s/tuesday-plenary-3475
https://atc.digitellinc.com/p/s/a-multi-center-international-registry-of-cardiac-transplantation-for-light-chain-al-and-transthyreitin-ttr-amyloidosis-3480
https://atc.digitellinc.com/p/s/the-protect-study-35-months-of-everolimus-monotherapy-vs-calcineurin-inhibitor-based-therapy-showed-to-be-a-safe-alternative-with-superior-renal-function-in-liver-transplant-recipients-3485
https://atc.digitellinc.com/p/s/pd-1-analysis-on-cd28-cd27sup-cd4-t-cells-allows-rapid-stimulation-independent-assessment-of-cmv-viremic-episodes-in-transplant-recipients-3490
https://atc.digitellinc.com/p/s/asts-awards-3495
https://atc.digitellinc.com/p/s/asts-presidential-address-3500
https://atc.digitellinc.com/p/s/controversies-in-transplantation-basic-establishingchimerismfor-transplant-tolerance-necessary-practical-3505
https://atc.digitellinc.com/p/s/establishing-chimerism-for-transplant-tolerance-necessary-practical-pro-3510
https://atc.digitellinc.com/p/s/establishing-chimerism-for-transplant-tolerance-necessary-practical-con-3515
https://atc.digitellinc.com/p/s/clinical-broader-follow-up-of-living-kidney-donors-by-theoptnis-feasible-and-scientifically-justified-debate-3520
https://atc.digitellinc.com/p/s/broader-follow-up-of-living-kidney-donors-by-the-optn-is-feasible-and-scientifically-justified-pro-3525
https://atc.digitellinc.com/p/s/broader-follow-up-of-living-kidney-donors-by-the-optn-is-feasible-and-scientifically-justified-con-3530
https://atc.digitellinc.com/p/s/alarmins-3535
https://atc.digitellinc.com/p/s/il-33-regulation-in-pulmonary-inflammation-3540
https://atc.digitellinc.com/p/s/endothelial-alarmins-and-allograft-rejection-3545
https://atc.digitellinc.com/p/s/inflammasome-networks-at-innate-adaptive-immune-interface-3550
https://atc.digitellinc.com/p/s/leukocyte-trafficking-to-inflammatory-sites-3555
https://atc.digitellinc.com/p/s/leukocyte-arrest-and-diapedesis-3560
https://atc.digitellinc.com/p/s/differential-trafficking-of-th1-vs-th17-cells-3565
https://atc.digitellinc.com/p/s/imaging-of-trafficking-3570
https://atc.digitellinc.com/p/s/ethical-issues-in-living-donation-3575
https://atc.digitellinc.com/p/s/what-obligations-do-we-have-to-living-donors-3580
https://atc.digitellinc.com/p/s/is-it-possible-to-be-a-truly-atruistic-donor-3585
https://atc.digitellinc.com/p/s/is-there-an-amount-of-benefit-that-balances-a-donor-death-3590
https://atc.digitellinc.com/p/s/simultaneous-liver-kidney-transplantation-stealing-or-saving-3595
https://atc.digitellinc.com/p/s/acute-and-chronic-kidney-disease-in-cirrhotic-patients-3600
https://atc.digitellinc.com/p/s/selection-of-appropriate-candidates-for-slk-biopsies-biomarkers-criteria-and-beyond-3605
https://atc.digitellinc.com/p/s/outcomes-following-simultaneous-liver-kidney-transplantation-vs-liver-transplant-alone-3610
https://atc.digitellinc.com/p/s/debate-relevance-of-donor-specific-antibodies-in-liver-transplantation-3615
https://atc.digitellinc.com/p/s/summary-of-humoral-immunity-testing-in-transplantation-3620
https://atc.digitellinc.com/p/s/pro-donor-specific-antibodies-are-important-and-should-be-performed-in-liver-transplant-recipients-3625
https://atc.digitellinc.com/p/s/con-donor-specific-antibodies-are-irrelevant-in-liver-transplant-recipients-3630
https://atc.digitellinc.com/p/s/social-media-and-organ-donation-3635
https://atc.digitellinc.com/p/s/social-media-and-organ-donation-the-facebook-experience-3640
https://atc.digitellinc.com/p/s/the-facebook-experience-3645
https://atc.digitellinc.com/p/s/the-donate-life-experience-3650
https://atc.digitellinc.com/p/s/transplantation-and-management-of-the-sensitized-patient-risk-and-reward-3655
https://atc.digitellinc.com/p/s/desensitization-what-have-we-learned-3660
https://atc.digitellinc.com/p/s/desensitization-therapies-in-patients-awaiting-kidney-transplantation-3665
https://atc.digitellinc.com/p/s/prophylactic-therapies-in-sensitized-patients-after-kidney-transplantation-3670
https://atc.digitellinc.com/p/s/approach-to-the-sensitized-patient-awaiting-heart-transplantation-impact-of-the-c1q-assay-3675
https://atc.digitellinc.com/p/s/assays-to-detect-circulating-antibodies-including-the-c1q-assay-3680
https://atc.digitellinc.com/p/s/clinical-approach-to-circulating-antibodies-why-are-they-bad-when-to-treat-and-use-of-the-virtual-crossmatch-3685
https://atc.digitellinc.com/p/s/treatment-options-for-the-sensitized-patient-3690
https://atc.digitellinc.com/p/s/advances-in-lung-transplantation-3695
https://atc.digitellinc.com/p/s/genomics-and-lung-transplantation-3700
https://atc.digitellinc.com/p/s/mechanical-bridging-to-lung-transplantation-3705
https://atc.digitellinc.com/p/s/advances-in-immunosuppression-after-lung-transplantation-3710
https://atc.digitellinc.com/p/s/utilization-of-deceased-donor-kidneys-3715
https://atc.digitellinc.com/p/s/the-us-experience-of-utilization-with-a-focus-upon-analysis-of-discarded-kidneys-3720
https://atc.digitellinc.com/p/s/the-european-experience-of-utilization-focusing-upon-biopsies-for-evaluating-kidney-quality-3725
https://atc.digitellinc.com/p/s/srtr-recommendations-for-prospective-study-3730
https://atc.digitellinc.com/p/s/allied-health-symposium-iii-they-have-survived-whats-next-adding-quality-to-survival-3735
https://atc.digitellinc.com/p/s/the-importance-of-assessing-quality-of-life-in-outcomes-research-3740
https://atc.digitellinc.com/p/s/mental-health-and-quality-of-life-3745
https://atc.digitellinc.com/p/s/caregiver-burden-in-organ-transplantation-3750
https://atc.digitellinc.com/p/s/facilitating-out-patient-care-in-a-tx-program-3755
https://atc.digitellinc.com/p/s/developing-the-transplant-pharmacy-practice-model-to-ensure-quality-in-multidisciplinary-patient-management-3760
https://atc.digitellinc.com/p/s/developments-in-lung-allocation-policy-lessons-learned-3765
https://atc.digitellinc.com/p/s/lung-transplant-allocation-the-european-experience-ishlt-3770
https://atc.digitellinc.com/p/s/lung-transplantation-in-the-us-current-and-emerging-allocation-3775
https://atc.digitellinc.com/p/s/the-marginal-lung-donor-novel-approaches-to-increasing-the-donor-3780
https://atc.digitellinc.com/p/s/ex-vivo-lung-perfusion-evlp-can-it-level-the-field-ishlt-3785
https://atc.digitellinc.com/p/s/a-change-of-heart-the-evolution-of-heart-allocation-policy-3790
https://atc.digitellinc.com/p/s/the-unos-2006-allocation-algorithm-for-donor-hearts-a-five-year-perspective-ast-3795
https://atc.digitellinc.com/p/s/the-eurotransplant-heart-allocation-policy-a-case-for-urgency-ishlt-3800
https://atc.digitellinc.com/p/s/a-heart-allocation-score-is-it-time-for-unos-to-make-this-3805
https://atc.digitellinc.com/p/s/the-impact-of-vads-on-heart-transplant-listing-ishlt-3810
https://atc.digitellinc.com/p/s/clinical-trials-for-attenuating-ischemia-reperfusion-3815
https://atc.digitellinc.com/p/s/diannexin-in-ischemia-reperfusion-injury-3820
https://atc.digitellinc.com/p/s/use-of-i5-np-for-the-prevention-of-ischemia-reperfusion-3825
https://atc.digitellinc.com/p/s/the-use-of-a-hapotocyte-growth-factor-for-the-prevention-of-dgf-3830
https://atc.digitellinc.com/p/s/pre-transplant-treatment-of-hepatocellular-cancer-keeping-the-wolf-at-bay-3835
https://atc.digitellinc.com/p/s/pre-operative-percuataneousttherapies-for-hcc-3840
https://atc.digitellinc.com/p/s/who-should-be-treated-pre-operatively-3845
https://atc.digitellinc.com/p/s/results-from-downstaging-protocols-3850
https://atc.digitellinc.com/p/s/immunosuppression-and-pregnancy-after-transplant-3855
https://atc.digitellinc.com/p/s/review-of-pregnancy-category-classifications-and-recommendations-for-immunosuppressants-in-organ-transplant-3860
https://atc.digitellinc.com/p/s/review-of-national-transplant-pregnancy-registry-data-outcomes-related-to-immunosuppression-3865
https://atc.digitellinc.com/p/s/the-role-of-the-national-transplant-pregnancy-registry-in-clinical-practice-3870
https://atc.digitellinc.com/p/s/living-kidney-transplantation-education-for-minority-patients-overcoming-barriers-building-strengths-3875
https://atc.digitellinc.com/p/s/hispanic-esrd-patients-barriers-and-progress-in-living-kidney-donation-education-3880
https://atc.digitellinc.com/p/s/interventions-to-overcome-interpersonal-logistical-and-financial-challenges-to-live-kidney-donation-among-african-americans-3885
https://atc.digitellinc.com/p/s/improving-knowledge-and-awareness-of-living-donor-transplant-among-african-american-end-stage-renal-disease-patients-3890
https://atc.digitellinc.com/p/s/the-new-face-of-vca-programs-3895
https://atc.digitellinc.com/p/s/developing-a-program-and-a-field-a-reconstructive-surgeons-perspective-3900
https://atc.digitellinc.com/p/s/research-priorities-for-vca-over-the-next-decade-3905
https://atc.digitellinc.com/p/s/vca-programs-and-opos-3910
https://atc.digitellinc.com/p/s/challenges-and-controversies-in-intestinal-and-multivisceral-transplantation-3915
https://atc.digitellinc.com/p/s/indications-and-technique-3920
https://atc.digitellinc.com/p/s/immunologic-challenges-3925
https://atc.digitellinc.com/p/s/long-term-outcomes-3930
https://atc.digitellinc.com/p/s/vascularized-organ-xenotransplantation-3935
https://atc.digitellinc.com/p/s/b-cell-depletion-and-costimulatory-blockade-in-pig-to-baboon-heart-xenotransplantation-3940
https://atc.digitellinc.com/p/s/genetic-modification-of-swine-and-innate-and-adaptive-immunity-in-lung-xenotransplantation-3945
https://atc.digitellinc.com/p/s/genetic-modification-of-donor-pigs-to-control-coagulation-dysregulation-3950
https://atc.digitellinc.com/p/s/innovators-in-transplantation-3955
https://atc.digitellinc.com/p/s/introduction-3960
https://atc.digitellinc.com/p/s/innovators-on-transplantation-3965
https://atc.digitellinc.com/p/s/wednesday-plenary-3970
https://atc.digitellinc.com/p/s/long-term-risk-of-esrd-attributable-to-live-kidney-donation-matching-with-healthy-non-donors-3975
https://atc.digitellinc.com/p/s/utilization-of-compatible-pairs-in-a-large-kidney-paired-donation-program-3980
https://atc.digitellinc.com/p/s/morphometric-age-as-a-predictor-of-post-liver-transplant-survival-3985
https://atc.digitellinc.com/p/s/the-high-cost-of-high-meld-waitlisted-patients-3990
https://atc.digitellinc.com/p/s/plenary-wednesday-basic-3995
https://atc.digitellinc.com/p/s/tim-3-overexpressing-t-lymphocytes-prevent-liver-innate-inflammation-response-4000
https://atc.digitellinc.com/p/s/mechanisms-of-intra-graft-regulatory-t-cell-suppressor-function-4005
https://atc.digitellinc.com/p/s/il-21r-plus-marginal-zone-precursor-mzp-b-cells-in-the-germinal-center-induce-il-10-dependent-allogeneic-tolerance-4010
https://atc.digitellinc.com/p/s/critical-role-of-notch-1-in-the-alloimmune-response-4015
https://atc.digitellinc.com/p/s/whats-hot-whats-new-4020
https://atc.digitellinc.com/p/s/whats-hot-whats-new-basic-4025
https://atc.digitellinc.com/p/s/whats-hot-whats-new-clinical-4030
https://atc.digitellinc.com/p/s/pre-meeting-symposium-advanced-immunology-updates-for-basic-and-clinical-scientists-4040
https://atc.digitellinc.com/p/s/pre-meeting-symposium-basic-immunology-and-transplant-immunology-for-the-clinician-4045
https://atc.digitellinc.com/p/s/pre-meeting-symposium-medical-care-of-the-kidney-transplant-recipient-4050
https://atc.digitellinc.com/p/s/pre-meeting-symposium-moving-forward-in-quality-and-outcomes-a-team-approach-4055
https://atc.digitellinc.com/p/s/pre-meeting-symposium-current-challenges-in-hpb-and-liver-transplant-surgery-4060
https://atc.digitellinc.com/p/s/pre-meeting-symposium-exciting-update-in-transplant-id-case-based-learning-4065
https://atc.digitellinc.com/p/s/pre-meeting-symposium-immune-monitoring-in-thoracic-organ-transplantation-4070
https://atc.digitellinc.com/p/s/sunrise-symposium-antibody-mediated-rejection-in-liver-transplantation-what-we-know-and-where-were-going-4075
https://atc.digitellinc.com/p/s/sunrise-symposium-best-practices-to-optimize-healthcare-information-technology-in-transplantation-the-electronic-future-is-now-4080
https://atc.digitellinc.com/p/s/sunrise-symposium-mechanisms-of-immunoregulation-in-response-to-liver-allografts-4085
https://atc.digitellinc.com/p/s/sunrise-symposium-transplantation-and-the-teenager-opening-pandoras-box-4090
https://atc.digitellinc.com/p/s/sunrise-symposium-performance-anxiety-improving-the-performance-asssessment-process-4095
https://atc.digitellinc.com/p/s/sunrise-symposium-infection-immunity-and-the-microbiome-4100
https://atc.digitellinc.com/p/s/sunrise-symposium-lung-transplantation-the-second-time-around-considerations-in-re-do-lung-transplantation-4105
https://atc.digitellinc.com/p/s/sunrise-symposium-pretransplant-immunological-risk-assessment-for-successful-transplantation-of-sensitized-patients-4110
https://atc.digitellinc.com/p/s/joint-plenary-i-4115
https://atc.digitellinc.com/p/s/asts-pioneer-award-4120
https://atc.digitellinc.com/p/s/ast-awards-4125
https://atc.digitellinc.com/p/s/state-of-the-art-address-complement-more-than-a-guard-against-pathogens-4130
https://atc.digitellinc.com/p/s/midday-symposium-when-transplanting-a-heart-is-not-enough-the-role-of-dual-organ-transplantation-4135
https://atc.digitellinc.com/p/s/midday-symposium-generic-tacrolimus-good-medicine-or-cheap-fix-4140
https://atc.digitellinc.com/p/s/midday-symposium-liver-allocation-strengths-problems-and-pitfalls-with-current-and-future-issues-4145
https://atc.digitellinc.com/p/s/midday-symposium-short-and-long-non-encoding-rna-mediated-regulation-of-immunity-4150
https://atc.digitellinc.com/p/s/midday-symposium-living-donation-is-safe-fact-or-fiction-4155
https://atc.digitellinc.com/p/s/midday-symposium-t-regulatory-cells-4160
https://atc.digitellinc.com/p/s/midday-symposium-kidney-transplantation-in-elderly-4165
https://atc.digitellinc.com/p/s/midday-symposium-regenerative-medicine-technologies-for-new-generation-bioartifical-endocrine-pancreas-4170
https://atc.digitellinc.com/p/s/midday-symposium-emerging-insights-in-viral-infections-and-solid-organ-transplantation-4175
https://atc.digitellinc.com/p/s/midday-symposium-long-term-results-of-clinical-tolerance-in-comparison-with-conventional-immunosuppression-4180
https://atc.digitellinc.com/p/s/midday-symposium-my-toughest-dollar-percent-and-case-technical-challenges-in-kidney-transplantation-4185
https://atc.digitellinc.com/p/s/transplantation-in-depth-the-impact-of-infection-and-trauma-on-the-immune-system-4190
https://atc.digitellinc.com/p/s/concurrent-session-kidney-antibody-mediated-rejection-i-4195
https://atc.digitellinc.com/p/s/concurrent-session-liver-pediatrics-4200
https://atc.digitellinc.com/p/s/concurrent-session-regulatory-issues-in-transplant-administration-4205
https://atc.digitellinc.com/p/s/concurrent-session-donor-derived-infectionlifestyletourismvaccines-4210
https://atc.digitellinc.com/p/s/concurrent-session-kidney-complications-late-graft-failure-4215
https://atc.digitellinc.com/p/s/concurrent-session-deceased-donor-management-4220
https://atc.digitellinc.com/p/s/concurrent-session-the-pit-and-the-pendulum-vads-dual-organs-and-other-matters-of-the-heart-4225
https://atc.digitellinc.com/p/s/concurrent-session-kidney-utilizationcenter-issues-4230
https://atc.digitellinc.com/p/s/concurrent-session-optimizing-renal-outcomes-in-liver-transplantation-4235
https://atc.digitellinc.com/p/s/concurrent-session-controversies-in-pancreas-transplantation-4240
https://atc.digitellinc.com/p/s/student-program-the-science-the-art-the-allure-of-transplantation-4245
https://atc.digitellinc.com/p/s/allied-health-symposium-sharpening-your-skills-practice-updates-for-the-allied-health-provider-4250
https://atc.digitellinc.com/p/s/pediatric-symposium-update-on-management-of-rare-diseases-4255
https://atc.digitellinc.com/p/s/concurrent-session-kidney-antibody-mediated-rejection-ii-4260
https://atc.digitellinc.com/p/s/concurrent-session-kidney-living-donor-issues-i-4265
https://atc.digitellinc.com/p/s/concurrent-session-liver-retransplantation-and-other-complications-4270
https://atc.digitellinc.com/p/s/concurrent-session-economics-policy-and-ethics-4275
https://atc.digitellinc.com/p/s/concurrent-session-pediatric-kidney-transplantation-4280
https://atc.digitellinc.com/p/s/concurrent-session-alloantibodies-and-rejection-animal-models-4285
https://atc.digitellinc.com/p/s/concurrent-session-t-cell-mediated-rejection-animal-models-4290
https://atc.digitellinc.com/p/s/concurrent-session-t-cell-biology-4295
https://atc.digitellinc.com/p/s/concurrent-session-regulatory-t-cells-4300
https://atc.digitellinc.com/p/s/concurrent-session-liver-transplant-rejection-animal-models-4305
https://atc.digitellinc.com/p/s/concurrent-session-lung-optimizing-outcomes-4310
https://atc.digitellinc.com/p/s/student-program-surgery-breakout-4315
https://atc.digitellinc.com/p/s/student-program-medicine-breakout-4320
https://atc.digitellinc.com/p/s/student-program-pharmacy-breakout-4325
https://atc.digitellinc.com/p/s/student-program-basic-science-breakout-4330
https://atc.digitellinc.com/p/s/sunrise-symposium-alcohol-abuse-and-liver-transplantation-outcomes-treatment-and-ethical-considerations-4335
https://atc.digitellinc.com/p/s/sunrise-symposium-antibodies-in-thoracic-transplantation-shedding-new-light-on-the-subject-4340
https://atc.digitellinc.com/p/s/sunrise-symposium-managing-the-kidney-waitlist-4345
https://atc.digitellinc.com/p/s/sunrise-symposium-stem-cell-modification-and-cellular-reprogramming-strategies-4350
https://atc.digitellinc.com/p/s/sunrise-symposium-transplantation-of-organs-from-hiv-infected-donors-hope-put-in-practice-4355
https://atc.digitellinc.com/p/s/sunrise-symposium-state-of-the-art-issues-in-intestinal-failure-4360
https://atc.digitellinc.com/p/s/sunrise-symposium-transplantation-in-the-era-of-value-based-care-4365
https://atc.digitellinc.com/p/s/joint-plenary-ii-4370
https://atc.digitellinc.com/p/s/asts-grants-4375
https://atc.digitellinc.com/p/s/asts-presidential-address-4380
https://atc.digitellinc.com/p/s/state-of-the-art-address-transforming-trillions-of-points-of-data-from-studies-and-trials-into-new-drugs-and-diagnostics-4385
https://atc.digitellinc.com/p/s/midday-symposium-achieving-hcv-eradication-in-all-transplant-recipients-4390
https://atc.digitellinc.com/p/s/midday-symposium-kidney-antibody-mediated-rejection-4395
https://atc.digitellinc.com/p/s/midday-symposium-autoimmunity-during-allograft-rejection-4400
https://atc.digitellinc.com/p/s/midday-symposium-optimizing-donor-heart-availability-for-transplantation-4405
https://atc.digitellinc.com/p/s/midday-symposium-new-insights-into-memory-t-cell-biology-4410
https://atc.digitellinc.com/p/s/midday-symposium-challenges-in-implementing-kidney-paired-donation-4415
https://atc.digitellinc.com/p/s/midday-symposium-vascularized-composite-allotransplantation-update-immunosuppression-immune-monitoring-and-implementation-4420
https://atc.digitellinc.com/p/s/midday-symposium-kidney-bioengineering-and-regeneration-state-of-the-art-4425
https://atc.digitellinc.com/p/s/midday-symposium-state-of-the-art-cmv-prevention-and-therapy-4430
https://atc.digitellinc.com/p/s/midday-symposium-liver-transplantation-plumbing-clogs-clots-and-leaks-4435
https://atc.digitellinc.com/p/s/concurrent-session-kidney-desensitization-4440
https://atc.digitellinc.com/p/s/concurrent-session-immune-monitoring-i-4445
https://atc.digitellinc.com/p/s/concurrent-session-liver-transplantation-viral-hepatitis-4450
https://atc.digitellinc.com/p/s/concurrent-session-kidney-immunosupression-minimization-4455
https://atc.digitellinc.com/p/s/concurrent-session-kidney-surgical-techniquecomplications-4460
https://atc.digitellinc.com/p/s/concurrent-session-transplant-tolerance-animal-models-i-4465
https://atc.digitellinc.com/p/s/concurrent-session-id-epidemiology-resistance-geographic-infections-4470
https://atc.digitellinc.com/p/s/concurrent-session-tolerance-clinical-studies-4475
https://atc.digitellinc.com/p/s/concurrent-session-optimizing-immunosuppression-in-pancreas-transplantation-4480
https://atc.digitellinc.com/p/s/concurrent-session-ischemia-reperfusion-injury-basic-mechanisms-4485
https://atc.digitellinc.com/p/s/concurrent-session-antibodies-and-graft-injury-translational-4490
https://atc.digitellinc.com/p/s/concurrent-session-heart-de-mystification-rejection-and-antibodies-of-all-types-4495
https://atc.digitellinc.com/p/s/concurrent-session-kidney-hospitalizationreadmission-4500
https://atc.digitellinc.com/p/s/pediatricallied-health-symposium-why-dont-they-do-what-we-say-adherence-and-self-care-in-pediatric-transplant-recipients-4505
https://atc.digitellinc.com/p/s/concurrent-session-kidney-novel-agents-4510
https://atc.digitellinc.com/p/s/concurrent-session-kidney-living-donor-issues-ii-4515
https://atc.digitellinc.com/p/s/concurrent-session-liver-transplantation-for-hepatocellular-carcinoma-4520
https://atc.digitellinc.com/p/s/concurrent-session-kidney-induction-4525
https://atc.digitellinc.com/p/s/concurrent-session-donor-and-recipient-optimization-for-liver-transplant-4530
https://atc.digitellinc.com/p/s/concurrent-session-kidney-kdpi-and-non-ideal-kidneys-4535
https://atc.digitellinc.com/p/s/concurrent-session-mechanisms-of-resistance-to-costimulatory-blockade-4540
https://atc.digitellinc.com/p/s/concurrent-session-t-cell-help-and-alloimmunity-4545
https://atc.digitellinc.com/p/s/concurrent-session-b-cells-new-insights-from-animal-models-4550
https://atc.digitellinc.com/p/s/concurrent-session-immune-regulation-and-graff-survival-4555
https://atc.digitellinc.com/p/s/concurrent-session-basic-mechanisms-of-chronic-injury-and-fibrosis-4560
https://atc.digitellinc.com/p/s/concurrent-session-viral-infections-cmv-hbv-hcv-hiv-norovirus-4565
https://atc.digitellinc.com/p/s/concurrent-session-disparities-in-healthcare-access-4570
https://atc.digitellinc.com/p/s/sunrise-symposium-cdc-high-risk-4575
https://atc.digitellinc.com/p/s/sunrise-symposium-transitioning-adolescent-to-adult-care-its-time-to-move-4580
https://atc.digitellinc.com/p/s/sunrise-symposium-microbiota-colon-a-new-bug-in-transplantation-4585
https://atc.digitellinc.com/p/s/sunrise-symposium-best-practices-in-live-kidney-donation-4590
https://atc.digitellinc.com/p/s/sunrise-symposium-technical-perspectives-in-dcd-liver-transplantation-4595
https://atc.digitellinc.com/p/s/sunrise-symposium-hla-epitope-matching-is-it-ready-for-prime-time-4600
https://atc.digitellinc.com/p/s/sunrise-symposium-progress-in-islet-transplantation-4605
https://atc.digitellinc.com/p/s/joint-plenary-iii-4610
https://atc.digitellinc.com/p/s/ast-awards-4615
https://atc.digitellinc.com/p/s/ast-presidential-address-4620
https://atc.digitellinc.com/p/s/controversies-in-transplantation-do-we-have-the-immunosuppressive-tool-box-we-need-or-should-tolerance-be-the-goal-4625
https://atc.digitellinc.com/p/s/controversies-in-transplantation-most-effective-strategies-to-increase-the-liver-donor-pool-4630
https://atc.digitellinc.com/p/s/midday-symposium-b-cell-development-4635
https://atc.digitellinc.com/p/s/midday-symposium-cardiovascular-disease-in-kidney-transplantation-4640
https://atc.digitellinc.com/p/s/midday-symposium-the-media-and-transplantation-4645
https://atc.digitellinc.com/p/s/midday-symposium-immune-metabolomics-4650
https://atc.digitellinc.com/p/s/midday-symposium-the-future-of-pancreas-transplantation-4655
https://atc.digitellinc.com/p/s/midday-symposium-donor-derived-infections-the-devil-inside-4660
https://atc.digitellinc.com/p/s/midday-symposium-liver-kidney-transplantation-a-civil-cage-match-4665
https://atc.digitellinc.com/p/s/midday-symposium-living-liver-transplantation-there-has-to-be-an-easier-way-to-earn-a-living-4670
https://atc.digitellinc.com/p/s/midday-symposium-new-developments-in-solid-organ-transplant-biomarkers-4675
https://atc.digitellinc.com/p/s/midday-symposium-expanding-the-live-donor-kidney-4680
https://atc.digitellinc.com/p/s/concurrent-session-kidney-cardiovascular-and-metabolic-4685
https://atc.digitellinc.com/p/s/concurrent-session-liver-immunosuppression-and-rejection-4690
https://atc.digitellinc.com/p/s/concurrent-session-liver-living-donors-and-partial-grafts-4695
https://atc.digitellinc.com/p/s/concurrent-session-kidney-antibodies-and-allograft-injury-4700
https://atc.digitellinc.com/p/s/concurrent-session-ptld-and-other-malignancies-4705
https://atc.digitellinc.com/p/s/concurrent-session-transplant-tolerance-animal-models-ii-4710
https://atc.digitellinc.com/p/s/concurrent-session-kidney-pregnancy-metabolic-complications-malignancy-4715
https://atc.digitellinc.com/p/s/concurrent-session-composite-tissue-allografts-basic-and-translational-4720
https://atc.digitellinc.com/p/s/concurrent-session-small-bowel-transplantation-4725
https://atc.digitellinc.com/p/s/concurrent-session-islet-transplantation-basic-4730
https://atc.digitellinc.com/p/s/concurrent-session-disparities-in-donation-and-transplant-outcomes-4735
https://atc.digitellinc.com/p/s/concurrent-session-glomerulonephritisrecurrent-disease-4740
https://atc.digitellinc.com/p/s/concurrent-session-late-breaking-4745
https://atc.digitellinc.com/p/s/pediatric-symposium-cardiovascular-disease-and-obesity-in-pediatric-transplantation-4750
https://atc.digitellinc.com/p/s/concurrent-session-kidney-living-donor-issues-iii-4755
https://atc.digitellinc.com/p/s/concurrent-session-kidney-delayed-graft-function-and-older-age-4760
https://atc.digitellinc.com/p/s/concurrent-session-kidney-complications-other-4765
https://atc.digitellinc.com/p/s/concurrent-session-kidney-acute-cellular-rejection-4770
https://atc.digitellinc.com/p/s/concurrent-session-kidney-risk-prediction-4775
https://atc.digitellinc.com/p/s/concurrent-session-bk-virus-infection-after-kidney-transplantation-4780
https://atc.digitellinc.com/p/s/concurrent-session-immune-monitoring-ii-4785
https://atc.digitellinc.com/p/s/concurrent-session-linking-innate-and-adaptive-alloimmune-responses-4790
https://atc.digitellinc.com/p/s/concurrent-session-psychosocial-and-treatment-adherence-4795
https://atc.digitellinc.com/p/s/concurrent-session-new-immunosuppression-strategies-primate-models-4800
https://atc.digitellinc.com/p/s/concurrent-session-strategies-to-minimize-ischemia-reperfusion-injury-4805
https://atc.digitellinc.com/p/s/concurrent-session-liver-transplant-allocation-policy-4810
https://atc.digitellinc.com/p/s/sunrise-symposium-hoops-gaps-and-approvals-anticipating-and-overcoming-medication-cost-barriers-4815
https://atc.digitellinc.com/p/s/sunrise-symposium-tailoring-current-immunosuppressive-therapy-in-liver-transplantation-disease-specific-regimens-4820
https://atc.digitellinc.com/p/s/sunrise-symposium-womens-health-post-transplant-updates-and-strategies-for-care-4825
https://atc.digitellinc.com/p/s/sunrise-symposium-ischemia-reperfusion-injury-and-initiation-of-innate-immunity-in-transplantation-4830
https://atc.digitellinc.com/p/s/sunrise-symposium-robotic-assisted-kidney-transplantation-4835
https://atc.digitellinc.com/p/s/sunrise-symposium-bk-virus-infection-in-kidney-transplantation-4840
https://atc.digitellinc.com/p/s/sunrise-symposium-pediatric-transplant-surgery-a-case-based-discussion-of-technical-and-management-challenges-4845
https://atc.digitellinc.com/p/s/sunrise-symposium-xenotransplantation-an-update-4850
https://atc.digitellinc.com/p/s/joint-plenary-iv-4855
https://atc.digitellinc.com/p/s/innovators-in-transplantation-4860
https://atc.digitellinc.com/p/s/whats-hot-whats-new-4865
https://atc.digitellinc.com/p/s/basic-genetics-of-hla-4890
https://atc.digitellinc.com/p/s/generation-of-hla-antibodies-4895
https://atc.digitellinc.com/p/s/the-abcs-of-hla-antibodies-4900
https://atc.digitellinc.com/p/s/getting-it-to-transplant-4905
https://atc.digitellinc.com/p/s/theoretical-and-practical-aspects-of-hla-antibodies-as-a-basis-for-clinical-decision-making-bringing-the-lab-to-the-clinic-4910
https://atc.digitellinc.com/p/s/antibody-mediated-rejection-in-the-transplanted-heart-4920
https://atc.digitellinc.com/p/s/monitoring-for-anti-hla-antibodies-following-transplantation-4925
https://atc.digitellinc.com/p/s/putting-it-all-together-4930
https://atc.digitellinc.com/p/s/update-on-innate-immunity-4940
https://atc.digitellinc.com/p/s/update-on-b-cell-subsets-and-b-cell-alloimmunity-4955
https://atc.digitellinc.com/p/s/top-10-immunology-papers-of-the-year-4970
https://atc.digitellinc.com/p/s/overview-what-does-an-immune-response-look-like-start-to-finish-4980
https://atc.digitellinc.com/p/s/inflammation-and-innate-immunity-and-their-role-in-graft-rejection-4985
https://atc.digitellinc.com/p/s/development-and-detection-of-donor-reactive-t-cell-responses-4990
https://atc.digitellinc.com/p/s/b-cells-and-antibody-mediated-effector-mechanisms-in-graft-injury-5000
https://atc.digitellinc.com/p/s/t-cell-and-b-cell-targeted-immunosuppression-in-transplantation-5005
https://atc.digitellinc.com/p/s/impact-of-immunological-memory-on-graft-outcome-5010
https://atc.digitellinc.com/p/s/understanding-and-interpreting-genomic-studies-in-transplantation-5015
https://atc.digitellinc.com/p/s/pearls-of-the-pre-operative-cardio-hemodynamic-assessment-5030
https://atc.digitellinc.com/p/s/when-to-say-enough-is-enough-the-validity-of-pre-operative-futility-assessments-5040
https://atc.digitellinc.com/p/s/best-practices-in-the-peri-operative-care-of-the-liver-transplant-patient-post-transplant-optimizing-early-patient-liver-graft-survival-5045
https://atc.digitellinc.com/p/s/intra-operative-care-what-goes-in-must-come-out-5050
https://atc.digitellinc.com/p/s/early-graft-dysfunction-donor-issues-and-surgical-complications-5060
https://atc.digitellinc.com/p/s/optimizing-nutrition-and-physical-functioning-recovering-from-frailty-5065
https://atc.digitellinc.com/p/s/immunosuppression-current-approaches-and-future-strategies-5080
https://atc.digitellinc.com/p/s/immunological-assessment-of-the-transplant-recipient-5085
https://atc.digitellinc.com/p/s/the-pathology-of-rejection-5090
https://atc.digitellinc.com/p/s/kidney-issues-in-candidate-evaluation-5100
https://atc.digitellinc.com/p/s/evaluation-of-the-combined-organ-transplant-candidate-5105
https://atc.digitellinc.com/p/s/evaluation-of-the-living-kidney-donor-5110
https://atc.digitellinc.com/p/s/kidney-expect-the-unexpected-complications-5120
https://atc.digitellinc.com/p/s/surgical-complications-after-kidney-transplantation-for-the-non-surgeon-5125
https://atc.digitellinc.com/p/s/recurrent-disease-management-5130
https://atc.digitellinc.com/p/s/kidney-transplant-infections-5140
https://atc.digitellinc.com/p/s/the-pre-transplant-infectious-disease-evaluation-5145
https://atc.digitellinc.com/p/s/bk-virus-prevention-and-treatment-5150
https://atc.digitellinc.com/p/s/qa-discussion-5155
https://atc.digitellinc.com/p/s/ensuring-the-overall-financial-health-of-your-transplant-program-5165
https://atc.digitellinc.com/p/s/maximizing-medicare-cost-report-reimbursement-5170
https://atc.digitellinc.com/p/s/regulatory-overview-organ-transplantation-the-first-government-takeover-of-health-care-5175
https://atc.digitellinc.com/p/s/building-a-qapi-program-to-improve-outcomes-and-meet-regulatory-requirements-5180
https://atc.digitellinc.com/p/s/transplant-program-leadership-session-2-optimizing-your-transplant-centers-performance-5185
https://atc.digitellinc.com/p/s/leading-and-managing-change-to-improve-your-program-5190
https://atc.digitellinc.com/p/s/mitigating-the-threat-of-an-sia-5195
https://atc.digitellinc.com/p/s/using-data-in-managing-a-transplant-center-5200
https://atc.digitellinc.com/p/s/managing-transplant-coordinators-to-maximize-outcomes-5205
https://atc.digitellinc.com/p/s/ptld-for-the-transplant-specialist-risk-factors-diagnosis-initial-treatment-strategies-5215
https://atc.digitellinc.com/p/s/radiology-imaging-infection-and-mimics-for-the-transplant-specialist-5225
https://atc.digitellinc.com/p/s/exciting-updates-in-transplant-id-case-based-learning-an-ounce-of-prevention-is-worth-a-pound-of-cure-5235
https://atc.digitellinc.com/p/s/avoidance-is-not-always-the-answer-transplant-perioperative-prophylaxis-and-surgical-site-infections-5240
https://atc.digitellinc.com/p/s/o-candida-transplant-fungal-prophylaxis-including-a-pre-emptive-therapy-approach-and-endemic-fungi-5245
https://atc.digitellinc.com/p/s/travel-after-transplant-the-icing-on-the-cake-5255
https://atc.digitellinc.com/p/s/exciting-updates-in-transplant-id-case-based-learning-treatment-keeping-the-wolves-at-bay-5260
https://atc.digitellinc.com/p/s/mdro-in-transplant-the-dark-side-of-the-force-5270
https://atc.digitellinc.com/p/s/diarrhea-some-people-think-its-really-funny-5275
https://atc.digitellinc.com/p/s/on-your-toes-rapid-fire-cases-the-4am-phone-call-5280
https://atc.digitellinc.com/p/s/maximizing-efficiency-of-living-donor-evaluations-5290
https://atc.digitellinc.com/p/s/exploring-options-for-sensitized-patients-5295
https://atc.digitellinc.com/p/s/managing-complex-psychosocial-situations-5300
https://atc.digitellinc.com/p/s/effective-pharmacologic-evaluation-of-transplant-candidates-5305
https://atc.digitellinc.com/p/s/collaboration-at-its-finest-a-case-based-approach-highlighting-the-significance-of-the-multi-disciplinary-team-transplant-phase-5310
https://atc.digitellinc.com/p/s/advanced-transplant-providers-in-the-or-providing-more-than-first-assist-5315
https://atc.digitellinc.com/p/s/best-practice-for-a-multidisciplinary-approach-to-discharge-planning-how-we-do-it-5320
https://atc.digitellinc.com/p/s/collaboration-at-its-finest-a-case-based-approach-highlighting-the-significance-of-the-multi-disciplinary-team-post-transplant-phase-5325
https://atc.digitellinc.com/p/s/ensuring-adequate-living-donor-follow-up-in-the-post-donation-setting-5330
https://atc.digitellinc.com/p/s/optimizing-the-role-of-the-pharmacist-in-the-ambulatory-clinic-5335
https://atc.digitellinc.com/p/s/novel-outpatient-services-to-improve-outcomes-and-decrease-readmissions-use-of-specialty-pharmacy-and-transplant-based-infusion-services-to-generate-revenue-5350
https://atc.digitellinc.com/p/s/novel-outpatient-services-to-improve-outcomes-and-decrease-readmissions-post-discharge-hotel-follow-up-to-decrease-length-of-stay-and-prevent-readmissions-5355
https://atc.digitellinc.com/p/s/controversies-and-strategies-surrounding-substance-use-in-transplant-candidates-5360
https://atc.digitellinc.com/p/s/opioids-and-methadone-in-transplant-candidates-5370
https://atc.digitellinc.com/p/s/components-of-the-transplant-addictions-evaluation-5375
https://atc.digitellinc.com/p/s/clinical-transplant-tolerance-molecular-and-cellular-biomarkers-5380
https://atc.digitellinc.com/p/s/b-cells-biomarkers-of-spontaneous-transplant-tolerance-5385
https://atc.digitellinc.com/p/s/functional-assessment-for-clinical-tolerance-5395
https://atc.digitellinc.com/p/s/new-roles-for-macrophages-5400
https://atc.digitellinc.com/p/s/tissue-resident-macrophages-in-islets-and-hearts-5405
https://atc.digitellinc.com/p/s/gmscr-promotes-macrophage-alternative-activation-after-renal-ir-injury-5410
https://atc.digitellinc.com/p/s/sign-and-regulatory-macrophages-and-transplant-tolerance-immunity-online-now-5415
https://atc.digitellinc.com/p/s/renal-controversies-in-liver-transplantation-5420
https://atc.digitellinc.com/p/s/renal-transplant-alone-in-patients-with-liver-disease-what-are-the-limits-5425
https://atc.digitellinc.com/p/s/debate-on-the-approaches-to-renal-allocation-in-the-liver-transplant-candidaterecipient-slkt-vs-liver-only-with-safety-net-5430
https://atc.digitellinc.com/p/s/pro-liver-only-with-safety-net-5435
https://atc.digitellinc.com/p/s/sex-and-drugs-in-transplantation-5440
https://atc.digitellinc.com/p/s/sexual-function-and-dysfunction-in-the-transplant-recipient-5445
https://atc.digitellinc.com/p/s/family-planning-and-contraception-for-donors-and-recipients-5450
https://atc.digitellinc.com/p/s/peri-and-post-menopausal-health-in-transplant-recipients-5455
https://atc.digitellinc.com/p/s/reaching-consensus-on-amr-in-lung-transplantation-5460
https://atc.digitellinc.com/p/s/the-pathology-of-lung-amr-5465
https://atc.digitellinc.com/p/s/the-immunology-of-lung-amr-5470
https://atc.digitellinc.com/p/s/putting-it-all-together-how-does-the-clinician-define-and-treat-lung-amr-5475
https://atc.digitellinc.com/p/s/top-new-papers-in-transplant-infectious-disease-5480
https://atc.digitellinc.com/p/s/viruses-top-new-papers-in-transplant-infectious-disease-5485
https://atc.digitellinc.com/p/s/bacteria-top-new-papers-in-transplant-infectious-disease-5490
https://atc.digitellinc.com/p/s/fungi-top-new-papers-in-transplant-infectious-disease-5495
https://atc.digitellinc.com/p/s/repairing-organs-ex-vivo-5500
https://atc.digitellinc.com/p/s/running-an-organ-repair-center-5505
https://atc.digitellinc.com/p/s/the-potential-of-normothermic-preservation-5510
https://atc.digitellinc.com/p/s/the-significance-of-pulsatility-for-endothelial-protection-5515
https://atc.digitellinc.com/p/s/informed-decision-making-in-living-organ-donation-5520
https://atc.digitellinc.com/p/s/what-do-patients-and-donors-want-to-know-about-the-risks-of-living-donation-and-how-do-they-make-decisions-5530
https://atc.digitellinc.com/p/s/joint-plenary-session-i-5540
https://atc.digitellinc.com/p/s/three-year-graft-loss-risk-in-kidney-transplants-dynamic-patient-level-data-improve-predictive-efficacy-5545
https://atc.digitellinc.com/p/s/non-human-primate-lung-allograft-survival-is-prolonged-by-il-6-inhibition-and-atg-treatment-possibly-through-expansion-of-peripheral-regulatory-t-cells-5550
https://atc.digitellinc.com/p/s/acute-rejection-in-non-human-primates-treated-with-belatacept-is-mediated-by-a-unique-cd8-memory-subset-5555
https://atc.digitellinc.com/p/s/thoracic-simulation-allocation-modeling-tsam-of-a-6-tier-allocation-strategy-5560
https://atc.digitellinc.com/p/s/a-5-year-multicenter-evaluation-of-seasonal-influenza-infection-in-transplant-recipients-5565
https://atc.digitellinc.com/p/s/state-of-the-art-address-thymus-transplantation-an-approach-to-tolerance-induction-5570
https://atc.digitellinc.com/p/s/frontiers-in-inflammation-relevant-to-transplantation-5595
https://atc.digitellinc.com/p/s/inflammasome-independent-regulation-of-il-1-family-cytokines-5605
https://atc.digitellinc.com/p/s/rapid-fire-state-of-the-art-in-xenotransplantation-5615
https://atc.digitellinc.com/p/s/heart-5620
https://atc.digitellinc.com/p/s/lung-5635
https://atc.digitellinc.com/p/s/islet-5640
https://atc.digitellinc.com/p/s/a-year-following-the-new-kidney-allocation-system-kas-whats-working-whats-not-5645
https://atc.digitellinc.com/p/s/is-it-achieving-the-goals-5650
https://atc.digitellinc.com/p/s/does-it-help-kas-find-a-home-for-high-kdpi-kidneys-5655
https://atc.digitellinc.com/p/s/hla-challenges-impact-on-nationally-allocated-kidneys-to-the-extremely-sensitized-hla-challenges-impact-on-nationally-allocated-kidneys-to-the-extremely-sensitized-kidney-transplant-candidate-5660
https://atc.digitellinc.com/p/s/amr-in-liver-transplantation-5665
https://atc.digitellinc.com/p/s/histopathologic-consequences-of-dsa-in-liver-5670
https://atc.digitellinc.com/p/s/chronic-amr-in-liver-transplant-the-next-frontier-5680
https://atc.digitellinc.com/p/s/predictors-of-survival-after-lung-transplant-5685
https://atc.digitellinc.com/p/s/effects-of-declining-health-status-on-the-lung-transplant-waiting-list-on-wait-list-mortality-and-posttransplant-survival-5690
https://atc.digitellinc.com/p/s/obesity-and-advanced-age-in-lung-transplant-5695
https://atc.digitellinc.com/p/s/the-impact-of-single-vs-bilateral-lung-transplant-on-survival-5700
https://atc.digitellinc.com/p/s/donor-derived-infections-new-insights-on-the-use-of-infected-donors-5705
https://atc.digitellinc.com/p/s/hindsight-is-2020-5710
https://atc.digitellinc.com/p/s/risk-of-hiv-transmission-among-increased-risk-donors-5715
https://atc.digitellinc.com/p/s/communication-enhances-transplant-outcomes-5720
https://atc.digitellinc.com/p/s/whats-new-for-the-organ-procurement-and-transplantation-network-and-scientific-registry-of-transplant-recipients-5725
https://atc.digitellinc.com/p/s/metrics-to-assess-pre-transplant-program-performance-5730
https://atc.digitellinc.com/p/s/the-unmet-need-who-are-the-potential-donors-5735
https://atc.digitellinc.com/p/s/measuring-deceased-donor-progress-and-promise-5740
https://atc.digitellinc.com/p/s/liver-transplantation-for-malignancy-state-of-the-art-and-future-directions-5745
https://atc.digitellinc.com/p/s/hepatic-resection-versus-transplantation-for-hcc-in-the-era-of-hepatitis-c-treatment-5750
https://atc.digitellinc.com/p/s/how-far-can-we-push-it-with-hepatocellular-carcinoma-canshould-we-change-our-indications-5755
https://atc.digitellinc.com/p/s/should-we-be-using-mtor-inhibitors-for-all-patients-with-hcc-5760
https://atc.digitellinc.com/p/s/role-of-liver-transplantation-in-patients-with-colorectal-hepatic-metastases-5765
https://atc.digitellinc.com/p/s/developing-new-therapy-for-transplant-recipients-what-are-the-barriers-5770
https://atc.digitellinc.com/p/s/what-are-the-unmet-needs-in-transplantation-how-can-we-move-forward-5775
https://atc.digitellinc.com/p/s/regulatory-barriers-to-new-therapy-5780
https://atc.digitellinc.com/p/s/kidney-transplantation-technical-challenges-5790
https://atc.digitellinc.com/p/s/transplantation-of-anatomically-complex-kidneys-5795
https://atc.digitellinc.com/p/s/treatment-of-early-and-late-ureteral-complications-5800
https://atc.digitellinc.com/p/s/transplant-renal-artery-pseudoanerysm-and-other-vascular-complications-5805
https://atc.digitellinc.com/p/s/b-cells-5810
https://atc.digitellinc.com/p/s/basic-mechanisms-of-b-cell-tolerance-and-anergy-5815
https://atc.digitellinc.com/p/s/new-insights-into-mucosal-antibody-responses-5820
https://atc.digitellinc.com/p/s/poly-reactive-antibodies-markers-and-mechanisms-5835
https://atc.digitellinc.com/p/s/targeting-b-cells-in-transplantation-5840
https://atc.digitellinc.com/p/s/utilizing-electronic-dashboards-to-create-a-culture-of-quality-and-transparency-5850
https://atc.digitellinc.com/p/s/electronic-documentation-practices-to-foster-multi-disciplinary-participation-in-the-quality-and-compliance-process-5855
https://atc.digitellinc.com/p/s/electronic-medication-error-reporting-to-enhance-patient-safety-5860
https://atc.digitellinc.com/p/s/allied-health-symposium-1-identifying-opportunities-to-incorporate-quality-improvement-and-research-into-your-day-developing-pharmacists-and-allied-health-professionals-into-clinicaltranslational-scie-5865
https://atc.digitellinc.com/p/s/fitting-clinical-research-into-your-already-busy-practice-5870
https://atc.digitellinc.com/p/s/pediatric-symposium-1-improving-long-term-outcomes-in-pediatric-transplantation-pediatric-late-liver-graft-outcomes-moving-the-needle-5885
https://atc.digitellinc.com/p/s/clinical-manifestations-of-late-allograft-injury-in-childrenapproach-to-histologic-assessment-in-long-term-pediatric-liver-allograft-5890
https://atc.digitellinc.com/p/s/malt-study-mehtods-implementation-primary-and-secondary-analysis-5900
https://atc.digitellinc.com/p/s/pediatric-symposium-1-improving-long-term-outcomes-in-pediatric-transplantation-tolerance-after-pediatric-solid-organ-transplantation-how-close-are-we-to-prime-time-5905
https://atc.digitellinc.com/p/s/tolerance-determinants-definitions-and-forms-5910
https://atc.digitellinc.com/p/s/immune-monitoring-current-assays-and-clinical-application-in-pediatric-solid-organ-transplantation-5915
https://atc.digitellinc.com/p/s/taking-tolerance-to-the-bedside-models-of-tolerance-induction-and-when-immunosuppression-is-needed-lessons-from-iwith-5920
https://atc.digitellinc.com/p/s/pediatric-symposium-2-antibodies-good-bad-and-customized-antibody-mediated-graft-injury-in-pediatric-organ-transplantation-5925
https://atc.digitellinc.com/p/s/basics-of-antibody-mediated-graft-injury-5930
https://atc.digitellinc.com/p/s/the-science-the-art-and-the-allure-of-transplantation-fundamental-concepts-of-transplantation-5935
https://atc.digitellinc.com/p/s/expanding-transplantation-is-more-than-just-wishing-practical-thoughts-from-the-asts-president-5940
https://atc.digitellinc.com/p/s/nephrology-is-more-than-just-dialysis-kidney-transplantation-for-the-win-5945
https://atc.digitellinc.com/p/s/liver-transplantation-is-more-than-just-surgery-its-really-big-surgery-5950
https://atc.digitellinc.com/p/s/outcomes-research-is-more-than-just-excel-data-more-data-and-statistics-5955
https://atc.digitellinc.com/p/s/id-is-more-than-just-bacteria-hcv-and-hiv-in-the-spotlight-5965
https://atc.digitellinc.com/p/s/rejection-is-more-than-just-something-that-happened-in-high-school-the-immune-system-5970
https://atc.digitellinc.com/p/s/the-heart-is-more-than-just-for-breaking-thoracic-transplantation-5975
https://atc.digitellinc.com/p/s/concurrent-session-living-kidney-donation-risk-factors-for-adverse-long-term-outcome-5985
https://atc.digitellinc.com/p/s/short-term-post-donation-renal-function-in-living-kidney-donors-5990
https://atc.digitellinc.com/p/s/obesity-is-associated-with-increased-risk-of-esrd-among-living-kidney-donors-5995
https://atc.digitellinc.com/p/s/incidence-and-renal-consequences-of-type-2-diabetes-mellitus-in-kidney-donors-6000
https://atc.digitellinc.com/p/s/risk-of-esrd-in-potential-hiv-plus-live-kidney-donors-6005
https://atc.digitellinc.com/p/s/risk-prediction-of-end-stage-renal-disease-in-living-kidney-donors-6010
https://atc.digitellinc.com/p/s/impact-of-donor-recipient-relationship-on-development-of-ckd-6015
https://atc.digitellinc.com/p/s/are-prior-living-kidney-donors-with-esrd-being-listed-and-receiving-transplantation-priority-in-a-timely-manner-6020
https://atc.digitellinc.com/p/s/concurrent-session-novel-markers-of-long-term-kidney-transplant-outcomes-6025
https://atc.digitellinc.com/p/s/complement-binding-donor-specific-anti-hla-antibodies-are-associated-with-severe-kidney-allograft-arteriosclerosis-6030
https://atc.digitellinc.com/p/s/molecular-significance-of-microvascular-inflammation-and-c4d-negative-transplant-glomerulopathy-6035
https://atc.digitellinc.com/p/s/beyond-the-bones-the-association-between-vitamin-d-graft-outcomes-and-vascular-disease-6040
https://atc.digitellinc.com/p/s/clinical-significance-of-non-hla-antibodies-in-the-development-of-microcirculation-inflammation-in-allograft-tissue-after-kidney-transplantation-6045
https://atc.digitellinc.com/p/s/complexity-of-hyalinosis-in-renal-transplant-biopsies-donor-age-glomerular-disease-and-time-6050
https://atc.digitellinc.com/p/s/pulse-pressure-and-gfr-decay-in-kidney-transplant-recipients-6055
https://atc.digitellinc.com/p/s/impact-of-pretransplant-non-donor-specific-hla-immunization-mainly-class-1-immunization-leads-to-poor-immunologic-outcome-and-graft-loss-6060
https://atc.digitellinc.com/p/s/concurrent-session-kidney-transplantation-outcomes-matching-and-marginal-donors-6065
https://atc.digitellinc.com/p/s/a-virtual-crossmatch-algorithm-that-mimics-the-sensitivity-of-flow-cytometric-crossmatch-6070
https://atc.digitellinc.com/p/s/us-dialysis-facility-characteristics-associated-with-racial-disparities-in-access-to-the-kidney-deceased-donor-transplant-waiting-list-6075
https://atc.digitellinc.com/p/s/evaluation-of-scoring-systems-predicting-patient-survival-at-time-of-kidney-transplantation-6080
https://atc.digitellinc.com/p/s/does-dcd-donor-time-to-death-after-withdrawal-of-support-affect-recipient-outcomes-implications-of-time-to-death-at-a-high-volume-center-in-the-united-states-6085
https://atc.digitellinc.com/p/s/donor-recipient-absolute-weight-mismatch-and-the-risk-of-graft-loss-in-renal-transplantation-6090
https://atc.digitellinc.com/p/s/the-impact-of-early-acute-rejection-and-delayed-graft-function-on-graft-outcomes-at-six-months-in-adult-deceased-donor-kidney-recipients-6095
https://atc.digitellinc.com/p/s/factors-associated-with-acute-rejections-in-kidney-transplant-recipients-time-for-hla-dr-matching-in-elderly-recipients-6100
https://atc.digitellinc.com/p/s/concurrent-session-kidney-acute-cellular-rejection-clinical-outcomes-and-pathological-characteristics-6105
https://atc.digitellinc.com/p/s/clinical-significance-of-isolated-v1-arteritis-in-renal-transplantation-6110
https://atc.digitellinc.com/p/s/molecular-assessment-of-kidney-transplant-biopsies-performs-similarly-in-medulla-and-cortex-6115
https://atc.digitellinc.com/p/s/malignancies-contribute-to-presensitization-with-alloreactive-t-cells-in-kidney-transplant-recipients-6120
https://atc.digitellinc.com/p/s/post-transplant-t-cell-alloreactive-perturbation-precedes-the-advent-of-humoral-immunity-in-kidney-transplant-patients-6125
https://atc.digitellinc.com/p/s/the-effect-of-donor-age-on-acute-rejection-age-the-clinical-impact-of-donor-immuno-senescence-in-the-modern-immunosuppressive-era-6130
https://atc.digitellinc.com/p/s/reversibility-of-acute-kidney-rejection-according-to-the-banff-2013-classification-a-retrospective-cohort-study-6135
https://atc.digitellinc.com/p/s/molecular-profiles-of-renal-allograft-rejection-6140
https://atc.digitellinc.com/p/s/concurrent-session-the-kidney-in-liver-transplantation-6145
https://atc.digitellinc.com/p/s/the-effect-of-dri-and-kdpi-on-outcomes-of-high-meld-patients-undergoing-simultaneous-liver-kidney-transplant-6155
https://atc.digitellinc.com/p/s/utility-in-treating-renal-failure-in-end-stage-liver-disease-with-simultaneous-liver-kidney-transplantation-6160
https://atc.digitellinc.com/p/s/acute-kidney-injury-after-liver-transplantation-is-set-in-motion-early-after-reperfusion-of-the-liver-graft-a-prospective-cohort-study-6165
https://atc.digitellinc.com/p/s/at1r-antibodies-at-1-year-negatively-impact-5-year-native-renal-function-in-liver-transplant-recipients-6170
https://atc.digitellinc.com/p/s/evaluation-of-the-major-adverse-cardiac-events-risk-with-everolimus-based-calcineurin-inhibitor-reduction-or-withdrawal-regimen-in-liver-transplant-recipients-3-year-ipost-hoci-analysis-of-the-randomi-6180
https://atc.digitellinc.com/p/s/concurrent-session-cardiovascular-complications-in-kidney-transplantation-6185
https://atc.digitellinc.com/p/s/validation-of-a-simplified-cost-effective-clinical-risk-stratification-that-predicts-myocardial-ischemic-events-in-kidney-transplant-candidates-6190
https://atc.digitellinc.com/p/s/clinical-and-subclinical-cardiac-events-after-kidney-transplantation-ktx-6195
https://atc.digitellinc.com/p/s/predicting-obstructive-coronary-artery-disease-in-asymptomatic-patients-undergoing-renal-transplantation-using-a-simple-risk-score-6200
https://atc.digitellinc.com/p/s/using-predictive-modeling-to-manage-cardiovascular-risk-and-improve-kidney-transplant-outcomes-6205
https://atc.digitellinc.com/p/s/sociodemographic-and-comorbidity-differences-between-dialysis-waitlisted-and-transplant-patients-in-the-uk-findings-from-the-attom-study-6210
https://atc.digitellinc.com/p/s/impact-of-induction-therapy-on-cardiovascular-events-in-kidney-transplant-recipients-6215
https://atc.digitellinc.com/p/s/influence-of-lipid-levels-on-cardiovascular-events-after-early-conversion-from-calcineurin-inhibitor-to-everolimus-24-m-analysis-of-the-elevate-study-6220
https://atc.digitellinc.com/p/s/concurrent-session-donor-management-all-organs-6225
https://atc.digitellinc.com/p/s/activated-cytoprotective-mechanisms-in-dbd-kidneys-correlate-with-kidney-function-in-transplant-recipients-a-study-using-clinical-samples-from-the-uk-quod-biobank-6230
https://atc.digitellinc.com/p/s/normothermic-ex-vivo-liver-perfusion-nevlp-using-steen-solution-as-preservation-technique-for-liver-transplantation-first-clinical-results-6235
https://atc.digitellinc.com/p/s/deceased-organ-donor-management-does-hospital-volume-matter-6240
https://atc.digitellinc.com/p/s/the-phs-increased-risk-label-is-associated-with-non-utilization-of-hundreds-of-organs-per-year-6245
https://atc.digitellinc.com/p/s/are-we-refusing-good-organs-outcomes-of-ventilator-management-of-sub-optimal-lung-donors-6250
https://atc.digitellinc.com/p/s/pancreas-transplantation-from-pediatric-donors-a-unos-registry-analysis-6255
https://atc.digitellinc.com/p/s/comparison-of-three-approaches-for-laparoscopic-donor-nephrectomy-transvaginal-transumbilical-single-site-and-retroperitoneal-6260
https://atc.digitellinc.com/p/s/concurrent-session-challenges-in-hearts-and-vads-striking-back-6265
https://atc.digitellinc.com/p/s/pregnancy-outcomes-in-17-female-heart-transplant-recipients-with-the-initial-diagnosis-of-congenital-heart-defect-6270
https://atc.digitellinc.com/p/s/the-quilty-effect-in-pediatric-heart-transplant-recipients-6275
https://atc.digitellinc.com/p/s/solid-phase-assay-demonstrates-high-rates-of-allosensitization-in-pediatric-heart-recipients-6280
https://atc.digitellinc.com/p/s/a-risk-quantification-score-for-heart-transplants-a-heart-donor-risk-index-6285
https://atc.digitellinc.com/p/s/the-impact-of-complement-binding-donor-specific-antibodies-in-the-first-year-after-heart-transplantation-6290
https://atc.digitellinc.com/p/s/dilution-of-patient-sera-improves-mfi-correlation-with-complement-fixation-in-solid-phase-assay-assessment-6295
https://atc.digitellinc.com/p/s/the-largest-single-center-experience-with-total-artificial-heart-implantation-characterization-of-outcome-6300
https://atc.digitellinc.com/p/s/concurrent-session-kidney-transplant-cni-minimization-6305
https://atc.digitellinc.com/p/s/everolimus-with-low-dose-tacrolimus-vs-a-standard-immunosuppressive-regimen-renal-histology-at-6-months-in-de-novo-renal-transplant-patients-6310
https://atc.digitellinc.com/p/s/impact-of-early-calcineurin-inhibitor-withdrawal-on-renal-function-and-urinary-protein-excretion-24-month-analyses-of-the-elevate-study-6315
https://atc.digitellinc.com/p/s/relationship-between-clinical-events-and-everolimus-exposure-at-12-months-in-ide-novoi-renal-transplant-recipients-6320
https://atc.digitellinc.com/p/s/everolimus-in-combination-with-reduced-dose-tacrolimus-is-effective-as-a-prophylaxis-of-acute-rejection-in-low-to-moderate-immunologic-risk-ide-novoi-kidney-transplantation-patients-6325
https://atc.digitellinc.com/p/s/impact-of-low-dose-tacrolimus-with-everolimus-regimen-on-renal-pathology-and-t-regulatory-cells-in-kidney-transplant-6330
https://atc.digitellinc.com/p/s/prospective-randomized-open-trial-designed-to-reduce-the-incidence-of-cytomegalovirus-cmv-infection-in-de-novo-kidney-transplant-recipients-two-year-results-6335
https://atc.digitellinc.com/p/s/better-long-term-renal-function-with-lower-incidence-of-acute-rejection-and-lower-cmv-infection-in-renal-transplant-patients-treated-with-a-combination-of-tacrolimus-and-everolimus-6340
https://atc.digitellinc.com/p/s/concurrent-session-policy-and-practice-implications-for-long-term-outcomes-6345
https://atc.digitellinc.com/p/s/effect-of-mtor-inhibitors-on-the-risk-of-cancer-development-after-kidney-transplantation-in-chinese-population-6350
https://atc.digitellinc.com/p/s/short-uk-dialysis-does-not-significantly-impact-on-live-donor-kidney-allograft-survival-6355
https://atc.digitellinc.com/p/s/efficacy-and-renal-function-in-kidney-transplant-recipients-receiving-tacrolimus-tac-based-immunosuppressive-regimens-in-combination-with-everolimus-evr-versus-mycophenolate-mpa-6360
https://atc.digitellinc.com/p/s/monitoring-of-de-novo-dsa-post-alemtuzumab-induction-in-renal-transplant-recipients-one-year-follow-up-6365
https://atc.digitellinc.com/p/s/mycophenolic-acid-product-discontinuation-prior-to-conception-analysis-of-pregnancies-in-kidney-transplant-recipients-6370
https://atc.digitellinc.com/p/s/immediate-introduction-of-everolimus-does-not-affect-wound-healing-and-delayed-graft-function-in-kidney-transplant-recipients-3-months-results-from-neverwound-study-6375
https://atc.digitellinc.com/p/s/sirolimus-regimen-and-viral-serology-as-risk-factors-for-outcomes-of-adult-kidney-transplants-14-year-cumulative-data-in-the-united-states-6380
https://atc.digitellinc.com/p/s/concurrent-session-sot-hiv-hbv-and-hcv-6385
https://atc.digitellinc.com/p/s/initial-experience-treating-hepatitis-c-positive-kidney-transplant-recipients-with-non-interferon-containing-regimens-successes-and-challenges-6390
https://atc.digitellinc.com/p/s/kidney-transplantation-in-hiv-patients-effect-of-race-on-the-choice-of-anti-thymocyte-globulin-induction-immunosuppression-6395
https://atc.digitellinc.com/p/s/donors-with-isolated-anti-hbc-hbcab-only-antibodies-true-evidence-for-past-infection-or-laboratory-artifact-toward-a-simple-confirmatory-test-for-hbcab-6400
https://atc.digitellinc.com/p/s/kidney-retransplantation-is-associated-with-higher-mortality-risk-among-hiv-plus-vs-hiv-recipients-6405
https://atc.digitellinc.com/p/s/the-use-of-sofosbuvir-sof-containing-direct-antiviral-agents-daa-based-regimens-requires-increase-in-tacrolimus-tac-doses-in-kidney-transplant-kt-recipients-with-hepatitis-c-virus-hcv-infection-6410
https://atc.digitellinc.com/p/s/efficacy-and-safety-of-direct-antiviral-agents-daa-based-therapies-for-hepatitis-c-virus-hcv-infection-in-kidney-transplant-kt-recipients-6415
https://atc.digitellinc.com/p/s/utilization-of-hcv-positive-donors-kidneys-potential-benefits-in-the-era-of-direct-acting-antiviral-daa-therapy-6420
https://atc.digitellinc.com/p/s/concurrent-session-kidney-amr-making-the-diagnosis-6425
https://atc.digitellinc.com/p/s/circulating-angiotensin-ii-receptor-possible-marker-for-antibody-mediated-tissue-injury-6430
https://atc.digitellinc.com/p/s/mapping-heterogeneity-in-antibody-mediated-rejection-using-molecular-phenotypes-and-archetype-analysis-6435
https://atc.digitellinc.com/p/s/positive-lymphocytes-flow-cytometry-crossmatch-due-to-at1r-antibodies-in-absence-of-hla-dsa-6440
https://atc.digitellinc.com/p/s/criteria-for-the-diagnosis-of-microvascular-inflammation-mvi-in-kidney-transplant-biopsies-ktxbx-6445
https://atc.digitellinc.com/p/s/comparison-of-c4d-deposition-in-renal-biopsies-with-luminex-based-c3d-single-antigen-bead-sab-detection-6455
https://atc.digitellinc.com/p/s/urine-cell-free-supernatant-metabolites-diagnostic-of-antibody-mediated-rejection-in-kidney-allografts-6460
https://atc.digitellinc.com/p/s/concurrent-session-older-and-high-risk-kidney-transplant-recipientsdonors-6465
https://atc.digitellinc.com/p/s/frailty-in-kt-recipients-of-all-ages-6470
https://atc.digitellinc.com/p/s/improved-health-related-quality-of-life-also-in-older-recipients-following-kidney-transplantation-6475
https://atc.digitellinc.com/p/s/short-term-changes-in-hrqol-following-kidney-transplantation-6480
https://atc.digitellinc.com/p/s/association-of-pre-transplant-midodrine-use-and-complications-after-kidney-transplantation-6485
https://atc.digitellinc.com/p/s/cognitive-impairment-in-kidney-transplant-recipients-6490
https://atc.digitellinc.com/p/s/black-ethnicity-as-a-risk-factor-for-poor-kidney-allograft-outcomes-post-transplantation-6495
https://atc.digitellinc.com/p/s/safety-of-a-short-one-year-waiting-time-in-kidney-transplant-candidates-treated-for-cancer-6500
https://atc.digitellinc.com/p/s/concurrent-session-kidney-donor-surgery-and-outcomes-6505
https://atc.digitellinc.com/p/s/learning-curve-of-laparoscopic-donor-nephrectomy-for-abdominal-transplant-surgery-fellows-6510
https://atc.digitellinc.com/p/s/acute-operative-complications-and-15-and-10-year-outcomes-in-living-donors-by-type-of-live-donor-nephrectomy-uk-cohort-study-6515
https://atc.digitellinc.com/p/s/the-oldest-and-coldest-in-kidney-paired-donation-experience-of-the-national-kidney-registry-6520
https://atc.digitellinc.com/p/s/living-donor-kidney-transplant-outcomes-have-improved-over-the-last-decade-6525
https://atc.digitellinc.com/p/s/nondirected-kidney-donation-donating-more-than-a-kidney-6530
https://atc.digitellinc.com/p/s/association-of-neighborhood-poverty-and-living-donor-kidney-transplant-rates-by-donor-relationship-to-recipient-6535
https://atc.digitellinc.com/p/s/concurrent-session-kidney-immune-monitoring-1-6545
https://atc.digitellinc.com/p/s/a-non-invasive-blood-transcriptional-assay-ksort-monitors-alloimmune-response-in-the-sailor-randomized-multicenter-trial-6550
https://atc.digitellinc.com/p/s/detecting-renal-allograft-inflammation-using-quantitative-urine-metabolomics-and-cxcl10-6555
https://atc.digitellinc.com/p/s/mrna-expression-of-baff-and-april-receptors-increases-in-acute-rejection-in-kidney-transplant-recipients-6560
https://atc.digitellinc.com/p/s/micrornas-in-urinary-sediments-as-non-invasive-tool-to-detect-acute-rejection-after-kidney-transplantation-6565
https://atc.digitellinc.com/p/s/vdj-immune-repertoire-sequencing-predicts-patients-at-risk-of-alloimmune-injury-6570
https://atc.digitellinc.com/p/s/rapid-detection-of-urinary-cxcl9-as-a-diagnostic-and-prognostic-tool-for-managing-acute-cellular-rejection-acr-in-kidney-transplantation-6575
https://atc.digitellinc.com/p/s/implications-of-subclinical-borderline-acute-cellular-rejection-detected-in-protocol-biopsies-on-graft-outcomes-6580
https://atc.digitellinc.com/p/s/concurrent-session-impact-of-new-allocation-systems-and-novel-tools-for-performance-enhancement-in-abdominal-transplantation-6585
https://atc.digitellinc.com/p/s/big-data-predictive-solution-to-optimize-kidney-transplant-outcome-and-resource-utilization-6590
https://atc.digitellinc.com/p/s/a-multidisciplinary-approach-to-reviewing-patient-care-in-abdominal-transplantation-6595
https://atc.digitellinc.com/p/s/kidney-waitlist-management-with-lean-six-sigma-6600
https://atc.digitellinc.com/p/s/impact-of-the-kidney-allocation-system-with-deceased-donor-kidney-utilization-at-the-dsa-level-6605
https://atc.digitellinc.com/p/s/impact-of-the-kidney-allocation-system-with-deceased-donor-kidney-transplantation-a-single-center-experience-6610
https://atc.digitellinc.com/p/s/assessing-the-impact-of-the-share35-liver-allocation-policy-survival-outcomes-among-liver-re-transplant-recipients-6615
https://atc.digitellinc.com/p/s/the-finances-of-broader-sharing-of-livers-following-share-35-6620
https://atc.digitellinc.com/p/s/concurrent-session-delayed-graft-function-and-protocol-biopsy-6625
https://atc.digitellinc.com/p/s/understanding-the-drivers-behind-an-early-post-kas-rise-in-delayed-graft-function-dgf-rates-6630
https://atc.digitellinc.com/p/s/the-first-impressions-a-study-in-pre-and-post-implantation-renal-grafts-for-early-detection-markers-of-delayed-graft-function-and-recovery-6635
https://atc.digitellinc.com/p/s/acute-inflammation-chronic-damage-and-renal-dysfunction-in-renal-transplant-recipients-with-delayed-graft-function-dgf-6640
https://atc.digitellinc.com/p/s/associations-between-deceased-donor-urine-mcp-1-and-kidney-transplant-outcomes-6645
https://atc.digitellinc.com/p/s/surveillance-renal-allograft-biopsies-prognosticate-graft-function-6650
https://atc.digitellinc.com/p/s/a-systematic-over-view-of-five-year-results-of-serial-protocol-kidney-transplant-biopsies-6655
https://atc.digitellinc.com/p/s/the-treatment-of-borderline-lesion-in-protocol-biopsies-did-not-improve-the-outcome-in-kidney-transplant-recipients-6660
https://atc.digitellinc.com/p/s/concurrent-session-hepatic-malignancies-6665
https://atc.digitellinc.com/p/s/predictors-of-ultrasound-failure-to-detect-hepatocellular-carcinoma-in-cirrhotic-livers-6670
https://atc.digitellinc.com/p/s/pre-transplant-loco-regional-therapy-for-hepatocellular-carcinoma-and-post-transplant-outcomes-a-national-study-6675
https://atc.digitellinc.com/p/s/traditionally-unacceptable-organs-promote-liver-transplantation-in-patients-with-long-waiting-times-in-the-share-35-era-6680
https://atc.digitellinc.com/p/s/hepatocellular-carcinoma-decreases-chance-of-successful-hcv-therapy-in-the-current-era-6685
https://atc.digitellinc.com/p/s/is-pretransplant-determination-of-hepatocellular-carcinoma-tumor-grade-using-needle-biopsy-reliable-for-transplant-candidate-selection-analysis-of-217-liver-transplant-recipients-6690
https://atc.digitellinc.com/p/s/the-influence-of-rising-lab-meld-on-vascular-invasion-in-hcc-6695
https://atc.digitellinc.com/p/s/visceral-adiposity-is-associated-with-increased-recurrence-of-hepatocellular-carcinoma-following-liver-transplantation-6700
https://atc.digitellinc.com/p/s/concurrent-session-allograft-tolerance-1-animal-models-6705
https://atc.digitellinc.com/p/s/erythropoietin-epo-mediates-spontaneous-kidney-transplant-tolerance-in-mice-6710
https://atc.digitellinc.com/p/s/designing-a-novel-highly-selective-immunoproteasome-inhibitor-that-promotes-longterm-heart-allograft-acceptance-while-inducing-immune-cell-exhaustion-treg-induction-and-memory-cell-suppression-6715
https://atc.digitellinc.com/p/s/tracking-of-endogenous-graft-reactive-tregs-reveals-their-peripheral-enrichment-during-transplantation-tolerance-6720
https://atc.digitellinc.com/p/s/alfa-1-monotherapy-induced-tolerance-is-dependent-on-indirect-cd8-t-cells-and-augments-a-population-of-cd8-cells-with-a-suppressor-phenotype-6725
https://atc.digitellinc.com/p/s/role-of-regulatory-t-cells-in-induction-of-tolerance-in-mouse-vascularized-osteomyocutaneous-allotransplantation-under-combined-costimulation-blockade-6730
https://atc.digitellinc.com/p/s/engineering-a-hybrid-thymus-to-promote-transplant-tolerance-6735
https://atc.digitellinc.com/p/s/mechanisms-of-alloantigen-specific-regulation-after-donor-specific-transfusion-and-costimulatory-blockade-in-yfp-foxp3tdtomred-ebi3-marker-mice-6740
https://atc.digitellinc.com/p/s/concurrent-session-chronic-allograft-rejection-animal-models-6745
https://atc.digitellinc.com/p/s/mir-21-in-chronic-allograft-vasculopathy-6750
https://atc.digitellinc.com/p/s/ameliorating-progression-of-allograft-vasculopathy-by-targeting-the-t-follicular-helper-cell-subset-6755
https://atc.digitellinc.com/p/s/conditional-deletion-of-mtor-in-myeloid-cells-inhibits-chronic-allograft-rejection-a-novel-role-for-macrophages-in-transplant-vasculopathy-6760
https://atc.digitellinc.com/p/s/batf-deficiency-in-tolerant-lung-allograft-recipients-are-resistant-to-anti-mhc-and-anti-self-antigen-mediated-pathogenesis-of-obliterative-airway-disease-6765
https://atc.digitellinc.com/p/s/obliterative-bronchiolitis-following-lung-transplantation-is-preceded-by-depletion-of-airway-submucosal-glands-and-basal-stem-cells-6770
https://atc.digitellinc.com/p/s/intracellular-opn-is-an-essential-protective-factor-for-cardiac-endothelial-cell-and-the-long-term-heart-graft-survival-6775
https://atc.digitellinc.com/p/s/hif-1a-stabilization-in-the-recipient-accelerates-cardiac-allograft-rejection-6780
https://atc.digitellinc.com/p/s/concurrent-session-organ-transplantation-in-the-era-of-highly-resistant-pathogens-6785
https://atc.digitellinc.com/p/s/factors-and-outcomes-associated-with-daptomycin-non-susceptible-enterococcal-infections-in-solid-organ-transplant-recipients-6790
https://atc.digitellinc.com/p/s/prior-infection-or-colonization-with-carbapenem-resistant-enterobacteriaceae-is-not-an-absolute-contraindication-for-solid-organ-transplantation-6795
https://atc.digitellinc.com/p/s/characteristics-and-outcomes-of-vancomycin-resistant-ienterococcusi-bacteremia-after-liver-transplant-6800
https://atc.digitellinc.com/p/s/colonization-and-risk-of-bacteremia-by-multi-drug-resistant-organisms-in-intestinal-transplant-recipients-6805
https://atc.digitellinc.com/p/s/the-impact-of-pre-transplant-infections-on-post-liver-transplant-outcomes-6810
https://atc.digitellinc.com/p/s/clinical-impact-of-the-verigene-r-blood-culture-system-on-rapid-diagnosis-and-antibiotic-optimization-in-bacteremic-solid-organ-transplant-sot-recipients-6815
https://atc.digitellinc.com/p/s/infectious-complication-in-extremely-elderly-kidney-transplant-kt-recipients-a-leading-cause-of-death-6820
https://atc.digitellinc.com/p/s/concurrent-session-liver-immunosuppression-and-rejection-6825
https://atc.digitellinc.com/p/s/mothers-are-often-sensitized-and-sensitive-antibody-mediated-rejection-in-child-to-mother-living-donor-liver-transplantation-6830
https://atc.digitellinc.com/p/s/clinical-rejection-risk-assessment-with-allospecific-cd154-plus-t-cytotoxic-memory-cells-cd154-plus-tcm-after-pediatric-liver-or-intestine-transplantation-ltx-itx-6835
https://atc.digitellinc.com/p/s/proteoforms-novel-biomarkers-for-acute-rejection-in-liver-transplant-recipients-6840
https://atc.digitellinc.com/p/s/profiling-immunologic-risk-for-acute-rejection-in-liver-transplantation-recipient-age-is-a-robust-risk-factor-6845
https://atc.digitellinc.com/p/s/a-sustained-viral-response-achieved-with-sofosbuvirledipasvir-may-increase-the-incidence-of-acute-cellular-rejection-post-liver-transplantation-6850
https://atc.digitellinc.com/p/s/evaluation-of-the-long-term-outcomes-with-everolimus-after-calcineurin-inhibitor-withdrawal-36m-results-of-the-h2304-and-protect-extension-studies-6855
https://atc.digitellinc.com/p/s/everolimus-versus-mycophenolate-mofetil-in-combination-with-tacrolimus-a-propensity-score-matching-analysis-in-liver-transplantation-6860
https://atc.digitellinc.com/p/s/concurrent-session-lung-transplant-moving-the-field-forward-6865
https://atc.digitellinc.com/p/s/exosomes-with-lung-associated-self-antigens-collagen-v-and-k-alpha-1-tubulin-role-in-rejection-following-human-lung-transplantation-6870
https://atc.digitellinc.com/p/s/microarray-analysis-of-transbronchial-and-mucosal-biopsies-in-lung-transplant-recipients-detects-molecular-changes-of-t-cell-mediated-inflammation-6875
https://atc.digitellinc.com/p/s/high-risk-age-window-for-graft-loss-in-pediatric-lung-and-heart-transplant-recipients-6880
https://atc.digitellinc.com/p/s/resolution-of-undefined-etiology-of-respiratory-infections-in-lung-transplant-patients-with-unbiased-metagenomic-sequencing-6885
https://atc.digitellinc.com/p/s/increasing-tacrolimus-time-in-therapeutic-range-is-associated-with-less-cellular-rejection-in-lung-transplant-recipients-6890
https://atc.digitellinc.com/p/s/utility-of-six-minute-walk-distance-in-predicting-lung-transplant-benefit-in-the-lung-allocation-score-era-6895
https://atc.digitellinc.com/p/s/successful-maintenance-belatacept-based-immunosuppression-in-lung-transplantation-recipients-who-failed-calcineurin-inhibitors-6900
https://atc.digitellinc.com/p/s/pregnancy-donors-recipients-and-a-link-to-tolerance-6910
https://atc.digitellinc.com/p/s/national-transplant-pregnancy-registry-2500-pregnancy-outcomes-after-transplantation-6920
https://atc.digitellinc.com/p/s/obesity-and-nash-in-transplant-6930
https://atc.digitellinc.com/p/s/novel-nash-therapies-in-the-transplant-setting-6935
https://atc.digitellinc.com/p/s/sarcopenic-obesity-assessing-frailty-and-risk-in-the-face-of-obesity-6940
https://atc.digitellinc.com/p/s/timing-and-results-with-bariatric-surgerys-in-liver-transplantation-6945
https://atc.digitellinc.com/p/s/do-high-risk-transplant-recipients-take-higher-risk-when-treated-with-generic-tacrolimus-6950
https://atc.digitellinc.com/p/s/pharmacokinetic-studies-of-brand-and-five-generic-tacrolimus-formulation-in-high-risk-transplant-recipients-6960
https://atc.digitellinc.com/p/s/evaluating-transplant-donor-and-recipients-pharmacogenetics-and-its-impact-on-variability-in-tacrolimus-and-metabolites-pharmacokinetics-6965
https://atc.digitellinc.com/p/s/heart-does-my-patient-have-amr-and-how-do-i-treat-it-6970
https://atc.digitellinc.com/p/s/case-1-patient-with-normal-graft-function-no-antibodies-crossed-at-the-time-of-transplant-no-dsa-but-persistent-ihc-staining-6975
https://atc.digitellinc.com/p/s/case-2-patient-with-low-mfi-dsa-ihc-staining-and-normal-graft-function-6980
https://atc.digitellinc.com/p/s/case-3-patient-with-ihc-staining-dsa-and-abnormal-graft-function-6985
https://atc.digitellinc.com/p/s/you-cant-always-get-what-you-want-multidrug-resistant-organisms-6990
https://atc.digitellinc.com/p/s/overview-and-impact-of-multidrug-resistant-organisms-on-transplantation-6995
https://atc.digitellinc.com/p/s/on-the-minus-side-highly-resistant-gram-negative-organisms-and-transplantation-7000
https://atc.digitellinc.com/p/s/organ-donor-management-maximizing-quality-and-quantity-of-donated-organs-7010
https://atc.digitellinc.com/p/s/the-toxic-milieu-hemodynamic-changes-of-brain-death-7015
https://atc.digitellinc.com/p/s/im-feeling-hormonal-review-of-endocrine-therapies-during-organ-donor-management-7020
https://atc.digitellinc.com/p/s/newer-technologies-and-the-use-of-hypothermia-in-organ-donor-management-7025
https://atc.digitellinc.com/p/s/cell-death-pathways-and-transplantation-7030
https://atc.digitellinc.com/p/s/regulated-necrosis-kidney-injury-and-transplantation-7035
https://atc.digitellinc.com/p/s/effects-of-regulated-cell-death-in-the-kidney-on-the-lung-7040
https://atc.digitellinc.com/p/s/management-of-urologic-issues-and-complications-with-renal-transplant-7050
https://atc.digitellinc.com/p/s/bladder-physiology-before-and-after-renal-transplant-7055
https://atc.digitellinc.com/p/s/contemporary-management-of-urinary-tract-infections-classification-work-up-and-therapy-management-of-reflux-in-the-renal-allograft-associated-with-infection-7060
https://atc.digitellinc.com/p/s/understanding-and-managing-urinary-symptoms-in-the-renal-transplant-patient-7065
https://atc.digitellinc.com/p/s/endoscopic-management-of-ureteral-strictures-stones-or-other-ureteral-pathology-in-the-transplant-ureter-7070
https://atc.digitellinc.com/p/s/management-of-bladder-outlet-obstruction-in-the-transplant-patient-7075
https://atc.digitellinc.com/p/s/joint-plenary-session-ii-7080
https://atc.digitellinc.com/p/s/ledipasvirsofosbuvir-ldvsof-for-12-or-24-weeks-is-safe-and-effective-in-kidney-transplant-recipients-with-chronic-genotype-1-or-4-hcv-infection-7085
https://atc.digitellinc.com/p/s/regulatory-t-cell-infusion-can-enhance-memory-t-cell-and-alloantibody-responses-in-lymphodepleted-nonhuman-primate-heart-allograft-recipients-7090
https://atc.digitellinc.com/p/s/impact-on-renal-function-of-stepwise-withdrawal-of-tacrolimus-combined-with-everolimus-and-ec-mps-ivsi-standard-treatment-combining-tacrolimus-and-ec-mps-in-de-novo-liver-transplant-recipients-results-7095
https://atc.digitellinc.com/p/s/prevalence-of-polyreactive-innate-like-b-cells-among-graft-infiltrating-b-cells-in-human-cardiac-allograft-vasculopathy-7100
https://atc.digitellinc.com/p/s/state-of-the-art-address-crispr-biology-and-the-frontier-of-genome-engineering-7105
https://atc.digitellinc.com/p/s/immune-cell-trafficking-in-vivo-new-insights-7110
https://atc.digitellinc.com/p/s/in-vivo-imaging-of-alloreactive-t-cells-7125
https://atc.digitellinc.com/p/s/innate-lymphoid-cells-7130
https://atc.digitellinc.com/p/s/pancreas-transplantation-how-i-do-it-7150
https://atc.digitellinc.com/p/s/how-i-perform-the-complex-pancreatic-transplant-case-7160
https://atc.digitellinc.com/p/s/how-i-manage-the-post-operative-pancreatic-transplant-recipient-7165
https://atc.digitellinc.com/p/s/understanding-and-minimizing-the-costs-of-living-kidney-donation-7170
https://atc.digitellinc.com/p/s/financial-burdens-of-living-donation-in-the-current-us-system-7175
https://atc.digitellinc.com/p/s/what-approaches-do-we-need-to-develop-to-minimize-the-financial-costs-associated-with-living-donation-that-may-preclude-individuals-from-exercising-their-wishes-7185
https://atc.digitellinc.com/p/s/viral-hepatitis-pre-peri-and-post-liver-transplantation-7190
https://atc.digitellinc.com/p/s/when-to-treat-decompensated-hcv-patients-to-avoid-transplant-the-point-of-no-return-7195
https://atc.digitellinc.com/p/s/perioperativeprophylactic-hcv-treatment-optimally-timing-and-treatment-7200
https://atc.digitellinc.com/p/s/heart-controversies-in-immunosuppression-7210
https://atc.digitellinc.com/p/s/debate-1-the-use-of-induction-therapy-to-delay-the-introduction-of-calcineurins-is-effective-in-mitigating-renal-dysfunction-post-transplant-7215
https://atc.digitellinc.com/p/s/pro-7220
https://atc.digitellinc.com/p/s/con-7225
https://atc.digitellinc.com/p/s/debate-2-all-patients-who-develop-post-transplant-renal-dysfunction-should-be-converted-to-a-cni-free-regimen-7235
https://atc.digitellinc.com/p/s/pro-7240
https://atc.digitellinc.com/p/s/con-7245
https://atc.digitellinc.com/p/s/rebuttals-7250
https://atc.digitellinc.com/p/s/debate-3-all-patients-should-be-converted-to-a-psi-based-regimen-by-3-months-after-cardiac-transplantation-7255
https://atc.digitellinc.com/p/s/con-7265
https://atc.digitellinc.com/p/s/cutting-edge-topics-in-cmv-and-transplant-7275
https://atc.digitellinc.com/p/s/savvy-approaches-to-prevention-7280
https://atc.digitellinc.com/p/s/predicting-the-future-immunodiagnostics-and-cmv-7285
https://atc.digitellinc.com/p/s/challenging-clinical-cmv-cases-7290
https://atc.digitellinc.com/p/s/far-from-the-madding-crowd-best-practices-in-opo-and-transplant-center-leadership-7295
https://atc.digitellinc.com/p/s/performance-anxiety-when-less-focus-on-metrics-leads-to-more-transplants-7300
https://atc.digitellinc.com/p/s/risk-adjustment-and-program-specific-reports-friend-or-foe-7305
https://atc.digitellinc.com/p/s/opportunities-and-best-practices-for-transplant-center-and-opo-interaction-7310
https://atc.digitellinc.com/p/s/technical-challenges-in-liver-transplantation-7315
https://atc.digitellinc.com/p/s/challenging-intraoperative-reconstruction-problems-cases-with-audience-response-and-panel-discussion-7325
https://atc.digitellinc.com/p/s/surgical-management-challenges-after-liver-transplant-cases-with-audience-response-and-panel-discussion-7330
https://atc.digitellinc.com/p/s/new-avenues-for-developing-biomarkers-7335
https://atc.digitellinc.com/p/s/aptamer-based-biomarker-discovery-7340
https://atc.digitellinc.com/p/s/monitoring-donor-derived-dna-as-a-marker-of-graft-injury-7345
https://atc.digitellinc.com/p/s/impact-of-belatacept-in-the-clinic-7355
https://atc.digitellinc.com/p/s/early-conversion-to-a-mtor-using-a-belatacept-based-regimen-7370
https://atc.digitellinc.com/p/s/planned-conversion-from-a-cni-based-regimen-to-belatacept-7375
https://atc.digitellinc.com/p/s/detecting-and-dealing-with-non-adherence-in-transplant-recipients-7380
https://atc.digitellinc.com/p/s/methods-and-technologies-to-improve-adherence-in-the-transplant-recipients-7395
https://atc.digitellinc.com/p/s/adherence-in-transplantation-applying-findings-from-the-malt-and-bright-studies-7400
https://atc.digitellinc.com/p/s/malt-study-methods-implementation-primary-and-secondary-analysis-results-7405
https://atc.digitellinc.com/p/s/insights-from-malt-effects-of-barriers-to-adherence-transition-of-responsibility-for-care-and-psychosocial-variables-7410
https://atc.digitellinc.com/p/s/putting-it-all-together-implications-of-malt-results-to-clinical-research-and-to-post-transplant-care-7415
https://atc.digitellinc.com/p/s/how-can-the-bright-study-transform-transplant-programs-care-provision-7430
https://atc.digitellinc.com/p/s/concurrent-session-kidney-transplantation-allocation-discard-and-hcv-7435
https://atc.digitellinc.com/p/s/where-are-the-kdpi-0-20-percent-kidneys-going-in-the-new-kas-a-major-allocation-shift-7440
https://atc.digitellinc.com/p/s/understanding-the-initial-rise-in-kidney-discard-rates-observed-post-kas-7445
https://atc.digitellinc.com/p/s/kidney-donor-profile-index-trend-analyses-7450
https://atc.digitellinc.com/p/s/use-of-small-10kg-kidney-donors-in-the-us-7455
https://atc.digitellinc.com/p/s/utilization-and-post-transplant-outcomes-associated-with-hepatitis-c-plus-donor-kidneys-in-the-advent-of-direct-acting-antivirals-7460
https://atc.digitellinc.com/p/s/superior-waitlist-and-equivalent-transplant-outcomes-among-hepatitis-c-rna-positive-patients-who-are-willing-to-accept-hepatitis-c-seropositive-kidneys-7465
https://atc.digitellinc.com/p/s/daas-rapidly-clear-hcv-viremia-in-recipients-of-hcv-plus-donor-kidneys-7470
https://atc.digitellinc.com/p/s/concurrent-session-viral-hepatitis-7475
https://atc.digitellinc.com/p/s/utilization-and-discard-of-hcv-plus-donor-livers-in-the-advent-of-direct-acting-antiviral-therapy-7480
https://atc.digitellinc.com/p/s/hepatitis-e-virus-hev-infection-among-kidney-transplant-patients-in-a-northeast-us-center-7485
https://atc.digitellinc.com/p/s/high-efficacy-of-ledipasvirsofosbuvir-with-ribavirin-in-hcv-genotype-1-infected-patients-with-decompensated-liver-disease-analysis-by-meld-score-from-the-solar-1-and-solar-2-trials-7495
https://atc.digitellinc.com/p/s/time-course-of-hepatic-graft-function-improvement-after-ledipasivirsofosbuvir-treatment-in-liver-transplant-recipients-with-hcv-and-fibrosis-or-cirrhosis-who-achieved-svr-7500
https://atc.digitellinc.com/p/s/decline-of-hcv-rna-and-core-antigen-predictors-of-achieving-svr-in-transplant-recipients-undergoing-daa-therapy-7505
https://atc.digitellinc.com/p/s/large-single-center-experience-of-sofosbuvir-and-ledipasvir-therapy-for-the-treatment-of-post-liver-transplant-patients-with-hepatitis-c-virus-7510
https://atc.digitellinc.com/p/s/concurrent-session-identifying-antibodies-tools-of-the-trade-7515
https://atc.digitellinc.com/p/s/relationship-between-mean-fluorescence-intensity-and-c1qc3d-fixing-capacities-of-anti-hla-antibodies-7520
https://atc.digitellinc.com/p/s/fc-receptor-binding-assay-for-functional-assessment-of-hla-antibodies-initial-clinical-validation-7525
https://atc.digitellinc.com/p/s/blindspots-in-hla-antibody-testing-recognition-is-first-step-to-nirvana-7530
https://atc.digitellinc.com/p/s/an-improved-method-for-the-evaluation-of-microvascular-inflammation-in-renal-allograft-biopsies-7535
https://atc.digitellinc.com/p/s/blocking-fc-receptor-in-flow-cytometric-crossmatch-refining-an-old-assay-to-improve-patient-management-7540
https://atc.digitellinc.com/p/s/effect-of-complement-inhibition-therapy-eculizumab-in-patients-with-c1q-binding-donor-specific-anti-hla-antibodies-a-molecular-appraisal-7545
https://atc.digitellinc.com/p/s/composite-score-to-define-the-risk-of-allograft-loss-after-standard-of-care-treatment-of-antibody-mediated-rejection-in-kidney-transplantation-7550
https://atc.digitellinc.com/p/s/concurrent-session-kidney-immune-monitoring-2-7555
https://atc.digitellinc.com/p/s/mining-the-human-proteome-for-monitoring-renal-transplant-injury-7560
https://atc.digitellinc.com/p/s/common-molecular-features-of-human-kidney-transplant-rejection-reflect-mechanistic-sharing-between-t-cell-mediated-and-antibody-mediated-rejection-7565
https://atc.digitellinc.com/p/s/cd57-plus-cd4-t-cells-persist-in-the-periphery-following-kidney-transplantation-7570
https://atc.digitellinc.com/p/s/pre-transplant-panel-of-reactive-t-cells-prt-as-an-independent-predictor-of-2-year-kidney-graft-function-7575
https://atc.digitellinc.com/p/s/human-b-cell-cytokines-predict-renal-allograft-rejection-and-early-transplant-outcomes-7580
https://atc.digitellinc.com/p/s/elevated-intragraft-expression-of-innate-immunity-and-cell-death-related-markers-characterizes-deceased-donor-conditions-and-is-a-risk-factor-for-adverse-graft-outcome-7585
https://atc.digitellinc.com/p/s/concurrent-session-molecular-and-bio-markers-in-hearts-and-vads-a-new-hope-7595
https://atc.digitellinc.com/p/s/serial-peripheral-blood-mononuclear-cell-expression-profiling-reveals-inflammatory-genomic-storm-following-mechanical-circulatory-support-surgery-7600
https://atc.digitellinc.com/p/s/a-p2x7r-mutation-with-hypermetabolic-t-cells-th1th17-skewing-and-reduced-cardiac-allograft-survival-7605
https://atc.digitellinc.com/p/s/natural-killer-cd16fcr-profiles-may-associate-with-enhanced-humoral-responsiveness-in-heart-transplant-recipients-with-cardiac-allograft-vasculopathy-7610
https://atc.digitellinc.com/p/s/primary-graft-failure-following-cardiac-transplantation-is-associated-with-elevated-pre-transplant-levels-of-pro-inflammatory-factors-7615
https://atc.digitellinc.com/p/s/a-new-diagnostic-score-for-microvascular-inflammation-in-antibody-mediated-rejection-in-heart-transplantation-7620
https://atc.digitellinc.com/p/s/donor-specific-antibody-is-a-major-independent-predictor-of-accelerated-heart-allograft-vasculopathy-cav-7625
https://atc.digitellinc.com/p/s/elevated-urinary-11-dehydrothromboxane-b2-is-associated-with-increased-bleeding-risk-in-left-ventricular-assist-device-patients-7630
https://atc.digitellinc.com/p/s/concurrent-session-living-donor-liver-transplantation-7635
https://atc.digitellinc.com/p/s/live-donor-liver-transplantation-for-nash-the-toronto-experience-7640
https://atc.digitellinc.com/p/s/live-donor-champion-program-time-to-redefine-living-liver-donation-7645
https://atc.digitellinc.com/p/s/hepatic-hemodynamics-hd-and-portal-flow-modulation-pm-tactical-use-in-small-for-size-sfs-live-donor-liver-transplantation-ldlt-7650
https://atc.digitellinc.com/p/s/durable-clinical-and-immunologic-advantage-of-living-donor-liver-transplantation-ldlt-in-children-7655
https://atc.digitellinc.com/p/s/impact-of-preoperative-body-composition-on-outcomes-after-living-donor-liver-transplantation-7665
https://atc.digitellinc.com/p/s/improving-the-efficiency-safety-and-cost-of-evaluating-living-donor-liver-candidates-using-single-sequence-mri-7670
https://atc.digitellinc.com/p/s/concurrent-session-novel-predictors-of-outcome-big-data-and-technology-7675
https://atc.digitellinc.com/p/s/implementation-of-telehealth-is-associated-with-improved-timeliness-of-kidney-transplant-waitlist-evaluation-at-a-va-center-7680
https://atc.digitellinc.com/p/s/provider-attitudes-toward-shared-mobile-decision-aid-utilized-among-patients-evaluated-for-kidney-transplantation-ichoose-kidney-randomized-trial-7685
https://atc.digitellinc.com/p/s/intervention-development-for-the-uaullocation-usuystem-ucuhanges-for-ueuquity-in-kidunuey-uturansplantation-ascent-study-7690
https://atc.digitellinc.com/p/s/predictors-of-patient-uncertainty-regarding-treatment-options-among-end-stage-renal-disease-patients-evaluated-for-kidney-transplantation-7695
https://atc.digitellinc.com/p/s/clinical-prediction-tool-to-guide-referral-of-elderly-dialysis-patients-for-kidney-transplant-evaluation-7700
https://atc.digitellinc.com/p/s/the-association-of-life-expectancy-by-resident-zip-code-and-kidney-transplant-outcomes-what-is-true-baseline-risk-7705
https://atc.digitellinc.com/p/s/role-of-cardiac-evaluation-and-management-in-kidney-and-liver-transplant-candidates-7710
https://atc.digitellinc.com/p/s/concurrent-session-clinical-science-tolerance-clinical-studies-7715
https://atc.digitellinc.com/p/s/early-post-transplant-immunosuppression-is-withdrawal-final-outcomes-of-the-itn030st-awish-study-7720
https://atc.digitellinc.com/p/s/primary-outcome-of-iwith-a-multi-center-clinical-trial-of-complete-immunosuppression-withdrawal-isw-in-stable-pediatric-liver-transplant-lt-recipients-7725
https://atc.digitellinc.com/p/s/seven-year-follow-up-of-a-phase-2-clinical-trial-to-induce-tolerance-in-living-donor-renal-transplant-recipients-7730
https://atc.digitellinc.com/p/s/hla-identical-or-haploidentical-combined-kidney-and-bone-marrow-transplantation-for-multiple-myeloma-with-end-stage-renal-failure-7735
https://atc.digitellinc.com/p/s/tolerance-induction-with-donor-bone-marrow-transplantation-in-kidney-transplantation-7740
https://atc.digitellinc.com/p/s/clonal-expansion-of-donor-specific-tregs-following-combined-kidney-and-bone-marrow-transplantation-7745
https://atc.digitellinc.com/p/s/results-of-a-phase-1-trial-of-treg-adoptive-cell-transfer-tract-in-de-novo-living-donor-kidney-transplant-recipients-7750
https://atc.digitellinc.com/p/s/initial-experience-with-donor-specific-tregs-in-kidney-transplantation-7755
https://atc.digitellinc.com/p/s/concurrent-session-various-viruses-vaccines-and-sot-7760
https://atc.digitellinc.com/p/s/evaluation-of-a-novel-global-immunity-assay-to-predict-infections-in-organ-transplant-recipients-7765
https://atc.digitellinc.com/p/s/diversity-of-influenza-antibody-repertoire-in-transplant-recipients-with-natural-influenza-infection-7770
https://atc.digitellinc.com/p/s/early-conversion-to-everolimus-in-ide-novoi-renal-transplant-recipients-incidence-of-viral-infections-in-the-randomized-controlled-elevate-study-7775
https://atc.digitellinc.com/p/s/assessment-of-chikungunya-igm-prevalence-among-deceased-organ-and-tissue-donors-using-two-enzyme-immunoassay-eia-kits-7780
https://atc.digitellinc.com/p/s/viral-gastroenteritis-in-adult-and-pediatric-solid-organ-transplant-sot-patients-7785
https://atc.digitellinc.com/p/s/one-year-post-vzv-booster-still-equal-response-in-renal-transplant-recipients-compared-to-healthy-persons-7790
https://atc.digitellinc.com/p/s/high-incidence-of-herpes-zoster-after-kidney-liver-heart-and-lung-transplantation-7795
https://atc.digitellinc.com/p/s/foxp3-controls-oxidative-phosphorylation-in-regulatory-t-cells-7805
https://atc.digitellinc.com/p/s/direct-il-33-stimulation-of-t-regulatory-cells-via-suppression-of-tumorigenicity-2-st2-is-required-for-effective-control-of-alloimmune-responses-7810
https://atc.digitellinc.com/p/s/il-2-therapy-restores-the-impaired-function-of-regulatory-t-cells-induced-by-calcineurin-inhibitors-in-liver-transplantation-7815
https://atc.digitellinc.com/p/s/t-bet-regulates-ntreg-stability-and-suppression-in-an-islet-allograft-model-7820
https://atc.digitellinc.com/p/s/deptor-inhibits-mtorc1-in-cd4sup-plus-sup-t-cells-and-increases-treg-function-by-stabilizing-foxp3-expression-7825
https://atc.digitellinc.com/p/s/human-and-mouse-treg-use-lymphotoxin-for-migration-across-lymphatic-endothelium-7830
https://atc.digitellinc.com/p/s/nadsup-plus-suppromotes-allograft-survival-independently-of-cd4sup-plus-supcd25sup-plus-supfoxp3sup-plus-sup-regulatory-t-cells-7835
https://atc.digitellinc.com/p/s/concurrent-session-b-cells-in-rejection-and-tolerance-animal-models-7840
https://atc.digitellinc.com/p/s/prolongation-of-graft-survival-by-anti-tim1-is-specifically-mediated-by-il-10-plus-bregs-and-is-not-dependent-on-il-35-or-plasma-cell-differentiation-7845
https://atc.digitellinc.com/p/s/fate-of-endogenous-alloreactive-b-cells-in-transplant-tolerance-7850
https://atc.digitellinc.com/p/s/b-lymphocytes-prevent-transplantation-tolerance-in-nod-mice-by-limiting-cd4-treg-function-7855
https://atc.digitellinc.com/p/s/expansion-of-regulatory-b-cells-and-their-potential-role-in-transplantation-tolerance-7860
https://atc.digitellinc.com/p/s/tracking-endogenous-b-cells-recognizing-allogeneic-mhc-class-ii-in-mice-7865
https://atc.digitellinc.com/p/s/belatacept-does-not-inhibit-plasmablast-formation-supported-by-follicular-t-helper-cells-but-favors-the-development-of-transitional-regulatory-b-cells-in-kidney-transplant-patients-7870
https://atc.digitellinc.com/p/s/targeting-ifn-g-expressing-tim-4sup-plus-supb-effector-beff-cells-as-a-novel-strategy-to-prevent-allograft-rejection-7875
https://atc.digitellinc.com/p/s/concurrent-session-kidney-pediatrics-7880
https://atc.digitellinc.com/p/s/pediatric-access-to-kidney-transplantation-under-kas-7885
https://atc.digitellinc.com/p/s/early-hospital-readmission-following-pediatric-kidney-transplantation-7890
https://atc.digitellinc.com/p/s/adherence-patterns-in-adolescent-and-young-adult-kidney-transplant-recipients-7895
https://atc.digitellinc.com/p/s/angiotensin-ii-type-1-receptor-antibodies-are-associated-with-allograft-loss-in-pediatric-renal-transplantation-7900
https://atc.digitellinc.com/p/s/predictors-of-early-rejection-and-allograft-failure-in-pediatric-kidney-transplantation-impact-of-histology-and-behavior-7905
https://atc.digitellinc.com/p/s/acute-kidney-injury-aki-associated-with-chronic-kidney-disease-ckd-in-paediatric-non-kidney-transplant-recipients-7910
https://atc.digitellinc.com/p/s/graft-outcomes-in-pediatric-kidney-transplants-are-better-with-laparoscopic-donor-nephrectomy-and-high-volume-centers-7915
https://atc.digitellinc.com/p/s/concurrent-session-kidney-induction-therapy-1-7920
https://atc.digitellinc.com/p/s/pre-transplant-igm-to-post-transplant-igg-dsa-conversion-may-be-affected-by-immunosuppression-7925
https://atc.digitellinc.com/p/s/long-term-outcomes-of-atg-versus-il-2-receptor-antagonist-in-low-risk-kidney-transplant-recipients-donor-factors-7930
https://atc.digitellinc.com/p/s/everolimus-evr-versus-mycophenolate-sodium-mps-for-recipients-of-kidney-transplants-from-expanded-criteria-donors-ecd-receiving-anti-thymocyte-globulin-r-atg-and-tacrolimus-tac-7935
https://atc.digitellinc.com/p/s/earlier-repletion-of-lymphocytes-after-alemtuzumab-induction-is-associated-with-a-lower-incidence-of-infection-following-renal-transplantation-7940
https://atc.digitellinc.com/p/s/induction-therapy-with-rabbit-antithymocyte-globulin-ratg-thymoglobulinsup-r-sup-vs-basiliximab-after-kidney-transplantation-a-health-economic-analysis-from-a-german-perspective-7945
https://atc.digitellinc.com/p/s/evaluation-of-a-risk-stratified-induction-immunosuppression-protocol-utilizing-low-dose-antithymocyte-globulin-in-renal-transplantation-7950
https://atc.digitellinc.com/p/s/b-cell-signature-profiling-in-kidney-transplant-patients-on-thymoglobulin-7955
https://atc.digitellinc.com/p/s/concurrent-session-innate-immunity-in-rejection-and-tolerance-animal-models-7960
https://atc.digitellinc.com/p/s/toll-like-receptor-tlr-9-induced-resistance-to-murine-cardiac-allograft-tolerance-is-dependent-upon-c3a-and-c5a-receptor-c3arc5ar-signaling-7965
https://atc.digitellinc.com/p/s/c5a-induces-csf1-dependent-regulatory-macrophage-mreg-development-required-for-murine-allograft-tolerance-7970
https://atc.digitellinc.com/p/s/gsk3beta-regulates-macrophage-pro-inflammatory-immune-activation-via-ampk-mediated-induction-of-small-heterodimer-partner-shp-7975
https://atc.digitellinc.com/p/s/macrophage-specific-deletion-of-rhoa-impedes-macrophage-functions-and-abrogates-chronic-rejection-of-cardiac-allograft-7980
https://atc.digitellinc.com/p/s/donor-derived-monocytes-migrate-to-the-contralateral-lung-and-cause-neutrophilia-following-single-lung-transplant-7985
https://atc.digitellinc.com/p/s/modification-of-dc-phenotype-and-function-via-targeted-porous-silicon-nanoparticles-7990
https://atc.digitellinc.com/p/s/distinct-phenotype-and-function-of-plasmacytoid-dendritic-cells-from-kidney-allografts-in-tolerant-recipients-7995
https://atc.digitellinc.com/p/s/concurrent-session-kidney-transplant-recipient-long-term-outcomes-session-i-8000
https://atc.digitellinc.com/p/s/long-term-death-censored-graft-loss-in-the-dekaf-study-8005
https://atc.digitellinc.com/p/s/post-transplant-monitoring-of-donor-specific-anti-hla-antibodies-and-their-characteristics-improves-risk-stratification-of-kidney-allograft-loss-8010
https://atc.digitellinc.com/p/s/levels-of-vegf-c-plgf-and-follistatin-at-12-months-post-transplantation-are-associated-with-increased-risk-for-long-term-progressive-renal-dysfunction-8015
https://atc.digitellinc.com/p/s/predictors-of-egfr-slope-at-one-year-in-kidney-transplants-a-big-data-approach-8020
https://atc.digitellinc.com/p/s/natural-history-of-response-to-wounding-in-human-kidney-transplants-8025
https://atc.digitellinc.com/p/s/impact-of-machine-perfusion-on-long-term-kidney-transplant-outcomes-8030
https://atc.digitellinc.com/p/s/optimal-donorrecipient-pairing-for-high-kdpi-grafts-can-yield-similar-survival-to-medium-kdpi-grafts-8035
https://atc.digitellinc.com/p/s/concurrent-session-belatacept-and-steroid-withdrawal-in-kidney-transplantation-8040
https://atc.digitellinc.com/p/s/a-pathway-to-belatacept-monotherapy-alemtuzumab-belatacept-and-rapamycin-for-kidney-transplantation-8045
https://atc.digitellinc.com/p/s/the-optimal-time-point-for-steroid-withdrawal-after-kidney-transplantation-is-one-year-after-engraftment-8050
https://atc.digitellinc.com/p/s/graft-survival-of-steroid-avoidance-protocols-in-pediatric-kidney-transplantation-a-propensity-score-analysis-8055
https://atc.digitellinc.com/p/s/early-steroid-withdrawal-in-african-american-kidney-transplant-recipients-a-propensity-score-matching-analysis-8060
https://atc.digitellinc.com/p/s/everolimus-plus-reduced-exposure-cyclosporin-versus-mycophenolic-acid-plus-cyclosporin-seven-year-follow-up-of-australia-and-new-zealand-kidney-transplant-recipients-in-the-a2309-study-8065
https://atc.digitellinc.com/p/s/everolimuslow-tacrolimustac-compared-to-mparegulartac-for-renal-transplantation-in-the-elderly-recipient-preliminary-analysis-of-the-neverold-trial-8070
https://atc.digitellinc.com/p/s/comparison-of-clinical-outcomes-of-belatacept-and-tacrolimus-based-immunosuppression-in-renal-transplant-recipients-8075
https://atc.digitellinc.com/p/s/concurrent-session-antibody-mediated-rejection-in-kidney-transplantation-de-novo-dsa-8080
https://atc.digitellinc.com/p/s/de-novo-anti-hla-dsa-characteristics-and-subclinical-antibody-mediated-kidney-allograft-injuries-8085
https://atc.digitellinc.com/p/s/significant-association-of-vitamin-d-receptor-vdr-gene-polymorphism-and-incidence-of-de-novo-dsa-in-renal-transplantation-8090
https://atc.digitellinc.com/p/s/phenotype-and-outcome-of-antibody-mediated-rejection-due-to-pre-existing-and-emde-novo-emdsa-in-kidney-recipients-8095
https://atc.digitellinc.com/p/s/epitope-load-is-predictive-of-de-novo-donor-specific-antibodies-occurrence-in-renal-transplant-recipients-after-conversion-from-cyclosporine-to-everolimus-8100
https://atc.digitellinc.com/p/s/igm-donor-specific-antibodies-are-frequently-associated-with-c1q-binding-dndsa-in-renal-transplant-recipients-8105
https://atc.digitellinc.com/p/s/randomized-controlled-study-evaluating-adherence-monitoring-with-electronic-feedback-on-reducing-renal-allograft-rejection-8110
https://atc.digitellinc.com/p/s/increased-access-to-transplantation-of-highly-sensitized-patients-facilitated-by-the-new-kidney-allocation-system-8115
https://atc.digitellinc.com/p/s/concurrent-session-acute-kidney-injury-and-recovery-after-transplantation-8120
https://atc.digitellinc.com/p/s/ykl-40-predicts-renal-recovery-in-deceased-donor-transplantation-8125
https://atc.digitellinc.com/p/s/deceased-donor-urine-c5a-predicts-donor-and-recipient-acute-kidney-injury-8130
https://atc.digitellinc.com/p/s/financial-cost-of-cold-ischemia-time-in-kidney-transplantation-8135
https://atc.digitellinc.com/p/s/many-discarded-kidneys-are-similar-to-kidneys-accepted-for-transplantation-as-judged-by-their-histologic-lesions-and-molecular-aki-scores-8140
https://atc.digitellinc.com/p/s/delayed-graft-function-dgf-does-not-accelerate-progression-of-fibrosis-during-the-first-year-after-deceased-donor-kidney-transplantation-8145
https://atc.digitellinc.com/p/s/influence-of-akin-stage-on-the-outcome-of-deceased-donor-kidney-transplantation-ddktx-8150
https://atc.digitellinc.com/p/s/is-prolonged-cold-ischemia-a-contraindication-to-using-kidneys-from-acute-kidney-injury-donors-8155
https://atc.digitellinc.com/p/s/concurrent-session-xenotransplantation-animal-models-8160
https://atc.digitellinc.com/p/s/the-impact-of-sequential-gene-modifications-on-cardiac-xenograft-survival-8165
https://atc.digitellinc.com/p/s/inclusion-of-human-tissue-factor-pathway-inhibitor-or-thrombomodulin-transgenes-attenuates-critical-consumptive-thrombocytopenia-in-cardiac-xenotransplantation-8170
https://atc.digitellinc.com/p/s/costimulation-blockade-by-anti-cd40-antibody-prevents-humoral-and-cellular-rejection-of-heterotopic-pig-cardiac-xenograft-8175
https://atc.digitellinc.com/p/s/comparison-of-early-engraftment-immunobiology-of-xenoislets-and-alloislets-in-a-dual-transplant-model-8180
https://atc.digitellinc.com/p/s/porcine-islets-engineered-to-display-sa-fasl-protein-on-their-surface-induce-tolerance-in-mice-following-transplantation-into-the-liver-or-under-the-kidney-capsule-8185
https://atc.digitellinc.com/p/s/impact-of-mixed-xenogeneic-porcine-hematopoietic-chimerism-on-human-nk-cell-recognition-in-a-humanized-mouse-model-8190
https://atc.digitellinc.com/p/s/human-leukocyte-antigen-e-expression-on-porcine-galtkohcd46-cells-improves-ex-vivo-xenograft-survival-and-attenuates-injury-8195
https://atc.digitellinc.com/p/s/concurrent-session-pediatric-liver-transplant-8200
https://atc.digitellinc.com/p/s/increased-waitlist-death-and-removal-in-pediatric-liver-transplant-recipients-denied-exception-requests-8205
https://atc.digitellinc.com/p/s/long-term-outcomes-after-pediatric-liver-transplantation-for-malignant-liver-tumors-effects-of-era-and-age-8210
https://atc.digitellinc.com/p/s/sudden-increase-in-allocation-score-for-pediatric-liver-transplant-candidates-predicts-waitlist-mortality-8215
https://atc.digitellinc.com/p/s/long-term-outcome-of-de-novo-autoimmune-hepatitis-in-pediatric-recipients-of-liver-transplantation-8220
https://atc.digitellinc.com/p/s/the-medication-level-variability-index-mlvi-a-behavioral-biomarker-predicts-late-allograft-rejection-in-pediatric-liver-transplant-recipients-a-prospective-multisite-study-8225
https://atc.digitellinc.com/p/s/utility-of-a-routine-bench-cholangiogram-for-deceased-split-liver-procedure-8230
https://atc.digitellinc.com/p/s/concurrent-session-late-breaking-8235
https://atc.digitellinc.com/p/s/pediatric-heart-transplantation-across-a-positive-cross-match-is-associated-with-high-rates-of-amr-but-no-difference-in-short-term-graft-loss-dysfunction-and-death-ctotc-04-study-8240
https://atc.digitellinc.com/p/s/share35-liver-allocation-is-associated-with-increased-early-graft-failure-rate-8245
https://atc.digitellinc.com/p/s/development-and-validation-of-a-molecular-microscope-diagnostic-system-mmdx-for-heart-transplant-biopsies-8250
https://atc.digitellinc.com/p/s/banked-ebv-specific-t-cells-for-treatment-of-rituximab-refractory-ebv-plus-b-cell-lymphoma-in-solid-organ-transplantation-recipients-8255
https://atc.digitellinc.com/p/s/early-proteomic-predictors-of-late-chronic-kidney-disease-in-liver-transplant-recipients-8260
https://atc.digitellinc.com/p/s/concurrent-session-medication-errors-variability-and-adherence-8265
https://atc.digitellinc.com/p/s/predictive-model-for-medication-errors-in-a-chronic-kidney-transplant-clinic-8270
https://atc.digitellinc.com/p/s/pharmacist-impact-on-medication-errors-in-a-chronic-kidney-transplant-clinic-8275
https://atc.digitellinc.com/p/s/high-risk-pharmacogenetic-pgx-variants-in-kidney-transplant-tx-recipients-8280
https://atc.digitellinc.com/p/s/p-glycoprotein-function-association-with-race-gender-and-tacrolimus-pharmacokinetics-8285
https://atc.digitellinc.com/p/s/variation-in-co-medication-use-according-to-kidney-transplant-immunosuppressive-regimen-application-of-integrated-registry-and-pharmacy-claims-data-8290
https://atc.digitellinc.com/p/s/non-adherence-is-associated-with-increased-risk-of-rejection-and-graft-loss-8295
https://atc.digitellinc.com/p/s/does-post-transplant-adherence-come-at-a-cost-8300
https://atc.digitellinc.com/p/s/concurrent-session-kidney-desensitization-8305
https://atc.digitellinc.com/p/s/a-prospective-carfilzomib-based-desensitization-trial-phase-1-results-8310
https://atc.digitellinc.com/p/s/long-term-assessment-of-the-safety-and-efficacy-of-ivig-and-rituximab-based-desensitization-des-8315
https://atc.digitellinc.com/p/s/impact-of-the-new-kidney-allocation-system-kas-on-transplant-rates-and-outcomes-in-broadly-hla-sensitized-hs-patients-transplanted-after-desensitization-des-8320
https://atc.digitellinc.com/p/s/survival-benefit-of-living-donor-aboi-kidney-transplantation-8325
https://atc.digitellinc.com/p/s/incidence-and-impact-of-de-novo-dsa-dndsa-formation-on-transplant-outcomes-in-hla-sensitized-hs-patients-transplanted-after-ivg-plus-rituximab-desensitization-des-8330
https://atc.digitellinc.com/p/s/rnaseq-transcriptome-analysis-of-bone-marrow-cd138sup-plus-sup-plasma-cell-responses-to-carfilzomib-monotherapy-desensitization-8335
https://atc.digitellinc.com/p/s/anti-angiotensin-ii-type-1-receptor-antibody-reduction-with-proteasome-inhibitor-based-desensitization-8340
https://atc.digitellinc.com/p/s/concurrent-session-challenges-to-graft-survival-and-tolerance-animal-models-8345
https://atc.digitellinc.com/p/s/cd4-t-cell-mediated-help-is-required-for-intra-allograft-proliferation-of-endogenous-memory-cd8-t-cells-and-their-ability-to-mediate-rejection-of-cardiac-allografts-subjected-to-prolonged-ischemia-8350
https://atc.digitellinc.com/p/s/absence-of-receptors-for-c3a-or-c5a-prevent-alloreactive-cd8-t-effector-cell-teff-expansion-but-differentially-impact-memory-tmem-persistence-posttransplantation-8355
https://atc.digitellinc.com/p/s/combined-cd122-and-costimulation-blockade-prolongs-allograft-survival-by-controlling-expansion-and-effector-function-of-memory-cd8-t-cells-8360
https://atc.digitellinc.com/p/s/ageing-as-a-barrier-to-transplant-tolerance-8365
https://atc.digitellinc.com/p/s/enhanced-il-6-production-impedes-transplant-tolerance-induction-in-lupus-prone-mice-8370
https://atc.digitellinc.com/p/s/abrogating-donor-derived-myd88-signaling-impairs-the-recruitment-of-recipient-neutrophils-and-cd8-t-cells-into-lung-allografts-in-mice-8375
https://atc.digitellinc.com/p/s/fecal-microbiota-transplant-results-in-durable-changes-to-host-microbiota-that-correlate-with-allograft-outcome-8380
https://atc.digitellinc.com/p/s/concurrent-session-cmv-immune-monitoring-and-microrna-responses-8385
https://atc.digitellinc.com/p/s/cmv-immune-monitoring-with-a-cmv-elispot-test-in-kidney-transplant-patients-8390
https://atc.digitellinc.com/p/s/the-presence-of-cmv-specific-t-cells-in-cmv-seronegative-kidney-transplant-recipients-predicts-outcome-after-kidney-transplantation-8395
https://atc.digitellinc.com/p/s/an-interventional-study-evaluating-cell-mediated-immunity-to-guide-therapy-for-cmv-viremia-8400
https://atc.digitellinc.com/p/s/cytometric-deep-profiling-of-the-cd8-plus-t-cell-compartment-in-transplant-patients-with-cmv-viremia-8405
https://atc.digitellinc.com/p/s/assessing-return-of-cmv-specific-cellular-immunity-using-the-t-spoticmv-isoon-after-kidney-transplant-with-thymoglobulin-8410
https://atc.digitellinc.com/p/s/association-of-cytomegalovirus-specific-t-cell-mediated-immunity-with-the-risk-of-cmv-infection-occurrence-in-kidney-transplant-recipients-8415
https://atc.digitellinc.com/p/s/human-microrna-responses-are-predictive-of-cmv-reactivation-following-solid-organ-transplant-8420
https://atc.digitellinc.com/p/s/concurrent-session-clinical-pancreas-transplantation-1-8425
https://atc.digitellinc.com/p/s/is-facilitated-pancreas-allocation-effective-8430
https://atc.digitellinc.com/p/s/how-did-the-new-kidney-and-pancreas-allocation-systems-effect-pancreas-utilization-in-the-first-six-months-8435
https://atc.digitellinc.com/p/s/protective-impact-of-the-kidney-in-spk-transplants-mechanisms-for-improved-outcomes-compared-with-solitary-transplants-8440
https://atc.digitellinc.com/p/s/the-survival-benefit-of-pancreas-andor-kidney-transplantation-for-patients-with-type-1-diabetes-8445
https://atc.digitellinc.com/p/s/impact-of-early-hospital-readmission-following-simultaneous-pancreas-kidney-transplantation-8450
https://atc.digitellinc.com/p/s/simultaneous-pancreas-and-kidney-transplantation-for-type-2-diabetes-8455
https://atc.digitellinc.com/p/s/donation-after-cardiac-death-dose-not-impact-short-and-long-term-graft-outcomes-in-simultaneous-pancreas-and-kidney-transplantation-8460
https://atc.digitellinc.com/p/s/concurrent-session-pathways-of-allograft-rejection-animal-models-8465
https://atc.digitellinc.com/p/s/the-role-of-pi3kgamma-and-pi3kdelta-in-alloimmunity-8470
https://atc.digitellinc.com/p/s/transfer-of-donor-derived-exosomes-to-recipient-ag-presenting-cells-is-critical-for-allograft-recognition-8475
https://atc.digitellinc.com/p/s/nk-activating-mcmv-strain-is-associated-with-increased-murine-renal-transplant-injury-8485
https://atc.digitellinc.com/p/s/the-20s-proteasome-active-within-exosome-like-vesicles-released-by-apoptotic-cells-accelerates-rejection-8490
https://atc.digitellinc.com/p/s/blocking-mhc-class-ii-on-human-endothelium-mitigates-acute-rejection-of-vessel-allografts-by-effector-memory-t-cells-8495
https://atc.digitellinc.com/p/s/characterization-of-human-islet-transplant-specific-exosomes-in-a-xenoislet-transplantation-model-8500
https://atc.digitellinc.com/p/s/concurrent-session-liver-transplantation-peri-operative-considerations-8505
https://atc.digitellinc.com/p/s/pre-listing-prescription-narcotic-use-survival-implications-in-liver-transplantation-8510
https://atc.digitellinc.com/p/s/non-invasive-biomarkers-for-graft-quality-and-outcome-post-liver-transplantation-8515
https://atc.digitellinc.com/p/s/hospitalizations-for-cardiovascular-disease-after-liver-transplantation-in-the-united-states-epidemiology-outcomes-and-costs-8520
https://atc.digitellinc.com/p/s/experience-using-a-discharge-calculator-for-discharge-planning-post-liver-transplantation-olt-8525
https://atc.digitellinc.com/p/s/probability-risk-factors-and-long-term-outcomes-of-biliary-complications-after-hepatic-artery-thrombosis-in-adult-liver-transplant-recipients-20-years-experience-from-a-single-center-8530
https://atc.digitellinc.com/p/s/biliary-epithelial-damage-regenerative-capacity-and-local-immune-response-after-cold-storage-of-dbd-livers-determine-biliary-complications-after-liver-transplantation-8535
https://atc.digitellinc.com/p/s/when-living-donor-liver-allografts-fail-exploring-the-pitfalls-of-retransplantation-using-deceased-donor-organs-8540
https://atc.digitellinc.com/p/s/concurrent-session-metabolic-complications-in-kidney-transplantation-8545
https://atc.digitellinc.com/p/s/denosumab-prevents-bone-mineral-density-loss-in-ide-novoi-kidney-transplant-recipients-results-from-a-randomized-controlled-trial-8550
https://atc.digitellinc.com/p/s/treatments-against-renin-angiotensin-aldosterone-system-could-influence-fgf23-and-klotho-levels-in-renal-transplant-recipients-8555
https://atc.digitellinc.com/p/s/effect-of-angiotensin-converting-enzyme-inhibitor-acei-or-angiotensin-receptor-blockade-arb-exposure-on-intragraft-gene-expression-of-kidney-transplant-patients-8560
https://atc.digitellinc.com/p/s/serum-bicarbonate-and-long-term-outcomes-in-kidney-transplant-recipients-8565
https://atc.digitellinc.com/p/s/enhanced-activation-of-hemostasis-during-kidney-transplantation-in-patients-on-dialysis-compared-to-pre-emptively-transplanted-patients-8570
https://atc.digitellinc.com/p/s/pre-transplant-bariatric-surgery-and-one-year-graft-loss-risk-in-kidney-transplants-8575
https://atc.digitellinc.com/p/s/smoking-exposure-among-kidney-allograft-recipients-and-outcomes-after-transplant-8580
https://atc.digitellinc.com/p/s/molecular-microscopic-approach-to-chronic-allograft-injury-8585
https://atc.digitellinc.com/p/s/chronic-t-cell-mediated-rejection-does-it-exist-and-how-to-diagnose-by-molecular-microscope-8595
https://atc.digitellinc.com/p/s/evaluation-of-molecular-profiles-in-calcineurin-inhibitor-toxicity-after-kidney-transplant-input-to-chronic-allograft-dysfunction-8600
https://atc.digitellinc.com/p/s/fat-and-inflammation-basic-8605
https://atc.digitellinc.com/p/s/the-adipose-tissue-immune-system-8610
https://atc.digitellinc.com/p/s/diet-and-inflammation-8615
https://atc.digitellinc.com/p/s/hyperlipidemia-prevents-transplant-tolerance-8620
https://atc.digitellinc.com/p/s/liver-retransplantation-who-and-how-8625
https://atc.digitellinc.com/p/s/indications-and-selection-of-the-optimal-candidate-for-retransplantation-8630
https://atc.digitellinc.com/p/s/surgical-controversies-and-obstacles-in-liver-re-transplantation-8635
https://atc.digitellinc.com/p/s/making-it-work-the-second-time-around-optimizing-outcomes-8640
https://atc.digitellinc.com/p/s/imminent-death-donation-8645
https://atc.digitellinc.com/p/s/imminent-death-donation-an-alternative-to-dcd-8650
https://atc.digitellinc.com/p/s/in-support-of-the-dead-donor-rule-is-death-really-that-complicated-8655
https://atc.digitellinc.com/p/s/ethical-dilemmas-related-to-the-internet-and-transplant-8665
https://atc.digitellinc.com/p/s/googling-your-patients-helpful-or-a-headache-8670
https://atc.digitellinc.com/p/s/potential-pitfalls-of-seeking-living-donors-online-8675
https://atc.digitellinc.com/p/s/the-effect-of-social-media-on-public-perception-about-transplant-8680
https://atc.digitellinc.com/p/s/women-in-transplant-networking-breakfast-8685
https://atc.digitellinc.com/p/s/career-development-basics-for-a-successful-career-in-transplantation-8690
https://atc.digitellinc.com/p/s/panel-discussion-8700
https://atc.digitellinc.com/p/s/bk-virus-and-the-renal-allograft-a-360-degree-view-8705
https://atc.digitellinc.com/p/s/understanding-bk-virus-associated-nephropathy-from-the-viruss-viewpoint-8710
https://atc.digitellinc.com/p/s/the-immune-response-to-bk-virus-after-kidney-transplantation-8715
https://atc.digitellinc.com/p/s/pathophysiology-of-bk-virus-infection-in-the-kidney-nephropathy-rejection-and-malignancy-8720
https://atc.digitellinc.com/p/s/the-current-status-of-the-us-workforce-of-transplant-surgeons-and-new-paradigms-in-transplant-training-8725
https://atc.digitellinc.com/p/s/a-career-in-transplant-surgery-and-the-current-status-of-the-surgical-workforce-in-transplantation-8730
https://atc.digitellinc.com/p/s/tracking-into-transplantation-shortened-training-program-8735
https://atc.digitellinc.com/p/s/evaluation-of-the-medically-complex-living-kidney-donor-8745
https://atc.digitellinc.com/p/s/living-kidney-donors-with-kidney-stones-8750
https://atc.digitellinc.com/p/s/living-kidney-donors-with-microscopic-hematuria-8755
https://atc.digitellinc.com/p/s/living-kidney-donors-with-prediabetes-and-metabolic-syndrome-8760
https://atc.digitellinc.com/p/s/joint-plenary-session-iii-8765
https://atc.digitellinc.com/p/s/would-transplanting-kidneys-currently-being-discarded-in-the-us-place-programs-at-risk-for-regulatory-review-8770
https://atc.digitellinc.com/p/s/a-single-histoneprotein-acetyltransferase-tip60-is-absolutely-essential-for-treg-survival-and-function-and-its-inhibition-abrogates-induction-of-treg-dependent-allograft-tolerance-8775
https://atc.digitellinc.com/p/s/short-duration-perioperative-administration-of-ledipasvirsofosbuvir-is-safe-and-effective-in-preventing-hcv-recurrence-after-liver-transplant-8780
https://atc.digitellinc.com/p/s/reenacting-the-civil-war-geographic-disparities-in-transplantation-8785
https://atc.digitellinc.com/p/s/the-argument-in-favor-of-redistricting-and-potential-solutionsmodels-8790
https://atc.digitellinc.com/p/s/cellular-therapy-versus-enhancing-endogenous-immunoregulation-to-transfer-or-to-induce-8810
https://atc.digitellinc.com/p/s/cellular-therapy-8815
https://atc.digitellinc.com/p/s/enhance-endogenous-immunoregulation-8820
https://atc.digitellinc.com/p/s/rebuttal-8825
https://atc.digitellinc.com/p/s/rebuttal-8830
https://atc.digitellinc.com/p/s/discussion-8835
https://atc.digitellinc.com/p/s/autophagy-and-immunity-8840
https://atc.digitellinc.com/p/s/b-cell-autophagy-8850
https://atc.digitellinc.com/p/s/innate-and-adaptive-immune-memory-8860
https://atc.digitellinc.com/p/s/evolving-status-of-long-term-t-cell-memory-to-pathogens-8875
https://atc.digitellinc.com/p/s/toward-adopting-molecular-diagnostics-as-standard-of-care-in-transplantation-8880
https://atc.digitellinc.com/p/s/from-discovery-science-to-standard-of-care-a-lesson-from-breast-cancer-8885
https://atc.digitellinc.com/p/s/report-on-consensus-conference-for-transplant-molecular-diagnostics-from-the-banff-2015-meeting-8890
https://atc.digitellinc.com/p/s/adopting-a-molecular-test-for-transplant-care-8895
https://atc.digitellinc.com/p/s/cross-disciplinary-understanding-of-the-risk-of-frailty-in-transplantation-8920
https://atc.digitellinc.com/p/s/why-does-frailty-matter-in-solid-organ-transplantation-8925
https://atc.digitellinc.com/p/s/measures-and-methods-how-does-one-measure-frailty-8930
https://atc.digitellinc.com/p/s/fixing-frailty-is-the-goal-feasible-or-desirable-in-solid-organ-transplantation-8935
https://atc.digitellinc.com/p/s/liver-allocation-8940
https://atc.digitellinc.com/p/s/what-have-we-learned-from-share-35-8945
https://atc.digitellinc.com/p/s/improving-allocation-and-distribution-by-defining-the-best-metrics-8950
https://atc.digitellinc.com/p/s/financial-and-logistical-considerations-in-redistricting-8955
https://atc.digitellinc.com/p/s/panel-discussion-8960
https://atc.digitellinc.com/p/s/esrd-attributable-to-kidney-donation-8965
https://atc.digitellinc.com/p/s/esrd-in-the-general-population-in-relatives-with-those-with-esrd-8970
https://atc.digitellinc.com/p/s/known-etiology-of-esrd-in-kidney-donors-8975
https://atc.digitellinc.com/p/s/increasing-deceased-donor-organs-overcoming-barriers-to-donor-intervention-research-8985
https://atc.digitellinc.com/p/s/deceased-donor-intervention-research-researchers-perspective-8995
https://atc.digitellinc.com/p/s/deceased-donor-intervention-research-where-do-we-go-from-here-who-should-be-consented-donor-family-organ-recipient-or-both-9000
https://atc.digitellinc.com/p/s/updates-in-thoracic-and-combined-thoracicabdominal-organ-allocation-9005
https://atc.digitellinc.com/p/s/changes-and-updates-to-the-lung-allocation-and-heartlung-allocation-9010
https://atc.digitellinc.com/p/s/updates-and-changes-to-heart-allocation-9015
https://atc.digitellinc.com/p/s/combined-thoracic-and-abdominal-organ-allocation-9020
https://atc.digitellinc.com/p/s/liver-disease-in-the-non-liver-transplant-patient-9025
https://atc.digitellinc.com/p/s/the-transplant-candidate-with-abnormal-lfts-9030
https://atc.digitellinc.com/p/s/the-transplant-recipient-with-abnormal-liver-function-tests-9035
https://atc.digitellinc.com/p/s/novel-solutions-to-geographic-disparities-in-kidney-transplantation-9045
https://atc.digitellinc.com/p/s/an-update-on-the-optn-process-to-improve-geographic-disparities-in-allocation-of-kidneys-9050
https://atc.digitellinc.com/p/s/novel-methods-to-address-geographic-disparity-9055
https://atc.digitellinc.com/p/s/geographic-disparities-reflect-local-practice-and-donation-patterns-9060
https://atc.digitellinc.com/p/s/subclinical-tcmr-and-abmr-in-kidney-transplantation-pathogenesis-and-management-9065
https://atc.digitellinc.com/p/s/subclinical-tcmr-and-abmr-in-the-unsensitized-patient-risk-factors-pathogenesis-histological-phenotypes-surveillance-and-evolution-9070
https://atc.digitellinc.com/p/s/subclinical-tcmr-and-abmr-in-the-sensitized-patient-risk-factors-pathogenesis-histological-phenotypes-surveillance-and-evolution-9075
https://atc.digitellinc.com/p/s/clinical-management-of-sub-clinical-rejection-and-future-studies-9080
https://atc.digitellinc.com/p/s/allied-health-symposium-2-transplant-pharmacy-in-the-21st-century-strengthening-an-identity-through-optimal-practice-fulfilling-responsibilities-to-the-pharmacy-department-9085
https://atc.digitellinc.com/p/s/impact-of-the-transplant-pharmacist-on-formulary-management-an-administrative-and-clinical-perspective-9090
https://atc.digitellinc.com/p/s/balancing-clinical-and-operational-responsibilities-establishing-a-role-at-a-new-transplant-program-and-a-large-established-center-9095
https://atc.digitellinc.com/p/s/optimizing-information-technology-in-daily-activities-an-inpatient-and-outpatient-perspective-9100
https://atc.digitellinc.com/p/s/allied-health-symposium-2-transplant-pharmacy-in-the-21st-century-strengthening-an-identity-through-optimal-practice-the-pharmacists-role-in-individualizing-patient-care-9105
https://atc.digitellinc.com/p/s/optimizing-medication-therapy-management-in-the-hospital-setting-providing-effective-patient-care-in-traditional-and-nontraditional-roles-9110
https://atc.digitellinc.com/p/s/education-techniques-in-patients-with-learning-challenges-a-focus-on-methods-for-those-with-poor-health-literacy-and-sensory-impairment-9115
https://atc.digitellinc.com/p/s/overcoming-financial-hurdles-in-the-post-transplant-setting-optimizing-insurance-coverage-and-use-of-alternative-methods-9120
https://atc.digitellinc.com/p/s/allied-health-symposium-2-transplant-pharmacy-in-the-21st-century-strengthening-an-identity-through-optimal-practice-responsibilities-of-the-transplant-pharmacist-to-the-transplant-center-9125
https://atc.digitellinc.com/p/s/pharmacist-involvement-in-qapi-programing-providing-oversight-and-leadership-in-qapi-projects-9130
https://atc.digitellinc.com/p/s/optimizing-the-role-of-the-pharmacist-in-the-ambulatory-clinic-impact-on-pre-and-post-transplant-care-9135
https://atc.digitellinc.com/p/s/successfully-billing-for-pharmacist-services-in-the-ambulatory-setting-effective-strategies-for-a-hospital-based-and-private-practice-setting-9140
https://atc.digitellinc.com/p/s/evolving-role-of-antibody-mediated-rejection-in-pediatric-liver-transplantation-9145
https://atc.digitellinc.com/p/s/prevention-and-treatment-strategies-for-antibody-mediated-rejection-9150
https://atc.digitellinc.com/p/s/pediatric-symposium-2-antibodies-good-bad-and-customized-consensus-and-controversies-in-vaccination-in-pediatric-sot-debate-9155
https://atc.digitellinc.com/p/s/vaccinating-our-candidates-and-recipients-the-whys-and-hows-debate-9160
https://atc.digitellinc.com/p/s/should-willingness-to-vaccinate-be-a-precondition-for-pediatric-sot-pro-9165
https://atc.digitellinc.com/p/s/rebuttal-and-discussion-9170
https://atc.digitellinc.com/p/s/pediatric-symposium-2-antibodies-good-bad-and-customized-one-size-fits-some-customization-in-pediatric-renal-transplantation-9175
https://atc.digitellinc.com/p/s/the-right-donor-for-the-right-patient-advising-pediatric-patients-in-a-new-era-of-deceased-donor-allocation-and-live-donor-risk-tolerance-9185
https://atc.digitellinc.com/p/s/recurrent-diseases-and-pediatric-kidney-transplantation-using-limited-data-to-devise-rational-treatment-strategies-9190
https://atc.digitellinc.com/p/s/concurrent-session-kidney-immunosuppression-novel-agents-9195
https://atc.digitellinc.com/p/s/polyclonal-treg-adoptive-therapy-for-control-of-subclinical-kidney-transplant-inflammation-task-pilot-trial-9200
https://atc.digitellinc.com/p/s/a-molecular-biopsy-test-for-probability-of-non-adherence-9205
https://atc.digitellinc.com/p/s/blockade-of-hla-antibody-triggered-classical-complement-activation-by-high-affinity-humanized-monoclonal-anti-c1s-antibody-tnt009-results-of-a-first-in-human-phase-1-trial-9210
https://atc.digitellinc.com/p/s/investigating-posttransplant-allo-donor-specific-cd57sup-plus-sup-cells-in-patients-with-alemtuzumab-induction-and-belatacept-based-regimen-9215
https://atc.digitellinc.com/p/s/anti-il6r-therapy-tocilizumab-improves-long-term-patient-and-graft-survival-in-patients-with-chronic-antibody-mediated-rejection-and-transplant-glomerulopathy-9220
https://atc.digitellinc.com/p/s/establishing-the-relationship-between-receptor-occupancy-serum-exposure-and-pathway-inhibition-by-the-blocking-non-depleting-anti-cd40-antibody-cfz533-to-inform-dose-selection-in-clinical-transplantat-9225
https://atc.digitellinc.com/p/s/c1-inhibitor-in-acute-antibody-mediated-rejection-non-responsive-to-conventional-therapy-in-kidney-transplant-recipients-a-pilot-study-9230
https://atc.digitellinc.com/p/s/concurrent-session-its-just-not-the-donor-impact-of-recipient-factors-on-outcomes-9235
https://atc.digitellinc.com/p/s/successful-treatment-of-hepatitis-c-in-renal-transplant-recipients-with-directly-acting-antiviral-agents-9240
https://atc.digitellinc.com/p/s/analysis-of-fsgs-focal-segmental-glomerulosclerosis-recurrence-after-renal-transplantation-9245
https://atc.digitellinc.com/p/s/insights-into-the-treatment-of-post-transplant-focal-glomerulosclerosis-experience-gained-from-a-concise-diagnostic-and-management-protocol-9250
https://atc.digitellinc.com/p/s/recurrence-of-fsgs-post-kidney-transplantation-salvage-therapy-with-acthar-r-gel-9255
https://atc.digitellinc.com/p/s/renal-outcome-with-eculizumab-in-patients-with-ahus-with-native-and-transplanted-kidneys-pooled-analysis-of-100-patients-9260
https://atc.digitellinc.com/p/s/early-post-renal-transplant-ahus-in-patients-with-heterozygous-cfhr3-cfhr1-deletion-9265
https://atc.digitellinc.com/p/s/treatment-of-hepatitis-c-viral-infection-with-novel-direct-acting-antivirals-in-kidney-transplant-recipients-single-center-experience-9270
https://atc.digitellinc.com/p/s/concurrent-session-kidney-amr-predicting-the-patient-at-risk-9275
https://atc.digitellinc.com/p/s/is-c3d-fixing-donor-specific-hla-antibody-detection-really-necessary-9280
https://atc.digitellinc.com/p/s/hla-antibody-in-transplant-recipients-during-transition-from-paediatrics-9285
https://atc.digitellinc.com/p/s/dsa-after-transplant-increases-risk-of-renal-allograft-failure-independent-of-concurrent-biopsy-results-the-dekaf-study-data-9290
https://atc.digitellinc.com/p/s/immunogenic-hla-dr-eplet-mismatches-as-predictors-of-transplant-glomerulopathy-9295
https://atc.digitellinc.com/p/s/association-of-ultrastructural-changes-in-renal-allograft-biopsies-with-antibody-mediated-rejection-amr-and-graft-outcomes-9300
https://atc.digitellinc.com/p/s/antibody-mediated-rejection-and-mixed-acute-rejection-long-term-results-and-predictive-factors-for-graft-loss-following-proteasome-inhibitor-therapy-9305
https://atc.digitellinc.com/p/s/evaluation-of-the-toxicity-profile-of-proteasome-inhibitor-based-therapy-for-antibody-mediated-rejection-9310
https://atc.digitellinc.com/p/s/concurrent-session-kidney-paired-exchange-outcomes-and-issues-9315
https://atc.digitellinc.com/p/s/a-kidney-paired-donation-standard-acquisition-charge-pilot-program-9320
https://atc.digitellinc.com/p/s/removing-geographic-and-financial-barriers-for-directed-living-kidney-donations-lessons-from-kidney-paired-donation-9325
https://atc.digitellinc.com/p/s/analysis-of-broken-chains-in-kidney-paired-donation-during-an-8-year-period-within-the-national-kidney-registry-9330
https://atc.digitellinc.com/p/s/characteristics-of-compatible-pair-participants-in-living-donor-kidney-transplant-exchanges-9335
https://atc.digitellinc.com/p/s/reciprocity-for-compatible-pair-participation-in-kidney-paired-donation-9340
https://atc.digitellinc.com/p/s/global-kidney-exchange-9345
https://atc.digitellinc.com/p/s/accumulation-of-highly-sensitized-patients-in-a-kpd-registry-9350
https://atc.digitellinc.com/p/s/concurrent-session-clinical-vascularized-composite-allotransplantation-9355
https://atc.digitellinc.com/p/s/first-bilateral-hand-transplant-in-a-child-short-term-medical-outcomes-and-challenges-9360
https://atc.digitellinc.com/p/s/first-clinical-experience-with-belatacept-in-3-hand-transplanted-patients-9365
https://atc.digitellinc.com/p/s/development-of-a-vascularized-thymus-sternum-composite-tissue-allograft-model-in-non-human-primates-9370
https://atc.digitellinc.com/p/s/vascularized-composite-allograft-tolerance-with-transient-high-dose-tacrolimus-across-a-full-mhc-mismatch-in-a-large-animal-model-9375
https://atc.digitellinc.com/p/s/systematic-pathological-component-scores-for-skin-containing-vascularized-composite-allografts-9380
https://atc.digitellinc.com/p/s/latest-vca-statistics-in-the-us-9385
https://atc.digitellinc.com/p/s/ex-situ-perfusion-of-a-human-limb-for-24-hours-9390
https://atc.digitellinc.com/p/s/concurrent-session-ptld-and-malignancies-9395
https://atc.digitellinc.com/p/s/identification-of-micrornas-in-ebvsup-plus-sup-b-cell-lymphomas-and-secreted-exosomes-9400
https://atc.digitellinc.com/p/s/examining-the-risk-for-post-transplant-viral-infections-and-lymphoproliferative-disorder-ptld-in-kidney-transplant-patients-pts-receiving-calcineurin-inhibitor-based-immunosuppression-cni-is-compared--9405
https://atc.digitellinc.com/p/s/integrative-multi-cohort-analysis-of-epstein-barr-virus-ebv-positive-and-negative-tumor-samples-to-identify-gene-signatures-associated-with-ebv-oncogenesis-9410
https://atc.digitellinc.com/p/s/targeting-the-constitutively-active-pi3kaktmtor-signaling-pathway-in-epstein-barr-virus-b-cell-lymphomas-9415
https://atc.digitellinc.com/p/s/effects-of-immunosuppression-and-sun-exposure-on-immune-cell-populations-in-skin-and-blood-of-kidney-transplant-recipients-9420
https://atc.digitellinc.com/p/s/outcomes-of-solid-organ-transplant-recipients-with-pre-existing-malignancies-9425
https://atc.digitellinc.com/p/s/hematopoietic-cell-transplant-and-solid-organ-transplantation-a-first-report-of-the-us-experience-9430
https://atc.digitellinc.com/p/s/concurrent-session-kidney-polyomavirus-9435
https://atc.digitellinc.com/p/s/25-hydroxyvitamin-d-insufficiency-is-associated-with-higher-risk-of-bk-virus-re-activation-after-kidney-transplantation-9440
https://atc.digitellinc.com/p/s/bk-polyomavirus-seroreactivity-of-kidney-donors-predicts-viremia-and-nephropathy-in-recipients-9445
https://atc.digitellinc.com/p/s/immune-response-to-bk-virus-in-renal-transplant-recipients-9450
https://atc.digitellinc.com/p/s/influence-of-the-tacrolimus-metabolism-rate-on-bkv-infection-after-kidney-transplantation-9455
https://atc.digitellinc.com/p/s/bk-nephropathy-but-not-isolated-bk-viremia-associated-with-de-novo-dsa-despite-similar-immunosuppression-reduction-9460
https://atc.digitellinc.com/p/s/potential-applications-of-viral-mirna-assays-in-the-management-of-transplant-patients-with-polyomavirus-bk-infection-9465
https://atc.digitellinc.com/p/s/hla-class-ii-and-bk-virus-reactivation-in-renal-transplant-recipients-9470
https://atc.digitellinc.com/p/s/concurrent-session-kidney-length-of-stayreadmission-9475
https://atc.digitellinc.com/p/s/early-hospital-readmission-following-kidney-re-transplantation-9480
https://atc.digitellinc.com/p/s/enhanced-recovery-after-kidney-transplantation-48-hour-length-of-stay-in-living-and-deceased-donor-transplant-recipients-9485
https://atc.digitellinc.com/p/s/center-level-variation-in-association-between-early-hospital-readmission-and-survival-following-kidney-transplantation-9490
https://atc.digitellinc.com/p/s/a-retrospective-study-of-simultaneous-bilateral-nephrectomies-and-renal-transplantation-in-recipients-with-polycystic-kidney-disease-9495
https://atc.digitellinc.com/p/s/day-2-discharge-after-kidney-transplantation-complications-health-care-utilization-and-long-term-clinical-outcomes-9500
https://atc.digitellinc.com/p/s/a-nationwide-analysis-of-reoperation-after-kidney-transplant-9505
https://atc.digitellinc.com/p/s/mortality-and-graft-loss-attributable-to-readmission-following-kidney-transplantation-9510
https://atc.digitellinc.com/p/s/concurrent-session-liver-meld-allocation-and-donor-issues-dcdecd-1-9515
https://atc.digitellinc.com/p/s/survival-benefit-of-dcd-livers-9520
https://atc.digitellinc.com/p/s/impact-of-proximity-meldpeld-points-on-liver-redistricting-scenario-9525
https://atc.digitellinc.com/p/s/skipping-comparable-local-waitlist-candidates-under-share-35-9530
https://atc.digitellinc.com/p/s/what-are-the-charges-and-costs-of-transplanting-high-meld-patients-9535
https://atc.digitellinc.com/p/s/impact-of-early-allograft-dysfunction-ead-and-its-components-on-patient-survival-following-liver-transplantation-lt-long-term-outcomes-up-to-10-years-9540
https://atc.digitellinc.com/p/s/factors-associated-with-mortality-among-a-large-population-of-patients-with-cirrhosis-and-a-low-meld-15-9545
https://atc.digitellinc.com/p/s/the-impact-of-cms-policy-on-delisting-of-too-sick-liver-transplant-candidates-9550
https://atc.digitellinc.com/p/s/concurrent-session-allograft-tolerance-2-animal-models-9555
https://atc.digitellinc.com/p/s/rapamycin-encapsulated-nanoparticles-as-pre-treatment-in-lung-transplantation-9560
https://atc.digitellinc.com/p/s/receptor-tyrosine-kinase-mer-mediates-expansion-of-mdscs-critical-for-transplantation-tolerance-9565
https://atc.digitellinc.com/p/s/nk-cells-are-required-in-b-cell-dependent-antibody-mediated-islet-transplant-tolerance-9570
https://atc.digitellinc.com/p/s/high-pd-l1cd86-mfi-ratio-and-il-10-secretion-characterize-maturation-resistant-human-regulatory-dendritic-cells-dcregs-generated-for-clinical-testing-in-transplantation-9575
https://atc.digitellinc.com/p/s/long-lasting-skin-allograft-tolerance-induced-and-maintained-by-short-term-vascularized-bone-marrow-transplant-in-a-mouse-model-9580
https://atc.digitellinc.com/p/s/a-novel-murine-orthotopic-forelimb-transplantation-model-that-allows-for-reliable-assessment-of-post-transplant-upper-extremity-function-9585
https://atc.digitellinc.com/p/s/tgfb-in-regulatory-b-cells-dependent-tolerance-9590
https://atc.digitellinc.com/p/s/concurrent-session-t-cell-biology-and-alloimmunity-animal-models-9595
https://atc.digitellinc.com/p/s/microfluidics-to-characterize-leukocyte-trafficking-into-allografts-and-the-resolution-of-inflammation-9600
https://atc.digitellinc.com/p/s/mtorc2-negatively-regulates-dendritic-cell-dc-metabolism-and-the-allostimulatory-function-of-donor-dcs-in-organ-transplantation-9605
https://atc.digitellinc.com/p/s/lymph-node-stromal-laminins-differentially-regulate-t-cell-immunity-and-tolerance-9610
https://atc.digitellinc.com/p/s/sphingosine-1-phosphate-s1p-receptors-differentially-regulate-murine-and-human-cd4-t-cell-migration-across-lymphatic-endothelium-9615
https://atc.digitellinc.com/p/s/thymus-is-required-for-t-cells-reconstitution-following-antibody-mediated-lymphoablation-9620
https://atc.digitellinc.com/p/s/role-of-nrp1-in-cd4-plus-t-cell-allo-activation-9625
https://atc.digitellinc.com/p/s/profiling-metabolic-differences-between-graft-vs-pathogen-elicited-cd8sup-plus-sup-t-cell-responses-9630
https://atc.digitellinc.com/p/s/concurrent-session-living-donation-and-transplant-operational-and-economic-factors-9635
https://atc.digitellinc.com/p/s/financial-burdens-and-coping-mechanisms-of-living-kidney-donors-9640
https://atc.digitellinc.com/p/s/return-on-investment-for-financial-assistance-for-living-kidney-donors-in-the-united-states-9645
https://atc.digitellinc.com/p/s/who-should-decide-potential-living-kidney-donor-preferences-for-making-decisions-about-risk-9650
https://atc.digitellinc.com/p/s/offering-hcv-positive-kidneys-to-hcv-negative-patients-on-the-kidney-transplant-waitlist-is-lifesaving-results-of-a-markov-model-9655
https://atc.digitellinc.com/p/s/the-impact-of-readmission-following-kidney-transplantation-is-readmission-becoming-more-risky-9660
https://atc.digitellinc.com/p/s/functional-status-and-comorbidity-are-associated-with-high-costs-after-liver-transplantation-9665
https://atc.digitellinc.com/p/s/have-we-gone-too-far-defining-performance-outliers-one-third-of-kidney-transplant-programs-now-identified-for-low-performance-within-three-years-9670
https://atc.digitellinc.com/p/s/concurrent-session-disparities-in-transplant-access-and-outcomes-9675
https://atc.digitellinc.com/p/s/pregnancy-excludes-women-from-successful-living-donor-transplantation-9680
https://atc.digitellinc.com/p/s/african-american-primary-renal-transplant-recipients-are-at-a-significantly-higher-risk-to-develop-de-novo-dsa-9685
https://atc.digitellinc.com/p/s/racial-disparities-in-perioperative-complications-after-live-kidney-donation-9690
https://atc.digitellinc.com/p/s/investigating-geographic-variation-in-the-number-of-deceased-donor-transplants-performed-in-the-us-9695
https://atc.digitellinc.com/p/s/crisis-on-the-waiting-list-for-children-listed-in-low-volume-solid-organ-transplant-centers-9700
https://atc.digitellinc.com/p/s/the-impact-of-body-mass-index-uu-35-on-kidney-transplant-outcomes-a-systematic-review-9705
https://atc.digitellinc.com/p/s/twenty-years-of-evolving-trends-in-racial-disparities-for-adult-kidney-transplant-recipient-9710
https://atc.digitellinc.com/p/s/concurrent-session-ischemic-injury-and-organ-preservation-animal-models-9715
https://atc.digitellinc.com/p/s/ischemia-reperfusion-induced-murine-heart-transplant-rejection-is-complement-dependent-9720
https://atc.digitellinc.com/p/s/ho-1sirt1p53-axis-regulates-macrophage-activation-and-attenuates-liver-ischemia-reperfusion-injury-in-mice-9725
https://atc.digitellinc.com/p/s/subnormothermic-machine-perfusion-snmp-leads-to-increased-bile-production-and-secretion-of-hydrophilic-bile-acids-after-liver-transplantation-when-compared-to-cold-storage-cs-9730
https://atc.digitellinc.com/p/s/machine-perfusion-mp-at-21degc-simulates-hibernation-metabolic-pathways-in-a-non-hibernator-mammal-9735
https://atc.digitellinc.com/p/s/cold-storage-stabilization-of-gap-junctions-reduces-post-transplant-ischemia-reperfusion-injury-9740
https://atc.digitellinc.com/p/s/early-alloantibody-responses-against-donor-mhc-class-i-and-class-ii-molecules-are-differentially-affected-by-prolonged-cold-ischemia-storage-of-renal-allografts-9745
https://atc.digitellinc.com/p/s/serelaxin-decreases-the-severity-of-cold-ischemia-reperfusion-injury-after-liver-transplantation-in-mice-9750
https://atc.digitellinc.com/p/s/concurrent-session-kidney-waitlist-management-and-kas-initial-results-9755
https://atc.digitellinc.com/p/s/99-percent-and-100-percent-cpra-patients-since-kas-a-substantial-increase-in-transplants-with-strong-evidence-of-a-bolus-effect-9760
https://atc.digitellinc.com/p/s/significant-increase-in-wait-list-removals-for-candidates-considered-too-sick-from-the-us-kidney-transplant-waiting-list-9765
https://atc.digitellinc.com/p/s/automated-web-based-monitoring-identifies-significant-clinical-changes-in-patients-awaiting-kidney-transplant-9770
https://atc.digitellinc.com/p/s/geographic-differences-in-racial-disparity-reduction-in-kidney-transplant-rates-before-and-after-the-new-kidney-allocation-system-9775
https://atc.digitellinc.com/p/s/subtype-compatible-a2a2b-b-transplantation-under-kas-increases-access-3-fold-for-blood-type-b-patients-yet-very-few-candidates-are-listed-as-eligible-9780
https://atc.digitellinc.com/p/s/wait-list-removals-and-transplant-rates-are-significantly-associated-with-transplant-center-performance-oversight-9785
https://atc.digitellinc.com/p/s/impact-of-cold-ischemia-time-on-the-outcomes-of-kidneys-with-kdpi-85-percent-mate-kidney-analysis-9790
https://atc.digitellinc.com/p/s/concurrent-session-kidney-transplant-recipient-long-term-outcomes-session-2-9795
https://atc.digitellinc.com/p/s/predicting-the-timing-of-graft-failure-in-de-novo-dsa-positive-patients-9800
https://atc.digitellinc.com/p/s/non-invasive-minimalistic-approach-using-cell-free-micrornas-in-paired-plasma-and-urine-samples-for-early-diagnosis-of-chronic-renal-allograft-dysfunction-9805
https://atc.digitellinc.com/p/s/igg-dilutions-subclasses-c1q-and-igm-determining-relevant-testing-for-de-novo-dsa-and-outcome-prediction-9810
https://atc.digitellinc.com/p/s/impact-of-delayed-graft-function-varies-by-demographic-and-clinical-characteristics-in-deceased-donor-kidney-transplantation-9815
https://atc.digitellinc.com/p/s/lower-renal-graft-function-and-accelerated-fibrosis-in-hiv-infected-transplant-recipients-with-previous-hivan-compared-to-non-hivan-hiv-positive-transplant-recipients-9820
https://atc.digitellinc.com/p/s/dynamics-of-delayed-graft-function-associated-risk-in-deceased-donor-kidney-transplantation-9825
https://atc.digitellinc.com/p/s/better-never-than-late-differences-in-outcomes-and-risk-factors-for-early-and-late-rejection-after-kidney-transplantation-9830
https://atc.digitellinc.com/p/s/concurrent-session-living-kidney-donor-evaluation-9835
https://atc.digitellinc.com/p/s/potential-kidney-donors-with-asymptomatic-micorsocpic-hematuria-histopathological-findings-and-outcomes-9840
https://atc.digitellinc.com/p/s/pre-donation-weight-loss-postpones-living-kidney-donation-without-attaining-the-desired-weight-maintenance-in-the-midterm-9845
https://atc.digitellinc.com/p/s/motivation-and-stress-associated-with-non-directed-kidney-donation-9850
https://atc.digitellinc.com/p/s/the-live-donor-champion-program-a-novel-approach-to-identifying-live-kidney-donors-9855
https://atc.digitellinc.com/p/s/lower-rates-of-living-donor-kidney-transplantationld-among-african-americans-what-prevents-higher-rates-of-donation-9860
https://atc.digitellinc.com/p/s/predonation-prescription-narcotic-use-a-novel-risk-factor-for-readmission-after-living-donor-nephrectomy-9865
https://atc.digitellinc.com/p/s/kidney-structural-characteristics-as-predictors-of-long-term-kidney-function-in-living-kidney-donors-9870
https://atc.digitellinc.com/p/s/concurrent-session-the-high-kdpi-kidney-outcomes-and-optimal-utilization-9875
https://atc.digitellinc.com/p/s/informing-informed-consent-for-high-kdpi-kidneys-9880
https://atc.digitellinc.com/p/s/the-relationship-between-kidney-donor-profile-index-and-six-month-egfr-in-deceased-donor-recipients-9885
https://atc.digitellinc.com/p/s/analysis-of-local-versus-imported-expanded-criteria-donor-ecd-kidneys-a-single-center-experience-with-497-ecd-kidney-transplants-9890
https://atc.digitellinc.com/p/s/survival-benefit-of-high-kdpi-kidneys-among-obese-transplant-candidates-9895
https://atc.digitellinc.com/p/s/lessons-learned-transplanting-high-kdpi-kidneys-over-a-decade-improvements-in-graft-survival-stem-from-lower-rates-of-early-graft-loss-9900
https://atc.digitellinc.com/p/s/high-kdpi-kidneys-85-percent-do-not-adversely-affect-hrqol-after-kidney-transplantation-9905
https://atc.digitellinc.com/p/s/standardized-pre-implantation-kidney-biopsies-of-expanded-criteria-donors-to-improve-the-kidney-donor-profile-index-kdpi-for-the-evaluation-of-marginal-donors-9910
https://atc.digitellinc.com/p/s/concurrent-session-small-bowel-transplantation-9915
https://atc.digitellinc.com/p/s/intestinal-retransplantation-in-children-single-center-experience-9920
https://atc.digitellinc.com/p/s/normothermic-ex-vivo-perfusion-of-the-intestine-the-introduction-of-an-innovative-physiologic-model-with-novel-biomarkers-9925
https://atc.digitellinc.com/p/s/il-17-producing-ccr6sup-plus-supcd4sup-plus-sup-th17-cells-drive-intestinal-allograft-rejection-in-humans-9930
https://atc.digitellinc.com/p/s/conditional-long-term-intestine-patient-and-graft-survival-is-improving-under-ratg-immunosuppression-in-pediatric-intestine-transplantation-9935
https://atc.digitellinc.com/p/s/innate-lymphoid-cells-play-a-key-role-in-controlling-antimicrobial-defense-in-intestinal-transplant-recipients-9940
https://atc.digitellinc.com/p/s/outcomes-of-isolated-pediatric-small-intestine-transplants-using-vascular-homografts-9945
https://atc.digitellinc.com/p/s/generation-of-naive-donor-derived-lymphocytes-from-graft-resident-lymphoid-progenitors-after-human-intestinal-transplantation-9950
https://atc.digitellinc.com/p/s/concurrent-session-psychosocial-and-treatment-adherence-9955
https://atc.digitellinc.com/p/s/delays-in-the-live-kidney-donor-evaluation-process-9960
https://atc.digitellinc.com/p/s/incidence-of-depression-following-live-kidney-donation-9965
https://atc.digitellinc.com/p/s/prospective-randomized-controlled-study-evaluating-the-impact-of-an-electronic-feedback-system-on-medication-adherence-in-solid-organ-transplantation-9970
https://atc.digitellinc.com/p/s/transplant-education-increases-wait-listing-rates-in-dialysis-centers-with-supportive-administration-and-knowledgeable-staff-9975
https://atc.digitellinc.com/p/s/barriers-to-comprehensive-transplant-education-at-us-for-profit-dialysis-centers-and-associations-with-waitlist-access-9980
https://atc.digitellinc.com/p/s/coping-with-patient-death-on-pediatric-liver-transplant-teams-9985
https://atc.digitellinc.com/p/s/peer-mentoring-to-improve-access-to-kidney-transplantation-in-the-southeast-9990
https://atc.digitellinc.com/p/s/concurrent-session-clinical-pancreas-transplantation-2-9995
https://atc.digitellinc.com/p/s/potent-induction-therapy-improves-graft-outcome-in-younger-pancreas-transplant-recipients-30-years-of-age-10000
https://atc.digitellinc.com/p/s/the-impact-of-one-year-individual-or-dual-organ-rejection-in-simultaneous-pancreas-kidney-transplant-on-kidney-graft-survival-a-unos-registry-analysis-2000-2013-10005
https://atc.digitellinc.com/p/s/impact-of-early-acute-rejection-ar-on-pancreas-transplant-pt-outcomes-10010
https://atc.digitellinc.com/p/s/antibody-mediated-rejection-in-pancreas-transplantation-10015
https://atc.digitellinc.com/p/s/conversion-from-tacrolimus-to-belatacept-in-pancreas-transplant-alone-recipients-with-chronic-kidney-disease-10020
https://atc.digitellinc.com/p/s/incidence-and-indications-for-pancreatectomy-after-late-pancreas-allograft-failure-10025
https://atc.digitellinc.com/p/s/pancreas-after-islet-transplantation-a-successful-treatment-option-after-a-failed-islet-transplant-10030
https://atc.digitellinc.com/p/s/concurrent-session-diabetes-and-obesity-in-kidney-transplantation-10035
https://atc.digitellinc.com/p/s/outcomes-of-pediatric-en-bloc-kidney-peb-grafts-after-loss-of-a-single-kidney-10040
https://atc.digitellinc.com/p/s/evolution-of-body-composition-and-associations-to-glucose-metabolism-during-the-first-year-after-kidney-transplantation-10045
https://atc.digitellinc.com/p/s/surgical-site-infection-does-not-fully-explain-the-impact-of-obesity-on-post-transplant-outcomes-10050
https://atc.digitellinc.com/p/s/morbid-obesity-and-functional-status-as-predictors-of-surgical-complication-after-renal-transplantation-10055
https://atc.digitellinc.com/p/s/impact-of-morbid-obesity-on-breakthrough-cmv-infection-in-kidney-transplant-recipients-10060
https://atc.digitellinc.com/p/s/outcomes-following-inguinal-hernia-repair-in-kidney-transplant-recipients-10065
https://atc.digitellinc.com/p/s/early-post-transplant-patient-graft-survival-and-rejection-rates-under-kas-10070
https://atc.digitellinc.com/p/s/concurrent-session-liver-meld-allocation-and-donor-issues-dcdecd-2-10075
https://atc.digitellinc.com/p/s/modified-normothermic-extracorporeal-liver-perfusion-for-discarded-human-livers-10080
https://atc.digitellinc.com/p/s/a-users-guide-to-maximizing-utility-and-outcome-in-70-year-old-donors-10085
https://atc.digitellinc.com/p/s/liver-intestine-candidates-benefit-from-national-sharing-10090
https://atc.digitellinc.com/p/s/muscle-function-mass-and-quality-in-obese-liver-transplant-candidates-results-from-the-functional-assessment-in-liver-transplantation-frailt-study-10095
https://atc.digitellinc.com/p/s/the-impact-of-share-35-on-liver-allocation-and-utilization-one-dsas-experience-10100
https://atc.digitellinc.com/p/s/relative-distribution-of-livers-from-hcv-plus-donors-in-the-us-10105
https://atc.digitellinc.com/p/s/geographic-variation-in-liver-supply-and-demand-10110
https://atc.digitellinc.com/p/s/concurrent-session-b-cells-and-antibody-mediated-rejection-animal-models-10115
https://atc.digitellinc.com/p/s/allo-specific-memory-b-cell-recall-responses-are-dependent-on-b-cell-autophagy-10120
https://atc.digitellinc.com/p/s/designing-and-synthesizing-a-novel-highly-selective-immunoproteasome-inhibitor-that-promotes-long-term-heart-allograft-acceptance-while-reducing-plasma-cells-and-donor-specific-antibodies-10125
https://atc.digitellinc.com/p/s/selective-deletion-of-notch2-on-b-cells-abrogates-alloantibody-production-in-fully-mhc-mismatched-cardiac-and-skin-transplant-models-10130
https://atc.digitellinc.com/p/s/ctla4-negatively-regulates-donor-reactive-cxcr5-plus-pd1-plus-t-follicular-helper-cell-responses-following-transplantation-10135
https://atc.digitellinc.com/p/s/differential-regulation-of-the-microvascular-endothelial-cell-mediated-allogeneic-cd4-plus-t-cell-response-by-anti-hla-dr-and-dq-alloantibodies-in-an-inflammatory-context-10140
https://atc.digitellinc.com/p/s/nk-cells-play-a-critical-role-in-mediating-inflammation-and-graft-failure-during-antibody-mediated-rejection-of-kidney-allografts-10145
https://atc.digitellinc.com/p/s/metallothionein-accelerates-anti-mhc-induced-small-airway-obliteration-and-fibrosis-by-negatively-regulating-il-10-and-regulatory-cells-10150
https://atc.digitellinc.com/p/s/concurrent-session-novel-approaches-and-potential-targets-for-promoting-tolerance-animal-models-10155
https://atc.digitellinc.com/p/s/rapamycin-nanotherapy-delays-heart-transplant-rejection-10160
https://atc.digitellinc.com/p/s/mechanistic-insights-into-how-targeting-of-hdac10-promotes-foxp3-plus-treg-cell-suppressive-activity-gene-expression-and-metabolism-and-enhances-allograft-survival-10165
https://atc.digitellinc.com/p/s/aquaporin-4-blockade-is-a-novel-strategy-to-prevent-t-cell-activation-and-effector-functions-10170
https://atc.digitellinc.com/p/s/successful-treatment-of-established-acute-allograft-rejection-with-delayed-ctla-4ig-10175
https://atc.digitellinc.com/p/s/2b4-over-expression-impairs-donor-reactive-cd8-plus-t-cell-proliferation-and-accumulation-following-transplantation-10180
https://atc.digitellinc.com/p/s/type-i-interferon-induced-cross-competition-of-il-10-signaling-and-its-role-in-the-abrogation-of-transplant-tolerance-10185
https://atc.digitellinc.com/p/s/pre-transplant-infusion-of-extracorporeal-photopheresis-treated-donor-splenocytes-leads-to-long-term-liver-allograft-survival-and-donor-specific-tolerance-in-rats-10190
https://atc.digitellinc.com/p/s/concurrent-session-ischemia-reperfusion-injury-clinical-innovation-10195
https://atc.digitellinc.com/p/s/controlled-oxygenated-rewarming-and-subnormothermic-machine-perfusion-of-steatotic-livers-first-clinical-results-10200
https://atc.digitellinc.com/p/s/hypothermic-machine-perfusion-is-also-beneficial-for-deceased-donor-kidneys-when-cold-ischemic-time-is-short-and-a-short-cold-ischemic-time-is-also-beneficial-when-kidneys-are-machine-perfused-10205
https://atc.digitellinc.com/p/s/slpi-in-the-perfusion-liquid-a-predictor-marker-of-short-and-long-term-clinical-outcomes-10210
https://atc.digitellinc.com/p/s/defective-post-reperfusion-metabolic-recovery-directly-associates-with-incident-delayed-graft-function-10215
https://atc.digitellinc.com/p/s/glycine-is-graft-protective-and-improves-kidney-function-after-liver-transplantation-data-from-hegpol-trial-10220
https://atc.digitellinc.com/p/s/matrix-metalloproteinase-9-in-human-orthotopic-liver-transplant-biopsies-10225
https://atc.digitellinc.com/p/s/dna-methylation-patterns-and-association-with-graft-injury-severity-post-liver-transplantation-10230
https://atc.digitellinc.com/p/s/concurrent-session-kidney-induction-therapy-2-10235
https://atc.digitellinc.com/p/s/the-impact-of-ritonavir-boosted-protease-inhibitors-and-non-depleting-antibody-induction-on-outcomes-in-hiv-infected-kidney-transplant-recipients-10240
https://atc.digitellinc.com/p/s/induction-therapy-with-depleting-antibodies-in-low-immunological-risk-renal-transplant-patients-treated-with-a-steroid-free-regimen-comparison-of-alemtuzumab-vs-antithymocyte-globulin-10245
https://atc.digitellinc.com/p/s/associations-of-risk-factors-and-kidney-retransplant-outcomes-vary-between-three-common-induction-agents-results-from-the-analysis-of-over-ten-thousand-cases-in-ten-years-10250
https://atc.digitellinc.com/p/s/outcomes-of-depleting-antibody-induction-in-kidney-transplantation-a-paired-kidney-analysis-10255
https://atc.digitellinc.com/p/s/induction-immunosuppression-and-post-transplant-outcomes-in-kidney-recipients-with-hepatitis-c-virus-10260
https://atc.digitellinc.com/p/s/tailored-rabbit-anti-thymocyte-globulin-induction-ratg-dosing-for-kidney-transplantation-10265
https://atc.digitellinc.com/p/s/antithymocyte-globulin-atg-versus-anti-interleukin-2-receptor-anti-il-2r-as-induction-therapy-for-kidney-transplantation-after-a-nonrenal-transplant-10270
https://atc.digitellinc.com/p/s/concurrent-session-bone-marrow-transplantation-and-chimerism-animal-models-10275
https://atc.digitellinc.com/p/s/combination-of-veto-cell-transfer-and-inkt-cell-therapy-establishes-complete-hematopoietic-chimerism-in-non-myeloablative-bmt-recipients-10280
https://atc.digitellinc.com/p/s/post-transplantation-high-dose-cyclophosphamide-treatment-promotes-immune-tolerance-after-skin-solid-organ-and-vascularized-composite-allotransplantation-10285
https://atc.digitellinc.com/p/s/tolerogenic-interactions-between-host-cd8sup-plus-supmyeloid-dendritic-cells-and-natural-killer-t-cells-are-required-for-acceptance-of-combined-organ-and-bone-marrow-transplants-after-tli-conditioning-10290
https://atc.digitellinc.com/p/s/delayed-induction-of-mixed-chimerism-permits-kidney-induced-cardiac-allograft-tolerance-to-be-applied-to-recipients-of-cadaveric-organs-10295
https://atc.digitellinc.com/p/s/blockade-of-the-asc-coreceptor-enhances-hematopoietic-stem-cell-engraftment-10300
https://atc.digitellinc.com/p/s/administration-of-il-33-before-allogeneic-stem-cell-transplantation-expands-recipient-treg-that-prevent-graft-vs-host-disease-10305
https://atc.digitellinc.com/p/s/immunoregulation-new-concepts-relevant-to-transplantation-10315
https://atc.digitellinc.com/p/s/immunoregulatory-effects-of-erythropoietin-10320
https://atc.digitellinc.com/p/s/the-role-of-il-10-in-microbiome-associated-immune-modulation-and-disease-10330
https://atc.digitellinc.com/p/s/leveling-the-playing-field-how-to-minimize-racial-and-ethnic-disparities-in-access-to-transplantation-10335
https://atc.digitellinc.com/p/s/factors-underlying-race-related-differences-in-access-to-transplantation-10340
https://atc.digitellinc.com/p/s/educational-strategies-to-minimize-race-related-disparities-in-access-to-transplantation-10350
https://atc.digitellinc.com/p/s/advancing-transplant-care-using-pharmacogenomics-10355
https://atc.digitellinc.com/p/s/pharmacogenomics-of-transplant-immunosuppression-and-association-with-transplant-outcomes-10360
https://atc.digitellinc.com/p/s/implementing-pharmacogenetic-variants-in-the-transplant-clinic-the-current-evidence-10365
https://atc.digitellinc.com/p/s/telemedicine-excite-engage-and-enhance-patient-centered-care-in-transplantation-and-living-donation-10375
https://atc.digitellinc.com/p/s/transplant-evaluation-and-technology-doing-more-with-less-time-10380
https://atc.digitellinc.com/p/s/innovative-telemedicine-education-practices-in-the-transplant-and-donation-phase-effective-and-time-saving-strategies-10385
https://atc.digitellinc.com/p/s/telemedicine-post-transplant-expanding-where-healthcare-happens-10390
https://atc.digitellinc.com/p/s/the-nuts-and-bolts-of-phs-increased-risk-donors-10395
https://atc.digitellinc.com/p/s/phs-increased-risk-donors-whats-the-risk-data-thus-far-10400
https://atc.digitellinc.com/p/s/the-devil-is-in-the-detail-what-everyone-needs-to-know-about-using-phs-increased-risk-donors-10405
https://atc.digitellinc.com/p/s/the-kpd-plateau-what-we-can-do-about-it-10415
https://atc.digitellinc.com/p/s/international-exchange-could-it-offer-a-solution-to-the-stalled-pairs-10420
https://atc.digitellinc.com/p/s/quality-markers-for-paired-exchange-is-it-equitable-and-transparent-10425
https://atc.digitellinc.com/p/s/disparities-in-kpd-possible-solutions-10430
https://atc.digitellinc.com/p/s/joint-plenary-session-iv-10435
https://atc.digitellinc.com/p/s/donor-derived-toll-like-receptor-dependent-intravascular-monocytes-cause-primary-lung-graft-dysfunction-10445
https://atc.digitellinc.com/p/s/novel-function-of-cd4sup-plus-sup-t-cell-deptor-in-treg-homeostasis-and-alloimmunity-10450
https://atc.digitellinc.com/p/s/hla-identical-renal-transplant-tolerance-using-donor-hematopoietic-stems-cells-dhsc-role-of-immunoregulation-10455
https://atc.digitellinc.com/p/s/outcomes-associated-with-carbapenem-resistant-enterobacteriaceae-infection-after-solid-organ-transplantation-in-a-multicenter-study-10460
https://atc.digitellinc.com/p/s/rituximab-induction-in-cardiac-transplantation-is-associated-with-accelerated-coronary-artery-vasculopathy-ctot11-10465
https://atc.digitellinc.com/p/s/lost-and-found-in-translation-our-quest-to-improve-long-term-outcomes-and-healthspan-10470
https://atc.digitellinc.com/p/s/approaches-to-tolerance-across-allogenetic-and-xenogenetic-barriers-10475
https://atc.digitellinc.com/p/s/whats-hot-whats-new-10480
https://atc.digitellinc.com/p/s/basic-10485
https://atc.digitellinc.com/p/s/clinical-10490
https://atc.digitellinc.com/p/s/pediatric-symposium-1-improving-long-term-outcomes-in-pediatric-transplantation-long-term-follow-up-achilles-heel-of-pediatric-transplantation-10495
https://atc.digitellinc.com/p/s/what-are-they-thinking-developmental-and-psychological-factors-that-affect-adherence-and-compliance-in-pediatric-transplant-recipients-10500
https://atc.digitellinc.com/p/s/innovators-in-transplantation-10505
https://atc.digitellinc.com/p/s/looking-back-on-ethical-issues-in-transplantation-50-years-after-the-1966-ciba-foundation-conference-10510
https://atc.digitellinc.com/p/s/concurrent-session-surgical-videos-10515
https://atc.digitellinc.com/p/s/pure-laparoscopic-extended-right-hemihepatectomy-in-a-living-donor-10520
https://atc.digitellinc.com/p/s/living-donor-domino-liver-transplantation-using-the-fap-liver-without-retrohepatic-ivc-10525
https://atc.digitellinc.com/p/s/robotic-assisted-radical-cystoprostratectomy-and-intracorporeal-ileal-conduit-urinary-diversion-for-kidney-transplant-recipient-10535
https://atc.digitellinc.com/p/s/bench-procedure-for-combined-liver-small-bowel-allograft-10540
https://atc.digitellinc.com/p/s/laparoscopic-transplant-nephrectomy-for-intra-abdominal-kidney-10545
https://atc.digitellinc.com/p/s/totally-robotic-living-donor-kidney-transplantation-the-vaginal-route-10550
https://atc.digitellinc.com/p/s/live-donor-nephrectomy-when-things-go-wrong-10555
https://atc.digitellinc.com/p/s/the-worlds-first-pediatric-bilateral-hand-transplant-10560
https://atc.digitellinc.com/p/s/update-on-b-cell-subsets-and-alloimmunity-10600
https://atc.digitellinc.com/p/s/update-on-regulatory-t-cells-10605
https://atc.digitellinc.com/p/s/update-on-memory-t-cells-10610
https://atc.digitellinc.com/p/s/top-10-immunology-papers-of-the-year-10615
https://atc.digitellinc.com/p/s/overview-of-the-immune-response-10625
https://atc.digitellinc.com/p/s/inflammation-and-innate-immunity-and-their-impact-on-allograft-rejection-10630
https://atc.digitellinc.com/p/s/development-and-detection-of-donor-reactive-t-cell-responses-10635
https://atc.digitellinc.com/p/s/t-cell-mediated-rejection-effector-mechanisms-10640
https://atc.digitellinc.com/p/s/b-cellantibody-mediated-rejection-10645
https://atc.digitellinc.com/p/s/t-cell-and-b-cell-targeted-immunosuppression-in-transplantation-10650
https://atc.digitellinc.com/p/s/impact-of-immunologic-memory-10655
https://atc.digitellinc.com/p/s/understanding-and-interpreting-genomic-studies-in-transplantation-10660
https://atc.digitellinc.com/p/s/tolerance-10665
https://atc.digitellinc.com/p/s/rush-10675
https://atc.digitellinc.com/p/s/northwestern-10680
https://atc.digitellinc.com/p/s/cleveland-clinic-10685
https://atc.digitellinc.com/p/s/mdr-gnr-bacteria-10695
https://atc.digitellinc.com/p/s/vre-best-practice-and-insights-10700
https://atc.digitellinc.com/p/s/from-the-pharmd-desk-top-10-things-tid-docs-should-know-10705
https://atc.digitellinc.com/p/s/hla-genetics-immunogenicity-and-epitopes-10715
https://atc.digitellinc.com/p/s/hla-antibody-effector-pathways-10720
https://atc.digitellinc.com/p/s/cell-and-solid-phase-based-assays-the-basics-10725
https://atc.digitellinc.com/p/s/histopathology-and-molecular-diagnostics-10735
https://atc.digitellinc.com/p/s/the-abcs-of-assessing-renal-function-10745
https://atc.digitellinc.com/p/s/hyponatremia-why-we-care-and-what-to-do-about-it-10750
https://atc.digitellinc.com/p/s/pro-can-we-predict-irreversible-renal-failure-and-need-for-slk-10760
https://atc.digitellinc.com/p/s/immunobiology-of-rejection-for-the-nephrologist-10775
https://atc.digitellinc.com/p/s/immunosuppression-current-approaches-and-future-strategies-10780
https://atc.digitellinc.com/p/s/immunological-assessment-of-the-transplant-recipient-10785
https://atc.digitellinc.com/p/s/non-tissue-diagnosis-of-rejection-10790
https://atc.digitellinc.com/p/s/optimizing-resources-to-make-it-happen-10800
https://atc.digitellinc.com/p/s/assessing-and-improving-medication-adherence-prior-to-transplant-10805
https://atc.digitellinc.com/p/s/having-the-difficult-conversation-10810
https://atc.digitellinc.com/p/s/fungus-among-us-state-of-the-art-diagnostics-10820
https://atc.digitellinc.com/p/s/an-ounce-or-a-pound-of-fungal-prevention-10825
https://atc.digitellinc.com/p/s/antifungal-treatment-10830
https://atc.digitellinc.com/p/s/evaluation-of-the-combined-organ-transplant-candidate-10840
https://atc.digitellinc.com/p/s/evaluation-of-the-living-kidney-donor-10850
https://atc.digitellinc.com/p/s/impact-of-the-new-kidney-allocation-system-on-transplant-program-workflow-10860
https://atc.digitellinc.com/p/s/ntm-help-10870
https://atc.digitellinc.com/p/s/respiratory-viruses-10875
https://atc.digitellinc.com/p/s/using-high-risk-donors-impact-of-the-heroin-epidemic-on-the-donor-pool-and-recipient-management-10890
https://atc.digitellinc.com/p/s/approach-to-the-highly-sensitized-patient-10900
https://atc.digitellinc.com/p/s/treatment-of-early-abmr-whats-the-evidence-10905
https://atc.digitellinc.com/p/s/de-novo-dsa-preventionrisk-assessment-10910
https://atc.digitellinc.com/p/s/de-novo-dsa-abmr-treatment-where-are-we-10915
https://atc.digitellinc.com/p/s/preserving-renal-function-during-the-liver-transplant-procedure-10925
https://atc.digitellinc.com/p/s/early-post-transplant-nephroprotective-strategies-10930
https://atc.digitellinc.com/p/s/late-renal-protection-immunosuppression-and-ckd-management-10935
https://atc.digitellinc.com/p/s/the-slk-allocation-policy-is-appropriate-10940
https://atc.digitellinc.com/p/s/the-slk-allocation-policy-needs-to-be-modified-10945
https://atc.digitellinc.com/p/s/management-of-malignancy-in-the-post-transplant-setting-10955
https://atc.digitellinc.com/p/s/management-of-recurrent-complement-mediated-glomerular-diseases-10960
https://atc.digitellinc.com/p/s/surgical-complications-after-kidney-transplantation-for-the-non-surgeon-10965
https://atc.digitellinc.com/p/s/list-exchangenational-kidney-registry-10975
https://atc.digitellinc.com/p/s/alturistic-donors-10980
https://atc.digitellinc.com/p/s/desensitization-protocols-10985
https://atc.digitellinc.com/p/s/on-your-toes-rapid-fire-cases-with-the-id-cop-executive-committee-members-10995
https://atc.digitellinc.com/p/s/challenging-cases-in-cmv-11005
https://atc.digitellinc.com/p/s/bk-virus-prevention-and-treatment-11010
https://atc.digitellinc.com/p/s/accepting-high-kdpi-kidneys-the-who-what-when-and-how-11020
https://atc.digitellinc.com/p/s/the-ethics-of-liver-transplantation-in-the-management-of-alcoholic-liver-disease-11035
https://atc.digitellinc.com/p/s/amyloid-what-a-tangled-web-we-weave-considerations-when-assessing-patients-for-transplant-who-have-amyloid-11050
https://atc.digitellinc.com/p/s/cardiac-amyloid-clinical-trials-past-present-and-future-11055
https://atc.digitellinc.com/p/s/combined-organ-transplantation-for-amyloidosis-kidney-and-liver-11060
https://atc.digitellinc.com/p/s/a-journey-from-diagnosis-to-post-transplant-life-amyloid-lifecycle-presentation-case-and-discussion-by-all-panelists-11065
https://atc.digitellinc.com/p/s/machine-perfusion-to-enhance-standard-livers-and-recover-otherwise-discarded-organs-11075
https://atc.digitellinc.com/p/s/establishing-machine-perfusion-as-the-standard-of-care-in-the-uk-11080
https://atc.digitellinc.com/p/s/can-we-implement-machine-perfusion-nationally-in-the-us-11085
https://atc.digitellinc.com/p/s/identification-and-management-of-high-pharmacologic-risk-candidates-11095
https://atc.digitellinc.com/p/s/structuring-and-sustaining-transplant-pharmacy-services-in-the-pre-transplant-setting-11100
https://atc.digitellinc.com/p/s/pharmacologic-risk-assessment-in-living-donors-11105
https://atc.digitellinc.com/p/s/practical-challenges-in-intestinal-transplant-a-discussion-of-cases-with-major-centers-11110
https://atc.digitellinc.com/p/s/expanding-recipient-access-advanced-age-11140
https://atc.digitellinc.com/p/s/expanding-recipient-access-the-role-of-extracorporeal-membranous-oxygenation-ecmo-11145
https://atc.digitellinc.com/p/s/expanding-recipient-access-the-impact-of-esophageal-dysmotility-11150
https://atc.digitellinc.com/p/s/pro-the-ckdpc-web-based-lifetime-esrd-risk-calculator-should-not-be-used-to-counsel-and-select-young-living-kidney-donor-candidates-11160
https://atc.digitellinc.com/p/s/con-the-ckdpc-web-based-lifetime-esrd-risk-calculator-should-not-be-used-to-counsel-and-select-young-living-kidney-donor-candidates-11165
https://atc.digitellinc.com/p/s/top-5-papers-viruses-11175
https://atc.digitellinc.com/p/s/top-5-papers-bacteria-11180
https://atc.digitellinc.com/p/s/top-5-papers-fungi-et-al-11185
https://atc.digitellinc.com/p/s/evaluation-of-frailty-and-association-with-post-transplant-outcomes-11200
https://atc.digitellinc.com/p/s/key-domains-of-the-psychosocial-assessment-in-vca-11215
https://atc.digitellinc.com/p/s/psychosocial-aspects-of-genitourinary-transplantation-and-review-of-the-current-experience-11225
https://atc.digitellinc.com/p/s/the-tortuous-path-to-allograft-specific-therapies-11230
https://atc.digitellinc.com/p/s/from-licensure-to-application-whats-next-for-allogeneic-islet-transplantation-11240
https://atc.digitellinc.com/p/s/stem-cell-derived-beta-cells-11250
https://atc.digitellinc.com/p/s/pure-laparoscopic-donor-right-hepatectomy-using-icg-technique-11260
https://atc.digitellinc.com/p/s/hybrid-and-other-modified-laparoscopic-donor-hepectomy-11265
https://atc.digitellinc.com/p/s/autoimmunity-in-lung-transplantation-11280
https://atc.digitellinc.com/p/s/apoptotic-exosomes-the-missing-link-between-tissue-injury-autoantibodies-and-rejection-11285
https://atc.digitellinc.com/p/s/basic-how-b-cells-influence-the-immune-response-11300
https://atc.digitellinc.com/p/s/translational-regulatory-b-cells-in-kidney-transplant-recipients-11305
https://atc.digitellinc.com/p/s/clinical-b-cell-modulation-in-transplantation-11310
https://atc.digitellinc.com/p/s/the-impact-of-alloantibodysubclinical-amr-on-chronic-allograft-injury-11320
https://atc.digitellinc.com/p/s/what-is-the-impact-of-clinical-amr-on-long-term-outcomes-11325
https://atc.digitellinc.com/p/s/therapies-for-amr-what-works-and-is-there-anything-new-11330
https://atc.digitellinc.com/p/s/negative-impacts-of-cmv-on-the-transplant-allograft-and-optimal-prevention-11340
https://atc.digitellinc.com/p/s/the-t-cell-response-to-cmv-infection-bench-to-bedside-11345
https://atc.digitellinc.com/p/s/anti-cmv-armamentarium-of-the-future-11350
https://atc.digitellinc.com/p/s/treatment-of-hepatitis-c-before-and-after-non-liver-transplantation-11365
https://atc.digitellinc.com/p/s/management-of-hepatitis-b-in-organ-transplant-candidates-and-recipients-11370
https://atc.digitellinc.com/p/s/differentiation-of-tissue-resident-memory-t-cells-11380
https://atc.digitellinc.com/p/s/tissue-resident-memory-t-cells-in-lung-inflammation-and-asthma-11385
https://atc.digitellinc.com/p/s/impact-of-donor-derived-tissue-resident-cells-on-alloimmunity-following-transplantation-11390
https://atc.digitellinc.com/p/s/re-transplantation-of-a-vca-con-11405
https://atc.digitellinc.com/p/s/expanding-the-lung-donor-pool-use-of-increased-risk-donors-11420
https://atc.digitellinc.com/p/s/expanding-the-current-donor-pool-donation-after-circulatory-determination-of-death-dcdd-11425
https://atc.digitellinc.com/p/s/basic-t-cell-memory-11435
https://atc.digitellinc.com/p/s/translational-t-cell-memory-11440
https://atc.digitellinc.com/p/s/clinical-t-cell-memory-11445
https://atc.digitellinc.com/p/s/epidemiology-of-deceased-donor-kidney-discards-in-the-united-states-11465
https://atc.digitellinc.com/p/s/pro-biopsy-of-deceased-donor-kidneys-provides-valuable-information-11470
https://atc.digitellinc.com/p/s/strategies-to-decrease-organ-discard-from-pumps-to-policy-11480
https://atc.digitellinc.com/p/s/mechanisms-of-transendothelial-migration-11490
https://atc.digitellinc.com/p/s/tregs-and-transendothelial-migration-11500
https://atc.digitellinc.com/p/s/the-endothelium-and-its-role-in-allograft-rejection-11505
https://atc.digitellinc.com/p/s/management-of-post-transplant-diabetes-mellitus-11520
https://atc.digitellinc.com/p/s/new-treatment-guidelines-and-the-management-of-post-transplant-dyslipidemias-11525
https://atc.digitellinc.com/p/s/bariatric-surgery-in-the-transplant-patient-effects-on-immunosuppression-11530
https://atc.digitellinc.com/p/s/surveillance-biopsies-to-diagnose-amr-risk-vs-benefit-in-children-11540
https://atc.digitellinc.com/p/s/is-there-evidence-for-dsa-and-biopsy-surveillance-in-children-after-a-solid-organ-transplant-11545
https://atc.digitellinc.com/p/s/bortezomib-and-newer-therapies-for-the-treatment-of-amr-in-children-11550
https://atc.digitellinc.com/p/s/case-2-11560
https://atc.digitellinc.com/p/s/should-this-kid-get-a-transplant-11565
https://atc.digitellinc.com/p/s/impact-of-neurocognitive-disease-on-transplant-eligibility-11570
https://atc.digitellinc.com/p/s/case-3-11575
https://atc.digitellinc.com/p/s/why-transplant-surgery-is-exciting-thoughts-from-the-asts-president-11595
https://atc.digitellinc.com/p/s/why-transplant-medicine-is-exciting-thoughts-from-the-ast-president-11600
https://atc.digitellinc.com/p/s/why-bile-is-exciting-liver-transplantation-11605
https://atc.digitellinc.com/p/s/why-urine-is-exciting-kidney-transplantation-11610
https://atc.digitellinc.com/p/s/why-big-data-is-exciting-outcomes-research-in-transplantation-11615
https://atc.digitellinc.com/p/s/why-mice-are-exciting-basic-science-research-in-transplantation-11620
https://atc.digitellinc.com/p/s/why-bugs-are-exciting-transplant-id-11625
https://atc.digitellinc.com/p/s/why-drugs-are-exciting-transplant-pharmacology-11630
https://atc.digitellinc.com/p/s/why-things-are-exciting-above-the-diaphragm-thoracic-transplantation-11635
https://atc.digitellinc.com/p/s/making-sense-of-hyperparathyroidism-after-kidney-transplantation-11645
https://atc.digitellinc.com/p/s/tough-break-managing-osteoporosis-after-transplantation-11650
https://atc.digitellinc.com/p/s/use-of-novel-oral-anticoagulants-in-the-transplant-population-11655
https://atc.digitellinc.com/p/s/biologics-in-management-of-inflammatory-bowel-diseases-post-transplantation-11660
https://atc.digitellinc.com/p/s/hiv-management-post-transplantation-11665
https://atc.digitellinc.com/p/s/overview-of-the-new-slk-policy-11675
https://atc.digitellinc.com/p/s/delayed-implantation-of-the-kidney-allograft-11680
https://atc.digitellinc.com/p/s/appropriate-monitoring-of-the-kidney-graft-in-slk-11685
https://atc.digitellinc.com/p/s/bone-marrow-derived-hematopoietic-stem-and-progenitor-cells-infiltrate-allogeneic-and-syngeneic-transplants-11695
https://atc.digitellinc.com/p/s/best-practices-in-the-use-of-deceased-after-cardiac-death-hepatic-allografts-11715
https://atc.digitellinc.com/p/s/future-directions-in-dcd-liver-transplantation-is-the-pump-the-solution-11720
https://atc.digitellinc.com/p/s/new-basic-and-translational-science-in-protecting-dcd-allografts-11725
https://atc.digitellinc.com/p/s/zika-virus-infections-screening-recommendations-and-outcome-data-11735
https://atc.digitellinc.com/p/s/nontuberculous-mycobacteria-infections-management-of-transplant-candidates-and-recipients-11740
https://atc.digitellinc.com/p/s/strongyloides-infection-post-transplant-screening-and-management-of-donors-and-recipients-11745
https://atc.digitellinc.com/p/s/making-sense-of-it-all-understanding-the-regulatory-requirements-for-pharmacists-11755
https://atc.digitellinc.com/p/s/youve-been-cited-a-review-of-common-pharmacy-related-regulatory-citations-and-potential-corrective-actions-11760
https://atc.digitellinc.com/p/s/getting-more-with-less-innovative-approaches-to-expanding-pharmacy-services-11765
https://atc.digitellinc.com/p/s/generation-of-kidney-and-pancreas-from-pluripotent-stem-cells-via-blastocyst-complementation-11780
https://atc.digitellinc.com/p/s/pro-maintaining-minimal-volume-solid-organ-pancreas-transplant-programs-11795
https://atc.digitellinc.com/p/s/con-maintaining-minimal-volume-solid-organ-pancreas-transplant-programs-11800
https://atc.digitellinc.com/p/s/immune-monitoring-for-cardiac-transplantation-where-are-we-in-2017-11810
https://atc.digitellinc.com/p/s/microrna-11820
https://atc.digitellinc.com/p/s/molecular-microscope-11825
https://atc.digitellinc.com/p/s/summary-of-the-current-practice-of-slk-transplantation-11835
https://atc.digitellinc.com/p/s/the-new-slk-transplant-policy-what-it-does-and-why-11840
https://atc.digitellinc.com/p/s/crippling-limitations-of-the-new-slk-policy-11845
https://atc.digitellinc.com/p/s/does-tolerance-outperform-optimized-immunosuppression-11850
https://atc.digitellinc.com/p/s/regulatory-cells-and-tolerance-11855
https://atc.digitellinc.com/p/s/chimerism-and-tolerance-it-works-so-what-are-the-barriers-11860
https://atc.digitellinc.com/p/s/disparities-in-opportunities-for-transplantation-11870
https://atc.digitellinc.com/p/s/sex-differences-in-kidney-transplant-outcomes-and-allocation-11875
https://atc.digitellinc.com/p/s/reproductive-health-following-solid-organ-transplant-11880
https://atc.digitellinc.com/p/s/immune-checkpoint-inhibitors-emerging-targets-for-induction-of-anti-tumor-immunity-and-transplantation-tolerance-11885
https://atc.digitellinc.com/p/s/when-is-chronic-atrial-fibrillation-a-contraindication-to-liver-transplantation-11895
https://atc.digitellinc.com/p/s/significant-coronary-artery-disease-when-is-it-critical-when-to-revascularize-11900
https://atc.digitellinc.com/p/s/mitigating-pulmonary-hypertension-to-allow-for-successful-liver-transplantation-11905
https://atc.digitellinc.com/p/s/optimal-management-of-cardiac-dysfunction-after-liver-transplantation-11910
https://atc.digitellinc.com/p/s/case-presentation-11920
https://atc.digitellinc.com/p/s/pro-mechanical-circulatory-support-rather-should-be-used-in-patients-who-are-not-thought-candidates-for-transplantation-due-to-concerns-over-compliance-11925
https://atc.digitellinc.com/p/s/con-mechanical-circulatory-support-rather-should-be-used-in-patients-who-are-not-thought-candidates-for-transplantation-due-to-concerns-over-compliance-11930
https://atc.digitellinc.com/p/s/case-presentation-11935
https://atc.digitellinc.com/p/s/con-destination-therapy-patients-who-are-intermacs-profile-4-5-should-be-implanted-as-destination-therapy-11945
https://atc.digitellinc.com/p/s/case-presentation-11950
https://atc.digitellinc.com/p/s/pro-older-patients-with-comorbidities-should-be-referred-for-destination-therapy-rather-than-transplantation-11955
https://atc.digitellinc.com/p/s/con-older-patients-with-comorbidities-should-be-referred-for-destination-therapy-rather-than-transplantation-11960
https://atc.digitellinc.com/p/s/the-health-economic-consequences-of-delayed-graft-function-11975
https://atc.digitellinc.com/p/s/therapeutic-strategies-to-reduce-iri-and-dgf-does-anything-work-11980
https://atc.digitellinc.com/p/s/role-of-donor-dendritic-cell-derived-exosomes-in-the-allo-immune-response-11990
https://atc.digitellinc.com/p/s/hiv-positive-to-positive-transplantation-first-year-results-and-outcomes-in-the-usa-12010
https://atc.digitellinc.com/p/s/hiv-positive-transplantations-results-with-maraviroc-and-mtor-inhibitors-12020
https://atc.digitellinc.com/p/s/immune-tolerance-in-pregnancy-12030
https://atc.digitellinc.com/p/s/t-cell-exhaustion-in-chronic-viral-infection-12040
https://atc.digitellinc.com/p/s/testing-for-apol-1-gene-variants-in-the-setting-of-deceased-donor-kidney-transplantation-opportunities-and-barriers-12050
https://atc.digitellinc.com/p/s/apol-1-and-living-kidney-donation-balancing-autonomy-and-safety-12055
https://atc.digitellinc.com/p/s/impact-of-apol-1-the-impact-of-screening-on-access-to-kidney-transplantation-among-african-americans-transplantation-of-kidneys-from-living-and-deceased-organ-donors-12060
https://atc.digitellinc.com/p/s/new-strategies-for-the-management-of-acute-on-chronic-liver-failure-12070
https://atc.digitellinc.com/p/s/infection-in-the-wait-listed-liver-transplant-candidate-12075
https://atc.digitellinc.com/p/s/too-sick-for-transplant-frailty-nutrition-and-predictive-score-assessments-12080
https://atc.digitellinc.com/p/s/evolution-of-liver-transplant-for-hcc-20-years-post-milan-12090
https://atc.digitellinc.com/p/s/evolution-of-unos-policies-for-hcc-what-does-the-future-hold-12095
https://atc.digitellinc.com/p/s/hcc-and-nash-the-sleeping-giant-and-the-potential-future-12100
https://atc.digitellinc.com/p/s/lesions-learned-from-esrd-in-the-general-population-12110
https://atc.digitellinc.com/p/s/what-can-the-srtr-database-teach-us-12115
https://atc.digitellinc.com/p/s/warm-perfusion-of-the-kidney-12130
https://atc.digitellinc.com/p/s/warm-perfusion-in-liver-transplantation-12135
https://atc.digitellinc.com/p/s/warm-perfusion-of-the-heart-12140
https://atc.digitellinc.com/p/s/lesions-from-the-real-world-a-cms-transplant-center-case-study-12155
https://atc.digitellinc.com/p/s/the-optn-coin-project-early-data-from-a-new-approach-to-program-oversight-12160
https://atc.digitellinc.com/p/s/the-basics-developing-a-qapi-program-12165
https://atc.digitellinc.com/p/s/survey-readiness-how-will-you-make-your-allstar-team-shine-12170
https://atc.digitellinc.com/p/s/data-analytics-making-better-business-decisions-and-expanding-your-qapi-program-12175
https://atc.digitellinc.com/p/s/report-from-the-ast-adherence-task-force-real-world-options-for-promoting-adherence-12185
https://atc.digitellinc.com/p/s/use-of-once-daily-immunosuppression-regimens-to-promote-adherence-in-the-pediatricadolescent-population-12190
https://atc.digitellinc.com/p/s/technology-based-interventions-to-promote-adherence-in-adult-and-pediatric-populations-12195
https://atc.digitellinc.com/p/s/lost-in-translation-speaking-with-generation-z-12205
https://atc.digitellinc.com/p/s/social-media-and-peer-mentoring-as-bridges-to-the-adult-world-12210
https://atc.digitellinc.com/p/s/are-they-really-ready-assessing-readiness-for-transition-to-the-adult-world-12215
https://atc.digitellinc.com/p/s/fungal-diagnostics-one-case-at-a-time-12225
https://atc.digitellinc.com/p/s/prophylaxis-pre-emption-and-treatment-best-way-to-get-that-fun-guy-12230
https://atc.digitellinc.com/p/s/infectious-barriers-do-they-really-exist-12250
https://atc.digitellinc.com/p/s/regulatory-barriers-are-there-solutions-12255
https://atc.digitellinc.com/p/s/dendritic-cells-and-allograft-rejection-experimental-perspective-12265
https://atc.digitellinc.com/p/s/translational-approaches-to-dendritic-cell-therapy-12270
https://atc.digitellinc.com/p/s/what-is-really-an-extended-criteria-donor-are-all-extended-criteria-grafts-created-equal-12280
https://atc.digitellinc.com/p/s/the-challenges-involved-in-allocating-extended-criteria-donors-12285
https://atc.digitellinc.com/p/s/planning-a-strategy-for-optimal-use-of-extended-criteria-donors-based-on-the-last-15-years-of-experience-12290
https://atc.digitellinc.com/p/s/rejection-in-2017-big-or-little-deal-in-liver-recipients-12300
https://atc.digitellinc.com/p/s/complete-immunosuppression-withdrawal-in-children-and-adults-how-close-are-we-12305
https://atc.digitellinc.com/p/s/personalized-immunosuppression-is-it-ready-for-prime-time-and-if-not-when-12310
https://atc.digitellinc.com/p/s/overview-of-t-cell-metabolism-12320
https://atc.digitellinc.com/p/s/modulation-of-glycolytic-pathways-to-modulate-t-cell-responses-12330
https://atc.digitellinc.com/p/s/pharmacology-of-opioids-drug-interactions-and-screening-methods-12340
https://atc.digitellinc.com/p/s/opioid-substitution-therapy-use-in-transplant-candidates-transplant-psychiatristaddiction-specialist-12345
https://atc.digitellinc.com/p/s/integrated-care-and-pain-management-for-transplant-candidates-12350
https://atc.digitellinc.com/p/s/financial-implications-of-an-anonymous-non-directed-living-donor-registry-kickstarting-kidney-paired-donation-chains-to-maximize-the-impact-of-individual-donations-12360
https://atc.digitellinc.com/p/s/ethical-implications-organ-donation-entering-the-social-media-space-12365
https://atc.digitellinc.com/p/s/social-media-and-organ-donation-optimizing-impact-12370
https://atc.digitellinc.com/p/s/issues-of-childbearing-fertility-infertility-and-assisted-reproduction-in-transplant-recipients-12380
https://atc.digitellinc.com/p/s/pregnancy-and-delivery-management-12385
https://atc.digitellinc.com/p/s/the-second-and-third-generation-children-and-grandchildren-of-transplant-recipients-12390
https://atc.digitellinc.com/p/s/the-transplant-administrator-and-physician-director-partnership-in-leading-the-transplant-team-12400
https://atc.digitellinc.com/p/s/leading-your-team-through-change-12405
https://atc.digitellinc.com/p/s/keep-off-of-my-land-preventing-and-resolving-boundary-conflicts-in-transplant-multidisciplinary-teams-12410
https://atc.digitellinc.com/p/s/con-innate-allorecognition-12425
https://atc.digitellinc.com/p/s/con-rebuttals-12435
https://atc.digitellinc.com/p/s/con-hcv-plus-organs-should-only-be-used-in-recipients-with-active-hcv-12450
https://atc.digitellinc.com/p/s/con-rebuttals-12460
https://atc.digitellinc.com/p/s/alternative-models-for-liver-allocation-using-nearest-neighbor-algorithms-12470
https://atc.digitellinc.com/p/s/burden-of-liver-disease-as-a-measure-of-disparity-in-liver-allocation-12475
https://atc.digitellinc.com/p/s/basic-regulated-cell-death-in-transplantation-12490
https://atc.digitellinc.com/p/s/translational-approaches-to-prevent-ischemia-reperfusion-injury-12495
https://atc.digitellinc.com/p/s/clinical-clinically-applicable-strategies-to-attenuate-ischemia-reperfusion-injury-12500
https://atc.digitellinc.com/p/s/insulin-pump-v-transplantation-12510
https://atc.digitellinc.com/p/s/solid-organ-v-islet-cell-12515
https://atc.digitellinc.com/p/s/type-1-v-type-2-12520
https://atc.digitellinc.com/p/s/developing-pancreatic-tissue-from-es-and-ips-cells-12540
https://atc.digitellinc.com/p/s/the-very-real-costs-of-living-kidney-donation-12550
https://atc.digitellinc.com/p/s/more-than-just-semantics-where-is-the-line-between-disincentive-and-incentives-12555
https://atc.digitellinc.com/p/s/phs-increased-donors-can-we-do-more-12570
https://atc.digitellinc.com/p/s/dtac-perspectives-on-expanding-the-donor-pool-12575
https://atc.digitellinc.com/p/s/contraception-what-is-the-best-option-for-transplant-recipients-12590
https://atc.digitellinc.com/p/s/contemplating-conception-preconception-guidelines-for-transplant-recipients-12595
https://atc.digitellinc.com/p/s/pregnancies-fathered-by-transplant-recipients-immunosuppression-and-outcomes-12600
https://atc.digitellinc.com/p/s/regulatory-t-cell-trafficking-12615
https://atc.digitellinc.com/p/s/regulatory-t-cells-as-therapy-in-clinical-transplantation-12620
https://atc.digitellinc.com/p/s/walking-a-fine-line-optimal-and-novel-treatments-of-bk-nephropathy-a-case-discussion-12635
https://atc.digitellinc.com/p/s/trouble-on-the-horizon-how-to-monitor-for-rejection-in-the-setting-of-bk-infection-12640
https://atc.digitellinc.com/p/s/leveraging-knowledge-innovation-team-work-and-technology-in-referral-outreach-12655
https://atc.digitellinc.com/p/s/theres-no-i-in-research-12660
https://atc.digitellinc.com/p/s/where-are-the-new-therapeutic-agents-and-how-can-we-get-more-12670
https://atc.digitellinc.com/p/s/how-does-industry-make-a-gono-go-decision-about-novel-therapies-in-transplantation-12675
https://atc.digitellinc.com/p/s/barriers-to-off-label-use-and-repurposing-drugs-for-use-in-transplantation-12680
https://atc.digitellinc.com/p/s/newest-therapies-for-the-treatment-of-hepatitis-c-12690
https://atc.digitellinc.com/p/s/updates-in-antiviral-therapies-12695
https://atc.digitellinc.com/p/s/novel-treatment-interventions-to-improve-medication-adherence-and-outcomes-12705
https://atc.digitellinc.com/p/s/basixilimab-induction-and-delayed-calcineurin-inhibitors-introduction-12710
https://atc.digitellinc.com/p/s/everolimus-and-low-dose-tacrolimus-12715
https://atc.digitellinc.com/p/s/kidney-transplant-induction-in-the-real-world-alemtuzumab-12720
https://atc.digitellinc.com/p/s/kidney-transplant-induction-in-the-real-world-rabbit-antithymocyte-globulin-12725
https://atc.digitellinc.com/p/s/kidney-transplant-induction-in-the-real-world-basiliximab-12730
https://atc.digitellinc.com/p/s/belatacept-the-emory-experience-12735
https://atc.digitellinc.com/p/s/belatacept-the-university-of-cincinnati-experience-12740
https://atc.digitellinc.com/p/s/enhancing-the-hospital-to-home-transition-for-families-of-pediatric-solid-organ-transplant-recipients-setting-the-stage-for-long-term-success-12750
https://atc.digitellinc.com/p/s/risky-business-how-can-we-help-teens-navigate-common-lifestyle-challenges-12755
https://atc.digitellinc.com/p/s/transition-from-pediatric-to-adult-care-customizing-patient-and-hospital-resources-to-foster-successful-outcomes-12760
https://atc.digitellinc.com/p/s/implications-of-kas-on-organ-allocation-for-children-12765
https://atc.digitellinc.com/p/s/finding-the-right-donor-for-the-infant-liver-recipient-live-donor-split-or-whole-organ-12770
https://atc.digitellinc.com/p/s/stepping-up-strategies-to-enhance-live-donation-in-pediatric-transplantation-12775
https://atc.digitellinc.com/p/s/transplanting-hepatitis-c-kidneys-into-negative-kidney-recipients-thinker-trial-12785
https://atc.digitellinc.com/p/s/expander-1-exploring-renal-transplants-using-hepatitis-c-infected-donors-for-hcv-negative-recipients-12790
https://atc.digitellinc.com/p/s/emerging-application-of-active-immune-targeted-delivery-in-transplantation-12795
https://atc.digitellinc.com/p/s/uptake-of-extracellular-mitochondria-activates-human-endothelial-cells-that-stimulate-alloreactive-effector-t-cell-responses-12800
https://atc.digitellinc.com/p/s/long-term-liver-and-kidney-survival-following-combined-liver-kidney-transplantation-with-or-without-preformed-donor-specific-antibodies-12810
https://atc.digitellinc.com/p/s/tacrolimus-appears-to-be-a-protective-factor-for-de-novo-dsa-formation-in-non-sensitized-kidney-transplant-patients-12815
https://atc.digitellinc.com/p/s/long-term-outcome-of-antibody-mediated-rejection-due-to-pre-existing-vs-de-novo-dsa-in-kidney-allograft-recipients-12820
https://atc.digitellinc.com/p/s/association-with-tacrolimus-intraindividual-variability-acute-microinflammation-based-on-1-year-transplanted-kidney-biopsy-after-transplantation-and-biopsy-proven-acute-rejection-12825
https://atc.digitellinc.com/p/s/biological-interplay-between-circulating-hla-sp-alloreactive-memory-b-cells-and-long-lived-plasma-cells-in-kidney-transplant-patients-undergoing-chronic-abmr-12830
https://atc.digitellinc.com/p/s/lower-mean-tacrolimus-troughs-increase-risk-of-de-novo-donor-specific-antibodies-in-the-first-year-of-kidney-transplant-12835
https://atc.digitellinc.com/p/s/kidney-transplant-rejection-associated-with-dq-eplet-mismatches-12840
https://atc.digitellinc.com/p/s/characterization-of-a-b-lymphocyte-signature-predictive-of-chronic-lung-allograft-dysfunction-12850
https://atc.digitellinc.com/p/s/b-cell-derived-cytokines-rather-than-tb-cognate-interactions-mediate-cd8-t-cell-reconstitution-following-lymphoablation-12855
https://atc.digitellinc.com/p/s/dual-targeting-with-carfilzomib-and-tocilizumab-abrogates-antibody-mediated-rejection-and-prolongs-survival-in-a-highly-sensitized-rhesus-model-of-kidney-transplantation-12860
https://atc.digitellinc.com/p/s/effective-targeting-plasma-cells-with-daratumumab-anti-cd38-and-mozobil-anti-cxcr4-in-a-sensitized-non-human-primate-model-12865
https://atc.digitellinc.com/p/s/dual-targeting-of-costimulation-and-proteasome-to-desensitize-and-prolong-graft-survival-of-sensitized-nonhuman-primates-12870
https://atc.digitellinc.com/p/s/thrombalexin-use-of-a-cytotopic-anticoagulant-to-reduce-thrombotic-microangiopathy-in-a-highly-sensitized-model-of-kidney-transplantation-12875
https://atc.digitellinc.com/p/s/taci-polymorphisms-associated-with-de-novo-alloantibodies-in-humans-and-allograft-rejection-in-mice-12880
https://atc.digitellinc.com/p/s/sirolimus-prolonged-survival-after-living-donor-liver-transplantation-for-hcc-beynd-milan-criteria-outcome-of-a-multicenter-prospective-randomized-phase-ii-trial-clinicaltrialsgov-identifier-nct013747-12895
https://atc.digitellinc.com/p/s/increasing-liver-transplant-waitlist-dropout-for-hepatocellular-carcinoma-with-widening-geographical-disparities-implications-for-organ-allocation-12900
https://atc.digitellinc.com/p/s/multicenter-validation-of-a-clinicopathologic-risk-score-to-predict-hepatocellular-carcinoma-recurrence-following-liver-transplantation-analysis-of-4984-patients-from-the-us-multicenter-hcc-transplant-12905
https://atc.digitellinc.com/p/s/a-pretransplant-model-incorporating-serum-biomarkers-is-superior-to-the-milan-criteria-in-stratifying-risk-of-hepatocellular-carcinoma-recurrence-following-liver-transplantation-analysis-of-4407-patie-12910
https://atc.digitellinc.com/p/s/long-wait-time-regions-for-liver-transplantation-for-hcc-have-a-higher-cumulative-incidence-of-death-12915
https://atc.digitellinc.com/p/s/hispanic-paradox-in-patients-with-liver-cirrhosis-12920
https://atc.digitellinc.com/p/s/can-viral-load-be-used-as-a-surrogate-marker-in-clinical-studies-of-cytomegalovirus-in-solid-organ-transplantation-a-systematic-review-and-metaanalysis-12930
https://atc.digitellinc.com/p/s/contribution-of-new-generation-sequencing-to-cmv-resistance-analysis-in-renal-transplant-recipients-on-behalf-of-the-cmv-resist-group-12935
https://atc.digitellinc.com/p/s/bk-virus-cytomegalovirus-and-epstein-barr-virus-reactivation-in-renal-transplant-patients-results-from-a-large-multicenter-study-12940
https://atc.digitellinc.com/p/s/prospective-randomized-trial-for-predicting-cmv-infection-according-to-baseline-cmv-specific-t-cell-immunity-in-kidney-transplant-patients-12945
https://atc.digitellinc.com/p/s/pre-transplant-cmv-specific-t-cell-immunity-is-an-additional-independent-variable-predicting-cmv-infection-after-kidney-transplantation-12950
https://atc.digitellinc.com/p/s/impact-of-t-cell-depletion-on-cmv-specific-memory-t-and-b-cell-homeostatic-proliferation-after-kidney-transplantation-12955
https://atc.digitellinc.com/p/s/efficacy-and-safety-of-asp0113-versus-placebo-in-cmv-seronegative-kidney-transplant-patients-receiving-an-organ-from-a-cmv-seropositive-donor-12960
https://atc.digitellinc.com/p/s/to-accept-or-not-accept-that-is-the-question-donor-heart-selection-process-and-outcome-of-discarded-organs-transplanted-in-another-center-12970
https://atc.digitellinc.com/p/s/minimal-effect-of-broader-heart-sharing-on-regional-outcomes-12975
https://atc.digitellinc.com/p/s/trends-in-the-number-and-medical-urgency-of-adult-heart-transplant-candidates-listed-as-status-1a-from-2006-2015-12980
https://atc.digitellinc.com/p/s/precise-antibody-characterization-using-multiple-solid-phase-assay-platforms-is-critical-for-accurate-virtual-crossmatching-12985
https://atc.digitellinc.com/p/s/redefining-pediatric-heart-status-1a-and-1b-criteria-results-of-early-policy-evaluation-12990
https://atc.digitellinc.com/p/s/the-ultimate-calculated-panel-reactive-antibody-value-predicts-mortality-after-heart-transplantation-12995
https://atc.digitellinc.com/p/s/simultaneous-or-sequential-heart-liver-transplantation-confer-superior-survival-in-patients-with-listed-for-heart-liver-transplantation-a-national-analysis-13000
https://atc.digitellinc.com/p/s/autophagy-regulates-lg3-maturation-and-export-in-apoptotic-exosome-like-vesicles-13010
https://atc.digitellinc.com/p/s/cd16a-activated-nk-cells-in-abmr-are-highly-similar-to-cd3-activated-effector-t-cells-in-tcmr-13015
https://atc.digitellinc.com/p/s/cmv-infected-kidney-grafts-drive-the-expansion-of-blood-born-cmv-specific-t-cells-restricted-by-shared-hla-molecules-through-presentation-on-donors-cells-13020
https://atc.digitellinc.com/p/s/glycolytic-and-glutaminolytic-metabolism-supports-il-15-induced-inflammatory-response-of-temra-cd8-from-kidney-transplant-recipients-13025
https://atc.digitellinc.com/p/s/innate-lymphoid-cells-play-a-critical-role-in-regulating-allograft-homeostasis-in-human-intestinal-transplantation-13030
https://atc.digitellinc.com/p/s/mtor-inhibition-diminishes-peripheral-blood-cd8-plus-cd28-cd38-plus-effectormemory-t-cells-and-facilitates-resolution-of-belatacept-refractory-kidney-rejection-13035
https://atc.digitellinc.com/p/s/a-novel-3-dimensional-culture-system-enables-in-vitro-study-of-human-bone-marrow-plasma-cells-13040
https://atc.digitellinc.com/p/s/de-novo-donor-specific-antibodies-after-allograft-nephrectomy-13050
https://atc.digitellinc.com/p/s/de-novo-non-donor-specific-hla-antibodies-are-associated-with-inferior-allograft-outcomes-after-kidney-and-simultaneous-kidney-pancreas-transplantation-13055
https://atc.digitellinc.com/p/s/blood-transfusion-induced-donor-specific-antibodies-are-associated-with-rejection-and-graft-failure-13060
https://atc.digitellinc.com/p/s/significant-allosensitisation-despite-early-within-24-hour-graft-nephrectomy-13065
https://atc.digitellinc.com/p/s/outcomes-of-protocol-allograft-kidney-biopsy-in-denovo-donor-specific-antibodies-13070
https://atc.digitellinc.com/p/s/graft-survival-in-de-novo-donor-specific-antibodies-and-positive-flow-crossmatch-kidney-transplants-is-influenced-by-class-i-and-class-ii-13075
https://atc.digitellinc.com/p/s/incidence-of-de-novo-donor-specific-antibodies-following-kidney-transplantation-13080
https://atc.digitellinc.com/p/s/more-rapid-decline-in-male-vs-female-living-kidney-donations-lkd-varies-by-income-13090
https://atc.digitellinc.com/p/s/assessment-of-the-risk-index-for-living-donor-kidney-transplantation-lkdpi-in-a-european-cohort-13095
https://atc.digitellinc.com/p/s/shared-epitopes-contribute-to-accumulation-of-highly-sensitized-patients-in-kidney-paired-donation-program-13100
https://atc.digitellinc.com/p/s/zero-hla-mismatch-matters-in-abo-incompatible-kidney-transplant-13105
https://atc.digitellinc.com/p/s/post-donation-remaining-donor-kidney-function-as-measured-by-ckd-epi-formula-at-2-years-correlates-and-is-predicted-by-remaining-donor-kidney-volume-13110
https://atc.digitellinc.com/p/s/advanced-donation-within-a-paired-exchange-program-13115
https://atc.digitellinc.com/p/s/hla-eplet-mismatches-predict-dsa-formation-graft-survival-and-re-transplantation-rate-in-pediatric-renal-transplantation-13130
https://atc.digitellinc.com/p/s/inflammatory-cytokines-are-associated-with-angiotensin-ii-type-1-receptor-antibodies-and-vascular-inflammation-in-pediatric-renal-transplantation-13135
https://atc.digitellinc.com/p/s/clinical-and-histopathologic-features-of-antibody-mediated-rejection-abmr-in-highly-sensitized-hs-vs-non-sensitized-ns-pediatric-renal-transplant-recipients-13140
https://atc.digitellinc.com/p/s/longitudinal-study-of-donor-specific-antibodies-in-a-pediatric-kidney-transplant-population-response-to-optimization-of-anti-proliferative-therapy-13145
https://atc.digitellinc.com/p/s/is-peri-transplant-plasmapheresis-effective-in-the-prevention-of-recurrence-of-fsgs-13150
https://atc.digitellinc.com/p/s/hla-c-mismatching-and-humoral-alloimmune-responses-in-pediatric-kidney-recipients-with-subclinical-vascular-injury-13155
https://atc.digitellinc.com/p/s/acute-cellar-rejection-and-long-term-graft-survival-in-pediatric-kidney-transplant-recipients-13160
https://atc.digitellinc.com/p/s/de-novo-use-of-everolimus-reduces-late-onset-cytomegalovirus-primary-disease-occurring-after-antiviral-prophylaxis-discontinuation-in-kidney-transplant-recipients-13170
https://atc.digitellinc.com/p/s/impact-of-antihypertensive-aht-choice-and-advagraf-r-dose-on-interstitial-fibrosistubular-atrophy-ifta-and-ifta-progression-in-renal-allografts-24-months-post-transplantation-tx-13175
https://atc.digitellinc.com/p/s/impact-of-antihypertensive-aht-choice-and-advagraf-r-dose-on-immunologic-events-in-renal-allografts-24-months-post-transplantation-tx-13180
https://atc.digitellinc.com/p/s/de-novo-low-dose-sirolimus-versus-mycophenolate-mofetil-in-combination-with-extended-release-tacrolimus-in-kidney-transplant-recipients-13185
https://atc.digitellinc.com/p/s/infusion-of-polyclonal-tregs-modulates-subclinical-kidney-transplant-inflammation-final-report-of-task-pilot-trial-13190
https://atc.digitellinc.com/p/s/molecular-profiles-of-renal-allograft-biopsies-at-12-months-post-renal-transplant-in-patients-exposed-to-low-dose-cni-and-everolimus-vs-patients-exposed-to-full-dose-cni-and-mmf-13195
https://atc.digitellinc.com/p/s/tacrolimus-time-in-therapeutic-range-predicts-adverse-clinical-outcomes-in-the-first-year-of-kidney-transplant-13200
https://atc.digitellinc.com/p/s/disease-progression-on-neoadjuvant-chemotherapy-is-a-strong-predictor-of-recurrence-for-pediatric-hepatoblastoma-13210
https://atc.digitellinc.com/p/s/personalizing-immunosuppression-with-molecular-phenotyping-in-pediatric-liver-transplantation-13215
https://atc.digitellinc.com/p/s/predicting-immunologic-risk-for-acute-rejection-in-pediatric-liver-transplantation-13220
https://atc.digitellinc.com/p/s/efficacy-and-safety-of-everolimus-with-reduced-tacrolimus-or-cyclosporine-in-pediatric-liver-transplant-recipients-12-month-results-from-h2305-study-13225
https://atc.digitellinc.com/p/s/20-and-25-year-outcomes-following-pediatric-liver-transplantation-13230
https://atc.digitellinc.com/p/s/impact-of-peri-transplant-viral-upper-respiratory-infection-on-pediatric-liver-transplant-outcomes-13235
https://atc.digitellinc.com/p/s/assessing-self-efficacy-during-the-transition-from-pediatric-to-adult-liver-transplant-care-13240
https://atc.digitellinc.com/p/s/high-regulatory-t-cells-rate-early-after-lung-transplantation-is-associated-with-bronchiolitis-obliterans-syndrome-development-13250
https://atc.digitellinc.com/p/s/novel-personalized-immune-monitoring-assay-for-predicting-operational-tolerance-by-using-humanized-mouse-model-13255
https://atc.digitellinc.com/p/s/compartmental-infiltration-of-kidney-allograft-with-monocyte-macrophage-subtypes-defines-the-type-of-rejection-13260
https://atc.digitellinc.com/p/s/pre-transplant-circulating-tnfr2-plus-regulatory-t-cells-predict-acute-rejection-within-the-first-6-months-after-kidney-transplantation-13265
https://atc.digitellinc.com/p/s/genome-wide-genotyping-in-1022-heart-transplantation-recipients-and-758-donors-reveal-association-with-acute-allograft-rejection-13270
https://atc.digitellinc.com/p/s/pre-transplant-evaluation-of-ksort-to-assess-risk-for-rejection-in-highly-sensitized-patients-13275
https://atc.digitellinc.com/p/s/a-universal-strategy-to-characterize-allograft-infiltrating-cells-by-bioinformatics-deconvolution-of-next-generation-sequencing-data-13280
https://atc.digitellinc.com/p/s/the-impact-of-social-support-on-kidney-transplant-listing-decisions-results-from-a-discrete-choice-experiment-13290
https://atc.digitellinc.com/p/s/a-possible-unintended-consequence-of-the-kidney-allocation-system-the-effect-of-duration-of-dialysis-on-mental-health-outcomes-13295
https://atc.digitellinc.com/p/s/antidepressant-medication-use-before-and-after-kidney-transplant-implications-for-post-transplant-outcomes-13300
https://atc.digitellinc.com/p/s/tacrolimus-intra-patient-variability-determined-from-daily-trough-levels-in-adherent-kidney-and-liver-transplant-recipients-13305
https://atc.digitellinc.com/p/s/educational-strategies-for-increased-wait-listing-rates-opportunities-for-dialysis-center-intervention-13310
https://atc.digitellinc.com/p/s/predictors-of-web-based-patient-portal-usage-among-kidney-and-liver-transplant-recipients-13315
https://atc.digitellinc.com/p/s/substance-abuse-in-acute-liver-failure-time-to-talk-about-opiates-13320
https://atc.digitellinc.com/p/s/living-and-deceased-donor-uterus-transplantation-the-2-arm-czech-uterus-transplant-trial-the-first-year-report-with-four-cases-done-so-far-13330
https://atc.digitellinc.com/p/s/clinical-significance-of-alloantibodies-in-hand-transplantation-impact-on-rejection-and-functional-outcome-13335
https://atc.digitellinc.com/p/s/potential-mechanism-involving-regulatory-t-cells-in-induction-of-tolerance-in-mouse-vascularized-composite-allotransplantation-under-combined-costimulation-blockade-13340
https://atc.digitellinc.com/p/s/molecular-analysis-of-acute-rejection-in-formalin-fixed-paraffin-embedded-clinical-face-transplant-biopsies-13355
https://atc.digitellinc.com/p/s/preventing-of-rejection-of-vascularized-composite-allografts-by-targeting-t-cell-metabolism-13360
https://atc.digitellinc.com/p/s/desensitization-versus-deceased-donor-kidney-transplantation-what-to-choose-when-both-become-available-13370
https://atc.digitellinc.com/p/s/even-with-national-sharing-the-prospects-of-a-100-percent-sensitized-patient-receiving-a-transplant-vary-dramatically-depending-on-the-precise-cpra-value-13375
https://atc.digitellinc.com/p/s/a-prospective-iterative-trial-of-carfizomib-based-desensitization-trial-initial-comparative-observations-13380
https://atc.digitellinc.com/p/s/induction-of-proliferative-responses-in-b-cell-and-plasma-cell-populations-following-proteasome-inhibitor-desensitization-treatment-in-rhesus-macacques-and-humans-13385
https://atc.digitellinc.com/p/s/in-vivo-administration-of-plerixafor-in-humans-mobilizes-bone-marrow-resident-plasma-cells-that-demonstrate-apoptosis-in-both-bone-marrow-and-peripheral-blood-13390
https://atc.digitellinc.com/p/s/extended-experience-with-tocilizumab-anti-il6r-for-difficult-to-desensitize-des-patients-awaiting-hla-incompatible-kidney-transplant-13395
https://atc.digitellinc.com/p/s/characterization-of-human-plasma-cell-proteasome-adaptations-to-proteasome-inhibitor-therapy-a-precision-medicine-approach-to-overcome-drug-resistance-in-desensitization-13400
https://atc.digitellinc.com/p/s/nucleic-acid-scavenging-microfiber-mesh-inhibits-trauma-induced-inflammation-and-thrombosis-after-organ-transplantation-13410
https://atc.digitellinc.com/p/s/host-derived-intragraft-dendritic-cells-are-extensively-cross-dressed-by-donor-mhc-13415
https://atc.digitellinc.com/p/s/circulating-inflammatory-factors-in-deceased-organ-donors-result-in-innate-immune-activation-13420
https://atc.digitellinc.com/p/s/accelerated-rejection-of-secondary-third-party-allografts-in-older-recipients-is-facilitated-by-an-augmented-innate-immune-response-13425
https://atc.digitellinc.com/p/s/reduction-of-recipient-cell-cross-dressing-with-donor-mhc-molecules-prolongs-allograft-survival-in-mice-13430
https://atc.digitellinc.com/p/s/the-role-of-natural-killer-cells-in-recognition-and-killing-of-stem-cells-and-stem-cell-derived-hepatoblasts-13435
https://atc.digitellinc.com/p/s/necroptotic-cellular-death-modulates-tnfalpha-mediated-inflammation-and-cardiac-allograft-rejection-in-mice-13440
https://atc.digitellinc.com/p/s/is-deceased-donor-kidney-transplantation-ddtx-justified-in-patients-with-more-than-10-years-of-pre-tx-dialysis-exposure-13450
https://atc.digitellinc.com/p/s/harnessing-scientific-and-technological-advances-to-improve-equity-in-kidney-allocation-policies-13455
https://atc.digitellinc.com/p/s/increase-in-post-transplant-mortality-under-kas-13460
https://atc.digitellinc.com/p/s/unintended-consequence-of-the-new-kidney-allocation-system-ndash-disproportionate-allocation-of-high-quality-kidneys-to-highly-sensitized-recipients-13465
https://atc.digitellinc.com/p/s/geographic-disparity-in-kidney-transplantation-after-kas-13470
https://atc.digitellinc.com/p/s/waitlist-desensitization-and-the-rate-of-deceased-donor-kidney-transplantation-after-implementation-of-the-kidney-allocation-system-13475
https://atc.digitellinc.com/p/s/reduction-in-kidney-offer-acceptance-at-centers-undergoing-systems-improvement-agreements-13480
https://atc.digitellinc.com/p/s/causes-and-long-term-consequences-of-diarrhea-after-kidney-transplantation-13490
https://atc.digitellinc.com/p/s/maternal-risks-and-pregnancy-outcomes-after-kidney-transplantation-a-single-center-experience-13495
https://atc.digitellinc.com/p/s/venous-thromboembolism-and-the-risk-of-death-and-graft-loss-in-kidney-transplant-recipients-13500
https://atc.digitellinc.com/p/s/effect-of-everolimus-based-immunosuppressive-regimen-on-new-onset-of-diabetes-after-kidney-transplantation-a-24-month-subanalysis-from-the-elevate-study-13505
https://atc.digitellinc.com/p/s/outcomes-following-hysterectomy-in-kidney-transplant-recipients-13510
https://atc.digitellinc.com/p/s/outcomes-following-colectomy-in-kidney-transplant-recipients-13515
https://atc.digitellinc.com/p/s/ambulatory-antibiotic-utilization-and-outcomes-in-an-adult-kidney-transplant-population-a-pharmacovigilance-analysis-13520
https://atc.digitellinc.com/p/s/immunosuppression-and-graft-rejection-in-living-related-hla-identical-renal-transplantation-13530
https://atc.digitellinc.com/p/s/preceeding-the-rejection-clinical-results-of-a-saliva-test-after-renal-transplantation-13535
https://atc.digitellinc.com/p/s/a-search-for-a-biomarker-which-predicts-belatacept-resistant-rejection-13540
https://atc.digitellinc.com/p/s/organs-with-extended-cold-ischemia-time-may-offer-aged-kidney-transplant-recipients-new-options-in-an-expanded-donor-pool-13545
https://atc.digitellinc.com/p/s/short-term-adverse-effects-of-early-borderline-changes-in-renal-allograft-biopsies-13550
https://atc.digitellinc.com/p/s/the-innate-immune-system-may-play-an-enhanced-role-in-acute-cellular-rejection-in-patients-on-belatacept-based-immunosuppression-13555
https://atc.digitellinc.com/p/s/tacrolimus-trough-concentration-variability-and-disparities-in-african-american-kidney-transplantation-13560
https://atc.digitellinc.com/p/s/meld-based-allocation-leads-to-inferior-survival-after-liver-transplantation-13575
https://atc.digitellinc.com/p/s/normothermic-regional-perfusion-of-donors-following-circulatory-death-improves-outcomes-in-liver-transplantation-13580
https://atc.digitellinc.com/p/s/share35-increasing-biliary-complications-and-healthcare-resources-13585
https://atc.digitellinc.com/p/s/improving-liver-allocation-using-optimized-neighborhoods-13590
https://atc.digitellinc.com/p/s/kidney-quality-dramatically-influences-patient-and-death-censored-graft-survival-in-slk-recipients-13595
https://atc.digitellinc.com/p/s/increased-use-of-donation-after-cardiac-death-donors-increases-access-to-transplantation-without-adverse-effect-on-outcomes-13600
https://atc.digitellinc.com/p/s/a-low-dose-anti-hepatitis-b-immunoglobulin-regimen-for-prophylaxis-of-hepatitis-b-recurrence-13615
https://atc.digitellinc.com/p/s/use-of-ledipasvirsofosbuvir-with-or-without-ribavirin-in-patients-post-liver-transplant-evaluation-of-real-world-datasets-13620
https://atc.digitellinc.com/p/s/direct-acting-antiviral-drugs-are-highly-effective-in-hepatitis-c-hcv-patients-with-end-stage-renal-disease-eskd-and-advanced-liver-disease-ald-13625
https://atc.digitellinc.com/p/s/assessment-of-attitudes-toward-use-of-hepatitis-c-positive-liver-allografts-in-us-transplant-centers-13630
https://atc.digitellinc.com/p/s/a-multi-center-experience-of-direct-acting-anti-viral-agents-in-hcv-positive-patients-receiving-hcv-positive-livers-13635
https://atc.digitellinc.com/p/s/does-cirrhosis-regress-in-hcv-liver-transplant-recipients-achieving-sustained-virologic-response-in-the-era-of-direct-acting-antiviral-agents-13640
https://atc.digitellinc.com/p/s/antibody-mapping-by-protein-microarray-revealed-a-unique-repertoire-in-lung-transplant-recipients-that-developed-chronic-lung-allograft-dysfunction-13650
https://atc.digitellinc.com/p/s/circulating-exosomes-isolated-from-human-lung-transplant-recipients-with-rejection-are-immunogenic-and-induce-antibodies-to-lung-associated-self-antigens-kalpha1-tubulin-and-collagen-v-13655
https://atc.digitellinc.com/p/s/addition-of-fev1-drop-to-las-may-improve-access-of-cf-patients-to-transplant-analysis-of-the-srtr-and-us-cf-foundation-patient-registries-13660
https://atc.digitellinc.com/p/s/truth-in-pathology-autopsy-findings-in-lungs-declined-for-transplantation-13665
https://atc.digitellinc.com/p/s/respiratory-viral-infections-following-human-lung-transplant-can-induce-exosomes-with-lung-self-antigens-kalpha1tubulin-and-collagen-v-13670
https://atc.digitellinc.com/p/s/poor-outcomes-on-the-waiting-list-for-pediatric-lung-retransplant-patients-listed-in-low-volume-centers-13675
https://atc.digitellinc.com/p/s/risk-factors-for-post-transplant-lymphoproliferative-disorders-in-epstein-barr-virus-mismatch-lung-transplant-recipients-13680
https://atc.digitellinc.com/p/s/treating-hepatitis-c-plus-patients-before-or-after-kidney-transplantation-a-medical-decision-analysis-13690
https://atc.digitellinc.com/p/s/transplantation-of-organs-from-donors-with-hepatitis-c-the-potential-to-substantially-increase-transplant-activity-13695
https://atc.digitellinc.com/p/s/protease-inhibitor-based-regimens-are-associated-with-inferior-outcomes-in-hiv-infected-kidney-transplant-recipients-13700
https://atc.digitellinc.com/p/s/deceased-donors-with-a-history-of-iv-drug-use-and-donor-derived-hepatitis-c-virus-13705
https://atc.digitellinc.com/p/s/hcv-plus-waitlist-candidates-more-likely-to-die-waiting-for-kidney-transplant-from-hcv-donor-13710
https://atc.digitellinc.com/p/s/knowledge-and-attitudes-associated-with-willingness-to-accept-hiv-plus-organs-among-persons-living-with-hiv-13715
https://atc.digitellinc.com/p/s/bk-virus-infection-and-risk-of-urinary-tract-cancers-among-kidney-transplant-patients-in-the-transplant-cancer-match-study-13720
https://atc.digitellinc.com/p/s/multiple-dosing-of-anti-c1s-antibody-tnt009-effect-on-hla-antibody-triggered-complement-activation-in-healthy-volunteers-and-kidney-transplant-recipients-with-antibody-mediated-rejection-13730
https://atc.digitellinc.com/p/s/higher-tacrolimus-blood-levels-predict-better-graft-survival-in-kidney-recipients-with-de-novo-dsa-13735
https://atc.digitellinc.com/p/s/influence-of-donor-specific-antibodies-on-renal-function-in-kidney-transplant-recipients-following-early-switch-from-calcineurin-inhibitor-to-everolimus-subanalysis-from-the-elevate-study-13740
https://atc.digitellinc.com/p/s/experience-with-the-bacterial-enzyme-ides-igg-endopeptidase-for-desensitization-of-highly-hla-sensitized-hs-kidney-allograft-recipients-13745
https://atc.digitellinc.com/p/s/reduced-conversion-from-igm-anti-hla-dsa-to-igg-anti-hla-dsa-in-belatacept-treated-vs-cyclosporine-treated-patients-in-benefit-and-benefit-ext-trials-13750
https://atc.digitellinc.com/p/s/post-transplant-reduction-in-pre-existing-donor-specific-antibody-levels-after-belatacept-vs-cyclosporine-based-immunosuppression-13755
https://atc.digitellinc.com/p/s/changes-in-peripheral-blood-gene-expression-profile-after-calcineurin-inhibitor-cni-withdrawal-in-kidney-transplant-recipients-13760
https://atc.digitellinc.com/p/s/endoscopic-ultrasound-guided-biopsy-sampling-of-the-pancreas-transplant-the-future-of-graft-surveillance-13770
https://atc.digitellinc.com/p/s/assessment-of-the-association-between-measures-of-metabolic-function-and-pancreas-graft-survival-13775
https://atc.digitellinc.com/p/s/lessons-learned-from-simultaneous-biopsies-of-both-kidney-and-pancreas-grafts-in-recipients-of-simultaneous-kidney-pancreas-transplants-13780
https://atc.digitellinc.com/p/s/anti-angiotensin-type-1-receptor-antibodies-associate-with-rejection-in-simultaneous-pancreas-and-kidney-transplant-and-pancreas-transplant-alone-recipients-13790
https://atc.digitellinc.com/p/s/access-to-simultaneous-pancreas-and-kidney-transplant-spk-should-not-be-restricted-to-bmi-gt-28-13795
https://atc.digitellinc.com/p/s/the-benefits-of-pancreas-after-kidney-pak-transplantation-13800
https://atc.digitellinc.com/p/s/ectopic-lymphoid-structures-are-present-in-type-i-t-cell-mediated-kidney-transplant-rejection-13810
https://atc.digitellinc.com/p/s/de-novo-dsa-with-t-cell-mediated-rejection-tcmr-leads-to-early-allograft-scarring-and-dysfunction-13815
https://atc.digitellinc.com/p/s/tracking-the-in-vitro-phenotype-and-proliferative-capacity-of-cd57-plus-cd4-t-cells-13820
https://atc.digitellinc.com/p/s/high-ctla-4-expression-and-diminished-foxo3-expression-underlie-differential-cd28-signaling-on-human-memory-th17-cells-13825
https://atc.digitellinc.com/p/s/2b4-mediated-inhibition-of-proliferation-and-glycolytic-function-attenuates-t-cell-alloreactivity-13830
https://atc.digitellinc.com/p/s/rapamycin-directly-alters-human-endothelial-cell-alloimmunogenicity-13835
https://atc.digitellinc.com/p/s/genomic-analysis-of-gene-expression-in-human-kidney-transplants-identifies-moxd1-as-a-key-driver-for-renal-fibrosis-13840
https://atc.digitellinc.com/p/s/the-gut-microbiota-regulates-murine-cardiac-transplant-outcome-13850
https://atc.digitellinc.com/p/s/a-single-skin-commensal-strain-is-sufficient-to-accelerate-skin-transplant-rejection-13855
https://atc.digitellinc.com/p/s/non-invasive-detection-of-rejection-with-immunopet-imaging-13860
https://atc.digitellinc.com/p/s/regulation-of-t-cell-migration-by-specifically-targeting-lymphotoxin-beta-receptor-ltbetar-mediated-non-canonical-nfkb-signaling-13865
https://atc.digitellinc.com/p/s/role-of-donor-derived-tissue-resident-memory-t-cells-in-modulating-alloimmunity-13870
https://atc.digitellinc.com/p/s/tsubfrsubtsubfhsub-cell-ratio-correlates-with-anti-donor-germinal-center-reactivity-and-donor-specific-antibody-formation-following-transplantation-13875
https://atc.digitellinc.com/p/s/tim-3-ceacam1-checkpoint-regulation-of-t-cell-activation-and-hepatocellular-function-in-liver-transplantation-13880
https://atc.digitellinc.com/p/s/impact-of-mtor-inhibition-on-tolerance-induction-following-heart-transplantation-13890
https://atc.digitellinc.com/p/s/applicability-and-safety-of-a-regulatory-t-cell-therapy-in-adult-liver-transplantation-the-ldquothrilrdquo-phase-i-first-in-human-trial-13895
https://atc.digitellinc.com/p/s/tolerant-pediatric-liver-transplant-lt-recipients-tol-from-wisp-r-nct00320606-split-into-two-phenotypically-distinct-groups-by-pd1-expression-on-cd4-plus-t-cells-at-baseline-prior-to-immunosuppression-13900
https://atc.digitellinc.com/p/s/eight-year-follow-up-of-a-phase-2-clinical-trial-to-induce-tolerance-in-living-donor-renal-transplant-recipients-13905
https://atc.digitellinc.com/p/s/relationship-between-mixed-chimerism-and-tolerance-in-hla-matched-and-mismatched-recipients-of-kidney-and-hematopoietic-cell-transplants-13910
https://atc.digitellinc.com/p/s/a-molecular-signature-characterized-by-dominance-of-negative-regulation-over-cytotoxic-effectors-in-tolerant-kidney-allograft-recipients-13915
https://atc.digitellinc.com/p/s/dominant-role-of-clonal-deletion-in-achieving-immune-tolerance-after-unrelated-cord-blood-transplantation-13920
https://atc.digitellinc.com/p/s/improving-communication-of-srtr-transplant-program-outcomes-evaluations-using-a-5-tier-system-13930
https://atc.digitellinc.com/p/s/is-the-current-heart-allocation-system-just-and-fair-for-blood-type-o-recipients-ndash-a-propensity-matched-analysis-of-34353-patients-in-the-unos-registry-13935
https://atc.digitellinc.com/p/s/mhc-class-ii-peptide-complexes-displayed-on-activated-t-cells-guide-treg-suppression-13940
https://atc.digitellinc.com/p/s/hcc-and-liver-transplantation-following-the-recent-allocation-policy-change-13945
https://atc.digitellinc.com/p/s/successful-induction-of-tolerance-of-fully-allogeneic-lung-graft-with-adenosine-asub2asub-receptor-a2ar-agonist-in-mhc-defined-clawn-miniature-swine-13955
https://atc.digitellinc.com/p/s/induction-of-sensitization-and-resistance-to-transplant-tolerance-by-allogeneic-pregnancy-13960
https://atc.digitellinc.com/p/s/induction-of-delayed-renal-allograft-tolerance-using-only-clinically-available-reagents-in-non-human-primates-13965
https://atc.digitellinc.com/p/s/induction-of-mixed-chimerism-to-prolong-liver-allograft-survival-in-cynomolgus-monkeys-13970
https://atc.digitellinc.com/p/s/mouse-fcs-may-contain-lymphoid-progenitor-cells-that-have-the-capacity-to-generate-b-and-t-cells-italicin-vivoitalic-13975
https://atc.digitellinc.com/p/s/acute-mouse-cmv-infection-abrogates-transplant-tolerance-by-modulating-myeloid-cell-differentiation-and-function-a-possible-role-for-transcription-factor-rorgammat-13980
https://atc.digitellinc.com/p/s/designing-a-novel-selective-immunoproteasome-inhibitor-reveals-a-critical-role-of-the-ip-and-stat5-pathway-in-regulating-t-cell-exhaustion-and-promoting-long-term-heart-allograft-acceptance-13985
https://atc.digitellinc.com/p/s/a-proof-of-concept-for-liver-graft-modification-using-warm-ex-vivo-perfusion-ldquoitalicit-is-not-just-about-rescuing-marginal-graftsitalicrdquo-13995
https://atc.digitellinc.com/p/s/expression-of-injury-and-repair-genes-in-ex-vivo-perfused-swing-lung-transplants-14000
https://atc.digitellinc.com/p/s/kidney-injury-molecule-1-mitigates-tissue-damage-from-transplant-renal-ischemia-reperfusion-injury-14005
https://atc.digitellinc.com/p/s/normothermic-donor-lung-preservation-with-portable-evlp-significantly-reduces-ischemiareperfusion-injury-in-lung-recipients-by-promoting-cytokine-antagonists-14010
https://atc.digitellinc.com/p/s/treating-ischemically-damaged-porcine-kidneys-with-mesenchymal-stromal-cells-during-normothermic-machine-perfusion-14015
https://atc.digitellinc.com/p/s/extra-renal-cardiac-injury-is-associated-with-upregulation-of-nod2-and-nlrp3-in-the-heart-after-renal-iri-14020
https://atc.digitellinc.com/p/s/dendritic-cell-expression-of-rictor-mtorc2-but-not-raptor-mtorc1-protects-against-renal-ischemia-reperfusion-injury-14025
https://atc.digitellinc.com/p/s/gene-expression-profiling-for-the-identification-and-classification-of-antibody-mediated-heart-rejection-14035
https://atc.digitellinc.com/p/s/clinical-correlation-of-endomyocardial-biopsies-molecular-profiling-taking-rejection-diagnosis-beyond-histology-14040
https://atc.digitellinc.com/p/s/young-african-american-heart-transplant-recipients-have-an-elevated-risk-of-post-transplant-mortality-14045
https://atc.digitellinc.com/p/s/validation-of-a-prediction-model-for-cardiac-allograft-vasculopathy-14050
https://atc.digitellinc.com/p/s/high-titer-de-novo-donor-specific-hla-alloantibodies-and-cardiac-allograft-vasculopathy-after-pediatric-heart-transplantation-14055
https://atc.digitellinc.com/p/s/primary-graft-dysfunction-after-pediatric-heart-transplant-14060
https://atc.digitellinc.com/p/s/antibodies-to-angiotensin-type-ii-receptor-i-are-associated-with-primary-graft-dysfunction-after-orthotopic-heart-transplant-in-patients-with-ventricular-assist-device-as-bridge-to-transplant-14065
https://atc.digitellinc.com/p/s/chagas-disease-and-outcome-in-kidney-transplant-14075
https://atc.digitellinc.com/p/s/influenza-viral-dynamics-in-a-large-cohort-of-transplant-patients-with-natural-influenza-infection-14080
https://atc.digitellinc.com/p/s/mutations-in-influenza-a-virus-and-clinical-implications-in-transplant-recipients-14085
https://atc.digitellinc.com/p/s/clinical-risk-factors-for-bronchiolitis-obliterans-syndrome-bos-in-lung-transplant-recipients-ltrs-results-of-an-international-cohort-study-14090
https://atc.digitellinc.com/p/s/hepatitis-b-virus-infection-is-associated-with-recurrent-nephropathy-after-kidney-transplantation-14095
https://atc.digitellinc.com/p/s/hepatitis-e-virus-associated-cryoglobulinemia-in-solid-organ-transplant-recipients-a-prospective-study-14100
https://atc.digitellinc.com/p/s/impact-of-donor-bk-virus-replication-on-posttransplant-bkv-replication-after-living-donor-transplantation-14110
https://atc.digitellinc.com/p/s/bk-polyomavirus-specific-9mer-t-cell-responses-predict-control-of-viremia-in-kidney-transplant-recipients-first-report-from-the-swiss-transplant-cohort-study-14115
https://atc.digitellinc.com/p/s/noninvasive-prognostication-of-renal-allograft-failure-following-bk-virus-associated-nephropathy-a-validation-study-14120
https://atc.digitellinc.com/p/s/resumption-of-standard-dose-immunosuppression-following-resolution-of-bk-viremia-does-not-lead-to-viremia-recurrence-14125
https://atc.digitellinc.com/p/s/calibration-of-bk-virus-nucleic-acid-amplification-testing-to-the-1supstsup-who-international-standard-for-bk-virus-14130
https://atc.digitellinc.com/p/s/repeat-biopsies-after-the-diagnosis-of-bk-virus-associated-nephropathy-importance-of-integrating-clinical-and-pathological-findings-14135
https://atc.digitellinc.com/p/s/urinary-retention-associated-with-polyomavirus-bk-viruria-and-higher-peak-blood-bk-following-kidney-transplant-ktx-14140
https://atc.digitellinc.com/p/s/employment-patterns-after-kidney-transplantation-rates-contributing-factors-and-outcomes-14150
https://atc.digitellinc.com/p/s/emergency-department-utilization-among-kidney-transplant-recipients-in-the-united-states-14155
https://atc.digitellinc.com/p/s/dementia-and-alzheimers-disease-among-older-kidney-transplant-recipients-14160
https://atc.digitellinc.com/p/s/impact-of-cognitive-impairment-on-kidney-transplantation-listing-between-sexes-14165
https://atc.digitellinc.com/p/s/prescription-opioid-use-before-and-after-kidney-transplant-implications-for-post-transplant-outcomes-14170
https://atc.digitellinc.com/p/s/post-donation-experiences-of-non-directed-altruistic-living-kidney-donors-in-the-united-states-14175
https://atc.digitellinc.com/p/s/factors-predicting-30-day-hospital-readmission-after-kidney-transplant-14180
https://atc.digitellinc.com/p/s/liver-retransplantation-the-largest-post-meld-single-center-experience-14190
https://atc.digitellinc.com/p/s/contemporary-outcomes-and-risk-factors-of-acute-graft-versus-host-disease-after-liver-transplant-14195
https://atc.digitellinc.com/p/s/effects-of-liver-transplantation-on-cardiac-function-in-patients-transplanted-for-nash-cirrhosis-14200
https://atc.digitellinc.com/p/s/risk-of-ischemic-biliary-injury-is-not-associated-with-prolonged-hepatic-artery-ischemic-times-during-liver-transplantation-14205
https://atc.digitellinc.com/p/s/cardiovascular-events-are-a-substantial-and-increasing-cause-of-graft-loss-in-liver-transplant-recipients-14210
https://atc.digitellinc.com/p/s/clinical-evaluation-of-the-safety-and-preliminary-efficacy-of-continuous-infusion-of-treprostinil-to-prevent-ischemia-and-reperfusion-injury-in-adult-orthotopic-liver-transplant-recipients-14215
https://atc.digitellinc.com/p/s/early-acute-cellular-rejectioneacr-as-a-marker-of-immunologic-competency-following-liver-transplantationlt-14220
https://atc.digitellinc.com/p/s/increased-long-term-mortality-20-years-after-living-kidney-donation-14230
https://atc.digitellinc.com/p/s/apol1-genotype-does-not-affect-donor-renal-function-post-live-kidney-donation-14235
https://atc.digitellinc.com/p/s/italicapolipoprotein-l1italic-amp-chronic-kidney-disease-risk-in-young-potential-living-kidney-donors-14240
https://atc.digitellinc.com/p/s/impact-of-cold-ischemia-time-on-outcomes-in-kidney-paired-donation-kpd-14245
https://atc.digitellinc.com/p/s/post-donation-gfr-changes-in-living-kidney-donors-14250
https://atc.digitellinc.com/p/s/long-term-consequences-of-post-donation-preeclampsia-14255
https://atc.digitellinc.com/p/s/analysis-of-differences-in-living-donor-and-recipient-pairs-estimated-gfr-at-six-months-over-time-14260
https://atc.digitellinc.com/p/s/survival-outcomes-from-dcd-transplant-are-comparable-to-dbd-transplant-from-kidneys-procured-from-donors-50-years-of-age-a-unosoptn-propensity-score-matched-pair-analysis-14270
https://atc.digitellinc.com/p/s/expression-of-t-cell-mediated-rejection-tcmr-associated-genes-in-native-and-renal-allograft-renal-biopsies-with-inflamed-scars-i-ifta-14275
https://atc.digitellinc.com/p/s/circulating-donor-specific-anti-hla-antibodies-accelerate-the-progression-of-interstitial-fibrosis-in-kidney-allografts-14280
https://atc.digitellinc.com/p/s/the-use-of-very-high-kdpi-kidneys-in-elderly-kidney-transplant-recipients-discarded-in-the-us-but-successfully-transplanted-in-europe-14285
https://atc.digitellinc.com/p/s/a-non-invasive-urinary-common-rejection-module-ucrm-gene-expression-score-quantifies-and-differentiates-kidney-transplant-injury-14290
https://atc.digitellinc.com/p/s/epigenetic-modifications-in-the-progression-to-chronic-renal-allograft-injury-14295
https://atc.digitellinc.com/p/s/is-death-with-a-functioning-graft-dwf-really-death-with-function-data-from-the-long-term-deterioration-of-kidney-allograft-function-dekaf-study-14300
https://atc.digitellinc.com/p/s/ctla4-ig-inhibits-effector-cd8sup-plus-sup-t-cell-function-in-vivo-and-rescues-ongoing-acute-allograft-rejection-14315
https://atc.digitellinc.com/p/s/cd4-t-cell-migration-across-lymphatic-endothelium-is-enhanced-by-sphingosine-1-phosphate-s1p-and-differentially-regulated-by-s1p-receptors-s1pr-14320
https://atc.digitellinc.com/p/s/binding-of-antigens-by-its-specific-antibodies-results-in-exosome-formation-leading-to-rejection-of-syngeneic-murine-cardiac-grafts-14325
https://atc.digitellinc.com/p/s/differential-effects-of-the-novel-atp-competitive-mtor-inhibitor-torkinib-azd2014-and-rapamycin-on-alloimmunity-and-transplant-survival-14330
https://atc.digitellinc.com/p/s/tieing-statins-to-microvascular-stability-and-endothelial-cell-immunogenicity-14335
https://atc.digitellinc.com/p/s/increased-ischemic-inflammation-induces-recipient-endogenous-memory-cd4-cell-graft-dendritic-cell-interactions-to-provide-help-for-activation-of-endogenous-memory-cd8-t-cells-14340
https://atc.digitellinc.com/p/s/improved-outcomes-after-liver-transplantation-from-controlled-dcd-donors-with-normothermic-regional-perfusion-14350
https://atc.digitellinc.com/p/s/early-results-of-the-uk-revive-trial-for-ex-vivo-liver-warm-blood-perfusion-of-dcd-and-dbd-livers-using-the-portable-organ-care-system-ocstrade-liver-technology-14355
https://atc.digitellinc.com/p/s/ischemia-reperfusion-injury-induced-innate-immune-signaling-in-human-orthotopic-liver-transplantation-14360
https://atc.digitellinc.com/p/s/first-report-of-human-liver-transplantation-after-normothermic-machine-perfusion-nmp-in-the-united-states-14365
https://atc.digitellinc.com/p/s/36-hours-of-ex-vivo-warm-cellular-perfusion-of-swine-liver-using-the-organ-care-system-ocstrade-liver-with-excellent-functional-metabolic-and-histological-outcomes-14370
https://atc.digitellinc.com/p/s/results-of-the-initial-phase-of-the-portable-organ-care-system-ocstrade-liver-protect-pivotal-trial-14375
https://atc.digitellinc.com/p/s/ex-situ-extended-limb-preservation-a-protocol-for-porcine-limb-perfusion-14380
https://atc.digitellinc.com/p/s/transplant-economics-post-implementation-of-the-affordable-care-act-and-the-budget-control-act-sequestration-adjustment-on-medicare-reimbursement-14390
https://atc.digitellinc.com/p/s/the-impact-of-the-new-kidney-allocation-system-on-length-of-dialysis-prior-to-transplantation-14395
https://atc.digitellinc.com/p/s/a-new-methodology-for-measuring-and-monitoring-equity-in-access-to-deceased-donor-kidney-transplants-14400
https://atc.digitellinc.com/p/s/increasing-organ-supply-in-the-us-a-systematic-review-of-presumed-consent-vs-informed-consent-2006-2016-14405
https://atc.digitellinc.com/p/s/the-unfunded-optnunos-mandate-of-living-kidney-donor-follow-up-fewer-than-50-percent-of-centers-in-compliance-14410
https://atc.digitellinc.com/p/s/vendor-to-center-in-0-60-a-safe-and-effective-blueprint-for-creating-an-in-house-on-call-system-for-organ-offers-14415
https://atc.digitellinc.com/p/s/we-wish-this-would-never-happen-again-implementation-of-an-adverse-event-review-system-to-improve-the-safety-of-pediatric-solid-organ-transplant-sot-patients-14420
https://atc.digitellinc.com/p/s/safety-and-activity-of-anti-c1s-humanized-monoclonal-antibody-tnt009-in-late-antibody-mediated-kidney-allograft-rejection-results-of-a-first-in-human-phase-1-trial-14430
https://atc.digitellinc.com/p/s/composite-prognostic-score-improves-clinical-benefit-in-kidney-recipients-receiving-standard-of-care-therapy-for-antibody-mediated-rejection-14435
https://atc.digitellinc.com/p/s/complement-activating-anti-hla-antibodies-identification-of-specific-histo-mmolecular-phenotype-of-rejection-for-complement-targeting-therapy-14440
https://atc.digitellinc.com/p/s/saftey-and-long-term-outcomes-of-tocilizumab-anti-il6r-tcz-therapy-in-treatment-of-chronic-antibody-mediated-rejection-cabmr-and-transplant-glomerulopathy-tg-in-highly-hla-sensitized-hs-patients-pts-14445
https://atc.digitellinc.com/p/s/experience-with-obinutuzumab-type-ii-anti-cd20-in-kidney-transplant-patients-with-donor-specific-antibody-dsa-plus-antibody-mediated-rejection-14450
https://atc.digitellinc.com/p/s/belatacept-for-chronic-antibody-mediated-rejection-in-kidney-transplantation-14455
https://atc.digitellinc.com/p/s/rapid-depletion-of-circulating-dsa-and-treatment-of-acute-antibody-mediated-rejection-with-the-combination-of-ctla-4igbelatacept-and-bortezomib-in-mouse-and-man-14460
https://atc.digitellinc.com/p/s/meta-analysis-of-clinical-significance-of-complement-activating-anti-hla-dsa-in-kidney-transplantation-14465
https://atc.digitellinc.com/p/s/the-molecular-phenotypes-of-rejection-in-kidney-transplant-biopsies-14470
https://atc.digitellinc.com/p/s/the-natural-history-of-kidney-rejection-how-do-molecular-disease-states-change-over-time-in-patients-with-repeat-indication-biopsies-14475
https://atc.digitellinc.com/p/s/lower-incidence-of-dsa-induced-chronic-antibody-mediated-rejection-in-abo-incompatible-renal-transplantation-14480
https://atc.digitellinc.com/p/s/glomerular-cd45-immunostaining-in-post-perfusion-graft-biopsies-predicting-rejection-14485
https://atc.digitellinc.com/p/s/endocapillary-nk-cells-are-increased-in-indication-renal-transplant-biopsies-with-antibody-and-t-cell-mediated-rejection-14490
https://atc.digitellinc.com/p/s/immunodominant-donor-specific-antibody-reduction-with-proteasome-inhibitor-based-treatment-clinical-variability-and-implications-for-long-term-graft-survival-14495
https://atc.digitellinc.com/p/s/comprehensive-functional-assessment-of-the-pathogenic-potential-of-immunodominant-donor-specific-antibody-following-treatment-of-late-antibody-mediated-rejection-or-mixed-acute-rejection-14505
https://atc.digitellinc.com/p/s/strategy-for-analysis-of-donor-specific-antibody-repertoire-paired-immunoglobulin-heavy-and-light-chain-analysis-of-individual-memory-b-cells-14510
https://atc.digitellinc.com/p/s/generation-of-natural-antibodies-post-transplant-and-association-with-kidney-allograft-loss-14515
https://atc.digitellinc.com/p/s/b-cell-deficiency-inhibits-both-antibody-mediated-rejection-and-t-cell-mediated-acute-rejection-in-a-rat-kidney-transplant-model-14520
https://atc.digitellinc.com/p/s/donor-specific-b-cell-responses-predicting-the-future-of-kidney-transplants-14525
https://atc.digitellinc.com/p/s/antibodies-specific-for-hla-class-i-and-lung-associated-self-antigens-kalpha1tubulin-and-collagen-v-induces-exosomes-following-in-vitro-binding-to-human-airway-epithelial-cells-14530
https://atc.digitellinc.com/p/s/tim-4-identifies-pro-inflammatory-b-effector-cells-that-are-potent-drivers-of-alloimmunity-and-allograft-rejection-through-expression-of-both-ifn-gamma-and-il-17-14535
https://atc.digitellinc.com/p/s/gene-expression-during-development-of-chronic-antibody-mediated-rejection-in-renal-allografts-from-non-human-primates-validation-of-markers-used-in-humans-and-sequential-changes-in-protocol-biopsies-14545
https://atc.digitellinc.com/p/s/sulfatide-selective-nkt-cells-mediate-m2-to-m1-polarization-resulting-in-amelioration-of-kidney-fibrosis-14550
https://atc.digitellinc.com/p/s/podocyte-participates-in-the-st2-related-renal-fibrosis-14555
https://atc.digitellinc.com/p/s/macrophage-specific-deletion-of-rhoa-inhibits-fractalkine-signaling-and-abrogates-chronic-rejection-of-cardiac-allograft-14560
https://atc.digitellinc.com/p/s/hla-dr-based-murine-transplant-model-for-studying-collagen-type-v-autoimmunity-in-chronic-allograft-rejection-14565
https://atc.digitellinc.com/p/s/podocyte-specific-knockdown-of-shroom3-causes-albuminuria-and-foot-process-effacement-by-interaction-with-fyn-14570
https://atc.digitellinc.com/p/s/the-degree-of-nk-cell-activation-determines-the-ability-of-donor-specific-antibodies-to-mediate-acute-vs-chronic-rejection-of-kidney-allografts-14575
https://atc.digitellinc.com/p/s/cumulative-deficits-frailty-index-for-transplant-candidates-predicts-candidacy-for-solid-organ-transplantation-14585
https://atc.digitellinc.com/p/s/provision-of-highly-specialized-aftercare-by-the-transplant-center-strongly-improves-patient-and-allograft-survival-in-long-term-follow-up-after-kidney-transplantation-14590
https://atc.digitellinc.com/p/s/one-year-graft-and-patient-survival-of-deceased-donor-kidney-transplants-under-kas-14595
https://atc.digitellinc.com/p/s/epts-is-a-poor-predictor-of-post-kt-mortality-for-older-recipients-14600
https://atc.digitellinc.com/p/s/impact-of-bariatric-surgery-on-risk-of-organ-rejection-among-solid-organ-transplant-recipients-14605
https://atc.digitellinc.com/p/s/training-for-transplant-frailty-assessment-and-optimization-in-kidney-transplant-candidates-14610
https://atc.digitellinc.com/p/s/a-cost-comparison-for-telehealth-utilization-in-the-kidney-transplant-waitlist-evaluation-process-at-a-va-center-14615
https://atc.digitellinc.com/p/s/donor-warm-ischemic-time-80min-is-an-important-predictor-of-kidney-graft-survival-from-donors-after-cardiac-death-14625
https://atc.digitellinc.com/p/s/single-kidney-transplantation-from-dcd-maastricht-category-3-donors-60-years-is-it-safe-14630
https://atc.digitellinc.com/p/s/assessment-and-transplantation-of-declined-human-kidneys-using-emex-vivoem-normothermic-kidney-perfusion-14635
https://atc.digitellinc.com/p/s/a-humanized-anti-cd47-monoclonal-antibody-therapy-alleviates-ischemia-reperfusion-injury-of-porcine-renal-allografts-donated-after-cardiac-death-14640
https://atc.digitellinc.com/p/s/cd47-blockade-reduces-ischemiareperfusion-injury-in-donation-after-cardiac-death-rat-kidney-transplantation-14645
https://atc.digitellinc.com/p/s/five-year-outcomes-after-transplantation-of-kidneys-from-deceased-donors-with-acute-kidney-injury-14650
https://atc.digitellinc.com/p/s/outcomes-with-kidney-transplant-from-deceased-donors-with-acute-kidney-injury-and-prolonged-cold-ischemia-time-unos-analysis-14655
https://atc.digitellinc.com/p/s/the-cumulative-united-states-experience-with-transplants-txs-from-living-donors-lds-140156-ld-txs-in-28-years-14665
https://atc.digitellinc.com/p/s/intensive-care-unit-enhanced-recovery-pathway-for-liver-transplant-recipients-a-prospective-observational-study-14670
https://atc.digitellinc.com/p/s/comparing-the-role-of-post-transplant-readmissions-and-bed-days-on-total-one-year-cost-of-care-14675
https://atc.digitellinc.com/p/s/effects-of-new-kpd-histocompatibility-policy-on-refusal-rate-and-transplants-14680
https://atc.digitellinc.com/p/s/a-kidney-paired-donation-standard-acquisition-charge-14685
https://atc.digitellinc.com/p/s/how-much-is-a-kidney-worth-comparing-kidney-transplant-strategies-in-liver-transplant-candidates-14690
https://atc.digitellinc.com/p/s/hope-act-the-first-year-14695
https://atc.digitellinc.com/p/s/the-clinical-and-economic-burden-of-pneumonia-in-canadian-solid-organ-transplant-recipients-14705
https://atc.digitellinc.com/p/s/effect-of-academic-detailing-with-prescribers-as-an-antimicrobial-stewardship-intervention-in-solid-organ-transplant-patients-14710
https://atc.digitellinc.com/p/s/adoptive-immunotherapy-with-liver-allograft-derived-lymphocytes-compensate-for-the-susceptibility-to-post-liver-transplant-blood-stream-infection-associated-with-fcgr3a-snp-14715
https://atc.digitellinc.com/p/s/fosfomycin-tromeltamol-fos-is-an-effective-alternative-in-post-renal-transplant-urinary-tract-infection-prophylaxis-caused-by-italicescherichia-coliitalic-and-italicenterococcus-faecalisitalic-without-14720
https://atc.digitellinc.com/p/s/importance-of-acquisition-of-carbapenemase-kpc-producing-italicenterobacteriaceaeitalic-in-solid-organ-transplant-recipients-a-single-center-experience-14725
https://atc.digitellinc.com/p/s/gut-microbiota-urinary-tract-infection-axis-in-kidney-transplant-recipients-14730
https://atc.digitellinc.com/p/s/high-mortality-in-transplant-recipients-associated-with-coccidioidomycosis-derived-from-organ-donors-14735
https://atc.digitellinc.com/p/s/performance-based-vs-self-reported-functional-assessment-on-outcomes-after-kidney-transplant-14745
https://atc.digitellinc.com/p/s/patient-and-kidney-allograft-survival-in-recipients-with-end-stage-renal-disease-from-amyloidosis-14750
https://atc.digitellinc.com/p/s/neutropenia-in-kidney-transplantation-a-hidden-threat-to-graft-survival-14755
https://atc.digitellinc.com/p/s/quantitative-analysis-of-10-year-surveillance-renal-allograft-biopsies-14760
https://atc.digitellinc.com/p/s/vosub2peaksub-a-significant-marker-of-all-cause-mortality-among-patients-with-end-stage-renal-disease-being-evaluated-for-kidney-transplant-14765
https://atc.digitellinc.com/p/s/dna-methylation-dynamics-from-ischemiareperfusion-injury-to-long-term-allograft-function-14770
https://atc.digitellinc.com/p/s/simple-kidney-transplant-graft-survival-ktgs-calculator-predicts-5-and-10-year-allograft-survival-14775
https://atc.digitellinc.com/p/s/the-associations-between-body-mass-index-and-kidney-transplant-outcomes-are-mediated-by-weight-adjusted-immunosuppression-dosing-14785
https://atc.digitellinc.com/p/s/evolution-of-lipid-profile-and-major-adverse-cardiac-events-in-kidney-transplant-recipients-converted-from-calcineurin-inhibitor-to-everolimus-24-month-subanalysis-from-elevate-study-14790
https://atc.digitellinc.com/p/s/beyond-the-bones-the-association-between-vitamin-d-graft-outcomes-malignancy-and-vascular-disease-14795
https://atc.digitellinc.com/p/s/impact-of-type-of-recipient-diabetes-on-1-and-3-year-kidney-allograft-and-patient-outcomes-14800
https://atc.digitellinc.com/p/s/kidney-transplant-recipient-intermediate-and-long-term-outcomes-for-living-donor-gifted-lithiasis-14805
https://atc.digitellinc.com/p/s/the-relationship-between-frailty-and-decreased-physical-performance-with-death-on-the-kidney-transplant-waiting-list-14810
https://atc.digitellinc.com/p/s/outcomes-of-infrainguinal-revascularization-in-renal-transplant-patients-14815
https://atc.digitellinc.com/p/s/the-take-it-intervention-improves-medication-adherence-in-adolescent-kidney-transplant-recipients-14825
https://atc.digitellinc.com/p/s/belatacept-after-kidney-transplantation-in-adolescents-14830
https://atc.digitellinc.com/p/s/a-dedicated-young-adult-service-with-a-youth-worker-increases-engagement-of-teenagers-and-young-adults-with-kidney-transplantation-and-impacts-favourably-on-clinical-outcomes-14835
https://atc.digitellinc.com/p/s/in-clinic-systems-to-address-adherence-barriers-decrease-late-allograft-rejection-for-kidney-transplant-patients-14840
https://atc.digitellinc.com/p/s/stable-deceased-donor-transplantation-rates-among-pediatric-candidates-post-kas-implementation-14845
https://atc.digitellinc.com/p/s/p-lkdpi-a-donor-risk-index-for-pediatric-recipients-of-living-donor-kidney-transplantation-14850
https://atc.digitellinc.com/p/s/kdpi-and-small-lt20-kg-pediatric-kidney-donors-14855
https://atc.digitellinc.com/p/s/live-donor-liver-transplantation-using-grafts-with-more-than-two-bile-ducts-ndash-does-it-affect-patient-outcome-14865
https://atc.digitellinc.com/p/s/a-donor-bmi-greater-than-30-is-not-a-contraindication-for-live-liver-donation-14870
https://atc.digitellinc.com/p/s/abo-incompatibility-using-ritiuximab-does-not-increase-hepatocellular-carcinoma-recurrence-after-liver-transplantation-14875
https://atc.digitellinc.com/p/s/technical-refinement-to-prevent-hepatic-outflow-disturbance-in-right-lobe-living-donor-liver-transplantation-simplified-one-orifice-venoplasty-14880
https://atc.digitellinc.com/p/s/forty-six-consecutive-cases-of-pure-live-donor-right-or-extended-right-hepatectomy-single-surgeon-initial-1-year-experience-14885
https://atc.digitellinc.com/p/s/largest-us-series-of-minimally-invasive-full-and-laparoscopy-assisted-living-donor-hepatectomy-14890
https://atc.digitellinc.com/p/s/evaluation-of-the-enhanced-recovery-after-surgery-protocol-in-living-liver-donors-14895
https://atc.digitellinc.com/p/s/novel-cell-intrinsic-role-of-the-adaptor-protein-tsad-in-maintaining-alloimmune-t-regulatory-cell-function-14920
https://atc.digitellinc.com/p/s/maximizing-the-potential-of-treg-based-therapies-for-transplant-rejection-via-computational-immune-modeling-effect-of-dose-timing-and-distribution-14925
https://atc.digitellinc.com/p/s/the-phenotypic-and-functional-characteristics-of-a-novel-cd11bsup-plus-supcd11csup-plus-supf480sup-plus-sup-monocytic-myeloid-derived-suppressor-cell-subset-14930
https://atc.digitellinc.com/p/s/early-evolution-and-immunopathologic-phenotype-of-treg-rich-organized-lymphoid-structures-tols-associated-with-immunological-tolerance-in-accepted-mouse-kidney-allografts-14935
https://atc.digitellinc.com/p/s/utility-of-il-2-complexes-in-promoting-vascularized-composite-allograft-survival-14945
https://atc.digitellinc.com/p/s/ccr7sup-plus-supcd8sup-plus-supt-cell-suppresses-effector-t-cell-related-allo-immune-responses-in-kidney-transplant-recipients-14950
https://atc.digitellinc.com/p/s/a-regulatory-t-cell-treg-intrinsic-role-for-p27kip1-in-acquired-transplant-tolerance-14955
https://atc.digitellinc.com/p/s/a-multidimensional-prognostic-score-and-nomogram-to-predict-kidney-transplant-survival-the-integrative-box-ibox-system-14965
https://atc.digitellinc.com/p/s/community-health-center-proximity-and-liver-transplant-waitlist-mortality-14970
https://atc.digitellinc.com/p/s/vital-role-of-the-corest-complex-as-a-master-regulator-of-foxp3-plus-t-regulatory-cell-gene-expression-and-suppressive-function-14975
https://atc.digitellinc.com/p/s/anti-cd40-mab-promotes-kidney-immunoregulatory-capacity-in-nhp-transplants-by-altering-kidney-tubular-cell-tec-expression-of-cd40-and-il-6-14985
https://atc.digitellinc.com/p/s/mesenchymal-stem-cells-suppress-t-cell-proliferation-and-improve-allograft-survival-in-a-nonhuman-primate-transplant-model-14990
https://atc.digitellinc.com/p/s/maintenance-of-the-phenotype-and-abundance-of-islet-resident-macrophages-promotes-islet-graft-survival-and-appears-to-prevent-type-1-diabetes-14995
https://atc.digitellinc.com/p/s/prominence-of-graft-infiltrating-pd-l1suphisup-cross-dressed-dendritic-cells-in-mouse-liver-transplant-tolerance-15000
https://atc.digitellinc.com/p/s/combination-alphacd28-plus-alphacd40-costimulation-blockade-attenuates-acute-and-chronic-rejection-in-non-human-primates-15005
https://atc.digitellinc.com/p/s/abrogating-myd88-signaling-in-donor-lung-resident-hematopoietic-cells-promotes-cell-based-tolerance-induction-in-lung-allografts-in-mice-15010
https://atc.digitellinc.com/p/s/dual-costimulatory-blockades-failed-to-achieve-transplant-tolerance-despite-induction-of-mixed-chimerism-in-nhps-15015
https://atc.digitellinc.com/p/s/specific-gene-expression-signature-of-complement-activating-donor-specific-anti-hla-antibody-mediated-rejection-in-kidney-allografts-15025
https://atc.digitellinc.com/p/s/c5b-9-deposition-in-glomerular-capillaries-is-responsible-for-poor-allograft-survival-in-antibody-mediated-rejection-15030
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-correlates-with-antibody-mediated-rejection-in-kidney-allografts-15035
https://atc.digitellinc.com/p/s/a-molecular-approach-to-chronic-rejection-antibody-or-t-cell-mediated-15040
https://atc.digitellinc.com/p/s/similar-elevation-of-gene-expression-associated-with-antibody-mediated-rejection-abmr-of-renal-allografts-can-be-detected-in-both-plasma-exosomes-pexo-and-biopsies-bx-by-assessing-mrna-transcript-prof-15045
https://atc.digitellinc.com/p/s/early-and-late-antibody-mediated-rejection-and-mixed-acute-rejection-are-clinically-distinct-and-demonstrate-biologic-differences-in-immunodominant-donor-specific-antibody-characteristics-15050
https://atc.digitellinc.com/p/s/pre-transplant-hla-specific-b-cell-breadth-of-reactivity-in-a-novel-multiplex-bead-based-assay-predicts-rejection-in-kidney-transplant-recipients-15055
https://atc.digitellinc.com/p/s/left-sided-donor-nephrectomy-predisposes-living-kidney-donors-to-latent-adrenal-insufficiency-with-symptoms-of-fatigue-and-inferior-quality-of-life-15065
https://atc.digitellinc.com/p/s/inferior-graft-and-patient-survival-after-living-donor-renal-transplantation-of-negatively-selected-right-kidneys-15070
https://atc.digitellinc.com/p/s/outcomes-of-hand-assisted-laparoscopic-right-donor-nephrectomy-single-center-experience-15075
https://atc.digitellinc.com/p/s/bariatric-surgery-prior-to-living-kidney-donation-a-solution-to-expand-the-donor-pool-15080
https://atc.digitellinc.com/p/s/outcome-of-living-donor-transplantation-in-pediatric-recipients-over-the-last-three-decades-by-era-an-analysis-of-unos-database-15085
https://atc.digitellinc.com/p/s/temporal-trends-and-variation-in-bmi-thresholds-for-living-donation-across-the-us-15090
https://atc.digitellinc.com/p/s/evolution-of-health-related-quality-of-life-hrqol-in-kidney-donors-15095
https://atc.digitellinc.com/p/s/simplified-classification-of-pancreas-transplant-insufficiency-15105
https://atc.digitellinc.com/p/s/assessment-of-simple-indices-based-on-a-single-fasting-blood-sample-in-search-for-an-optimal-tool-to-estimate-beta-cell-function-after-islet-transplantation-15110
https://atc.digitellinc.com/p/s/type-1-diabetic-patients-have-better-endothelial-function-after-simultaneous-pancreas-kidney-transplantation-than-after-kidney-transplantation-with-continued-insulin-therapy-15115
https://atc.digitellinc.com/p/s/assessment-of-islet-damage-during-isolation-utilizing-mirnas-and-its-significance-with-post-transplant-outcome-in-tpiat-15120
https://atc.digitellinc.com/p/s/10-years-or-more-of-follow-up-after-total-pancreatectomy-and-intra-portal-islet-auto-transplantation-tpiat-for-treatment-of-chronic-pancreatitis-is-it-a-durable-operation-15125
https://atc.digitellinc.com/p/s/pregnancy-after-kidney-pancreas-transplantation-maternal-and-offspring-outcomes-15130
https://atc.digitellinc.com/p/s/belatacept-in-chronic-kidney-disease-stabilizes-and-improves-renal-function-in-pancreas-transplant-recipients-intermediate-results-15135
https://atc.digitellinc.com/p/s/benefits-of-induction-in-recipients-of-acute-renal-failure-donor-kidneys-15145
https://atc.digitellinc.com/p/s/outcomes-with-steroid-avoidance-regimen-after-kidney-transplantation-without-induction-immunosuppression-15150
https://atc.digitellinc.com/p/s/cs58c-15155
https://atc.digitellinc.com/p/s/induction-therapy-in-low-risk-elderly-kidney-transplant-recipients-donor-factors-15160
https://atc.digitellinc.com/p/s/ivig-plus-rituximab-desensitization-des-combined-with-alemtuzumab-atz-induction-does-not-increase-risk-for-viral-infections-vis-and-associated-complications-in-hla-sensitized-hs-kidney-transplant-pati-15165
https://atc.digitellinc.com/p/s/five-year-outcomes-with-alemtuzumab-induction-therapy-in-elderly-renal-transplant-recipients-15170
https://atc.digitellinc.com/p/s/impact-of-alemtuzumab-induction-on-hepatitis-c-treatment-outcomes-post-renal-transplantation-15175
https://atc.digitellinc.com/p/s/current-practice-and-center-level-variation-in-simultaneous-liver-kidney-listing-15185
https://atc.digitellinc.com/p/s/delayed-renal-implantation-improves-survival-following-simultaneous-liver-kidney-transplantation-in-high-acuity-recipients-15190
https://atc.digitellinc.com/p/s/post-liver-transplant-lt-early-allograft-dysfunction-ead-modulates-the-effect-of-pre-lt-kidney-function-on-post-lt-survival-15195
https://atc.digitellinc.com/p/s/hepatic-ischemia-reperfusion-injury-after-liver-transplantation-is-associated-with-acute-kidney-injury-15200
https://atc.digitellinc.com/p/s/renal-function-after-liver-transplantation-alone-in-patients-meeting-the-proposed-unos-simultaneous-liver-kidney-slk-criteria-15205
https://atc.digitellinc.com/p/s/effect-of-hypothermic-pulsatile-machine-perfusion-on-kidney-delayed-graft-function-in-simultaneous-liver-kidney-transplantation-a-single-center-study-15210
https://atc.digitellinc.com/p/s/non-renal-factors-predicting-combined-liver-kidney-transplantation-for-non-dialysis-requiring-wait-listed-end-stage-liver-disease-patients-14-years-of-us-experience-15215
https://atc.digitellinc.com/p/s/absence-of-independent-and-additional-predictive-ability-of-preimplantation-kidney-allograft-biopsies-for-long-term-outcome-population-based-study-15225
https://atc.digitellinc.com/p/s/donor-recipient-matching-based-on-hla-epitopes-improves-outcome-in-kidney-transplant-recipients-15230
https://atc.digitellinc.com/p/s/a-mutation-of-the-erythropoietin-receptor-correlates-with-improved-function-of-deceased-donor-renal-transplants-15240
https://atc.digitellinc.com/p/s/procurement-kidney-biopsy-versus-kdri-for-predicting-graft-survival-15245
https://atc.digitellinc.com/p/s/elevated-donor-hba1c-confers-impaired-overall-survival-following-renal-allotransplantation-in-recipients-of-allografts-from-donors-with-diabetes-mellitus-a-national-analysis-15250
https://atc.digitellinc.com/p/s/transplant-readiness-assessment-clinic-a-new-approach-to-kidney-waitlist-management-in-the-kas-era-15255
https://atc.digitellinc.com/p/s/alcohol-induced-hepatic-cirrhosis-is-rising-among-young-adults-15265
https://atc.digitellinc.com/p/s/factors-associated-with-death-or-transplant-in-low-meld-patients-15270
https://atc.digitellinc.com/p/s/life-threatening-disparities-in-calculated-meld-due-to-variation-in-laboratory-methods-within-a-unos-region-15275
https://atc.digitellinc.com/p/s/meld-exception-score-lsam-modeling-of-a-fixed-floor-15280
https://atc.digitellinc.com/p/s/women-are-delisted-for-being-too-sick-for-liver-transplant-more-frequently-than-men-15285
https://atc.digitellinc.com/p/s/candidate-sex-and-size-disparity-in-liver-offer-acceptance-15290
https://atc.digitellinc.com/p/s/the-objective-liver-frailty-index-significantly-improves-the-clinician-eyeball-test-to-predict-mortality-in-liver-transplant-candidates-15295
https://atc.digitellinc.com/p/s/gut-microbial-metabolite-improves-function-and-prolongs-kidney-allograft-survival-in-mice-15305
https://atc.digitellinc.com/p/s/aquaporin-4-blockade-alters-t-cell-anatomical-distribution-and-prolongs-cardiac-allograft-survival-in-sensitized-recipients-15310
https://atc.digitellinc.com/p/s/lymphotoxin-lt-beta-receptor-mediated-non-classical-nfkappab-signaling-in-lymphatic-endothelial-eells-lec-is-required-for-homeostatic-t-cell-migration-15315
https://atc.digitellinc.com/p/s/extracellular-mitochondria-cause-b7-costimulation-blockade-resistant-allograft-rejection-in-mice-15320
https://atc.digitellinc.com/p/s/donor-italicbatf3italic-dependent-dendritic-cells-initiate-acute-rejection-in-a-skin-transplantation-model-15325
https://atc.digitellinc.com/p/s/fcgriib-mediated-coinhibition-attenuates-donor-reactive-cd8-plus-t-cell-responses-15330
https://atc.digitellinc.com/p/s/lymph-node-stromal-laminins-differentially-regulate-t-cell-activation-15335
https://atc.digitellinc.com/p/s/proteomic-profiles-of-deceased-donor-kidney-biopsies-obtained-prior-to-transplantation-correlate-with-allograft-function-at-one-year-15345
https://atc.digitellinc.com/p/s/donor-derived-transmission-events-in-2015-2016-analysis-of-the-optn-ad-hoc-disease-transmission-advisory-committee-dtac-15350
https://atc.digitellinc.com/p/s/modifiable-deceased-organ-donor-critical-care-parameters-impact-donor-lung-utilization-15355
https://atc.digitellinc.com/p/s/current-status-of-hiv-to-hiv-transplants-in-the-united-states-15360
https://atc.digitellinc.com/p/s/using-donors-with-false-positive-hiv-tests-an-unexpected-benefit-of-the-hope-act-15365
https://atc.digitellinc.com/p/s/release-of-hmgb1-in-serum-and-urine-of-brain-death-donors-is-associated-with-delayed-graft-function-dgf-of-the-kidney-15370
https://atc.digitellinc.com/p/s/center-volume-does-not-influence-the-risk-associated-with-using-high-dri-donor-livers-15375
https://atc.digitellinc.com/p/s/italicex-vivoitalic-normothermic-perfusion-of-isolated-segmental-porcine-bowel-a-novel-functional-model-of-the-small-intestine-15385
https://atc.digitellinc.com/p/s/myeloid-derived-suppressor-cells-mdsc-accumulate-in-intestinal-transplant-it-recipients-rc-and-suppress-recipient-t-cell-t-response-against-donor-antigen-15390
https://atc.digitellinc.com/p/s/renal-outcomes-following-intestinal-transplantation-15395
https://atc.digitellinc.com/p/s/graft-versus-host-disease-in-intestine-transplantation-15400
https://atc.digitellinc.com/p/s/effect-of-preformed-donor-specific-antibodies-in-intestinemultivisceral-transplantation-15405
https://atc.digitellinc.com/p/s/intraabdominal-infections-iai-and-bloodstream-infections-in-small-intestinal-and-multivisceral-transplants-imvtx-15410
https://atc.digitellinc.com/p/s/evaluation-of-cytomegalovirus-prophylaxis-regimens-in-intestinal-transplant-recipients-a-single-center-experience-15415
https://atc.digitellinc.com/p/s/results-of-biliary-reconstruction-with-ptfe-graft-in-liver-transplantation-15425
https://atc.digitellinc.com/p/s/robotic-kidney-transplantation-bakirkoy-experience-15430
https://atc.digitellinc.com/p/s/retrospective-analysis-of-multiple-hemodialysis-access-modalities-15435
https://atc.digitellinc.com/p/s/five-year-experience-with-laparoscopic-sleeve-gastrectomy-in-obese-renal-transplant-candidates-15440
https://atc.digitellinc.com/p/s/outcomes-following-cholecystectomy-in-kidney-transplant-recipients-15445
https://atc.digitellinc.com/p/s/the-effect-of-the-procurement-surgeon-on-transplanted-abdominal-organ-outcomes-an-optnsrtr-analysis-to-evaluate-regional-organ-procurement-collaboration-15450
https://atc.digitellinc.com/p/s/when-does-the-learning-curve-end-a-high-volume-single-center-experience-with-laparoscopic-donor-nephrectomy-over-16-years-15455
https://atc.digitellinc.com/p/s/orthotopic-liver-transplantation-of-xenogeneic-livers-repopulated-with-autologous-hepatocytes-proof-of-normal-function-and-consistent-survival-15465
https://atc.digitellinc.com/p/s/autologous-expanded-tregs-and-porcine-hematopoietic-cells-to-prolong-xenogeneic-pig-skin-graft-acceptance-in-baboons-15470
https://atc.digitellinc.com/p/s/addition-of-hepcrhcd55htfpihcd47-modulates-multi-lineage-cell-sequestration-and-coagulation-activation-by-galtkohcd46-transgenic-pig-livers-perfused-ex-vivo-with-human-blood-15475
https://atc.digitellinc.com/p/s/prolonged-survival-with-co-stimulatory-blockade-based-immunosuppression-in-pig-to-primate-liver-xenotransplantation-15480
https://atc.digitellinc.com/p/s/early-detection-of-xenograft-rejection-or-injury-by-donor-derived-cell-free-dna-in-pig-to-baboon-cardiac-xenotransplantation-15485
https://atc.digitellinc.com/p/s/cd4-depletion-is-necessary-and-sufficient-for-long-term-nonhuman-primate-xenotransplant-survival-15490
https://atc.digitellinc.com/p/s/cd28-directed-immunotherapy-is-more-potent-than-belatacept-in-a-nonhuman-primate-xenotransplant-model-15495
https://atc.digitellinc.com/p/s/il-21r-antagonist-inhibits-differentiation-of-b-cells-towards-plasmablasts-upon-alloantigen-stimulation-15505
https://atc.digitellinc.com/p/s/early-results-of-immune-profile-emerging-before-detection-of-de-novo-humoral-alloimmunity-in-kidney-transplant-recipients-15510
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-predicts-biopsy-proven-acute-cellular-rejection-in-pediatric-kidney-transplant-recipients-15515
https://atc.digitellinc.com/p/s/ctla4ig-suppresses-memory-responses-to-hla-a2-plus-skin-grafts-in-a-mouse-model-of-allosensitization-by-reducing-cd138-plus-plasma-cells-15520
https://atc.digitellinc.com/p/s/cd8-plus-tab-supp-cells-suppress-the-production-of-multiple-alloantibody-isotypes-in-response-to-mhc-mismatched-cellular-and-vascularized-allografts-15525
https://atc.digitellinc.com/p/s/b-cells-in-liver-transplant-tolerance-15530
https://atc.digitellinc.com/p/s/importance-of-b-cell-antigen-specificity-in-breg-dependent-tolerance-15535
https://atc.digitellinc.com/p/s/donation-after-circulatory-death-dcd-kidneys-are-more-likely-to-be-discarded-than-kidneys-from-neurologically-brain-dead-donors-nbd-15545
https://atc.digitellinc.com/p/s/donor-age-is-the-most-important-predictor-of-longterm-graft-function-in-simultaneous-pancreas-kidney-transplantation-from-donors-after-cardiac-death-15550
https://atc.digitellinc.com/p/s/use-of-hepatitis-c-infected-organs-for-kidney-transplantation-a-medical-decision-analysis-15555
https://atc.digitellinc.com/p/s/higher-mortality-among-candidates-who-refuse-to-accept-dcd-kidney-offers-15565
https://atc.digitellinc.com/p/s/higher-mortality-among-candidates-who-refused-increased-infectious-risk-kidney-offers-15570
https://atc.digitellinc.com/p/s/delayed-graft-function-and-long-term-graft-survival-in-dbd-and-dcd-kidney-recipients-15575
https://atc.digitellinc.com/p/s/just-keeps-getting-worse-racial-and-ethnic-disparities-in-access-to-live-donor-kidney-transplantation-in-the-us-over-the-last-twenty-years-15585
https://atc.digitellinc.com/p/s/how-to-improve-pre-kidney-transplant-education-for-hispanics-preferences-and-perceptions-of-northwestern-memorial-hospitals-hispanic-transplant-program-15590
https://atc.digitellinc.com/p/s/transplant-center-variability-in-disparities-for-african-american-kidney-transplant-recipients-15595
https://atc.digitellinc.com/p/s/at-home-transplant-education-increases-black-and-low-income-dialysis-patients-transplant-knowledge-attitudes-informed-decision-making-and-pursuit-an-explore-transplant-at-home-randomized-controlled-tr-15600
https://atc.digitellinc.com/p/s/dialysis-facility-providers-awareness-of-racial-disparities-in-kidney-transplantation-15605
https://atc.digitellinc.com/p/s/geographic-disparities-in-access-to-deceased-donor-kidney-transplant-15610
https://atc.digitellinc.com/p/s/dramatic-shifts-in-prognosis-outcomes-and-baseline-risk-among-wait-listed-kidney-transplant-candidates-in-the-united-states-15615
https://atc.digitellinc.com/p/s/the-new-kidney-allocation-system-in-france-meets-its-targets-improving-age-and-hla-dr-qd-matching-for-young-adults-15625
https://atc.digitellinc.com/p/s/utility-of-weighted-composite-endpoints-in-kidney-transplantation-15630
https://atc.digitellinc.com/p/s/unexplained-cost-variation-for-liver-transplantation-a-national-study-of-us-transplant-centers-15635
https://atc.digitellinc.com/p/s/donor-age-or-quality-a-qualitative-analysis-of-livers-declined-for-830-15640
https://atc.digitellinc.com/p/s/cultural-competency-of-a-mobile-customized-patient-education-tool-for-improving-potential-kidney-transplant-recipients-knowledge-and-decision-making-15645
https://atc.digitellinc.com/p/s/analysis-of-outcomes-in-high-risk-kidney-transplants-15650
https://atc.digitellinc.com/p/s/outcomes-of-organs-transplants-when-the-donor-is-a-prior-recipient-15655
https://atc.digitellinc.com/p/s/inhibition-of-liver-natural-killer-cells-activation-through-co-transplantation-of-pre-activated-mesenchymal-stem-cells-contributes-to-improvement-of-islet-graft-survival-15665
https://atc.digitellinc.com/p/s/igm-immunotherapy-restores-immune-homeostasis-in-type-1-diabetes-15680
https://atc.digitellinc.com/p/s/long-term-drug-free-survival-of-tiny-cynomolgus-islet-allografts-15685
https://atc.digitellinc.com/p/s/a-combination-of-anti-cd40l-ab-rapamycin-and-donor-apoptotic-cells-prolongs-allogeneic-pancreatic-islet-survival-in-sensitized-mice-by-regulating-memory-responses-15690
https://atc.digitellinc.com/p/s/optimization-of-pancreatic-islet-like-clusters-from-hipscs-for-cell-therapy-in-type-1-diabetes-15695
https://atc.digitellinc.com/p/s/identifying-the-specific-causes-and-the-determinants-of-outcome-in-kidney-recipients-with-transplant-glomerulopathy-a-multicenter-study-15705
https://atc.digitellinc.com/p/s/the-impact-of-delayed-graft-function-on-long-term-graft-survival-adjusted-for-donor-kidney-quality-assessed-by-the-kdpi-15710
https://atc.digitellinc.com/p/s/belatacept-conversion-in-kidney-recipients-with-low-gfr-does-not-improve-renal-function-15715
https://atc.digitellinc.com/p/s/outcomes-of-kidney-transplantation-after-primary-repeat-and-kidney-after-nonrenal-solid-organ-transplantation-10-years-unos-database-analysis-15720
https://atc.digitellinc.com/p/s/twenty-year-trends-in-outcomes-and-costs-following-kidney-transplantation-15725
https://atc.digitellinc.com/p/s/is-there-an-association-between-number-of-outpatient-primary-care-visits-opv-and-outcomes-in-kidney-transplantation-ktp-15730
https://atc.digitellinc.com/p/s/laparoscopic-sleeve-gastrectomy-improves-renal-transplant-candidacy-and-posttransplant-outcomes-in-morbidly-obese-patients-15735
https://atc.digitellinc.com/p/s/co-stimulation-blockade-to-minimize-and-withdraw-long-term-calcineurin-inhibitors-cni-in-simultaneous-pancreas-and-kidney-transplant-spk-15745
https://atc.digitellinc.com/p/s/us-outcomes-in-early-liver-transplantation-for-alcoholic-hepatitis-results-from-the-american-consortium-of-early-liver-transplantation-for-alcoholic-hepatitis-accelerate-ah-15750
https://atc.digitellinc.com/p/s/phase-3-trial-of-transplantation-of-human-islets-in-type-1-diabetes-t1d-post-renal-transplantation-15755
https://atc.digitellinc.com/p/s/efficacy-and-safety-of-everolimus-with-reduced-exposure-tacrolimus-and-corticosteroid-withdrawal-in-de-novo-pediatric-renal-transplant-recipients-12-month-results-from-the-cradle-study-15760
https://atc.digitellinc.com/p/s/emerging-safety-and-tolerability-of-obinutuzumab-a-type-2-anti-cd20-monoclonal-antibody-for-the-desensitization-of-renal-transplant-candidates-15765
https://atc.digitellinc.com/p/s/a-novel-equation-grail-gfr-assessment-in-liver-disease-correctly-classifies-patients-with-reduced-gfr-and-predicts-development-of-esrd-15770
https://atc.digitellinc.com/p/s/blood-and-biopsy-genomic-signatures-of-acute-rejection-in-liver-transplant-recipients-15775
https://atc.digitellinc.com/p/s/long-term-outcomes-after-liver-transplantation-tx-with-everolimus-evr-and-mycophenolic-acid-mpa-in-a-calcineurin-inhibitor-free-regimen-the-certitude-trial-15785
https://atc.digitellinc.com/p/s/impact-of-a-b-cell-targeting-agent-on-antibody-mediated-rejection-and-graft-survival-in-liver-transplantation-with-preformed-dsas-15790
https://atc.digitellinc.com/p/s/foxp3-rs3761548-ac-plus-aa-genotype-is-a-risk-factor-for-steroid-resistant-rejection-after-liver-transplantation-15795
https://atc.digitellinc.com/p/s/a-comparison-of-desensitization-protocols-rituximab-withwithout-plasmapheresis-in-abo-incompatible-living-donor-liver-transplantation-15800
https://atc.digitellinc.com/p/s/the-combined-effects-of-induction-regimens-and-antiviral-prophylaxis-on-the-risk-of-cmv-infection-in-different-serostatus-subgroups-after-liver-transplantation-15805
https://atc.digitellinc.com/p/s/not-all-cellular-rejections-are-the-same-differences-in-early-and-late-hepatic-allograft-rejection-15810
https://atc.digitellinc.com/p/s/no-gains-in-long-term-survival-following-liver-transplantation-over-the-past-three-decades-15815
https://atc.digitellinc.com/p/s/determinants-of-severe-interstitial-fibrosis-in-kidney-allografts-major-impact-of-circulating-donor-specific-anti-hla-antibodies-15825
https://atc.digitellinc.com/p/s/nephrectomy-of-the-failed-first-kidney-allograft-predisposes-kidney-transplant-recipients-to-presensitization-with-alloreactive-t-cells-and-inferior-allograft-survival-after-retransplantation-15830
https://atc.digitellinc.com/p/s/clinical-outcomes-of-abo-and-hla-incompatible-kidney-transplantation-nationwide-cohort-study-15835
https://atc.digitellinc.com/p/s/acute-cellular-rejection-is-associated-with-increased-risk-of-early-and-late-graft-failure-15840
https://atc.digitellinc.com/p/s/immune-sensitization-during-pregnancy-reduces-long-term-benefit-for-kidney-recipients-of-offspring-living-donors-15845
https://atc.digitellinc.com/p/s/center-level-differences-in-outcomes-following-high-kdpi-kidney-transplants-15850
https://atc.digitellinc.com/p/s/prolonged-dialysis-prior-to-renal-transplantation-15855
https://atc.digitellinc.com/p/s/a-phase-two-randomised-placebo-controlled-trial-belimumab-in-renal-transplantation-targets-naiumlve-activated-memory-and-antibody-producing-b-cells-whilst-sparing-regulatory-b-cells-15865
https://atc.digitellinc.com/p/s/experience-with-belatacept-ctla4-ig-conversion-in-highly-hla-sensitized-hs-and-abo-incompatible-aboi-patients-who-received-incompatible-kidney-transplants-post-desensitization-des-15870
https://atc.digitellinc.com/p/s/belatacept-conversion-for-calcineurin-inhibitor-cni-toxicity-our-first-100-patients-15875
https://atc.digitellinc.com/p/s/il-7-receptor-heterogeneity-as-a-mechanism-for-repertoire-change-during-post-depletional-homeostatic-proliferation-and-its-relation-to-costimulation-blockade-resistant-rejection-15880
https://atc.digitellinc.com/p/s/a-novel-belatacept-regimen-to-optimize-efficacy-and-safety-15885
https://atc.digitellinc.com/p/s/stability-of-immune-phenotype-alloreactive-and-antiviral-immunity-after-switch-to-belatacept-based-regimen-after-kidney-transplantation-15890
https://atc.digitellinc.com/p/s/impact-of-belatacept-conversion-on-kidney-transplant-function-histology-and-gene-expression-15895
https://atc.digitellinc.com/p/s/signal-inhibitory-regulatory-protein-alpha-regulates-pathologic-reactive-oxygen-species-in-acute-kidney-injury-15905
https://atc.digitellinc.com/p/s/accumulating-mitochondrial-dna-in-aging-augments-inflammatory-responses-subsequent-to-iri-15915
https://atc.digitellinc.com/p/s/trpv4-channels-mediate-pulmonary-edema-and-inflammation-during-ischemia-reperfusion-injury-15920
https://atc.digitellinc.com/p/s/myeloid-ho-1-orchestrates-liver-graft-function-via-sirt1p53-signaling-from-mouse-to-human-15925
https://atc.digitellinc.com/p/s/donor-derived-nonclassical-monocytes-produce-mip-2-to-recruit-recipient-neutrophils-and-cause-ischemia-reperfusion-injury-after-lung-transplant-15930
https://atc.digitellinc.com/p/s/glucocorticoid-receptor-relaxin-signaling-in-liver-transplant-ischemia-reperfusion-injury-iri-from-bench-to-bedside-15935
https://atc.digitellinc.com/p/s/inhibition-of-multiple-nodes-in-the-pi3kaktmtor-pathway-synergistically-suppresses-epstein-barr-virus-b-cell-lymphomas-15945
https://atc.digitellinc.com/p/s/ebv-specific-cd8sup-plus-sup-t-cells-from-pediatric-thoracic-vs-abdominal-transplant-recipients-are-shaped-differently-by-the-chronic-ebv-loads-with-potential-impact-on-the-risk-of-ptld-15950
https://atc.digitellinc.com/p/s/the-mirnome-of-ebv-plus-ptld-is-distinct-from-ebv-plus-infectious-mononucleosis-15955
https://atc.digitellinc.com/p/s/genomic-diversity-of-epstein-barr-virus-in-post-transplant-lymphoproliferative-disorder-15960
https://atc.digitellinc.com/p/s/rituximab-desensitization-des-and-alemtuzumab-induction-significantly-reduced-ebv-viremia-and-post-transplant-lymphoproliferative-disorder-ptld-in-hla-sensitized-hs-kidney-transplant-patients-15970
https://atc.digitellinc.com/p/s/risk-of-primary-central-nervous-system-lymphoma-in-solid-organ-transplant-recipients-15975
https://atc.digitellinc.com/p/s/tissue-transcriptional-profile-of-portal-inflammation-with-interface-activity-in-pediatric-liver-transplant-lt-recipients-with-normal-liver-tests-closely-resembles-t-cell-mediated-rejection-tcmr-15985
https://atc.digitellinc.com/p/s/outcomes-from-a-multinational-randomised-controlled-trial-comparing-normothermic-machine-perfusion-with-static-cold-storage-in-human-liver-transplantation-15990
https://atc.digitellinc.com/p/s/costimulation-independent-acute-rejection-requires-cd127-signaling-15995
https://atc.digitellinc.com/p/s/maribavir-for-treatment-of-cytomegalovirus-infections-resistant-or-refractory-to-ganciclovir-or-foscarnet-in-solid-organ-transplant-recipients-a-phase-2-study-16005
https://atc.digitellinc.com/p/s/donor-sirpa-polymorphism-modulates-the-innate-immune-response-to-allogeneic-grafts-16010
https://atc.digitellinc.com/p/s/dysregulated-innate-immune-response-is-a-robust-predictor-of-allograft-injury-and-survival-across-all-transplanted-organs-16015
https://atc.digitellinc.com/p/s/inflammasome-unfolded-protein-response-and-t-cell-immunity-in-daih-16020
https://atc.digitellinc.com/p/s/basic-16030
https://atc.digitellinc.com/p/s/translational-16035
https://atc.digitellinc.com/p/s/clinical-16040
https://atc.digitellinc.com/p/s/setting-up-a-de-novo-robotic-assisted-kidney-transplant-programme-a-guide-in-10-safe-steps-16050
https://atc.digitellinc.com/p/s/laparoscopic-assisted-living-donor-right-hepatectomy-16055
https://atc.digitellinc.com/p/s/enhanced-recovery-after-kidney-transplantation-the-benefit-of-a-single-minimal-access-incision-16060
https://atc.digitellinc.com/p/s/3d-printing-meets-robotic-kidney-transplantation-a-hybrid-model-for-training-16065
https://atc.digitellinc.com/p/s/orthotopic-kidney-transplantation-in-a-highly-hla-sensitized-patient-with-pelvic-vascular-complications-16070
https://atc.digitellinc.com/p/s/control-of-the-bleeding-from-inferior-vena-cava-during-right-live-donor-nephrectomy-16080
https://atc.digitellinc.com/p/s/joint-award-session-16085
https://atc.digitellinc.com/p/s/asts-pioneer-award-16090
https://atc.digitellinc.com/p/s/ast-lifetime-achievement-awards-16095
https://atc.digitellinc.com/p/s/asts-awards-16100
https://atc.digitellinc.com/p/s/asts-presidential-address-16105
https://atc.digitellinc.com/p/s/ast-awards-16110
https://atc.digitellinc.com/p/s/ast-presidential-address-16115
https://atc.digitellinc.com/p/s/high-risk-donors-what-the-department-of-health-says-or-doesnt-say-16130
https://atc.digitellinc.com/p/s/hepatitis-c-donors-do-new-therapies-mean-new-options-16135
https://atc.digitellinc.com/p/s/ocs-is-it-ready-for-prime-time-16140
https://atc.digitellinc.com/p/s/dcd-hearts-small-step-or-great-leap-in-expanding-the-donor-pool-16145
https://atc.digitellinc.com/p/s/time-to-kidney-transplantation-following-live-donor-candidate-referral-16155
https://atc.digitellinc.com/p/s/living-kidney-donor-pharmaceutical-care-needs-identified-through-linked-transplant-registry-and-pharmacy-claims-data-16160
https://atc.digitellinc.com/p/s/living-kidney-donors-battling-high-attrition-rates-during-evaluation-process-16165
https://atc.digitellinc.com/p/s/financial-burden-and-time-to-returning-to-work-among-living-kidney-donors-16170
https://atc.digitellinc.com/p/s/hot-updates-emerging-re-emerging-pjp-and-endemic-fungi-16175
https://atc.digitellinc.com/p/s/impact-of-ritonavir-on-graft-function-in-human-immunodeficiency-virus-infected-kidney-transplant-recipients-16180
https://atc.digitellinc.com/packages/14/view
https://atc.digitellinc.com/packages/34/view
https://atc.digitellinc.com/packages/59/view
https://atc.digitellinc.com/packages/69/view
https://atc.digitellinc.com/packages/74/view
https://atc.digitellinc.com/packages/79/view
https://atc.digitellinc.com/packages/99/view
https://atc.digitellinc.com/packages/104/view
https://atc.digitellinc.com/packages/109/view
https://atc.digitellinc.com/packages/114/view
https://atc.digitellinc.com/p/s/regulatory-quality-what-you-need-to-know-clinical-perspective-16323
https://atc.digitellinc.com/p/s/program-approaching-the-slippery-slope-16329
https://atc.digitellinc.com/p/s/how-to-see-your-way-clear-again-16335
https://atc.digitellinc.com/p/s/things-that-i-wish-i-had-known-panel-discussion-16341
https://atc.digitellinc.com/p/s/crisis-management-overall-concepts-16353
https://atc.digitellinc.com/p/s/crisis-planning-and-management-how-to-survive-a-living-donor-death-16359
https://atc.digitellinc.com/p/s/disaster-planning-natural-or-environmental-16365
https://atc.digitellinc.com/p/s/how-to-manage-a-survey-that-is-not-going-well-16377
https://atc.digitellinc.com/p/s/balancing-strategy-with-firefighting-16383
https://atc.digitellinc.com/p/s/obesity-and-transplantation-tackling-a-weighty-issue-16395
https://atc.digitellinc.com/p/s/you-dont-have-to-like-them-but-approaches-to-caring-for-difficult-or-hostile-patients-16401
https://atc.digitellinc.com/p/s/assessing-patients-for-skin-cancer-pre-and-post-transplant-16407
https://atc.digitellinc.com/p/s/palliative-medicine-and-end-of-life-care-16413
https://atc.digitellinc.com/p/s/a2-to-b-or-not-to-b-16425
https://atc.digitellinc.com/p/s/understanding-c1q-16431
https://atc.digitellinc.com/p/s/liver-tumor-staging-16437
https://atc.digitellinc.com/p/s/long-term-impact-of-high-risk-donors-on-graft-and-recipient-outcomes-16443
https://atc.digitellinc.com/p/s/update-on-innate-sensors-inflammasome-activation-and-inflammation-16455
https://atc.digitellinc.com/p/s/update-on-regulated-cell-death-mechanisms-and-implications-16461
https://atc.digitellinc.com/p/s/update-on-mechanisms-of-t-cell-dysfunction-16467
https://atc.digitellinc.com/p/s/update-on-non-coding-rna-in-regulation-of-immune-responses-16473
https://atc.digitellinc.com/p/s/update-on-metabolic-control-of-immune-responses-16479
https://atc.digitellinc.com/p/s/update-on-epigenetic-regulation-of-immune-responses-16485
https://atc.digitellinc.com/p/s/update-on-microbiota-in-regulation-of-immunity-and-tolerance-16491
https://atc.digitellinc.com/p/s/top-10-immunology-papers-of-the-year-16497
https://atc.digitellinc.com/p/s/an-overview-of-immune-responses-from-inception-to-memory-16509
https://atc.digitellinc.com/p/s/the-innate-immune-response-dangers-sensors-and-cells-16515
https://atc.digitellinc.com/p/s/t-cells-and-their-effector-mechanisms-in-rejection-16521
https://atc.digitellinc.com/p/s/the-life-cycle-of-b-cells-and-their-roles-in-alloimmunity-16527
https://atc.digitellinc.com/p/s/essential-mechanisms-regulating-immune-responses-16533
https://atc.digitellinc.com/p/s/the-holy-grail-of-transplantation-tolerance-16539
https://atc.digitellinc.com/p/s/memory-cells-and-their-impact-on-allograft-tolerance-16545
https://atc.digitellinc.com/p/s/therapeutic-approaches-to-rejection-16551
https://atc.digitellinc.com/p/s/chronic-graft-rejection-mechanisms-and-emerging-approaches-16557
https://atc.digitellinc.com/p/s/immunobiology-of-rejection-for-the-nephrologist-16569
https://atc.digitellinc.com/p/s/immunological-assessment-of-the-transplant-recipient-16575
https://atc.digitellinc.com/p/s/immunosuppression-current-approaches-and-future-strategies-16581
https://atc.digitellinc.com/p/s/beyond-conventional-pathology-new-approaches-to-diagnose-rejection-potential-use-and-advantages-16587
https://atc.digitellinc.com/p/s/evaluation-of-the-combined-organ-transplant-candidate-16599
https://atc.digitellinc.com/p/s/evaluation-of-the-living-kidney-donor-16605
https://atc.digitellinc.com/p/s/surgical-complications-after-kidney-transplantation-for-the-non-surgeon-16617
https://atc.digitellinc.com/p/s/management-of-malignancy-pre-and-post-transplant-considerations-and-management-16623
https://atc.digitellinc.com/p/s/management-of-the-failingfailed-allograft-16629
https://atc.digitellinc.com/p/s/challenging-cases-in-cmv-16641
https://atc.digitellinc.com/p/s/bk-virus-prevention-and-treatment-16647
https://atc.digitellinc.com/p/s/id-evaluation-of-the-living-donor-16659
https://atc.digitellinc.com/p/s/hiv-plus-candidate-pre-transplant-evaluation-and-post-transplant-management-16665
https://atc.digitellinc.com/p/s/immunosuppression-considerations-for-the-id-physician-16671
https://atc.digitellinc.com/p/s/fungi-among-us-the-antifungal-landscape-16683
https://atc.digitellinc.com/p/s/non-tuberculous-mycobacteria-from-outbreaks-to-candidates-16689
https://atc.digitellinc.com/p/s/parasites-sot-and-travel-a-long-and-winding-road-16695
https://atc.digitellinc.com/p/s/dermatology-and-transplant-infectious-disease-16707
https://atc.digitellinc.com/p/s/radiology-and-transplant-infectious-disease-16713
https://atc.digitellinc.com/p/s/operation-a-surgeons-view-of-tid-16719
https://atc.digitellinc.com/p/s/managing-and-mitigating-transplant-infections-rapid-fire-cases-dare-to-diagnose-16725
https://atc.digitellinc.com/p/s/reaching-adulthood-comes-at-a-price-16743
https://atc.digitellinc.com/p/s/how-do-i-assess-fibrosis-in-patients-with-congenital-heart-disease-16749
https://atc.digitellinc.com/p/s/the-nodular-liver-in-the-older-adult-with-heart-disease-is-it-cirrhosis-16761
https://atc.digitellinc.com/p/s/focal-liver-lesions-in-congestive-hepatopathy-is-it-hcc-16767
https://atc.digitellinc.com/p/s/how-do-i-assess-cardiovascular-physiology-in-end-stage-liver-disease-pearls-and-pitfalls-16779
https://atc.digitellinc.com/p/s/cirrhotic-cardiomyopathy-myth-or-reality-16785
https://atc.digitellinc.com/p/s/evaluation-and-management-of-ischemic-heart-disease-prior-to-liver-transplantation-from-regulatory-to-reality-critical-coronary-artery-stenosis-is-45-year-old-with-a-meld-of-40-16797
https://atc.digitellinc.com/p/s/valvular-heart-disease-and-liver-transplant-is-tavr-an-option-critical-valvular-heart-disease-how-to-approach-16803
https://atc.digitellinc.com/p/s/biology-of-abmr-16815
https://atc.digitellinc.com/p/s/abmr-effector-pathways-16821
https://atc.digitellinc.com/p/s/hot-topics-in-abmr-pathology-diagnostics-16827
https://atc.digitellinc.com/p/s/hot-topics-in-abmr-serum-diagnostics-16833
https://atc.digitellinc.com/p/s/access-for-the-highly-sensitized-patient-16845
https://atc.digitellinc.com/p/s/is-there-a-standard-of-care-for-abmr-16851
https://atc.digitellinc.com/p/s/is-there-a-link-between-acutechronic-abmr-16857
https://atc.digitellinc.com/p/s/is-there-anything-in-the-pipeline-for-abmr-16863
https://atc.digitellinc.com/p/s/how-should-we-monitor-and-immunosuppress-16875
https://atc.digitellinc.com/p/s/getting-kids-to-adulthood-managing-the-pediatric-population-16881
https://atc.digitellinc.com/p/s/a-third-chance-which-patients-and-when-for-retransplantation-16887
https://atc.digitellinc.com/p/s/screening-evaluation-and-treatment-of-porto-pulmonary-hypertension-poph-16899
https://atc.digitellinc.com/p/s/current-approach-to-hepatopulmonary-syndrome-hps-diagnosis-and-management-16905
https://atc.digitellinc.com/p/s/intraopertaive-management-of-portopulmonary-hypertension-and-hepatopulmonary-hypertension-16911
https://atc.digitellinc.com/p/s/predicting-lymphocyte-crossmatch-outcomes-virtually-16923
https://atc.digitellinc.com/p/s/utilization-of-virtual-crossmatching-across-all-solid-organ-types-with-accuracy-limitations-for-hitting-the-target-16929
https://atc.digitellinc.com/p/s/virtual-crossmatch-patient-outcomes-and-future-directions-16935
https://atc.digitellinc.com/p/s/hopkins-team-use-of-hcv-plus-donors-should-be-considered-standard-of-care-16947
https://atc.digitellinc.com/p/s/upenn-team-use-of-hcv-plus-donors-should-be-restricted-to-research-protocols-16953
https://atc.digitellinc.com/p/s/upenn-rebuttal-supporting-restriction-to-research-position-16959
https://atc.digitellinc.com/p/s/translational-science-in-vca-where-are-we-now-16971
https://atc.digitellinc.com/p/s/current-status-of-vca-in-the-united-states-16977
https://atc.digitellinc.com/p/s/where-now-from-here-ethical-considerations-in-vca-16983
https://atc.digitellinc.com/p/s/adult-16995
https://atc.digitellinc.com/p/s/pediatric-17001
https://atc.digitellinc.com/p/s/unos-policy-updates-17007
https://atc.digitellinc.com/p/s/optimizing-medical-management-of-the-obese-liver-transplant-candidate-17019
https://atc.digitellinc.com/p/s/bariatric-surgery-and-liver-transplantation-who-when-and-how-17025
https://atc.digitellinc.com/p/s/perioperative-morbidity-and-long-term-patient-and-graft-survival-in-morbidly-obese-liver-transplant-recipients-17031
https://atc.digitellinc.com/p/s/cmv-virology-what-the-clinician-needs-to-know-17043
https://atc.digitellinc.com/p/s/cmv-immune-monitoring-are-we-there-yet-17049
https://atc.digitellinc.com/p/s/new-antivirals-for-cmv-17055
https://atc.digitellinc.com/p/s/pancreas-transplant-alone-17067
https://atc.digitellinc.com/p/s/spk-v-kidney-alone-17073
https://atc.digitellinc.com/p/s/living-donor-kidney-pancreas-after-kidney-17079
https://atc.digitellinc.com/p/s/autophagy-and-memory-17091
https://atc.digitellinc.com/p/s/mechanisms-and-implications-of-regulated-cell-death-17097
https://atc.digitellinc.com/p/s/autophagy-in-regulation-of-organ-injury-and-repair-17103
https://atc.digitellinc.com/p/s/chimeric-antigen-receptors-and-donor-specific-tregs-in-transplantation-17115
https://atc.digitellinc.com/p/s/tregs-promote-chimerism-and-tolerance-17121
https://atc.digitellinc.com/p/s/suppression-anergy-and-tolerance-inter-relations-17127
https://atc.digitellinc.com/p/s/neurocognitive-outcomes-in-very-young-transplant-recipients-17139
https://atc.digitellinc.com/p/s/infectious-complications-in-very-young-transplant-recipients-17145
https://atc.digitellinc.com/p/s/immunological-considerations-for-the-young-transplant-recipient-17151
https://atc.digitellinc.com/p/s/pro-liver-transplantation-for-alcoholic-hepatitis-just-one-more-drink-17163
https://atc.digitellinc.com/p/s/con-liver-transplantation-for-alcoholic-hepatitis-a-liver-down-the-drain-17169
https://atc.digitellinc.com/p/s/pro-rebuttals-17175
https://atc.digitellinc.com/p/s/con-rebuttals-17181
https://atc.digitellinc.com/p/s/pro-should-we-continue-prioritizing-kidney-heart-and-kidney-liver-transplant-candidates-over-kidney-alone-candidates-17193
https://atc.digitellinc.com/p/s/con-should-we-continue-prioritizing-kidney-heart-and-kidney-liver-transplant-candidates-over-kidney-alone-candidates-17199
https://atc.digitellinc.com/p/s/pro-rebuttals-17205
https://atc.digitellinc.com/p/s/con-rebuttals-17211
https://atc.digitellinc.com/p/s/pro-better-class-ii-matching-is-critical-in-pediatric-renal-transplant-recipients-in-light-of-the-high-incidence-of-medication-non-adherence-and-subsequent-development-of-destructive-donor-specific-an-17223
https://atc.digitellinc.com/p/s/con-even-with-improved-medical-management-and-dialysis-modalities-children-and-adolescents-must-be-transplanted-as-soon-as-possible-irrespective-of-hla-mismatching-17229
https://atc.digitellinc.com/p/s/pro-rebuttals-17235
https://atc.digitellinc.com/p/s/con-rebuttals-17241
https://atc.digitellinc.com/p/s/cortical-reorganization-after-limb-transplantation-17253
https://atc.digitellinc.com/p/s/effects-of-ex-situ-perfusion-in-limb-transplantation-17259
https://atc.digitellinc.com/p/s/barriers-and-opportunities-in-vca-donation-17265
https://atc.digitellinc.com/p/s/some-like-it-hot-17277
https://atc.digitellinc.com/p/s/some-like-it-cold-17283
https://atc.digitellinc.com/p/s/some-like-it-on-the-rocks-17289
https://atc.digitellinc.com/p/s/competing-priorities-medical-urgency-vs-predicted-outcomes-in-heart-allocation-17301
https://atc.digitellinc.com/p/s/candidate-risk-score-weighing-waitlist-mortality-in-heart-allocation-17307
https://atc.digitellinc.com/p/s/heart-allocation-score-vs-the-real-world-17313
https://atc.digitellinc.com/p/s/reforming-the-heart-transplant-waitlist-17319
https://atc.digitellinc.com/p/s/antibody-mediated-rejection-in-the-lung-transplant-overview-incidence-treatment-and-outcome-the-utsw-experience-17331
https://atc.digitellinc.com/p/s/alloantibodies-and-autoantibodies-in-lung-transplant-17337
https://atc.digitellinc.com/p/s/anti-collagen-v-autoimmunity-of-the-lung-chronic-rejection-and-bronchiolitis-obliterans-syndrome-bos-17343
https://atc.digitellinc.com/p/s/top-bacterial-papers-17355
https://atc.digitellinc.com/p/s/top-viral-papers-17361
https://atc.digitellinc.com/p/s/top-fungal-papers-17367
https://atc.digitellinc.com/p/s/basic-science-17379
https://atc.digitellinc.com/p/s/translational-17385
https://atc.digitellinc.com/p/s/clinical-17391
https://atc.digitellinc.com/p/s/mechanisms-guiding-effector-cd8-t-cell-differentiation-17403
https://atc.digitellinc.com/p/s/epigenetic-control-of-cd8-plus-t-cell-responses-to-viral-infections-17409
https://atc.digitellinc.com/p/s/self-tolerance-and-epigenetic-imprinting-17415
https://atc.digitellinc.com/p/s/peripheral-neurons-in-regulation-of-immune-responses-17427
https://atc.digitellinc.com/p/s/exosomes-in-regulation-of-immune-response-17433
https://atc.digitellinc.com/p/s/the-impact-of-microbiota-on-immunity-and-immune-regulation-17439
https://atc.digitellinc.com/p/s/management-of-the-transplant-recipient-with-dsa-and-a-negative-cxm-17451
https://atc.digitellinc.com/p/s/treatment-of-amr-17457
https://atc.digitellinc.com/p/s/treatment-of-cmr-17463
https://atc.digitellinc.com/p/s/role-of-myeloid-cells-in-tissue-fibrosis-17475
https://atc.digitellinc.com/p/s/endothelial-mesenchymal-transition-emt-in-tissue-fibrosis-17481
https://atc.digitellinc.com/p/s/metabolic-switch-and-fibrosis-17487
https://atc.digitellinc.com/p/s/genomics-of-kidney-transplant-fibrosis-17493
https://atc.digitellinc.com/p/s/chronic-allograft-dysfunction-of-the-lung-clinical-genomic-and-immunological-insights-17499
https://atc.digitellinc.com/p/s/non-adherence-the-psychologists-perspective-17511
https://atc.digitellinc.com/p/s/population-surveillance-to-identify-at-risk-patients-17517
https://atc.digitellinc.com/p/s/assessing-and-managing-pre-transplant-non-adherence-17523
https://atc.digitellinc.com/p/s/mhealth-applications-the-good-the-bad-and-the-ugly-17535
https://atc.digitellinc.com/p/s/in-clinic-tools-tips-and-theory-to-mitigate-non-adherence-after-transplant-17541
https://atc.digitellinc.com/p/s/discussion-of-interesting-cases-surrounding-medication-non-adherence-17547
https://atc.digitellinc.com/p/s/thoughts-from-the-eic-of-ajt-17559
https://atc.digitellinc.com/p/s/the-donor-side-perspectives-from-the-opos-17565
https://atc.digitellinc.com/p/s/liver-transplantation-17571
https://atc.digitellinc.com/p/s/kidney-transplantation-17577
https://atc.digitellinc.com/p/s/outcomes-research-in-transplantation-17583
https://atc.digitellinc.com/p/s/basic-science-research-in-transplantation-17589
https://atc.digitellinc.com/p/s/transplant-id-17595
https://atc.digitellinc.com/p/s/transplant-pharmacology-17601
https://atc.digitellinc.com/p/s/vca-17607
https://atc.digitellinc.com/p/s/creating-effective-clinical-systems-workflow-staffing-17619
https://atc.digitellinc.com/p/s/effective-communication-skills-are-learned-not-born-how-to-maximize-your-workplace-communication-17625
https://atc.digitellinc.com/p/s/presenting-a-plan-to-leadership-and-effecting-change-17631
https://atc.digitellinc.com/p/s/informed-consent-ensuring-patients-hear-what-they-need-to-know-17643
https://atc.digitellinc.com/p/s/electronic-education-17649
https://atc.digitellinc.com/p/s/patient-education-and-staff-training-17655
https://atc.digitellinc.com/p/s/pro-hep-c-nat-positive-donors-should-be-considered-for-heart-transplantation-17667
https://atc.digitellinc.com/p/s/con-hep-c-nat-positive-donors-should-not-be-considered-for-heart-transplantation-17673
https://atc.digitellinc.com/p/s/pro-rebuttals-17679
https://atc.digitellinc.com/p/s/con-rebuttals-17685
https://atc.digitellinc.com/p/s/how-well-does-the-current-allocation-system-predict-a-successful-transplant-17697
https://atc.digitellinc.com/p/s/the-impact-of-age-on-survival-in-lung-transplant-17703
https://atc.digitellinc.com/p/s/acute-rejection-and-chronic-lung-allograft-dysfunction-immune-mechanisms-and-treatment-strategies-17709
https://atc.digitellinc.com/p/s/to-transplant-or-not-to-transplant-that-is-the-question-can-we-define-futility-17721
https://atc.digitellinc.com/p/s/management-of-aki-who-should-be-offered-rrt-17727
https://atc.digitellinc.com/p/s/prevention-and-management-of-sepsis-clear-and-present-danger-17733
https://atc.digitellinc.com/p/s/the-steatotic-liver-donor-17745
https://atc.digitellinc.com/p/s/the-donation-after-cardiac-death-dcd-donor-17751
https://atc.digitellinc.com/p/s/the-elderly-donor-17757
https://atc.digitellinc.com/p/s/the-unknown-unknowns-of-donors-17769
https://atc.digitellinc.com/p/s/donors-with-known-infections-17775
https://atc.digitellinc.com/p/s/balancing-the-donor-pool-17781
https://atc.digitellinc.com/p/s/non-directed-donor-benefitsprotections-should-be-greater-than-those-for-directed-donors-17793
https://atc.digitellinc.com/p/s/acceptance-criteria-should-differ-for-non-directed-and-directed-living-donors-17799
https://atc.digitellinc.com/p/s/non-directed-donors-a-local-or-national-resource-17805
https://atc.digitellinc.com/p/s/establishing-yourself-as-a-new-practitioner-17817
https://atc.digitellinc.com/p/s/building-an-effective-yet-unique-transplant-clinical-practice-17823
https://atc.digitellinc.com/p/s/could-you-be-my-mentor-17829
https://atc.digitellinc.com/p/s/tools-to-incorporate-student-pharmacists-in-pharmacy-and-research-services-17835
https://atc.digitellinc.com/p/s/tools-for-efficiently-providing-quality-education-to-students-and-residents-17841
https://atc.digitellinc.com/p/s/tools-to-build-and-advance-your-career-17847
https://atc.digitellinc.com/p/s/what-the-pediatric-transplant-hepatologist-needs-to-know-17859
https://atc.digitellinc.com/p/s/what-the-pediatric-transplant-nephrologist-needs-to-know-17865
https://atc.digitellinc.com/p/s/what-the-pediatric-transplant-cardiologist-needs-to-know-17871
https://atc.digitellinc.com/p/s/what-the-pediatric-transplant-pulmonologist-needs-to-know-17877
https://atc.digitellinc.com/p/s/transplant-program-behaviors-comparison-of-aggressive-and-passive-programs-17889
https://atc.digitellinc.com/p/s/opo-utilization-experiences-comparison-of-high-organ-utilization-vs-low-organ-utilization-17895
https://atc.digitellinc.com/p/s/the-role-of-regulation-in-influencing-utilization-17901
https://atc.digitellinc.com/p/s/update-zika-dengue-chikungunya-and-west-nile-17913
https://atc.digitellinc.com/p/s/strongyloides-and-other-worms-approaching-screening-17919
https://atc.digitellinc.com/p/s/endemic-mycoses-17925
https://atc.digitellinc.com/p/s/cell-free-dna-in-graft-rejection-and-tolerance-17937
https://atc.digitellinc.com/p/s/metabolic-reprogramming-in-the-control-of-inflammation-and-tissue-injury-17943
https://atc.digitellinc.com/p/s/impact-of-aging-on-graft-immunogenicity-and-injury-17955
https://atc.digitellinc.com/p/s/impact-of-aging-on-graft-immunogenicity-and-injury-17961
https://atc.digitellinc.com/p/s/impact-of-aging-on-graft-immunogenicity-and-injury-17967
https://atc.digitellinc.com/p/s/managing-mcs-complications-a-growth-industry-17979
https://atc.digitellinc.com/p/s/long-term-consequences-of-short-term-support-17985
https://atc.digitellinc.com/p/s/stroke-driveline-infection-gi-bleed-best-evidence-or-best-guessing-17991
https://atc.digitellinc.com/p/s/flow-too-much-too-little-just-right-18003
https://atc.digitellinc.com/p/s/let-me-out-of-here-outflow-of-ldlt-grafts-v5-v8-and-other-issues-18009
https://atc.digitellinc.com/p/s/how-low-can-we-go-avoidance-of-sfss-or-how-to-manage-it-successfully-18015
https://atc.digitellinc.com/p/s/case-presentation-elderly-nash-patient-with-cardiac-and-renal-disease-18027
https://atc.digitellinc.com/p/s/case-presentation-surgical-challenges-the-hostile-abdomen-18033
https://atc.digitellinc.com/p/s/case-presentation-intra-and-postoperative-management-of-severe-portopulmonary-hypertension-18039
https://atc.digitellinc.com/p/s/case-presentation-futile-transplants-the-patient-on-multiple-pressors-and-ventilator-support-18045
https://atc.digitellinc.com/p/s/case-presentation-transplanting-jehovahs-witness-with-acute-and-chronic-disease-18051
https://atc.digitellinc.com/p/s/state-of-the-art-cmv-prevention-18063
https://atc.digitellinc.com/p/s/preventing-the-consequences-of-ebv-18069
https://atc.digitellinc.com/p/s/state-of-the-art-respiratory-viruses-18075
https://atc.digitellinc.com/p/s/basic-science-18087
https://atc.digitellinc.com/p/s/translational-18093
https://atc.digitellinc.com/p/s/clinical-18099
https://atc.digitellinc.com/p/s/molecular-dissection-of-t-cell-dysfunction-18111
https://atc.digitellinc.com/p/s/effects-of-cmv-on-t-cell-inflation-and-immunosenescence-18117
https://atc.digitellinc.com/p/s/t-cell-dysfunction-and-its-clinical-impacttranslation-18123
https://atc.digitellinc.com/p/s/targeted-nanodelivery-of-immunosuppression-drugs-18135
https://atc.digitellinc.com/p/s/anti-peg-antibodies-current-issues-and-beyond-pegylation-18141
https://atc.digitellinc.com/p/s/nanomaterials-at-the-crossroads-of-tissue-engineering-and-cancer-immunity-18147
https://atc.digitellinc.com/p/s/protection-of-donors-in-kpd-programs-insurance-lost-wages-coverage-of-donation-related-complications-access-to-living-donor-transplantation-for-donors-developing-esrd-18159
https://atc.digitellinc.com/p/s/expanding-kpd-novel-approaches-vouchers-deceased-donors-to-start-chains-compatible-pairs-reciprocity-18165
https://atc.digitellinc.com/p/s/electronic-management-tools-for-donor-evaluation-and-management-18171
https://atc.digitellinc.com/p/s/show-me-the-data-understanding-unos-data-services-benchmarking-reports-and-cusum-overview-18183
https://atc.digitellinc.com/p/s/making-use-of-the-data-avoiding-pitfalls-in-qapi-design-18189
https://atc.digitellinc.com/p/s/all-hands-on-deck-case-presentation-srtr-data-utilization-to-develop-projection-models-of-future-risk-18195
https://atc.digitellinc.com/p/s/beyond-cnis-and-prednisone-unique-immunosuppression-in-pregnant-transplant-recipients-18207
https://atc.digitellinc.com/p/s/got-milk-lactation-considerations-in-transplant-recipients-18213
https://atc.digitellinc.com/p/s/its-hot-in-here-menopause-and-hormonal-management-post-transplant-18219
https://atc.digitellinc.com/p/s/liver-transplantation-for-otc-18231
https://atc.digitellinc.com/p/s/liver-transplantation-for-hemochromatosis-18237
https://atc.digitellinc.com/p/s/liver-kidney-transplantation-for-oxaluria-18243
https://atc.digitellinc.com/p/s/economic-impact-of-graft-loss-for-kidney-liver-and-heart-review-of-a-commercially-insured-population-18255
https://atc.digitellinc.com/p/s/financial-neutrality-for-living-donors-how-much-will-it-cost-to-ensure-no-donor-is-out-of-pocket-18261
https://atc.digitellinc.com/p/s/extending-medicare-coverage-for-life-in-the-current-era-18267
https://atc.digitellinc.com/p/s/a-painful-topic-the-impact-of-opiate-use-in-transplant-candidates-and-recipients-18285
https://atc.digitellinc.com/p/s/a-painful-topic-the-impact-of-opiate-use-in-transplant-candidates-and-recipients-18291
https://atc.digitellinc.com/p/s/how-much-is-too-much-tobacco-and-alcohol-use-in-transplant-candidates-and-recipients-18297
https://atc.digitellinc.com/p/s/how-much-is-too-much-tobacco-and-alcohol-use-in-transplant-candidates-and-recipients-18303
https://atc.digitellinc.com/p/s/its-not-all-dope-outcomes-risks-and-potential-merits-to-transplanting-a-marijuana-user-18315
https://atc.digitellinc.com/p/s/rolling-it-all-together-marijuana-and-immunosuppression-18321
https://atc.digitellinc.com/p/s/getting-into-the-weeds-whats-your-policy-on-marijuana-use-in-the-transplant-candidate-18327
https://atc.digitellinc.com/p/s/getting-into-the-weeds-whats-your-policy-on-marijuana-use-in-the-transplant-candidate-18333
https://atc.digitellinc.com/p/s/getting-into-the-weeds-whats-your-policy-on-marijuana-use-in-the-transplant-candidate-18339
https://atc.digitellinc.com/p/s/panel-discussion-18345
https://atc.digitellinc.com/p/s/liver-transplantation-for-metastatic-colorectal-cancer-18357
https://atc.digitellinc.com/p/s/liver-transplantation-for-advanced-hepatoblastoma-18363
https://atc.digitellinc.com/p/s/liver-transplantation-for-metastatic-neuroendocrine-tumors-18369
https://atc.digitellinc.com/p/s/spk-18381
https://atc.digitellinc.com/p/s/living-donor-kidney-pancreas-after-kidney-18387
https://atc.digitellinc.com/p/s/evaluating-the-transplant-candidates-health-literacy-best-tools-for-assessment-18399
https://atc.digitellinc.com/p/s/identification-and-management-of-waitlisted-patients-with-low-health-literacy-18405
https://atc.digitellinc.com/p/s/optimizing-post-transplant-education-in-recipients-with-low-health-literacy-18411
https://atc.digitellinc.com/p/s/gender-and-sex-matter-whats-all-the-fuss-about-gender-and-sex-in-clinical-and-preclinical-research-18423
https://atc.digitellinc.com/p/s/sex-cells-what-does-xx-and-xy-mean-for-cell-based-therapies-18429
https://atc.digitellinc.com/p/s/efficacy-of-immunosuppression-and-impact-of-sex-18435
https://atc.digitellinc.com/p/s/what-makes-patients-teenyoung-adult-patients-different-from-adults-18447
https://atc.digitellinc.com/p/s/the-surgical-and-immunological-risks-teenyoung-adult-transplant-and-retransplant-18453
https://atc.digitellinc.com/p/s/teenyoung-adult-patients-what-to-do-before-something-stupid-happens-18459
https://atc.digitellinc.com/p/s/histocompatability-101-titer-mfi-mesf-subclass-eplets-and-more-18471
https://atc.digitellinc.com/p/s/pathology-101-pathological-manifestations-chronic-amr-18477
https://atc.digitellinc.com/p/s/diagnosis-and-management-of-chronic-amr-in-liver-transplantation-18483
https://atc.digitellinc.com/p/s/antibiotics-use-and-c-difficile-18495
https://atc.digitellinc.com/p/s/antibiotics-and-mdros-18501
https://atc.digitellinc.com/p/s/antimicrobial-stewardship-vs-id-consult-18507
https://atc.digitellinc.com/p/s/sepsis-how-fast-can-we-get-a-diagnosis-18519
https://atc.digitellinc.com/p/s/nodules-in-the-lung-throw-me-a-line-18525
https://atc.digitellinc.com/p/s/next-generation-viral-diagnostics-18531
https://atc.digitellinc.com/p/s/construction-of-organs-by-tissue-engineering-18543
https://atc.digitellinc.com/p/s/clinical-translation-of-xenografts-18549
https://atc.digitellinc.com/p/s/evolving-barriers-in-xenotransplantation-arena-18555
https://atc.digitellinc.com/p/s/the-impact-of-kas-on-waitlist-management-18567
https://atc.digitellinc.com/p/s/assessment-of-cardiovascular-risk-for-waitlisted-individuals-18573
https://atc.digitellinc.com/p/s/real-time-vs-delayed-recipient-workup-delayed-18579
https://atc.digitellinc.com/p/s/real-time-vs-delayed-recipient-workup-real-time-18585
https://atc.digitellinc.com/p/s/regulatory-hurdles-to-implementation-fda-and-industry-perspectives-18597
https://atc.digitellinc.com/p/s/new-perfusion-technology-implementation-experience-in-the-europe-18603
https://atc.digitellinc.com/p/s/how-will-opos-adopt-new-perfusion-technology-18609
https://atc.digitellinc.com/p/s/gender-based-disparity-in-transplant-access-and-outcomes-bias-or-biology-18621
https://atc.digitellinc.com/p/s/pragmatic-trials-in-dialysis-facilities-to-increase-early-access-to-kidney-transplantation-18627
https://atc.digitellinc.com/p/s/developing-cultural-competency-in-transplant-centers-to-improve-access-to-transplantation-18633
https://atc.digitellinc.com/p/s/pro-microbiomemicrobiota-18645
https://atc.digitellinc.com/p/s/con-microbiomemicrobiota-18651
https://atc.digitellinc.com/p/s/pro-rebuttals-18657
https://atc.digitellinc.com/p/s/con-rebuttals-18663
https://atc.digitellinc.com/p/s/pro-18675
https://atc.digitellinc.com/p/s/con-18681
https://atc.digitellinc.com/p/s/pro-rebuttal-18687
https://atc.digitellinc.com/p/s/con-rebuttal-18693
https://atc.digitellinc.com/p/s/pregnancy-outcomes-across-solid-organ-transplantation-18705
https://atc.digitellinc.com/p/s/contraception-management-in-solid-organ-transplantation-time-for-improvement-18711
https://atc.digitellinc.com/p/s/when-babies-have-babies-outcomes-and-challenges-for-pediatric-transplant-recipients-who-have-children-18717
https://atc.digitellinc.com/p/s/how-we-make-decisions-under-risk-18729
https://atc.digitellinc.com/p/s/where-decisions-have-impact-the-program-the-patient-the-waiting-list-18735
https://atc.digitellinc.com/p/s/how-decisions-can-be-optimized-resources-at-your-disposal-18741
https://atc.digitellinc.com/p/s/the-akickd-continuum-the-changing-toolbox-to-assess-renal-function-18753
https://atc.digitellinc.com/p/s/how-to-avoid-futility-a-surgical-perspective-on-managing-risk-with-slkt-18759
https://atc.digitellinc.com/p/s/impact-of-the-new-slkt-policy-lessons-learned-18765
https://atc.digitellinc.com/p/s/current-proposals-for-liver-transplant-allocation-rationale-and-implications-18777
https://atc.digitellinc.com/p/s/evaluating-access-to-a-transplant-waitlist-and-impact-on-demand-metrics-18783
https://atc.digitellinc.com/p/s/population-based-metrics-versus-wait-listed-metrics-of-demand-18789
https://atc.digitellinc.com/p/s/donors-with-hiv-18801
https://atc.digitellinc.com/p/s/donors-with-hcv-18807
https://atc.digitellinc.com/p/s/donors-with-hbv-18813
https://atc.digitellinc.com/p/s/repeat-pancreas-transplantation-18825
https://atc.digitellinc.com/p/s/deceased-donor-selection-and-operative-techniques-18831
https://atc.digitellinc.com/p/s/diagnosis-and-management-of-allograft-dysfunction-18837
https://atc.digitellinc.com/p/s/basic-science-18849
https://atc.digitellinc.com/p/s/translational-science-18855
https://atc.digitellinc.com/p/s/clinical-science-18861
https://atc.digitellinc.com/p/s/innate-memory-cells-18873
https://atc.digitellinc.com/p/s/regulatory-t-cell-memory-18879
https://atc.digitellinc.com/p/s/pregnancy-induced-t-cell-memory-18885
https://atc.digitellinc.com/p/s/exploration-of-new-study-endpoints-and-development-of-biomarkers-as-tools-to-facilitate-drug-development-in-transplantation-18897
https://atc.digitellinc.com/p/s/considerations-in-drug-safety-profiles-and-the-implications-for-relabeling-existing-agents-18903
https://atc.digitellinc.com/p/s/identification-and-use-of-existing-datasets-for-the-purposes-of-validating-new-endpoints-and-defining-safety-profiles-18909
https://atc.digitellinc.com/p/s/donor-evaluation-and-procurement-18921
https://atc.digitellinc.com/p/s/recipient-selection-and-allocation-18927
https://atc.digitellinc.com/p/s/education-and-research-opportunities-18933
https://atc.digitellinc.com/p/s/cant-get-enough-rapid-metabolizers-18945
https://atc.digitellinc.com/p/s/more-than-little-adults-immunosuppression-considerations-in-pediatrics-18951
https://atc.digitellinc.com/p/s/tipping-the-scales-immunosuppression-management-in-high-bmi-recipients-18957
https://atc.digitellinc.com/p/s/overview-of-nam-report-on-donor-intervention-research-18969
https://atc.digitellinc.com/p/s/does-the-uaga-need-to-be-updated-18975
https://atc.digitellinc.com/p/s/forecast-for-a-national-donor-registry-18981
https://atc.digitellinc.com/p/s/informed-consent-recommendations-from-the-nam-18987
https://atc.digitellinc.com/p/s/national-oversight-how-can-this-be-provided-18993
https://atc.digitellinc.com/p/s/cognitive-screeningmanagement-19005
https://atc.digitellinc.com/p/s/frailty-assessment-19011
https://atc.digitellinc.com/p/s/clinical-tolerance-trials-in-pediatric-transplantation-where-are-we-in-2018-19047
https://atc.digitellinc.com/p/s/avoiding-early-fibrosis-to-ensure-long-term-graft-survival-in-pediatric-kidney-transplantation-19053
https://atc.digitellinc.com/p/s/improving-graft-longevity-pediatric-liver-transplantation-19059
https://atc.digitellinc.com/p/s/pro-utilization-of-high-risk-donor-organs-for-pediatric-transplantation-19071
https://atc.digitellinc.com/p/s/con-utilization-of-high-risk-donor-organs-for-pediatric-transplantation-19077
https://atc.digitellinc.com/p/s/pro-rebuttals-19083
https://atc.digitellinc.com/p/s/con-rebuttals-19089
https://atc.digitellinc.com/p/s/utilization-of-high-risk-donor-organs-for-pediatric-transplantation-19095
https://atc.digitellinc.com/p/s/uterus-transplantation-the-early-experience-19107
https://atc.digitellinc.com/p/s/pregnancy-outcomes-in-liver-and-kidney-donors-19113
https://atc.digitellinc.com/p/s/the-female-mechanical-circulatory-support-patient-special-considerations-19119
https://atc.digitellinc.com/p/s/management-of-symptom-burden-in-cirrhotic-patients-on-the-waitlist-19137
https://atc.digitellinc.com/p/s/obstacles-to-integrating-palliative-care-into-liver-transplantation-the-patient-the-caregiver-and-the-transplant-provider-from-a-transplant-hepatologists-perspective-19143
https://atc.digitellinc.com/p/s/strategies-to-integrate-palliative-care-in-liver-transplantation-from-the-palliative-care-doctors-perspective-19149
https://atc.digitellinc.com/p/s/the-abcs-of-immunosuppression-billing-in-the-ambulatory-care-setting-19161
https://atc.digitellinc.com/p/s/shifting-infusions-to-the-ambulatory-setting-challenges-and-advantages-19167
https://atc.digitellinc.com/p/s/utilizing-home-infusion-to-shorten-length-of-stay-and-prevent-readmissions-19173
https://atc.digitellinc.com/p/s/closed-loops-vs-outside-specialty-pharmacy-services-for-the-transplant-patient-19179
https://atc.digitellinc.com/p/s/pro-marijuana-is-not-the-gateway-drug-strategies-for-liver-transplant-candidates-in-legalized-states-19191
https://atc.digitellinc.com/p/s/con-sifting-through-the-weeds-marijuana-use-is-not-appropriate-for-liver-transplant-candidates-19197
https://atc.digitellinc.com/p/s/pro-rebuttals-19203
https://atc.digitellinc.com/p/s/con-rebuttals-19209
https://atc.digitellinc.com/p/s/pro-presumed-consent-19221
https://atc.digitellinc.com/p/s/con-presumed-consent-19227
https://atc.digitellinc.com/p/s/pro-rebuttals-19233
https://atc.digitellinc.com/p/s/con-rebuttals-19239
https://atc.digitellinc.com/p/s/kidney-19251
https://atc.digitellinc.com/p/s/liver-19257
https://atc.digitellinc.com/p/s/heart-19263
https://atc.digitellinc.com/p/s/lung-19269
https://atc.digitellinc.com/p/s/history-and-current-status-of-transplant-surgery-fellow-education-and-accreditation-19281
https://atc.digitellinc.com/p/s/development-of-and-current-status-of-type-2-cme-options-for-practicing-transplant-surgeons-19287
https://atc.digitellinc.com/p/s/the-tacc-where-are-we-going-in-training-the-next-generation-of-transplant-surgeons-19293
https://atc.digitellinc.com/p/s/cme-educating-and-re-certifying-ourselves-19299
https://atc.digitellinc.com/p/s/dysbiosis-in-liver-transplant-candidates-and-recipients-cause-or-effect-19311
https://atc.digitellinc.com/p/s/microbiome-as-a-risk-factor-for-post-transplant-metabolic-complications-19317
https://atc.digitellinc.com/p/s/intestinal-microbiome-as-a-target-for-prevention-and-treatment-of-multi-drug-resistant-infection-in-transplant-recipients-19323
https://atc.digitellinc.com/p/s/unique-features-of-composite-tissue-transplant-rejection-19335
https://atc.digitellinc.com/p/s/challenges-of-uterus-transplants-beyond-pregnancy-19341
https://atc.digitellinc.com/p/s/stem-cell-derived-organoids-in-kidney-transplantation-19347
https://atc.digitellinc.com/p/s/molecular-biomarkers-of-spontaneous-transplant-tolerance-19359
https://atc.digitellinc.com/p/s/molecular-biomarkers-of-induced-transplant-tolerance-19365
https://atc.digitellinc.com/p/s/phenotypic-and-functional-assessment-for-clinical-transplant-tolerance-19371
https://atc.digitellinc.com/p/s/the-national-landscape-of-living-kidney-donor-follow-up-in-the-united-states-19383
https://atc.digitellinc.com/p/s/the-srtr-living-donor-collective-pilot-a-scientific-registry-of-living-donors-19389
https://atc.digitellinc.com/p/s/international-perspectives-on-living-donor-follow-up-19395
https://atc.digitellinc.com/p/s/basic-science-19407
https://atc.digitellinc.com/p/s/translational-19413
https://atc.digitellinc.com/p/s/clinical-19419
https://atc.digitellinc.com/p/s/carfilzomib-and-belatacept-reduces-dsa-and-prolongs-survival-in-a-highly-sensitized-rhesus-model-of-kidney-transplantation-19455
https://atc.digitellinc.com/p/s/designing-novel-selective-immunoproteasome-inhibitors-reveals-a-critical-role-of-the-immunoproteasome-in-protecting-antibody-secreting-b-cells-from-apoptosis-19461
https://atc.digitellinc.com/p/s/depletion-resistant-effector-memory-t-cells-mediate-thymoglobulin-refractory-allograft-rejection-in-human-intestinal-transplant-recipients-19467
https://atc.digitellinc.com/p/s/superiority-of-early-everolimus-based-quadruple-immunosuppression-versus-standard-triple-therapy-after-lung-transplantation-12-months-results-from-prospective-4everlung-study-in-germany-19473
https://atc.digitellinc.com/p/s/mtorc2-deficiency-in-cd11c-plus-dendritic-cells-promotes-acute-kidney-injury-19485
https://atc.digitellinc.com/p/s/myeloid-derived-suppressor-cells-suppress-with-enhanced-donor-specificity-in-donor-ecdi-sp-treated-recipients-19491
https://atc.digitellinc.com/p/s/glycolytic-bias-in-mtorc2-deficient-dendritic-cells-potentiates-antigen-specific-immunity-and-accelerates-graft-rejection-19497
https://atc.digitellinc.com/p/s/origin-and-traffic-of-donor-derived-extracellular-vesicles-during-allo-sensitization-19503
https://atc.digitellinc.com/p/s/donor-deficiency-of-rip3-phosphokinase-activity-shortens-cardiac-allograft-survival-in-the-setting-of-costimulation-blockade-19509
https://atc.digitellinc.com/p/s/in-vivo-imaging-and-function-of-renal-tertiary-lymphoid-organs-19515
https://atc.digitellinc.com/p/s/dap12-and-its-triggering-co-receptor-trem2-play-key-roles-in-regulation-of-mouse-and-human-liver-dc-function-and-control-of-liver-ischemia-reperfusion-injury-19521
https://atc.digitellinc.com/p/s/an-effective-tolerance-approach-for-porcine-islet-xenotransplantation-in-humanized-mice-19533
https://atc.digitellinc.com/p/s/early-blockade-of-toll-like-receptor-4-reduces-ischemia-reperfusion-injury-and-improves-islet-transplantation-outcomes-19539
https://atc.digitellinc.com/p/s/ultra-low-dose-of-il-2-produces-long-term-drug-free-survival-of-cynomolgus-islets-allografts-19545
https://atc.digitellinc.com/p/s/nfkb-inhibitor-improves-glycemic-control-after-syngeneic-islet-transplantation-by-suppression-of-proinflammatory-and-apoptotic-gene-expression-in-a-cerulein-induced-pancreatitis-model-19551
https://atc.digitellinc.com/p/s/human-pancreatic-ecm-scaffolds-for-islet-culture-and-transplantation-19557
https://atc.digitellinc.com/p/s/identification-of-exosomal-isletokines-released-by-pancreatic-islets-in-response-to-inflammatory-stress-19563
https://atc.digitellinc.com/p/s/improvement-of-metabolic-function-after-intra-portal-allogeneic-islet-transplantation-by-induction-treatment-of-the-non-hematopoetic-erytropoetin-analogue-cibinetide-in-a-mouse-model-19569
https://atc.digitellinc.com/p/s/ischemia-reperfusion-injury-and-risk-for-antibody-mediated-rejection-abmr-in-hla-sensitized-patients-treated-with-c1-esterase-inhibitor-c1inh-19581
https://atc.digitellinc.com/p/s/anti-angiotensin-ii-type-1-receptor-antibodies-at1r-ab-induce-a-specific-phenotype-of-rejection-distinct-from-hla-antibody-mediated-rejection-19587
https://atc.digitellinc.com/p/s/five-year-outcomes-after-randomized-treatment-by-rituximab-in-early-acute-antibody-mediated-rejection-in-renal-transplantation-long-term-outcomes-of-the-ritux-erah-study-19593
https://atc.digitellinc.com/p/s/the-role-of-donor-derived-cell-free-dna-in-identification-of-injury-in-kidney-allografts-with-antibody-mediated-rejection-and-de-novo-dsa-19599
https://atc.digitellinc.com/p/s/mrna-transcript-profiles-of-14-genes-in-plasma-exosome-predict-risk-for-antibody-mediated-rejection-abmr-of-renal-allografts-19605
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-identifies-antibody-mediated-rejection-with-graft-injury-in-dsa-positive-kidney-transplant-recipients-19611
https://atc.digitellinc.com/p/s/pre-transplant-assessment-of-amr-risk-by-novel-donorrecipient-non-hla-variants-19617
https://atc.digitellinc.com/p/s/inflammatory-frailty-index-and-mortality-after-kidney-transplantation-19629
https://atc.digitellinc.com/p/s/predicting-survival-after-deceased-donor-kidney-transplants-by-donor-recipient-match-who-can-tolerate-a-high-kdpi-kidney-19635
https://atc.digitellinc.com/p/s/transplant-hospitals-increase-volumes-and-acceptance-rates-under-the-coiin-project-19641
https://atc.digitellinc.com/p/s/is-kdpi-valid-for-hepatitis-c-aviremic-kidneys-19647
https://atc.digitellinc.com/p/s/impact-of-the-new-kidney-allocation-system-a2a2b-gt-b-policy-on-access-to-transplantation-among-minority-candidates-19653
https://atc.digitellinc.com/p/s/two-years-of-the-hope-act-19659
https://atc.digitellinc.com/p/s/geographic-variation-in-deceased-donor-kidney-waitlist-deaths-after-declining-an-organ-offer-19665
https://atc.digitellinc.com/p/s/everolimus-with-reduced-dose-calcineurin-inhibitor-versus-mycophenolate-with-standard-dose-calcineurin-inhibitor-in-italicde-novoitalic-kidney-transplant-recipients-renal-function-results-from-the-tra-19677
https://atc.digitellinc.com/p/s/the-transform-study-infection-outcomes-with-everolimus-plus-reduced-calcineurin-inhibitor-and-mycophenolate-plus-standard-calcineurin-inhibitor-regimens-in-de-novo-kidney-transplant-recipients-19683
https://atc.digitellinc.com/p/s/effect-of-everolimus-with-reduced-calcineurin-inhibitor-on-efficacy-and-safety-in-de-novo-kidney-transplant-recipients-12-month-results-from-the-us-cohort-of-transform-study-19689
https://atc.digitellinc.com/p/s/simplified-once-daily-immunosuppressive-regimen-for-stable-kidney-recipients-19695
https://atc.digitellinc.com/p/s/the-athena-study-12-months-safety-and-efficacy-data-from-everolimus-combined-with-tacrolimus-or-cyclosporine-compared-to-a-standard-tacrolimus-mycophenolate-regimen-in-de-novo-kidney-transplant-patien-19701
https://atc.digitellinc.com/p/s/allograft-function-after-12-months-with-everolimus-plus-either-tacrolimus-or-cyclosporine-compared-to-a-standard-regimen-of-tacrolimus-with-mpa-in-de-novo-renal-transplant-recipients-the-athena-study-19707
https://atc.digitellinc.com/p/s/investigation-of-lower-treatment-failure-rate-seen-among-black-kidney-recipients-on-lcp-tacrolimus-vs-ir-tacrolimus-subgroup-analyses-of-two-phase-3-trials-19713
https://atc.digitellinc.com/p/s/introduction-of-direct-acting-antivirals-for-hcv-fewer-kidney-discards-but-a-long-way-to-go-19725
https://atc.digitellinc.com/p/s/mortality-and-kidney-transplantation-outcomes-among-chronic-dialysis-patients-who-are-seropositive-for-hepatitis-c-virus-19731
https://atc.digitellinc.com/p/s/use-of-hepatitis-c-treatments-after-kidney-transplantation-impact-of-the-direct-acting-antiviral-era-19737
https://atc.digitellinc.com/p/s/transplantation-of-kidneys-from-hepatitis-c-virus-hcv-antibody-ab-positive-nat-negative-donors-to-hcv-negative-patients-results-in-seroconversion-but-not-viral-transmission-19743
https://atc.digitellinc.com/p/s/the-thinker-trial-quality-of-life-results-at-6-and-12-month-follow-up-among-hepatitis-c-negative-patients-who-received-kidney-transplants-from-deceased-donors-with-hepatitis-c-infection-19749
https://atc.digitellinc.com/p/s/the-impact-of-rituximab-dose-on-hepatitis-b-virus-reactivation-in-hbsag-negativeanti-hbc-positive-kidney-transplant-recipients-19755
https://atc.digitellinc.com/p/s/impacts-of-hbsag-seropositive-status-on-patient-and-graft-survival-after-kidney-transplantation-in-the-era-of-new-antiviral-therapy-a-meta-analysis-19761
https://atc.digitellinc.com/p/s/potential-living-donors-identified-through-social-media-19773
https://atc.digitellinc.com/p/s/landscape-of-living-donor-kidney-transplantation-with-international-donors-in-the-united-states-19779
https://atc.digitellinc.com/p/s/the-altruistic-living-kidney-donor-phenotype-from-inquiry-to-donation-19785
https://atc.digitellinc.com/p/s/renal-function-blood-pressure-and-histologic-changes-in-living-kidney-transplant-recipients-from-hypertensive-donors-19791
https://atc.digitellinc.com/p/s/the-impact-of-age-matching-on-graft-function-and-graft-survival-after-living-donor-kidney-transplantation-19797
https://atc.digitellinc.com/p/s/estimated-gfr-at-donor-screening-and-achieved-measured-gfr-after-living-kidney-donation-19803
https://atc.digitellinc.com/p/s/factors-related-to-suboptimal-recovery-of-renal-function-after-living-donor-nephrectomy-19809
https://atc.digitellinc.com/p/s/eplet-mismatches-and-de-novo-donor-surface-antibody-development-in-pediatric-renal-transplant-recipients-19821
https://atc.digitellinc.com/p/s/inferior-patient-and-graft-survival-in-highly-sensitized-adult-kidney-transplant-recipients-with-a-prior-transplant-compared-to-pediatric-kidney-transplant-recipients-an-analysis-of-optn-data-19827
https://atc.digitellinc.com/p/s/epitopeeplet-mismatch-in-pediatric-renal-transplantation-and-development-of-donor-specific-antibody-19833
https://atc.digitellinc.com/p/s/safety-and-efficacy-of-tocilizumab-anti-il6r-tcz-therapy-in-the-treatment-of-chronic-antibody-mediated-rejection-cabmr-in-pediatric-renal-transplant-recipients-19839
https://atc.digitellinc.com/p/s/feasibility-of-a-national-class-ii-matching-strategy-for-pediatric-kidney-transplant-candidates-19845
https://atc.digitellinc.com/p/s/endothelin-1-type-a-receptor-antibodies-are-associated-with-elevated-il-8-arteritis-and-decline-in-renal-function-in-pediatric-renal-transplant-recipients-19851
https://atc.digitellinc.com/p/s/molecular-profiling-of-the-injury-repair-response-in-early-subclinical-inflammation-19857
https://atc.digitellinc.com/p/s/mtor-inhibition-with-everolimus-in-de-novo-living-donor-liver-transplantation-24-months-results-from-the-h2307-pivotal-trial-19869
https://atc.digitellinc.com/p/s/donor-specific-b-cell-tolerance-after-successful-abo-blood-type-incompatible-aboi-living-donor-liver-transplantation-ldlt-19875
https://atc.digitellinc.com/p/s/treatment-of-post-transplant-hepatitis-c-hcv-with-direct-acting-antiviral-daa-agents-may-improve-liver-function-but-does-not-lead-to-an-increase-in-liver-rejection-19881
https://atc.digitellinc.com/p/s/assessment-of-a-discharge-transplant-knowledge-quiz-and-its-impact-on-outcomes-in-liver-transplant-recipients-19887
https://atc.digitellinc.com/p/s/safety-of-antithymocyte-globulin-use-in-donation-after-circulatory-death-dcd-liver-transplantation-19893
https://atc.digitellinc.com/p/s/clinical-application-of-mesenchymal-stromal-cells-with-a-simplified-protocol-for-abo-incompatible-liver-transplantation-in-severe-hepatic-failure-patients-19899
https://atc.digitellinc.com/p/s/steroid-sparing-maintenance-immunosuppression-is-associated-with-decreased-mortality-after-simultaneous-liver-kidney-transplantation-19905
https://atc.digitellinc.com/p/s/hidden-risk-of-liver-transplantation-for-nonalcoholic-steatohepatitis-a-propensity-score-matched-study-19917
https://atc.digitellinc.com/p/s/opiate-use-trends-after-liver-transplantation-and-the-factors-associated-with-post-transplant-opiate-dependence-19923
https://atc.digitellinc.com/p/s/higher-early-post-liver-transplant-mortality-in-recipients-with-severe-alcoholic-hepatitis-versus-alcoholic-cirrhosis-19929
https://atc.digitellinc.com/p/s/intestinal-microbiome-diversity-is-associated-with-liver-disease-etiology-and-predicts-post-liver-transplant-mortality-19935
https://atc.digitellinc.com/p/s/evolving-trends-in-demographic-and-medical-characteristics-of-liver-transplant-recipients-19941
https://atc.digitellinc.com/p/s/complex-combined-thoracicliver-transplant-a-seven-year-experience-19947
https://atc.digitellinc.com/p/s/the-transplant-death-index-a-novel-method-to-identify-disenfranchised-liver-transplant-waitlist-candidates-19953
https://atc.digitellinc.com/p/s/impact-of-changes-to-the-las-calculation-19965
https://atc.digitellinc.com/p/s/molecular-phenotypes-of-injury-and-rejection-in-lung-transplant-transbronchial-biopsies-19971
https://atc.digitellinc.com/p/s/evlp-on-donor-lungs-national-trends-and-outcomes-19977
https://atc.digitellinc.com/p/s/increase-in-potentially-resistant-non-aspergillus-molds-isolated-in-lung-transplant-recipients-after-voriconazole-and-posaconazole-prophylaxis-19983
https://atc.digitellinc.com/p/s/survival-rates-of-patients-with-previous-cardiac-surgery-undergoing-lung-transplant-19989
https://atc.digitellinc.com/p/s/a-propensity-matched-survival-analysis-do-simultaneous-liver-lung-transplant-recipients-need-a-liver-19995
https://atc.digitellinc.com/p/s/prospective-trial-using-pulmonary-rehabilitation-to-treat-frailty-20001
https://atc.digitellinc.com/p/s/increased-pre-transplant-rejection-risk-measured-with-allospecific-t-cells-predicts-delayed-immunosuppression-minimization-in-children-with-intestine-transplantation-20013
https://atc.digitellinc.com/p/s/the-protective-effect-of-multivisceral-transplantation-on-intestinal-allograft-rejection-ndash-its-correlation-with-t-cell-macrochimerism-from-a-long-term-prospective-study-20019
https://atc.digitellinc.com/p/s/temporal-and-geographical-trends-of-intestinal-transplantation-in-the-usa-20025
https://atc.digitellinc.com/p/s/cd8-plus-tissue-resident-memory-t-cells-are-key-effector-cells-in-intestinal-transplantation-patients-with-gvhd-20031
https://atc.digitellinc.com/p/s/development-of-a-novel-assay-system-for-ex-vivo-t-cell-mediated-rejection-responses-in-intestinal-grafts-20037
https://atc.digitellinc.com/p/s/cytomegalovirus-cmv-infection-in-small-intestinal-and-multivisceral-transplant-recipients-the-role-of-donor-selection-on-cmv-incidence-and-outcomes-20043
https://atc.digitellinc.com/p/s/comparison-of-induction-and-maintenance-immunosuppression-regimens-in-intestinal-and-multivisceral-transplantation-an-analysis-of-the-unos-registry-20049
https://atc.digitellinc.com/p/s/the-role-of-cd46-in-early-islet-engraftment-in-a-dual-transplant-model-20061
https://atc.digitellinc.com/p/s/prevention-of-an-adaptive-immune-response-by-fda-approved-immunosuppressive-agents-in-baboons-with-pig-artery-patch-xenografts-20067
https://atc.digitellinc.com/p/s/human-thrombomodulin-expression-on-genetically-modified-donor-pigs-is-required-to-maintain-the-anti-coagulation-profile-20073
https://atc.digitellinc.com/p/s/hepcrhtbmhcd47ho-1-contributes-to-increased-survival-reduced-platelet-sequestration-and-modulation-of-coagulation-activation-in-galtkohcd46-porcine-livers-perfused-with-human-blood-20079
https://atc.digitellinc.com/p/s/islet-xenotransplantation-a-quest-for-clinically-available-immunosuppression-regimens-20085
https://atc.digitellinc.com/p/s/genetically-modified-porcine-erythrocytes-a-cell-model-for-studying-human-preformed-antibody-dependent-xenoimmune-responses-in-vitro-20091
https://atc.digitellinc.com/p/s/selection-and-stratification-of-anti-hla-a-and-hla-b-sensitized-patients-in-pig-to-human-xenotransplantation-20097
https://atc.digitellinc.com/p/s/kidney-transplant-rejection-is-associated-with-robust-and-prolonged-bioenergetic-reprogramming-and-metabolic-maladaptation-20109
https://atc.digitellinc.com/p/s/th17-and-nk-responses-are-differentially-induced-in-renal-allografts-according-to-recipient-murine-cytomegalovirus-dose-and-strain-20115
https://atc.digitellinc.com/p/s/type-i-nkt-cells-augment-humoral-and-cellular-alloimmunity-in-response-to-hepatocyte-transplantation-20121
https://atc.digitellinc.com/p/s/senolytic-drug-treatment-attenuates-mtdna-mediated-inflammatory-injury-in-old-donors-and-prolongs-cardiac-allograft-survival-20127
https://atc.digitellinc.com/p/s/graft-dendritic-cell-p40-homodimers-activate-donor-reactive-endogenous-memory-cd8-t-cells-within-higher-risk-allografts-20133
https://atc.digitellinc.com/p/s/vla-4-blockade-inhibits-early-endogenous-memory-cd8-t-cell-infiltration-into-higher-risk-cardiac-allografts-and-donor-reactive-t-cell-priming-20139
https://atc.digitellinc.com/p/s/hematopoietic-cell-kinase-hck-regulates-effector-and-regulatory-t-cell-treg-function-20145
https://atc.digitellinc.com/p/s/recurrent-fsgs-post-transplantation-prevalence-and-risk-factors-20157
https://atc.digitellinc.com/p/s/multicentre-epidemiological-study-on-prevalence-of-recurrent-glomerular-disease-post-transplantation-in-the-united-kingdom-20163
https://atc.digitellinc.com/p/s/recurrence-of-immunoglobulin-a-nephropathy-in-related-donor-kidney-transplant-recipients-20169
https://atc.digitellinc.com/p/s/iga-recurrence-in-a-single-center-with-a-protocol-biopsy-program-20175
https://atc.digitellinc.com/p/s/treatment-outcomes-of-recurrent-primary-focal-segmental-glomerulosclerosis-fsgs-after-kidney-transplantation-20181
https://atc.digitellinc.com/p/s/redo-kidney-transplant-in-fsgs-20187
https://atc.digitellinc.com/p/s/thirty-six-consecutive-kidney-transplants-in-recipients-with-atypical-hemolytic-uremic-syndrome-a-single-centre-experience-20193
https://atc.digitellinc.com/p/s/transplanting-kidneys-from-hcv-infected-donors-into-hcv-negative-recipients-longer-term-and-extended-results-of-the-thinker-trial-20205
https://atc.digitellinc.com/p/s/use-of-hcv-ab-plus-nat-donors-in-hcv-naive-renal-transplant-recipients-20211
https://atc.digitellinc.com/p/s/donor-derived-renal-cell-carcinoma-rcc-transmission-events-2008-2016-a-report-of-the-optn-disease-transmission-advisory-committee-dtac-20217
https://atc.digitellinc.com/p/s/the-benefit-of-higher-kdpi-renal-transplantation-over-waiting-for-a-better-offer-20223
https://atc.digitellinc.com/p/s/outcomes-of-dcd-renal-transplantation-from-donors-with-acute-kidney-injury-20229
https://atc.digitellinc.com/p/s/outcomes-analysis-of-liver-transplantation-combined-with-neoadjuvant-therapy-in-patients-with-unresectable-locally-advanced-cholangiocarcinoma-20235
https://atc.digitellinc.com/p/s/determining-the-relative-immunogenicity-of-hla-mismatches-with-calcineurin-inhibitor-immunosuppression-an-analysis-of-the-benefit-and-benefit-ext-renal-transplant-cohort-20241
https://atc.digitellinc.com/p/s/immunophenotype-of-cells-infiltrating-the-graft-explains-the-benefits-of-belatacept-20253
https://atc.digitellinc.com/p/s/the-best-trial-a-prospective-randomized-multicenter-trial-of-belatacept-based-cni-and-corticosteroid-free-immunosuppression-20259
https://atc.digitellinc.com/p/s/clinical-outcomes-of-conversion-from-calcineurin-inhibitor-to-belatacept-based-immunosuppression-in-highly-sensitized-kidney-transplant-recipients-20265
https://atc.digitellinc.com/p/s/belatacept-maintenance-immunosuppression-use-and-outcomes-in-the-real-world-clinical-setting-using-optnunos-kidney-transplant-registry-20271
https://atc.digitellinc.com/p/s/belatacept-in-kidney-transplant-recipients-with-preformed-donor-specific-anti-hla-antibodies-results-of-the-belacor-trial-20277
https://atc.digitellinc.com/p/s/tissue-talks-grafts-histological-findings-10-years-after-belatacept-or-cni-20283
https://atc.digitellinc.com/p/s/precision-medicine-for-determining-the-efficacy-of-a-novel-belatacept-regimen-20289
https://atc.digitellinc.com/p/s/cannabis-dependence-or-abuse-before-and-after-kidney-transplantation-implications-for-post-transplant-outcomes-20301
https://atc.digitellinc.com/p/s/marijuana-use-should-not-preclude-consideration-for-kidney-transplantation-20307
https://atc.digitellinc.com/p/s/outcome-implications-of-benzodiazepines-and-opioid-co-prescriptions-before-kidney-transplantation-20313
https://atc.digitellinc.com/p/s/risk-factors-for-chronic-opioid-use-after-kidney-transplantation-20319
https://atc.digitellinc.com/p/s/assessment-and-validation-of-potential-predictors-of-non-adherence-in-contemporary-kidney-transplant-recipients-20325
https://atc.digitellinc.com/p/s/prevalence-of-frailty-among-kidney-transplant-recipients-in-the-united-states-20331
https://atc.digitellinc.com/p/s/is-age-a-potential-barrier-to-pursuing-living-donor-kidney-transplant-ldkt-20337
https://atc.digitellinc.com/p/s/disparity-in-access-to-kidney-allograft-offers-among-hiv-plus-transplant-candidates-20349
https://atc.digitellinc.com/p/s/urinary-tract-infections-after-renal-transplantation-is-male-gender-a-risk-factor-for-resistant-microorganisms-20355
https://atc.digitellinc.com/p/s/clinical-outcomes-of-patients-with-bk-viremia-in-abo-incompatible-kidney-transplantation-and-comparison-with-abo-compatible-kidney-transplantation-20361
https://atc.digitellinc.com/p/s/kidney-transplant-patients-with-polycystic-kidney-disease-have-a-lower-risk-of-post-transplant-bk-infection-compared-to-other-causes-of-esrd-20367
https://atc.digitellinc.com/p/s/ciprofloxacin-for-bk-viremia-prophylaxis-in-kidney-transplant-recipients-results-of-a-prospective-randomized-controlled-trial-20373
https://atc.digitellinc.com/p/s/aggressive-immunosuppression-minimization-shortens-bk-viremia-does-not-improve-outcome-but-increases-the-risk-of-de-novo-donor-specific-antibodies-in-kidney-recipients-20379
https://atc.digitellinc.com/p/s/longitudinal-analysis-of-community-respiratory-virus-infection-in-kidney-transplant-recipients-20385
https://atc.digitellinc.com/p/s/evolving-etiologies-for-readmissions-and-their-impact-on-graft-survival-in-kidney-transplantation-20397
https://atc.digitellinc.com/p/s/use-of-proton-pump-inhibitors-is-associated-with-lower-magnesium-and-iron-status-and-excess-mortality-in-renal-transplant-recipients-20403
https://atc.digitellinc.com/p/s/metformin-use-after-kidney-transplantation-a-safe-option-in-carefully-selected-patients-20409
https://atc.digitellinc.com/p/s/gut-microbiota-mycophenolate-mofetil-and-post-transplant-diarrhea-in-kidney-transplant-recipients-20415
https://atc.digitellinc.com/p/s/aceiarb-use-within-one-year-of-kidney-transplant-is-associated-with-less-aki-and-graft-loss-in-older-recipients-20421
https://atc.digitellinc.com/p/s/secular-trends-in-the-medical-complexity-and-outcomes-of-medicare-insured-patients-undergoing-kidney-transplant-20427
https://atc.digitellinc.com/p/s/impact-of-elevated-psa-and-prostate-cancer-in-esrd-on-time-to-transplant-and-survival-20433
https://atc.digitellinc.com/p/s/delayed-graft-function-in-simultaneous-liver-kidney-transplantation-20445
https://atc.digitellinc.com/p/s/a-medical-decision-analysis-for-the-use-of-donation-after-cardiac-death-donors-for-simultaneous-liver-kidney-transplant-20451
https://atc.digitellinc.com/p/s/disparate-candidate-selection-practices-and-substantial-use-of-low-kdpi-kidneys-in-combined-heart-kidney-and-liver-kidney-transplantation-2012-2016-20457
https://atc.digitellinc.com/p/s/ischemia-reperfusion-injury-in-liver-transplantation-is-associated-with-acute-kidney-injury-role-of-inflammatory-mediators-20463
https://atc.digitellinc.com/p/s/influence-of-liver-allograft-steatosis-on-postoperative-acute-kidney-injury-20469
https://atc.digitellinc.com/p/s/factors-associated-with-the-development-of-chronic-kidney-disease-after-liver-transplantation-20475
https://atc.digitellinc.com/p/s/kidney-quality-influences-patient-and-graft-survival-in-liver-transplant-recipients-with-end-stage-renal-disease-20481
https://atc.digitellinc.com/p/s/discard-and-post-transplant-outcomes-associated-with-organs-donated-after-drug-overdose-death-20493
https://atc.digitellinc.com/p/s/kidney-registration-volume-vs-expectation-impact-of-esrd-burden-and-outreach-20499
https://atc.digitellinc.com/p/s/impact-of-local-liver-supply-on-liver-offer-acceptance-20505
https://atc.digitellinc.com/p/s/worsening-racialethnic-disparities-in-pediatric-kidney-transplant-outcomes-in-the-us-20511
https://atc.digitellinc.com/p/s/development-and-validation-of-a-socioeconomic-kidney-transplant-derailers-index-ktdi-20517
https://atc.digitellinc.com/p/s/race-income-and-insurance-status-predict-migration-for-liver-transplantation-in-the-united-states-20523
https://atc.digitellinc.com/p/s/the-impact-of-early-versus-late-clinical-outcomes-on-disparities-in-african-american-kidney-transplant-recipients-20529
https://atc.digitellinc.com/p/s/anti-tirc7-antibody-acts-synergistically-with-tacrolimus-in-promoting-graft-survival-in-a-rat-kidney-transplant-model-20541
https://atc.digitellinc.com/p/s/combination-proteasome-inhibition-and-anti-baff-therapy-permits-highly-sensitized-rhesus-kidney-transplantation-20547
https://atc.digitellinc.com/p/s/approaches-to-prevention-of-antibody-rebound-after-hla-sensitization-in-a-mouse-model-20553
https://atc.digitellinc.com/p/s/prolonged-graft-survival-in-old-recipients-is-abrogated-by-immunosuppressive-treatment-with-ctla4-ig-20559
https://atc.digitellinc.com/p/s/metabolic-therapy-as-a-platform-for-ctla4ig-costimulation-blockade-in-preventing-allograft-rejection-20565
https://atc.digitellinc.com/p/s/screening-of-rhoarock-inhibitors-for-the-ability-to-prevent-chronic-rejection-of-mouse-cardiac-allografts-20571
https://atc.digitellinc.com/p/s/alveolar-macrophages-derived-from-mcmv-latently-infected-donors-drives-the-viral-reactivation-and-dissemination-following-the-orthotopic-left-lung-transplantation-in-mice-20577
https://atc.digitellinc.com/p/s/comparing-outcomes-between-induction-immunosuppressive-therapies-in-simultaneous-heartkidney-transplantation-20589
https://atc.digitellinc.com/p/s/impact-of-infections-on-patients-with-left-ventricle-assist-deviceslvad-allo-sensitization-and-heart-transplantation-20595
https://atc.digitellinc.com/p/s/the-utility-of-a-cd31cd68-dual-immunohistochemical-stain-to-improve-accurate-diagnosis-of-antibody-mediated-rejection-in-cardiac-transplantation-20601
https://atc.digitellinc.com/p/s/outcomes-of-c4d-plus-immunostaining-in-heart-transplantation-is-all-immunologic-amr-bad-20607
https://atc.digitellinc.com/p/s/t-cell-mediated-rejection-poses-greater-risk-to-graft-survival-than-antibody-mediated-rejection-in-heart-transplants-20613
https://atc.digitellinc.com/p/s/elevated-serum-penteraxin-in-cardiac-allograft-antibody-mediated-rejection-from-cytokine-arrays-to-patients-with-abmr-20619
https://atc.digitellinc.com/p/s/high-frequency-of-hla-dq-de-novo-donor-specific-antibodies-is-independent-of-the-number-of-mismatches-in-heart-transplant-20625
https://atc.digitellinc.com/p/s/elevated-skin-specific-non-hla-antibodies-correlate-with-acute-rejection-episodes-in-clinical-vca-20637
https://atc.digitellinc.com/p/s/donor-bone-marrow-cxcr4-plus-foxp3-plus-treg-cells-are-essential-for-costimulation-blockade-induced-long-term-survival-of-murine-limb-transplants-20643
https://atc.digitellinc.com/p/s/outcomes-after-hiv-plus-kidney-transplant-a-hope-in-action-study-20649
https://atc.digitellinc.com/p/s/ctla4-ig-and-bortezomib-successfully-reverses-established-dsa-responses-in-allograft-sensitized-recipients-20661
https://atc.digitellinc.com/p/s/prevention-and-reversal-of-diabetes-through-restoration-of-b-and-t-cell-regulation-and-immune-homeostasis-20667
https://atc.digitellinc.com/p/s/dependency-on-cd4-t-cells-foreign-protein-and-cd22-for-generation-of-antibody-response-to-non-self-blood-group-a-antigen-in-a-mouse-model-20673
https://atc.digitellinc.com/p/s/b-cell-immune-repertoire-sequencing-identifies-pre-transplant-rejection-risk-20679
https://atc.digitellinc.com/p/s/ex-vivo-expanded-regulatory-b-cells-promote-allograft-survival-through-il-10-dependent-pathway-20685
https://atc.digitellinc.com/p/s/mitochondrial-autophagy-proteins-bnip3-and-nix-maintain-memory-b-cell-survival-20691
https://atc.digitellinc.com/p/s/aprilblys-blockade-improves-depletion-of-antibody-secreting-b-cells-compared-to-blys-blockade-alone-in-sensitized-murine-kidney-transplant-model-20697
https://atc.digitellinc.com/p/s/significant-anti-cmvbkv-effect-of-a-modern-everolimus-based-regimen-comparted-to-a-standard-tacrolimus-mpa-regimen-in-de-novo-kidney-transplant-recipients-athena-12-months-data-on-infections-20709
https://atc.digitellinc.com/p/s/cmv-specific-cell-mediated-immunity-after-valgancyclovir-prophylaxis-predicts-late-onset-cmv-infection-in-kidney-transplant-patients-20715
https://atc.digitellinc.com/p/s/kidney-transplant-allocation-with-cmv-seromatching-reduces-cmv-infection-without-affecting-wait-times-20721
https://atc.digitellinc.com/p/s/the-incidence-of-polyomavirus-bk-and-cytomegalovirus-infections-in-renal-transplant-recipients-following-rituximab-administration-20727
https://atc.digitellinc.com/p/s/prospective-multi-center-observational-study-of-cell-mediated-immunity-for-cytomegalovirus-infection-in-kidney-transplant-recipients-20733
https://atc.digitellinc.com/p/s/t-cell-depletion-does-not-increase-the-risk-of-cmv-infection-in-donor-positive-recipient-negative-kidney-transplants-due-to-the-absence-of-preformed-cmv-specific-cell-mediated-immunity-20739
https://atc.digitellinc.com/p/s/cmv-mismatch-still-negatively-affects-patient-and-graft-survival-in-the-era-of-cmv-prophylactic-and-preemptive-therapy-a-paired-kidney-analysis-20745
https://atc.digitellinc.com/p/s/improving-dcd-livers-graft-function-using-cd47-blockade-in-the-setting-of-normothermic-liver-perfusion-20757
https://atc.digitellinc.com/p/s/extra-renal-effects-of-estrogen-receptor-alpha-mediate-protection-from-renal-ischemia-reperfusion-injury-20763
https://atc.digitellinc.com/p/s/prolonged-cold-ischemia-storage-of-renal-allografts-shifts-dsa-specificity-and-enchances-glomerular-injury-20769
https://atc.digitellinc.com/p/s/circulating-exosomes-with-lung-self-antigens-kalpha1tubulin-and-collagen-v-and-immune-regulatory-proteins-in-lung-transplant-recipient-with-primary-graft-dysfunction-20775
https://atc.digitellinc.com/p/s/sirt1-ikaros-axis-promotes-macrophage-m2-polarization-and-protects-liver-graft-from-ischemia-reperfusion-injury-20781
https://atc.digitellinc.com/p/s/recipient-ho-1-deficiency-decreases-post-transplant-graft-ho-1-expression-and-exacerbates-liver-transplant-damage-20787
https://atc.digitellinc.com/p/s/recombinant-relaxin-protects-liver-transplants-from-ischemia-reperfusion-damage-via-hepatocyte-glucocorticoid-receptor-from-bench-to-bedside-20793
https://atc.digitellinc.com/p/s/the-first-series-of-ischemia-free-liver-transplantation-in-human-20805
https://atc.digitellinc.com/p/s/qpi-1002-a-sirna-targeting-p53-improvement-in-outcomes-following-acute-kidney-injury-aki-cardiac-surgery-to-aki-donors-20811
https://atc.digitellinc.com/p/s/normothermic-machine-perfusion-nmp-preservation-for-human-liver-transplantation-in-the-cleveland-clinic-20817
https://atc.digitellinc.com/p/s/pharmacological-defatting-of-steatotic-human-livers-using-a-novel-perfusion-solution-during-normothermic-machine-perfusion-20823
https://atc.digitellinc.com/p/s/one-pump-versus-two-pump-normothermic-ex-vivo-perfusion-machines-in-discarded-human-livers-20829
https://atc.digitellinc.com/p/s/extracellular-microvesicles-from-liver-perfusate-micrornas-cellular-cross-talk-and-early-post-liver-transplant-outcomes-20835
https://atc.digitellinc.com/p/s/resuscitation-and-viability-testing-of-initially-declined-livers-using-sequential-hypo-and-normothermic-machine-perfusion-with-an-acellular-fluid-20841
https://atc.digitellinc.com/p/s/bortezomib-in-late-antibody-mediated-kidney-transplant-rejection-a-double-blind-randomized-placebo-controlled-trial-borteject-study-20853
https://atc.digitellinc.com/p/s/tocilizumab-stabilizes-renal-function-in-kidney-transplant-recipients-with-chronic-active-antibody-mediated-rejection-caamr-20859
https://atc.digitellinc.com/p/s/extended-experience-using-tocilizumab-anti-il6r-tcz-for-the-treatment-of-chronic-antibody-mediated-rejection-cabmr-20865
https://atc.digitellinc.com/p/s/class-ii-anti-hla-igg2-and-igg3-dsas-predict-poorer-outcomes-in-chronic-antibody-mediated-rejection-of-renal-allografts-20871
https://atc.digitellinc.com/p/s/antibody-verified-eplet-mismatches-as-determinants-of-premature-kidney-transplant-loss-20877
https://atc.digitellinc.com/p/s/treatment-of-active-chronic-antibody-mediated-rejection-with-rituximab-ivig-and-plasma-exchange-20883
https://atc.digitellinc.com/p/s/inflammation-in-scarred-areas-i-ifta-is-a-reflection-of-parenchymal-injury-response-to-wounding-not-t-cell-mediated-rejection-20889
https://atc.digitellinc.com/p/s/alemtuzumab-is-associated-with-higher-rates-of-de-novo-donor-specific-antibody-dsa-in-patients-with-no-pre-transplant-dsa-20901
https://atc.digitellinc.com/p/s/decreased-long-term-survival-with-antithymocyte-globulin-induction-in-elderly-kidney-transplant-recipients-20907
https://atc.digitellinc.com/p/s/thymoglobulin-induction-in-hiv-positive-kidney-transplant-recipients-report-on-transplant-and-hiv-outcomes-20913
https://atc.digitellinc.com/p/s/effect-of-induction-therapy-on-cd4-cell-count-recovery-following-renal-transplantation-in-hiv-positive-recipients-a-single-center-experience-20919
https://atc.digitellinc.com/p/s/thymoglobulin-induction-decreases-risk-of-death-in-hla-sensitized-kidney-recipients-20925
https://atc.digitellinc.com/p/s/clinical-and-pathological-findings-in-hepatitis-c-positive-renal-transplant-recipients-following-alemtuzumab-induction-20931
https://atc.digitellinc.com/p/s/deceased-donor-urinary-biomarker-signature-and-the-effectiveness-of-peritransplant-lymphocyte-depletion-on-early-renal-allograft-function-20937
https://atc.digitellinc.com/p/s/nephrosclerosis-beyond-that-expected-for-age-is-predictive-of-early-new-onset-hypertension-htn-in-living-kidney-donors-lkd-20949
https://atc.digitellinc.com/p/s/prospective-double-blind-randomized-trial-comparing-the-use-of-ketorolac-and-lyrica-versus-soc-plus-placebo-during-live-donor-nephrectomy-for-transplant-20955
https://atc.digitellinc.com/p/s/trends-patterns-and-recipient-outcomes-of-kidney-transplants-from-older-gt60-living-donors-a-unos-database-analysis-20961
https://atc.digitellinc.com/p/s/donor-hypothermia-outcomes-in-living-kidney-transplantation-20967
https://atc.digitellinc.com/p/s/probability-of-developing-chronic-kidney-disease-1-year-after-living-donor-nephrectomy-correlates-with-baseline-kidney-volume-and-function-20973
https://atc.digitellinc.com/p/s/effects-of-a-multimodal-pain-control-regimen-in-living-donor-laparoscopic-nephrectomies-20979
https://atc.digitellinc.com/p/s/relationship-between-living-kidney-donor-follow-up-gfr-and-recipient-graft-loss-20985
https://atc.digitellinc.com/p/s/association-of-health-literacy-with-adverse-outcomes-among-kidney-transplant-candidates-and-recipients-20997
https://atc.digitellinc.com/p/s/validation-of-a-transplant-knowledge-quiz-and-its-impact-on-outcomes-in-kidney-transplant-recipients-21003
https://atc.digitellinc.com/p/s/modifiable-causes-of-racial-disparities-in-living-donor-kidney-transplant-21009
https://atc.digitellinc.com/p/s/non-medical-factors-predict-receipt-and-type-of-kidney-transplant-in-veterans-21015
https://atc.digitellinc.com/p/s/quality-of-social-support-network-and-access-to-transplant-what-matters-21021
https://atc.digitellinc.com/p/s/efficacy-of-at-home-transplant-education-on-transplant-knowledge-and-pursuit-in-low-income-and-black-dialysis-patients-with-varying-educational-characteristics-21027
https://atc.digitellinc.com/p/s/exercise-rehabilitations-effect-on-employment-and-school-rates-in-kidney-transplant-patients-21033
https://atc.digitellinc.com/p/s/assessment-and-outcomes-of-medication-nonadherence-in-pediatric-kidney-transplant-recipients-results-from-the-impact-study-21045
https://atc.digitellinc.com/p/s/are-donation-after-cardiac-death-dcd-kidneys-unsuitable-for-pediatric-recipients-21051
https://atc.digitellinc.com/p/s/low-kidney-supply-to-demand-ratio-and-multi-organ-transplant-centers-are-negatively-associated-with-pediatric-renal-transplant-rates-post-kidney-allocation-system-implementation-an-analysis-of-optn-da-21057
https://atc.digitellinc.com/p/s/bk-polyomavirus-bkpyv-specific-t-cells-as-a-diagnostic-and-prognostic-marker-for-bkpyv-infections-after-pediatric-kidney-transplantation-21063
https://atc.digitellinc.com/p/s/comparison-of-bmi-waist-circumference-and-waist-to-height-ratio-for-identification-of-cardiovascular-risk-in-pediatric-kidney-transplant-recipients-21069
https://atc.digitellinc.com/p/s/improved-renal-allograft-survival-for-pre-emptive-paediatric-renal-transplant-recipients-in-the-united-kingdom-21075
https://atc.digitellinc.com/p/s/isolated-pre-transplant-angiotensin-ii-type-i-receptor-antibodies-at1r-ab-are-not-associated-with-reduced-graft-function-or-hypertension-htn-in-pediatric-kidney-transplant-ped-ktx-patients-pts-21081
https://atc.digitellinc.com/p/s/clinical-implications-of-positive-crossmatch-in-liver-retransplants-21093
https://atc.digitellinc.com/p/s/the-impact-of-donor-specific-alloantibodies-on-long-term-outcomes-of-liver-re-transplantation-21099
https://atc.digitellinc.com/p/s/outcomes-in-liver-and-combined-liver-kidney-retransplantation-21105
https://atc.digitellinc.com/p/s/livers-from-donation-after-circulatory-death-donors-can-be-safely-used-for-retransplantation-21111
https://atc.digitellinc.com/p/s/retransplantation-after-living-donor-liver-transplantation-analysis-of-data-from-the-a2all-study-21117
https://atc.digitellinc.com/p/s/outcomes-of-pregnancies-in-female-liver-transplant-recipients-21123
https://atc.digitellinc.com/p/s/long-term-follow-up-of-patients-with-primary-sclerosing-cholangitis-undergoing-liver-transplantation-with-duct-to-duct-biliary-reconstruction-21129
https://atc.digitellinc.com/p/s/diagnostic-accuracy-of-non-invasive-test-of-hepatic-fibrosis-in-liver-transplant-recipients-21141
https://atc.digitellinc.com/p/s/impact-of-direct-acting-antiviral-agents-daas-for-hepatitis-c-virus-hcv-induced-liver-diseases-on-registration-and-outcome-on-waiting-list-wl-for-liver-transplant-lt-21147
https://atc.digitellinc.com/p/s/impact-of-direct-acting-antivirals-of-hepatitis-c-virus-therapy-on-tacrolimus-dosing-post-liver-transplant-21153
https://atc.digitellinc.com/p/s/private-insurance-is-associated-with-reduce-access-to-hcv-therapy-after-liver-transplantation-21159
https://atc.digitellinc.com/p/s/direct-acting-antiviral-therapy-immune-mediated-graft-dysfunction-in-liver-transplant-recipients-with-hepatitis-c-21165
https://atc.digitellinc.com/p/s/incidence-of-acute-cellular-rejection-in-liver-transplant-patients-receiving-direct-acting-antivirals-for-hepatitis-c-treatment-21171
https://atc.digitellinc.com/p/s/making-sense-of-hepatitis-b-reactivation-risk-in-anti-hbc-antibody-ab-positive-liver-transplant-recipients-21177
https://atc.digitellinc.com/p/s/impact-of-pre-transplant-dialysis-on-esrd-free-and-patient-survival-in-heart-transplant-alone-and-in-simultaneous-heartkidney-transplant-recipients-unos-data-analysis-21195
https://atc.digitellinc.com/p/s/analyzing-geographic-disparity-in-the-us-heart-allocation-system-21201
https://atc.digitellinc.com/p/s/geographic-variation-in-the-survival-benefit-of-heart-transplantation-21207
https://atc.digitellinc.com/p/s/waiting-for-the-optimal-donor-for-mcs-patients-awaiting-heart-transplant-21213
https://atc.digitellinc.com/p/s/providing-actual-echocardiographic-images-to-centers-markedly-increases-transplantation-of-deceased-donor-hearts-21219
https://atc.digitellinc.com/p/s/do-recent-heart-transplant-patients-need-to-reside-close-to-the-transplanting-center-a-look-at-the-impact-of-commuting-times-on-clinical-outcomes-21225
https://atc.digitellinc.com/p/s/increasing-use-of-exceptions-after-changes-to-pediatric-heart-allocation-21231
https://atc.digitellinc.com/p/s/enrichment-of-endogenous-donor-reactive-tregs-in-the-spleen-and-graft-during-transplantation-tolerance-is-the-result-of-treg-proliferation-and-conversion-from-tconv-21243
https://atc.digitellinc.com/p/s/differential-effects-of-inhibiting-glycolysis-on-human-treg-subsets-21249
https://atc.digitellinc.com/p/s/central-role-of-mef2-transcription-factors-in-regulation-of-foxp3-expression-and-treg-function-21255
https://atc.digitellinc.com/p/s/early-evolution-and-pathologic-characteristics-of-treg-rich-organized-lymphoid-structures-tols-associated-with-immunological-tolerance-in-accepted-mouse-kidney-allografts-21261
https://atc.digitellinc.com/p/s/the-mark-of-zorro-il35-coated-exosomes-cross-dress-and-exhaust-recipient-t-and-b-cells-during-transplant-tolerance-21267
https://atc.digitellinc.com/p/s/c5ar-regulates-myeloid-derived-suppressor-cells-mdscs-in-transplantation-21273
https://atc.digitellinc.com/p/s/cd4-plus-t-cells-are-key-barriers-to-tolerance-resistance-to-islet-allografts-in-autoimmune-nod-mice-21279
https://atc.digitellinc.com/p/s/outcomes-of-organ-transplantation-from-donors-with-cancer-history-21291
https://atc.digitellinc.com/p/s/a-novel-nomogram-based-approach-for-defining-the-effect-of-transplantation-on-cancer-recurrence-risk-21297
https://atc.digitellinc.com/p/s/organ-transplantation-associated-with-high-incidence-of-anal-cancer-and-pre-cancer-lesions-among-hiv-infected-women-and-men-21303
https://atc.digitellinc.com/p/s/prospective-analysis-of-ebv-plus-ptld-incidence-in-pediatric-transplant-recipients-in-the-modern-era-21309
https://atc.digitellinc.com/p/s/programmed-cell-death-ligand-1-pd-l1-expression-is-associated-with-subtypes-of-post-transplant-lymphoproliferative-disorders-ptld-21315
https://atc.digitellinc.com/p/s/detection-of-different-gene-expression-profiles-in-cd8-plus-t-cells-from-chronic-high-ebv-load-carriers-after-pediatric-heart-and-liver-transplantation-21321
https://atc.digitellinc.com/p/s/characterization-of-viral-and-host-cell-genomic-alterations-in-ebv-plus-ptld-21327
https://atc.digitellinc.com/p/s/transplant-surgeon-perspectives-on-general-surgery-in-transplant-recipients-21339
https://atc.digitellinc.com/p/s/robotic-pancreas-transplantation-in-obese-recipients-preliminary-results-21345
https://atc.digitellinc.com/p/s/simultaneous-versus-pretransplant-native-nephrectomy-in-autosomal-dominant-polycystic-kidney-disease-patients-21351
https://atc.digitellinc.com/p/s/variation-in-post-transplant-opiate-prescribing-patterns-across-transplant-centers-21357
https://atc.digitellinc.com/p/s/incisional-hernia-repair-after-abdominal-solid-organ-transplant-and-living-kidney-donation-a-single-institution-experience-21363
https://atc.digitellinc.com/p/s/post-reperfusion-portal-flow-rate-impacts-liver-allograft-and-patient-survival-in-patients-with-pre-transplant-portal-vein-thrombosis-21369
https://atc.digitellinc.com/p/s/comparison-of-three-approaches-for-laparoscopic-donor-nephrectomy-transvaginal-transumbilical-single-site-and-retroperitoneal-21375
https://atc.digitellinc.com/p/s/molecular-analysis-of-acute-cellular-rejection-in-clinical-face-transplants-21387
https://atc.digitellinc.com/p/s/histone-deacetylase-inhibition-mitigates-limb-ischemia-reperfusion-injury-21393
https://atc.digitellinc.com/p/s/first-birth-after-uterus-transplant-in-the-us-21399
https://atc.digitellinc.com/p/s/an-individualized-strategy-using-virus-and-immune-based-markers-to-prevent-cytomegalovirus-disease-after-face-transplantation-21405
https://atc.digitellinc.com/p/s/unsupervised-analysis-of-the-alloimmune-response-in-a-novel-model-of-vascularized-composite-allotransplantation-21411
https://atc.digitellinc.com/p/s/mechanisms-of-vascularized-bone-marrow-graft-protection-of-vascularized-composite-allografts-21417
https://atc.digitellinc.com/p/s/end-stage-renal-disease-after-face-transplant-21423
https://atc.digitellinc.com/p/s/containment-of-carbapenem-resistant-enterobacteriaceae-cre-infections-at-a-solid-organ-transplant-centre-21435
https://atc.digitellinc.com/p/s/risk-factors-and-outcomes-with-extended-spectrum-beta-lactamase-producing-enterobacteriaceae-bloodstream-infections-among-solid-organ-transplant-recipients-21441
https://atc.digitellinc.com/p/s/a-multi-center-analysis-of-risk-factors-for-pneumocystis-pneumonia-pcp-in-solid-organ-transplant-recipients-21447
https://atc.digitellinc.com/p/s/risk-factors-for-invasive-fungal-infections-among-lung-transplant-recipients-21453
https://atc.digitellinc.com/p/s/serum-cytokines-as-markers-of-influenza-infection-outcomes-after-transplantation-21459
https://atc.digitellinc.com/p/s/humoral-immune-response-to-seasonal-influenza-infection-in-transplant-recipients-21465
https://atc.digitellinc.com/p/s/brincidofovir-was-used-to-successfully-treat-adenovirus-infections-in-solid-organ-transplant-recipients-and-other-immunocompromised-patients-21471
https://atc.digitellinc.com/p/s/apoptotic-exosome-like-vesicles-induce-endothelial-cell-plasticity-21483
https://atc.digitellinc.com/p/s/endothelial-cell-heterogeneity-governs-basal-and-inducible-inflammatory-responses-relevant-to-allograft-injury-21489
https://atc.digitellinc.com/p/s/p16ink4a-deletion-in-vascular-endothelium-improves-kidney-regeneration-post-ischemia-reperfusion-injury-21495
https://atc.digitellinc.com/p/s/novel-function-of-tie2-in-immunoregulation-21501
https://atc.digitellinc.com/p/s/recombinant-thrombomodulin-alpha-attenuates-kidney-graft-damage-after-long-cold-ischemia-time-in-a-rat-kidney-transplant-model-21507
https://atc.digitellinc.com/p/s/rapamycin-impairs-human-endothelial-cell-alloimmunogenicity-independent-of-pd-1pd-1-ligand-inhibitory-signaling-21513
https://atc.digitellinc.com/p/s/dual-inhibition-of-pi3k-and-mtorc2-causes-erk-hyperactivation-induced-by-hla-ii-antibody-in-human-endothelium-21519
https://atc.digitellinc.com/p/s/endoplasmic-reticulum-stress-sensor-ire1alpha-deficiency-promotes-infiltrating-macrophage-polarization-and-induces-long-term-renal-allograft-acceptance-in-mice-21531
https://atc.digitellinc.com/p/s/targeted-donor-complement-blockade-after-brain-death-prevents-delayed-graft-function-but-not-progression-to-antibody-mediated-rejection-in-a-non-human-primate-model-of-kidney-allo-transplantation-21537
https://atc.digitellinc.com/p/s/linking-donor-ischemia-reperfusion-injury-iri-to-costimulatory-blockade-resistant-murine-heart-graft-rejection-through-complement-initiated-necroptosis-21543
https://atc.digitellinc.com/p/s/mertk-mediates-transplant-tolerance-via-ifn-a-regulation-of-mdscs-and-tregs-21549
https://atc.digitellinc.com/p/s/t-cell-expression-of-c5a-receptor-2-augments-murine-regulatory-t-cell-generation-and-regulatory-t-cell-dependent-cardiac-allograft-survival-21555
https://atc.digitellinc.com/p/s/identification-of-human-sirpa-diversity-that-could-regulate-innate-allorecognition-21561
https://atc.digitellinc.com/p/s/serelaxin-notch1-signaling-promotes-macrophage-m2-differentiation-and-alleviates-hepatocellular-damage-in-orthotopic-liver-transplantation-from-mouse-to-human-21567
https://atc.digitellinc.com/p/s/inflammation-in-fibrotic-areas-i-ifta-identifies-a-t-cell-mediated-rejection-component-of-ifta-with-poor-kidney-allograft-outcome-21579
https://atc.digitellinc.com/p/s/kidney-allograft-vascular-disease-post-transplant-ktx-risk-factors-and-implications-21585
https://atc.digitellinc.com/p/s/rna-seq-based-analysis-of-renal-allograft-biopsies-reveals-key-mediators-of-interstitial-fibrosistubular-atrophy-21591
https://atc.digitellinc.com/p/s/factor-analysis-fa-identifies-5-major-axes-of-kidney-transplant-biopsy-ktxbx-pathology-21597
https://atc.digitellinc.com/p/s/effect-of-acute-vascular-inflammation-v-on-death-censored-graft-failure-dcgf-following-kidney-transplant-ktx-21603
https://atc.digitellinc.com/p/s/factor-analysis-fa-of-renal-transplant-biopsy-ktxbx-data-enables-objective-assessment-of-risk-for-subsequent-death-censored-graft-failure-dcgf-21609
https://atc.digitellinc.com/p/s/thrombotic-microangiopathy-after-renal-transplantation-a-clinicopathological-study-and-identification-of-prognostic-factors-21615
https://atc.digitellinc.com/p/s/identifying-the-specific-causes-of-kidney-allograft-loss-a-population-based-study-21627
https://atc.digitellinc.com/p/s/population-based-modeling-of-prototypes-and-determinants-of-allograft-function-trajectories-after-kidney-transplantation-implications-for-patient-monitoring-and-risk-stratification-21633
https://atc.digitellinc.com/p/s/validation-of-an-integrative-and-dynamic-prognostic-score-for-response-to-therapy-in-solid-organ-transplants-21639
https://atc.digitellinc.com/p/s/improving-prediction-of-post-transplant-death-and-graft-loss-with-expanded-clinical-data-collection-21645
https://atc.digitellinc.com/p/s/can-immunosuppression-maintenance-after-renal-allograft-failure-prevent-further-sensitization-21651
https://atc.digitellinc.com/p/s/long-term-kidney-transplant-survival-after-deceased-donor-acute-kidney-injury-21657
https://atc.digitellinc.com/p/s/predictors-of-graft-survival-at-the-time-of-a-kidney-transplant-indication-biopsy-21663
https://atc.digitellinc.com/p/s/a-follow-up-report-on-the-use-of-ivig-plus-rituximab-to-reduce-donor-specific-antibodies-and-improve-transplant-rates-in-highly-sensitized-patients-awaiting-deceased-donor-kidney-transplantation-21675
https://atc.digitellinc.com/p/s/effects-of-ides-on-hla-sab-c1q-sab-and-cdc-xm-21681
https://atc.digitellinc.com/p/s/modified-dfpp-can-eliminate-donor-reactive-igg-antibody-with-preserving-fibrinogen-before-kidney-transplantation-21687
https://atc.digitellinc.com/p/s/how-safe-is-crossing-the-abo-blood-group-barrier-a-meta-analysis-to-determine-the-additive-risk-of-abo-incompatible-kidney-transplantation-21693
https://atc.digitellinc.com/p/s/pilot-study-of-plasma-cell-niche-targeted-therapy-for-enhancement-of-proteasome-inhibitor-effectiveness-21699
https://atc.digitellinc.com/p/s/preformed-donor-reactive-t-cells-that-persist-after-abo-desensitization-independently-predict-severe-acute-cellular-rejection-after-living-donor-kidney-transplantation-21705
https://atc.digitellinc.com/p/s/impact-of-the-new-kas-on-transplant-rates-in-highly-hla-sensitized-hs-patients-after-desenstization-des-3yrs-post-implementation-21711
https://atc.digitellinc.com/p/s/morbidity-outcomes-in-live-kidney-donors-in-the-uk-15-year-compartive-cohort-study-21723
https://atc.digitellinc.com/p/s/familial-risk-of-end-stage-renal-disease-in-healthy-live-kidney-donors-21729
https://atc.digitellinc.com/p/s/mortality-and-esrd-in-older-live-kidney-donors-with-hypertension-21735
https://atc.digitellinc.com/p/s/long-term-renal-and-patient-risks-for-living-kidney-donors-21741
https://atc.digitellinc.com/p/s/pre-donation-body-mass-index-associations-with-outcomes-in-living-kidney-donors-a-single-centre-experience-21747
https://atc.digitellinc.com/p/s/post-donation-egfr-levels-predicts-new-onset-antihypertensive-medication-use-after-living-kidney-donation-21753
https://atc.digitellinc.com/p/s/pre-donation-egfr-early-post-donation-egfr-and-subsequent-esrd-risk-in-living-kidney-donors-21759
https://atc.digitellinc.com/p/s/antihypertensive-medication-use-after-kidney-transplant-practice-variation-and-clinical-outcomes-21771
https://atc.digitellinc.com/p/s/prevention-of-new-onset-diabetes-after-transplantation-using-bariatric-surgery-21777
https://atc.digitellinc.com/p/s/kidney-transplantation-and-progression-of-peripheral-arterial-disease-in-the-ipsilateral-lower-extremity-21783
https://atc.digitellinc.com/p/s/new-onset-diabetes-after-kidney-transplant-comparisons-of-risks-associated-with-various-steroid-containing-calcineurin-inhibitor-and-sirolimus-regimens-21789
https://atc.digitellinc.com/p/s/a-novel-score-for-predicting-mortality-and-graft-failure-after-kidney-transplant-21795
https://atc.digitellinc.com/p/s/frailty-assessment-pilot-study-in-older-kidney-transplant-recipients-21801
https://atc.digitellinc.com/p/s/the-effect-of-perioperative-antiplateletanticoagulant-therapy-on-the-incidence-of-early-postoperative-thromboembolic-complications-and-bleeding-in-kidney-transplantation-a-dual-center-retrospective-co-21807
https://atc.digitellinc.com/p/s/robotic-assisted-live-donor-kidney-transplantation-technique-and-outcomes-21819
https://atc.digitellinc.com/p/s/vesicoureteral-reflux-after-kidney-transplantation-influences-long-term-graft-survival-21825
https://atc.digitellinc.com/p/s/robotic-kidney-transplantation-in-obese-recipients-the-new-standard-21831
https://atc.digitellinc.com/p/s/impact-of-the-differences-between-body-mass-index-of-recipient-and-donor-in-a-population-of-robotic-kidney-transplant-21837
https://atc.digitellinc.com/p/s/use-of-surgically-placed-transversus-abdominis-plane-tap-block-catheter-with-local-anesthetic-infusion-in-renal-transplantation-21843
https://atc.digitellinc.com/p/s/novel-vascular-inflow-offers-renal-transplantation-to-recipients-with-severe-central-and-peripheral-vascular-disease-21849
https://atc.digitellinc.com/p/s/do-reconstruction-techniques-for-two-renal-arteries-affect-long-term-graft-survival-after-living-donor-renal-transplantation-21855
https://atc.digitellinc.com/p/s/the-predictive-power-of-meld-is-decreasing-in-the-era-of-older-sicker-patients-21867
https://atc.digitellinc.com/p/s/accepting-a-dcd-liver-may-improve-patient-survival-compared-to-waiting-for-a-non-dcd-liver-21873
https://atc.digitellinc.com/p/s/a-novel-dropout-risk-score-in-hepatocellular-carcinoma-hcc-patients-listed-for-liver-transplant-lt-identifying-a-threshold-that-predicts-worse-post-lt-survival-in-short-wait-regions-21879
https://atc.digitellinc.com/p/s/health-and-economic-disparities-in-waitlist-access-and-liver-distribution-policy-21885
https://atc.digitellinc.com/p/s/estimation-of-mortality-on-the-wait-list-21891
https://atc.digitellinc.com/p/s/deceased-pediatric-donor-livers-how-current-policy-drives-allocation-and-transplantation-21897
https://atc.digitellinc.com/p/s/development-and-validation-of-flf-transplant-score-to-predict-mortality-of-status-1a-candidates-21903
https://atc.digitellinc.com/p/s/anticoagulation-in-pediatric-liver-transplantation-the-pros-and-cons-21915
https://atc.digitellinc.com/p/s/survival-benefit-of-partial-grafts-in-pediatric-candidates-with-acute-liver-failure-awaiting-liver-transplantation-srtr-analysis-over-26-years-21921
https://atc.digitellinc.com/p/s/frequency-of-whole-organ-in-lieu-of-split-liver-transplantation-over-the-last-decade-children-experienced-increased-wait-time-and-death-21927
https://atc.digitellinc.com/p/s/geographic-disparity-in-access-to-deceased-donor-liver-transplantation-for-pediatric-candidates-21933
https://atc.digitellinc.com/p/s/outcomes-of-pediatric-donor-liver-grafts-for-adult-transplantation-a-national-analysis-21939
https://atc.digitellinc.com/p/s/should-more-donation-after-cardiac-death-livers-be-used-in-pediatric-transplantation-21945
https://atc.digitellinc.com/p/s/t-cell-exhaustion-contributes-to-operational-tolerance-of-liver-allografts-in-pediatric-liver-transplant-recipients-21951
https://atc.digitellinc.com/p/s/the-stunning-rise-in-organ-donors-deceased-from-drug-overdose-21963
https://atc.digitellinc.com/p/s/the-financial-impact-of-the-opioid-epidemic-on-kidney-transplantation-readmissions-21969
https://atc.digitellinc.com/p/s/economic-evaluation-of-contemporary-kidney-transplant-practice-21975
https://atc.digitellinc.com/p/s/cost-effectiveness-of-hepatitis-c-positive-donor-kidney-transplantation-for-hepatitis-c-negative-recipients-with-concomitant-direct-acting-anti-viral-therapy-21981
https://atc.digitellinc.com/p/s/improved-opo-performance-drives-broader-organ-sharing-in-the-united-states-21987
https://atc.digitellinc.com/p/s/demographic-and-geographic-differences-in-the-proportion-of-liver-disease-deaths-captured-by-the-transplant-waitlist-in-the-united-states-2011-2015-21993
https://atc.digitellinc.com/p/s/consequences-of-being-listed-at-a-small-pancreas-program-22005
https://atc.digitellinc.com/p/s/obesity-is-not-associated-with-worse-outcomes-for-type-2-diabetic-simultaneous-pancreas-kidney-spk-transplant-recipients-22011
https://atc.digitellinc.com/p/s/major-adverse-cardiovascular-events-following-simultaneous-pancreas-and-kidney-transplantation-a-study-of-the-united-kingdom-transplant-registry-22017
https://atc.digitellinc.com/p/s/pancreas-transplant-alone-pta-outcome-is-best-in-brittle-diabetic-patients-without-advanced-nephropathy-22023
https://atc.digitellinc.com/p/s/declining-number-of-pancreas-after-kidney-transplants-despite-significant-improvement-in-outcome-22029
https://atc.digitellinc.com/p/s/pancreas-transplant-in-the-elderly-patient-should-it-be-done-22035
https://atc.digitellinc.com/p/s/pancreas-graft-function-10-years-the-cumulative-us-experience-22041
https://atc.digitellinc.com/p/s/cognition-and-self-management-in-liver-transplant-recipients-22053
https://atc.digitellinc.com/p/s/risk-factors-for-chronic-opioid-use-after-liver-transplantation-22059
https://atc.digitellinc.com/p/s/medication-adherence-does-where-you-live-matter-22065
https://atc.digitellinc.com/p/s/digital-enabled-refills-and-medication-adherence-among-transplant-recipients-22071
https://atc.digitellinc.com/p/s/development-of-an-individualized-online-shared-decision-making-tool-for-kidney-transplant-candidates-22077
https://atc.digitellinc.com/p/s/information-needs-of-adolescent-transplant-recipients-transitioning-to-adult-care-22083
https://atc.digitellinc.com/p/s/using-the-explore-transplant-ontario-program-to-increase-transplant-knowledge-and-readiness-among-patients-on-maintenance-dialysis-22089
https://atc.digitellinc.com/p/s/deceased-donor-initiated-kidney-transplant-exchanges-and-the-forgotten-incompatible-directed-donor-recipients-22101
https://atc.digitellinc.com/p/s/the-ethical-turmoil-of-imminent-death-donation-22107
https://atc.digitellinc.com/p/s/living-liver-donor-follow-up-fewer-than-half-of-centers-meet-follow-up-requirements-in-the-us-22113
https://atc.digitellinc.com/p/s/legal-status-criminal-history-and-substance-use-in-listing-decisions-22119
https://atc.digitellinc.com/p/s/trends-and-policy-influences-on-multiple-listing-practices-for-kidney-transplantation-between-2000-and-2017-22125
https://atc.digitellinc.com/p/s/lab-turnaround-times-a-performance-improvement-project-in-post-kidneypancreas-transplant-clinic-22131
https://atc.digitellinc.com/p/s/taking-your-centers-temperature-using-a-heat-map-to-target-your-transplant-specific-education-for-regulatory-compliance-22137
https://atc.digitellinc.com/p/s/ablation-of-irf4-induces-transplant-tolerance-by-driving-intrinsic-t-cell-dysfunction-22149
https://atc.digitellinc.com/p/s/alloreactive-b-cells-acquire-cell-intrinsic-hyporesponsiveness-in-tolerant-recipients-22155
https://atc.digitellinc.com/p/s/acquired-resistance-to-transplantation-tolerance-as-a-result-of-prior-pregnancy-requires-b-cells-22161
https://atc.digitellinc.com/p/s/identification-of-anti-inflammatory-and-pro-inflammatory-gut-microbiota-that-determine-graft-survival-22167
https://atc.digitellinc.com/p/s/transplantation-tolerance-prevents-cmv-reactivation-and-preserves-kidney-allograft-function-in-a-d-plus-r-transplant-setting-22173
https://atc.digitellinc.com/p/s/enhancement-of-intrinsic-apoptosis-via-bcl-2-inhibition-promotes-induction-of-robust-mixed-chimerism-and-renal-allograft-tolerance-without-myelosuppression-in-nonhuman-primates-22179
https://atc.digitellinc.com/p/s/robust-hematopoietic-mixed-chimerism-and-donor-specific-skin-allograft-tolerance-after-non-genotoxic-anti-cd117-immunotoxin-conditioning-and-donor-bone-marrow-allotransplantation-22185
https://atc.digitellinc.com/p/s/activity-nanosensors-for-early-and-noninvasive-detection-of-acute-organ-transplant-rejection-22197
https://atc.digitellinc.com/p/s/cfz533-a-new-anti-cd40-mab-demonstrates-comparable-efficacy-and-better-renal-function-versus-tacrolimus-in-de-novo-cni-free-kidney-transplantation-22203
https://atc.digitellinc.com/p/s/superior-outcomes-using-normothermic-regional-perfusion-in-cdcd-liver-transplantation-22209
https://atc.digitellinc.com/p/s/risk-of-esrd-in-prior-living-kidney-donors-22215
https://atc.digitellinc.com/p/s/t-cell-exhaustion-in-kidney-transplant-patients-22227
https://atc.digitellinc.com/p/s/single-cell-analysis-of-graft-infiltrating-t-cells-in-cardiac-allograft-vasculopathy-22233
https://atc.digitellinc.com/p/s/donor-reactive-eomesdermin-cd8-plus-t-cells-are-significantly-upregulated-early-after-transplant-in-kidney-transplant-patients-without-rejection-22239
https://atc.digitellinc.com/p/s/a-transcriptomic-signature-in-pbmc-from-kidney-transplant-recipients-at-baseline-predicts-early-acute-rejection-22245
https://atc.digitellinc.com/p/s/allogeneic-t-follicular-and-t-conventional-responses-assessed-by-proliferation-cytokine-production-and-tcr-clonality-22251
https://atc.digitellinc.com/p/s/pro-inflammatory-b-cells-predict-progressive-minimal-early-renal-allograft-inflammation-which-is-associated-with-poor-graft-outcomes-22257
https://atc.digitellinc.com/p/s/molecular-assessment-of-pre-implantation-donor-biopsies-effects-of-prolonged-cold-ischemia-time-and-development-of-delayed-graft-function-22263
https://atc.digitellinc.com/p/s/respiratory-viral-infections-induces-exosomes-and-antibodies-to-lung-self-antigens-kalpha1tubulin-and-collagen-v-following-human-lung-transplantation-22275
https://atc.digitellinc.com/p/s/il-17-is-critical-for-airway-epithelial-injury-after-transplantation-22281
https://atc.digitellinc.com/p/s/upregulated-il-33-in-heart-transplants-modulates-local-myeloid-populations-to-protect-against-chronic-allograft-rejection-22287
https://atc.digitellinc.com/p/s/cd40-signaling-in-proximal-tubules-regulates-fibrosis-in-both-hypertension-and-chronic-allograft-rejection-22293
https://atc.digitellinc.com/p/s/macrophage-depletion-of-rcmv-latently-infected-allografts-ameliorates-accelerated-chronic-cardiac-rejection-22299
https://atc.digitellinc.com/p/s/il-21-regulates-creation-of-tertiary-lymphoid-organs-in-chronic-allograft-rejection-22305
https://atc.digitellinc.com/p/s/donor-specific-antibody-mediates-chronic-but-not-acute-kidney-allograft-rejection-in-the-absence-of-natural-killer-cells-22311
https://atc.digitellinc.com/p/s/liver-stiffness-measurement-but-not-controlled-attenuation-parameter-is-increased-in-deceased-liver-donors-at-the-time-of-transplant-procurement-22323
https://atc.digitellinc.com/p/s/causes-of-death-among-deceased-donors-22329
https://atc.digitellinc.com/p/s/donor-liver-apoptosis-is-associated-with-early-allograft-dysfunction-and-short-time-graft-survival-after-liver-transplantation-22335
https://atc.digitellinc.com/p/s/unraveling-the-neuroimmunological-pathways-surrounding-brain-death-systematic-study-of-clinically-relevant-serum-biomarker-changes-during-donor-management-from-admission-to-procurement-22341
https://atc.digitellinc.com/p/s/examples-of-the-observer-effect-in-transplantation-unintended-consequences-of-regulation-and-selected-outcome-metrics-22347
https://atc.digitellinc.com/p/s/skeletons-in-the-closet-an-insight-into-donor-liver-discards-in-the-us-22353
https://atc.digitellinc.com/p/s/trends-in-liver-transplantation-with-older-liver-donors-in-the-united-states-22359
https://atc.digitellinc.com/p/s/parsing-the-100-percent-cpra-kidney-transplant-candidates-who-gets-transplanted-22371
https://atc.digitellinc.com/p/s/impact-of-the-kidney-allocation-system-on-young-pediatric-recipients-22377
https://atc.digitellinc.com/p/s/impact-of-kdpi-and-cpra-on-outcomes-in-kidney-transplant-recipients-22383
https://atc.digitellinc.com/p/s/estimated-impact-of-the-number-of-simultaneous-offers-on-kidney-delay-and-discard-22389
https://atc.digitellinc.com/p/s/multi-organ-m-o-prioritization-of-kidneys-time-for-policy-modification-22395
https://atc.digitellinc.com/p/s/optimizing-outcomes-with-a-collaborative-approach-after-kidney-transplant-in-hepatitis-c-positive-recipients-receiving-hepatitis-c-positive-grafts-22401
https://atc.digitellinc.com/p/s/no-kidney-left-behind-are-we-maximizing-utilization-of-deceased-donors-with-aki-22407
https://atc.digitellinc.com/p/s/early-steroid-withdrawal-and-kidney-transplant-outcomes-for-recipients-with-delayed-graft-function-22419
https://atc.digitellinc.com/p/s/impact-of-rapid-discontinuation-of-prednisone-on-kidney-transplant-outcomes-in-at-risk-subpopulations-an-optnsrtr-analysis-22425
https://atc.digitellinc.com/p/s/clinical-impact-of-denovo-or-recurrent-donor-specific-antibodies-in-the-first-year-post-kidney-transplant-in-patients-on-early-steroid-withdrawal-immunosupression-regimen-22431
https://atc.digitellinc.com/p/s/prevalence-and-impact-of-cyp3a5-genomic-variances-on-clinical-outcomes-among-african-american-kidney-transplant-recipients-22437
https://atc.digitellinc.com/p/s/time-in-therapeutic-range-predicts-dsa-development-and-acute-rejection-in-kidney-recipients-with-high-tacrolimus-coefficient-of-variation-22443
https://atc.digitellinc.com/p/s/tacrolimus-metabolism-in-subjects-with-potentially-absent-cyp3a-activity-22449
https://atc.digitellinc.com/p/s/development-of-denovo-dsa-after-one-year-post-kidney-transplant-and-clinical-outcomes-in-patient-on-steroid-free-immunosupression-22455
https://atc.digitellinc.com/p/s/natural-history-and-determinants-of-infectious-complications-after-kidney-transplantation-a-nationwide-prospective-population-based-cohort-22467
https://atc.digitellinc.com/p/s/gut-microbiota-dysbiosis-is-an-independent-risk-factor-for-development-of-urinary-tract-infections-in-kidney-transplantation-22473
https://atc.digitellinc.com/p/s/cell-free-dna-sequencing-for-diagnosing-infections-estimating-growth-rates-and-characterizing-antibiotic-resistomes-in-urine-supernatants-22479
https://atc.digitellinc.com/p/s/proton-pump-inhibitor-utilization-is-associated-with-higher-rates-of-italicclostridium-difficileitalic-infection-and-hypomagnesemia-after-kidney-transplant-22485
https://atc.digitellinc.com/p/s/pneumocystis-jiroveci-pneumonia-pjp-in-kidney-and-pancreas-transplant-recipients-in-the-present-era-of-routine-post-transplant-prophylaxis-risk-factors-and-outcomes-22491
https://atc.digitellinc.com/p/s/the-etiologies-and-impact-of-hospitalization-in-older-kidney-transplant-recipients-22497
https://atc.digitellinc.com/p/s/frailty-is-predictive-of-early-post-transplant-infection-in-older-renal-transplant-recipients-22503
https://atc.digitellinc.com/p/s/the-first-9-years-of-kpd-through-the-national-kidney-registry-characteristics-of-donors-and-recipients-compared-to-national-transplant-registries-22515
https://atc.digitellinc.com/p/s/temporal-changes-in-the-characteristics-and-sensitization-of-kidney-paired-donation-registrants-22521
https://atc.digitellinc.com/p/s/the-advantage-of-utilizing-abo-and-hla-compatible-pairs-in-kidney-paired-donation-22527
https://atc.digitellinc.com/p/s/early-considerations-for-deceased-donor-chains-22533
https://atc.digitellinc.com/p/s/400-kidney-paired-donor-transplants-at-a-single-center-the-methodist-san-antonio-experience-22539
https://atc.digitellinc.com/p/s/early-graft-losses-in-national-pke-programs-gone-but-lost-forever-22545
https://atc.digitellinc.com/p/s/what-deceased-donors-do-kpd-candidates-accept-22551
https://atc.digitellinc.com/p/s/non-invasive-diagnostic-of-renal-allograft-rejection-via-urine-metabolites-using-nmr-spectroscopy-22563
https://atc.digitellinc.com/p/s/unique-gene-expression-signatures-in-urine-distinguish-bk-virus-nephropathy-from-acute-rejection-in-kidney-transplant-patients-with-graft-dysfunction-22569
https://atc.digitellinc.com/p/s/identification-of-noninvasive-and-mechanistically-informative-biomarkers-predictive-of-reversal-of-acute-cellular-rejection-acr-in-kidney-allografts-22575
https://atc.digitellinc.com/p/s/validating-molecular-microscope-readings-and-estimating-agreement-with-histology-22581
https://atc.digitellinc.com/p/s/early-microcirculation-inflammation-associated-with-tcmr-leads-to-poor-graft-outcomes-in-kidney-transplant-recipients-ktrs-22587
https://atc.digitellinc.com/p/s/inflammation-in-scarred-areas-i-ifta-defining-the-response-to-standard-treatment-of-t-cell-mediated-rejection-in-kidney-recipients-22593
https://atc.digitellinc.com/p/s/il-6-inhibition-with-tocilizumab-to-promote-tregs-and-control-renal-graft-inflammation-a-prospective-randomized-controlled-trial-22599
https://atc.digitellinc.com/p/s/the-risk-factors-of-acute-rejection-in-patients-with-bk-nephropathy-after-the-reduction-of-immunosuppression-22611
https://atc.digitellinc.com/p/s/medullary-tissue-sampling-in-renal-allograft-biopsy-is-more-sensitive-for-pathologic-diagnosis-of-pvn-22617
https://atc.digitellinc.com/p/s/intragraft-gene-expression-differentiates-polyomavirus-nephropathy-from-t-cell-mediated-rejection-22623
https://atc.digitellinc.com/p/s/diagnostic-value-and-confounding-factors-of-urinary-biomarkers-in-the-non-invasive-screening-of-renal-allograft-inflammation-22629
https://atc.digitellinc.com/p/s/viral-specific-cytotoxic-t-cell-viral-tc-responses-in-highly-hla-sensitized-patients-hs-maintained-on-tacrolimus-and-everolimus-post-hlai-kidney-transplant-22635
https://atc.digitellinc.com/p/s/comparison-of-recipients-with-early-and-late-presenting-polyomavirus-nephropathy-pvn-with-regard-to-histological-findings-and-graft-survival-what-is-the-influence-of-cd4cd8-ratio-on-the-presenting-tim-22641
https://atc.digitellinc.com/p/s/origin-and-pattern-of-human-polyomaviruses-replication-after-kidney-transplantation-a-prospective-study-22647
https://atc.digitellinc.com/p/s/impact-of-donor-hepatectomy-time-during-organ-procurement-in-donation-after-circulatory-death-liver-transplantation-the-united-kingdom-experience-22659
https://atc.digitellinc.com/p/s/liver-transplant-survival-index-for-recipients-with-high-meld-score-a-model-for-post-transplant-survival-in-severely-ill-patients-22665
https://atc.digitellinc.com/p/s/intentional-transplantation-of-hepatitis-c-positive-livers-into-hepatitis-negative-recipients-report-of-the-first-case-series-in-the-world-22671
https://atc.digitellinc.com/p/s/are-deceased-donor-characteristics-associated-with-liver-graft-failure-among-low-meld-patients-receiving-a-liver-transplant-changing-22677
https://atc.digitellinc.com/p/s/balloon-occluded-retrograde-transvenous-obliteration-brto-for-the-treatment-of-medically-refractory-hepatic-encephalopathy-he-in-patients-with-esld-and-significant-portal-venous-shunting-22683
https://atc.digitellinc.com/p/s/donation-after-circulatory-death-donor-liver-transplantation-without-ischemic-cholangiopathy-is-it-time-to-expand-dcd-liver-donor-pool-22689
https://atc.digitellinc.com/p/s/liver-transplantation-using-pediatric-versus-adult-donor-grafts-in-adult-recipients-22695
https://atc.digitellinc.com/p/s/a-calculator-for-kidney-transplant-waitlist-outcomes-under-the-new-kidney-allocation-system-22707
https://atc.digitellinc.com/p/s/variation-in-cost-of-death-and-graft-failure-across-all-solid-organs-22713
https://atc.digitellinc.com/p/s/cost-effectiveness-of-lifelong-medicare-immunosuppressant-drug-coverage-for-kidney-transplant-recipients-in-the-current-era-22719
https://atc.digitellinc.com/p/s/broader-geographic-sharing-and-impact-on-lung-transplant-waitlist-time-and-lung-allocation-score-22725
https://atc.digitellinc.com/p/s/significant-alteration-in-transplant-center-performance-assessment-with-extended-patient-follow-up-time-22731
https://atc.digitellinc.com/p/s/evaluating-center-performance-beyond-patient-and-graft-survival-22737
https://atc.digitellinc.com/p/s/program-specific-survival-from-listing-variability-and-association-with-pretransplant-and-posttransplant-metrics-22743
https://atc.digitellinc.com/p/s/pancreas-transplant-recipients-with-end-stage-renal-disease-benefit-from-kidney-transplantation-22755
https://atc.digitellinc.com/p/s/morphometric-and-metabolic-correlates-of-frailty-in-pancreas-transplant-recipients-22761
https://atc.digitellinc.com/p/s/outcomes-of-de-novo-donor-specific-antibodies-in-pancreas-transplant-recipients-22767
https://atc.digitellinc.com/p/s/enteric-conversion-after-bladder-drained-pancreas-transplantation-the-wisconsin-experience-22773
https://atc.digitellinc.com/p/s/a-novel-approach-to-preserve-pancreatic-islet-grafts-in-extrahepatic-space-for-reversal-of-diabetes-using-parathyroid-gland-co-transplantation-22779
https://atc.digitellinc.com/p/s/ten-year-follow-up-of-islet-recipients-on-anti-lfa1-therapy-over-immunosuppression-leads-to-operational-tolerance-22785
https://atc.digitellinc.com/p/s/improved-long-term-outcomes-of-pancreas-transplantation-analysis-of-allograft-half-lives-and-predictive-demographic-factors-22791
https://atc.digitellinc.com/p/s/ablation-of-both-mtor-and-stat3-in-t-cells-induces-heart-transplant-acceptance-in-donor-skin-sensitized-mice-22803
https://atc.digitellinc.com/p/s/cd4-t-cells-require-both-s1pr1-and-s1pr4-for-afferent-lymphatic-migration-22809
https://atc.digitellinc.com/p/s/glycogen-synthase-kinase-3-beta-regulates-liver-inflammation-activation-and-resolution-by-controlling-ampk-activities-22815
https://atc.digitellinc.com/p/s/lymphatic-endothelium-requires-s1pr2-for-t-cell-transendothelial-migration-22821
https://atc.digitellinc.com/p/s/recipient-ifnar1-signaling-supports-costimulation-independent-rejection-by-promoting-t-cell-activation-22827
https://atc.digitellinc.com/p/s/lymph-node-stromal-laminins-affect-graft-survival-through-regulation-of-cd4-t-cell-proliferation-and-migration-22833
https://atc.digitellinc.com/p/s/altered-function-of-cytomegalovirus-specific-t-cells-in-transplant-recipients-22839
https://atc.digitellinc.com/p/s/discovery-and-validation-of-a-urinary-exosome-mrna-signature-for-the-diagnosis-of-human-kidney-transplant-rejection-22851
https://atc.digitellinc.com/p/s/prospective-multicenter-validation-of-human-transitional-b-cell-cytokines-as-a-predictive-biomarker-in-renal-transplantation-22857
https://atc.digitellinc.com/p/s/shared-hla-specificities-between-the-blood-and-transplant-donor-increases-the-risk-of-de-novo-dsa-development-following-blood-transfusion-in-transplant-recipients-22863
https://atc.digitellinc.com/p/s/a-novel-peripheral-blood-mrna-biomarker-predicts-subclinical-rejection-and-kidney-transplant-outcomes-22869
https://atc.digitellinc.com/p/s/unbiased-sequencing-of-urine-cell-free-dna-cfdna-to-evaluation-urine-virome-and-associated-renal-allograft-damage-22875
https://atc.digitellinc.com/p/s/urinary-c5b-9-is-an-independent-predictor-of-graft-failure-in-renal-transplant-recipients-22881
https://atc.digitellinc.com/p/s/dsa-with-tcmr-identifies-high-risk-renal-transplant-recipients-that-can-be-predicted-by-proinflammatory-transitional-b-cells-22887
https://atc.digitellinc.com/p/s/ho-1-regulates-sirt1ndash-autophagy-pathway-in-liver-transplantation-from-mouse-to-human-22899
https://atc.digitellinc.com/p/s/engineering-regulatory-t-cells-with-interleukin-il-2-nanogel-for-improved-alloimmune-suppression-22905
https://atc.digitellinc.com/p/s/pge2beta-cateninxbp1-signaling-controls-mesenchymal-stem-cell-mediated-immune-regulation-in-liver-ischemia-and-reperfusion-injury-22911
https://atc.digitellinc.com/p/s/ex-vivo-expanded-human-cd19-plus-tim-1-plus-b-regulatory-cells-can-prolong-allograft-survival-in-humanized-mouse-model-of-skin-transplantation-and-are-dependent-on-tim-1-media-22917
https://atc.digitellinc.com/p/s/confirmation-of-the-feasibility-of-ex-vivo-creation-of-a-novel-human-multi-chimeric-cells-therapy-for-tolerance-induction-in-vascularized-composite-allotransplantation-22923
https://atc.digitellinc.com/p/s/ex-vivo-expanded-regulatory-t-cells-combined-with-short-term-costimulation-blockade-prevent-rejection-of-vascularized-composite-allografts-22929
https://atc.digitellinc.com/p/s/curative-correction-of-fah-deficiency-by-chimeric-stem-cells-transplantation-22935
https://atc.digitellinc.com/p/s/genome-wide-non-hla-alloimmunity-contributes-to-graft-loss-after-kidney-transplantation-22947
https://atc.digitellinc.com/p/s/presence-of-donor-specific-antibodies-is-associated-with-accelerated-podocyte-detachment-22953
https://atc.digitellinc.com/p/s/role-of-c1q-binding-donor-specific-anti-hla-antibodies-in-premature-and-accelerated-kidney-allograft-interstitial-fibrosis-22959
https://atc.digitellinc.com/p/s/a-low-level-of-de-novo-dsa-sialylation-is-associated-with-a-decreased-of-allograft-survival-in-non-sensitized-kidney-transplant-recipients-22965
https://atc.digitellinc.com/p/s/hla-eplet-mismatch-and-donor-specific-antibodies-in-kidney-transplantation-22971
https://atc.digitellinc.com/p/s/two-trajectories-of-post-dsa-egfr-after-kidney-transplant-22977
https://atc.digitellinc.com/p/s/all-dq-dsa-may-not-be-equal-comparing-outcomes-between-de-novo-dq-dsa-specificities-22983
https://atc.digitellinc.com/p/s/not-all-hla-mismatches-are-equal-determining-the-relative-de-novo-dsa-induction-capacity-of-hla-mismatches-22995
https://atc.digitellinc.com/p/s/hard-to-place-kidney-offers-system-level-predictors-of-discard-23001
https://atc.digitellinc.com/p/s/temporal-trends-predictive-factors-and-regional-differences-in-discard-of-increased-risk-kidneys-23007
https://atc.digitellinc.com/p/s/waitlist-survival-is-approaching-survival-after-kidney-transplantation-23013
https://atc.digitellinc.com/p/s/increasing-the-donor-pool-for-highly-sensitized-patients-with-allele-specific-antibodies-optimizing-the-virtual-crossmatch-vxm-23019
https://atc.digitellinc.com/p/s/outcome-of-second-kidney-transplantation-according-to-previous-pediatric-donor-type-a-retrospective-cohort-analysis-23025
https://atc.digitellinc.com/p/s/expression-of-the-senescence-marker-p16ink4a-in-kidney-implantation-biopsies-is-uniquely-associated-with-poor-late-graft-function-23031
https://atc.digitellinc.com/p/s/tacrolimus-pharmacokinetics-pk-at-low-medium-and-high-trough-levels-in-patients-converted-from-twice-daily-immediate-release-tacrolimus-tacbid-to-once-daily-extended-release-tacrolimus-lcpt-23043
https://atc.digitellinc.com/p/s/follow-up-of-patients-treated-with-the-igg-endopeptidase-ides-for-desensitization-and-hla-incompatible-hlai-kidney-transplantation-23049
https://atc.digitellinc.com/p/s/efficacy-and-safety-of-bleselumab-in-kidney-transplant-recipients-a-phase-2-randomized-open-label-study-23055
https://atc.digitellinc.com/p/s/a-phase-i-clinical-trial-of-donor-derived-mic-cell-infusion-for-the-induction-of-donor-specific-hyporesponsiveness-after-living-donor-kidney-transplantation-tol-1-study-23061
https://atc.digitellinc.com/p/s/rna-expression-profiling-of-renal-allografts-in-the-cynomolgus-monkey-identifies-tolerance-23067
https://atc.digitellinc.com/p/s/b-cell-reconstitution-36-month-analysis-of-patients-post-alemtuzumab-induction-followed-by-belatacept-based-immunosuppression-23073
https://atc.digitellinc.com/p/s/emergence-of-a-costimulation-susceptible-t-cell-repertoire-post-alemtuzumab-induction-23079
https://atc.digitellinc.com/p/s/meeting-optn-requirements-for-living-kidney-donation-follow-up-findings-from-the-kdoc-study-23091
https://atc.digitellinc.com/p/s/national-study-of-living-donor-program-protocols-processes-and-resources-within-us-transplant-centers-23097
https://atc.digitellinc.com/p/s/center-variation-in-six-month-post-donation-follow-up-of-obese-living-kidney-donors-23103
https://atc.digitellinc.com/p/s/donor-safety-in-obese-patients-1038-consecutive-robotic-living-donor-nephrectomies-23109
https://atc.digitellinc.com/p/s/living-kidney-donation-impact-of-transplant-center-labor-organization-and-resources-23115
https://atc.digitellinc.com/p/s/few-gender-differences-in-attitudes-and-experiences-after-live-kidney-donation-with-minor-changes-over-time-23121
https://atc.digitellinc.com/p/s/the-living-donor-lost-wages-trial-study-rationale-protocol-and-update-23127
https://atc.digitellinc.com/p/s/dialysis-modality-inflammation-and-frailty-in-kidney-transplant-candidates-23139
https://atc.digitellinc.com/p/s/the-impact-of-aorto-iliac-calcifications-on-patient-and-graft-survival-in-renal-transplant-recipients-using-the-tasc-ii-classification-23145
https://atc.digitellinc.com/p/s/predictive-scores-for-delayed-graft-function-based-on-hypothermic-machine-perfusion-variables-in-kidney-transplantation-23151
https://atc.digitellinc.com/p/s/impact-of-center-volume-on-kidney-transplant-outcomes-in-contemporary-us-transplant-practice-23157
https://atc.digitellinc.com/p/s/cold-pulsatile-machine-perfusion-versus-static-cold-storage-in-kidneys-from-donation-after-circulatory-death-a-multi-centre-randomised-controlled-trial-23163
https://atc.digitellinc.com/p/s/enhancing-coordination-across-healthcare-settings-through-a-web-based-transplant-referral-exchange-t-rex-platform-23169
https://atc.digitellinc.com/p/s/rituximab-interference-in-b-cell-crossmatch-a-problem-solved-23175
https://atc.digitellinc.com/p/s/liver-transplantation-for-patients-with-hepatocellular-carcinoma-presenting-beyond-milan-criteria-analysis-of-789-patients-from-the-us-multicenter-hcc-transplant-consortium-23193
https://atc.digitellinc.com/p/s/improving-prognostication-amongst-patients-undergoing-liver-transplantation-for-hepatocellular-carcinoma-an-international-16-center-study-to-validate-and-recalibrate-halthcc-23199
https://atc.digitellinc.com/p/s/influence-of-initial-tumor-burden-and-wait-times-on-post-transplant-outcomes-after-down-staging-of-hepatocellular-carcinoma-hcc-23205
https://atc.digitellinc.com/p/s/hla-dr4-matching-and-hepatocellular-carcinoma-recurrence-after-liver-transplantation-23211
https://atc.digitellinc.com/p/s/long-term-risk-of-solid-organ-de-novo-malignancies-after-liver-transplantation-a-french-national-study-on-11226-patients-23217
https://atc.digitellinc.com/p/s/post-transplant-outcomes-under-the-new-hcc-exception-policy-23223
https://atc.digitellinc.com/p/s/financial-burden-of-liver-transplant-vs-resection-for-hcc-23229
https://atc.digitellinc.com/p/s/long-term-outcomes-after-living-liver-donation-analysis-of-national-data-base-23241
https://atc.digitellinc.com/p/s/long-term-medical-financial-psychosocial-and-overall-health-related-quality-of-life-after-living-donation-in-liver-transplantation-23247
https://atc.digitellinc.com/p/s/the-feasibility-of-laparoscopic-living-donor-right-hepatectomy-compared-to-open-surgery-including-100-laparoscopic-cases-23253
https://atc.digitellinc.com/p/s/ldlt-for-high-meld-recipients-a-single-center-experience-23259
https://atc.digitellinc.com/p/s/living-donor-liver-transplantation-for-alcoholic-liver-disease-data-from-the-a2all-study-23265
https://atc.digitellinc.com/p/s/effect-of-hla-antibodies-on-graft-survival-in-adult-live-donor-liver-transplantation-23271
https://atc.digitellinc.com/p/s/short-and-long-term-outcomes-of-interventional-radiology-treatment-for-vascular-complications-following-living-donor-liver-transplantation-the-efficacy-of-stent-placement-23277
https://atc.digitellinc.com/p/s/interferon-b-promotes-regulatory-t-cell-treg-induction-and-prolongs-allograft-survival-23289
https://atc.digitellinc.com/p/s/a-3c-approach-drives-epigenetic-fixation-of-foxp3-expression-and-stabilizes-treg-cell-lineage-and-therapeutic-function-23295
https://atc.digitellinc.com/p/s/lymphotoxin-beta-receptor-modulation-in-lymphatic-endothelial-cells-alters-regulatory-t-cell-dynamics-23301
https://atc.digitellinc.com/p/s/mechanisms-of-deptor-function-in-cd4sup-plus-sup-t-cell-subsets-23307
https://atc.digitellinc.com/p/s/ox40-costimulation-prevents-induction-of-foxp3sup-plus-sup-tregs-through-upregulation-of-novel-repressors-of-foxp3-gene-expression-23313
https://atc.digitellinc.com/p/s/torc1-inhibition-protects-activated-human-regulatory-t-cells-from-self-inflicted-damage-via-granzyme-b-23319
https://atc.digitellinc.com/p/s/in-vivo-visualization-of-regulatory-b-cells-reveals-ag-dependent-t-cell-interactions-that-suppress-subsequent-t-celldc-interactions-23325
https://atc.digitellinc.com/p/s/hiv-hbv-and-hcv-screening-with-nat-and-serology-in-the-opo-setting-23337
https://atc.digitellinc.com/p/s/donor-derived-transmissions-in-2016-2017-analysis-of-the-optn-ad-hoc-disease-transmission-advisory-committee-dtac-23343
https://atc.digitellinc.com/p/s/waitlist-outcomes-and-access-to-liver-transplantation-for-hiv-plus-candidates-23349
https://atc.digitellinc.com/p/s/outcomes-after-hiv-plus-liver-transplant-a-hope-in-action-study-23355
https://atc.digitellinc.com/p/s/heart-and-lung-transplantation-outcomes-in-hiv-positive-recipients-23361
https://atc.digitellinc.com/p/s/hcv-ab-plus-nat-organ-donors-and-the-challenges-of-eclipse-windows-analysis-of-the-optnunos-ad-hoc-disease-transmission-advisory-committee-dtac-23367
https://atc.digitellinc.com/p/s/antiviral-therapy-for-donor-derived-hepatitis-c-virus-infection-after-solid-organ-transplantation-23373
https://atc.digitellinc.com/p/s/medical-crowdfunding-for-organ-transplant-patients-23385
https://atc.digitellinc.com/p/s/as-clear-as-mud-volatility-of-the-five-tier-quality-assessment-of-kidney-transplant-centers-in-the-united-states-23391
https://atc.digitellinc.com/p/s/positive-relationship-between-transplant-center-volume-and-utilization-of-hard-to-place-liver-allografts-after-late-declines-23397
https://atc.digitellinc.com/p/s/cost-impacts-of-alternative-kidney-transplant-immunosuppression-a-national-cohort-study-23403
https://atc.digitellinc.com/p/s/transplant-community-perceptions-of-the-benefits-and-drawbacks-of-alternative-quality-metrics-for-regulation-23409
https://atc.digitellinc.com/p/s/liver-transplantation-outcomes-after-share-35-analysis-of-nash-recipients-from-unos-database-23415
https://atc.digitellinc.com/p/s/the-cost-savings-of-preemptive-kidney-transplantation-23421
https://atc.digitellinc.com/p/s/improving-the-organ-donation-referral-process-through-telemedicine-23433
https://atc.digitellinc.com/p/s/hospital-readmissions-following-abo-incompatible-live-donor-kidney-transplantation-a-national-study-23439
https://atc.digitellinc.com/p/s/using-the-srtr-expected-survival-worksheet-to-estimate-expected-number-of-events-23445
https://atc.digitellinc.com/p/s/reducing-no-show-rate-and-filling-cancelled-appointments-multi-faceted-interventions-markedly-reduced-time-to-kidney-transplant-evaluation-23451
https://atc.digitellinc.com/p/s/racing-to-activation-using-lean-principles-to-effectively-manage-your-waitlist-with-predicted-improved-outcomes-23457
https://atc.digitellinc.com/p/s/impact-of-ambulatory-transplant-pharmacy-services-on-outcomes-and-readmissions-in-adult-abdominal-transplant-recipients-23463
https://atc.digitellinc.com/p/s/medication-reconciliation-in-abdominal-transplantation-23469
https://atc.digitellinc.com/p/s/relationship-between-mixed-chimerism-and-acceptance-of-hla-matched-and-mismatched-kidney-transplants-after-withdrawal-of-immunosuppressive-drugs-23481
https://atc.digitellinc.com/p/s/long-term-follow-up-of-a-phase-2-clinical-trial-to-induce-tolerance-in-living-donor-renal-transplant-recipients-23487
https://atc.digitellinc.com/p/s/pd-l1-may-serve-as-a-biomarker-for-chimerism-induced-tolerance-in-kidney-transplant-recipients-23493
https://atc.digitellinc.com/p/s/non-myeloablative-conditioning-with-low-dose-total-body-irradiation-in-place-of-cyclophosphamide-induces-mixed-chimerism-and-long-term-immunosuppression-free-allograft-survival-without-acute-kidney-in-23499
https://atc.digitellinc.com/p/s/immunity-and-tolerance-after-bilateral-orthotopic-lung-transplant-bolt-in-tandem-with-a-cd3-plus-cd19-plus-depleted-vertebral-bone-marrow-transplant-bolt-plus-bmt-from-1-of-8-hla-matched-cadaveric-don-23505
https://atc.digitellinc.com/p/s/long-term-histologic-allograft-health-is-preserved-despite-rejection-during-protocolized-immunosuppression-withdrawal-isw-in-stable-pediatric-liver-transplant-recipients-23511
https://atc.digitellinc.com/p/s/development-of-post-transplant-dsa-following-immunosuppression-minimizationwithdrawal-in-liver-transplant-recipients-23517
https://atc.digitellinc.com/p/s/specific-monocyte-memory-to-allogeneic-mhc-mediated-by-paired-immunoglobulin-receptors-pir-23529
https://atc.digitellinc.com/p/s/identification-of-macrophage-innate-receptors-in-recognition-and-rejection-of-allogeneic-non-self-in-transplantation-23535
https://atc.digitellinc.com/p/s/role-of-b-cell-intrinsic-nlrp3-in-the-development-of-chronic-rejection-23541
https://atc.digitellinc.com/p/s/an-early-look-at-the-optns-new-slk-allocation-policy-23547
https://atc.digitellinc.com/p/s/despite-the-growing-impact-of-the-american-opioid-epidemic-on-organ-donation-a-small-percentage-of-drug-intoxication-deaths-result-in-organ-donation-23553
https://atc.digitellinc.com/p/s/everolimus-with-reduced-calcineurin-inhibitor-exposure-in-de-novo-kidney-transplant-recipients-efficacy-and-safety-outcomes-from-the-transform-study-23559
https://atc.digitellinc.com/p/s/the-results-of-the-prism-prediction-of-rejection-in-sensitized-patient-blood-samples-trial-with-a-novel-bioassay-23571
https://atc.digitellinc.com/p/s/early-results-from-usher-a-pilot-trial-of-transplanting-hcv-infected-hearts-into-hcv-negative-recipients-followed-by-anti-viral-therapy-23577
https://atc.digitellinc.com/p/s/interim-results-of-the-ksort-in-the-sailor-randomized-multicenter-trial-23583
https://atc.digitellinc.com/p/s/t-cell-phenotypes-predict-infectious-risk-in-transplanted-children-23589
https://atc.digitellinc.com/p/s/superior-renal-function-with-cni-free-everolimus-over-standard-cni-based-regimen-18-months-data-from-the-randomized-multi-center-mandela-trial-in-de-novo-heart-transplant-recipients-23595
https://atc.digitellinc.com/p/s/offspring-living-kidney-donors-should-not-be-ruled-out-23601
https://atc.digitellinc.com/p/s/results-of-litmus-nct-02541916-the-liver-immune-tolerance-bio-marker-utilization-study-23607
https://atc.digitellinc.com/p/s/joint-award-session-23625
https://atc.digitellinc.com/p/s/ast-awards-23631
https://atc.digitellinc.com/p/s/ast-lifetime-achievement-awards-23637
https://atc.digitellinc.com/p/s/asts-awards-23643
https://atc.digitellinc.com/p/s/asts-pioneer-award-23649
https://atc.digitellinc.com/p/s/asts-presidential-address-intro-23661
https://atc.digitellinc.com/p/s/ast-presidential-address-intro-23667
https://atc.digitellinc.com/p/s/state-of-the-art-address-vca-past-present-and-future-23673
https://atc.digitellinc.com/p/s/emerging-role-of-the-purinergic-system-in-transplant-rejection-23703
https://atc.digitellinc.com/p/s/induction-therapy-choices-and-the-risk-for-infection-23727
https://atc.digitellinc.com/p/s/detection-and-management-of-delirium-23733
https://atc.digitellinc.com/p/s/post-op-complications-common-in-older-adults-23745
https://atc.digitellinc.com/p/s/immunobiology-and-the-risks-for-rejection-and-infection-on-the-older-recipient-23763
https://atc.digitellinc.com/p/s/maintenance-immunosuppression-considerations-23769
https://atc.digitellinc.com/p/s/other-medication-concerns-with-older-recipients-23781
https://atc.digitellinc.com/p/s/role-of-innate-allorecognition-pathways-in-mouse-renal-allograft-rejection-26673
https://atc.digitellinc.com/p/s/oxygenated-hypothermic-machine-perfusion-of-kidneys-donated-after-circulatory-death-an-international-randomised-controlled-trial-26678
https://atc.digitellinc.com/p/s/discovery-and-validation-of-an-early-post-transplant-biomarker-model-predictive-of-chronic-kidney-disease-in-liver-transplant-recipients-26683
https://atc.digitellinc.com/p/s/bcl-2-inhibition-with-venetoclax-promotes-induction-of-mixed-chimerism-and-renal-allograft-tolerance-without-severe-myelosuppression-in-non-human-primate-26688
https://atc.digitellinc.com/p/s/an-8-gene-expression-assay-in-peripheral-blood-for-diagnosis-of-antibody-mediated-rejection-after-kidney-transplantation-26698
https://atc.digitellinc.com/p/s/nk-cells-are-associated-with-alloimmune-failure-in-transplanted-children-26703
https://atc.digitellinc.com/p/s/circulating-t-follicular-helper-proliferation-and-memory-b-cell-activation-correlate-with-donor-specific-allo-antibody-occurrence-and-antibody-mediated-rejection-after-kidney-transplantation-26708
https://atc.digitellinc.com/p/s/impact-of-cytomegalovirus-on-the-immune-system-of-healthy-humans-26713
https://atc.digitellinc.com/p/s/a-molecular-analysis-of-graft-survival-in-the-interheart-study-26718
https://atc.digitellinc.com/p/s/one-study-a-consortium-model-of-clinical-trials-optimized-for-comparing-new-immune-therapies-via-centralized-immune-monitoring-26723
https://atc.digitellinc.com/p/s/viability-testing-and-transplantation-of-marginal-donor-livers-vittal-trial-metabolomics-of-ex-vivo-normothermically-machine-perfused-livers-discloses-molecular-signatures-predictive-of-graft-viabilit-26728
https://atc.digitellinc.com/p/s/shroom3-regulates-glomerular-hypertrophy-after-uninephrectomy-via-mtor-26738
https://atc.digitellinc.com/p/s/zfyve21-is-a-novel-complement-induced-rab5-effector-protein-mediating-cardiac-allograft-vasculopathy-26743
https://atc.digitellinc.com/p/s/novel-activation-responses-by-endothelial-cells-within-the-pro-tolerogenic-intragraft-microenvironment-26748
https://atc.digitellinc.com/p/s/apoptotic-exosome-like-vesicles-induce-endothelial-cell-plasticity-and-accelerate-allograft-vascular-remodeling-26753
https://atc.digitellinc.com/p/s/cytomegalovirus-cmv-infection-induces-an-angiogenic-response-through-hepatic-stellate-cells-hscs-and-leads-to-early-post-transplant-liver-fibrosis-lf-and-poor-graft-survival-26758
https://atc.digitellinc.com/p/s/ligation-of-hla-class-il-molecules-disrupts-endothelial-barrier-through-src-dependent-ve-cadherin-destabilization-26763
https://atc.digitellinc.com/p/s/sphingosine-1-phosphate-receptor-2-regulates-migration-through-endothelial-cell-vcam-and-adherens-junctions-26768
https://atc.digitellinc.com/p/s/prevention-of-graft-ischemia-reperfusion-injury-in-ischemia-free-liver-transplantation-26778
https://atc.digitellinc.com/p/s/cd4-t-cell-derived-ngal-mediates-experimental-acute-kidney-injury-26783
https://atc.digitellinc.com/p/s/sirna-uptake-during-ex-vivo-hypothermic-and-normothermic-liver-machine-perfusion-beginning-of-a-new-era-of-organ-preservation-26788
https://atc.digitellinc.com/p/s/senescent-cell-clearance-with-senolytic-drugs-improves-cardiac-allograft-survival-by-targeting-mt-dna-mediated-immune-responses-26793
https://atc.digitellinc.com/p/s/minimizing-kidney-ischemia-reperfusion-injury-by-transferring-exogenous-mitochondria-26798
https://atc.digitellinc.com/p/s/anti-cd45rb-antibody-therapy-attenuates-renal-ischemia-reperfusion-injury-by-inducing-regulatory-b-cells-26803
https://atc.digitellinc.com/p/s/pd-1cd3cd4-cd8-double-negative-t-cells-are-early-responders-during-kidney-ischemia-reperfusion-injury-and-regulated-by-non-classical-mhc-molecules-26808
https://atc.digitellinc.com/p/s/impact-of-glomerulitis-at-4-month-biopsy-on-long-term-kidney-allograft-outcomes-26818
https://atc.digitellinc.com/p/s/population-based-modeling-of-prototypes-and-determinants-of-allograft-function-trajectories-after-kidney-transplantation-impact-for-patient-monitoring-and-risk-stratification-26823
https://atc.digitellinc.com/p/s/mortality-and-morbidity-in-kidney-transplant-recipients-with-a-failing-graft-26828
https://atc.digitellinc.com/p/s/room-for-optimism-improvement-in-long-term-patient-and-graft-survival-of-kidney-transplants-in-the-united-states-over-the-past-three-decades-26833
https://atc.digitellinc.com/p/s/the-graft-and-patient-survival-of-kidney-transplantation-according-to-ethnicity-in-us-kidney-transplant-recipients-26838
https://atc.digitellinc.com/p/s/cmv-risk-status-remains-a-relevant-risk-factor-for-long-term-outcomes-26843
https://atc.digitellinc.com/p/s/bisphosphonates-effectively-improve-the-long-term-renal-transplant-outcomes-a-single-center-retrospective-study-26848
https://atc.digitellinc.com/p/s/national-landscape-of-hope-act-transplant-candidates-and-recipients-in-the-united-states-26858
https://atc.digitellinc.com/p/s/regional-disparities-in-the-transplant-rates-across-unos-regions-pre-and-post-kidney-allocation-system-policy-implementation-26863
https://atc.digitellinc.com/p/s/changes-in-kidney-offer-acceptance-for-pediatric-candidates-post-kas-26868
https://atc.digitellinc.com/p/s/impact-of-donor-hepatitis-c-virus-infection-on-kidney-transplant-outcomes-in-the-direct-acting-antiretroviral-era-time-to-revise-the-kdpi-26873
https://atc.digitellinc.com/p/s/exploring-the-drivers-of-the-early-decline-in-one-year-patient-survival-after-kas-26878
https://atc.digitellinc.com/p/s/longer-term-outcomes-for-hepatitis-c-virus-negative-recipients-of-kidneys-from-hepatitis-c-virus-nucleic-acid-test-positive-donors-the-thinker-trial-26883
https://atc.digitellinc.com/p/s/accelerating-kidney-allocation-simultaneously-expiring-offers-26888
https://atc.digitellinc.com/p/s/transplantation-of-kidneys-from-hepatitis-c-infected-donors-to-hepatitis-c-negative-recipients-26898
https://atc.digitellinc.com/p/s/hope-in-action-a-multicenter-prospective-study-of-hiv-to-hiv-kidney-transplantation-26903
https://atc.digitellinc.com/p/s/hope-act-donors-with-organs-recovered-for-transplant-the-first-two-years-26908
https://atc.digitellinc.com/p/s/outcomes-in-non-a1-and-non-a1-b-to-b-deceased-donor-renal-transplantation-are-comparable-to-b-donor-renal-transplants-26913
https://atc.digitellinc.com/p/s/did-coiin-cohort-a-maintain-graft-survival-performance-while-increasing-moderate-to-high-kdpi-transplants-26918
https://atc.digitellinc.com/p/s/significant-increase-in-moderate-to-high-kdpi-kidney-transplants-using-a-multi-operational-approach-results-from-the-coiin-collaborative-innovation-and-improvement-network-initiative-26923
https://atc.digitellinc.com/p/s/long-term-outcomes-following-uncontrolled-donation-after-cardiac-death-kidney-transplantation-opportunity-for-increasing-donor-pool-26928
https://atc.digitellinc.com/p/s/costimulation-blockade-modulates-humoral-responses-in-highly-sensitized-transplant-recipients-26938
https://atc.digitellinc.com/p/s/evaluation-of-the-safety-and-tolerability-of-clazakizumab-r-anti-il-6-monoclonal-as-a-desensitization-agent-in-highly-hla-sensitized-esrd-patients-nct03380962-26943
https://atc.digitellinc.com/p/s/long-term-outcomes-of-eculizumab-treated-positive-crossmatch-recipients-allograft-survival-histologic-findings-and-natural-history-of-the-donor-specific-antibodies-26948
https://atc.digitellinc.com/p/s/safety-and-efficacy-of-imlifidase-in-highly-sensitized-kidney-transplant-patients-results-from-a-phase-2-study-26953
https://atc.digitellinc.com/p/s/anti-hla-igm-antibodies-are-reduced-in-highly-hla-sensitized-patients-transplanted-after-imlifidase-ides-treatment-26958
https://atc.digitellinc.com/p/s/eight-year-outcomes-following-abo-incompatible-kidney-transplantation-performed-after-desensitization-by-antigen-unspecific-immunoadsorption-devices-26963
https://atc.digitellinc.com/p/s/bortezomib-based-induction-therapy-decreases-delayed-graft-function-in-high-risk-kidney-transplantation-26968
https://atc.digitellinc.com/p/s/robotic-assisted-versus-open-techniques-for-living-donor-kidney-transplant-recipients-a-comparison-using-propensity-score-analysis-26978
https://atc.digitellinc.com/p/s/single-cell-sequencing-of-human-kidney-allograft-26983
https://atc.digitellinc.com/p/s/enhanced-recovery-after-surgery-protocols-in-kidney-transplantation-time-to-change-practice-26988
https://atc.digitellinc.com/p/s/robotic-assisted-kidney-transplant-outcomes-in-obese-candidates-26993
https://atc.digitellinc.com/p/s/simultaneous-robotic-kidney-transplantation-and-bariatric-surgery-for-morbidly-obese-patients-with-end-stage-renal-failure-26998
https://atc.digitellinc.com/p/s/robotic-assisted-versus-open-kidney-transplantation-in-non-obese-recipients-27003
https://atc.digitellinc.com/p/s/the-safety-of-surveillance-and-indication-biopsies-in-kidney-transplantation-a-series-of-2000-biopsies-27008
https://atc.digitellinc.com/p/s/early-use-of-everolimus-plus-reduced-tacrolimus-vs-standard-tacrolimus-in-de-novo-livertransplant-recipients-12-months-efficacy-and-safety-data-from-hephaistos-study-27018
https://atc.digitellinc.com/p/s/igg4-subclass-class-2-donor-specific-antibody-dsa-is-associated-with-subclinical-rejection-in-stable-pediatric-liver-transplant-lt-recipients-with-normal-liver-tests-27023
https://atc.digitellinc.com/p/s/frailty-associated-with-increased-rates-of-acute-cellular-rejection-within-3-months-after-liver-transplantation-27028
https://atc.digitellinc.com/p/s/late-acute-rejection-increases-risk-of-graft-failure-in-ldlt-recipients-data-from-the-a2all-cohort-27033
https://atc.digitellinc.com/p/s/impact-of-delayed-kidney-transplantation-on-positive-crossmatch-liver-kidney-transplantation-27038
https://atc.digitellinc.com/p/s/molecular-analysis-of-rejection-and-injury-in-human-liver-transplant-biopsies-first-results-of-the-interliver-study-27048
https://atc.digitellinc.com/p/s/incidence-and-risk-of-allograft-rejection-after-cardiac-transplantation-in-left-ventricular-assist-device-patients-27058
https://atc.digitellinc.com/p/s/low-frequency-of-canonical-human-leukocyte-antigen-alloimmunization-in-heart-transplantation-candidates-with-ventricular-assist-devices-27063
https://atc.digitellinc.com/p/s/does-the-type-of-pre-heart-transplant-desensitization-therapy-affect-5-year-post-transplant-outcomes-27068
https://atc.digitellinc.com/p/s/upregulation-of-endothelial-hla-class-ii-as-a-marker-of-antibody-mediated-rejection-in-heart-allograft-biopsies-27073
https://atc.digitellinc.com/p/s/identification-and-determinants-of-cardiac-allograft-vasculopathy-trajectories-after-heart-transplantation-27078
https://atc.digitellinc.com/p/s/more-than-meets-the-eye-the-use-of-serial-intravascular-ultrasound-for-assessment-of-cardiac-allograft-vasculopathy-after-heart-transplantation-27083
https://atc.digitellinc.com/p/s/multi-omics-approach-to-accurately-assess-early-graft-injury-in-liver-transplantation-27098
https://atc.digitellinc.com/p/s/improved-transplant-outcomes-in-ischemia-free-liver-transplantation-a-report-of-the-first-30-cases-27103
https://atc.digitellinc.com/p/s/histologic-ischemia-reperfusion-injury-in-liver-transplantation-a-large-single-center-experience-27108
https://atc.digitellinc.com/p/s/normothermic-regional-perfusion-of-kidneys-a-single-non-retrieval-centre-experience-27113
https://atc.digitellinc.com/p/s/hepatocyte-sirt1-modulates-atf4chop-and-mitigates-liver-transplant-ischemia-reperfusion-injury-from-bench-to-bedside-27118
https://atc.digitellinc.com/p/s/brief-normothermic-machine-perfusion-is-superior-to-cold-storage-alone-a-paired-discarded-human-kidney-analysis-27123
https://atc.digitellinc.com/p/s/impact-of-preoperative-rifaximin-use-on-reducing-graft-injury-in-liver-transplantation-a-propensity-matched-analysis-27128
https://atc.digitellinc.com/p/s/risk-factors-for-1-5-year-de-novo-cancers-after-kidney-transplant-ktx-with-first-year-immunosuppression-is-data-an-analysis-of-the-choosing-immune-suppression-by-efficacy-and-morbidity-cistem-study-27138
https://atc.digitellinc.com/p/s/lower-incidence-of-posttransplant-malignancies-under-vitamin-d-calcidiol-treatment-in-kidney-transplantation-27143
https://atc.digitellinc.com/p/s/lower-rates-of-epstein-barr-virus-viremia-and-post-transplant-lymphoproliferative-disease-in-pediatric-solid-organ-transplant-recipients-who-received-valganciclovir-prophylaxis-27148
https://atc.digitellinc.com/p/s/regulation-of-host-microrna-expression-by-natural-variants-of-epstein-barr-virus-ebv-latent-membrane-protein-1-lmp1-27153
https://atc.digitellinc.com/p/s/mass-cytometry-based-characterization-of-adaptive-immunity-in-transplant-recipients-with-self-limiting-or-chronic-ebv-viremia-27158
https://atc.digitellinc.com/p/s/immune-cell-types-and-host-gene-signatures-associated-with-epstein-barr-virus-ebv-post-transplant-lymphoproliferative-disorder-ptld-27163
https://atc.digitellinc.com/p/s/ex-vivo-perfusion-mediated-delivery-of-rituximab-to-clear-latent-epstein-barr-virus-27168
https://atc.digitellinc.com/p/s/endothelial-cell-replacement-a-closer-step-to-personalized-tissue-engineered-transplants-27178
https://atc.digitellinc.com/p/s/mhc-molecule-ablated-human-endothelial-cells-form-alloimmune-evasive-microvessels-27183
https://atc.digitellinc.com/p/s/hepatic-stellate-cells-and-liver-derived-endothelial-cells-improve-scaffold-free-3d-bioprinted-liver-model-27193
https://atc.digitellinc.com/p/s/development-and-characterization-of-human-derived-xenograft-model-for-hepatocellular-carcinoma-27203
https://atc.digitellinc.com/p/s/kidney-regeneration-with-biomimetic-vascular-scaffolds-based-on-vascular-corrosion-casts-27208
https://atc.digitellinc.com/p/s/impact-of-immunosuppressive-drug-withdrawal-on-persistent-mixed-chimerism-in-recipients-of-hla-haplo-identical-kidney-and-hematopoietic-cell-transplants-27218
https://atc.digitellinc.com/p/s/persistent-mixed-chimerism-immune-reconstitution-and-tolerance-in-recipients-of-hla-matched-kidney-and-hematopoietic-cell-transplants-27223
https://atc.digitellinc.com/p/s/use-of-low-dose-interleukin-2-to-expand-regulatory-t-cells-and-facilitate-the-complete-discontinuation-of-immunosuppression-in-human-liver-transplantation-27228
https://atc.digitellinc.com/p/s/tolerance-induction-with-hematopoietic-stem-cells-in-kidney-transplantations-27233
https://atc.digitellinc.com/p/s/results-of-litmus-nct-02541916-the-liver-immune-tolerance-bio-marker-utilization-study-27238
https://atc.digitellinc.com/p/s/preliminary-mechanistic-studies-of-regulatory-dendritic-cell-dcreg-cell-infusion-in-living-donor-liver-transplant-recipients-27243
https://atc.digitellinc.com/p/s/an-open-label-proof-of-principle-phase-2a-study-to-evaluate-autologous-hematopoietic-stem-cell-transplantation-for-allogeneic-organ-transplant-tolerance-ascott-27248
https://atc.digitellinc.com/p/s/the-effects-of-anti-baff-monoclonal-antibody-in-the-hla-a2-sensitized-mouse-model-27258
https://atc.digitellinc.com/p/s/decay-accelerating-factor-daf-regulates-germinal-center-b-cell-and-alloantibody-formation-27268
https://atc.digitellinc.com/p/s/autoantibody-production-significantly-decreased-with-aprilblys-blockade-in-murine-chronic-rejection-kidney-transplant-model-27273
https://atc.digitellinc.com/p/s/b-cell-specific-ire1a-deficiency-protects-renal-allografts-from-rejection-via-inhibition-of-donor-specific-antibodies-and-induction-of-b-regulatory-cells-27278
https://atc.digitellinc.com/p/s/antibody-suppressor-cd8-plus-t-cells-require-cxcr5-27283
https://atc.digitellinc.com/p/s/anti-donor-m-h-c-class-i-i-alloantibody-induce-glomerular-injury-in-mouse-renal-allografts-subjected-to-prolonged-cold-ischemia-27288
https://atc.digitellinc.com/p/s/mismatched-epitope-and-de-novo-dsa-development-an-analysis-of-the-benefit-and-benefit-ext-renal-transplant-cohorts-27298
https://atc.digitellinc.com/p/s/successful-kidney-transplantation-of-highly-sensitized-candidates-across-positive-cross-match-and-strong-donor-specific-hla-dp-antibodies-without-desensitization-27303
https://atc.digitellinc.com/p/s/solving-target-recognition-and-activation-mediated-by-non-hla-agonistic-antibodies-targeting-etar-27308
https://atc.digitellinc.com/p/s/inhibition-of-mtorc2-causes-hyper-phosphorylation-of-erk-induced-by-co-ligation-of-hla-i-and-ii-antibody-27313
https://atc.digitellinc.com/p/s/computational-assessment-of-t-cell-and-b-cell-allorecognition-to-predict-donor-hla-immunogenicity-27318
https://atc.digitellinc.com/p/s/physiochemical-hla-properties-identify-low-immunogenic-donorrecipient-pairs-predicting-long-term-kidney-graft-survivals-27323
https://atc.digitellinc.com/p/s/can-imputation-of-hla-allele-level-typing-be-used-clinically-in-a-multiethnic-population-27328
https://atc.digitellinc.com/p/s/eculizumab-deposition-in-renal-transplants-27338
https://atc.digitellinc.com/p/s/prevention-of-ischemia-reperfusion-injury-iri-and-abmr-in-hla-sensitized-patients-treated-with-c1-esterase-inhibitor-c1inh-long-term-follow-up-27343
https://atc.digitellinc.com/p/s/the-role-of-neutrophil-extracellular-traps-in-kidney-acute-antibody-mediated-rejection-27348
https://atc.digitellinc.com/p/s/de-novo-donor-specific-antibody-and-panel-reactivity-antibody-are-critical-risk-factors-for-antibody-mediated-rejection-of-kidney-allograft-after-simultaneous-liver-kidney-transplantation-a-single-cen-27353
https://atc.digitellinc.com/p/s/prognostic-value-of-c3d-fixing-preformed-donor-specific-antibody-in-crossmatch-positive-living-kidney-transplantation-27358
https://atc.digitellinc.com/p/s/cd19-cell-behavior-in-the-12-months-following-a-single-dose-of-rituximab-in-patients-with-humoral-rejection-clinical-and-histological-outcomes-27363
https://atc.digitellinc.com/p/s/kinetics-of-pretransplant-dsa-post-transplant-histology-and-graft-failure-after-kidney-transplantation-27368
https://atc.digitellinc.com/p/s/antirejection-efficacy-in-de-novo-renal-transplant-recipients-receiving-everolimus-with-a-reduced-exposure-calcineurin-inhibitor-based-regimen-24-month-results-from-the-transform-study-27378
https://atc.digitellinc.com/p/s/efficacy-and-safety-outcomes-with-de-novo-use-of-everolimus-based-regimen-in-renal-transplant-recipients-with-delayed-graft-function-from-the-transform-study-27383
https://atc.digitellinc.com/p/s/the-use-of-mtor-inhibitors-prevents-acute-cellular-rejection-in-kidney-transplantation-on-belatacept-therapy-27388
https://atc.digitellinc.com/p/s/early-steroid-withdrawal-in-african-american-deceased-donor-renal-transplant-recipients-with-alemtuzumab-induction-is-graft-loss-on-the-horizon-27393
https://atc.digitellinc.com/p/s/early-outcomes-comparing-two-steroid-avoidance-protocols-in-pediatric-renal-transplantation-27398
https://atc.digitellinc.com/p/s/impact-of-steroid-free-protocol-on-incidence-of-posttransplantation-diabetes-mellitus-a-prospective-randomized-multicenter-open-label-controlled-trial-in-renal-transplant-recipients-27403
https://atc.digitellinc.com/p/s/whats-in-a-high-dose-an-analysis-of-tacrolimus-pharmacokinetic-parameters-in-rapid-metabolizers-27408
https://atc.digitellinc.com/p/s/preemptive-kidney-transplantation-is-there-a-role-for-abo-incompatible-transplantation-27418
https://atc.digitellinc.com/p/s/recipient-outcomes-following-transplantation-of-allografts-from-older-live-kidney-donors-with-hypertension-27423
https://atc.digitellinc.com/p/s/external-validation-of-the-living-kidney-donor-profile-index-lkdpi-in-the-canadian-kidney-transplant-recipient-population-27428
https://atc.digitellinc.com/p/s/risk-factors-for-recurrence-and-predictors-of-response-in-kidney-transplant-recipients-with-primary-fsgs-27433
https://atc.digitellinc.com/p/s/potential-living-kidney-donors-interest-in-kidney-paired-and-non-directed-donation-27438
https://atc.digitellinc.com/p/s/apolipoprotein-l1-genotyping-in-potential-african-american-living-kidney-donors-27443
https://atc.digitellinc.com/p/s/living-donor-conversion-rates-as-a-quality-measure-for-kidney-program-efficiency-for-both-new-referrals-and-existing-listed-candidates-27448
https://atc.digitellinc.com/p/s/efficacy-and-safety-with-empagliflozin-in-renal-transplant-recipients-with-post-transplant-diabetes-mellitus-27458
https://atc.digitellinc.com/p/s/belatacept-based-simultaneous-calcineurin-inhibitor-avoidanceearly-corticosteroid-withdrawal-is-associated-with-low-new-onset-diabetes-risk-27463
https://atc.digitellinc.com/p/s/lifestyle-intervention-in-renal-transplant-recipients-a-multicenter-randomized-clinical-trial-27468
https://atc.digitellinc.com/p/s/long-term-outcomes-in-patients-with-obesity-and-renal-disease-after-sleeve-gastrectomy-27473
https://atc.digitellinc.com/p/s/recurrent-diabetic-nephropathy-despite-intensive-glycemic-control-an-observational-cohort-study-27478
https://atc.digitellinc.com/p/s/the-evolution-of-body-mass-index-after-kidney-transplantation-in-recipients-with-a-previous-laparoscopic-sleeve-gastrectomy-27483
https://atc.digitellinc.com/p/s/comparison-of-two-glucagon-like-peptide-1-analogs-glp-1-dulaglutide-vs-liraglutide-for-the-management-of-diabetes-in-solid-organ-transplant-sot-27488
https://atc.digitellinc.com/p/s/utilization-of-donor-kidneys-with-acute-kidney-injury-in-pediatric-transplantation-27498
https://atc.digitellinc.com/p/s/have-graft-outcomes-improved-for-pediatric-transplant-recipients-since-the-implementation-the-kidney-allocation-system-27503
https://atc.digitellinc.com/p/s/undernutrition-is-associated-with-impaired-t-cell-protective-immunity-in-pediatric-kidney-transplantation-27508
https://atc.digitellinc.com/p/s/differences-in-wait-time-graft-quality-and-outcome-for-pediatric-kidney-recipients-in-the-post-kidney-allocation-system-era-27513
https://atc.digitellinc.com/p/s/united-kingdom-national-outcomes-of-transplants-from-paediatric-donors-10-years-experience-27518
https://atc.digitellinc.com/p/s/effect-of-everolimus-with-reduced-exposure-tacrolimus-and-early-steroid-elimination-in-pediatric-kidney-transplant-recipients-36-month-outcomes-from-the-cradle-study-27523
https://atc.digitellinc.com/p/s/emergence-of-anti-hla-antibodies-after-catch-up-vaccinations-in-pediatric-kidney-transplant-candidates-27528
https://atc.digitellinc.com/p/s/adjuvant-immunotherapeutic-approach-for-liver-transplant-recipients-with-hepatocellular-carcinoma-using-donor-liver-derived-natural-killer-cells-27538
https://atc.digitellinc.com/p/s/prospective-multi-regional-study-of-down-staging-of-hepatocellular-carcinoma-to-within-milan-criteria-before-liver-transplantation-27543
https://atc.digitellinc.com/p/s/sustained-biologic-response-to-neoadjuvant-therapy-predicts-excellent-liver-transplant-outcomes-for-locally-advanced-intrahepatic-cholangiocarcinoma-27548
https://atc.digitellinc.com/p/s/outcomes-of-liver-transplantation-for-mixed-hepatocellular-cholangiocarcioma-27553
https://atc.digitellinc.com/p/s/predicting-hcc-recurrence-following-liver-transplant-a-machine-learning-approach-27558
https://atc.digitellinc.com/p/s/decreased-cancer-susceptibility-in-tolerant-liver-transplant-recipients-another-benefit-of-tolerance-27563
https://atc.digitellinc.com/p/s/spindle-and-kinetochore-associated-complex-subunit-3-promotes-tumor-growth-by-regulating-cdk2p53-phosphorylation-in-hepatocellular-carcinoma-27568
https://atc.digitellinc.com/p/s/transplant-center-practices-are-the-primary-drivers-of-united-states-donation-after-circulatory-death-liver-transplantation-27578
https://atc.digitellinc.com/p/s/variations-in-dcd-procurement-procedures-across-opos-and-their-effects-on-liver-transplant-outcomes-27583
https://atc.digitellinc.com/p/s/utilization-of-dcd-donors-50-years-old-for-liver-transplantation-27588
https://atc.digitellinc.com/p/s/ready-for-prime-time-intentional-allocation-of-hepatitis-c-positive-livers-into-hepatitis-c-negative-recipients-27593
https://atc.digitellinc.com/p/s/a-priori-identification-of-hard-to-place-livers-27598
https://atc.digitellinc.com/p/s/continuous-distribution-lsam-simulation-study-27603
https://atc.digitellinc.com/p/s/dome-a-new-strategy-for-prioritizing-hepatocellular-carcinoma-patients-on-the-liver-transplant-waitlist-27608
https://atc.digitellinc.com/p/s/targeting-cell-metabolism-for-efficient-large-scale-expansion-of-functional-regulatory-t-cells-27618
https://atc.digitellinc.com/p/s/how-and-why-dyrk1a-is-required-for-optimal-foxp3-treg-functions-27623
https://atc.digitellinc.com/p/s/role-of-mhc-class-ii-in-b-cell-and-regulatory-t-cell-development-27628
https://atc.digitellinc.com/p/s/torc1-inhibition-in-vitro-and-in-a-humanized-mouse-model-protects-activated-human-regulatory-t-cells-from-self-inflicted-damage-via-granzyme-b-27633
https://atc.digitellinc.com/p/s/undernutrition-and-leptin-deficiency-modulates-t-cell-immunity-in-transplantation-27638
https://atc.digitellinc.com/p/s/erythropoietin-ameliorates-parent-to-f1-murine-graft-versus-host-disease-by-inhibiting-tsubfhsub-27643
https://atc.digitellinc.com/p/s/the-mir17-92-cluster-promotes-costimulation-resistant-effector-memory-t-cell-mediated-alloresponses-27648
https://atc.digitellinc.com/p/s/outcomes-for-robotic-pancreas-transplants-in-obese-candidates-27658
https://atc.digitellinc.com/p/s/long-term-survival-after-kidney-pancreas-transplantation-lessons-from-world-largest-series-of-long-term-survivors-27663
https://atc.digitellinc.com/p/s/circulating-donor-specific-antibody-and-biopsy-c4d-positivity-in-pancreas-rejection-increase-the-probability-of-earlier-return-to-insulin-after-rejection-27668
https://atc.digitellinc.com/p/s/donor-insulin-therapy-predicts-better-graft-survival-in-pancreas-transplantation-27673
https://atc.digitellinc.com/p/s/impact-of-simultaneous-pancreas-kidney-transplantation-on-cardiovascular-risk-in-type-1-diabetic-patients-27678
https://atc.digitellinc.com/p/s/repeat-pancreas-transplant-after-pancreas-graft-failure-in-simultaneous-pancreas-and-kidney-transplants-is-associated-with-better-kidney-graft-survivalbbbb-27683
https://atc.digitellinc.com/p/s/belatacept-based-cni-free-immunosuppression-in-pancreas-transplantation-results-at-4-years-27688
https://atc.digitellinc.com/p/s/the-risk-of-systematic-error-in-liver-transplant-opioid-research-27698
https://atc.digitellinc.com/p/s/african-american-living-kidney-donors-perceptions-of-apol1-genetic-testing-and-its-impact-on-ethnic-identity-27703
https://atc.digitellinc.com/p/s/use-of-latent-class-analysis-to-identify-patient-symptom-burden-subgroups-after-living-donor-kidney-transplant-27708
https://atc.digitellinc.com/p/s/patient-reported-transplant-related-symptoms-in-kidney-transplant-recipients-27713
https://atc.digitellinc.com/p/s/belatacept-treated-patients-experience-improved-health-related-quality-of-life-and-lower-symptom-distress-compared-to-cyclosporine-treated-patients-an-analysis-of-the-benefit-and-benefit-ext-cohorts-27718
https://atc.digitellinc.com/p/s/technology-triggered-adherence-intervention-preliminary-findings-27723
https://atc.digitellinc.com/p/s/alcohol-recidivism-in-liver-transplant-recipients-with-alcoholic-liver-disease-does-six-months-abstinence-rule-still-holds-true-27728
https://atc.digitellinc.com/p/s/opioid-and-benzodiazepine-use-in-lung-transplant-candidates-a-national-survey-of-policies-and-practices-27738
https://atc.digitellinc.com/p/s/the-burden-of-recipient-driving-distance-and-post-lung-transplant-outcomes-a-national-cohort-study-27743
https://atc.digitellinc.com/p/s/lung-transplant-outcomes-after-cabg-27748
https://atc.digitellinc.com/p/s/outcomes-of-adult-lung-transplant-recipients-of-donation-after-circulatory-death-allografts-in-the-us-27753
https://atc.digitellinc.com/p/s/center-variability-in-organ-offer-acceptance-and-waitlist-mortality-in-lung-transplantation-27758
https://atc.digitellinc.com/p/s/assessment-of-physical-frailty-is-positively-correlated-with-las-score-in-lung-transplant-candidates-27763
https://atc.digitellinc.com/p/s/the-impact-of-removing-dsa-as-a-first-unit-of-lung-allocation-preliminary-results-27768
https://atc.digitellinc.com/p/s/evaluation-of-influenza-virus-antibody-response-in-naturally-infected-and-vaccinated-transplant-recipients-by-protein-microarray-27778
https://atc.digitellinc.com/p/s/a-comparison-of-cell-mediated-immune-responses-among-organ-transplant-recipients-receiving-high-dose-vs-standard-dose-influenza-vaccine-27783
https://atc.digitellinc.com/p/s/vaccination-rates-and-relation-to-health-beliefs-in-inner-city-kidney-transplant-recipients-ktrs-27788
https://atc.digitellinc.com/p/s/burden-of-respiratory-syncytial-disease-among-hospitalized-immunocompromised-adults-27793
https://atc.digitellinc.com/p/s/a-single-center-experience-with-a-6-month-regimen-of-pneumocystis-jiroveci-pneumonia-prophylaxis-in-hiv-positive-kidney-transplant-recipients-27798
https://atc.digitellinc.com/p/s/the-spread-of-hiv-donation-throughout-a-dsa-27803
https://atc.digitellinc.com/p/s/liver-transplant-candidate-attitudes-towards-organs-from-increased-risk-donors-a-single-center-survey-27808
https://atc.digitellinc.com/p/s/exogenous-erythropoietin-administration-promotes-murine-cardiac-allograft-survival-via-a-myeloid-cell-dependent-mechanism-27818
https://atc.digitellinc.com/p/s/fifteen-year-outcomes-in-the-astellas-double-blind-randomized-controlled-trial-rct-comparing-early-corticosteroid-withdrawal-cswd-and-long-term-corticosteroid-therapy-continuation-ccs-in-kidney-transp-27823
https://atc.digitellinc.com/p/s/butyrate-producing-gut-bacteria-and-future-development-of-viral-infections-in-kidney-transplant-recipients-27828
https://atc.digitellinc.com/p/s/mtorc2-restricts-mtorc1-metabolic-function-in-dendritic-cells-to-limit-their-allostimulatory-activity-27838
https://atc.digitellinc.com/p/s/myeloid-axl-promotes-cardiac-allograft-vasculopathy-27843
https://atc.digitellinc.com/p/s/fty720-regulates-mitochondria-biogenesis-in-dendritic-cells-to-prevent-kidney-ischemic-reperfusion-injury-27848
https://atc.digitellinc.com/p/s/dendritic-cells-transduced-with-autoimmune-regulator-exhibit-immature-properties-and-prolong-heart-allograft-survival-27853
https://atc.digitellinc.com/p/s/tertiary-lymphoid-organs-in-renal-chronic-allograft-rejection-27858
https://atc.digitellinc.com/p/s/prolongation-of-allograft-survival-via-donor-mhc-chimerism-induced-by-exosomes-27863
https://atc.digitellinc.com/p/s/microscopic-hepatic-steatosis-prior-to-liver-transplantation-influences-clinical-outcomes-27908
https://atc.digitellinc.com/p/s/super-resolution-evaluation-of-the-glomerular-basement-membrane-changes-in-the-course-of-transplant-glomerulopathy-27913
https://atc.digitellinc.com/p/s/the-frequency-of-tissue-resident-donor-t-and-nk-cells-in-peripheral-blood-after-lung-transplantation-is-modulated-by-normothermic-ex-vivo-lung-perfusion-27918
https://atc.digitellinc.com/p/s/assessment-of-serum-tim3-and-gal9-levels-in-predicting-the-risk-of-infection-after-kidney-transplantation-27923
https://atc.digitellinc.com/p/s/targeted-proteomic-analysis-detects-acute-t-cell-mediated-kidney-allograft-rejection-in-belatacept-treated-patients-27928
https://atc.digitellinc.com/p/s/elevated-podocyte-specific-urinary-extracellular-vesicles-in-patients-with-fsgs-recurrence-after-kidney-transplantation-27933
https://atc.digitellinc.com/p/s/cytof-and-rnaseq-analyses-unravel-early-phenotypic-and-transcriptional-changes-in-antibody-secreting-and-memory-b-cells-1-year-prior-to-antibody-mediated-rejection-27938
https://atc.digitellinc.com/p/s/a-comprehensive-and-updated-analysis-of-combined-heart-kidney-transplants-utilizing-the-united-network-for-organ-sharing-database-27948
https://atc.digitellinc.com/p/s/what-are-you-smoking-the-impact-of-donor-drug-use-on-long-term-survival-post-transplant-27953
https://atc.digitellinc.com/p/s/donors-and-drugs-how-often-do-they-mix-utilization-of-donors-based-on-toxicology-findings-27958
https://atc.digitellinc.com/p/s/preliminary-results-from-a-multicenter-national-trial-of-antiviral-facilitated-transplantation-of-hepatitis-c-hearts-to-expand-the-donor-pool-27963
https://atc.digitellinc.com/p/s/how-do-we-choose-predicting-utilization-of-cardiac-donors-and-the-effect-of-era-27968
https://atc.digitellinc.com/p/s/geographic-disparities-in-heart-transplant-rates-27973
https://atc.digitellinc.com/p/s/the-national-landscape-of-heart-transplant-candidates-with-hiv-27978
https://atc.digitellinc.com/p/s/granulocyte-colony-stimulating-factor-g-csf-and-granulocyte-macrophage-colony-stimulating-factor-gm-csf-administration-augments-the-incidence-of-peripheral-blood-suppressive-regulatory-t-cells-in-nonh-27988
https://atc.digitellinc.com/p/s/mitochondrial-dysfunction-and-metabolic-reprogramming-critical-features-of-cyclosporine-a-nephrotoxicity-27993
https://atc.digitellinc.com/p/s/impact-of-selective-cd28-blockade-on-protective-immunity-to-a-murine-epstein-barr-virus-homolog-27998
https://atc.digitellinc.com/p/s/interruption-of-notch-signaling-via-blockade-of-delta-like-ligands-1-and-4-prevents-co-stimulation-blockade-resistant-allograft-rejection-28003
https://atc.digitellinc.com/p/s/dual-targeting-desensitization-with-carfilzomib-plus-lulizumab-significantly-prolongs-kidney-transplant-survival-in-allosensitized-nonhuman-primates-28008
https://atc.digitellinc.com/p/s/graft-perfusion-with-alvespimycin-an-hsp90-inhibitor-suppresses-il-2-and-il-12p40-production-in-graft-infiltrating-cells-leading-to-prolongation-of-graft-survival-in-murine-heart-transplantation-28013
https://atc.digitellinc.com/p/s/bezlotoxumab-for-prevention-of-recurrent-clostridium-difficile-infection-in-solid-organ-transplant-recipients-at-an-academic-medical-center-28028
https://atc.digitellinc.com/p/s/routine-molecular-clostridioides-difficile-screening-and-overtreatment-in-solid-organ-transplant-recipients-28033
https://atc.digitellinc.com/p/s/contemporary-us-prevalence-and-outcomes-of-pneumocystis-jirovecii-pneumonia-and-toxoplasmosis-in-pediatric-solid-organ-and-hematopoietic-cell-transplantation-recipients-28038
https://atc.digitellinc.com/p/s/infectious-complications-of-eculizumab-use-in-abdominal-organ-transplant-recipients-28043
https://atc.digitellinc.com/p/s/spontaneous-bacterial-peritonitis-prophylaxis-increases-the-risk-of-multi-drug-resistant-cultures-and-infections-in-liver-transplant-patients-28048
https://atc.digitellinc.com/p/s/predictors-of-multidrug-resistant-organisms-among-solid-organ-transplant-donors-28053
https://atc.digitellinc.com/p/s/the-outcomes-after-an-infection-in-older-liver-transplant-recipients-is-comparable-to-younger-adults-28058
https://atc.digitellinc.com/p/s/ceacam1-p38-signaling-axis-alleviates-peri-transplant-liver-injury-from-mouse-to-human-28068
https://atc.digitellinc.com/p/s/histone-deacetylase-2-knockout-in-renal-tubular-cells-is-protective-in-renal-ischemia-reperfusion-injury-28073
https://atc.digitellinc.com/p/s/glycogen-synthase-kinase-3alpha-serine-21-phosphorylation-inhibits-hepatocyte-autophagy-to-facilitate-liver-ischemia-reperfusion-injury-28078
https://atc.digitellinc.com/p/s/an-immediate-and-persistent-post-reperfusion-metabolic-collapse-precedes-delayed-graft-function-dgf-28083
https://atc.digitellinc.com/p/s/defatting-steatotic-rat-livers-during-ex-situ-normothermic-perfusion-improves-lactate-clearance-and-bile-quality-28088
https://atc.digitellinc.com/p/s/apoptosis-during-cold-ischemia-and-rewarming-involves-a-caspase-independent-pathway-28093
https://atc.digitellinc.com/p/s/recipient-antibiotics-pretreatment-protects-liver-transplants-from-ischemia-reperfusion-injury-via-prostaglandin-e2-from-bench-to-bedside-28098
https://atc.digitellinc.com/p/s/epitop-matching-predicts-immunization-in-kidney-transplant-recipients-with-allograft-failure-leading-to-worse-outcomes-28108
https://atc.digitellinc.com/p/s/c4d-positivity-in-renal-biopsies-following-asub2sub-to-b-kidney-transplantation-not-all-a-b-o-incompatibilities-are-equal-28113
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-initiates-de-novo-donor-specific-antibody-dsa-responses-28118
https://atc.digitellinc.com/p/s/humoral-immune-responses-to-kidney-associated-non-hla-antigens-is-not-associated-with-progression-to-chronic-immune-injury-in-kidney-transplant-recipients-28123
https://atc.digitellinc.com/p/s/angiotensin-ii-type-1-receptor-antibodies-improve-risk-stratification-for-kidney-allograft-outcomes-at-the-time-of-transplantation-28128
https://atc.digitellinc.com/p/s/circulating-mirnas-regulate-gene-expression-in-kidney-tissue-during-transplant-glomerulopathy-28133
https://atc.digitellinc.com/p/s/the-use-of-dd-cfdna-as-a-predictive-tool-for-outcome-decreased-kidney-function-28138
https://atc.digitellinc.com/p/s/regional-differences-in-transplantation-for-expected-post-transplant-survival-top-20-percent-candidates-28148
https://atc.digitellinc.com/p/s/measuring-and-monitoring-disparities-in-access-to-kidney-transplantation-associated-with-being-listed-for-a-multi-organ-transplant-mot-28153
https://atc.digitellinc.com/p/s/the-immigrant-bonus-non-us-deceased-donor-kidney-transplant-recipients-have-superior-outcomes-versus-us-citizen-recipients-a-retrospective-study-of-30092-subjects-using-the-organ-procurement-and-trans-28158
https://atc.digitellinc.com/p/s/dialysis-facility-profit-status-and-referral-for-kidney-transplantation-28163
https://atc.digitellinc.com/p/s/factors-related-to-international-travel-for-transplantation-among-us-listed-kidney-transplant-candidates-28168
https://atc.digitellinc.com/p/s/racialethnic-and-socio-economic-disparities-single-versus-multi-organ-transplant-recipients-28173
https://atc.digitellinc.com/p/s/hard-to-place-kidney-offers-through-the-lens-of-the-united-network-for-organ-sharing-organ-center-28178
https://atc.digitellinc.com/p/s/the-degree-of-glomerulosclerosis-in-procurement-renal-biopsy-and-its-implications-in-predicting-graft-outcomes-in-marginal-donor-kidneys-28188
https://atc.digitellinc.com/p/s/kidney-transplant-outcomes-and-organ-acceptance-practice-patterns-nationwide-analyses-of-the-us-and-france-28193
https://atc.digitellinc.com/p/s/impact-of-cold-and-warm-ischemia-time-on-outcomes-for-kidneys-donated-after-cardiac-death-28198
https://atc.digitellinc.com/p/s/increase-in-deceased-donor-acceptance-rate-after-implementing-uniform-acceptance-criteria-28203
https://atc.digitellinc.com/p/s/machine-perfusion-allows-use-of-high-kdpi-and-prolonged-cold-ischemia-time-in-deceased-donors-a-single-center-effort-to-decrease-discard-rates-28208
https://atc.digitellinc.com/p/s/kidney-donor-outcomes-50-years-post-donation-28213
https://atc.digitellinc.com/p/s/an-international-comparison-of-kidney-utilization-in-the-united-states-and-united-kingdom-what-can-be-learned-28218
https://atc.digitellinc.com/p/s/patient-reported-outcomes-in-a-prospective-multicenter-trial-of-belatacept-based-cni-and-corticosteroid-free-immunosuppression-regimens-in-kidney-transplantation-28228
https://atc.digitellinc.com/p/s/cognitive-function-and-risk-of-adverse-outcomes-in-kidney-transplant-candidates-28233
https://atc.digitellinc.com/p/s/evaluation-of-medication-burden-in-kidney-transplant-recipients-at-time-of-index-hospitalization-28238
https://atc.digitellinc.com/p/s/your-path-to-transplant-education-increases-patients-transplant-knowledge-attitudes-informed-decision-making-and-pursuit-an-randomized-controlled-trial-28243
https://atc.digitellinc.com/p/s/getting-life-back-kidney-transplantation-in-the-elderly-patient-28248
https://atc.digitellinc.com/p/s/the-effect-of-kidney-transplantation-on-neurocognitive-function-a-prospective-study-28253
https://atc.digitellinc.com/p/s/non-adherence-with-diet-and-dialysis-prescription-predictors-of-non-adherence-post-transplant-28258
https://atc.digitellinc.com/p/s/predictors-and-outcomes-of-acute-graft-versus-host-disease-after-liver-transplant-28268
https://atc.digitellinc.com/p/s/renoportal-anastomosis-in-liver-transplantation-results-from-a-propensity-score-based-outcome-analysis-28273
https://atc.digitellinc.com/p/s/the-impact-of-portal-flow-after-reperfusion-on-graft-outcomes-after-deceased-donor-liver-transplantation-28278
https://atc.digitellinc.com/p/s/the-impact-of-sleeve-gastrectomy-following-liver-transplant-in-patients-with-non-alcoholic-steatosis-a-five-year-experience-28283
https://atc.digitellinc.com/p/s/proximal-splenic-artery-embolization-for-refractory-ascites-and-hydrothorax-after-liver-transplant-a-single-center-analysis-of-factors-associated-with-success-28288
https://atc.digitellinc.com/p/s/the-impact-of-extra-anatomical-hepatic-artery-reconstruction-during-living-donor-transplantation-on-biliary-complications-and-graft-and-patient-survival-28293
https://atc.digitellinc.com/p/s/the-comparative-safety-and-efficacy-of-direct-acting-oral-anticoagulants-relative-to-warfarin-following-liver-transplantation-28298
https://atc.digitellinc.com/p/s/is-kidney-transplantation-actually-a-cost-effective-alternative-also-for-older-patients-28308
https://atc.digitellinc.com/p/s/diminishing-scientific-registry-of-transplant-recipients-risk-adjusted-mortality-reaction-to-flagging-artifact-of-modeling-or-both-28313
https://atc.digitellinc.com/p/s/the-collaborative-improvement-and-innovation-network-coiin-impact-on-deceased-donor-transplant-rates-and-offer-acceptance-practices-28318
https://atc.digitellinc.com/p/s/opo-aggressiveness-index-a-novel-opo-performance-metric-that-incentivizes-pursuit-of-marginal-deceased-donor-candidates-28323
https://atc.digitellinc.com/p/s/association-of-pretransplant-and-posttransplant-5-tier-ratings-with-candidate-mortality-after-listing-28328
https://atc.digitellinc.com/p/s/increased-access-to-transplantation-for-medicaid-patients-following-medicaid-expansion-28333
https://atc.digitellinc.com/p/s/simulated-tier-variability-28338
https://atc.digitellinc.com/p/s/external-validation-of-the-dcd-n-score-and-a-linear-prediction-model-to-identify-potential-candidates-for-donation-after-circulatory-death-a-nation-wide-cohort-study-28348
https://atc.digitellinc.com/p/s/comparison-of-minimal-incision-kidney-transplantation-with-conventional-incision-kidney-transplantation-interim-report-of-a-randomized-controlled-trial-28353
https://atc.digitellinc.com/p/s/surgeon-readiness-for-entry-into-practice-a-survey-of-abdominal-transplant-surgeons-in-the-united-states-28358
https://atc.digitellinc.com/p/s/national-trends-in-bariatric-surgical-practice-for-patients-with-end-stage-renal-disease-28363
https://atc.digitellinc.com/p/s/tdcavaline-reverse-obesity-and-ameliorate-alloimmune-responses-through-a-decreased-hypothalamic-expression-of-mch-28368
https://atc.digitellinc.com/p/s/post-operative-opioid-requirements-in-living-kidney-and-liver-donors-28373
https://atc.digitellinc.com/p/s/efficacy-and-safety-of-percutaneous-embolization-compared-with-nephrectomy-to-treat-graft-intolerance-synndrome-in-late-graft-failure-patients-28378
https://atc.digitellinc.com/p/s/cd46-transgene-modification-and-thrombosis-in-neonatal-porcine-islet-xenotransplantation-28388
https://atc.digitellinc.com/p/s/progress-using-genetically-engineered-pigs-for-lung-xenotransplantation-28393
https://atc.digitellinc.com/p/s/anti-cd154-cd40-costimulation-blockade-is-superior-to-tacrolimus-in-prolonging-survival-in-pig-to-nonhuman-primate-renal-xenotransplantation-28398
https://atc.digitellinc.com/p/s/the-role-of-cd47sirpa-and-cd47tsp-1-pathways-in-pig-to-baboon-kidney-transplantation-using-hcd47-transgenic-kidneys-28403
https://atc.digitellinc.com/p/s/newly-revealed-antibody-targets-lead-to-the-early-loss-of-triple-knockout-pig-kidneys-in-a-pig-to-baboon-model-28408
https://atc.digitellinc.com/p/s/kidney-xenotransplantation-from-genetically-engineered-pigs-to-baboons-with-fda-approved-immunosuppressive-therapy-28413
https://atc.digitellinc.com/p/s/utilizing-ides-to-eliminate-residual-antibodies-targeting-xenografts-28418
https://atc.digitellinc.com/p/s/high-numbers-of-differentiated-cd8supsupcd28sup-sup-t-cells-are-associated-with-a-substantially-lowered-risk-for-late-rejection-and-graft-loss-after-kidney-transplantation-28428
https://atc.digitellinc.com/p/s/biomarker-candidate-discovery-for-kidney-allograft-monitoring-via-urinary-exosome-proteome-analysis-28433
https://atc.digitellinc.com/p/s/microrna-375-provides-an-objective-measure-of-pancreas-quality-in-organ-donors-28438
https://atc.digitellinc.com/p/s/a-metagene-signature-of-lymphocytic-bronchitis-following-lung-transplantation-28443
https://atc.digitellinc.com/p/s/advanced-immunological-t-cell-ageing-defined-by-a-very-low-thymic-function-identifies-patients-with-a-substantial-increased-risk-for-long-term-mortality-after-kidney-transplantation-28448
https://atc.digitellinc.com/p/s/characterizing-the-dominant-phenotype-in-kidney-transplant-biopsies-improving-the-prediction-of-risk-by-a-global-view-of-rejection-injury-and-atrophy-fibrosis-28453
https://atc.digitellinc.com/p/s/gut-dysbiosis-predominates-post-transplant-diarrhea-in-kidney-transplant-recipients-a-validation-study-28458
https://atc.digitellinc.com/p/s/a-cmv-vaccine-based-on-non-replicating-lymphocytic-choriomeningitis-virus-vectors-expressing-gb-and-pp65-is-safe-and-immunogenic-in-healthy-volunteers-and-entering-a-phase-2-trial-in-kidney-transplant-28468
https://atc.digitellinc.com/p/s/donor-graft-cmv-serostatus-influences-the-development-of-arterial-and-venous-vascular-events-in-seronegative-recipients-after-organ-transplantation-28473
https://atc.digitellinc.com/p/s/letermovir-for-the-treatment-and-secondary-prophylaxis-of-drug-resistant-cmv-in-solid-organ-transplant-recipients-28483
https://atc.digitellinc.com/p/s/risk-stratification-of-cytomegalovirus-seropositive-kidney-transplant-recipients-for-cmv-infection-28488
https://atc.digitellinc.com/p/s/using-a-commercially-available-assay-that-measures-cytomegalovirus-specific-cd4-and-cd8-t-cell-immunity-to-predict-clinically-significant-cytomegalovirus-events-in-solid-organ-transplant-recipients-28493
https://atc.digitellinc.com/p/s/preemptive-therapy-is-cost-effective-when-compared-to-prophylaxis-in-cytomegalovirus-donor-positive-recipient-negative-liver-transplant-recipients-28498
https://atc.digitellinc.com/p/s/incidence-of-autoresuscitation-in-donation-after-circulatory-death-donors-28508
https://atc.digitellinc.com/p/s/occult-liver-graft-fibrosis-prior-to-transplantation-influences-clinical-outcomes-28513
https://atc.digitellinc.com/p/s/risk-factors-to-define-an-extended-criteria-donor-heart-do-not-appear-to-have-cumulative-adverse-effects-after-heart-transplantation-28518
https://atc.digitellinc.com/p/s/discard-patterns-in-donors-with-non-alcoholic-fatty-liver-disease-nafld-28523
https://atc.digitellinc.com/p/s/intra-abdominal-hypertension-and-abdominal-compartment-syndrome-an-organ-procurement-organizations-experience-28528
https://atc.digitellinc.com/p/s/organ-donation-is-an-indication-for-renal-replacement-therapy-rrt-28533
https://atc.digitellinc.com/p/s/transplanting-thoracic-organs-from-hcv-donors-to-uninfected-patients-evaluation-of-lung-allografts-28548
https://atc.digitellinc.com/p/s/success-in-lung-transplantation-outcomes-after-receiving-a-standardized-desensitization-therapy-28553
https://atc.digitellinc.com/p/s/circulating-exosomes-isolated-from-human-lung-transplant-recipients-with-respiratory-viral-infections-contain-nucleic-acids-specific-to-virus-and-can-lead-to-activation-of-stress-proteins-28558
https://atc.digitellinc.com/p/s/bronchoalveolar-lavage-biomarkers-predict-lung-transplant-survival-28563
https://atc.digitellinc.com/p/s/not-all-donor-specific-antibodies-are-equal-predictors-of-risk-of-chronic-lung-allograft-dysfunction-28568
https://atc.digitellinc.com/p/s/decline-in-club-cell-secretory-protein-results-in-immune-responses-to-lung-self-antigens-ka1-tubulin-and-collagen-v-and-development-of-chronic-rejection-following-human-lung-transplantation-28573
https://atc.digitellinc.com/p/s/association-between-respiratory-virus-infections-and-the-development-of-de-novo-hla-donor-specific-antibodies-in-lung-transplant-recipients-28578
https://atc.digitellinc.com/p/s/the-protective-effects-of-theranostic-magnetic-nanoparticles-as-carriers-for-sirna-mn-sirna-on-pancreatic-islet-cells-after-transplant-28588
https://atc.digitellinc.com/p/s/islet-xenotransplantation-a-quest-for-clinically-available-immunosuppression-regimens-28593
https://atc.digitellinc.com/p/s/preservation-of-pancreatic-islets-with-stem-cell-derived-cd34-vascular-endothelial-progenitor-cells-28598
https://atc.digitellinc.com/p/s/resolution-of-hyperglycemia-following-islet-allograft-transplantation-in-non-immunosuppressed-mice-28603
https://atc.digitellinc.com/p/s/toll-like-receptor-2-mobilizes-regulatory-t-cell-lymphatic-migration-by-stimulating-lymphotoxin-expression-28608
https://atc.digitellinc.com/p/s/omentum-an-alternative-home-for-pancreatic-islet-transplant-28613
https://atc.digitellinc.com/p/s/role-of-nf-kb-in-release-of-isletokines-via-exosomes-in-response-to-islet-stress-28618
https://atc.digitellinc.com/p/s/clazakizumab-as-an-agent-to-reduce-donor-specific-hla-antibodies-and-improve-outcomes-in-patients-with-chronic-and-active-antibody-mediated-rejection-post-kidney-transplantation-28628
https://atc.digitellinc.com/p/s/clazakizumab-clz-anti-il-6-antibody-and-tocilizumab-tcz-anti-il-6-receptor-r-antibody-treatments-differentially-affect-il-6il-6r-signaling-by-modulating-soluble-il-6r-sil-6r-and-gp130-sgp130-in-kidney-28633
https://atc.digitellinc.com/p/s/using-ensembles-of-machine-learning-classifiers-to-maximize-the-accuracy-and-stability-of-molecular-biopsy-interpretation-28638
https://atc.digitellinc.com/p/s/impact-of-belatacept-conversion-on-renal-function-histology-and-gene-expression-in-kidney-transplant-patients-with-chronic-active-antibody-mediated-rejection-28643
https://atc.digitellinc.com/p/s/comparing-antibody-mediated-rejection-with-or-without-detectable-dsa-similar-pathology-and-similar-poor-prognosis-28648
https://atc.digitellinc.com/p/s/long-term-outcomes-using-tocilizumab-for-the-treatment-of-chronic-antibody-mediated-rejection-28653
https://atc.digitellinc.com/p/s/a-prospective-randomized-multicenter-trial-b-e-s-t-trial-of-belatacept-based-c-n-i-and-corticosteroid-free-immunosuppression-final-two-year-results-28668
https://atc.digitellinc.com/p/s/conversion-from-calcineurin-inhibitors-to-belatacept-in-kidney-recipients-with-donor-specific-anti-hla-antibodies-and-calcineurin-inhibitor-nephrotoxicity-decreases-the-pathogenicity-of-donor-specific-28673
https://atc.digitellinc.com/p/s/predictors-of-graft-function-improvement-after-conversion-from-calcineurin-inhibitors-to-belatacept-in-kidney-recipients-with-calcineurin-inhibitor-nephrotoxicity-28678
https://atc.digitellinc.com/p/s/belatacept-monotherapy-in-kidney-transplant-recipients-with-failed-allografts-reduces-humoral-sensitization-in-a-single-center-randomized-controlled-trial-28683
https://atc.digitellinc.com/p/s/four-year-follow-up-of-kidney-transplantation-using-alemtuzumab-induction-and-belataceptsirolimus-maintenance-therapy-28688
https://atc.digitellinc.com/p/s/comparative-analysis-of-belatacept-and-mycophenolate-monotherapy-based-regimens-for-hla-identical-living-donor-kidney-transplantation-28693
https://atc.digitellinc.com/p/s/impact-of-belatacept-conversion-on-renal-function-histology-and-gene-expression-in-kidney-transplant-patients-with-interstitial-fibrosis-and-tubular-atrophy-28698
https://atc.digitellinc.com/p/s/6-minute-walk-testing-in-patients-on-the-kidney-transplant-waitlist-28708
https://atc.digitellinc.com/p/s/the-more-you-wait-the-more-you-lose-prostatectomy-and-kidney-transplant-waiting-time-in-end-stage-renal-disease-28713
https://atc.digitellinc.com/p/s/comparison-of-pregnancy-outcomes-by-conception-age-in-female-kidney-transplant-recipients-28718
https://atc.digitellinc.com/p/s/cardiovascular-mortality-in-transplant-patients-a-population-based-cohort-study-1988-2013-in-australia-and-new-zealand-28723
https://atc.digitellinc.com/p/s/extremes-of-body-mass-index-is-associated-with-inferior-renal-allograft-outcomes-in-type-2-diabetic-deceased-donor-renal-transplant-recipients-28728
https://atc.digitellinc.com/p/s/lower-extremity-impairment-and-frailty-among-adults-with-diabetes-awaiting-kidney-transplantation-28733
https://atc.digitellinc.com/p/s/aki-and-long-term-risk-for-cardiovascular-events-in-patients-after-kidney-transplantation-28738
https://atc.digitellinc.com/p/s/increase-in-48-month-cumulative-acute-rejection-rates-in-the-most-recent-cohort-the-2018-transplant-report-of-the-north-american-pediatric-renal-trials-and-collaborative-studies-naprtcs-28748
https://atc.digitellinc.com/p/s/epstein-barr-virus-ebv-specific-t-cells-as-a-diagnostic-marker-for-the-individual-ebv-specific-immune-response-after-pediatric-kidney-transplantation-28753
https://atc.digitellinc.com/p/s/standardizing-blood-pressure-measurement-across-17-pediatric-transplant-centers-the-improving-renal-outcomes-collaborative-28758
https://atc.digitellinc.com/p/s/elevated-donor-derived-cell-free-dna-dd-cfdna-levels-in-the-presence-of-donor-specific-antibodies-dsa-are-a-strong-predictor-of-antibody-mediated-rejection-abmr-in-pediatric-renal-transplant-recipient-28763
https://atc.digitellinc.com/p/s/tocilizumab-for-refractory-antibody-mediated-rejection-in-pediatric-kidney-transplantation-28768
https://atc.digitellinc.com/p/s/antithymocyte-globulin-is-associated-with-mature-t-cell-phenotypes-and-decreased-risk-of-non-ebv-infections-in-transplanted-children-28773
https://atc.digitellinc.com/p/s/successful-use-of-hizentra-to-address-bk-viremia-in-pediatric-transplant-population-28778
https://atc.digitellinc.com/p/s/not-for-the-faint-of-heart-the-impact-of-post-reperfusion-syndrome-during-liver-transplantation-using-livers-with-significant-macrosteatosis-28788
https://atc.digitellinc.com/p/s/reduction-in-waitlist-time-using-hcv-positive-liver-grafts-in-hcv-negative-recipients-28793
https://atc.digitellinc.com/p/s/digital-imaging-software-vs-the-eyeball-method-in-quantifying-steatosis-in-a-liver-biopsy-28798
https://atc.digitellinc.com/p/s/nothing-lasts-forever-so-of-the-donor-risk-index-for-liver-transplant-28808
https://atc.digitellinc.com/p/s/expanding-the-donor-pool-with-extended-criteria-dcd-livers-28813
https://atc.digitellinc.com/p/s/hope-in-action-a-multicenter-prospective-study-of-hiv-to-hiv-liver-transplantation-28818
https://atc.digitellinc.com/p/s/not-all-poor-metabolizers-are-clinically-equal-evaluating-weight-based-tacrolimus-outcomes-in-cyp3a-loss-of-function-variants-28828
https://atc.digitellinc.com/p/s/impact-of-liver-recipient-genotype-on-tacrolimus-28833
https://atc.digitellinc.com/p/s/tacrolimus-pharmacokinetics-in-young-middle-age-and-older-renal-transplant-recipients-impact-of-cyp3a5367-metabolic-composite-28838
https://atc.digitellinc.com/p/s/polymorphisms-in-mycophenolate-mofetil-glucuronidation-gene-are-associated-with-leukopenia-and-decreased-clad-free-survival-28848
https://atc.digitellinc.com/p/s/association-of-tacrolimus-level-variance-with-de-novo-dsa-within-the-first-2-years-after-renal-transplantation-28853
https://atc.digitellinc.com/p/s/intravenous-immunoglobulin-significantly-reduces-bioavailability-of-concomitantly-administered-anti-c5-monoclonal-antibodies-28858
https://atc.digitellinc.com/p/s/capitalizing-on-donor-density-to-increase-organ-pool-an-analysis-of-urban-and-rural-organ-donors-28868
https://atc.digitellinc.com/p/s/association-between-medicaid-expansion-under-the-affordable-care-act-and-preemptive-kidney-transplantation-of-low-income-medicaid-beneficiaries-28873
https://atc.digitellinc.com/p/s/creating-geographic-catchment-areas-for-solid-organ-transplant-centers-28878
https://atc.digitellinc.com/p/s/changes-in-the-fate-of-kdpi-35-percent-kidneys-before-and-after-implementation-of-the-new-kidney-allocation-system-28883
https://atc.digitellinc.com/p/s/wide-geographic-variability-in-the-proportion-of-donors-with-cardiac-death-lost-opportunities-for-organ-donation-28888
https://atc.digitellinc.com/p/s/a-15-year-experience-with-kidney-transplant-in-undocumented-immigrants-outcomes-and-an-argument-for-transplantation-28893
https://atc.digitellinc.com/p/s/geographic-trends-in-drug-intoxicated-deceased-donor-recovery-and-utilization-28898
https://atc.digitellinc.com/p/s/policy-changes-in-facilitated-pancreas-allocation-support-pancreas-utilization-28913
https://atc.digitellinc.com/p/s/pancreas-transplant-alone-using-donation-after-cardiac-death-donors-has-similar-outcomes-as-donation-after-brain-death-donors-28918
https://atc.digitellinc.com/p/s/pancreata-from-donors-with-renal-insufficiency-viable-for-transplant-28923
https://atc.digitellinc.com/p/s/outcomes-after-simultaneous-kidney-pancreas-versus-pancreas-after-kidney-transplantation-28928
https://atc.digitellinc.com/p/s/simultaneous-pancreas-and-kidney-transplant-outcomes-after-induction-therapy-with-thymoglobulin-compared-with-alemtuzumab-28933
https://atc.digitellinc.com/p/s/portal-endocrine-and-gastric-exocrine-drainage-technique-in-pancreatic-transplantation-28938
https://atc.digitellinc.com/p/s/b-cell-il-4-signaling-induces-the-il-10-secreting-tim-1-bregs-and-suppresses-t-cell-inflammatory-cytokines-28948
https://atc.digitellinc.com/p/s/high-fibre-diet-prevents-transplant-associated-dysbiosis-and-prevents-kidney-allograft-rejection-28953
https://atc.digitellinc.com/p/s/treg-and-bone-marrow-infusion-promotes-survival-of-donor-kidney-grafted-months-after-disappearance-of-mixed-chimerism-28963
https://atc.digitellinc.com/p/s/murine-cmv-infection-impairs-transplantation-tolerance-a-critical-role-of-intragraft-anergic-cd4-t-cells-28968
https://atc.digitellinc.com/p/s/tolerance-induction-by-myeloid-progenitor-cells-modulates-t-and-b-cell-responses-28973
https://atc.digitellinc.com/p/s/implication-of-melanocortin-receptors-in-alloimmunity-28978
https://atc.digitellinc.com/p/s/a-kidney-transplant-recipient-with-severe-acute-gvhd-promptly-rescued-by-donor-hla-targeted-serotherapy-28983
https://atc.digitellinc.com/p/s/pediatric-liver-retransplantation-prognostic-scoring-tool-29033
https://atc.digitellinc.com/p/s/lymphotoxin-beta-receptor-in-lymphatic-endothelial-cells-regulates-treg-migration-and-allograft-protection-29038
https://atc.digitellinc.com/p/s/actions-speak-louder-than-labs-the-impact-of-dialysis-compliance-on-posttransplant-outcomes-29043
https://atc.digitellinc.com/p/s/urinary-cell-mrna-sequencing-profiles-of-kidney-allograft-recipients-mirror-intragraft-events-and-demonstrate-enrichment-for-immune-cells-29053
https://atc.digitellinc.com/p/s/extracellular-vesicles-ev-mediate-antibody-independent-tubular-senescence-via-cyclin-dependent-kinase-inhibitors-p21p16-in-antibody-mediated-rejection-amr-29058
https://atc.digitellinc.com/p/s/plasmacytoid-dendritic-cell-mediated-graft-prolongation-requires-microrna-181-and-semaphorin-4a-29063
https://atc.digitellinc.com/p/s/platelets-augment-granzyme-k-production-by-macrophages-in-antibody-mediated-rejection-29068
https://atc.digitellinc.com/p/s/tissue-resident-memory-t-cells-in-murine-renal-transplantation-29073
https://atc.digitellinc.com/p/s/p40-homodimer-indirectly-induce-proliferation-of-endogenous-donor-reactive-memory-cd8-t-cells-within-high-risk-allografts-via-il-15-signaling-29078
https://atc.digitellinc.com/p/s/rejection-of-optic-and-sciatic-transplants-29083
https://atc.digitellinc.com/p/s/proteomics-reveals-compartment-specific-alterations-in-the-extracellular-matrix-of-kidney-allografts-with-antibody-mediated-rejection-29088
https://atc.digitellinc.com/p/s/laminin-a5-deficiency-in-lymph-node-stromal-cells-promotes-treg-migration-and-allograft-survival-29098
https://atc.digitellinc.com/p/s/regulating-t-cell-responses-by-forced-transgenic-expression-of-decay-accelerating-factor-daf-29103
https://atc.digitellinc.com/p/s/absence-of-protective-innate-lymphoid-cell-type-3-ilc3-and-persistence-of-proinflammatory-innate-lymphoid-cell-subsets-immediately-post-transplant-plays-a-appreciable-role-in-early-intestinal-barrier--29108
https://atc.digitellinc.com/p/s/local-il-33-regulates-heart-transplant-infiltrating-myeloid-cells-metabolism-and-differentiation-to-protect-against-chronic-rejection-29113
https://atc.digitellinc.com/p/s/complement-blockade-in-kidney-recipients-prevents-delayed-graft-function-and-antibody-mediated-rejection-in-non-human-primates-29118
https://atc.digitellinc.com/p/s/a-potential-role-for-ige-mediated-immune-response-in-the-pathogenesis-of-chronic-antibody-mediated-rejection-29123
https://atc.digitellinc.com/p/s/sirpa-typing-as-a-potential-tool-for-risk-stratification-in-kidney-transplantation-29128
https://atc.digitellinc.com/p/s/galectin-3-and-long-term-graft-failure-in-renal-transplant-recipients-a-prospective-cohort-study-29138
https://atc.digitellinc.com/p/s/impact-of-functional-delayed-graft-function-in-the-modern-era-of-kidney-transplantation-29143
https://atc.digitellinc.com/p/s/the-economic-burden-of-graft-failure-in-the-united-states-29148
https://atc.digitellinc.com/p/s/association-of-kdpi-and-dgf-with-dcd-kidney-transplants-outcomes-29153
https://atc.digitellinc.com/p/s/prophylactic-use-of-eculizumab-in-patients-at-high-risk-of-post-transplant-ahus-recurrence-improves-graft-outcomes-29158
https://atc.digitellinc.com/p/s/keeping-patients-lifetime-perspective-in-focus-modest-rates-and-wide-variation-in-preemptive-re-listing-for-kidney-transplantation-in-the-us-29163
https://atc.digitellinc.com/p/s/outcomes-of-single-and-en-bloc-pediatric-kidneys-according-to-kdpi-29168
https://atc.digitellinc.com/p/s/a-safe-anti-a2-titer-for-a-succesful-a2-incompatible-kidney-transplantation-29178
https://atc.digitellinc.com/p/s/kidney-transplants-outcomes-from-deceased-donors-with-acute-kidney-injury-29183
https://atc.digitellinc.com/p/s/the-effect-of-exclusive-virtual-crossmatch-to-allocate-deceased-donor-kidney-transplant-on-cold-ischemia-time-and-acute-rejection-29188
https://atc.digitellinc.com/p/s/non-immunologic-donor-recipient-pairing-hla-matching-and-graft-loss-in-deceased-donor-kidney-transplantation-29193
https://atc.digitellinc.com/p/s/multi-organ-transplant-results-in-lower-patient-and-graft-survival-than-kidney-alone-transplant-29198
https://atc.digitellinc.com/p/s/quantifying-donor-effects-on-transplant-outcomes-using-kidney-pairs-from-deceased-donors-29203
https://atc.digitellinc.com/p/s/unos-analysis-of-deceased-donor-renal-transplant-ddrtx-outcomes-in-sensitized-patients-after-implementation-of-the-kidney-allocation-system-kas-29208
https://atc.digitellinc.com/p/s/maternal-and-pregnancy-outcomes-after-living-donor-nephrectomy-in-a-multistate-cohort-29218
https://atc.digitellinc.com/p/s/center-level-variation-in-hla-incompatible-living-donor-kidney-transplantation-outcomes-29223
https://atc.digitellinc.com/p/s/living-kidney-donors-who-lose-weight-in-order-to-be-able-to-donate-gain-more-weight-after-donation-29228
https://atc.digitellinc.com/p/s/racial-variation-in-esrd-diagnosis-patterns-among-prior-living-kidney-donors-on-the-optn-kidney-waiting-list-29233
https://atc.digitellinc.com/p/s/sub-optimal-renal-recovery-and-progressive-chronic-kidney-disease-after-living-kidney-donation-29238
https://atc.digitellinc.com/p/s/changes-in-kidney-function-following-live-donor-nephrectomy-29243
https://atc.digitellinc.com/p/s/chronic-changes-on-time-zero-living-donor-allograft-biopsy-do-not-portend-future-kidney-function-29248
https://atc.digitellinc.com/p/s/the-end-of-non-directed-living-kidney-donation-the-national-kidney-registrys-family-voucher-program-29258
https://atc.digitellinc.com/p/s/global-kidney-exchange-29263
https://atc.digitellinc.com/p/s/compatible-pairs-in-paired-kidney-exchange-are-there-winners-and-loosers-29268
https://atc.digitellinc.com/p/s/are-we-underestimating-the-number-of-paired-kidney-exchange-transplants-in-the-united-states-relationship-insights-from-the-national-kidney-registry-29273
https://atc.digitellinc.com/p/s/transplant-nephrologist-29278
https://atc.digitellinc.com/p/s/kidney-paired-donation-transplant-outcomes-experiences-from-the-first-ten-years-of-the-national-kidney-registry-29283
https://atc.digitellinc.com/p/s/social-loafing-distribution-of-kidneys-with-multiple-renal-arteries-in-a-national-paired-kidney-exchange-program-29288
https://atc.digitellinc.com/p/s/impact-of-race-and-substance-use-on-listing-decisions-for-kidney-transplant-29298
https://atc.digitellinc.com/p/s/the-implementation-and-impact-of-an-opioid-minimization-protocol-in-an-urban-renal-transplant-population-29303
https://atc.digitellinc.com/p/s/kidney-transplantation-in-the-lower-income-bracket-of-south-korea-widening-gap-in-accessibility-and-inferior-graft-outcome-29308
https://atc.digitellinc.com/p/s/higher-level-of-social-support-is-associated-with-higher-likelihood-of-pursuit-of-living-donor-kidney-transplant-ldkt-29313
https://atc.digitellinc.com/p/s/the-risk-of-systematic-error-in-kidney-transplant-opioid-research-29318
https://atc.digitellinc.com/p/s/access-to-the-kidney-transplant-waitlist-for-patients-with-hiv-and-end-stage-renal-disease-29323
https://atc.digitellinc.com/p/s/earlier-transplant-education-as-ckd-progresses-ckd-3-5-patients-and-providers-weigh-in-29328
https://atc.digitellinc.com/p/s/factors-associated-with-cardiovascular-subclinical-target-organ-damage-in-liver-transplant-recipients-29378
https://atc.digitellinc.com/p/s/global-and-domain-specific-cognition-in-liver-transplant-recipients-29383
https://atc.digitellinc.com/p/s/management-of-anastomotic-biliary-strictures-after-liver-transplant-role-of-covered-metal-stents-29388
https://atc.digitellinc.com/p/s/post-liver-transplant-atrial-fibrillation-is-associated-with-markedly-reduced-short-and-long-term-patient-survival-29393
https://atc.digitellinc.com/p/s/presence-of-dsa-class-2-is-associated-with-fibrosis-progression-after-olt-29398
https://atc.digitellinc.com/p/s/meld-score-and-anti-angiotensin-receptor-antibody-predict-long-term-survival-of-liver-re-transplant-29403
https://atc.digitellinc.com/p/s/impact-of-coronary-artery-disease-on-long-term-mortality-after-liver-transplantation-29408
https://atc.digitellinc.com/p/s/difficult-outflow-reconstruction-using-eptfe-vascular-grafts-in-ldlt-technical-innovations-and-outcomes-29428
https://atc.digitellinc.com/p/s/donor-safety-for-minimal-invasive-hepatectoy-in-liver-transplantation-the-korean-organ-transplantation-registry-29433
https://atc.digitellinc.com/p/s/a-novel-program-of-directed-domino-and-split-liver-donations-increases-liver-transplants-29438
https://atc.digitellinc.com/p/s/primary-indications-and-waitlist-status-for-pediatric-living-donor-liver-transplants-ldlts-29443
https://atc.digitellinc.com/p/s/adult-living-donor-vs-deceased-donor-liver-transplant-ldlt-vs-ddlt-at-a-single-us-center-time-to-change-our-paradigm-for-liver-transplant-29448
https://atc.digitellinc.com/p/s/using-transplant-referral-regions-to-measure-access-to-kidney-transplant-29498
https://atc.digitellinc.com/p/s/center-level-probability-of-kidney-transplant-varies-considerably-for-waitlisted-patients-29503
https://atc.digitellinc.com/p/s/a-randomized-controlled-trial-of-interventions-to-promote-walking-after-abdominal-organ-transplantation-the-lift-study-29508
https://atc.digitellinc.com/p/s/trends-and-geographic-variation-in-the-recovery-of-organs-from-drug-overdose-deaths-with-donor-potential-29513
https://atc.digitellinc.com/p/s/reduction-in-early-readmission-in-kidney-recipients-outcomes-at-one-year-with-standardized-intensive-follow-up-29518
https://atc.digitellinc.com/p/s/variation-in-racial-disparities-in-liver-transplant-outcomes-by-hospital-quality-29523
https://atc.digitellinc.com/p/s/multicenter-cohort-study-of-frailty-and-access-to-kidney-transplantation-29528
https://atc.digitellinc.com/p/s/economic-impact-of-donor-hepatitis-c-kidney-transplantation-a-medicare-cost-analysis-29538
https://atc.digitellinc.com/p/s/improving-access-to-lung-transplant-through-donor-strategy-a-decision-analysis-29543
https://atc.digitellinc.com/p/s/incorporating-tangible-benefits-into-the-risk-benefit-analysis-of-living-organ-donation-decisions-29548
https://atc.digitellinc.com/p/s/the-increasing-financial-challenge-of-liver-transplantation-29553
https://atc.digitellinc.com/p/s/the-clinical-and-economic-impact-of-allosensitization-in-liver-alone-and-simultaneous-liver-kidney-transplantation-29558
https://atc.digitellinc.com/p/s/the-impact-of-transplant-hospital-organ-procurement-on-medicare-cost-report-reimbursement-29563
https://atc.digitellinc.com/p/s/patient-perspectives-of-informed-consent-for-deceased-donor-organ-intervention-research-29568
https://atc.digitellinc.com/p/s/quantifying-differential-infection-risks-in-hla-andor-abo-incompatible-kidney-transplant-recipients-29578
https://atc.digitellinc.com/p/s/evolution-of-hhv6-and-cmv-specific-t-cell-functional-responses-and-immune-cell-populations-after-kidney-transplant-29583
https://atc.digitellinc.com/p/s/nationwide-survey-of-human-t-cell-leukemia-virus-type-1-infected-kidney-transplant-recipients-in-japan-29588
https://atc.digitellinc.com/p/s/vaccine-response-as-a-predictor-of-kidney-transplant-rejection-and-serious-infection-29593
https://atc.digitellinc.com/p/s/risk-factors-for-1-5-year-major-infection-events-mie-after-kidney-transplant-ktx-including-first-year-immunosuppression-is-data-an-analysis-of-the-choosing-immune-suppression-in-renal-transplantation--29598
https://atc.digitellinc.com/p/s/the-impact-of-antibiotic-therapy-on-clinical-outcomes-in-kidney-transplant-recipients-with-asymptomatic-bacteriuria-29603
https://atc.digitellinc.com/p/s/infectious-complications-in-tocilizumab-treated-kidney-transplant-recipients-29608
https://atc.digitellinc.com/p/s/successful-weaning-of-parenteral-nutrition-after-serial-transverse-enteroplasty-the-largest-series-of-adult-short-gut-syndrome-patients-29618
https://atc.digitellinc.com/p/s/the-role-of-the-t-regulatory-cell-compartment-in-intestinal-transplant-patients-helpful-or-unhinged-29623
https://atc.digitellinc.com/p/s/an-international-multicentre-validation-study-of-the-toronto-listing-criteria-for-pediatric-intestinal-transplant-29628
https://atc.digitellinc.com/p/s/surgical-management-of-five-hundred-patients-with-chronic-gut-failure-at-a-single-center-autologous-reconstruction-versus-transplantation-29633
https://atc.digitellinc.com/p/s/a-national-survey-of-immunosuppression-strategies-in-intestinal-transplantation-29638
https://atc.digitellinc.com/p/s/first-report-and-mechanistic-analysis-of-operational-tolerance-after-intestinal-transplant-29643
https://atc.digitellinc.com/p/s/visceral-arterial-embolization-an-important-tool-for-managing-blood-loss-in-multivisceral-transplant-candidates-with-portomesenteric-thrombosis-29648
https://atc.digitellinc.com/p/s/pre-transplant-transcriptomic-signature-in-peripheral-blood-predicts-early-acute-rejection-after-kidney-transplant-29658
https://atc.digitellinc.com/p/s/promotion-of-chimerism-by-lymphohematopoietic-graft-versus-host-responses-in-patients-receiving-intestinal-transplantation-29663
https://atc.digitellinc.com/p/s/monitoring-circulating-t-follicular-helper-cells-polarization-activation-and-function-distinguishes-asymptomatic-donor-specific-anti-hla-antibody-positive-kidney-transplant-recipients-from-those-under-29668
https://atc.digitellinc.com/p/s/significantly-high-foxp3-mrna-in-the-renal-allograft-as-a-mechanism-of-tolerance-induced-by-transient-mixed-chimerism-in-non-human-primates-29673
https://atc.digitellinc.com/p/s/a-single-measurement-of-torque-teno-virus-helps-to-predict-mortality-in-renal-transplant-patients-29678
https://atc.digitellinc.com/p/s/outcomes-and-clinical-utility-of-the-ksort-assay-in-the-prism-prospective-clinical-trial-of-highly-sensitized-kidney-transplant-recipients-29688
https://atc.digitellinc.com/p/s/total-parenteral-nutrition-in-ex-vivo-lung-perfusion-addressing-metabolism-improves-both-inflammation-and-overall-graft-performance-29698
https://atc.digitellinc.com/p/s/normothermic-ex-vivo-kidney-perfusion-preservation-consistently-improves-extreme-marginal-graft-function-compared-to-hypothermic-machine-perfusion-29703
https://atc.digitellinc.com/p/s/donation-after-circulatory-death-kidneys-with-prolonged-delayed-graft-function-present-widespread-metabolic-and-translational-deficiencies-at-time-of-retrieval-29708
https://atc.digitellinc.com/p/s/ex-vivo-normothermic-perfusion-of-discarded-human-kidneys-reveals-cold-storage-induced-renal-fibrinogen-and-provides-a-platform-for-therapeutic-repair-29713
https://atc.digitellinc.com/p/s/organ-resilience-contributes-to-different-impact-of-delayed-graft-function-dgf-on-graft-survival-in-kidneys-donated-by-brain-death-dbd-and-circulatory-death-donors-dcd-29718
https://atc.digitellinc.com/p/s/effects-of-static-subnormothermic-preservation-of-extended-warm-ischemic-porcine-kidneys-assessed-by-ex-vivo-machine-perfusion-and-renal-transplant-model-29723
https://atc.digitellinc.com/p/s/mir-20a-inhibits-autophagy-by-targeting-akt-and-bim-in-renal-reperfusion-injury-29728
https://atc.digitellinc.com/p/s/effect-of-induction-therapy-on-outcomes-of-de-novo-renal-transplant-recipients-receiving-everolimus-with-reduced-dose-calcineurin-inhibitor-24-month-results-from-the-transform-study-29738
https://atc.digitellinc.com/p/s/to-each-their-own-center-level-variation-in-tailoring-induction-immunosuppression-to-kidney-transplant-recipients-29748
https://atc.digitellinc.com/p/s/association-of-lymphocyte-depleting-antibody-and-steroids-induction-with-the-risk-and-outcomes-of-post-transplant-diabetes-analysis-of-deceased-donor-kidney-transplants-29753
https://atc.digitellinc.com/p/s/basiliximab-versus-t-cell-depleting-induction-therapy-in-elderly-kidney-transplant-recipients-29763
https://atc.digitellinc.com/p/s/age-related-effects-on-thymic-output-and-homeostatic-t-cell-expansion-following-depletional-induction-29768
https://atc.digitellinc.com/p/s/is-alemtuzumab-induction-safe-in-septuagenarians-undergoing-deceased-donor-kidney-transplantation-29773
https://atc.digitellinc.com/p/s/increasing-time-in-therapeutic-range-of-tacrolimus-is-associated-with-superior-outcomes-in-living-kidney-transplants-29783
https://atc.digitellinc.com/p/s/ten-year-follow-up-of-a-phase-2-clinical-trial-to-induce-tolerance-in-living-donor-renal-transplant-recipients-29788
https://atc.digitellinc.com/p/s/improving-medication-adherence-and-outcomes-in-adult-kidney-transplant-patients-using-systemchange-results-of-the-medication-adherence-given-individual-change-magic-randomized-clinical-trial-29793
https://atc.digitellinc.com/p/s/tacrolimus-concentrations-can-be-reliably-measured-in-capillary-microsamples-29798
https://atc.digitellinc.com/p/s/patient-centered-auc-monitoring-of-tacrolimus-using-capillary-microsampling-29803
https://atc.digitellinc.com/p/s/lcp-tacrolimus-lcpt-envarsus-xr-dosing-considerations-in-de-novo-kidney-transplant-recipients-29808
https://atc.digitellinc.com/p/s/impact-of-once-daily-tacrolimus-on-trough-concentration-variability-in-stable-adolescent-and-young-adult-renal-transplant-recipients-29813
https://atc.digitellinc.com/p/s/opening-the-doors-of-hope-hiv-positive-living-kidney-donation-29823
https://atc.digitellinc.com/p/s/care-of-international-living-kidney-donor-candidates-in-the-us-a-survey-of-contemporary-experience-practice-and-challenges-29828
https://atc.digitellinc.com/p/s/assessing-pressure-to-donate-among-potential-living-kidney-donors-29833
https://atc.digitellinc.com/p/s/kidney-evaluation-in-living-kidney-donors-survey-of-us-transplant-centers-2018-29838
https://atc.digitellinc.com/p/s/estimated-glomerular-filtration-rate-at-donor-screening-to-predict-measured-glomerular-filtration-rate-after-living-kidney-donation-29843
https://atc.digitellinc.com/p/s/the-model-for-predicting-egfr-at-a-year-after-donation-in-living-related-kidney-transplant-donors-29848
https://atc.digitellinc.com/p/s/metabolic-and-cardiovascular-evaluation-in-living-kidney-donors-survey-of-us-transplant-centers-2018-29853
https://atc.digitellinc.com/p/s/vosub2peak-subsuperior-to-current-established-measure-of-post-kidney-transplant-survival-score-epts-score-29863
https://atc.digitellinc.com/p/s/can-cardiac-risk-predictor-models-be-trusted-in-kidney-transplant-recipients-29868
https://atc.digitellinc.com/p/s/positron-emission-tomography-pet-ct-global-coronary-flow-reserve-cfr-stratifies-cardiovascular-risk-among-renal-transplant-rtx-candidates-29873
https://atc.digitellinc.com/p/s/aorto-iliac-calcification-is-a-risk-factor-for-inferior-patient-and-graft-survival-in-kidney-transplant-recipients-a-systematic-review-and-meta-analysis-29878
https://atc.digitellinc.com/p/s/the-benefit-of-kidney-transplantation-over-the-waitlist-depends-on-the-patients-comorbidities-29883
https://atc.digitellinc.com/p/s/pre-transplant-cardiac-work-up-does-not-predict-post-transplant-cardiac-events-at-one-year-among-kidney-and-pancreas-transplant-recipients-29888
https://atc.digitellinc.com/p/s/protocol-cardiac-cathaterization-in-renal-transplant-candidates-29893
https://atc.digitellinc.com/p/s/epidemiology-and-outcomes-of-bkv-nephropathy-management-by-screening-policy-in-a-real-life-setting-29903
https://atc.digitellinc.com/p/s/impact-of-subclinical-bk-virus-associated-nephropathy-in-high-risk-recipients-29908
https://atc.digitellinc.com/p/s/deceased-donor-acute-kidney-injury-associates-with-less-bk-viremia-in-kidney-transplant-recipients-29913
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-in-urine-identifies-bkvn-with-graft-injury-in-bk-viruria-kidney-transplant-recipients-29918
https://atc.digitellinc.com/p/s/the-complexity-of-t-cell-mediated-rejection-scenarios-identifying-bk-in-biopsies-with-tcmr-29923
https://atc.digitellinc.com/p/s/predictors-of-response-to-intravenous-immunoglobulin-for-treatment-of-polyoma-nephropathy-29928
https://atc.digitellinc.com/p/s/concurrent-session-kidney-polyoma-29933
https://atc.digitellinc.com/p/s/concentric-circles-one-year-in-concentrated-organ-discard-and-waitlist-deaths-in-high-traffic-areas-29943
https://atc.digitellinc.com/p/s/ultra-short-duration-direct-acting-anti-viral-prophylaxis-to-prevent-virus-transmission-from-hepatitis-c-viremic-donors-to-hepatitis-c-negative-kidney-transplant-recipients-29948
https://atc.digitellinc.com/p/s/treg-suppressor-function-within-allografts-is-required-for-tolerance-29953
https://atc.digitellinc.com/p/s/treatment-modality-affects-outcomes-of-recurrent-hepatocellular-carcinoma-following-liver-transplantation-a-us-multicenter-analysis-of-2786-patients-29958
https://atc.digitellinc.com/p/s/after-10-years-the-results-of-hla-mismatched-combined-kidney-and-bone-marrow-transplantation-for-renal-allograft-tolerance-29963
https://atc.digitellinc.com/p/s/donate-hcv-trial-transplanting-thoracic-organs-from-hepatitis-c-donors-to-uninfected-patients-29968
https://atc.digitellinc.com/p/s/cni-free-therapy-with-iscalimab-anti-cd40-mab-preserves-allograft-histology-compared-to-standard-of-care-after-kidney-transplantation-29973
https://atc.digitellinc.com/p/s/a-randomized-controlled-clinical-trial-of-thymoglobulin-r-and-extended-delay-of-calcineurin-inhibitor-therapy-for-renal-protection-after-liver-transplantation-a-multicenter-study-29983
https://atc.digitellinc.com/p/s/recipients-with-model-for-end-stage-liver-disease-sodium-score-driven-by-renal-dysfunction-have-increased-post-transplant-mortality-29988
https://atc.digitellinc.com/p/s/early-impact-of-the-new-unos-slk-allocation-policy-improved-standardization-but-similar-utilization-29993
https://atc.digitellinc.com/p/s/hephaistos-study-outcome-on-renal-function-after-12-month-everolimus-plus-reduced-tacrolimus-in-de-novo-liver-transplant-recipients-versus-standard-tacrolimus-29998
https://atc.digitellinc.com/p/s/chronic-kidney-disease-among-liver-transplant-candidates-a-rising-burden-and-its-impact-on-post-liver-transplant-outcomes-30003
https://atc.digitellinc.com/p/s/the-use-of-native-kidney-biopsy-to-predict-renal-dysfunction-following-liver-transplantation-30008
https://atc.digitellinc.com/p/s/donation-after-cardiac-death-simultaneous-liver-kidney-an-updated-perspective-30013
https://atc.digitellinc.com/p/s/patterns-and-predictors-of-alcohol-use-after-early-liver-transplant-for-alcoholic-hepatitis-30023
https://atc.digitellinc.com/p/s/frailty-and-bmi-in-liver-transplant-candidates-9-center-functional-assessment-in-liver-transplantation-study-30028
https://atc.digitellinc.com/p/s/impact-of-recipient-age-in-combined-liver-kidney-transplantation-clkt-caution-is-needed-for-elderly-patients70-years-30033
https://atc.digitellinc.com/p/s/elevated-visceral-adiposity-is-associated-with-post-liver-transplant-mortality-and-poorly-correlates-with-bmi-in-a-prospective-cohort-study-30038
https://atc.digitellinc.com/p/s/halt-hcc-at-the-time-of-listing-is-superior-to-other-allocation-metrics-at-predicting-waitlist-dropout-an-srtr-analysis-30043
https://atc.digitellinc.com/p/s/favorable-waitlist-outcomes-in-patients-with-alcoholic-liver-disease-in-the-meld-na-era-30048
https://atc.digitellinc.com/p/s/tips-effectively-treats-refractory-hepatic-hydrothorax-a-multi-center-us-retrospective-study-of-1260-patients-30053
https://atc.digitellinc.com/p/s/selective-cd28-blockade-mediated-inhibition-of-t-follicular-helper-cell-and-dsa-responses-is-ctla-4-dependent-30068
https://atc.digitellinc.com/p/s/type-1-interferons-impair-the-key-immunoregulatory-activity-of-il-10-in-the-promotion-of-transplant-tolerance-30073
https://atc.digitellinc.com/p/s/fcghriib-is-a-novel-cdsub8sub-effector-t-cell-intrinsic-regulatory-pathway-that-correlates-with-freedom-from-rejection-in-renal-transplant-patients-30078
https://atc.digitellinc.com/p/s/lymphotoxin-signaling-regulates-t-cell-lymphatic-trafficking-30083
https://atc.digitellinc.com/p/s/memory-t-follicular-helper-cell-alloresponse-is-memory-b-cell-independent-and-inhibited-by-cd28-costimulation-blockade-30088
https://atc.digitellinc.com/p/s/circulating-donor-t-and-nk-cells-in-lung-transplantation-recipients-are-derived-from-the-donor-lung-parenchyma-and-represent-tissue-resident-memory-cells-30093
https://atc.digitellinc.com/p/s/concurrent-session-non-organ-specific-disparities-and-access-to-healthcare-ii-30103
https://atc.digitellinc.com/p/s/concurrent-session-non-organ-specific-disparities-and-access-to-healthcare-ii-30108
https://atc.digitellinc.com/p/s/concurrent-session-non-organ-specific-disparities-and-access-to-healthcare-ii-30113
https://atc.digitellinc.com/p/s/concurrent-session-non-organ-specific-disparities-and-access-to-healthcare-ii-30118
https://atc.digitellinc.com/p/s/concurrent-session-non-organ-specific-disparities-and-access-to-healthcare-ii-30123
https://atc.digitellinc.com/p/s/concurrent-session-non-organ-specific-disparities-and-access-to-healthcare-ii-30128
https://atc.digitellinc.com/p/s/concurrent-session-non-organ-specific-disparities-and-access-to-healthcare-ii-30133
https://atc.digitellinc.com/p/s/consideration-for-offering-hepatitis-c-antibody-positive-donor-grafts-to-all-patients-listed-for-transplant-30143
https://atc.digitellinc.com/p/s/optimal-timing-of-hepatitis-c-treatment-among-hivhcv-co-infected-end-stage-renal-disease-patients-pre-vs-post-transplant-30148
https://atc.digitellinc.com/p/s/hepatitis-c-treatment-and-transplant-outcomes-in-liver-transplant-recipients-with-hepatitis-c-positive-donors-30153
https://atc.digitellinc.com/p/s/hepatitis-c-positive-donor-to-negative-recipient-kidney-transplantation-a-single-center-real-world-experience-30158
https://atc.digitellinc.com/p/s/rapid-growth-of-hcv-infected-donors-for-hcv-uninfected-kidney-and-liver-transplant-recipients-in-the-united-states-30163
https://atc.digitellinc.com/p/s/renal-outcomes-from-expander-1-pilot-study-of-hcv-donor-kidneys-for-hcv-kidney-recipients-30168
https://atc.digitellinc.com/p/s/results-from-the-live-c-free-trial-30173
https://atc.digitellinc.com/p/s/opioid-minimization-in-kidney-transplant-achievable-quicker-than-you-think-30183
https://atc.digitellinc.com/p/s/role-of-procurement-and-reperfusion-biopsy-in-kidney-transplant-in-evaluating-and-predicting-outcomes-of-deceased-donor-kidneys-30188
https://atc.digitellinc.com/p/s/improving-living-donor-follow-up-30193
https://atc.digitellinc.com/p/s/using-liver-transplant-lt-data-and-analytics-to-improve-program-clinical-and-financial-performance-30198
https://atc.digitellinc.com/p/s/using-an-electronic-medical-record-tool-to-document-transplant-option-discussions-among-patients-with-egfr-20-mlmin173msup2sup-30203
https://atc.digitellinc.com/p/s/development-of-a-pharmacy-collaborative-practice-agreement-to-improve-efficiency-and-management-of-prescribing-in-a-renal-transplant-clinic-30208
https://atc.digitellinc.com/p/s/improving-the-organ-donation-process-updated-30213
https://atc.digitellinc.com/p/s/human-urine-derived-stem-cells-protect-against-renal-ischemia-reperfusion-injury-via-releasing-exosomal-mir-146a-5p-which-targets-irak1-in-a-rat-model-30223
https://atc.digitellinc.com/p/s/lineage-tracing-identifies-c-kit-cells-as-a-population-of-kidney-specific-stem-cells-during-development-and-in-acute-and-chronic-kidney-diseases-30228
https://atc.digitellinc.com/p/s/differences-of-gut-microbiota-composition-between-donor-and-recipient-may-predict-1-year-graft-function-30233
https://atc.digitellinc.com/p/s/engineering-regulatory-t-cells-with-tcr-signaling-responsive-interleukin-2-nanoparticles-provides-in-situ-suppression-of-alloimmunity-30238
https://atc.digitellinc.com/p/s/differentiation-and-characterization-of-human-endodermal-precursors-for-liver-cell-therapies-30243
https://atc.digitellinc.com/p/s/immunosuppression-increases-regenerative-potential-of-adult-rat-cardiac-progenitor-cells-in-allogeneic-rat-myocardial-infarction-model-30248
https://atc.digitellinc.com/p/s/mdscs-prolong-allogeneic-cardiac-graft-survival-by-regulating-interferon-type-1-signaling-30253
https://atc.digitellinc.com/p/s/three-year-outcomes-of-highly-sensitized-kidney-transplant-recipients-desensitized-with-imlifidase-ides-30263
https://atc.digitellinc.com/p/s/central-role-of-graft-resident-memory-t-cells-in-pathogenesis-of-gvhd-after-bowel-transplantation-30268
https://atc.digitellinc.com/p/s/abo-incompatibility-in-kidney-transplantation-can-increase-a-safety-margin-of-epitope-mismatch-levels-against-de-novo-dsa-production-30273
https://atc.digitellinc.com/p/s/alloreactive-b-cells-in-transplant-tolerant-recipients-cannot-differentiate-into-antibody-secreting-cells-but-can-suppress-donor-specific-igg-production-by-naive-b-cells-30278
https://atc.digitellinc.com/p/s/long-term-renal-function-following-islet-transplantation-in-the-clinical-islet-transplantation-consortium-30283
https://atc.digitellinc.com/p/s/intact-lymphatics-are-essential-for-costimulation-blockade-induced-lung-allograft-survival-30288
https://atc.digitellinc.com/p/s/costimulation-for-clinicians-30306
https://atc.digitellinc.com/p/s/diagnosis-of-amr-what-the-clinician-needs-to-know-30311
https://atc.digitellinc.com/p/s/basic-science-of-b-cell-mediated-rejection-from-a-clinicans-view-30316
https://atc.digitellinc.com/p/s/t-cell-subsets-what-a-clinician-needs-to-know-30321
https://atc.digitellinc.com/p/s/innate-immune-system-for-clinicians-30326
https://atc.digitellinc.com/p/s/t-regs-in-transplantation-30336
https://atc.digitellinc.com/p/s/endothelial-biology-30341
https://atc.digitellinc.com/p/s/antibody-mediated-injury-through-the-pathologists-lens-what-does-suspicious-mean-30351
https://atc.digitellinc.com/p/s/antibody-mediated-injury-from-the-nephrologists-perspective-current-dilemmas-and-future-directions-30356
https://atc.digitellinc.com/p/s/accommodation-to-antibodies-30361
https://atc.digitellinc.com/p/s/debate-pro-monitoring-for-donor-specific-antibody-on-a-routine-basis-is-necessary-30366
https://atc.digitellinc.com/p/s/debate-con-monitoring-for-donor-specific-antibody-on-a-routine-basis-is-not-necessary-30371
https://atc.digitellinc.com/p/s/debate-pro-rebuttal-30376
https://atc.digitellinc.com/p/s/debate-con-rebuttal-30381
https://atc.digitellinc.com/p/s/algorithims-for-epitope-matching-30386
https://atc.digitellinc.com/p/s/reviewing-available-data-on-outcomes-30391
https://atc.digitellinc.com/p/s/comprehensive-tour-of-non-hla-antibodies-30396
https://atc.digitellinc.com/p/s/clinical-relevance-of-non-hla-antibodies-30401
https://atc.digitellinc.com/p/s/playing-small-ball-administrative-and-clinical-challenges-30411
https://atc.digitellinc.com/p/s/innovations-in-growth-and-marketing-30416
https://atc.digitellinc.com/p/s/pros-and-cons-of-transplant-models-institutes-and-service-lines-30421
https://atc.digitellinc.com/p/s/common-errors-in-medicare-cost-report-preparation-30426
https://atc.digitellinc.com/p/s/implications-for-staffing-of-the-long-term-care-of-transplant-patients-30431
https://atc.digitellinc.com/p/s/managing-ckd-v-in-recipients-with-failing-kidney-allografts-are-transplant-nephrologists-up-to-the-task-30441
https://atc.digitellinc.com/p/s/increased-mortality-in-recipients-with-a-failed-kidney-allograft-why-so-high-30446
https://atc.digitellinc.com/p/s/outcomes-of-renal-re-transplantation-30451
https://atc.digitellinc.com/p/s/the-changing-face-of-sensitization-in-recipients-with-failing-kidney-allograft-30456
https://atc.digitellinc.com/p/s/collaborative-relationship-is-it-possible-to-improve-care-of-recipients-with-failing-kidney-allografts-30461
https://atc.digitellinc.com/p/s/molecular-approaches-to-chronic-allograft-injury-30471
https://atc.digitellinc.com/p/s/biomarkers-in-graft-rejection-30476
https://atc.digitellinc.com/p/s/single-cell-approaches-to-rejection-30481
https://atc.digitellinc.com/p/s/epigenetic-and-transplantation-30486
https://atc.digitellinc.com/p/s/dna-biomarkers-of-graft-rejection-30491
https://atc.digitellinc.com/p/s/linking-molecular-signatures-of-rejection-to-histology-30496
https://atc.digitellinc.com/p/s/learning-from-large-genonic-studies-in-transplantation-30501
https://atc.digitellinc.com/p/s/b-cell-biomarkers-for-transplantation-30506
https://atc.digitellinc.com/p/s/primary-graft-failure-in-heart-transplanation-30516
https://atc.digitellinc.com/p/s/management-of-common-post-transplant-complications-30521
https://atc.digitellinc.com/p/s/mechanical-circulatory-support-as-a-bridge-to-heart-transplantation-30526
https://atc.digitellinc.com/p/s/evaluation-for-heart-transplant-candidacy-key-concepts-30531
https://atc.digitellinc.com/p/s/monitoring-diagnosis-and-treatment-of-rejection-in-heart-transplantation-30536
https://atc.digitellinc.com/p/s/evaluation-for-lung-transplant-candidacy-key-concepts-30541
https://atc.digitellinc.com/p/s/the-use-of-mechanical-assist-devices-in-bridging-to-lung-transplantation-30546
https://atc.digitellinc.com/p/s/primary-graft-failure-in-lung-transplantation-30551
https://atc.digitellinc.com/p/s/monitoring-diagnosis-and-treatment-of-rejection-in-lung-transplantation-30556
https://atc.digitellinc.com/p/s/management-of-common-post-transplant-complications-30561
https://atc.digitellinc.com/p/s/challenges-of-nash-and-obesity-30571
https://atc.digitellinc.com/p/s/challenges-of-retransplantation-30576
https://atc.digitellinc.com/p/s/the-increasing-burden-of-renal-disease-30581
https://atc.digitellinc.com/p/s/how-to-transplant-low-meld-patients-30586
https://atc.digitellinc.com/p/s/new-and-extended-indications-for-lt-in-the-future-30591
https://atc.digitellinc.com/p/s/the-future-of-the-liver-transplant-workforce-surgeon-perspective-30596
https://atc.digitellinc.com/p/s/the-future-of-the-liver-transplant-workforce-mid-level-provider-perspective-30601
https://atc.digitellinc.com/p/s/the-future-of-the-liver-transplant-workforce-hepatologist-perspective-30606
https://atc.digitellinc.com/p/s/undocumented-immigrants-transplant-center-responsibilities-strategies-to-handle-difficult-situation-legal-and-fiscal-concerns-30616
https://atc.digitellinc.com/p/s/media-and-judicial-influence-on-optn-organ-allocation-policy-30621
https://atc.digitellinc.com/p/s/transplanting-hepc-plus-to-hepc-what-are-the-financial-implications-30626
https://atc.digitellinc.com/p/s/chronic-sorrow-a-link-to-adherence-30631
https://atc.digitellinc.com/p/s/development-of-app-staffing-models-supporting-inpt-and-outpt-tx-service-lines-30636
https://atc.digitellinc.com/p/s/apn-as-gatekeeper-in-diagnosis-of-cardiac-primary-dysfunction-30641
https://atc.digitellinc.com/p/s/avoiding-the-er-app-run-post-transplant-urgent-care-clinics-30646
https://atc.digitellinc.com/p/s/no-urine-no-problem-app-run-dgf-clinics-30651
https://atc.digitellinc.com/p/s/development-of-clinic-transplant-pharmacist-services-who-what-when-and-where-30656
https://atc.digitellinc.com/p/s/managing-infections-in-transplant-candidates-overview-of-pre-transplant-evaluation-30671
https://atc.digitellinc.com/p/s/managing-infections-in-transplant-candidates-mdros-treatment-and-does-it-affect-candidacy-30676
https://atc.digitellinc.com/p/s/managing-infections-in-transplant-candidates-lvad-infections-30681
https://atc.digitellinc.com/p/s/managing-complicated-infections-in-transplant-recipients-managing-post-transplant-tb-30686
https://atc.digitellinc.com/p/s/managing-complicated-infections-in-transplant-recipients-managing-bk-updates-in-therapeutic-options-30696
https://atc.digitellinc.com/p/s/managing-complicated-infections-in-transplant-recipients-non-aspergillus-moulds-30701
https://atc.digitellinc.com/p/s/tid-is-a-team-sport-the-cutting-edge-surgeons-perspective-of-managing-post-transplant-infections-30711
https://atc.digitellinc.com/p/s/tid-is-a-team-sport-a-day-in-the-life-the-pharmacists-role-in-management-of-sot-infections-30716
https://atc.digitellinc.com/p/s/tid-is-a-team-sporttell-me-why-the-path-to-diagnosis-of-sot-infections-30721
https://atc.digitellinc.com/p/s/cases-in-transplant-infections-stump-the-expert-30726
https://atc.digitellinc.com/p/s/getting-over-the-hump-barriers-of-hiv-pre-kidney-transplant-evaluation-30738
https://atc.digitellinc.com/p/s/pumping-up-the-pool-soliciting-hiv-plus-kidney-donors-30743
https://atc.digitellinc.com/p/s/in-the-home-stretch-successful-hiv-post-kidney-transplant-care-30748
https://atc.digitellinc.com/p/s/20-years-of-contributions-to-alf-management-an-update-from-the-alfsg-30758
https://atc.digitellinc.com/p/s/does-my-alf-patient-need-a-liver-transplant-30763
https://atc.digitellinc.com/p/s/successful-management-of-the-patient-with-acute-liver-failure-and-when-is-it-futile-30768
https://atc.digitellinc.com/p/s/antibody-accommodation-in-tissues-30778
https://atc.digitellinc.com/p/s/antibody-functionality-through-glycosylation-30783
https://atc.digitellinc.com/p/s/antibody-functions-in-grafts-30788
https://atc.digitellinc.com/p/s/understanding-regulation-of-antibody-production-30798
https://atc.digitellinc.com/p/s/emerging-therapies-for-desensitization-30803
https://atc.digitellinc.com/p/s/managing-de-novo-dsa-after-heart-transplantation-30808
https://atc.digitellinc.com/p/s/who-can-tolerate-a-marginal-kidney-predicting-survival-after-transplantation-30818
https://atc.digitellinc.com/p/s/phs-risk-status-time-for-a-change-30823
https://atc.digitellinc.com/p/s/can-we-predict-organ-discard-30828
https://atc.digitellinc.com/p/s/using-ex-vivo-lung-perfusion-for-functionally-impaired-and-standard-donor-lungs-30838
https://atc.digitellinc.com/p/s/high-risk-donors-and-post-transplant-recipient-outcomes-30843
https://atc.digitellinc.com/p/s/pushing-the-envelope-when-to-consider-the-extended-criteria-donor-30848
https://atc.digitellinc.com/p/s/hiv-and-hepatitis-c-donors-nuts-and-bolts-of-how-to-use-them-in-lung-transplantation-30853
https://atc.digitellinc.com/p/s/donor-recipient-gender-mismatch-in-liver-transplantation-30863
https://atc.digitellinc.com/p/s/gender-differences-in-post-transplant-outcomes-30868
https://atc.digitellinc.com/p/s/access-to-care-and-social-determinats-in-kidney-transplantation-30873
https://atc.digitellinc.com/p/s/conversion-to-improve-adherence-change-in-formulation-or-agent-30883
https://atc.digitellinc.com/p/s/conversion-to-improve-adherence-psychosocial-factors-and-therapy-30888
https://atc.digitellinc.com/p/s/conversion-to-improve-renal-function-in-patients-with-persistent-renal-dysfunction-change-to-mtor-inhibitor-30893
https://atc.digitellinc.com/p/s/conversion-to-improve-renal-function-in-patients-with-persistent-renal-dysfunction-change-to-belatacept-30898
https://atc.digitellinc.com/p/s/improve-access-for-patients-away-from-the-primary-transplant-center-telemedicine-and-mobile-clinics-30908
https://atc.digitellinc.com/p/s/educating-and-communicating-with-community-specialists-primary-care-providers-care-partners-and-patients-how-do-canadians-do-this-30913
https://atc.digitellinc.com/p/s/insurance-organizations-and-ensurance-of-transplant-health-care-role-of-lobbying-and-legislation-30918
https://atc.digitellinc.com/p/s/taking-transplant-medicine-to-the-community-outreach-models-communication-and-educational-endeavors-30923
https://atc.digitellinc.com/p/s/epidemiology-and-management-of-non-tuberculous-mycobacteria-in-lung-transplant-recipients-30933
https://atc.digitellinc.com/p/s/debate-pro-mycobacterium-abscessus-and-lung-transplant-to-transplant-or-not-to-transplant-30938
https://atc.digitellinc.com/p/s/debate-con-mycobacterium-abscessus-and-lung-transplant-to-transplant-or-not-to-transplant-30943
https://atc.digitellinc.com/p/s/debate-pro-rebuttal-30948
https://atc.digitellinc.com/p/s/debate-con-rebuttal-30953
https://atc.digitellinc.com/p/s/cardiovascular-disease-risk-factor-optimization-after-liver-transplantation-dos-donts-and-drug-management-clinician-perspective-30963
https://atc.digitellinc.com/p/s/cardiovascular-disease-risk-factor-optimization-after-liver-transplantation-dos-donts-and-drug-management-pharmacist-perspective-30968
https://atc.digitellinc.com/p/s/prevention-and-management-of-obesity-after-liver-transplantation-implications-for-immunosuppression-clinician-perspective-30973
https://atc.digitellinc.com/p/s/prevention-and-management-of-obesity-after-liver-transplantation-implications-for-immunosuppression-pharmacist-perspective-30978
https://atc.digitellinc.com/p/s/practical-strategies-for-glucose-control-and-diabetes-prevention-after-liver-transplant-where-are-we-now-clinician-perspective-30983
https://atc.digitellinc.com/p/s/practical-strategies-for-glucose-control-and-diabetes-prevention-after-liver-transplant-where-are-we-now-pharmacist-perspective-30988
https://atc.digitellinc.com/p/s/pediatric-nonadherence-30998
https://atc.digitellinc.com/p/s/transplanting-children-with-fsgs-diagnosis-prevention-and-management-of-recurrence-31003
https://atc.digitellinc.com/p/s/cardiovascular-risk-in-pediatric-kidney-recipients-burden-and-impact-31008
https://atc.digitellinc.com/p/s/nano-intervention-of-organs-to-improve-outcome-of-organ-transplant-31018
https://atc.digitellinc.com/p/s/advanced-regenerative-manufacturing-institute-technologies-to-make-the-tissues-of-tomorrow-31023
https://atc.digitellinc.com/p/s/manufacturing-a-new-population-of-cell-types-for-organ-engineering-and-transplantation-31028
https://atc.digitellinc.com/p/s/can-i-use-diet-and-medications-multidisciplinary-medical-management-of-the-patient-with-intestinal-failure-31038
https://atc.digitellinc.com/p/s/surgical-management-can-i-do-surgery-to-prevent-future-transplant-31043
https://atc.digitellinc.com/p/s/while-trying-to-avoid-a-transplant-how-do-we-treat-the-complications-from-intestinal-failure-and-tpn-31048
https://atc.digitellinc.com/p/s/joint-award-session-31058
https://atc.digitellinc.com/p/s/asts-research-grants-31063
https://atc.digitellinc.com/p/s/ast-pioneer-award-31068
https://atc.digitellinc.com/p/s/ast-awards-31073
https://atc.digitellinc.com/p/s/ast-lifetime-achievement-31078
https://atc.digitellinc.com/p/s/a-historical-look-at-the-use-of-donors-after-cardiac-death-in-pediatric-liver-and-kidney-transplant-31093
https://atc.digitellinc.com/p/s/debate-pro-using-donors-after-cardiac-death-in-pediatric-liver-and-kidney-transplant-recipients-31098
https://atc.digitellinc.com/p/s/debate-con-using-donors-after-cardiac-death-in-pediatric-liver-and-kidney-transplant-recipients-31103
https://atc.digitellinc.com/p/s/rebuttal-pro-31108
https://atc.digitellinc.com/p/s/rebuttal-con-31113
https://atc.digitellinc.com/p/s/basic-b-cells-in-antigen-presentation-31123
https://atc.digitellinc.com/p/s/translational-blunting-damage-from-pre-transplant-dsa-31128
https://atc.digitellinc.com/p/s/clinical-breg-therapy-is-now-the-time-31133
https://atc.digitellinc.com/p/s/debate-pro-family-vouchers-expanding-kidney-transplantation-and-the-next-great-thing-31143
https://atc.digitellinc.com/p/s/debate-con-family-vouchers-coercion-and-the-end-of-non-directed-donation-31148
https://atc.digitellinc.com/p/s/pro-rebuttal-31153
https://atc.digitellinc.com/p/s/con-rebuttal-31158
https://atc.digitellinc.com/p/s/new-understandings-of-pathogenesis-and-immune-response-to-epstein-barr-virus-infection-and-ebv-associated-ptld-in-solid-organ-transplant-recipients-31168
https://atc.digitellinc.com/p/s/persistent-ebv-viremia-lend-me-a-hand-31173
https://atc.digitellinc.com/p/s/the-international-pediatric-transplant-associations-ebvptld-consensus-guidelines-31178
https://atc.digitellinc.com/p/s/basic-mechanisms-of-lung-transplant-rejection-new-insights-from-pre-clinical-models-31188
https://atc.digitellinc.com/p/s/acute-and-humoral-rejection-after-lung-transplantation-risk-factors-and-mechanisms-31193
https://atc.digitellinc.com/p/s/clad-emerging-phenotypes-and-new-insights-into-mechanisms-and-treatments-31198
https://atc.digitellinc.com/p/s/lung-transplantation-and-the-microbiome-31203
https://atc.digitellinc.com/p/s/the-unique-problem-of-cmv-in-lung-transplant-challenges-and-solutions-31208
https://atc.digitellinc.com/p/s/underlying-infectious-risk-genetics-31218
https://atc.digitellinc.com/p/s/is-there-a-role-for-more-personalized-organ-allocationdonor-and-recipient-matching-31223
https://atc.digitellinc.com/p/s/could-more-personalized-immunosuppression-work-31238
https://atc.digitellinc.com/p/s/acquired-infectious-risk-impact-of-standard-and-novel-immunosuppression-proteosomes-checkpoint-inhibitors-car-t-31243
https://atc.digitellinc.com/p/s/what-is-the-ibox-and-how-can-it-help-31248
https://atc.digitellinc.com/p/s/measuring-net-state-and-pathogen-specific-immunity-31253
https://atc.digitellinc.com/p/s/can-omics-assist-us-in-moving-personalized-medicine-in-transplantation-31258
https://atc.digitellinc.com/p/s/immune-regulatory-role-of-platelets-31268
https://atc.digitellinc.com/p/s/platelets-as-inflammatory-mediators-31273
https://atc.digitellinc.com/p/s/platelets-in-alloimmune-rejection-31278
https://atc.digitellinc.com/p/s/assessing-the-need-for-heart-versus-combined-cardiac-and-kidney-transplantation-in-systolic-heart-failure-patients-with-chronic-kidney-disease-a-transplant-cardiologists-perspective-31288
https://atc.digitellinc.com/p/s/assessing-the-need-for-heart-versus-combined-cardiac-and-kidney-transplantation-in-systolic-heart-failure-patients-with-chronic-kidney-disease-a-transplant-nephrologists-perspective-31293
https://atc.digitellinc.com/p/s/timing-of-renal-transplantation-after-cardiac-transplantation-in-listed-heart-and-kidney-recipients-31298
https://atc.digitellinc.com/p/s/renal-protective-strategies-after-cardiac-transplantation-31303
https://atc.digitellinc.com/p/s/optimizing-doac-therapy-in-pre-and-post-transplant-patients-31313
https://atc.digitellinc.com/p/s/measuring-and-reversal-of-doacs-31318
https://atc.digitellinc.com/p/s/challenging-pre-transplant-cases-and-doac-management-31323
https://atc.digitellinc.com/p/s/antibody-mediated-rejection-can-we-confidently-diagnose-and-treat-it-yet-31333
https://atc.digitellinc.com/p/s/inflammation-and-fibrosis-in-clinically-ideal-liver-transplant-recipients-the-tip-of-the-iceberg-31338
https://atc.digitellinc.com/p/s/mechanistic-insight-into-chronic-graft-injury-what-are-rational-therapies-31343
https://atc.digitellinc.com/p/s/borderline-rejection-after-kidney-transplantation-is-it-borderline-31353
https://atc.digitellinc.com/p/s/impact-of-hla-epitope-matching-on-t-cell-mediated-rejection-31358
https://atc.digitellinc.com/p/s/cross-talk-between-b-and-t-cells-and-its-influence-on-tcmr-31363
https://atc.digitellinc.com/p/s/how-much-steatosis-is-there-the-donor-frozen-section-biopsy-31373
https://atc.digitellinc.com/p/s/macrosteatosis-how-far-can-you-go-31378
https://atc.digitellinc.com/p/s/asts-scientific-studies-committee-multicenter-trial-in-the-standardization-of-steatosis-31383
https://atc.digitellinc.com/p/s/tregs-optimization-31393
https://atc.digitellinc.com/p/s/treg-survival-and-death-31398
https://atc.digitellinc.com/p/s/tregs-on-trial-31403
https://atc.digitellinc.com/p/s/the-role-of-the-journal-in-keeping-the-public-informed-31413
https://atc.digitellinc.com/p/s/decision-making-in-drug-development-31418
https://atc.digitellinc.com/p/s/how-the-fda-assesses-risk-and-benefits-31423
https://atc.digitellinc.com/p/s/tnf-alpha-31453
https://atc.digitellinc.com/p/s/car-t-cells-31458
https://atc.digitellinc.com/p/s/epigenetic-drugs-and-immune-regulatiuon-31463
https://atc.digitellinc.com/p/s/trained-immunity-in-macrophages-relevance-to-transplant-31468
https://atc.digitellinc.com/p/s/nanobodies-in-immune-regulation-31473
https://atc.digitellinc.com/p/s/transplantation-the-big-picture-31483
https://atc.digitellinc.com/p/s/life-on-the-death-panels-transplant-making-its-own-policy-31488
https://atc.digitellinc.com/p/s/perspectives-of-a-transplant-surgeon-and-award-winning-author-31493
https://atc.digitellinc.com/p/s/liver-transplantation-big-operation-big-impact-31498
https://atc.digitellinc.com/p/s/kidney-transplantation-minimally-invasive-maximally-effective-31503
https://atc.digitellinc.com/p/s/outcomes-research-in-transplantation-data-all-around-us-31508
https://atc.digitellinc.com/p/s/basic-science-research-in-transplantation-the-quest-to-understand-the-immune-system-31513
https://atc.digitellinc.com/p/s/transplant-id-now-with-treatable-viruses-31518
https://atc.digitellinc.com/p/s/pharmacy-better-living-through-chemistry-31523
https://atc.digitellinc.com/p/s/pre-and-post-transplant-risk-for-estimation-of-recurrnece-including-utility-of-biomarkers-31534
https://atc.digitellinc.com/p/s/surveillance-and-prevention-of-hcc-recurrence-post-transplant-in-the-high-risk-patients-31539
https://atc.digitellinc.com/p/s/management-of-post-transplant-patients-with-recurrence-mtor-and-adjuvant-therapy-and-resection-31544
https://atc.digitellinc.com/p/s/making-friends-with-your-opo-initiatives-to-increase-deceased-donor-transplant-through-standardizes-mutually-agreeable-processes-31554
https://atc.digitellinc.com/p/s/celebrate-your-programs-success-and-learn-from-others-tools-to-track-performance-and-improve-quality-including-transqip-31559
https://atc.digitellinc.com/p/s/navigating-the-regulatory-waters-between-the-cms-and-optn-icebergs-31564
https://atc.digitellinc.com/p/s/the-patient-with-extensive-porto-mesenteric-thrombosis-is-this-always-an-indication-for-a-multi-visceral-transplant-31574
https://atc.digitellinc.com/p/s/should-patients-with-chronic-rejection-be-re-transplanted-and-if-not-can-we-treat-them-medically-31579
https://atc.digitellinc.com/p/s/the-patient-with-recurrent-desmoid-turns-and-unresectable-tumors-to-transplant-or-not-to-transplant-31584
https://atc.digitellinc.com/p/s/the-liver-after-a-fontan-procedure-31594
https://atc.digitellinc.com/p/s/debate-pro-combined-heart-and-liver-31599
https://atc.digitellinc.com/p/s/debate-con-heart-alone-31604
https://atc.digitellinc.com/p/s/rebuttal-pro-31609
https://atc.digitellinc.com/p/s/rebuttal-con-31614
https://atc.digitellinc.com/p/s/crisprcas9-how-i-do-it-31624
https://atc.digitellinc.com/p/s/gene-editing-in-xenotransplantation-31629
https://atc.digitellinc.com/p/s/the-elimination-of-disincentives-and-excuses-to-kidney-paired-donation-kpd-31644
https://atc.digitellinc.com/p/s/how-to-safely-transplant-the-most-difficult-cases-through-kpd-31649
https://atc.digitellinc.com/p/s/the-value-and-benefit-of-and-to-compatible-pairs-in-kpd-31654
https://atc.digitellinc.com/p/s/atp-in-transplantation-31664
https://atc.digitellinc.com/p/s/t-cell-metabolism-31669
https://atc.digitellinc.com/p/s/t-cell-mitochondrial-effects-31674
https://atc.digitellinc.com/p/s/long-and-short-acting-therapies-aspects-of-drug-development-other-than-graft-survival-that-also-are-important-safety-patient-reported-outcomes-and-compliance-31684
https://atc.digitellinc.com/p/s/the-transplant-therapeutics-consortium-the-public-private-partnership-approach-to-developing-novel-drug-development-tools-31689
https://atc.digitellinc.com/p/s/regulatory-approach-to-developing-biomarkers-and-surrogate-endpoints-in-transplantation-how-to-predict-long-term-outcomes-from-1-year-post-transplant-measures-31694
https://atc.digitellinc.com/p/s/cystinosis-no-longer-just-a-pediatric-disease-31704
https://atc.digitellinc.com/p/s/atypical-hemolytic-uremic-syndrome-high-risks-with-higher-rewards-31709
https://atc.digitellinc.com/p/s/cakut-congenital-anomalies-of-the-kidney-and-the-urinary-tract-beyond-the-transplant-31714
https://atc.digitellinc.com/p/s/ischemic-heart-disease-in-the-kidney-allograft-recipient-state-of-the-art-and-current-trials-in-2019-31724
https://atc.digitellinc.com/p/s/heart-failure-and-pulmonary-hypertension-in-the-kidney-allograft-recipient-31729
https://atc.digitellinc.com/p/s/evaluation-and-management-of-perioperative-risks-in-kidney-transplant-candidates-31734
https://atc.digitellinc.com/p/s/top-10-bacterial-papers-31744
https://atc.digitellinc.com/p/s/top-10-fungal-papers-31749
https://atc.digitellinc.com/p/s/top-10-viral-papers-31754
https://atc.digitellinc.com/p/s/how-to-define-fair-distribution-schemes-for-us-lung-allocation-31764
https://atc.digitellinc.com/p/s/impact-of-2017-elimination-of-dsa-as-the-first-unit-of-allocation-31769
https://atc.digitellinc.com/p/s/debate-pro-broader-geographic-sharing-increases-access-to-transplant-without-adversely-impacting-transplant-outcomes-31774
https://atc.digitellinc.com/p/s/debate-con-broader-geographic-sharing-threatens-lung-post-transplant-outcomes-31779
https://atc.digitellinc.com/p/s/debate-con-rebuttal-31784
https://atc.digitellinc.com/p/s/debate-pro-rebuttal-31789
https://atc.digitellinc.com/p/s/novel-anti-diabetic-agents-and-their-role-in-therapy-after-transplantation-31799
https://atc.digitellinc.com/p/s/key-steak-holders-bones-and-all-it-takes-to-keep-them-healthy-after-transplant-31804
https://atc.digitellinc.com/p/s/lipid-management-challenges-and-strategies-in-transplant-recipients-31809
https://atc.digitellinc.com/p/s/updates-in-hypertension-management-31814
https://atc.digitellinc.com/p/s/asts-presidential-address-31819
https://atc.digitellinc.com/p/s/state-of-the-art-address-synthetic-organs-31824
https://atc.digitellinc.com/p/s/non-directed-donation-in-ldlt-31834
https://atc.digitellinc.com/p/s/time-to-change-pardigm-for-liver-transplant-31839
https://atc.digitellinc.com/p/s/ldlt-lessons-from-overseas-where-it-works-and-where-it-doesnt-31844
https://atc.digitellinc.com/p/s/will-unos-policy-changes-bring-back-ldlt-31849
https://atc.digitellinc.com/p/s/clinical-assessment-of-the-deceased-kidney-donor-beyond-kdpi-31859
https://atc.digitellinc.com/p/s/histologic-assessment-of-donor-kidney-biopsies-are-they-helpful-or-do-they-merely-increase-the-discard-rate-31864
https://atc.digitellinc.com/p/s/molecular-assessment-of-preimplantation-biopsies-31869
https://atc.digitellinc.com/p/s/diagnostics-where-do-we-go-next-is-a-universal-threshold-attainable-or-should-we-move-to-individualized-medicine-approach-31879
https://atc.digitellinc.com/p/s/cmv-guidelines-and-personalized-medicine-immunodiagnostics-immunosuppression-and-best-prevention-31884
https://atc.digitellinc.com/p/s/novel-therapies-medications-vaccines-and-management-of-resistant-virus-31889
https://atc.digitellinc.com/p/s/bench-coinhibitory-pathways-in-transplantation-31899
https://atc.digitellinc.com/p/s/translational-preclinical-models-of-coinhibitory-blockade-31904
https://atc.digitellinc.com/p/s/clinical-bringing-coinhibitory-modulation-to-the-clinic-31909
https://atc.digitellinc.com/p/s/what-is-the-new-treatment-for-endocrinologist-31919
https://atc.digitellinc.com/p/s/is-pancreatic-transplant-surgery-a-cure-for-all-diabetics-31924
https://atc.digitellinc.com/p/s/nephrologists-central-role-in-decision-making-and-care-31929
https://atc.digitellinc.com/p/s/opioid-and-benzodiazepine-use-in-lung-transplant-candidates-a-national-survey-of-policies-and-practices-31939
https://atc.digitellinc.com/p/s/the-percs-of-transplant-prescription-drug-use-among-transplant-recipients-31944
https://atc.digitellinc.com/p/s/marijuana-post-transplant-31949
https://atc.digitellinc.com/p/s/importance-of-intestinal-and-liver-histopathology-in-the-patient-with-short-gut-syndrome-and-the-intestinal-transplant-recipient-acr-amr-chronic-rejection-and-other-complications-31959
https://atc.digitellinc.com/p/s/how-do-we-prevent-rejection-and-does-amr-in-the-intestinal-transplant-patient-exist-dsa-monitoring-protocol-intestinal-biopsies-pre-transplant-desensitization-31964
https://atc.digitellinc.com/p/s/complications-of-immunosuppression-ptld-gvhd-cancer-and-infections-31969
https://atc.digitellinc.com/p/s/recipient-with-meld-40-31979
https://atc.digitellinc.com/p/s/how-old-is-too-old-for-a-combined-liverkidney-transplantation-31984
https://atc.digitellinc.com/p/s/lessons-learned-from-the-liver-eaters-31989
https://atc.digitellinc.com/p/s/lymphatics-in-chronic-rejection-31999
https://atc.digitellinc.com/p/s/lymphatics-and-immunometabolism-32004
https://atc.digitellinc.com/p/s/lymph-node-scarring-in-transplantation-32009
https://atc.digitellinc.com/p/s/perfusion-emerges-from-the-niche-as-a-standard-of-practice-32019
https://atc.digitellinc.com/p/s/barriers-and-challenges-to-implementation-of-liver-nmp-program-at-your-transplant-center-32024
https://atc.digitellinc.com/p/s/perfusion-and-beyond-optimizing-marginal-livers-for-transplantation-future-approaches-32029
https://atc.digitellinc.com/p/s/identifying-patients-with-a-problem-pretransplant-screening-and-management-for-opioid-addiction-32039
https://atc.digitellinc.com/p/s/opioid-minimizing-medication-regimens-for-transplant-donors-and-recipients-32044
https://atc.digitellinc.com/p/s/designing-and-implementing-a-large-surgical-opioid-stewardship-program-32049
https://atc.digitellinc.com/p/s/care-of-the-transgender-transplant-recipient-32059
https://atc.digitellinc.com/p/s/hormonal-management-across-the-lifespancontraception-conception-and-menopause-32064
https://atc.digitellinc.com/p/s/long-term-health-in-women-after-transplant-bone-health-and-reproductive-malignancies-32069
https://atc.digitellinc.com/p/s/frailty-in-liver-transplantation-32079
https://atc.digitellinc.com/p/s/frailty-in-heart-transplantation-32084
https://atc.digitellinc.com/p/s/frailty-in-kidney-transplantation-32089
https://atc.digitellinc.com/p/s/frailty-in-lung-transplantation-32094
https://atc.digitellinc.com/p/s/proceeding-without-a-physical-xm-for-high-risk-patients-32104
https://atc.digitellinc.com/p/s/how-we-do-virtual-crossmatching-for-heart-transplantation-32109
https://atc.digitellinc.com/p/s/optimizing-unacceptable-antigen-listing-for-highly-sensitized-renal-transplant-candidates-32114
https://atc.digitellinc.com/p/s/how-to-avoid-breaking-the-chains-32119
https://atc.digitellinc.com/p/s/options-for-management-of-insufficient-portal-flow-in-pediatric-liver-transplant-32129
https://atc.digitellinc.com/p/s/how-i-do-the-hepatic-artery-anastamosis-microscope-versus-loops-32134
https://atc.digitellinc.com/p/s/choosing-the-type-and-graft-size-for-small-liver-recipeints-32139
https://atc.digitellinc.com/p/s/optimizing-vaccinations-pre-transplant-32229
https://atc.digitellinc.com/p/s/waitlist-management-the-role-of-the-advanced-practice-provider-32234
https://atc.digitellinc.com/p/s/beyond-the-basics-expanding-the-app-role-on-inpatient-services-32239
https://atc.digitellinc.com/p/s/the-evolution-of-the-app-in-transplant-32244
https://atc.digitellinc.com/p/s/7-on-7-off-creative-transplant-pharmacist-coverage-solutions-32249
https://atc.digitellinc.com/p/s/bankers-hours-no-more-weekend-and-holiday-transplant-pharmacist-solutions-32254
https://atc.digitellinc.com/p/s/it-takes-a-village-multidisciplinary-transitions-of-care-strategies-32259
https://atc.digitellinc.com/p/s/the-nih-apollo-study-assessing-apol1-in-transplant-outcomes-32273
https://atc.digitellinc.com/p/s/the-time-has-come-test-everyone-32278
https://atc.digitellinc.com/p/s/we-need-more-data-do-not-test-32283
https://atc.digitellinc.com/p/s/personality-disorders-and-transplantation-32293
https://atc.digitellinc.com/p/s/adaptation-to-illness-for-transplant-candidates-and-recipients-32298
https://atc.digitellinc.com/p/s/psychiatric-medications-and-transplantation-32303
https://atc.digitellinc.com/p/s/its-in-the-heights-eliminating-gender-based-disparity-in-liver-transplantation-32313
https://atc.digitellinc.com/p/s/pediatric-prioritization-is-it-a-moral-imperative-impact-on-public-opinion-and-organ-donation-32318
https://atc.digitellinc.com/p/s/psycosocial-evaluation-and-management-of-acute-alcoholic-hepatitis-needing-transplantation-32333
https://atc.digitellinc.com/p/s/early-and-late-outcome-of-transplantation-for-acute-alcoholic-hepatitis-32338
https://atc.digitellinc.com/p/s/ramification-of-transplanting-alcoholic-hepatitis-on-allocation-and-organ-donation-32343
https://atc.digitellinc.com/p/s/joint-ast-ipta-symposium-its-friday-night-of-a-long-weekend-and-the-pediatric-transplant-id-specialists-beeper-goes-off-32348
https://atc.digitellinc.com/p/s/who-what-when-where-and-why-antifungals-in-practice-32358
https://atc.digitellinc.com/p/s/antifungal-drugs-in-transplant-recipients-drug-drug-interactions-dosing-and-inhaled-iv-and-oral-formulations-32363
https://atc.digitellinc.com/p/s/new-diagnostics-which-are-worth-your-time-and-money-32368
https://atc.digitellinc.com/p/s/does-this-patient-need-antifungal-prophylaxis-32373
https://atc.digitellinc.com/p/s/ethical-issues-surrounding-pregnancy-following-sot-and-vca-32383
https://atc.digitellinc.com/p/s/is-any-drug-safe-during-pregnancy-32388
https://atc.digitellinc.com/p/s/monitoring-the-transplant-during-pregnancy-32393
https://atc.digitellinc.com/p/s/14-years-of-dtac-us-perspective-32403
https://atc.digitellinc.com/p/s/organ-vigilance-the-european-experience-32408
https://atc.digitellinc.com/p/s/project-notify-whats-it-all-about-32413
https://atc.digitellinc.com/p/s/spk-versus-ld-then-pak-versus-alternative-therapies-32423
https://atc.digitellinc.com/p/s/maintaining-adequacy-in-a-low-volume-program-32428
https://atc.digitellinc.com/p/s/regulation-and-stewardship-for-pancreas-transplant-programs-32433
https://atc.digitellinc.com/p/s/alloreative-cell-tracking-32443
https://atc.digitellinc.com/p/s/t-cell-cmv-responses-32448
https://atc.digitellinc.com/p/s/b-cell-antibodyomics-in-transplantation-32453
https://atc.digitellinc.com/p/s/until-death-do-us-part-the-art-and-science-of-matchmaking-marginal-donor-and-recipient-pairs-32463
https://atc.digitellinc.com/p/s/ill-take-it-how-a-large-center-decides-to-accept-the-hearts-that-the-smaller-center-declined-for-organ-quality-32468
https://atc.digitellinc.com/p/s/going-to-the-ends-of-the-earth-for-a-heart-the-uk-experience-with-heart-transplantation-from-dcd-donors-32473
https://atc.digitellinc.com/p/s/provider-perceived-common-immunosuppression-side-effects-and-management-in-kidney-transplant-recipients-32483
https://atc.digitellinc.com/p/s/treatment-of-recurrent-fsgs-32488
https://atc.digitellinc.com/p/s/management-challenges-in-bk-virus-associated-nephropathy-32493
https://atc.digitellinc.com/p/s/state-of-the-art-lecture-using-human-pluripoint-stem-cells-to-make-tissue-for-transplantation-32498
https://atc.digitellinc.com/p/s/transplant-metrics-drive-quality-patient-care-32508
https://atc.digitellinc.com/p/s/contemporary-use-of-transplant-metrics-have-perverse-effects-on-innovation-organ-utilization-and-access-to-care-32513
https://atc.digitellinc.com/p/s/panel-discussion-32518
https://atc.digitellinc.com/p/s/pediatric-vaccination-are-we-ready-to-give-live-viral-vaccines-post-transplant-32568
https://atc.digitellinc.com/p/s/vaccines-for-adult-transplant-recipients-new-data-32573
https://atc.digitellinc.com/p/s/b-sides-serology-novel-measures-of-vaccine-protection-32578
https://atc.digitellinc.com/p/s/long-term-graft-survival-in-pediatric-liver-transplant-patients-32588
https://atc.digitellinc.com/p/s/debate-pro-protocol-liver-biopsy-should-be-done-in-all-pediatric-liver-transplant-recipients-32593
https://atc.digitellinc.com/p/s/debate-con-protocol-liver-biopsy-should-be-done-in-all-pediatric-liver-transplant-recipients-32598
https://atc.digitellinc.com/p/s/rebuttal-pro-32603
https://atc.digitellinc.com/p/s/rebuttal-con-32608
https://atc.digitellinc.com/p/s/c4-article-challenges-and-solutions-for-appropriate-and-timely-medication-access-in-transplantation-32613
https://atc.digitellinc.com/p/s/complications-of-immunosuppression-in-vca-32658
https://atc.digitellinc.com/p/s/surgical-complications-in-vca-32663
https://atc.digitellinc.com/p/s/risks-of-mortality-and-end-stage-organ-damage-in-vca-32668
https://atc.digitellinc.com/p/s/history-and-evolution-of-banff-criteria-for-amr-32678
https://atc.digitellinc.com/p/s/what-is-data-to-support-the-changes-made-in-the-banff-2017-criteria-32683
https://atc.digitellinc.com/p/s/who-should-be-treated-for-amr-32688
https://atc.digitellinc.com/p/s/implementing-the-vision-the-organ-repair-center-where-regenerative-and-transplant-medicine-meet-32698
https://atc.digitellinc.com/p/s/enhancing-mitochondrial-quality-control-programs-to-improve-organ-preservation-by-normothermic-ex-vivo-liver-perfusion-32703
https://atc.digitellinc.com/p/s/regenerative-liver-replacement-resetting-terminal-liver-failure-from-inside-out-32708
https://atc.digitellinc.com/p/s/islet-transplantation-defining-outcomes-and-how-to-optimize-immunosuppression-32718
https://atc.digitellinc.com/p/s/cutting-edge-innovations-in-islet-transplantation-whats-new-and-whats-coming-32723
https://atc.digitellinc.com/p/s/how-to-overcome-financialregulatory-hurdles-for-islet-transplantation-in-the-united-states-32728
https://atc.digitellinc.com/p/s/macrophages-in-organ-ischemia-reperfusion-injury-32738
https://atc.digitellinc.com/p/s/macrophages-in-transplantation-tolerance-32743
https://atc.digitellinc.com/p/s/macrophage-heterogenicity-in-tissue-inflammation-and-homeostasis-32748
https://atc.digitellinc.com/p/s/regulatory-issues-in-donor-and-organ-interventional-studies-32758
https://atc.digitellinc.com/p/s/whole-body-approaches-to-intervention-32763
https://atc.digitellinc.com/p/s/molecular-approaches-to-organ-intervention-32768
https://atc.digitellinc.com/p/s/leveraging-research-and-technology-for-improved-decision-making-catching-up-to-the-21st-century-32778
https://atc.digitellinc.com/p/s/enhanced-performance-monitoring-a-better-look-inside-and-out-32783
https://atc.digitellinc.com/p/s/future-collaborative-improvement-projects-and-engaging-external-stakeholders-were-all-in-this-together-32788
https://atc.digitellinc.com/p/s/indications-and-patient-selection-for-slkt-vs-kidney-after-lt-transplant-hepatologist-perspective-32798
https://atc.digitellinc.com/p/s/two-years-after-policy-change-outcomes-decision-making-of-slkt-vs-kidney-after-lt-transplant-nephrology-perspective-32803
https://atc.digitellinc.com/p/s/surgical-perspectives-on-liver-kidney-simultaneous-vsshort-pump-vs-long-delay-safety-net-32808
https://atc.digitellinc.com/p/s/various-approaches-to-portal-vein-thrombosis-and-significant-venous-shunts-32818
https://atc.digitellinc.com/p/s/the-role-of-veno-venous-bypass-and-how-to-manage-outflow-issues-32823
https://atc.digitellinc.com/p/s/what-are-the-risks-and-benefits-of-arterial-conduits-results-of-the-conduit-study-32828
https://atc.digitellinc.com/p/s/dendritic-cell-intervention-32838
https://atc.digitellinc.com/p/s/medullary-stem-cell-intervention-32843
https://atc.digitellinc.com/p/s/car-treg-development-32848
https://atc.digitellinc.com/p/s/the-importance-of-work-life-balance-in-todays-society-the-novices-perspective-32863
https://atc.digitellinc.com/p/s/provider-burnout-why-is-it-happening-and-what-effects-does-it-have-32868
https://atc.digitellinc.com/p/s/provider-burnout-what-can-we-do-about-it-are-the-solutions-and-how-can-they-be-implemented-32873
https://atc.digitellinc.com/p/s/provider-burnout-how-to-promote-provider-wellness-through-lessons-learned-from-our-patients-32878
https://atc.digitellinc.com/p/s/every-breath-you-take-ecmo-for-nephrologists-32888
https://atc.digitellinc.com/p/s/be-still-my-heart-fundamentals-of-vad-management-for-nephrologists-32893
https://atc.digitellinc.com/p/s/renal-replacement-therapy-in-patients-with-mechanical-support-and-thoracic-transplants-32898
https://atc.digitellinc.com/p/s/advances-in-genetic-engineering-for-xenotransplantion-32908
https://atc.digitellinc.com/p/s/process-in-xeno-kidney-primate-work-32913
https://atc.digitellinc.com/p/s/process-in-xeno-islet-primate-work-and-clinical-trials-32918
https://atc.digitellinc.com/p/s/we-can-handle-the-infectious-concerns-32923
https://atc.digitellinc.com/p/s/debate-clinical-trial-for-xenotransplant-pro-we-are-ready-32928
https://atc.digitellinc.com/p/s/debate-clinical-trial-for-xenotransplant-con-i-am-not-sure-i-will-refer-my-patient-to-you-for-this-clincial-trial-32933
https://atc.digitellinc.com/p/s/outcomes-of-living-kidney-donation-among-african-american-donors-and-how-one-could-use-transplant-models-in-counseling-32958
https://atc.digitellinc.com/p/s/elevated-blood-pressure-is-it-ever-acceptable-to-approve-the-donor-32963
https://atc.digitellinc.com/p/s/discrepancies-in-kidney-sizevolume-how-do-you-decide-32968
https://atc.digitellinc.com/p/s/hcv-viremic-donors-in-liver-recipients-when-and-how-to-treat-32978
https://atc.digitellinc.com/p/s/hcv-viremic-donors-in-kidney-recipients-impact-on-wait-times-and-post-transplant-kidney-function-32983
https://atc.digitellinc.com/p/s/hcv-viremic-donors-in-heart-and-lung-recipients-novel-strategies-and-post-transplant-outcomes-32988
https://atc.digitellinc.com/p/s/should-i-transplant-this-liver-surgeon-perspective-32998
https://atc.digitellinc.com/p/s/should-my-patient-consider-this-offer-hepatologist-perspective-33003
https://atc.digitellinc.com/p/s/what-does-the-patient-under-about-this-liver-medical-ethicist-perspective-on-informed-consent-in-marginal-organ-transplantation-33008
https://atc.digitellinc.com/p/s/thinking-strategically-how-to-approach-cost-savings-33018
https://atc.digitellinc.com/p/s/delaying-valganciclovir-a-smart-move-or-playing-with-fire-33023
https://atc.digitellinc.com/p/s/cost-saving-strategies-for-transplant-programs-33028
https://atc.digitellinc.com/p/s/getting-the-underfunded-patient-out-the-door-33033
https://atc.digitellinc.com/p/s/debate-pro-presumed-consent-is-opt-in-a-cop-out-33043
https://atc.digitellinc.com/p/s/debate-con-presumed-consent-is-opt-in-a-cop-out-33048
https://atc.digitellinc.com/p/s/pro-rebuttal-33053
https://atc.digitellinc.com/p/s/con-rebuttal-33058
https://atc.digitellinc.com/p/s/t-follicular-cells-in-alloimmunity-33068
https://atc.digitellinc.com/p/s/follicular-regulatory-t-cells-33073
https://atc.digitellinc.com/p/s/human-circulating-t-follicular-helper-cells-33078
https://atc.digitellinc.com/p/s/intragraft-genomics-and-allograft-rejection-interheart-and-interlung-33088
https://atc.digitellinc.com/p/s/epigenetics-microrna-transcriptome-33093
https://atc.digitellinc.com/p/s/exosomes-and-proteomics-33098
https://atc.digitellinc.com/p/s/liver-transplantation-for-hilar-cholangiocarcinoma-have-we-mastered-this-33108
https://atc.digitellinc.com/p/s/liver-transplantation-for-intrahepatic-cholangiocarcinoma-can-it-work-33113
https://atc.digitellinc.com/p/s/the-promise-of-new-systemic-therapy-for-cholangiocarcinoma-and-its-implications-on-liver-transplantation-33118
https://atc.digitellinc.com/p/s/vca-vs-sot-innate-adaptive-immune-interface-33128
https://atc.digitellinc.com/p/s/nerve-regeneration-and-autoimmunity-33133
https://atc.digitellinc.com/p/s/how-qualitative-research-informs-clinical-decision-making-in-vca-33138
https://atc.digitellinc.com/p/s/atc-peoples-choice-award-33148
https://atc.digitellinc.com/p/cf/atc-2023-33149
https://atc.digitellinc.com/p/s/clinical-workflow-automation-in-organ-transplantation-33156
https://atc.digitellinc.com/p/s/a-more-informative-model-of-cardiovascular-disease-burden-in-kidney-transplantation-a-new-risk-adjustment-measure-33157
https://atc.digitellinc.com/p/s/opo-measured-donation-rate-is-highly-volatile-year-to-year-and-not-a-stable-quality-indicator-33158
https://atc.digitellinc.com/p/s/enhanced-retention-and-knowledge-transfer-using-digital-sop-approaches-33159
https://atc.digitellinc.com/p/s/30-and-365-readmissions-in-patients-with-orthotopic-liver-transplantation-in-a-large-volume-single-center-33160
https://atc.digitellinc.com/p/s/donor-derived-disease-transmission-events-in-germany-2016-2021-33161
https://atc.digitellinc.com/p/s/donor-transmitted-malignancy-in-organ-donation-and-solid-organ-transplantation-in-germany-2016-2021-33162
https://atc.digitellinc.com/p/s/creation-of-a-multidisciplinary-high-risk-committee-for-review-of-liver-transplant-candidates-with-significant-cardiopulmonary-risk-factors-33163
https://atc.digitellinc.com/p/s/improved-transplant-time-study-billing-and-compliance-using-communication-data-33164
https://atc.digitellinc.com/p/s/current-landscape-of-transplant-nephrology-fellowship-application-33165
https://atc.digitellinc.com/p/s/implementation-of-an-enhanced-recovery-after-surgery-pathway-for-deceased-donor-kidney-transplants-33166
https://atc.digitellinc.com/p/s/the-implementation-process-for-an-electronic-pre-visit-planning-tool-a-pediatric-kidney-transplant-quality-improvement-project-33167
https://atc.digitellinc.com/p/s/a-multidisciplinary-approach-optimizes-access-to-extended-release-tacrolimus-tablets-after-living-donor-kidney-transplantation-33168
https://atc.digitellinc.com/p/s/52-months-follow-up-of-a-cohort-in-the-transplant-continuum-after-using-a-new-electronic-medical-record-tool-to-document-transplant-option-discussions-among-patients-with-egfr-33169
https://atc.digitellinc.com/p/s/evaluation-of-clinical-outcomes-among-renal-transplant-recipients-obtaining-immunosuppression-prescriptions-from-insurance-mandated-specialty-pharmacies-33170
https://atc.digitellinc.com/p/s/oncology-screening-in-post-renal-transplant-patients-a-retrospective-review-of-adherence-to-screening-guidelines-in-a-canadian-health-region-33171
https://atc.digitellinc.com/p/s/developing-regulatory-and-operational-oversight-structures-for-clinical-xenotransplantation-33172
https://atc.digitellinc.com/p/s/addition-of-donor-critical-care-data-improves-performance-of-the-srtr-expected-heart-yield-model-33173
https://atc.digitellinc.com/p/s/adjusting-for-race-in-metrics-of-organ-procurement-organization-performance-33174
https://atc.digitellinc.com/p/s/enzymatic-conversion-of-blood-group-a-to-h-antigen-in-a-mouse-model-to-facilitate-abo-incompatible-transplantation-aboi-tx-kinetics-of-a-antigen-re-expression-33175
https://atc.digitellinc.com/p/s/the-role-and-mechanism-of-interleukin-34-il-34-in-acute-t-cell-mediated-rejection-of-renal-transplantation-33176
https://atc.digitellinc.com/p/s/the-alteration-of-monocyte-subsets-and-the-early-acute-rejection-after-kidney-transplantation-33177
https://atc.digitellinc.com/p/s/proteasome-dysfunction-a-potential-contributor-of-kidney-dysfunction-during-cold-storage-and-transplantation-33178
https://atc.digitellinc.com/p/s/iguratimod-upregulated-ptpn22-inhibited-b-cells-activation-then-attenuated-acute-antibody-mediated-rejection-and-prolonged-renal-graft-survival-in-mouse-kidney-transplant-model-33179
https://atc.digitellinc.com/p/s/acute-cellular-rejection-after-liver-transplant-is-associated-with-altered-gut-microbiome-composition-33180
https://atc.digitellinc.com/p/s/mapping-the-cellular-and-molecular-landscape-of-adaptive-immune-responses-in-kidney-allograft-rejection-33181
https://atc.digitellinc.com/p/s/performance-of-donor-derived-cell-free-dna-in-detecting-antibody-mediated-rejection-when-coupled-with-donor-specific-antibodies-33182
https://atc.digitellinc.com/p/s/usp25-deficiency-promotes-t-cell-dysfunction-and-transplant-acceptance-via-mitochondrial-dynamics-33183
https://atc.digitellinc.com/p/s/dihydroartemisinin-attenuates-acute-antibody-mediated-rejection-in-heart-transplantation-by-inhibiting-tfh-to-reduce-b-cells-activation-and-antibody-production-33184
https://atc.digitellinc.com/p/s/kidney-parenchymal-cells-in-acute-rejection-of-human-kidney-transplants-lest-we-forget-33185
https://atc.digitellinc.com/p/s/dsa-negative-microvascular-inflammation-in-kidney-transplant-biopsies-gene-expression-comparison-with-native-and-transplant-kidney-controls-33186
https://atc.digitellinc.com/p/s/noninvasive-quantification-of-granzyme-b-in-cardiac-allografts-using-targeted-ultrasound-imaging-33187
https://atc.digitellinc.com/p/s/acd154mab-tnx-1500-alone-or-with-rapamycin-mmf-acd28mab-vel-101-prolongs-cynomolgus-cardiac-allograft-survival-33188
https://atc.digitellinc.com/p/s/ilc2s-constrain-alloreactive-cd4-plus-t-cells-through-mhcii-mediated-allo-antigen-presentation-in-mouse-heart-transplant-33189
https://atc.digitellinc.com/p/s/characterization-of-the-directly-alloreactive-repertoire-of-graft-antigen-specific-cd4-plus-t-cells-in-peripheral-blood-33190
https://atc.digitellinc.com/p/s/antigen-specific-alloreactive-cd8-plus-t-cells-maintain-clonal-diversity-during-acute-rejection-33191
https://atc.digitellinc.com/p/s/extracellular-vesicles-released-by-donor-macrophages-semi-directly-stimulate-allogeneic-t-cells-33192
https://atc.digitellinc.com/p/s/detect-direct-allo-reactivity-via-quasi-public-allo-associated-cd8-plus-t-cell-clones-33193
https://atc.digitellinc.com/p/s/a-curious-case-of-subcutaneous-immunoglobulin-and-hla-interaction-33194
https://atc.digitellinc.com/p/s/tacrolimus-induced-thrombotic-microangiopathy-tma-complicated-by-anamnestic-donor-specific-antibodies-post-kidney-transplantation-33195
https://atc.digitellinc.com/p/s/uncovering-the-memory-response-in-sensitised-renal-patients-33196
https://atc.digitellinc.com/p/s/anti-hla-i-igg-fc-agalactosylation-drives-direct-endothelial-cell-activation-via-interferon-alpha-pathway-33197
https://atc.digitellinc.com/p/s/regulatory-b-cells-as-a-useful-biomarker-of-improved-graft-outcome-and-rejection-risk-in-kidney-transplant-patients-33198
https://atc.digitellinc.com/p/s/cd9-a-new-marker-for-regulatory-b-cells-33199
https://atc.digitellinc.com/p/s/marginal-zone-b-cells-play-both-effector-and-regulatory-roles-in-allogeneic-sensitization-33200
https://atc.digitellinc.com/p/s/individual-difference-in-the-frequency-of-alloreactive-memory-b-cells-in-sensitized-transplant-patients-33201
https://atc.digitellinc.com/p/s/nanostructured-mass-exchangers-as-liver-assist-devices-33202
https://atc.digitellinc.com/p/s/enhancing-anti-fibrotic-properties-of-mesenchymal-stem-cells-for-the-treatment-of-liver-fibrosis-33203
https://atc.digitellinc.com/p/s/identification-of-novel-genes-for-defatting-of-fatty-liver-via-crispr-inhibition-screening-33204
https://atc.digitellinc.com/p/s/modeling-of-non-alcoholic-steatohepatitis-ex-vivo-using-hepatocyte-like-cells-differentiated-from-human-induced-pluripotent-stem-cells-33205
https://atc.digitellinc.com/p/s/development-of-a-biovascular-pancreas-to-improve-efficacy-of-islet-transplant-in-type-1-diabetes-33206
https://atc.digitellinc.com/p/s/urinary-progenitor-cells-derived-from-kidney-mesenchyme-alleviate-acute-kidney-injury-in-mice-33207
https://atc.digitellinc.com/p/s/podocyte-differentiation-of-primary-human-glomerular-outgrowth-cells-33208
https://atc.digitellinc.com/p/s/study-of-the-repair-potentials-of-nephron-progenitor-cell-transplantation-in-kidney-injury-33209
https://atc.digitellinc.com/p/s/effect-of-aging-donors-on-metabolic-signature-and-cellular-senescence-of-ipsc-derived-hepatocyte-like-cells-33210
https://atc.digitellinc.com/p/s/initial-preclinical-evaluation-of-a-bioengineered-kidney-33211
https://atc.digitellinc.com/p/s/transplanting-old-organs-accelerates-aging-in-young-recipients-33212
https://atc.digitellinc.com/p/s/irf1znf350gpx4-mediated-ferroptosis-of-renal-tubular-epithelial-cells-promote-chronic-renal-allograft-interstitial-fibrosis-33213
https://atc.digitellinc.com/p/s/tertiary-lymphoid-organs-promote-allograft-rejection-33214
https://atc.digitellinc.com/p/s/single-nucleus-endothelial-multi-omics-reveals-myeloid-and-vascular-microheterogeneity-in-acute-rejection-of-human-cardiac-transplants-33215
https://atc.digitellinc.com/p/s/identification-of-microbial-signatures-and-compounds-that-associate-with-peritransplant-liver-damage-in-mouse-and-human-recipients-33216
https://atc.digitellinc.com/p/s/the-influence-of-metformin-on-natural-killer-cells-33217
https://atc.digitellinc.com/p/s/increased-deposition-of-complement-in-renal-mitochondria-following-cold-storage-and-transplantation-33218
https://atc.digitellinc.com/p/s/p2x7r-inhibition-impairs-training-of-macrophages-in-vitro-and-rescind-the-effect-of-training-in-allo-skin-graft-model-33219
https://atc.digitellinc.com/p/s/molecular-and-cellular-mechanisms-of-lipocalin-2-mediated-renoprotection-in-kidney-transplantation-33220
https://atc.digitellinc.com/p/s/type-1-innate-lymphoid-cellsnk-cells-protect-liver-orthotopic-transplants-from-ischemiareperfusion-injury-via-interferon-gh-mediated-pathway-33221
https://atc.digitellinc.com/p/s/differing-humoral-and-cellular-response-against-sars-cov-2-variants-by-vaccine-platform-in-solid-organ-transplant-recipients-33222
https://atc.digitellinc.com/p/s/the-xbp1s-agonist-ixa4-regulates-bile-acids-in-the-abcb4-knockout-model-of-primary-sclerosing-cholangitis-33223
https://atc.digitellinc.com/p/s/il-6-is-critical-in-mitotherapy-dependent-improvement-in-oxidative-capacity-and-energy-homeostasis-in-nih3t3-l1-adipocytes-33224
https://atc.digitellinc.com/p/s/immune-profiling-by-single-nuclei-rna-sequencing-reveals-a-signature-specific-to-the-onset-of-non-alcoholic-fatty-liver-disease-33225
https://atc.digitellinc.com/p/s/metabolic-reprogramming-during-dcd-heart-perfusion-33226
https://atc.digitellinc.com/p/s/ischemia-reperfusion-upregulates-mir-23a-5p-in-kidney-cells-to-induce-fibrosis-33227
https://atc.digitellinc.com/p/s/gclc-enzymatic-activity-as-a-measure-of-t-cell-activation-capacity-33228
https://atc.digitellinc.com/p/s/circulating-tfh-cells-from-dsa-plus-antibody-mediated-rejection-kidney-transplant-recipients-display-stem-like-features-and-decreased-mtorc1-dependency-33229
https://atc.digitellinc.com/p/s/a-novel-il-2-mutein-induces-regulatory-t-cell-rich-microenvironment-and-leads-to-alloantigen-specific-graft-acceptance-33230
https://atc.digitellinc.com/p/s/strategies-for-development-of-interleukin-2-therapy-in-transplant-recipients-what-works-and-what-doesnt-33231
https://atc.digitellinc.com/p/s/in-vitro-differentiation-of-hematopoietic-stem-cells-into-immunoregulatory-t-and-myeloid-cells-following-allogeneic-stimulation-33232
https://atc.digitellinc.com/p/s/tributyrin-as-a-metabolic-treatment-to-modulate-rejection-immune-responses-33233
https://atc.digitellinc.com/p/s/a-novel-source-of-vertebral-bone-adherent-mesenchymal-stem-cells-with-potent-immunoregulatory-function-33234
https://atc.digitellinc.com/p/s/intragraft-induction-of-regulatory-t-cells-and-the-emergence-ff-thymic-like-characteristics-in-accepted-kidney-allografts-33235
https://atc.digitellinc.com/p/s/human-regulatory-b-cells-prevent-effector-cd4-plus-cd25-t-cell-proliferation-though-a-mechanism-dependent-from-granzyme-b-and-lymphotoxin-alpha-33236
https://atc.digitellinc.com/p/s/st2-plus-reparative-regulatory-t-cell-therapy-for-inflammation-reduction-and-tissue-repair-33237
https://atc.digitellinc.com/p/s/donor-graft-tolerance-induced-by-alloantigen-specific-regulatory-t-cell-based-therapy-in-mouse-cardiac-transplantation-model-33238
https://atc.digitellinc.com/p/s/ifitm1-regulates-mitophagy-and-immunosuppressive-function-of-double-negative-t-cells-33239
https://atc.digitellinc.com/p/s/cd4-plus-t-cell-specific-hif1a-signaling-is-essential-for-th17treg-regulatory-axis-in-liver-transplantation-from-mouse-to-human-33240
https://atc.digitellinc.com/p/s/t-cell-ceacam1-tim-3-crosstalk-alleviates-hepatocellular-injury-in-mouse-and-human-liver-transplantation-33241
https://atc.digitellinc.com/p/s/generation-of-cd141-plus-cd163-plus-regulatory-dendritic-cells-from-living-donor-liver-transplant-perfusate-33242
https://atc.digitellinc.com/p/s/th1-cd4-plus-t-cells-enhance-the-development-and-expansion-of-alloprimed-antibody-suppressor-cxcr5-plus-cd8-plus-t-cells-33243
https://atc.digitellinc.com/p/s/effect-of-mammalian-target-of-rapamycin-inhibition-on-activated-regulatory-t-cell-expansion-in-kidney-transplantation-33244
https://atc.digitellinc.com/p/s/tcl1a-involvement-in-b-cells-in-long-term-kidney-transplantation-33245
https://atc.digitellinc.com/p/s/killer-ig-like-receptor-kir-expressing-regulatory-cd8-t-cells-inhibit-inflammatory-cd4-t-cells-in-a-peptide-specific-manner-33246
https://atc.digitellinc.com/p/s/infiltrating-cytotoxic-cd8-t-cells-are-reprogramed-to-an-exhaustedregulatory-phenotype-in-spontaneously-accepted-kidney-allografts-in-mice-33247
https://atc.digitellinc.com/p/s/novel-role-of-mif-cd74-signaling-in-immune-regulation-33248
https://atc.digitellinc.com/p/s/the-impact-of-the-pd1-pdl1-pathway-in-breg-induced-transplantation-tolerance-33249
https://atc.digitellinc.com/p/s/cellular-immunotherapy-with-qa1hla-e-specific-cd8-treg-for-alloimmune-response-modulation-33250
https://atc.digitellinc.com/p/s/longitudinal-evaluation-of-immune-single-cell-transcriptome-of-living-donor-kidney-transplant-recipients-tolerized-with-allogeneic-stem-cell-therapy-33251
https://atc.digitellinc.com/p/s/the-important-role-of-treg-in-the-ex-vivo-expanded-breg-induced-tolerance-33252
https://atc.digitellinc.com/p/s/high-throughput-drug-screening-identifies-novel-compounds-with-potential-to-enhance-immunoregulation-following-transplantation-33253
https://atc.digitellinc.com/p/s/confirming-regulatory-function-of-ex-vivo-expanded-human-bregs-tlr-33254
https://atc.digitellinc.com/p/s/tolerogenic-potential-of-foxp3-plus-exosomes-derived-from-alloantigen-specifically-expanded-regulatory-t-cells-33255
https://atc.digitellinc.com/p/s/r-for-hla-data-a-suite-of-tools-for-managing-and-analyzing-data-from-clinical-hla-laboratory-information-systems-33256
https://atc.digitellinc.com/p/s/genetic-variations-in-a-sestrin2sestrin3mtor-axis-and-development-of-new-onset-diabetes-after-renal-transplantation-33257
https://atc.digitellinc.com/p/s/non-hla-panel-reactive-antibodies-pra-determined-by-a-novel-multiplex-luminex-assay-correlates-with-kidney-transplant-outcomes-33258
https://atc.digitellinc.com/p/s/identification-of-unique-dq4-allo-reactivity-33259
https://atc.digitellinc.com/p/s/long-term-outcomes-of-primary-living-donor-kidney-transplants-in-the-united-statescomparing-hla-vs-eplet-mismatches-using-a-novel-weighted-imputation-method-33260
https://atc.digitellinc.com/p/s/impact-of-sars-cov2-mrna-vaccination-on-human-leukocyte-antigen-antibody-responses-in-kidney-transplant-33261
https://atc.digitellinc.com/p/s/high-resolution-hla-genotyping-informs-assessment-of-hla-t-cell-epitope-mismatches-associated-with-early-dsa-and-tcmr-in-kidney-transplant-recipients-33262
https://atc.digitellinc.com/p/s/donor-hla-discrepancies-have-decreased-with-time-33263
https://atc.digitellinc.com/p/s/impact-of-hla-evolutionary-divergence-and-eplet-mismatches-on-kidney-allograft-rejection-and-outcome-a-population-based-study-33264
https://atc.digitellinc.com/p/s/association-between-hla-molecular-mismatch-and-histological-rejection-in-kidney-allograft-33265
https://atc.digitellinc.com/p/s/analysis-of-virtual-hla-crossmatch-strategy-for-deceased-donor-kidney-transplantation-33266
https://atc.digitellinc.com/p/s/transcription-factor-nfatc4-gene-polymorphism-determines-susceptibility-bk-virus-infection-after-kidney-transplant-33267
https://atc.digitellinc.com/p/s/characteristics-of-kidney-candidates-with-hla-dpb1-unacceptable-antigen-assignment-33268
https://atc.digitellinc.com/p/s/changes-of-calculated-panel-reactive-antibody-in-waitlisted-kidney-transplant-candidates-utilizing-the-transplantation-toolbox-33269
https://atc.digitellinc.com/p/s/significance-of-pre-transplant-donor-specific-antibodies-detected-by-luminex-impact-on-renal-allograft-rejection-and-short-term-graft-survival-33270
https://atc.digitellinc.com/p/s/the-influence-of-hla-a-b-c-dr-types-and-hla-haplotypes-on-cmv-specific-cell-mediated-immunity-in-seropositive-korean-kidney-transplant-candidates-33271
https://atc.digitellinc.com/p/s/blood-based-transcriptomic-changes-during-two-cases-of-pig-to-human-kidney-xenotransplantation-33272
https://atc.digitellinc.com/p/s/endomyocardial-biopsy-technique-in-brain-dead-decedent-porcine-xenoheart-transplant-recipients-33273
https://atc.digitellinc.com/p/s/comparison-of-hemodynamic-and-echocardiographic-findings-in-two-brain-dead-decedent-xenoheart-transplant-recipients-33274
https://atc.digitellinc.com/p/s/the-effect-of-depletional-induction-strategies-on-non-human-primate-islet-xenotransplant-outcomes-33275
https://atc.digitellinc.com/p/s/neutrophil-extracellular-traps-in-xeno-islet-transplantation-and-cd46-gene-expression-33276
https://atc.digitellinc.com/p/s/nk-cells-are-implicated-in-early-rejection-in-pig-to-nonhuman-primate-renal-xenotransplantation-33277
https://atc.digitellinc.com/p/s/skin-grafts-from-genetically-engineered-pigs-in-squirrel-monkeys-survive-longer-than-allografts-33278
https://atc.digitellinc.com/p/s/longitudinal-monitoring-of-donor-cell-free-dna-in-porcine-kidney-xenotransplantations-33279
https://atc.digitellinc.com/p/s/trial-of-a-cardiac-xenotransplantation-regimen-in-a-preclinical-heterotopic-model-33280
https://atc.digitellinc.com/p/s/pilot-evaluation-of-a-clinical-xeno-heart-transplant-regimen-in-a-preclinical-model-33281
https://atc.digitellinc.com/p/s/pig-xenogeneic-stimulation-of-human-t-cells-induces-unique-transcriptional-changes-associated-with-pro-coagulant-and-pro-inflammatory-responses-33282
https://atc.digitellinc.com/p/s/mhc-matchmaker-for-mamu-and-sla-evaluating-epitope-mismatches-for-xenotransplantation-33283
https://atc.digitellinc.com/p/s/cell-based-assays-for-the-detection-of-class-i-sla-antibodies-33284
https://atc.digitellinc.com/p/s/perceptions-and-potential-barriers-of-personnel-involved-in-xenotransplant-research-33285
https://atc.digitellinc.com/p/s/attitudes-of-patients-with-renal-disease-on-xenotransplantation-a-systematic-review-33286
https://atc.digitellinc.com/p/s/the-critical-care-nursing-experience-with-xenotransplant-research-33287
https://atc.digitellinc.com/p/s/pig-organs-with-10-gene-edits-support-post-transplant-survival-in-non-human-primates-and-humans-33288
https://atc.digitellinc.com/p/s/models-of-islet-and-lung-xenotransplantation-in-human-immune-system-mice-33289
https://atc.digitellinc.com/p/s/human-leucocyte-antigen-a-forgotten-criterion-for-decellularization-success-33290
https://atc.digitellinc.com/p/s/ecdi-treated-donor-b-cell-infusions-prolong-allograft-survival-in-a-nonhuman-primate-kidney-transplantation-model-33291
https://atc.digitellinc.com/p/s/hla-molecular-mismatches-and-induced-donor-specific-tolerance-in-kidney-transplantation-33292
https://atc.digitellinc.com/p/s/peripheral-clonal-deletion-of-the-t-cell-repertoire-induces-allograft-tolerance-by-targeting-programmed-death-1-33293
https://atc.digitellinc.com/p/s/targeting-brd4-achieves-transplant-tolerance-by-abrogating-the-generation-of-effector-and-memory-t-cells-33294
https://atc.digitellinc.com/p/s/inhibition-of-cd154cd11b-interaction-using-a-novel-nanotherapeutic-improves-allograft-survival-33295
https://atc.digitellinc.com/p/s/higher-frequency-of-host-cd8-plus-memory-t-cells-correlates-with-failure-to-achieve-heart-allograft-tolerance-via-mixed-chimerism-and-il-6-signaling-blockade-in-multiparous-female-non-human-primates-33296
https://atc.digitellinc.com/p/s/il-6-receptor-blockade-attenuates-effector-t-cell-function-and-significantly-prolongs-kidney-allograft-survival-in-ctla4ig-treated-rhesus-monkeys-33297
https://atc.digitellinc.com/p/s/the-role-of-bob1-in-chronic-lung-allograft-dysfunction-33298
https://atc.digitellinc.com/p/s/critical-role-of-accelerated-senescence-in-driving-chronic-allograft-dysfunction-33299
https://atc.digitellinc.com/p/s/thymic-irradiation-and-donor-mesenchymal-stem-cell-infusions-to-alter-homeostatic-repopulation-in-a-nonhuman-primate-model-of-kidney-transplantation-33300
https://atc.digitellinc.com/p/s/the-role-of-ly49-plus-cd8-plus-regulatory-t-cell-in-mouse-cardiac-allograft-transplant-tolerance-33301
https://atc.digitellinc.com/p/s/the-paradoxical-impact-of-calcineurin-inhibitor-cni-therapy-following-transplantation-33302
https://atc.digitellinc.com/p/s/single-cell-rna-sequencing-identifies-peripheral-blood-mononuclear-cells-landscape-associated-with-operational-tolerance-in-kidney-transplant-recipient-33303
https://atc.digitellinc.com/p/s/a-novel-rorght-inverse-agonist-to-target-th17-in-sensitized-skin-allograft-mouse-model-33304
https://atc.digitellinc.com/p/s/identification-of-molecular-determinants-that-govern-the-self-renewal-and-effector-differentiation-potential-of-stem-like-cd4-plus-effector-precursors-33305
https://atc.digitellinc.com/p/s/fasting-mimicking-diet-prolongs-heart-transplant-survival-in-mice-33306
https://atc.digitellinc.com/p/s/mtor-inhibitor-nanoimmunotherapy-prolongs-cardiac-and-lung-allograft-survival-in-non-human-primates-nhps-33307
https://atc.digitellinc.com/p/s/interferon-beta-pretreatment-alleviates-allogeneic-renal-tubular-epithelial-cell-induced-nk-and-cd8-plus-t-cell-responses-via-the-irf7haenkg2a-axis-33308
https://atc.digitellinc.com/p/s/solid-organ-and-vascularize-composite-allotransplantation-have-distinct-requirements-for-localized-delivery-of-enhanced-costimulation-blockade-to-control-rejection-33309
https://atc.digitellinc.com/p/s/transplant-immunosuppressants-differentially-alter-intestinal-metabolic-activities-33310
https://atc.digitellinc.com/p/s/pro-tolerogenic-gut-microbiota-induce-distinct-metabolic-activities-after-cardiac-allografting-33311
https://atc.digitellinc.com/p/s/assessing-the-impact-of-calcineurin-versus-mtor-inhibitors-on-homeostatic-repopulation-when-used-with-belatacept-in-a-nonhuman-primate-model-of-kidney-transplantation-33312
https://atc.digitellinc.com/p/s/research-for-novel-mechanism-of-immunosuppression-through-pd-1pd-l1-pathway-33313
https://atc.digitellinc.com/p/s/homoharringtonine-promotes-mouse-heart-allograft-acceptance-by-expanding-regulatory-t-cells-and-enhancing-il-10-expression-33314
https://atc.digitellinc.com/p/s/single-cell-rna-sequencing-provides-insight-into-early-ischemiareperfusion-of-transplanted-kidney-33315
https://atc.digitellinc.com/p/s/urine-derived-stem-cell-attenuated-renal-fibrosis-via-klotho-activation-33316
https://atc.digitellinc.com/p/s/canonical-gpx4-mediated-ferroptosis-pathway-regulates-ischemia-reperfusion-injury-in-liver-transplantation-33317
https://atc.digitellinc.com/p/s/characterizing-gene-expression-with-deferoxamine-along-the-ferroptosis-signaling-pathway-using-a-novel-perfusion-regulated-organ-therapeutics-with-enhanced-controlled-testing-system-33318
https://atc.digitellinc.com/p/s/investigating-rna-interference-mediated-knockdown-of-fas-on-ischemia-reperfusion-injury-during-the-liver-transplantation-process-33319
https://atc.digitellinc.com/p/s/single-cell-atlas-of-immune-cell-chimerism-resolution-in-ischaemia-free-versus-conventional-liver-transplantation-33320
https://atc.digitellinc.com/p/s/recipient-macrophage-derived-xbp1-mitigates-ischemia-and-reperfusion-injury-mediated-via-regulating-tgfv1klf4-pathways-response-following-kidney-transplantation-33321
https://atc.digitellinc.com/p/s/a-novel-animal-model-for-utilizing-fatty-liver-grafts-orthotopic-fatty-liver-transplantation-in-mice-33322
https://atc.digitellinc.com/p/s/directing-tryptophan-immunometabolism-to-ameliorate-ischemia-reperfusion-injury-33323
https://atc.digitellinc.com/p/s/prolonged-warm-ischemia-injury-enhances-cellular-immune-responses-to-mouse-renal-allografts-33324
https://atc.digitellinc.com/p/s/applying-hibernation-biochemistry-to-reduce-ischemia-reperfusion-injury-in-solid-organ-transplantation-33325
https://atc.digitellinc.com/p/s/simulation-of-anoxic-cold-storage-and-oxygenated-ischemia-reperfusion-injury-models-to-study-drug-repositioning-in-donor-kidney-preservation-at-22-celsius-33326
https://atc.digitellinc.com/p/s/appropriate-dosing-of-gut-microbial-metabolite-phenylacetylglycine-alleviates-renal-ischemia-reperfusion-injury-33327
https://atc.digitellinc.com/p/s/gasdermin-d-mutation-is-protective-against-renal-ischemia-reperfusion-injury-33328
https://atc.digitellinc.com/p/s/beclin-1-dependent-autophagy-improves-renal-outcomes-following-unilateral-ureteral-obstruction-uuo-implications-for-post-transplant-fibrosis-33329
https://atc.digitellinc.com/p/s/the-pro-resolution-mechanism-of-glycogen-synthase-kinase-3-beta-inactivation-in-liver-ischemia-reperfusion-injury-33330
https://atc.digitellinc.com/p/s/normothermic-machine-perfusion-and-apol1-inflammation-and-hypoxia-axis-in-donor-kidney-33331
https://atc.digitellinc.com/p/s/a-direct-oral-factor-xa-inhibitor-edoxaban-ameriorates-hepatic-ischemia-reperfusion-injury-33332
https://atc.digitellinc.com/p/s/circular-rna-hipk3-an-immediate-responder-to-ischemic-reperfusion-injury-during-heart-transplantation-33333
https://atc.digitellinc.com/p/s/dietary-fiber-provides-protection-against-kidney-ischemia-reperfusion-injury-through-modulation-of-the-gut-microbiota-33334
https://atc.digitellinc.com/p/s/endothelial-connexin-43-gap-junctions-in-ischemia-reperfusion-injury-role-and-therapeutic-implications-for-solid-organ-transplantation-33335
https://atc.digitellinc.com/p/s/addition-of-an-oxygen-carrier-hemo2life-in-preservation-solution-for-preventing-ischemia-reperfusion-injuries-33336
https://atc.digitellinc.com/p/s/ninjurin-1-mediated-plasma-membrane-rupture-contributes-to-hepatic-ischemia-reperfusion-injury-33337
https://atc.digitellinc.com/p/s/ex-vivo-preconditioning-of-human-kidney-with-phd-inhibitor-upregulates-hif-target-genes-with-a-goal-to-mitigate-ischemia-reperfusion-injury-prior-to-transplant-33338
https://atc.digitellinc.com/p/s/utilization-of-oxygenated-solutions-during-procurement-back-benching-and-recipient-surgery-to-prevent-ischemic-reperfusion-injury-33339
https://atc.digitellinc.com/p/s/mitsugumin-53-mitigation-of-ischemia-reperfusion-injury-in-vitro-and-in-vivo-hepatocytes-33340
https://atc.digitellinc.com/p/s/therapeutic-role-of-cd38-on-liver-ischemia-reperfusion-injury-33341
https://atc.digitellinc.com/p/s/18v-glycyrrhetinic-acid-alleviates-ischemia-reperfusion-injury-induced-kidney-fibrosis-by-skewing-macrophage-polarization-towards-m2-phenotype-via-inhibiting-the-nlrirf7-signaling-pathway-33342
https://atc.digitellinc.com/p/s/n-acetylcysteine-successfully-meliorates-methaemoglobin-accumulation-during-extended-normothermic-machine-liver-perfusion-33343
https://atc.digitellinc.com/p/s/proteomic-effluent-analysis-reveals-down-regulation-of-novel-inflammatory-and-transcriptional-biomarkers-following-hypothermic-oxygenated-machine-perfusion-of-liver-allografts-33344
https://atc.digitellinc.com/p/s/immune-effects-of-extracellular-vesicles-generated-during-normothermic-ex-vivo-liver-perfusion-33345
https://atc.digitellinc.com/p/s/the-24-hour-normothermic-machine-perfusion-of-discarded-human-liver-grafts-33346
https://atc.digitellinc.com/p/s/preservation-of-dcd-kidney-grafts-using-subnormothermic-oxygenated-machine-perfusion-in-a-porcine-auto-transplant-model-33347
https://atc.digitellinc.com/p/s/development-of-an-extended-normothermic-machine-liver-perfusion-protocol-33348
https://atc.digitellinc.com/p/s/soluble-dna-a-proposed-biomarker-for-post-transplant-renal-function-in-hypothermic-perfused-kidney-allografts-33349
https://atc.digitellinc.com/p/s/acellular-ex-vivo-lung-perfusion-silences-pro-inflammatory-pathways-in-human-lung-endothelial-and-epithelial-cells-33350
https://atc.digitellinc.com/p/s/donor-lims1-genotype-as-an-important-determinant-of-allograft-kidney-response-to-ischemia-and-reperfusion-33351
https://atc.digitellinc.com/p/s/exploration-of-normothermic-machine-perfusion-strategies-in-rat-kidney-33352
https://atc.digitellinc.com/p/s/mitochondrial-markers-measured-during-normothermic-liver-perfusion-predict-early-posttransplant-outcomes-33353
https://atc.digitellinc.com/p/s/prolonged-donated-human-hearts-preservation-using-the-vps-encore-portable-oxygenated-machine-perfusion-device-33354
https://atc.digitellinc.com/p/s/molecular-mapping-of-nk-like-cd8-t-cell-atlas-in-kidney-transplantation-33355
https://atc.digitellinc.com/p/s/bulk-and-spatial-transcriptomic-analysis-of-preimplantation-kidney-biopsy-identified-interstitial-fibrosis-and-tubular-abnormalities-before-transplantation-33356
https://atc.digitellinc.com/p/s/transcriptomic-exploration-of-chronic-antibody-mediated-rejection-in-kidney-transplantation-33357
https://atc.digitellinc.com/p/s/development-of-a-novel-multiplex-digital-pcr-assay-for-same-day-measurement-of-donor-derived-cell-free-dna-33358
https://atc.digitellinc.com/p/s/cell-free-dna-derived-temporal-dynamics-and-trends-of-torque-teno-virus-in-kidney-transplant-33359
https://atc.digitellinc.com/p/s/increasing-the-accuracy-of-molecular-diagnosis-mdx-of-cardiac-tcmr-by-substituting-heart-specific-genes-for-kidney-specific-genes-in-archetype-analysis-33360
https://atc.digitellinc.com/p/s/itraq-and-mrm-based-proteomic-analysis-remarks-early-injury-index-associated-with-primary-dysfunction-after-liver-transplantation-33361
https://atc.digitellinc.com/p/s/novel-protein-biomarkers-as-predictors-of-autoimmune-type-1-diabetes-development-33362
https://atc.digitellinc.com/p/s/bone-marrow-from-focal-segmental-glomerulosclerosis-displays-activation-of-inflammatory-pathways-33363
https://atc.digitellinc.com/p/s/prediction-of-early-acute-rejection-after-kidney-transplantation-by-gut-microbiome-33364
https://atc.digitellinc.com/p/s/multicenter-prospective-observational-study-to-identify-and-validate-a-composite-of-urinary-exosomal-biomarkers-for-kidney-allograft-tubulointerstitial-fibrosis-33365
https://atc.digitellinc.com/p/s/evidence-of-field-cancerization-within-background-liver-parenchyma-of-transplant-recipients-with-hepatocellular-carcinoma-33366
https://atc.digitellinc.com/p/s/biomarker-discovery-through-transcriptional-spatial-profiling-of-allograft-biopsy-in-acute-t-cell-mediated-rejection-33367
https://atc.digitellinc.com/p/s/assessing-the-feasibility-of-the-banff-human-organ-transplant-panel-in-diagnosing-antibody-mediated-rejection-in-lung-transplant-biopsies-33368
https://atc.digitellinc.com/p/s/mir-1-3p-centric-lncrna-mirna-mrna-network-controls-hepatic-iri-in-human-orthotopic-liver-transplantation-33369
https://atc.digitellinc.com/p/s/expression-of-rejection-associated-transcripts-in-early-protocol-renal-transplant-biopsies-are-modulated-by-tacrolimus-exposure-and-hla-class-i-eplet-donor-recipient-mismatch-33370
https://atc.digitellinc.com/p/s/single-nucleus-sequencing-reveals-hippo-signaling-as-a-key-driver-of-human-liver-regeneration-33371
https://atc.digitellinc.com/p/s/a-pro-inflammatory-immune-state-is-influenced-by-perturbations-of-microbial-metabolites-in-renal-transplantation-33372
https://atc.digitellinc.com/p/s/single-lymphocyte-profiling-with-isoplexis-for-immune-stratification-a-pilot-study-33373
https://atc.digitellinc.com/p/s/utility-of-immune-function-monitoring-for-infectious-complications-in-liver-transplant-recipients-33374
https://atc.digitellinc.com/p/s/high-throughput-serologic-screening-demonstrates-influenza-vaccination-elicits-broadly-protective-serologic-responses-in-kidney-transplant-recipients-33375
https://atc.digitellinc.com/p/s/impact-of-age-on-hepatitis-b-virus-immunity-post-transplant-33376
https://atc.digitellinc.com/p/s/gaining-consensus-around-patient-risk-groups-and-prognostic-profiles-to-guide-cmv-management-among-patients-with-solid-organ-transplant-sot-insights-from-a-delphi-panel-with-sot-experts-33377
https://atc.digitellinc.com/p/s/prognostic-value-of-quantitative-real-time-pcr-forpneumocystis-jiroveciipneumonia-pjp-in-solid-organ-transplant-recipients-33378
https://atc.digitellinc.com/p/s/evaluation-of-the-incidence-of-nocardia-infection-in-solid-organ-transplant-recipients-on-opportunistic-infection-prophylaxis-33379
https://atc.digitellinc.com/p/s/nocardiosis-in-solid-organ-transplant-recipients-10-year-single-center-experience-33380
https://atc.digitellinc.com/p/s/urine-microbiome-profiling-in-kidney-transplant-recipients-33381
https://atc.digitellinc.com/p/s/heterotopic-hemifacial-transplantation-in-mice-33382
https://atc.digitellinc.com/p/s/dsba-l-deficiency-attenuates-lps-induced-acute-kidney-injury-via-nf-kbap-1-regulation-of-macrophage-polarization-33383
https://atc.digitellinc.com/p/s/elevation-in-fraction-or-quantity-of-donor-derived-cell-free-dna-at-1-and-3-month-after-kidney-transplant-is-associated-with-early-development-of-de-novo-donor-specific-antibody-33384
https://atc.digitellinc.com/p/s/the-function-of-small-non-coding-rnas-during-hepatic-iri-in-human-orthotopic-liver-transplantation-33385
https://atc.digitellinc.com/p/s/range-of-donor-derived-cell-free-dna-in-liver-transplant-recipients-an-exploratory-analysis-33386
https://atc.digitellinc.com/p/s/analysis-of-donor-derived-cell-free-dna-dd-cfdna-in-en-bloc-and-single-kidney-transplants-from-small-pediatric-donors-33387
https://atc.digitellinc.com/p/s/osteoprotegerin-reduces-antitumor-activity-of-liver-natural-killer-cells-and-increases-the-risk-of-hepatocellular-carcinoma-recurrence-33388
https://atc.digitellinc.com/p/s/exosomal-small-rna-signatures-from-donor-liver-preservation-fluid-associate-with-transplant-outcomes-33389
https://atc.digitellinc.com/p/s/a-biomarker-of-frailty-and-aging-in-liver-transplant-recipients-33390
https://atc.digitellinc.com/p/s/opportunity-to-detect-allograft-rejection-in-the-first-week-after-kidney-transplantation-using-a-non-invasive-multi-analyte-qsant-assay-33391
https://atc.digitellinc.com/p/s/crosstalk-between-recipient-adipose-tissue-tim4-plus-macrophages-and-donor-hepatocytes-is-critical-for-hepatocellular-protection-in-liver-transplantation-33392
https://atc.digitellinc.com/p/s/clinical-impact-of-incorporating-omnigraf-on-renal-function-33393
https://atc.digitellinc.com/p/s/regulatory-t-cells-in-chronically-rejected-human-lung-allografts-exhibit-a-gene-expression-program-suggesting-dysfunction-33394
https://atc.digitellinc.com/p/s/par-1-receptor-antibodies-induce-an-altered-macrophage-phenotype-via-tnfa-ap-1-and-micro-rna-hsa-let-7f-5p-33395
https://atc.digitellinc.com/p/s/cd4-plus-lymphocyte-immunophenotypes-cell-populations-and-a-possible-monitoring-tool-in-renal-transplantation-33396
https://atc.digitellinc.com/p/s/induction-of-delayed-immune-tolerance-after-reconstructive-transplantation-by-combining-donor-bone-marrow-transplantation-and-high-dose-cyclophosphamide-treatment-33397
https://atc.digitellinc.com/p/s/impact-of-removing-optn-region-from-vca-allocation-33398
https://atc.digitellinc.com/p/s/vascularized-composite-allograft-vca-trends-and-challenges-in-the-us-through-the-covid-era-33399
https://atc.digitellinc.com/p/s/muscle-edema-following-hypothermic-machine-perfusion-of-a-small-animal-hind-limb-graft-is-reduced-by-necrostatin-1-minocycline-and-q-vd-oph-33400
https://atc.digitellinc.com/p/s/continuous-vs-intermittent-subnomothermic-machine-perfusion-of-fasciocutaneous-flaps-in-swine-33401
https://atc.digitellinc.com/p/s/supercooling-to-extend-the-preservation-of-vca-in-a-pig-hindlimb-model-33402
https://atc.digitellinc.com/p/s/liver-or-thyroid-cancer-in-living-liver-donors-should-be-monitored-after-donor-hepatectomy-33403
https://atc.digitellinc.com/p/s/feasibility-pilot-study-on-lifestyle-interventions-for-weight-loss-in-obese-post-transplant-patients-33404
https://atc.digitellinc.com/p/s/adverse-childhood-experiences-and-pediatric-solid-organ-transplant-long-term-outcomes-single-center-study-33405
https://atc.digitellinc.com/p/s/cognition-and-patient-reported-outcomes-among-liver-transplant-recipients-33406
https://atc.digitellinc.com/p/s/sex-differences-in-trauma-history-in-liver-transplant-candidates-an-underrecognized-barrier-to-care-33407
https://atc.digitellinc.com/p/s/social-participation-in-kidney-transplant-recipients-kt-compared-to-patients-on-hemodialysis-hd-33408
https://atc.digitellinc.com/p/s/recovery-of-physical-function-pf-after-kidney-kt-versus-liver-lt-transplantation-33409
https://atc.digitellinc.com/p/s/patient-perspectives-on-weight-management-and-wellness-after-liver-transplantation-33410
https://atc.digitellinc.com/p/s/simplified-questionnaire-for-assessing-immunosuppression-adherence-in-kidney-transplant-recipients-33411
https://atc.digitellinc.com/p/s/current-practice-in-psychosocial-evaluation-and-follow-up-of-living-kidney-donors-33412
https://atc.digitellinc.com/p/s/leveling-up-a-literature-review-on-the-gamification-of-healthcare-33413
https://atc.digitellinc.com/p/s/significant-discrepancies-to-evaluate-organ-procurement-organization-performance-based-on-exclusion-criteria-33414
https://atc.digitellinc.com/p/s/transition-of-care-of-successful-kidney-transplant-patients-from-the-transplant-center-a-national-survey-of-referring-nephrologists-33415
https://atc.digitellinc.com/p/s/the-impact-of-the-clarifying-multiple-organ-transplant-policy-on-simultaneous-heart-kidney-transplants-33416
https://atc.digitellinc.com/p/s/what-are-the-top-organ-refusal-reasons-under-the-2021-updated-refusal-codes-33417
https://atc.digitellinc.com/p/s/understanding-public-perceptions-of-deemed-consent-legislation-for-organ-donation-in-canada-33418
https://atc.digitellinc.com/p/s/pediatric-priority-after-age-18-years-kids-gaming-the-system-33419
https://atc.digitellinc.com/p/s/advantages-of-pcr-blood-testing-vs-default-ab-typing-33420
https://atc.digitellinc.com/p/s/simultaneous-liver-kidney-transplant-organ-allocation-and-outcomes-33421
https://atc.digitellinc.com/p/s/from-one-million-to-two-the-growth-of-transplantation-in-the-united-states-33422
https://atc.digitellinc.com/p/s/the-effect-of-change-in-the-kidney-allocation-policy-on-outcomes-of-a-sole-transplant-center-in-a-single-donor-service-area-dsa-33423
https://atc.digitellinc.com/p/s/the-estimated-effect-of-broader-sharing-on-slk-transplants-33424
https://atc.digitellinc.com/p/s/changes-in-the-landscape-of-infectious-risk-donor-ird-organs-under-the-new-definition-of-ird-33425
https://atc.digitellinc.com/p/s/cms-final-rule-for-organ-donation-unintended-consequences-of-the-pancreas-research-loophole-33426
https://atc.digitellinc.com/p/s/distribution-and-timing-of-cytomegalovirus-testing-following-organ-blood-and-stem-cell-transplantation-in-a-us-claims-database-33427
https://atc.digitellinc.com/p/s/impact-of-kidney-allocation-system-changes-on-the-cost-of-post-transplant-medical-care-33428
https://atc.digitellinc.com/p/s/shifting-anti-thymocyte-globulin-induction-administration-to-outpatient-setting-increases-inpatient-cost-savings-and-transplant-reimbursement-33429
https://atc.digitellinc.com/p/s/nationwide-variation-in-practices-surrounding-the-eligibility-and-disclosure-of-deceased-kidney-offers-amidst-planned-living-kidney-donation-33430
https://atc.digitellinc.com/p/s/who-should-participate-in-first-in-human-pig-xenotransplant-clinical-trials-33431
https://atc.digitellinc.com/p/s/achieving-person-centered-metrics-a-qualitative-study-of-informational-needs-of-patients-care-givers-and-living-donors-about-the-us-solid-organ-transplant-system-33432
https://atc.digitellinc.com/p/s/patient-perspectives-on-the-bioethical-considerations-of-using-frailty-and-cognition-in-kt-decision-making-factors-33433
https://atc.digitellinc.com/p/s/using-cognitive-interviews-to-gather-public-views-and-for-health-literary-33434
https://atc.digitellinc.com/p/s/how-do-irb-members-and-ethicists-assess-the-risk-of-zoonotic-disease-transmission-in-xenotransplant-pig-kidney-clinical-trials-33435
https://atc.digitellinc.com/p/s/gender-and-leadership-in-liver-transplantation-defining-the-gap-33436
https://atc.digitellinc.com/p/s/urinary-tract-infections-in-renal-transplant-recipients-with-sulfamethoxazole-trimethoprim-versus-alternative-prophylactic-agents-for-pneumocystis-jirovecii-pneumonia-prophylaxis-33437
https://atc.digitellinc.com/p/s/risk-factors-for-pneumocystis-jirovecii-pneumonia-in-renal-transplant-recipients-a-case-control-study-from-the-usrds-database-33438
https://atc.digitellinc.com/p/s/infection-in-patients-on-belatacept-based-regimen-after-kidney-transplantation-33439
https://atc.digitellinc.com/p/s/an-unexpected-cause-of-kidney-injury-in-a-heart-transplant-patient-unmasking-bk-nephropathy-33440
https://atc.digitellinc.com/p/s/emphysematous-pyelonephritis-in-a-kidney-transplant-recipient-a-rare-complication-33441
https://atc.digitellinc.com/p/s/risk-of-opportunistic-infection-in-adult-kidney-transplant-recipients-treated-with-belatacept-a-retrospective-cohort-study-33442
https://atc.digitellinc.com/p/s/blinded-after-belatacept-a-case-report-33443
https://atc.digitellinc.com/p/s/now-you-c-me-v-now-you-dont-a-rare-case-of-cytomegalovirus-induced-glomerulonephritis-33444
https://atc.digitellinc.com/p/s/one-year-post-kidney-transplant-urinary-tract-infection-and-the-impact-on-kidney-transplant-outcomes-33445
https://atc.digitellinc.com/p/s/valacyclovir-for-prevention-of-cytomegalovirus-infection-after-kidney-transplantation-33446
https://atc.digitellinc.com/p/s/management-and-outcome-of-severe-multifactorial-anemia-in-jehovahs-witness-deceased-donor-kidney-transplant-recipient-a-case-report-33447
https://atc.digitellinc.com/p/s/early-removal-of-ureteric-stent-is-associated-with-lower-incidence-of-urinary-tract-infection-in-the-first-month-following-kidney-transplantation-33448
https://atc.digitellinc.com/p/s/belatacept-conversion-for-refractory-bk-polyoma-virus-nephropathy-in-kidney-transplant-patients-33449
https://atc.digitellinc.com/p/s/xanthogranulomatous-pyelonephritis-a-rare-post-transplant-complication-33450
https://atc.digitellinc.com/p/s/impact-of-rejection-treatment-in-kidney-transplant-patients-on-infection-development-33451
https://atc.digitellinc.com/p/s/double-strength-versus-single-strength-bactrim-for-prophylaxis-of-urinary-tract-infections-in-kidney-transplant-recipients-33452
https://atc.digitellinc.com/p/s/impact-of-ivig-on-the-treatment-of-bkv-in-kidney-transplant-recipients-33453
https://atc.digitellinc.com/p/s/bk-virus-infection-in-the-current-era-risk-factors-and-outcomes-of-large-kidney-transplant-cohort-33454
https://atc.digitellinc.com/p/s/transplantation-of-contaminated-kidneys-the-utility-of-perioperative-donor-perfusate-cultures-33455
https://atc.digitellinc.com/p/s/evaluation-of-a-ureteral-stent-removal-antibiotic-prophylaxis-protocol-in-kidney-transplant-recipients-33456
https://atc.digitellinc.com/p/s/discrepancy-analysis-between-histology-and-molecular-diagnoses-in-kidney-allograft-biopsies-a-single-center-experience-33457
https://atc.digitellinc.com/p/s/virus-specific-t-cells-therapy-promising-but-not-magical-33458
https://atc.digitellinc.com/p/s/clinical-characteristics-of-talaromyces-marneffei-infection-in-renal-transplant-recipients-33459
https://atc.digitellinc.com/p/s/kidney-donor-profile-index-in-hepatitis-c-positive-kidney-transplantation-33460
https://atc.digitellinc.com/p/s/low-level-asymptomatic-cytomegalovirus-viremia-after-prophylaxis-can-be-safely-monitored-in-kidney-transplant-recipients-33461
https://atc.digitellinc.com/p/s/incidence-of-bk-polyomavirus-in-us-vs-foreign-born-kidney-transplant-recipients-33462
https://atc.digitellinc.com/p/s/immediate-post-transplant-intravenous-iron-supplementation-and-risk-of-bacterial-infections-in-renal-transplant-recipients-33463
https://atc.digitellinc.com/p/s/the-effectiveness-of-device-associated-healthcare-infections-prevention-measures-in-the-incidence-of-infections-and-mortality-in-prevalent-kidney-transplant-recipients-admitted-to-an-intensive-care-un-33464
https://atc.digitellinc.com/p/s/bk-virus-high-threshold-results-correlation-between-urine-and-blood-samples-33465
https://atc.digitellinc.com/p/s/bk-viremia-after-kidney-transplantation-efficacy-of-stepwise-treatments-33466
https://atc.digitellinc.com/p/s/incidence-of-bk-polyoma-virus-infection-in-kidney-transplant-recipients-treated-with-belatacept-based-immunosuppression-33467
https://atc.digitellinc.com/p/s/utilization-of-a-cmv-t-cell-immunity-panel-in-directing-duration-of-valganciclovir-prophylaxis-in-cmv-high-risk-kidney-transplant-recipients-33468
https://atc.digitellinc.com/p/s/frequency-and-outcomes-of-bk-viremia-after-simultaneous-heart-kidney-transplant-a-single-center-experience-33469
https://atc.digitellinc.com/p/s/incidence-and-impact-of-bk-viremia-in-simultaneous-liver-kidney-transplant-recipients-33470
https://atc.digitellinc.com/p/s/efficacy-of-linezolid-combination-against-gram-positive-bacteria-in-preservation-fluid-33471
https://atc.digitellinc.com/p/s/assessment-of-post-transplant-bacteremias-caused-by-extended-spectrum-beta-lactamase-producing-bacteria-among-kidney-transplant-recipients-33472
https://atc.digitellinc.com/p/s/strategies-to-decrease-incidence-of-cdc-defined-central-line-associated-bloodstream-infections-in-the-liver-icu-33473
https://atc.digitellinc.com/p/s/ultra-short-direct-acting-antiviral-prophylaxis-in-hepatitis-c-virus-antibody-positive-donors-to-hepatitis-c-virus-naive-liver-transplant-recipients-33474
https://atc.digitellinc.com/p/s/impact-of-a-dosing-change-for-cmv-prophylaxis-on-rates-of-leukopenia-in-liver-transplant-recipients-33475
https://atc.digitellinc.com/p/s/impact-of-multi-drug-resistant-infections-in-the-medical-liver-intensive-unit-on-transplant-outcomes-33476
https://atc.digitellinc.com/p/s/antibacterial-prophylaxis-regimens-in-adult-orthotopic-liver-transplantation-and-incidence-of-post-operative-bacterial-infections-33477
https://atc.digitellinc.com/p/s/absence-of-hepatitis-b-reactivation-in-hepatitis-b-surface-antigen-negative-core-antibody-positive-liver-recipients-a-retrospective-cohort-study-33478
https://atc.digitellinc.com/p/s/opportunistic-viral-infections-in-transplant-recipients-of-hepatitis-c-viremic-donor-organs-33479
https://atc.digitellinc.com/p/s/outcomes-of-liver-transplantation-with-the-use-of-organs-from-donation-after-circulatory-death-and-hepatitis-c-positive-donors-33480
https://atc.digitellinc.com/p/s/outcomes-of-kidney-liver-and-simultaneous-liver-and-kidney-transplants-from-hepatitis-c-positive-donors-to-hepatitis-c-naive-recipients-a-large-single-center-experience-33481
https://atc.digitellinc.com/p/s/fungal-infections-confer-worse-outcomes-relative-to-bacterial-counterparts-in-the-multi-disciplinary-medical-intensive-liver-unit-33482
https://atc.digitellinc.com/p/s/the-impact-of-post-transplant-opportunistic-infection-on-autoimmune-liver-disease-post-liver-transplantation-33483
https://atc.digitellinc.com/p/s/the-learning-curve-of-covid-19-and-organ-donation-potential-missed-opportunities-in-the-covid-era-33484
https://atc.digitellinc.com/p/s/covid-19-incidence-in-a-national-solid-organ-transplant-cohort-mirrors-population-viral-circulation-33485
https://atc.digitellinc.com/p/s/covid-19-severity-of-patients-with-solid-organ-transplants-through-the-covid-19-variant-waves-33486
https://atc.digitellinc.com/p/s/the-new-normal-of-wait-list-mortality-in-kidney-transplantation-post-pandemic-33487
https://atc.digitellinc.com/p/s/association-between-severe-sars-cov-2-infection-and-de-novo-hla-donor-specific-antibody-production-in-lung-transplant-recipients-single-center-study-33488
https://atc.digitellinc.com/p/s/practices-and-perceptions-of-the-use-of-covid-19-positive-organs-in-solid-organ-transplant-an-international-survey-33489
https://atc.digitellinc.com/p/s/immunogenicity-safety-and-breakthrough-covid-19-infections-after-sars-cov-2-vaccination-in-organ-transplant-recipients-a-prospective-multicenter-canadian-study-33490
https://atc.digitellinc.com/p/s/the-impact-of-monoclonal-antibody-against-sars-cov2-and-vaccination-on-outcomes-in-kidney-transplant-recipients-with-covid-19-33491
https://atc.digitellinc.com/p/s/downregulation-of-senescent-pathways-with-upregulation-of-cytolytic-effectors-are-the-predominant-signatures-of-covid-19-disease-in-children-with-solid-organ-transplants-33492
https://atc.digitellinc.com/p/s/incidence-of-chronic-kidney-disease-in-renal-transplant-patients-after-sars-cov2-infection-33493
https://atc.digitellinc.com/p/s/transplantation-amid-a-pandemic-the-fall-and-rise-of-kidney-transplantation-in-the-united-states-33494
https://atc.digitellinc.com/p/s/differential-access-to-kidney-transplantation-in-older-adults-during-the-covid-19-pandemic-by-race-age-and-sex-33495
https://atc.digitellinc.com/p/s/optimal-matched-comparison-of-short-term-outcomes-in-kidney-recipients-from-covid-infected-versus-non-infected-deceased-donors-33496
https://atc.digitellinc.com/p/s/the-safety-of-severe-acute-respiratory-syndrome-coronavirus-2-vaccine-in-solid-organ-transplant-recipients-33497
https://atc.digitellinc.com/p/s/sars-cov-2-variant-dependent-mortality-in-abdominal-solid-organ-transplant-recipients-33498
https://atc.digitellinc.com/p/s/post-transplant-outcomes-in-covid-19-vaccinated-vs-unvaccinated-liver-transplant-recipients-is-there-a-price-to-pay-33499
https://atc.digitellinc.com/p/s/re-infections-with-sars-cov-2-and-severity-in-solid-organ-transplant-recipients-a-matched-case-control-study-33500
https://atc.digitellinc.com/p/s/covid-19-outcomes-in-lung-transplant-recipients-receiving-tixagevimabcilgavimab-pre-exposure-prophylaxis-a-single-center-experience-33501
https://atc.digitellinc.com/p/s/kidney-allografts-at-risk-for-graft-failure-following-covid-19-33502
https://atc.digitellinc.com/p/s/outcomes-in-kidney-transplant-recipients-hospitalized-with-covid-19-insights-from-a-nationally-representative-sample-33503
https://atc.digitellinc.com/p/s/covid-19-mortality-among-solid-organ-transplant-recipients-in-the-united-states-during-june-to-december-2020-33504
https://atc.digitellinc.com/p/s/bnt162b2-vs-mrna1273-in-solid-organ-transplant-recipients-propensity-score-analysis-of-japanese-national-cohort-study-33505
https://atc.digitellinc.com/p/s/sars-cov-2-variants-and-anti-spike-igg-levels-associated-with-covid-19-c19-in-solid-organ-transplant-recipients-sotr-with-and-without-tixagevimab-cilgavimab-tc-pre-exposure-prophylaxis-prep-33506
https://atc.digitellinc.com/p/s/risk-factors-for-breakthrough-covid-19-infections-in-solid-organ-transplant-recipients-receiving-tixagevimabcilgavimab-for-pre-exposure-prophylaxis-33507
https://atc.digitellinc.com/p/s/sotrovimab-as-pre-exposition-prophylaxis-in-kidney-transplant-recipients-neutralization-of-omicron-ba1-and-ba2-variants-33508
https://atc.digitellinc.com/p/s/sars-cov-2-infection-and-disease-in-pediatric-kidney-transplant-recipients-results-from-the-brazilian-multicenter-study-33509
https://atc.digitellinc.com/p/s/nirmatrelvirritonavir-for-mild-covid-19-in-abdominal-organ-transplant-recipients-33510
https://atc.digitellinc.com/p/s/sars-cov-2-antibody-kinetics-after-vaccination-in-solid-organ-transplant-recipients-multicenter-study-33511
https://atc.digitellinc.com/p/s/covid-19-hospitalization-rates-for-renal-transplant-recipients-on-belatacept-bela-a-retrospective-study-33512
https://atc.digitellinc.com/p/s/real-world-experience-with-molnupiravir-in-a-heterogeneous-population-of-solid-organ-transplant-recipients-33513
https://atc.digitellinc.com/p/s/immunogenicity-and-reactogenicity-of-sars-cov-2-mrna-vaccination-in-pediatric-solid-organ-transplant-recipients-ages-5-11-years-33514
https://atc.digitellinc.com/p/s/decreased-immunogenicity-after-sars-cov-2-vaccination-in-liver-and-kidney-transplant-recipients-33515
https://atc.digitellinc.com/p/s/sensitivity-of-anti-nucleocapsid-antibody-to-detect-prior-covid-19-in-vaccinated-solid-organ-transplant-recipients-33516
https://atc.digitellinc.com/p/s/the-difference-of-outcomes-against-covid-19-between-variants-of-concern-in-solid-organ-transplant-recipients-japanese-national-registry-study-33517
https://atc.digitellinc.com/p/s/impact-of-early-vs-late-bebtelovimab-administration-in-a-nurse-driven-program-for-solid-organ-transplant-recipients-with-mild-to-moderate-covid-19-a-propensity-score-analysis-33518
https://atc.digitellinc.com/p/s/single-center-review-of-tixagevimab-cilgavimab-use-in-solid-organ-transplant-recipients-33519
https://atc.digitellinc.com/p/s/covid-19-vaccine-stimulation-of-dsa-and-dd-cfdna-in-heart-transplant-patients-33520
https://atc.digitellinc.com/p/s/tixagevimabcilgavimab-for-prevention-of-covid-19-in-newly-transplanted-kidney-recipients-33521
https://atc.digitellinc.com/p/s/pre-exposure-tixagevimabcilgavimab-monoclonal-antibodies-reduces-covid-19-infection-in-heart-transplant-recipients-33522
https://atc.digitellinc.com/p/s/first-experiences-with-organ-transplantation-of-sars-cov-2-positive-organ-donors-in-germany-33523
https://atc.digitellinc.com/p/s/recombinant-sars-cov-2-antibodies-in-kidney-transplant-recipients-without-neutralizing-antibodies-following-full-vaccination-rescue-tx-33524
https://atc.digitellinc.com/p/s/the-effect-of-a-booster-dosemrnavaccine-on-covid-19-infection-in-kidney-transplant-recipients-after-inactivated-or-viral-vector-vaccine-immunization-33525
https://atc.digitellinc.com/p/s/recent-intravenous-immunoglobulin-ivig-lots-contains-neutralizing-igg-to-sars-cov-2-omicron-variant-33526
https://atc.digitellinc.com/p/s/the-impact-of-hormone-replacement-therapy-on-covid-19-outcomes-in-solid-organ-transplant-recipients-33527
https://atc.digitellinc.com/p/s/the-covid-19-pandemic-from-the-perspective-of-kidney-transplant-recipients-33528
https://atc.digitellinc.com/p/s/hook-prozone-effect-in-anti-spike-binding-antibody-level-following-vaccination-infection-or-monoclonal-antibody-in-solid-organ-transplant-recipients-33529
https://atc.digitellinc.com/p/s/early-referral-intervention-and-monitoring-of-kidney-transplant-recipients-saved-lives-during-the-covid-19-pandemic-33530
https://atc.digitellinc.com/p/s/content-analysis-of-us-transplant-centers-online-covid-19-related-resources-33531
https://atc.digitellinc.com/p/s/the-long-term-impact-of-sars-cov-2-infection-on-kidney-transplant-outcomes-33532
https://atc.digitellinc.com/p/s/increasing-use-of-covid-19-donors-in-solid-organ-transplantation-33533
https://atc.digitellinc.com/p/s/anti-spike-antibody-durability-after-sars-cov-2-vaccination-in-adolescent-solid-organ-transplant-recipients-33534
https://atc.digitellinc.com/p/s/kidney-transplant-patients-should-be-immunized-with-moderna-moderna-1273-rather-than-pfizer-biontech-bnt162b2-vaccines-33535
https://atc.digitellinc.com/p/s/sars-cov-2-vaccination-is-associated-with-dsa-development-in-kidney-transplant-recipients-33536
https://atc.digitellinc.com/p/s/lack-of-association-between-vitamin-d-levels-and-mortality-in-kidney-transplant-recipients-with-covid-19-33537
https://atc.digitellinc.com/p/s/covid-19-vaccination-strategies-and-seroconversion-in-solid-organ-transplant-recipients-a-living-systematic-review-and-network-meta-analysis-of-observational-studies-33538
https://atc.digitellinc.com/p/s/comparison-of-outcomes-in-unvaccinated-versus-vaccinated-covid-19-kidney-transplant-recipients-is-the-taboo-justified-33539
https://atc.digitellinc.com/p/s/assessing-the-efficacy-of-evusheld-for-prevention-of-sars-cov-2-and-omicron-infections-in-solid-organ-transplant-recipients-33540
https://atc.digitellinc.com/p/s/number-of-covid-19-vaccine-doses-and-clinical-outcomes-in-solid-organ-transplant-recipients-a-living-systematic-review-and-network-meta-analysis-of-observational-studies-33541
https://atc.digitellinc.com/p/s/prospective-evaluation-of-sars-cov-2-spike-s-anti-receptor-binding-domain-rbd-igg-titers-after-administration-of-tixagevimab-cilgavimab-tc-pre-exposure-prophylaxis-prep-in-solid-organ-transplant-recip-33542
https://atc.digitellinc.com/p/s/covid-19-and-deceased-donor-organ-donation-33543
https://atc.digitellinc.com/p/s/covid-19-and-kidney-transplantation-in-older-adults-in-the-united-states-33544
https://atc.digitellinc.com/p/s/covid-19-breakthrough-infections-in-vaccinated-solid-organ-transplant-recipients-who-received-tixagevimabcilgavimab-evusheldtm-for-pre-exposure-prophylaxis-33545
https://atc.digitellinc.com/p/s/long-covid-in-kidney-transplant-recipients-in-the-omicron-predominance-a-longitudinal-cohort-study-33546
https://atc.digitellinc.com/p/s/outcomes-of-kidney-transplantation-recipients-with-covid-19-infection-282-cases-of-a-single-center-experience-33547
https://atc.digitellinc.com/p/s/when-you-need-to-dive-in-the-deep-end-transplanting-sars-cov-2-pcr-plus-recipients-33548
https://atc.digitellinc.com/p/s/outcomes-of-oral-antiviral-therapy-compared-to-monoclonal-antibody-against-sars-cov-2-and-vaccination-in-kidney-transplant-recipients-with-covid-19-33549
https://atc.digitellinc.com/p/s/comparative-one-year-allograft-outcomes-for-recipients-of-kidneys-from-sars-cov-2-nat-plus-donors-33550
https://atc.digitellinc.com/p/s/real-world-healthcare-resource-utilization-hcru-and-costs-among-patients-with-hematopoietic-stem-cell-transplant-hsct-or-solid-organ-transplant-sot-with-covid-19-in-a-commercially-insured-or-medicare--33551
https://atc.digitellinc.com/p/s/comparison-of-the-different-drugs-used-for-covid-19-omicron-in-patients-with-a-kidney-transplant-33552
https://atc.digitellinc.com/p/s/organ-donation-and-transplantation-recovery-during-the-first-two-years-of-the-covid-19-pandemic-a-comparison-of-canada-and-the-united-states-33553
https://atc.digitellinc.com/p/s/incidence-of-covid-in-vaccinated-patients-receiving-evusheld-33554
https://atc.digitellinc.com/p/s/novel-coronavirus-pneumonia-after-kidney-transplantation-analysis-of-risk-factors-33555
https://atc.digitellinc.com/p/s/a-multinational-study-assessing-treatment-patterns-clinical-outcomes-and-healthcare-resource-utilization-in-solid-organ-transplant-recipients-with-refractoryresistant-cytomegalovirus-infection-or-into-33556
https://atc.digitellinc.com/p/s/clinical-utility-of-hiv-confirmatory-testing-in-the-deceased-donor-organ-transplant-setting-33557
https://atc.digitellinc.com/p/s/clinically-significant-cytomegalovirus-infection-is-associated-with-allograft-loss-and-mortality-after-pancreas-transplantation-33558
https://atc.digitellinc.com/p/s/epidemiology-of-infectious-complications-in-kidney-transplant-recipients-with-antibody-mediated-rejection-a-prospective-multicenter-cohort-study-33559
https://atc.digitellinc.com/p/s/safety-and-immunogenicity-of-the-live-attenuated-varicella-vaccine-in-solid-organ-transplant-recipients-a-systematic-review-and-meta-analysis-33560
https://atc.digitellinc.com/p/s/single-center-experience-with-maribavir-for-the-treatment-of-cmv-infection-in-solid-organ-transplant-recipients-33561
https://atc.digitellinc.com/p/s/toxoplasmosis-prophylaxis-practices-survey-of-international-pediatric-solid-organ-transplant-centers-33562
https://atc.digitellinc.com/p/s/invasive-aspergillosis-in-liver-transplant-recipients-in-the-current-era-33563
https://atc.digitellinc.com/p/s/utilization-of-oral-step-down-antiviral-therapy-may-decrease-length-of-hospital-admission-for-resistant-cytomegalovirus-after-solid-organ-transplant-a-real-world-case-series-33564
https://atc.digitellinc.com/p/s/risk-factors-for-early-post-solid-organ-transplant-fungal-disease-a-systematic-review-and-meta-analysis-33565
https://atc.digitellinc.com/p/s/clinical-course-of-norovirus-in-adult-and-pediatric-solid-organ-and-hematopoietic-stem-cell-transplant-recipientsa-multi-center-retrospective-study-33566
https://atc.digitellinc.com/p/s/the-relevance-of-non-aspergillus-fumigatus-mold-infections-in-lung-transplant-recipients-multicentric-comparison-with-aspergillus-fumigatus-33567
https://atc.digitellinc.com/p/s/incidence-of-invasive-fungal-diseases-in-solid-organ-transplant-recipients-on-belatacept-for-organ-rejection-prophylaxis-a-single-center-retrospective-cohort-study-33568
https://atc.digitellinc.com/p/s/cytomegalovirus-viral-load-at-initiating-antiviral-pre-emptive-therapy-may-predict-longer-duration-of-dnaemia-and-antiviral-therapy-in-pediatric-allogeneic-hematopoietic-cell-transplantation-recipient-33569
https://atc.digitellinc.com/p/s/risk-factors-and-outcomes-of-recurrent-cytomegalovirus-infections-in-heart-transplant-recipients-33570
https://atc.digitellinc.com/p/s/assessment-of-biofire-r-pneumonia-panel-utility-in-lung-transplant-recipients-with-concern-for-respiratory-infection-33571
https://atc.digitellinc.com/p/s/successful-lung-transplantation-for-covid-19-pcr-positive-recipients-33572
https://atc.digitellinc.com/p/s/prophylaxis-and-risk-factors-for-nocardiosis-in-solid-organ-transplant-recipients-33573
https://atc.digitellinc.com/p/s/clinically-significant-cytomegalovirus-infection-is-associated-with-increased-mortality-after-heart-transplantation-33574
https://atc.digitellinc.com/p/s/use-of-a-cmv-specific-t-cell-immunity-panel-tcip-to-guide-secondary-prophylaxis-after-cmv-infection-33575
https://atc.digitellinc.com/p/s/clinical-outcomes-of-baloxavir-vs-oseltamivir-in-transplant-and-other-immunocompromised-patients-33576
https://atc.digitellinc.com/p/s/clinical-outcomes-of-lung-transplant-recipients-with-pre-transplant-mycobacterium-avium-complex-infection-33577
https://atc.digitellinc.com/p/s/risk-factors-and-outcomes-of-mucorales-infection-in-solid-organ-and-hematopoietic-stem-cell-transplant-recipients-33578
https://atc.digitellinc.com/p/s/breakthrough-invasive-fungal-infections-in-lung-transplant-recipients-receiving-universal-prophylaxis-a-single-center-retrospective-study-33579
https://atc.digitellinc.com/p/s/a-case-of-monkeypox-in-a-kidney-transplant-recipient-living-with-hiv-33580
https://atc.digitellinc.com/p/s/cefiderocol-utilization-in-lung-transplant-recipients-at-a-single-center-33581
https://atc.digitellinc.com/p/s/risk-factors-for-breakthrough-cytomegalovirus-infection-while-on-prophylaxis-in-kidney-and-pancreas-transplant-recipients-33582
https://atc.digitellinc.com/p/s/burden-of-cmv-infections-after-simultaneous-pancreas-kidney-transplantation-a-nationwide-cohort-study-33583
https://atc.digitellinc.com/p/s/fungemia-in-thoracic-organ-transplant-recipients-33584
https://atc.digitellinc.com/p/s/disseminated-monkeypox-infection-in-a-kidney-transplant-recipient-33585
https://atc.digitellinc.com/p/s/characterization-of-antifungal-prophylaxis-in-high-meld-liver-transplant-candidates-33586
https://atc.digitellinc.com/p/s/characterization-of-maribavir-for-management-of-resistant-or-refractory-cytomegalovirus-in-solid-organ-transplant-recipients-33587
https://atc.digitellinc.com/p/s/assessing-the-need-for-cytomegalovirus-antiviral-stewardship-in-high-risk-cardiothoracic-transplant-recipients-33588
https://atc.digitellinc.com/p/s/short-course-outcome-of-mycobacterium-abscessus-infections-in-fresh-lung-transplant-recipients-a-case-series-33589
https://atc.digitellinc.com/p/s/letermovir-as-step-down-antiviral-treatment-for-solid-organ-transplant-recipients-with-cytomegalovirus-infection-33590
https://atc.digitellinc.com/p/s/risk-factors-for-late-onset-pneumocystis-jirovecii-pneumonia-in-liver-transplant-recipients-33591
https://atc.digitellinc.com/p/s/real-world-experience-with-maribavir-for-the-treatment-of-cytomegalovirus-in-solid-organ-transplant-recipients-33592
https://atc.digitellinc.com/p/s/the-performance-of-bronchoalveolar-lavage-aspergillus-pcr-in-solid-organ-transplant-recipients-a-single-center-experience-33593
https://atc.digitellinc.com/p/s/letermovir-as-a-rescue-therapy-in-kidney-transplant-recipients-with-valganciclovirganciclovir-refractoryresistant-cmv-disease-33594
https://atc.digitellinc.com/p/s/comparing-efficacy-of-itraconazole-solution-versus-posaconazole-for-antifungal-prophylaxis-after-heart-transplant-33595
https://atc.digitellinc.com/p/s/pneumocystis-pneumonia-outbreaks-among-transplant-recipients-unraveling-the-mystery-33596
https://atc.digitellinc.com/p/s/cmv-seropositive-donor-status-in-cmv-seronegative-lung-transplant-recipients-is-associated-with-increased-mortality-across-the-age-span-data-from-the-srtr-33597
https://atc.digitellinc.com/p/s/low-dose-aspirin-does-not-reduce-the-incidence-of-bk-and-jc-polyomavirus-infections-in-renal-transplant-recipients-33598
https://atc.digitellinc.com/p/s/non-tuberculous-mycobacteria-in-lung-transplant-patients-treat-or-wait-33599
https://atc.digitellinc.com/p/s/risk-factors-for-invasive-fungal-infection-in-lung-transplant-recipients-on-universal-prophylaxis-with-inhaled-amphotericin-b-lipid-complex-33600
https://atc.digitellinc.com/p/s/hematological-and-immunologic-factors-associated-with-the-development-of-chronic-rhinosinusitis-in-transplant-patients-33601
https://atc.digitellinc.com/p/s/clinical-features-diagnosis-and-treatment-of-clostridium-difficile-infection-after-kidney-transplantation-33602
https://atc.digitellinc.com/p/s/end-of-treatment-positron-emission-tomography-response-and-outcomes-in-post-transplant-lymphoproliferative-disorder-ptld-33603
https://atc.digitellinc.com/p/s/the-maintenance-immunosuppressive-regimen-is-associated-with-survival-probability-after-post-transplant-lymphoproliferative-disease-with-a-positive-ebv-viremia-33604
https://atc.digitellinc.com/p/s/ebv-mirnas-bhrf1-1-and-bart2-5p-aggravate-post-transplant-lymphoproliferative-disorder-via-lzts2-pi3k-akt-axis-33605
https://atc.digitellinc.com/p/s/lung-transplant-recipients-perspectives-on-integration-of-pharmacogenomic-testing-to-transplant-care-33606
https://atc.digitellinc.com/p/s/variability-in-mycophenolate-mofetil-mmf-pharmacokinetics-and-dose-requirements-across-transplant-tx-types-33607
https://atc.digitellinc.com/p/s/successful-use-of-phenytoin-fosphenytoin-in-a-pediatric-transplant-recipient-with-nimatrelvir-ritonavir-induced-tacrolimus-toxicity-33608
https://atc.digitellinc.com/p/s/supratherapeutic-tacrolimus-levels-in-a-kidney-transplant-recipient-after-laparoscopic-sleeve-gastrectomy-33609
https://atc.digitellinc.com/p/s/multiple-mycophenolic-acid-enterohepatic-recirculation-peaks-after-oral-mmf-in-kidney-transplant-recipients-33610
https://atc.digitellinc.com/p/s/the-safety-and-efficacy-of-concomitant-sodium-zirconium-cyclosilicate-and-tacrolimus-use-in-heart-transplant-recipients-33611
https://atc.digitellinc.com/p/s/evaluation-of-the-effect-of-potassium-binders-on-extended-release-tacrolimus-33612
https://atc.digitellinc.com/p/s/apixaban-levels-in-liver-and-lung-transplant-recipients-receiving-tacrolimus-based-immunosuppression-a-prospective-real-world-pharmacokinetic-study-33613
https://atc.digitellinc.com/p/s/effect-of-tacrolimus-metabolism-rate-on-renal-function-among-hispanic-kidney-transplant-recipients-33614
https://atc.digitellinc.com/p/s/predicting-patient-outcomes-in-kidney-transplant-recipients-plasma-versus-whole-blood-tacrolimus-33615
https://atc.digitellinc.com/p/s/alemtuzumab-vs-anti-thymocyte-globulin-in-kidney-transplant-recipients-receiving-a-steroid-free-maintenance-regimen-33616
https://atc.digitellinc.com/p/s/early-experience-with-maribavir-in-solid-organ-transplant-recipients-33617
https://atc.digitellinc.com/p/s/incidence-of-oral-or-esophageal-candidiasis-with-and-without-topical-antifungal-prophylaxis-following-lung-transplant-33618
https://atc.digitellinc.com/p/s/real-world-adherence-to-belatacept-bela-maintenance-immunosuppression-is-guidelines-33619
https://atc.digitellinc.com/p/s/evaluation-of-oral-potassium-binders-in-decreasing-delayed-graft-function-in-renal-transplant-recipients-33620
https://atc.digitellinc.com/p/s/modelling-changes-in-the-pharmacokinetics-of-tacrolimus-during-pregnancy-after-kidney-transplantation-a-retrospective-cohort-study-33621
https://atc.digitellinc.com/p/s/a-pharmacist-survey-of-utilization-of-sodium-glucose-cotransporter-2-inhibitors-in-solid-organ-transplant-recipients-33622
https://atc.digitellinc.com/p/s/transplant-pharmacist-service-stewardship-a-service-line-pilot-33623
https://atc.digitellinc.com/p/s/gabapentin-concomitant-prescription-of-opioids-and-benzodiazepines-among-kidney-transplant-recipients-33624
https://atc.digitellinc.com/p/s/safety-and-efficacy-of-early-metformin-initiation-post-kidney-transplant-33625
https://atc.digitellinc.com/p/s/the-impact-of-sodium-zirconium-cyclosilicate-zs-9-use-on-the-incidence-of-delayed-graft-function-dgf-in-deceased-donor-kidney-transplant-recipients-ktrs-33626
https://atc.digitellinc.com/p/s/the-effectiveness-of-tixagevimabcilgavimab-evusheld-in-preventing-severe-sars-cov-2-covid-infection-after-kidney-transplantation-33627
https://atc.digitellinc.com/p/s/evaluating-the-use-of-glucagon-like-peptide-1-receptor-agonists-glp1-ra-in-a-matched-cohort-of-kidney-and-liver-transplant-recipients-33628
https://atc.digitellinc.com/p/s/predicting-patient-outcomes-in-kidney-transplant-recipients-plasma-versus-whole-blood-tacrolimus-33629
https://atc.digitellinc.com/p/s/impact-of-pre-transplant-pharmacist-evaluations-on-hepatitis-b-and-herpes-zoster-vaccination-rates-in-solid-organ-transplant-recipients-33630
https://atc.digitellinc.com/p/s/safety-and-efficacy-of-secondary-prophylaxis-with-valganciclovir-for-recurrent-cytomegalovirus-in-kidney-transplant-33631
https://atc.digitellinc.com/p/s/successful-opioid-minimization-following-kidney-transplant-33632
https://atc.digitellinc.com/p/s/efficacy-of-fidaxomicin-versus-oral-vancomycin-for-clostridium-difficile-infection-in-solid-organ-transplant-recipients-33633
https://atc.digitellinc.com/p/s/safety-and-efficacy-of-condensed-induction-dosing-of-rabbit-antithymocyte-globulin-in-kidney-transplant-recipients-33634
https://atc.digitellinc.com/p/s/use-of-remdesivir-in-solid-organ-transplant-recipients-with-covid-19-33635
https://atc.digitellinc.com/p/s/belatacept-discontinuation-in-stable-recipients-of-elevated-risk-kidney-transplants-33636
https://atc.digitellinc.com/p/s/dapsone-induced-anemia-in-solid-organ-transplant-recipients-with-normal-g6pd-activity-33637
https://atc.digitellinc.com/p/s/body-surface-area-valganciclovir-prophylactic-dosing-is-associated-with-higher-toxicities-compared-to-body-weight-dosing-in-pediatric-solid-organ-transplant-recipients-33638
https://atc.digitellinc.com/p/s/efficacy-of-a-de-novo-tacrolimus-extended-release-envarsus-xr-r-dosing-algorithm-33639
https://atc.digitellinc.com/p/s/cmv-t-cell-assays-may-be-useful-in-detecting-mtor-induced-immunity-33640
https://atc.digitellinc.com/p/s/evaluation-of-twice-daily-tacrolimus-switched-to-once-daily-tacrolimus-in-kidney-transplant-recipients-33641
https://atc.digitellinc.com/p/s/should-kidney-transplant-candidates-with-epts-of-20-percent-or-less-wait-for-a-donor-with-a-kdpi-of-20-percent-or-less-33642
https://atc.digitellinc.com/p/s/the-impact-of-new-kidney-allocation-policy-on-transplant-practice-in-the-united-states-33643
https://atc.digitellinc.com/p/s/change-in-organ-offer-volume-and-bypass-filter-settings-under-new-kidney-allocation-system-33644
https://atc.digitellinc.com/p/s/economic-evaluation-of-accepting-a-preemptive-kidney-transplant-from-a-high-kdpi-donor-in-older-adults-33645
https://atc.digitellinc.com/p/s/effect-of-recipient-donor-weight-mismatch-on-graft-survival-in-high-kidney-donor-profile-index-deceased-donor-kidney-transplants-33646
https://atc.digitellinc.com/p/s/improving-access-to-transplant-non-a1non-a1b-to-blood-group-b-deceased-donor-kidney-transplants-33647
https://atc.digitellinc.com/p/s/open-simultaneous-offers-for-high-kdri-kidneys-may-significantly-reduce-discards-33648
https://atc.digitellinc.com/p/s/patient-and-graft-survival-after-a2a2b-to-b-deceased-donor-kidney-transplantation-33649
https://atc.digitellinc.com/p/s/social-determinants-of-health-help-explain-disparities-in-access-to-multiple-listing-among-kidney-transplant-candidates-in-the-united-states-33650
https://atc.digitellinc.com/p/s/effect-of-kidney-allocation-policy-and-organ-donor-hospital-location-on-kidney-discard-33651
https://atc.digitellinc.com/p/s/impact-of-offer-filters-after-6-months-33652
https://atc.digitellinc.com/p/s/optimizing-a-race-free-kidney-donor-risk-index-33653
https://atc.digitellinc.com/p/s/predictive-ability-of-epts-in-pediatric-renal-recipients-33654
https://atc.digitellinc.com/p/s/peak-creatinine-improves-ability-to-predict-reduced-glomerular-filtration-rate-in-deceased-donors-with-diabetes-insipidus-33655
https://atc.digitellinc.com/p/s/quantifying-informed-consent-kidney-transplant-candidates-that-list-for-high-kdpi-donors-and-the-estimated-benefit-33656
https://atc.digitellinc.com/p/s/better-hla-matching-improved-kidney-allograft-survival-in-african-american-patients-with-race-adjusted-immunogenicity-thresholds-33657
https://atc.digitellinc.com/p/s/multiple-listing-in-kidney-transplantation-following-implementation-of-the-concentric-circle-kidney-allocation-policy-33658
https://atc.digitellinc.com/p/s/deviating-from-the-match-run-to-save-a-kidney-33659
https://atc.digitellinc.com/p/s/transplantation-of-kidneys-from-deceased-donors-receiving-dialysis-are-not-associated-with-adverse-long-term-allograft-outcomes-33660
https://atc.digitellinc.com/p/s/does-post-procurement-allocation-of-donation-after-circulatory-death-kidneys-affect-kidney-use-rates-33661
https://atc.digitellinc.com/p/s/application-of-spatial-clustering-methods-to-identify-fine-scale-geographic-disparities-in-deceased-donor-kidney-discards-33662
https://atc.digitellinc.com/p/s/geographic-variation-in-access-to-kidney-donors-under-continuous-distribution-framework-33663
https://atc.digitellinc.com/p/s/geographic-inequity-in-access-to-donors-persists-under-ring-based-kidney-allocation-33664
https://atc.digitellinc.com/p/s/transplant-centers-kidney-acceptance-rates-vary-even-after-risk-adjusting-for-donor-and-kidney-characteristics-as-well-as-cold-time-at-offer-33665
https://atc.digitellinc.com/p/s/how-does-hla-dr-frequency-impact-time-to-deceased-donor-kidney-transplant-in-the-current-kidney-allocation-system-33666
https://atc.digitellinc.com/p/s/the-impact-of-kidney-allocation-policy-change-on-center-waiting-times-and-volume-33667
https://atc.digitellinc.com/p/s/the-current-20-percent-kdpi-for-20-percent-epts-decreases-equity-of-access-to-deceased-donor-kidney-transplant-for-candidates-with-epts-greater-than-20-percent-due-to-double-dipping-33668
https://atc.digitellinc.com/p/s/usage-of-offer-filters-after-6-months-33669
https://atc.digitellinc.com/p/s/kidney-transplantation-in-extremely-old-deceased-donors-to-extremely-old-recipients-33670
https://atc.digitellinc.com/p/s/influence-of-dialysis-duration-on-transplant-outcomes-with-high-kidney-donor-profile-index-kdpi-kidneys-less-is-more-33671
https://atc.digitellinc.com/p/s/outcomes-of-transplanted-expedited-allocation-deceased-donor-kidneys-33672
https://atc.digitellinc.com/p/s/ai-enabled-digital-support-to-increase-placement-of-hard-to-place-deceased-donor-kidneys-33673
https://atc.digitellinc.com/p/s/kdpiepts-matching-for-high-creatinine-donors-goldilocks-redux-33674
https://atc.digitellinc.com/p/s/african-american-transplant-candidates-benefit-from-hla-matching-algorithms-tailored-to-race-33675
https://atc.digitellinc.com/p/s/intermediate-term-outcomes-of-recipient-and-kidney-graft-utilizing-false-and-true-positive-human-immunodeficiency-virus-deceased-donors-in-the-united-states-33676
https://atc.digitellinc.com/p/s/benchmark-outcomes-in-deceased-donor-kidney-transplantation-a-multicentre-analysis-of-80996-transplants-from-126-centres-33677
https://atc.digitellinc.com/p/s/outcomes-for-waitlisted-kidney-transplant-candidates-with-declined-kidney-donor-offers-a-retrospective-single-centre-uk-analysis-33678
https://atc.digitellinc.com/p/s/characterisation-of-deceased-donor-kidney-offers-combining-clinical-expert-knowledge-and-statistical-methods-to-select-relevant-donor-features-for-early-transplant-outcome-33679
https://atc.digitellinc.com/p/s/donor-hepatitis-c-positivity-does-not-increase-risk-of-rejection-in-renal-transplant-recipients-33680
https://atc.digitellinc.com/p/s/trends-in-discard-of-kidneys-from-covid-positive-donors-in-the-united-states-33681
https://atc.digitellinc.com/p/s/time-to-change-the-time-zero-biopsy-a-retrospective-analysis-of-kidney-graft-outcomes-33682
https://atc.digitellinc.com/p/s/validation-of-original-and-modified-donor-kidney-pathological-scoring-systems-for-prognostic-value-in-core-biopsy-specimens-33683
https://atc.digitellinc.com/p/s/10-year-trends-and-patters-of-kidney-transplantation-according-to-kdpi-score-and-factos-associated-with-allocation-of-higher-kdpi-score-33684
https://atc.digitellinc.com/p/s/impact-of-acute-kidney-injury-on-outcomes-of-deceased-kidney-transplantation-a-korean-nationwide-study-33685
https://atc.digitellinc.com/p/s/temporal-changes-in-the-utilization-of-kidneys-from-hepatitis-c-virus-infected-donors-in-the-united-states-33686
https://atc.digitellinc.com/p/s/clinical-significance-and-risk-factors-of-developing-slow-graft-function-in-immunological-low-risk-deceased-donor-kidney-transplantation-a-single-center-retrospective-study-33687
https://atc.digitellinc.com/p/s/outcomes-of-kidney-transplants-from-pediatric-donors-with-acute-kidney-injury-33688
https://atc.digitellinc.com/p/s/3-year-graft-outcomes-in-patients-transplanted-with-hepatitis-c-virus-antibody-positive-hcv-ab-plus-nucleic-acid-test-negative-nat-donor-kidneys-33689
https://atc.digitellinc.com/p/s/duration-of-the-agonal-phase-does-not-impact-delayed-graft-function-nor-one-year-renal-function-in-donation-after-circulatory-death-kidney-transplantation-33690
https://atc.digitellinc.com/p/s/expanding-minimum-acceptance-criteria-benefits-lower-volume-kidney-transplant-centers-33691
https://atc.digitellinc.com/p/s/analysis-of-donor-and-recipient-characteristics-in-donation-after-circulatory-death-kidney-transplants-resulting-in-primary-non-function-33692
https://atc.digitellinc.com/p/s/missing-the-match-a-national-survey-investigating-surgery-fellowship-education-in-renal-donor-recipient-matching-33693
https://atc.digitellinc.com/p/s/the-canadian-anatomic-kidney-score-caks-assessment-of-reproducibility-among-surgeons-and-trainees-across-canada-33694
https://atc.digitellinc.com/p/s/diagnostic-performance-of-preimplantation-biopsy-for-assessing-quality-of-deceased-donor-kidneys-33695
https://atc.digitellinc.com/p/s/loss-of-wait-time-advantage-for-hcv-positive-kidneys-in-hcv-negative-recipients-33696
https://atc.digitellinc.com/p/s/neonatal-kidney-donation-a-solution-for-organ-shortage-33697
https://atc.digitellinc.com/p/s/organ-survival-prediction-of-high-risk-recipients-based-on-reverse-survival-model-33698
https://atc.digitellinc.com/p/s/european-society-for-organ-transplantationesot-tlj-30-consensus-on-histopathological-analysis-of-pre-implantation-donor-kidney-biopsy-redefining-the-role-in-the-process-of-graft-assessment-33699
https://atc.digitellinc.com/p/s/does-donor-dialysis-duration-influence-kidney-transplant-outcomes-33700
https://atc.digitellinc.com/p/s/a-behavioral-study-on-the-effect-of-incorporating-glomerulosclerosis-into-the-kdpi-on-kidney-offer-acceptance-decisions-33701
https://atc.digitellinc.com/p/s/poor-sleep-quality-fatigue-societal-participation-and-health-related-quality-of-life-in-kidney-transplant-recipients-33702
https://atc.digitellinc.com/p/s/implementation-of-providing-web-based-information-to-patients-prior-to-kidney-transplant-evaluation-33703
https://atc.digitellinc.com/p/s/feasibility-and-impact-of-the-implementation-of-remote-patient-monitoring-combined-with-enhanced-education-and-monitoring-of-transplant-recipients-33704
https://atc.digitellinc.com/p/s/randomized-controlled-trial-testing-a-new-tool-that-helps-patients-find-transplant-centers-that-transplant-patients-like-them-33705
https://atc.digitellinc.com/p/s/racial-disparities-in-reactivation-on-the-kidney-transplant-waitlist-among-individuals-that-are-inactivated-for-being-temporarily-too-sick-33706
https://atc.digitellinc.com/p/s/the-influence-of-kidney-transplant-on-kidney-disease-patient-reported-outcomes-33707
https://atc.digitellinc.com/p/s/would-kidney-transplant-candidates-participate-in-a-first-in-human-pig-xenotransplant-clinical-trial-33708
https://atc.digitellinc.com/p/s/quality-of-life-changes-after-kidney-transplant-in-people-living-with-hiv-33709
https://atc.digitellinc.com/p/s/stress-perception-among-pre-kidney-transplant-patients-33710
https://atc.digitellinc.com/p/s/medical-noncompliance-labeling-of-racial-minority-esrd-patients-is-impacting-access-to-renal-transplantation-33711
https://atc.digitellinc.com/p/s/importance-of-spirituality-as-a-social-determinant-of-health-in-a-population-of-foreign-born-inner-city-kidney-transplant-recipients-33712
https://atc.digitellinc.com/p/s/proton-pump-inhibitor-use-fatigue-and-health-related-quality-of-life-in-kidney-transplant-recipients-results-from-the-transplant-lines-biobank-and-cohort-study-33713
https://atc.digitellinc.com/p/s/patient-recorded-outcomes-pros-after-kidney-transplantation-envarsus-vs-tacrolimus-multicenter-transplant-alliance-cohort-33714
https://atc.digitellinc.com/p/s/what-information-do-kidney-transplant-candidates-need-to-make-informed-treatment-decisions-about-participating-in-a-first-in-human-pig-xenotransplant-clinical-trial-33715
https://atc.digitellinc.com/p/s/variation-in-quality-of-life-in-elderly-patients-before-and-after-kidney-transplantation-implications-for-transplant-practice-33716
https://atc.digitellinc.com/p/s/multiple-processes-determine-donor-derived-cell-free-dna-release-from-kidney-transplants-in-abmr-tcmr-and-injury-33717
https://atc.digitellinc.com/p/s/the-level-of-anti-hla-sensitization-is-not-associated-with-an-increased-risk-of-acute-rejection-among-kidney-transplant-recipients-without-donor-specific-antibodies-33718
https://atc.digitellinc.com/p/s/effect-of-antiproliferative-dose-on-clinical-outcomes-in-adult-kidney-transplant-recipients-converted-to-belatacept-33719
https://atc.digitellinc.com/p/s/significance-of-surveillance-biopsy-in-detecting-subclinical-borderline-rejection-and-predicting-outcomes-in-high-risk-renal-transplant-recipients-33720
https://atc.digitellinc.com/p/s/clinical-relevance-of-preformed-donor-specific-anti-hla-antibody-in-kidney-transplant-recipients-transplanted-in-a-program-based-on-abdr-unacceptable-mismatches-33721
https://atc.digitellinc.com/p/s/validation-of-histomap-molecular-model-for-renal-allograft-rejection-diagnosis-in-a-multi-center-cohort-study-33722
https://atc.digitellinc.com/p/s/molecular-calls-of-minimal-histological-inflammation-is-it-safe-not-to-treat-33723
https://atc.digitellinc.com/p/s/immune-checkpoint-inhibitor-induced-acute-cellular-rejection-of-a-living-donor-kidney-transplant-33724
https://atc.digitellinc.com/p/s/chronic-active-t-cell-mediated-rejection-a-common-finding-on-renal-allograft-biopsies-33725
https://atc.digitellinc.com/p/s/the-molecular-microscope-mmdx-r-does-not-recognize-t-cell-mediated-rejection-tcmr-in-biopsies-with-mixed-tcmr-antibody-mediated-rejection-abmr-33726
https://atc.digitellinc.com/p/s/performance-of-combine-gene-profiling-and-donor-derived-cell-free-dna-dd-cf-dna-test-in-the-setttings-of-worsening-renal-allograft-function-33727
https://atc.digitellinc.com/p/s/the-outcome-and-risk-factor-of-refractory-t-cell-mediated-rejection-on-renal-allograft-transplantation-33728
https://atc.digitellinc.com/p/s/discordant-acute-rejection-in-combined-heart-and-kidney-transplant-recipient-patients-33729
https://atc.digitellinc.com/p/s/kidney-transplant-outcomes-in-an-elderly-veteran-population-33730
https://atc.digitellinc.com/p/s/utility-of-ramp-test-time-in-patients-undergoing-assessment-for-renal-transplantation-33731
https://atc.digitellinc.com/p/s/metabolic-outcomes-in-overweight-obese-robotic-assisted-kidney-transplant-recipients-single-center-experience-33732
https://atc.digitellinc.com/p/s/kidney-transplant-kt-recipients-with-high-body-mass-index-bmi-shows-better-survival-when-estimated-predicted-survival-epts-score-is-more-than-forty-33733
https://atc.digitellinc.com/p/s/renal-allograft-outcomes-in-recipients-with-new-onset-diabetes-after-transplantation-33734
https://atc.digitellinc.com/p/s/identifying-risks-for-new-onset-diabetes-post-transplantation-in-kidney-transplant-recipients-using-perioperative-continuous-glucose-monitoring-device-33735
https://atc.digitellinc.com/p/s/a-single-center-experience-with-sglt2-inhibitors-treatment-in-renal-transplant-recipients-33736
https://atc.digitellinc.com/p/s/comparison-of-12-month-outcomes-of-sglt2-inhibitors-between-african-american-and-caucasian-diabetic-kidney-transplant-recipients-33737
https://atc.digitellinc.com/p/s/outcomes-in-kidney-transplant-recipients-with-pretransplant-uncontrolled-diabetes-on-belatacept-versus-tacrolimus-based-immunosuppression-33738
https://atc.digitellinc.com/p/s/evaluation-of-the-prognostic-and-diagnostic-capacity-of-continuous-glucose-monitoring-cgm-regarding-post-transplantation-diabetes-mellitus-ptdm-early-after-kidney-transplantation-33739
https://atc.digitellinc.com/p/s/darbepoetin-utilization-in-renal-transplant-recipients-33740
https://atc.digitellinc.com/p/s/efficacy-and-safety-of-12-month-daprodustat-administration-in-post-renal-transplant-patients-33741
https://atc.digitellinc.com/p/s/safety-and-efficacy-of-hypoxia-inducible-factor-prolyl-hydroxylase-inhibitor-in-kidney-transplant-patients-with-post-transplant-anemia-33742
https://atc.digitellinc.com/p/s/association-of-serum-osteoprotegerin-with-vascular-calcification-cardiovascular-and-graft-outcomes-in-kidney-transplant-patients-results-from-the-know-kt-study-33743
https://atc.digitellinc.com/p/s/effect-of-vitamin-k2-supplementation-on-calcification-propensity-and-vascular-stiffness-in-vitamin-k-deficient-kidney-transplant-recipients-a-randomized-double-blind-placebo-controlled-clinical-trial-33744
https://atc.digitellinc.com/p/s/non-uremic-calciphylaxis-in-a-kidney-transplant-recipient-33745
https://atc.digitellinc.com/p/s/impact-of-blood-pressure-on-kidney-outcomes-after-kidney-transplantation-33746
https://atc.digitellinc.com/p/s/comparison-of-high-versus-low-revised-cardiac-risk-index-rcri-score-for-prediction-of-major-cardiovascular-events-mace-in-kidney-transplant-ktxr-33747
https://atc.digitellinc.com/p/s/mortality-and-graft-failure-after-coronary-angiogram-among-kidney-transplant-recipients-a-population-based-study-33748
https://atc.digitellinc.com/p/s/impact-of-subclinical-hfpef-for-recipients-of-kidney-transplantation-33749
https://atc.digitellinc.com/p/s/association-of-pre-transplant-dialysis-modality-with-incident-atrial-fibrillation-following-kidney-transplantation-33750
https://atc.digitellinc.com/p/s/management-of-atrial-fibrillation-after-kidney-transplant-do-we-need-a-new-metric-33751
https://atc.digitellinc.com/p/s/venous-thromboembolism-in-kidney-transplant-recipients-a-case-control-study-33752
https://atc.digitellinc.com/p/s/extended-duration-venous-thromboembolism-prophylaxis-in-kidney-transplant-recipients-after-hospital-discharge-is-not-associated-with-bleeding-33753
https://atc.digitellinc.com/p/s/sodium-zirconium-cyclosilicate-to-prevent-hyperkalemia-associated-complications-in-kidney-transplant-recipients-is-associated-with-less-fludrocortisone-use-33754
https://atc.digitellinc.com/p/s/monosodium-urate-crystal-depletion-in-renal-transplant-recipients-treated-with-pegloticase-protect-serial-dual-energy-computed-tomography-findings-33755
https://atc.digitellinc.com/p/s/the-association-between-self-reported-health-and-frailty-in-patients-undergoing-kidney-transplantation-33756
https://atc.digitellinc.com/p/s/whole-body-phase-angle-in-the-assessment-of-frailty-in-kidney-transplant-recipients-relationship-to-hand-grip-and-physical-strength-33757
https://atc.digitellinc.com/p/s/clinical-outcomes-in-kidney-transplant-recipients-with-nafld-vs-non-nafld-33758
https://atc.digitellinc.com/p/s/post-transplant-nephrocalcinosis-a-single-center-case-series-33759
https://atc.digitellinc.com/p/s/primary-care-utilization-by-kidney-transplant-recipients-33760
https://atc.digitellinc.com/p/s/comparison-of-office-home-and-ambulatory-blood-pressure-in-kidney-transplant-recipients-33761
https://atc.digitellinc.com/p/s/low-dose-aspirin-prophylaxis-of-transplant-renal-artery-stenosis-across-ages-categories-33762
https://atc.digitellinc.com/p/s/is-it-better-to-wait-for-paired-exchange-or-undergo-abo-incompatible-living-donor-kidney-transplantation-a-single-center-retrospective-review-33763
https://atc.digitellinc.com/p/s/impact-of-current-desensitization-protocols-and-surgical-outcomes-in-abo-incompatible-kidney-transplant-recipients-a-japanese-single-center-experience-33764
https://atc.digitellinc.com/p/s/perioperative-desensitization-with-intravenous-immunoglobulin-vs-bortezomib-in-positive-crossmatch-deceased-donor-kidney-transplants-24-months-outcomes-analysis-33765
https://atc.digitellinc.com/p/s/optimal-dose-of-rituximab-in-abo-incompatible-kidney-transplantation-in-patients-with-low-anti-ab-antibody-titers-a-single-center-retrospective-cohort-study-33766
https://atc.digitellinc.com/p/s/hla-desensitization-in-36-renal-transplant-recipients-single-centre-experience-33767
https://atc.digitellinc.com/p/s/effects-and-side-effects-of-desensitization-therapy-in-flow-cytometry-crossmatch-negative-low-dose-donor-specific-antibody-positive-renal-transplant-recipients-33768
https://atc.digitellinc.com/p/s/hla-incompatible-living-donor-kidney-transplantation-follow-up-results-of-a-monocentric-french-cohort-33769
https://atc.digitellinc.com/p/s/a-successful-double-lung-and-kidney-transplant-despite-strongly-positive-t-and-b-cell-cross-match-33770
https://atc.digitellinc.com/p/s/evolving-experience-with-aboi-transplantation-33771
https://atc.digitellinc.com/p/s/preconditioning-using-rituximab-in-kidney-transplantation-reduces-incidence-of-acute-t-cell-mediated-rejection-and-prevents-development-of-anti-hla-antibody-33772
https://atc.digitellinc.com/p/s/successful-transplantation-in-highly-sensitized-kidney-transplant-candidate-imlifidase-desensitization-c1q-binding-delisting-strategy-and-timely-treatment-of-acute-antibody-mediated-rejection-33773
https://atc.digitellinc.com/p/s/desensitization-and-immunomodulation-in-sensitized-kidney-transplant-recipients-a-delphi-method-consensus-from-the-european-guidelines-for-the-management-of-graft-recipients-engage-working-group-of-th-33774
https://atc.digitellinc.com/p/s/non-antigen-specific-immunoadsorption-is-a-risk-factor-for-severe-postoperative-infections-and-increased-mortality-in-abo-incompatible-kidney-transplant-recipients-33775
https://atc.digitellinc.com/p/s/association-between-induction-immunosuppression-and-donor-specific-hla-antibodies-in-combined-kidney-and-liver-transplant-recipients-a-single-center-experience-33776
https://atc.digitellinc.com/p/s/analysis-of-induction-therapy-in-patients-receiving-a-kidney-after-lung-transplant-33777
https://atc.digitellinc.com/p/s/necessity-of-induction-agent-modification-for-elderly-kidney-transplant-recipients-33778
https://atc.digitellinc.com/p/s/induction-comparison-of-antithymocyte-globulin-with-basiliximab-versus-antithymocyte-globulin-alone-in-renal-transplant-recipients-33779
https://atc.digitellinc.com/p/s/effectiveness-of-low-versus-standard-dose-of-rabbit-anti-thymocyte-globulin-induction-in-kidney-transplant-recipients-33780
https://atc.digitellinc.com/p/s/evaluation-of-the-safety-and-benefits-of-peripherally-administered-anti-thymocyte-globulin-p-ratg-in-kidney-transplant-kt-recipients-33781
https://atc.digitellinc.com/p/s/bk-polyomavirus-bkpyv-infection-incidence-in-an-elderly-population-following-changes-to-immunosuppression-induction-and-management-33782
https://atc.digitellinc.com/p/s/lower-dose-anti-thymocyte-globulin-induction-in-kidney-transplant-recipients-with-slow-or-delayed-graft-function-is-not-associated-with-higher-risk-of-rejection-or-de-novo-donor-specific-antibodies-33783
https://atc.digitellinc.com/p/s/rejection-and-infection-risk-after-basiliximab-induction-in-low-immunologic-risk-kidney-transplant-recipients-at-a-high-volume-transplant-center-33784
https://atc.digitellinc.com/p/s/association-between-induction-immunosuppression-and-de-novo-donor-specific-hla-antibody-production-in-combined-kidney-and-pancreas-transplant-recipients-a-single-center-experience-33785
https://atc.digitellinc.com/p/s/the-effect-of-induction-therapy-in-kidney-transplantation-a-network-meta-analysis-using-recent-data-33786
https://atc.digitellinc.com/p/s/death-and-overall-kidney-graft-survival-in-older-transplant-recipients-by-induction-type-in-the-united-states-33787
https://atc.digitellinc.com/p/s/single-dose-thymoglobulin-achieves-higher-efficacy-than-basiliximab-induction-without-compromisingsafety-in-pediatric-kidney-transplant-recipients-33788
https://atc.digitellinc.com/p/s/analysis-of-antithymocyte-globulin-induction-dose-and-incidence-of-post-transplant-lymphoproliferative-disorder-in-ebstein-barr-virus-high-risk-renal-transplant-recipients-33789
https://atc.digitellinc.com/p/s/optimal-dose-of-anti-tymocyte-globulin-as-induction-regimen-after-kidney-transplantation-analysis-of-the-nationwide-korean-organ-transplantation-registry-database-33790
https://atc.digitellinc.com/p/s/intermittent-dosing-of-rabbit-anti-thymocyte-globulin-induction-is-effective-for-rejection-prevention-in-high-risk-kidney-transplant-recipients-33791
https://atc.digitellinc.com/p/s/impact-of-induction-selection-on-incidence-and-severity-of-sars-cov-2-infection-in-kidney-transplant-recipients-33792
https://atc.digitellinc.com/p/s/steroid-free-immunosuppression-and-the-risk-of-rejection-in-elderly-renal-transplant-recipients-33793
https://atc.digitellinc.com/p/s/association-of-early-steroid-withdrawal-with-kidney-transplant-outcomes-by-dialysis-vintage-33794
https://atc.digitellinc.com/p/s/comparison-of-safety-outcomes-between-weight-based-and-fixed-dose-prednisone-taper-dosing-strategies-after-kidney-transplant-33795
https://atc.digitellinc.com/p/s/cytomegalovirus-cmv-infection-incidence-in-an-elderly-population-following-changes-to-immunosuppression-induction-and-management-33796
https://atc.digitellinc.com/p/s/no-antibody-induction-in-non-high-risk-kidney-transplant-recipients-is-effective-for-rejection-prevention-33797
https://atc.digitellinc.com/p/s/impact-of-calcineurin-inhibitor-use-after-graft-failure-on-sensitization-in-repeat-kidney-transplant-recipients-33798
https://atc.digitellinc.com/p/s/potential-tacrolimus-sparing-role-of-bisphosphonate-in-kidney-transplant-recipients-33799
https://atc.digitellinc.com/p/s/clinical-experience-with-use-of-budesonide-post-kidney-transplant-in-patients-with-iga-nephropathy-33800
https://atc.digitellinc.com/p/s/immunosuppression-protocol-change-from-immediate-release-to-extended-release-tacrolimus-in-kidney-transplant-recipients-impact-on-patient-and-provider-33801
https://atc.digitellinc.com/p/s/gastrointestinal-side-effects-in-de-novo-kidney-transplant-recipients-using-immediate-release-tacrolimus-versus-envarsus-xr-results-from-a-randomized-controlled-trial-33802
https://atc.digitellinc.com/p/s/a-comparative-analysis-of-envarsus-once-daily-to-tacrolimus-twice-daily-formulation-in-hispanic-kidney-transplant-recipients-33803
https://atc.digitellinc.com/p/s/belatacept-conversion-in-kidney-transplant-with-or-without-calcineurin-inhibitor-taper-33804
https://atc.digitellinc.com/p/s/infections-in-renal-transplant-treated-with-belatacept-33805
https://atc.digitellinc.com/p/s/immunosuppression-minimization-in-belatacept-treated-kidney-transplant-recipients-guided-by-combined-allosure-and-trugraf-monitoring-33806
https://atc.digitellinc.com/p/s/safety-of-early-transition-to-belatacept-based-immunosuppression-in-kidney-transplant-patients-33807
https://atc.digitellinc.com/p/s/renal-outcomes-of-high-risk-kidney-transplant-recipients-after-conversion-to-belatacept-based-immunosuppression-33808
https://atc.digitellinc.com/p/s/quadruple-immunosuppression-with-belatacept-cni-anti-metabolite-and-corticosteroids-for-refractory-antibody-mediated-rejection-33809
https://atc.digitellinc.com/p/s/delayed-belatacept-initiation-in-kidney-transplant-and-kidney-pancreas-transplant-in-steroid-sparing-regimens-early-experience-33810
https://atc.digitellinc.com/p/s/evaluation-of-a-belatacept-based-immunosuppression-regimen-in-kidney-transplant-recipients-33811
https://atc.digitellinc.com/p/s/incidence-of-opportunistic-infection-in-kidney-transplant-recipients-receiving-belatacept-versus-tacrolimus-early-post-transplant-33812
https://atc.digitellinc.com/p/s/assessment-of-induction-antithymocyte-globulin-dose-reduction-on-outcomes-of-de-novo-belatacept-immunosuppression-in-kidney-transplant-recipients-at-risk-for-delayed-graft-function-33813
https://atc.digitellinc.com/p/s/safety-and-efficacy-of-belatacept-conversion-following-kidney-transplant-33814
https://atc.digitellinc.com/p/s/tacrolimus-immunosuppression-maintains-greater-kidney-function-at-discharge-when-compared-to-belatacept-regimen-33815
https://atc.digitellinc.com/p/s/long-term-efficacy-and-safety-of-everolimus-compared-to-mycophenolate-in-a-steroid-free-regimen-33816
https://atc.digitellinc.com/p/s/long-term-outcomes-of-conversion-from-tacrolimus-to-sirolimus-in-kidney-transplant-recipients-an-8-year-follow-up-study-33817
https://atc.digitellinc.com/p/s/cognitive-outcomes-and-quality-of-life-in-stable-renal-transplant-patients-switched-from-twice-daily-immediate-release-tacrolimus-to-once-daily-extended-release-tacrolimus-envarsus-xr-33818
https://atc.digitellinc.com/p/s/immunosuppression-minimization-in-renal-transplant-recipients-with-transplant-excellence-based-on-the-trugraf-test-33819
https://atc.digitellinc.com/p/s/prediction-models-for-ideal-graft-function-after-living-donor-kidney-transplantation-are-useful-to-predict-graft-survival-33820
https://atc.digitellinc.com/p/s/living-kidney-donors-willingness-and-preferences-for-post-donation-follow-up-with-the-living-donor-collective-33821
https://atc.digitellinc.com/p/s/inadequate-iodine-intake-and-long-term-outcomes-after-kidney-transplantation-33822
https://atc.digitellinc.com/p/s/prediction-of-kidney-failure-in-potential-donors-prior-to-donation-33823
https://atc.digitellinc.com/p/s/high-class-ii-eplets-mismatch-with-variability-low-of-tacrolimus-level-are-associated-with-the-development-of-dn-dsa-and-poor-graft-outcomes-33824
https://atc.digitellinc.com/p/s/risk-and-outcomes-after-living-donor-nephrectomy-in-korea-15-year-single-center-outcome-33825
https://atc.digitellinc.com/p/s/the-impact-of-time-on-dialysis-before-transplantation-on-clinical-outcomes-for-hla-identical-siblings-kidney-transplant-recipients-33826
https://atc.digitellinc.com/p/s/association-between-dipstick-proteinuria-and-allograft-outcomes-in-living-donor-kidney-transplant-recipients-33827
https://atc.digitellinc.com/p/s/risk-factors-for-developing-low-estimated-glomerular-filtration-rate-and-albuminuria-in-living-kidney-donors-33828
https://atc.digitellinc.com/p/s/graft-survival-is-reduced-in-cmv-high-risk-kidney-transplant-recipients-with-early-neutropenia-33829
https://atc.digitellinc.com/p/s/risk-of-hyperuricemia-and-chronic-kidney-disease-in-living-kidney-donors-a-nationwide-population-based-cohort-study-with-propensity-score-matching-analysis-33830
https://atc.digitellinc.com/p/s/occurrence-of-hernias-in-the-post-living-donor-nephrectomy-population-a-single-center-review-33831
https://atc.digitellinc.com/p/s/delays-despite-priority-qualitative-interviews-of-living-kidney-donors-with-esrd-33832
https://atc.digitellinc.com/p/s/predicting-recipient-and-graft-survival-in-living-donor-kidney-transplant-can-the-risk-tools-be-helpful-in-pretransplant-counseling-33833
https://atc.digitellinc.com/p/s/novel-prediction-model-based-on-machine-learning-for-post-donation-renal-adaptation-in-living-kidney-donors-33834
https://atc.digitellinc.com/p/s/approach-to-improve-microsite-utilization-to-increase-living-donor-referrals-for-potential-kidney-transplant-candidates-33835
https://atc.digitellinc.com/p/s/assessing-the-utility-of-activated-partial-thromboplastin-time-aptt-testing-in-unselected-prospective-living-kidney-donors-33836
https://atc.digitellinc.com/p/s/improving-living-donors-selection-in-a-multiple-direct-donors-and-kidney-paired-exchange-settings-33837
https://atc.digitellinc.com/p/s/prediction-of-6-month-post-donation-serum-creatinine-in-living-kidney-donors-33838
https://atc.digitellinc.com/p/s/pre-donation-medication-patterns-among-living-kidney-donors-33839
https://atc.digitellinc.com/p/s/six-month-graft-function-in-recipients-of-kidneys-from-therapeutic-donors-33840
https://atc.digitellinc.com/p/s/survey-of-prior-non-directed-donors-actionable-items-to-increase-non-directed-live-organ-donors-33841
https://atc.digitellinc.com/p/s/transverse-abdominis-plane-and-rectus-sheath-block-after-hand-assisted-laparoscopic-live-donor-nephrectomy-33842
https://atc.digitellinc.com/p/s/robotic-versus-laparoscopic-living-donor-nephrectomy-techniques-a-retrospective-review-of-a-single-center-experience-33843
https://atc.digitellinc.com/p/s/no-i-dont-have-a-living-donor-disparities-in-access-to-kidney-transplants-33844
https://atc.digitellinc.com/p/s/live-kidney-donor-communication-beyond-the-optn-mandated-two-year-follow-up-33845
https://atc.digitellinc.com/p/s/the-outcomes-of-living-donors-aged-70-years-and-older-33846
https://atc.digitellinc.com/p/s/facilitators-and-barriers-to-the-implementation-of-the-live-donor-champion-program-33847
https://atc.digitellinc.com/p/s/national-attitudes-towards-living-kidney-donation-in-the-united-states-results-of-a-public-opinion-survey-33848
https://atc.digitellinc.com/p/s/presence-of-retained-renal-cysts-does-not-impact-kidney-function-recovery-after-living-kidney-donation-33849
https://atc.digitellinc.com/p/s/single-center-experience-with-autotransplantation-of-patients-with-nutcracker-syndrome-33850
https://atc.digitellinc.com/p/s/laparoscopic-donor-nephrectomy-training-in-the-uk-national-re-audit-of-the-trainee-experience-33851
https://atc.digitellinc.com/p/s/sex-and-gender-disparities-in-living-kidney-donation-a-scoping-review-33852
https://atc.digitellinc.com/p/s/assessing-public-dialogue-about-living-donation-from-anonymous-reddit-users-whos-in-the-room-and-what-do-they-share-33853
https://atc.digitellinc.com/p/s/loss-of-potential-living-kidney-donors-prior-to-donation-identifying-targeted-opportunities-for-greater-donor-support-33854
https://atc.digitellinc.com/p/s/what-i-desire-from-my-family-physician-the-living-kidney-donor-perspective-33855
https://atc.digitellinc.com/p/s/potential-living-kidney-donors-concerns-about-opting-out-and-preferences-for-an-alibi-results-from-a-multicenter-study-33856
https://atc.digitellinc.com/p/s/post-donation-remote-patient-monitoring-offers-the-opportunity-to-more-closely-follow-kidney-living-donors-33857
https://atc.digitellinc.com/p/s/the-first-decade-of-renal-transplantation-in-a-single-center-in-nepal-33858
https://atc.digitellinc.com/p/s/kidney-transplant-of-the-future-advanced-robotic-surgery-for-graft-implantation-33859
https://atc.digitellinc.com/p/s/robot-assisted-deceased-donors-kidney-transplants-in-obese-recipients-outcomes-and-challenges-33860
https://atc.digitellinc.com/p/s/influence-of-intraoperative-hemodynamics-and-pressor-use-on-delayed-graft-function-33861
https://atc.digitellinc.com/p/s/recycling-transplanted-kidneys-33862
https://atc.digitellinc.com/p/s/pyelovesicostomy-as-a-urinary-reconstruction-alternative-in-renal-transplantation-a-case-series-33863
https://atc.digitellinc.com/p/s/assessing-long-term-complications-of-kidney-transplantation-without-intraoperative-ureteral-dj-stent-a-single-center-experience-33864
https://atc.digitellinc.com/p/s/effect-of-reconstruction-type-of-dual-arteries-on-long-term-outcome-in-living-donor-kidney-transplantation-33865
https://atc.digitellinc.com/p/s/current-safety-and-outcomes-of-kidney-allograft-biopsy-33866
https://atc.digitellinc.com/p/s/single-port-robot-assisted-kidney-transplantation-learning-curve-from-a-single-institution-experience-33867
https://atc.digitellinc.com/p/s/vascular-complications-after-3035-live-donor-renal-transplants-incidence-risk-factors-management-and-a-focus-on-thrombotic-and-stenotic-events-33868
https://atc.digitellinc.com/p/s/functional-warm-ischemic-time-impacts-short-term-graft-function-in-donation-after-circulatory-death-renal-transplant-recipients-33869
https://atc.digitellinc.com/p/s/robotic-assisted-transplant-ureteral-reimplantation-for-the-management-of-post-transplant-ureteral-complications-a-case-series-33870
https://atc.digitellinc.com/p/s/impact-of-transversus-abdominus-plane-nerve-block-during-kidney-transplantation-on-patient-post-operative-opioid-usage-a-prospective-randomized-double-blinded-study-33871
https://atc.digitellinc.com/p/s/laparoscopic-kidney-transplantation-following-vaginal-insertion-of-kidney-graft-a-new-trick-for-an-old-dog-33872
https://atc.digitellinc.com/p/s/safety-and-efficacy-of-retroperitoneoscopic-native-nephrectomy-in-renal-transplant-recipients-with-autosomal-dominant-polycystic-kidney-disease-33873
https://atc.digitellinc.com/p/s/redefining-warm-ischemia-time-to-focus-on-temperature-33874
https://atc.digitellinc.com/p/s/surgical-results-of-urinary-tract-reconstruction-for-transplanted-kidney-vesicoureteral-reflux-33875
https://atc.digitellinc.com/p/s/immediate-rewarming-of-the-kidney-with-the-use-of-the-ice-blanket-technique-is-associated-with-worse-short-term-graft-function-33876
https://atc.digitellinc.com/p/s/to-biopsy-or-not-to-biopsy-kdpi-begs-the-question-33877
https://atc.digitellinc.com/p/s/robotic-kidney-transplantation-vs-traditional-open-kidney-transplant-in-setting-of-deceased-donation-a-single-center-experience-33878
https://atc.digitellinc.com/p/s/starting-successfully-steps-in-establishing-robotic-kidney-transplantation-program-with-early-outcomes-33879
https://atc.digitellinc.com/p/s/simultaneous-robotic-bilateral-nephrectomy-and-robotic-kidney-transplant-in-patients-with-symptomatic-polycystic-kidneys-a-case-series-33880
https://atc.digitellinc.com/p/s/training-in-robotic-transplant-surgery-33881
https://atc.digitellinc.com/p/s/two-to-tango-kidney-transplantation-anastomotic-time-is-influenced-by-both-resident-and-attending-experience-33882
https://atc.digitellinc.com/p/s/a-preliminary-clinical-study-on-safety-and-efficacy-of-ischemia-free-kidney-transplantation-33883
https://atc.digitellinc.com/p/s/what-factors-are-associated-with-re-transplantation-following-allograft-nephrectomy-33884
https://atc.digitellinc.com/p/s/slow-graft-function-following-pure-laparoscopic-vs-hand-assisted-laparoscopic-living-donor-nephrectomy-in-kidney-transplantation-33885
https://atc.digitellinc.com/p/s/combination-of-blood-gene-expression-allomap-and-donor-derived-cell-free-dna-allosure-to-diagnose-allograft-rejection-in-kidney-transplant-recipients-33886
https://atc.digitellinc.com/p/s/long-term-consequences-of-delayed-graft-function-in-pediatric-kidney-transplantation-33887
https://atc.digitellinc.com/p/s/normalizing-the-percent-donor-derived-cell-free-dna-percent-dd-cfdna-to-recipient-body-surface-area-bsa-or-to-donor-to-recipient-bsa-ratio-effects-on-the-diagnostic-performance-in-detecting-acute-tran-33888
https://atc.digitellinc.com/p/s/mycophenolate-mofetil-mmf-pharmacokinetic-profiles-and-dosage-modification-in-pediatric-kidney-transplant-patients-33889
https://atc.digitellinc.com/p/s/absolute-copies-is-better-than-percentage-of-donor-derived-cell-free-dna-as-a-marker-of-rejection-and-graft-injury-in-pediatric-kidney-transplantation-33890
https://atc.digitellinc.com/p/s/cellular-and-humoral-immune-response-after-sars-cov-2-vaccination-in-pediatric-kidney-recipients-33891
https://atc.digitellinc.com/p/s/steroid-based-vs-steroid-free-immunosuppression-in-paediatric-kidney-transplants-a-systematic-review-and-meta-analysis-33892
https://atc.digitellinc.com/p/s/urine-gene-expression-profiling-score-uromap-for-rejection-surveillance-in-pediatric-kidney-transplantation-33893
https://atc.digitellinc.com/p/s/lifelong-polyuria-continues-post-kidney-transplant-in-teenagers-with-end-stage-kidney-disease-lessons-learned-and-need-for-newer-strategies-beyond-native-nephrectomies-33894
https://atc.digitellinc.com/p/s/utility-of-donor-derived-cell-free-dna-and-tacrolimus-variability-in-monitoring-early-post-kidney-transplant-outcomes-33895
https://atc.digitellinc.com/p/s/intraoperative-fluid-management-for-pediatric-kidney-recipients-less-than-15kg-body-weight-with-retroperitoneal-surgical-approach-33896
https://atc.digitellinc.com/p/s/growth-trajectories-in-pediatric-kidney-transplant-recipients-33897
https://atc.digitellinc.com/p/s/renal-allograft-pathology-in-methylmalonic-aciduria-a-comparative-study-33898
https://atc.digitellinc.com/p/s/discordant-humoral-and-cellular-immune-responses-following-bnt162b-vaccination-in-pediatric-solid-organ-transplant-recipients-33899
https://atc.digitellinc.com/p/s/outcomes-of-transplantation-of-single-kidneys-from-splitting-en-bloc-pediatric-donor-kidneys-into-adult-recipients-a-single-center-experience-33900
https://atc.digitellinc.com/p/s/impact-of-using-pediatric-en-bloc-donors-with-low-glomerular-filtration-rate-gfr-in-adult-renal-transplants-33901
https://atc.digitellinc.com/p/s/application-of-gene-sequencing-in-pediatric-kidney-transplant-recipients-and-clinical-value-of-accurate-diagnosis-of-primary-nephropathy-33902
https://atc.digitellinc.com/p/s/association-of-post-transplant-lymphoproliferative-disorder-with-cumulative-rabbit-anti-thymocyte-globulin-exposure-in-pediatric-renal-transplant-recipients-33903
https://atc.digitellinc.com/p/s/effect-of-donor-type-on-graft-and-patient-survival-in-paediatric-recipients-of-kidney-and-liver-transplantation-33904
https://atc.digitellinc.com/p/s/a-scoping-review-of-pediatric-transplant-education-33905
https://atc.digitellinc.com/p/s/reduced-severe-neutropenia-with-steroid-avoidant-immunosuppression-in-pediatric-kidney-transplant-recipients-33906
https://atc.digitellinc.com/p/s/assessment-of-regional-outcomes-of-paediatric-renal-transplantation-in-the-uk-33907
https://atc.digitellinc.com/p/s/baby-steps-early-outcomes-at-a-pediatric-to-young-adult-transition-program-33908
https://atc.digitellinc.com/p/s/differential-effects-of-delayed-graft-function-in-pediatric-kidney-transplantation-by-age-group-33909
https://atc.digitellinc.com/p/s/pediatric-recipients-of-deceased-donor-kidney-transplants-from-donors-after-cardiac-death-a-single-center-study-33910
https://atc.digitellinc.com/p/s/long-term-outcomes-of-alemtuzumab-induction-in-pediatric-kidney-transplantation-33911
https://atc.digitellinc.com/p/s/perceptions-of-reproductive-health-in-adolescents-and-young-adults-with-kidney-transplants-33912
https://atc.digitellinc.com/p/s/induction-immunosuppression-in-low-risk-pediatric-kidney-transplant-recipients-from-pediatric-deceased-donors-33913
https://atc.digitellinc.com/p/s/external-validation-of-toulouse-rangueil-egfr12-prediction-model-after-living-donor-nephrectomy-33914
https://atc.digitellinc.com/p/s/understanding-humanistic-motivations-of-potential-living-donors-who-are-friends-and-acquaintances-compared-to-family-members-33915
https://atc.digitellinc.com/p/s/kidney-stone-incidence-in-living-kidney-donor-candidates-with-increased-metabolic-risk-33916
https://atc.digitellinc.com/p/s/in-the-era-of-computed-tomography-volumetry-is-isotope-renography-still-routinely-required-in-the-preparation-and-selection-of-living-kidney-donors-33917
https://atc.digitellinc.com/p/s/elderly-living-kidney-transplant-donors-and-their-renal-prognosis-33918
https://atc.digitellinc.com/p/s/does-living-donor-kidney-volume-or-measured-gfr-affect-recipient-allograft-function-33919
https://atc.digitellinc.com/p/s/impact-of-the-new-glomerular-filtration-rate-formulas-on-kidney-function-assessment-in-living-kidney-donors-and-candidates-33920
https://atc.digitellinc.com/p/s/prospective-study-of-donors-with-nephrolithiasis-at-the-time-of-transplant-evaluation-donate-33921
https://atc.digitellinc.com/p/s/clinical-relevance-and-characteristics-of-pre-transplant-donor-specific-anti-hla-dq-antibodies-in-kidney-transplantation-33922
https://atc.digitellinc.com/p/s/predicting-evaluation-completion-and-donation-by-relationship-type-identifying-opportunities-for-more-donors-33923
https://atc.digitellinc.com/p/s/non-hla-antibody-profiles-associated-with-antibody-mediated-rejection-and-graft-survival-in-kidney-transplantation-33924
https://atc.digitellinc.com/p/s/mixed-rejection-after-kidney-transplantation-and-its-relationship-with-dsa-timing-33925
https://atc.digitellinc.com/p/s/the-role-of-non-hla-antibodies-in-solid-organ-renal-transplantation-33926
https://atc.digitellinc.com/p/s/subclinical-antibody-mediated-rejection-detected-by-early-protocol-two-weeks-biopsies-in-highly-immunized-transplant-recipients-33927
https://atc.digitellinc.com/p/s/donor-specific-antibody-development-in-kidney-transplant-recipients-with-or-without-delayed-graft-function-receiving-alemtuzumab-induction-33928
https://atc.digitellinc.com/p/s/kidney-allograft-outcomes-in-diagnostic-and-suspicious-amr-with-peritubular-capillaritis-without-glomerulitis-33929
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-dd-cfdna-in-patients-with-antibody-mediated-rejection-abmr-and-non-hla-donor-specific-antibodies-dsa-33930
https://atc.digitellinc.com/p/s/histological-and-serological-evaluations-of-antibody-mediated-rejection-in-protocol-and-for-cause-renal-graft-biopsies-in-single-center-study-33931
https://atc.digitellinc.com/p/s/involvement-of-hla-epitope-mismatch-and-tacrolimus-trough-levels-in-de-novo-dsa-production-in-long-term-kidney-transplant-patients-33932
https://atc.digitellinc.com/p/s/association-between-donor-derived-cell-free-dna-dd-cfdna-hla-and-non-hla-antibodies-in-kidney-transplant-recipients-with-antibody-mediated-rejection-33933
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-dd-cfdna-results-and-clinical-outcomes-in-antibody-mediated-rejection-abmr-33934
https://atc.digitellinc.com/p/s/antibody-mediated-rejection-abmr-role-of-donor-derived-cell-free-dna-mmdx-and-traditional-histology-in-the-diagnosis-and-management-of-abmr-phenotypes-33935
https://atc.digitellinc.com/p/s/mixed-rejection-utility-of-donor-derived-cell-free-dna-mmdx-and-traditional-histology-in-the-diagnosis-and-management-of-combined-antibody-mediated-and-t-cell-mediated-rejection-33936
https://atc.digitellinc.com/p/s/outcomes-of-a2-to-b-deceased-donor-kidney-transplantation-33937
https://atc.digitellinc.com/p/s/improved-renal-outcomes-in-kidney-transplant-recipients-with-early-denovo-dsas-on-belatacept-versus-calcineurin-inhibitor-based-immunosuppression-33938
https://atc.digitellinc.com/p/s/graft-and-patient-survival-in-hyperimmunized-liver-kidney-and-kidney-transplant-recipients-33939
https://atc.digitellinc.com/p/s/abo-incompatible-kidney-transplantation-reduces-the-incidence-of-de-novo-donor-specific-antibodies-independent-from-the-hla-epitope-mismatch-load-33940
https://atc.digitellinc.com/p/s/clinicopathological-analyses-of-chronic-renal-allograft-arteriopathy-after-kidney-transplantation-33941
https://atc.digitellinc.com/p/s/development-of-anti-hla-antibodies-after-severe-bacterial-infection-requiring-immunosuppression-reduction-in-kidney-transplant-recipients-33942
https://atc.digitellinc.com/p/s/non-hla-antibodies-in-kidney-transplant-recipients-with-indication-and-follow-up-graft-biopsies-at-one-and-three-years-33943
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-utility-in-differentiating-acute-versus-chronic-active-antibody-mediated-rejection-33944
https://atc.digitellinc.com/p/s/novel-non-hla-antibodies-targeted-against-cardiolipin-are-associated-with-higher-risk-of-rejection-in-kidney-transplant-recipients-33945
https://atc.digitellinc.com/p/s/post-kidney-transplant-hospitalizations-and-long-term-graft-outcomes-33946
https://atc.digitellinc.com/p/s/pre-transplant-cognitive-function-does-not-adversely-affect-post-transplant-outcomes-33947
https://atc.digitellinc.com/p/s/immunofluorescence-linear-igg-of-glomerular-capillaries-correlates-with-early-proteinuria-in-kidney-allografts-33948
https://atc.digitellinc.com/p/s/kidney-transplant-recipients-with-enteric-risk-factors-for-hyperoxaluria-are-at-high-risk-for-transplant-nephrolithiasis-33949
https://atc.digitellinc.com/p/s/impact-of-bk-polyomavirus-plasma-viral-load-in-kidney-transplant-outcomes-33950
https://atc.digitellinc.com/p/s/risk-factors-for-death-censored-graft-loss-and-death-in-kidney-transplant-recipients-with-delayed-graft-function-33951
https://atc.digitellinc.com/p/s/pre-op-use-of-midodrine-a-risk-factor-for-poor-graft-outcomes-in-kidney-transplant-33952
https://atc.digitellinc.com/p/s/contrast-enhanced-magnetic-resonance-angiography-in-the-early-period-after-renal-transplantation-33953
https://atc.digitellinc.com/p/s/what-matters-now-did-not-always-matter-how-recipient-demographics-have-changed-risk-factors-in-deceased-kidney-transplantation-in-the-uk-33954
https://atc.digitellinc.com/p/s/impact-of-banff-score-in-protocol-biopsy-7-years-after-kidney-transplantation-to-the-prognosis-of-kidney-transplantation-33955
https://atc.digitellinc.com/p/s/validation-of-kidney-donor-profile-index-kdpi-for-long-term-outcomes-in-brazilian-kidney-transplant-recipients-33956
https://atc.digitellinc.com/p/s/outcomes-of-kidney-transplantation-in-patients-with-pre-transplant-malignancy-33957
https://atc.digitellinc.com/p/s/the-effect-of-continuation-of-angiotensin-converting-enzyme-inhibitor-and-angiotensin-receptor-blocker-before-kidney-transplantation-33958
https://atc.digitellinc.com/p/s/the-long-term-renal-outcome-and-pregnancy-complications-with-kidney-transplantation-of-iga-nephropathy-33959
https://atc.digitellinc.com/p/s/results-of-the-multimodal-aftercare-program-ktx360-indicate-an-improved-outcome-in-kidney-transplant-recipients-33960
https://atc.digitellinc.com/p/s/relationship-between-parathyroidectomy-calcium-phosphate-deposition-and-kidney-allograft-outcomes-33961
https://atc.digitellinc.com/p/s/successful-kidney-transplantation-improves-atrophic-bladder-capacity-and-function-within-3-months-after-transplantation-in-patients-with-end-stage-renal-disease-33962
https://atc.digitellinc.com/p/s/cardiovascular-decompensation-modifies-the-effect-of-delayed-graft-function-dgf-on-renal-transplant-outcomes-33963
https://atc.digitellinc.com/p/s/high-pretransplant-fgf-23-level-is-associated-with-poor-graft-survival-and-persistent-vitamin-d-insufficiency-in-kidney-transplant-patients-33964
https://atc.digitellinc.com/p/s/higher-density-of-interstitial-fibrosis-foci-predicts-death-censored-graft-loss-33965
https://atc.digitellinc.com/p/s/in-search-of-reasons-for-death-with-a-functioning-kidney-graft-and-reasons-for-overall-graft-failure-33966
https://atc.digitellinc.com/p/s/dialysis-modality-and-access-among-kidney-transplant-recipients-with-graft-failure-33967
https://atc.digitellinc.com/p/s/macrophage-polarization-induces-endothelium-to-myofibroblast-transition-in-chronic-allograft-dysfunction-33968
https://atc.digitellinc.com/p/s/associations-between-slow-graft-function-and-long-term-kidney-transplant-outcomes-33969
https://atc.digitellinc.com/p/s/risk-factors-for-rejection-at-1-year-in-kidney-transplant-recipients-with-delayed-graft-function-33970
https://atc.digitellinc.com/p/s/the-difference-of-outcomes-according-to-the-duration-of-delayed-graft-function-for-kidney-transplantation-15-years-experience-of-single-institution-33971
https://atc.digitellinc.com/p/s/impact-of-isolated-hla-dp-donor-specific-antibodies-on-graft-outcomes-after-kidney-transplantation-33972
https://atc.digitellinc.com/p/s/long-term-acute-rejection-and-graft-loss-incidences-in-prevalent-kidney-transplant-recipients-after-critical-care-survival-33973
https://atc.digitellinc.com/p/s/isolated-glomerulitis-is-associated-with-the-absence-of-antibody-mediated-rejection-by-molecular-diagnostics-33974
https://atc.digitellinc.com/p/s/prospective-assessment-of-the-need-for-and-added-value-of-molecular-diagnostics-of-kidney-allograft-biopsies-an-evaluation-in-clinical-practice-33975
https://atc.digitellinc.com/p/s/long-term-benefit-to-add-belatacept-in-kidney-receptors-with-de-novo-dsa-33976
https://atc.digitellinc.com/p/s/kidney-donors-older-than-50-years-have-an-increased-risk-for-calcineurin-inhibitor-induced-nephrotoxicity-33977
https://atc.digitellinc.com/p/s/impact-of-donor-specific-antibodies-on-deceased-donor-kidney-transplants-after-kas-implementation-33978
https://atc.digitellinc.com/p/s/recurrence-of-focal-segmental-glomerulosclerosis-and-hla-genotypes-after-kidney-transplantation-in-adults-33979
https://atc.digitellinc.com/p/s/pro-active-genetic-testing-in-kidney-transplant-recipients-33980
https://atc.digitellinc.com/p/s/parathyroid-allotransplantation-report-of-outcomes-in-3-patients-33981
https://atc.digitellinc.com/p/s/the-longest-survival-in-case-of-abo-incompatible-renal-transplant-since-1989-33982
https://atc.digitellinc.com/p/s/management-of-recurrence-of-c3-glomerulopathy-post-kidney-transplant-33983
https://atc.digitellinc.com/p/s/octreotide-in-recurrent-iga-nephropathy-case-series-33984
https://atc.digitellinc.com/p/s/repeat-transplantation-outcomes-in-patients-with-iga-nephropathy-33985
https://atc.digitellinc.com/p/s/study-design-of-a-prospective-clinical-data-registry-and-biorepository-on-post-transplant-glomerular-diseases-a-tango-initiative-33986
https://atc.digitellinc.com/p/s/relapse-of-fsgs-in-native-kidneys-post-kidney-transplantation-33987
https://atc.digitellinc.com/p/s/therapeutic-low-density-lipoprotein-apheresis-for-treatment-of-focal-segmental-glomerular-sclerosis-post-kidney-transplantation-33988
https://atc.digitellinc.com/p/s/management-of-recurrent-focal-segmental-glomerulosclerosis-post-transplant-using-low-density-lipoprotein-apheresis-ldla-33989
https://atc.digitellinc.com/p/s/kidney-transplant-from-donor-with-alports-syndrome-33990
https://atc.digitellinc.com/p/s/acquired-cystinuria-with-kidney-transplantation-33991
https://atc.digitellinc.com/p/s/a-stone-left-unturned-a-case-of-primary-hyperoxaluria-in-a-transplant-kidney-33992
https://atc.digitellinc.com/p/s/post-transplant-acute-intra-graft-sickle-cell-vaso-occlusive-crisis-in-patient-with-sickle-cell-trait-33993
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-testing-in-a-kidney-transplant-recipient-with-fsgs-recurrence-33994
https://atc.digitellinc.com/p/s/atypical-anti-glomerular-basement-membrane-nephritis-in-the-transplant-33995
https://atc.digitellinc.com/p/s/should-zero-hla-mismatched-donors-be-avoided-in-young-adults-with-iga-nephropathy-33996
https://atc.digitellinc.com/p/s/re-transplant-as-an-effect-modifier-of-early-steroid-withdrawal-in-deceased-donor-kidney-transplant-recipients-33997
https://atc.digitellinc.com/p/s/immunosuppression-and-iga-recurrence-after-kidney-transplant-a-unos-database-analysis-33998
https://atc.digitellinc.com/p/s/an-unexpected-case-of-28-dihydroxyadenine-nephropathy-after-kidney-transplantation-related-to-a-new-variants-of-aprt-gene-33999
https://atc.digitellinc.com/p/s/using-donor-derived-cell-free-dna-dd-cfdna-to-diagnose-subclinical-rejection-an-analysis-of-256-patients-at-a-single-institutions-3-year-study-34000
https://atc.digitellinc.com/p/s/ctss-tnc-and-mmp-7-as-potential-diagnostic-and-prognostic-biomarkers-for-delayed-graft-function-in-transplant-kidney-34001
https://atc.digitellinc.com/p/s/association-of-donor-derived-cell-free-dna-and-histology-in-kidney-transplant-recipients-with-bkpyv-viremia-34002
https://atc.digitellinc.com/p/s/association-of-serum-activin-level-with-progression-of-chronic-kidney-disease-in-patients-with-kidney-transplantation-results-from-the-know-kt-34003
https://atc.digitellinc.com/p/s/association-of-hla-molecular-mismatch-with-risk-and-severity-of-rejection-in-kidney-transplant-recipients-34004
https://atc.digitellinc.com/p/s/evaluation-of-nmr-based-gfr-estimating-for-kidney-transplant-recipients-in-a-clinical-routine-setting-34005
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-dd-cfdna-accurately-correlates-with-and-predicts-microvascular-inflammation-mvi-in-kidney-transplant-recipients-34006
https://atc.digitellinc.com/p/s/graft-function-in-kidney-transplant-patients-with-iga-nephropathy-is-influenced-by-mannose-binding-lectin-levels-34007
https://atc.digitellinc.com/p/s/molecular-signature-of-biopsies-with-thrombotic-microangiopathy-34008
https://atc.digitellinc.com/p/s/donor-drived-cell-free-dna-levels-are-predictive-of-rejection-in-a-prospective-trial-of-hiv-positive-kidney-transplant-recipients-34009
https://atc.digitellinc.com/p/s/evaluation-of-dd-cfdna-measures-in-kidney-transplant-recipients-more-than-two-years-post-transplantation-34010
https://atc.digitellinc.com/p/s/characteristics-and-outcomes-of-kidney-transplant-recipients-with-rejection-and-marked-elevations-in-donor-derived-cell-free-dna-dd-cfdna-34011
https://atc.digitellinc.com/p/s/performance-of-donor-derived-cell-free-dna-in-repeat-kidney-transplant-recipients-34012
https://atc.digitellinc.com/p/s/first-routine-clinical-application-of-molecular-microscope-diagnosis-mmdx-in-europe-34013
https://atc.digitellinc.com/p/s/tissue-transcriptomics-and-histology-influence-on-clinical-management-for-kidney-transplant-biopsy-results-34014
https://atc.digitellinc.com/p/s/clinical-utility-of-donor-derived-cell-free-dna-during-the-period-of-recovery-of-renal-function-after-kidney-transplantation-34015
https://atc.digitellinc.com/p/s/donor-derived-cfdna-fraction-levels-in-stable-kidney-transplant-recipients-in-the-first-year-after-transplant-34016
https://atc.digitellinc.com/p/s/ddcf-dna-and-allograft-injury-single-center-experience-34017
https://atc.digitellinc.com/p/s/serial-donor-derived-cell-free-dna-monitoring-during-belatacept-conversion-in-kidney-transplant-recipients-34018
https://atc.digitellinc.com/p/s/association-of-hla-eplet-mismatch-with-positive-gene-expression-and-dd-cfdna-biomarkers-in-kidney-transplant-recipients-34019
https://atc.digitellinc.com/p/s/prognostic-biomarkers-in-kidney-transplantation-a-meta-epidemiological-study-34020
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-dd-cfdna-in-100-kidney-transplant-recipients-with-indication-biopsy-results-of-a-prospective-single-center-trial-34021
https://atc.digitellinc.com/p/s/clinical-management-of-pregnant-transplant-recipients-utilization-of-fetal-fraction-and-dd-cfdna-34022
https://atc.digitellinc.com/p/s/integrating-data-from-early-kinetic-ddcfdna-after-transplantation-and-ibox-to-predict-long-term-renal-graft-outcomes-34023
https://atc.digitellinc.com/p/s/the-induction-of-regulatory-t-cells-by-once-daily-prolonged-release-tacrolimus-in-renal-transplant-recipients-34024
https://atc.digitellinc.com/p/s/lack-of-concordance-between-trugraf-gene-expression-profile-and-trac-dd-cfdna-results-an-interim-report-of-the-trulo-study-34025
https://atc.digitellinc.com/p/s/early-experience-using-donor-derived-cell-free-dna-for-the-surveillance-of-alloimmune-injury-in-kidney-transplantation-34026
https://atc.digitellinc.com/p/s/diagnosis-of-acute-graft-rejection-after-kidney-transplantation-using-metabolomic-profiling-of-biofluids-34027
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-accurately-identifies-allograft-injury-in-kidney-transplant-recipients-34028
https://atc.digitellinc.com/p/s/effect-of-donor-and-recipient-characteristics-on-donor-derived-cell-free-dna-levels-upto-one-year-post-kidney-transplant-34029
https://atc.digitellinc.com/p/s/association-of-exhausted-t-cell-with-adverse-graft-outcome-in-kidney-transplant-patients-34030
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-analysis-is-capable-of-detecting-antibody-mediated-rejection-in-one-year-biopsy-of-living-kidney-transplantation-34031
https://atc.digitellinc.com/p/s/changes-in-cfdna-associated-with-bk-viremia-in-kidney-transplant-recipients-34032
https://atc.digitellinc.com/p/s/biomarkers-of-cellular-senescence-and-decreased-physical-performance-in-patients-undergoing-kidney-transplantation-34033
https://atc.digitellinc.com/p/s/combined-genetic-signature-biomarkers-in-the-diagnosis-of-subclinical-rejection-of-transplanted-kidneys-34034
https://atc.digitellinc.com/p/s/impact-of-c1q-binding-on-rejection-rates-post-kidney-or-simultaneous-pancreas-kidney-transplantation-in-a-high-immunologic-risk-population-at-an-urban-transplant-center-34035
https://atc.digitellinc.com/p/s/clinical-utility-of-dd-cfdna-in-assessing-incomplete-recovery-of-kidney-function-after-transplantation-34036
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-surveillance-in-kidney-transplant-recipients-receiving-belatacept-based-maintenance-immunosuppression-34037
https://atc.digitellinc.com/p/s/increases-from-baseline-dd-cfdna-fraction-are-associated-with-acute-allograft-rejection-in-kidney-transplant-recipients-34038
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-is-not-confounded-by-cytomegalovirus-viremia-in-kidney-transplant-recipients-34039
https://atc.digitellinc.com/p/s/high-levels-of-donor-derived-cell-free-dna-in-the-early-post-transplant-phase-indicates-injury-independent-of-renal-function-status-34040
https://atc.digitellinc.com/p/s/performance-of-the-kidney-solid-organ-response-test-ksort-for-prediction-of-rejection-in-kidney-transplant-recipients-34041
https://atc.digitellinc.com/p/s/clinical-utility-of-trugraf-gene-expression-profile-and-trac-dd-cfdna-in-immunosuppressant-adjustments-an-interim-report-of-the-trulo-study-34042
https://atc.digitellinc.com/p/s/fetal-and-donor-derived-cell-free-dna-may-assist-in-differentiating-pregnancy-related-changes-from-allograft-rejection-in-kidney-transplant-recipients-34043
https://atc.digitellinc.com/p/s/monitoring-recovery-of-kidney-allograft-function-after-transplantation-using-a-multi-analyte-urine-based-test-qsant-34044
https://atc.digitellinc.com/p/s/real-time-measurements-of-urinary-biomarkers-for-deceased-donor-kidney-quality-assessment-34045
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-kinetics-in-hcv-positive-donor-organ-kidney-transplant-recipients-34046
https://atc.digitellinc.com/p/s/non-invasive-multimodality-testing-with-allosure-and-allomap-predicts-microvascular-inflammation-mvi-and-rejection-after-kidney-transplant-34047
https://atc.digitellinc.com/p/s/advyser-solid-organs-software-34048
https://atc.digitellinc.com/p/s/spatial-patterns-in-eskd-prevalence-and-referral-in-the-first-year-of-a-new-transplant-center-opportunities-to-improve-access-34049
https://atc.digitellinc.com/p/s/are-transplant-centers-where-we-need-them-a-geospatial-analysis-of-supply-and-demand-34050
https://atc.digitellinc.com/p/s/barriers-in-access-to-transplantation-in-central-texas-in-the-setting-of-a-new-transplant-program-34051
https://atc.digitellinc.com/p/s/environmental-performance-of-renal-replacement-therapy-comparative-lifecycle-assessments-of-dialysis-and-kidney-transplantation-34052
https://atc.digitellinc.com/p/s/mitigating-bias-in-machine-learning-improving-minority-specific-graft-failure-survival-prediction-with-synthetic-minority-oversampling-34053
https://atc.digitellinc.com/p/s/a-grounded-theory-approach-to-understanding-dialysis-providers-transplant-referral-decisions-for-patients-with-past-non-adherence-34054
https://atc.digitellinc.com/p/s/engaging-dialysis-teams-in-shared-decision-making-conversations-with-patients-to-improve-rates-of-kidney-transplantation-34055
https://atc.digitellinc.com/p/s/retooling-epts-in-era-of-continuous-distribution-34056
https://atc.digitellinc.com/p/s/how-does-the-relationship-between-raceethnicity-social-determinants-of-health-sdoh-and-census-tract-socioeconomic-status-ses-measures-impact-access-to-transplantation-34057
https://atc.digitellinc.com/p/s/kidney-transplantation-in-medically-complex-patients-is-it-a-risk-worth-taking-experience-of-a-high-volume-center-34058
https://atc.digitellinc.com/p/s/characteristics-of-multiple-listed-kidney-candidates-34059
https://atc.digitellinc.com/p/s/can-we-turn-back-time-using-non-race-based-egfr-formulas-for-waitlisted-patients-34060
https://atc.digitellinc.com/p/s/estimating-life-years-from-transplant-in-older-candidates-34061
https://atc.digitellinc.com/p/s/health-disparity-in-pre-emptive-transplant-and-dialysis-vintage-based-on-social-vulnerability-index-34062
https://atc.digitellinc.com/p/s/dialysis-providers-role-expectations-in-transplant-referral-decision-making-a-qualitative-study-34063
https://atc.digitellinc.com/p/s/reasons-for-referral-closure-among-patients-with-kidney-failure-referred-for-kidney-transplantation-in-the-southeastern-united-states-34064
https://atc.digitellinc.com/p/s/women-have-reduced-access-at-all-steps-of-the-complex-kidney-transplant-process-evidence-from-a-multi-regional-cohort-study-34065
https://atc.digitellinc.com/p/s/womens-access-to-waiting-list-and-renal-transplantation-argentinian-reality-34066
https://atc.digitellinc.com/p/s/disparities-in-access-to-kidney-transplantation-for-patients-of-asian-and-hispanic-ancestry-34067
https://atc.digitellinc.com/p/s/spanish-language-as-a-predictor-of-longer-kidney-transplant-evaluation-times-34068
https://atc.digitellinc.com/p/s/comprehensive-program-to-improve-equity-in-kidney-transplantation-34069
https://atc.digitellinc.com/p/s/examining-racial-equity-in-access-to-kidney-transplant-in-each-phase-of-the-process-34070
https://atc.digitellinc.com/p/s/where-do-ethnic-disparities-arise-in-the-living-kidney-donor-evaluation-process-34071
https://atc.digitellinc.com/p/s/living-donor-or-not-should-70-years-of-age-be-a-barrier-to-waitlisting-for-kidney-transplant-34072
https://atc.digitellinc.com/p/s/improving-post-kidney-transplant-related-outcomes-through-video-based-educational-platforms-34073
https://atc.digitellinc.com/p/s/outcomes-of-a-kidney-transplantation-exchange-program-in-very-highly-sensitized-patients-based-on-virtual-crossmatch-34074
https://atc.digitellinc.com/p/s/impact-of-culturally-competent-care-in-post-transplant-clinical-outcomes-among-hispanic-kidney-transplant-recipients-34075
https://atc.digitellinc.com/p/s/undergoing-an-organizational-level-intervention-reduces-perceived-discrimination-and-medical-mistrust-among-kidney-transplant-candidates-34076
https://atc.digitellinc.com/p/s/prevalence-of-medical-distrust-among-kidney-transplant-candidates-34077
https://atc.digitellinc.com/p/s/ambulance-utilization-by-kidney-transplant-recipients-34078
https://atc.digitellinc.com/p/s/native-american-disparities-in-access-to-kidney-transplantation-34079
https://atc.digitellinc.com/p/s/perceived-systemic-racism-and-discrimination-among-indigenous-kidney-transplant-recipients-and-donors-in-canada-34080
https://atc.digitellinc.com/p/s/kidney-transplantation-in-class-3-severely-obese-recipients-is-safeuk-renal-transplant-registry-data-analysis-since-year-2000-34081
https://atc.digitellinc.com/p/s/do-hispanic-patients-complete-kidney-transplant-evaluation-as-fast-as-non-hispanic-white-patients-34082
https://atc.digitellinc.com/p/s/cost-analysis-of-once-daily-extended-release-tacrolimus-and-twice-daily-immediate-release-tacrolimus-for-kidney-transplant-recipients-34083
https://atc.digitellinc.com/p/s/disparities-in-access-to-preemptive-referral-for-kidney-transplant-evaluation-among-patients-in-the-southeastern-united-states-34084
https://atc.digitellinc.com/p/s/apol1-genetic-risk-factors-eliminates-potential-living-kidney-donors-34085
https://atc.digitellinc.com/p/s/a-comprehensive-analysis-of-an-intensive-in-patient-post-transplant-physical-therapy-program-is-it-worth-the-effort-34086
https://atc.digitellinc.com/p/s/long-term-outcomes-and-risk-factors-for-graft-failure-following-second-liver-transplantation-34087
https://atc.digitellinc.com/p/s/dermatologic-manifestations-and-outcomes-of-patients-with-graft-vs-host-disease-following-liver-transplant-in-a-real-world-setting-34088
https://atc.digitellinc.com/p/s/mercedes-vs-reverse-lexus-in-liver-transplantation-who-has-the-better-incisional-warranty-34089
https://atc.digitellinc.com/p/s/detecting-hepatic-arterial-complications-and-acute-bleeding-after-liver-transplantation-contrast-enhanced-ultrasound-as-an-add-on-test-with-doppler-ultrasound-34090
https://atc.digitellinc.com/p/s/opioid-avoidance-protocol-following-liver-transplantation-34091
https://atc.digitellinc.com/p/s/internal-biliary-stent-in-adult-liver-transplantation-a-systematic-review-and-meta-analysis-34092
https://atc.digitellinc.com/p/s/management-and-outcomes-of-patients-requiring-tracheostomy-post-liver-transplant-34093
https://atc.digitellinc.com/p/s/is-alkaline-phosphatase-a-predictor-of-mortality-in-liver-transplant-patients-34094
https://atc.digitellinc.com/p/s/risk-factors-associated-with-vancomycin-resistant-enterococcus-bacteremia-in-liver-transplant-recipients-a-single-center-study-34095
https://atc.digitellinc.com/p/s/risk-of-skin-cancer-after-liver-transplantation-in-a-large-us-national-cohort-34096
https://atc.digitellinc.com/p/s/cautious-optimism-needed-in-using-dcd-livers-for-retransplantation-34097
https://atc.digitellinc.com/p/s/use-of-intravenous-hydroxocobalamin-for-vasoplegia-in-liver-transplant-recipients-34098
https://atc.digitellinc.com/p/s/ursodiol-prophylaxis-for-liver-transplantation-from-donation-after-cardiac-death-donors-34099
https://atc.digitellinc.com/p/s/de-novo-inflammatory-bowel-disease-after-solid-organ-transplantation-a-case-series-34100
https://atc.digitellinc.com/p/s/use-of-pcsk9-inhibitors-in-liver-transplant-recipients-a-single-center-review-34101
https://atc.digitellinc.com/p/s/total-bilirubin-as-a-predictor-of-autoimmune-liver-disease-recurrence-after-liver-transplantation-34102
https://atc.digitellinc.com/p/s/dyslipidemia-and-statin-use-following-adult-liver-transplantation-a-retrospective-review-34103
https://atc.digitellinc.com/p/s/interventional-radiology-guided-splenic-artery-embolism-in-liver-transplant-patients-a-10-year-experience-34104
https://atc.digitellinc.com/p/s/deep-venous-thrombosis-prophylaxis-post-liver-transplantation-in-the-setting-of-thrombocytopenia-and-coagulopathy-34105
https://atc.digitellinc.com/p/s/long-term-use-of-belatacept-in-two-liver-transplant-recipients-with-successful-stabilization-of-chronic-kidney-disease-34106
https://atc.digitellinc.com/p/s/the-utility-of-the-pirche-ii-score-in-risk-stratifying-simultaneous-liver-kidney-transplant-recipients-with-preformed-donor-specific-anti-hla-antibodies-34107
https://atc.digitellinc.com/p/s/one-size-does-not-fit-all-differential-benefits-of-simultaneous-liver-kidney-transplantation-by-kidney-eligibility-criteria-34108
https://atc.digitellinc.com/p/s/efficacy-of-basiliximab-in-delayed-tacrolimus-initiation-post-liver-transplantation-34109
https://atc.digitellinc.com/p/s/association-between-early-allograft-dysfunction-and-requirement-of-renal-replacement-therapy-in-liver-transplant-recipients-34110
https://atc.digitellinc.com/p/s/immunoprotective-effect-of-liver-allograft-on-patients-with-combined-liver-and-kidney-transplantation-34111
https://atc.digitellinc.com/p/s/the-efficacy-of-everolimus-in-liver-transplant-patients-34112
https://atc.digitellinc.com/p/s/the-impact-of-prioritization-of-multi-organ-kidney-allocation-for-liver-transplants-on-deaths-and-delisting-on-the-kidney-transplant-waiting-list-in-the-united-states-34113
https://atc.digitellinc.com/p/s/discordance-of-diastolic-dysfunction-by-echocardiography-for-cirrhotic-cardiomyopathy-34114
https://atc.digitellinc.com/p/s/sex-based-differences-of-circulatory-galectin-3-in-cirrhotic-patients-34115
https://atc.digitellinc.com/p/s/effectiveness-of-norepinephrine-infusion-protocol-in-achieving-the-resolution-of-hepatorenal-syndrome-34116
https://atc.digitellinc.com/p/s/liver-transplantation-for-hepatoportal-sclerosis-nodular-regenerative-hyperplasia-and-sinusoidal-obstructive-syndrome-34117
https://atc.digitellinc.com/p/s/liver-transplantation-for-post-covid-cholangiopathy-a-case-series-34118
https://atc.digitellinc.com/p/s/a-nuanced-look-of-diastolic-dysfunction-and-liver-transplant-outcomes-in-acute-alcohol-associated-hepatitis-34119
https://atc.digitellinc.com/p/s/clinical-outcomes-and-histologic-features-of-end-stage-kidney-disease-associated-noncirrhotic-portal-hypertension-34120
https://atc.digitellinc.com/p/s/evaluation-of-safety-and-efficacy-outcomes-with-regards-to-anti-xa-versus-activated-partial-thromboplastin-time-aptt-in-patients-with-liver-disease-being-managed-on-intravenous-heparin-infusion-34121
https://atc.digitellinc.com/p/s/a-multi-centre-non-interventional-study-to-assess-the-tolerability-and-effectiveness-of-extended-release-tacrolimus-lcpt-in-de-novo-liver-transplant-patients-34122
https://atc.digitellinc.com/p/s/early-conversion-to-everolimus-following-living-donor-liver-transplantation-34123
https://atc.digitellinc.com/p/s/short-term-alcohol-abstinence-prior-to-liver-transplantation-and-impact-on-rejection-34124
https://atc.digitellinc.com/p/s/steroid-free-immunosuppression-does-not-increase-the-risk-of-one-year-rejection-in-elderly-liver-transplant-recipients-34125
https://atc.digitellinc.com/p/s/graft-versus-host-disease-gvhd-in-adult-liver-transplant-recipients-a-single-center-experience-34126
https://atc.digitellinc.com/p/s/successful-treatment-of-acute-antibody-mediated-rejection-of-liver-allograft-with-imlifidase-34127
https://atc.digitellinc.com/p/s/mycophenolate-tolerability-in-liver-transplant-recipients-34128
https://atc.digitellinc.com/p/s/adverse-effects-of-new-onset-diabetes-after-liver-transplantation-34129
https://atc.digitellinc.com/p/s/rejection-in-liver-transplant-recipients-at-high-risk-for-invasive-fungal-infection-34130
https://atc.digitellinc.com/p/s/pulmonary-complications-of-everolimus-in-liver-transplant-patients-a-10-year-experience-34131
https://atc.digitellinc.com/p/s/extended-corticosteroid-induction-impact-on-outcomes-in-orthotopic-liver-transplant-34132
https://atc.digitellinc.com/p/s/acute-cellular-rejection-following-liver-transplantation-is-associated-with-fibrinolysis-changes-during-the-perioperative-period-34133
https://atc.digitellinc.com/p/s/immune-monitoring-after-living-donor-liver-transplantation-using-flow-based-quantitative-proliferation-assay-with-mixed-lymphocyte-reaction-a-single-center-long-term-experience-34134
https://atc.digitellinc.com/p/s/ggt-and-alt-predictors-of-rejection-in-optimal-itn056st-a-prospective-multicenter-trial-of-immunouppression-withdrawal-isw-in-stable-adult-liver-transplant-recipients-34135
https://atc.digitellinc.com/p/s/long-term-outcome-in-patients-undergoing-abo-incompatible-living-donor-liver-transplantation-retrospective-analysis-of-116-patients-reduced-rituximab-and-prophylactic-antibiotics-after-surgery-decreas-34136
https://atc.digitellinc.com/p/s/basiliximab-induction-with-reduced-dose-mycophenolate-in-simultaneous-liver-kidney-transplant-recipients-34137
https://atc.digitellinc.com/p/s/racial-disparities-among-liver-transplant-waitlist-candidates-before-and-after-acuity-circles-34138
https://atc.digitellinc.com/p/s/early-liver-transplant-for-alcohol-associated-liver-disease-outcomes-after-more-than-a-decade-of-experience-34139
https://atc.digitellinc.com/p/s/era-specific-improvements-in-age-disparate-outcomes-after-liver-transplantation-for-acute-liver-failure-a-population-based-analysis-of-the-united-kingdom-and-ireland-34140
https://atc.digitellinc.com/p/s/biomarkers-of-pre-transplant-immune-dysfunction-improve-risk-assessment-of-post-transplant-mortality-compared-with-conventional-clinical-risk-scores-34141
https://atc.digitellinc.com/p/s/comparison-of-liver-transplantation-outcomes-by-socioeconomic-factors-in-the-acuity-circles-era-34142
https://atc.digitellinc.com/p/s/identifying-ideal-liver-candidates-for-donor-after-cardiac-death-transplants-34143
https://atc.digitellinc.com/p/s/liver-related-frailty-biomarkers-are-associated-with-the-likelihood-of-undergoing-liver-transplantation-34144
https://atc.digitellinc.com/p/s/the-utilization-of-pre-albumin-in-liver-transplantation-34145
https://atc.digitellinc.com/p/s/liver-transplantation-for-acute-alcohol-induced-hepatitis-a-multidisciplinary-approach-leads-to-excellent-outcomes-34146
https://atc.digitellinc.com/p/s/a-pragmatic-tool-to-screen-for-moderate-to-severe-cognitive-impairment-among-candidates-for-liver-transplant-34147
https://atc.digitellinc.com/p/s/away-with-the-ana-does-routine-ana-screening-reduce-high-value-care-in-liver-transplant-evaluation-34148
https://atc.digitellinc.com/p/s/womens-health-history-an-important-and-under-addressed-topic-in-transplant-clinic-34149
https://atc.digitellinc.com/p/s/association-of-body-mass-index-with-post-transplant-outcomes-in-liver-transplant-recipients-34150
https://atc.digitellinc.com/p/s/liver-transplantation-for-patients-with-grade-3-acute-on-chronic-liver-failure-aclf-allows-durable-survival-benefit-despite-significant-early-post-operative-morbidity-34151
https://atc.digitellinc.com/p/s/early-outcomes-from-liver-transplantation-in-patients-with-high-risk-alcohol-use-a-novel-clinical-pathway-with-expanded-criteria-34152
https://atc.digitellinc.com/p/s/defining-the-minimal-clinically-important-differences-in-physical-frailty-using-the-liver-frailty-index-in-patients-with-cirrhosis-awaiting-liver-transplantation-34153
https://atc.digitellinc.com/p/s/comparison-of-malnutrition-muscle-depletion-and-frailty-assessment-in-liver-transplant-candidates-34154
https://atc.digitellinc.com/p/s/should-we-hesitate-to-do-re-transplants-for-hepatocellular-carcinoma-patients-with-high-malignancy-in-explant-pathology-after-initial-transplants-34155
https://atc.digitellinc.com/p/s/pd-1-inhibitor-prior-to-liver-transplantation-for-hepatocellular-carcinoma-is-not-associated-with-increased-graft-loss-34156
https://atc.digitellinc.com/p/s/early-hcc-recurrence-following-liver-resection-an-oncological-indicator-for-subsequent-salvage-liver-transplant-34157
https://atc.digitellinc.com/p/s/access-to-liver-transplant-referral-evaluation-and-listing-for-hepatocellular-carcinoma-patients-in-georgia-34158
https://atc.digitellinc.com/p/s/long-term-outcome-of-liver-transplantation-versus-resection-for-hepatocellular-carcinoma-a-single-center-experience-34159
https://atc.digitellinc.com/p/s/single-center-outcomes-of-first-cycle-yttrium-90-for-bridge-to-liver-transplantation-in-hepatocellular-carcinoma-patients-34160
https://atc.digitellinc.com/p/s/outcomes-following-donation-after-circulatory-death-liver-transplantation-for-hepatocellular-carcinoma-and-impact-of-direct-acting-anti-viral-therapy-34161
https://atc.digitellinc.com/p/s/racially-disparate-disease-progression-rates-in-early-stage-hepatocellular-carcinoma-patients-34162
https://atc.digitellinc.com/p/s/impact-of-neighborhood-deprivation-and-insurance-type-on-hepatocellular-carcinoma-stage-of-diagnosis-receipt-of-treatment-and-5-year-survival-within-a-large-integrated-healthcare-system-34163
https://atc.digitellinc.com/p/s/pre-liver-transplantation-locoregional-therapy-in-patients-with-hepatocellular-carcinoma-34164
https://atc.digitellinc.com/p/s/immune-checkpoint-inhibitors-for-cancer-recurrence-or-de-novo-cancer-after-liver-transplantation-34165
https://atc.digitellinc.com/p/s/clinical-utility-of-oncoguard-liver-test-to-further-classify-indeterminate-liver-lesions-in-a-high-risk-cirrhotic-population-at-risk-for-hcc-34166
https://atc.digitellinc.com/p/s/hepatocellular-carcinoma-exacerbates-adverse-outcomes-of-long-cold-ischemia-time-in-liver-transplantation-34167
https://atc.digitellinc.com/p/s/primary-hepatic-neuoendocrine-neoplasms-graded-as-net-g3-treated-with-liver-transplantation-34168
https://atc.digitellinc.com/p/s/ischemia-free-liver-transplantation-as-a-novel-approach-to-optimize-transplant-outcomein-the-acute-on-chronic-liver-failure-scenario-34169
https://atc.digitellinc.com/p/s/the-benefit-of-measuring-and-modulating-hepatic-artery-and-portal-vein-flows-in-deceased-donor-liver-transplantation-34170
https://atc.digitellinc.com/p/s/roboticincisional-hernia-repair-after-solid-abdominal-organ-transplantation-34171
https://atc.digitellinc.com/p/s/a-novel-mathematical-simulation-to-predict-liver-hemodynamic-alterations-for-living-donor-livertransplantation-and-partial-liver-resections-34172
https://atc.digitellinc.com/p/s/the-future-of-training-impact-of-normothermic-machine-perfusion-on-abdominal-transplant-fellowship-training-34173
https://atc.digitellinc.com/p/s/the-effect-of-loupe-magnification-on-occurrence-of-biliary-complication-after-liver-transplantation-34174
https://atc.digitellinc.com/p/s/variant-hepatic-artery-anatomy-and-cannulation-solutions-expanding-applications-of-normothermic-machine-perfusion-in-liver-transplantation-34175
https://atc.digitellinc.com/p/s/promoting-the-pawn-addressing-aberrant-anatomy-in-over-2500-liver-transplants-34176
https://atc.digitellinc.com/p/s/social-determinants-of-health-and-access-to-living-donor-liver-transplantation-from-2005-2021-34177
https://atc.digitellinc.com/p/s/the-impact-of-splenectomy-based-on-spleen-volume-in-living-donor-liver-transplantation-in-a-us-cohort-34178
https://atc.digitellinc.com/p/s/living-donor-liver-transplant-trends-in-the-era-of-acuity-circle-allocation-34179
https://atc.digitellinc.com/p/s/breakdown-of-liver-donor-and-recipient-relationships-at-university-of-pittsburgh-medical-center-34180
https://atc.digitellinc.com/p/s/improving-informed-consent-for-living-liver-donors-what-information-do-donors-want-about-their-recipient-34181
https://atc.digitellinc.com/p/s/is-the-incidence-of-de-novo-malignancies-after-living-donor-liver-transplantation-still-high-a-cohort-study-of-1781-recipients-using-annual-comparisons-of-standardized-incidence-ratios-34182
https://atc.digitellinc.com/p/s/determinants-of-optimal-outcomes-in-high-meld-living-donor-liver-transplantation-a-north-american-experience-34183
https://atc.digitellinc.com/p/s/transition-from-open-to-robot-assisted-donor-right-hepatectomy-program-for-adult-to-adult-living-liver-donation-early-outcomes-and-lessons-learned-34184
https://atc.digitellinc.com/p/s/biliary-reconstruction-for-multiple-graft-bile-ducts-does-not-impact-posttransplant-outcomes-compared-with-single-graft-bile-duct-during-living-donor-liver-transplantation-34185
https://atc.digitellinc.com/p/s/the-impact-of-enhanced-recovery-after-surgery-eras-protocol-in-living-liver-donors-34186
https://atc.digitellinc.com/p/s/an-intention-to-treat-analysis-of-live-donor-liver-transplantation-vs-deceased-donor-liver-transplantation-for-patients-with-alcoholic-liver-disease-34187
https://atc.digitellinc.com/p/s/human-dermis-as-a-new-substitute-for-middle-hepatic-vein-reconstruction-during-living-donor-liver-transplantation-outcome-of-clinical-trial-34188
https://atc.digitellinc.com/p/s/interaction-between-donor-and-recipient-raceethnicity-in-living-donor-liver-transplantation-34189
https://atc.digitellinc.com/p/s/left-lateral-section-liver-volumetry-with-a-light-detection-and-ranging-system-for-split-liver-transplantation-preliminary-results-in-a-cadaveric-model-34190
https://atc.digitellinc.com/p/s/how-far-left-can-we-go-high-risk-living-donor-liver-transplantation-using-left-lobe-graft-in-a-single-us-center-34191
https://atc.digitellinc.com/p/s/the-impact-of-allograft-portal-flow-in-split-liver-transplantation-is-portal-hyper-perfusion-harmful-like-living-donor-liver-transplantation-34192
https://atc.digitellinc.com/p/s/analysis-of-hemodynamic-state-and-oxygen-utilization-of-a-right-lobe-graft-during-living-donor-hepatectomy-34193
https://atc.digitellinc.com/p/s/higher-portal-vein-flow-per-gram-of-liver-tissue-is-associated-with-fewer-total-late-transplant-complications-in-adult-living-donor-liver-transplant-recipients-34194
https://atc.digitellinc.com/p/s/donor-splenic-vein-graft-to-improve-the-patency-of-portal-vein-in-pediatric-liver-transplantation-with-the-consideration-of-long-periods-of-postoperative-course-34195
https://atc.digitellinc.com/p/s/evaluation-of-oral-vs-intravenous-phosphate-replacement-in-liver-donors-34196
https://atc.digitellinc.com/p/s/advantage-and-feasibility-of-extended-left-lobe-graft-for-adult-to-adult-living-donor-liver-transplantation-34197
https://atc.digitellinc.com/p/s/long-term-mortality-of-living-liver-donors-a-systematic-review-and-meta-analysis-34198
https://atc.digitellinc.com/p/s/3-day-preservation-of-human-livers-through-supercooling-34199
https://atc.digitellinc.com/p/s/national-discard-trends-of-livers-from-donation-after-circulatory-death-dcd-donors-an-11-year-analysis-34200
https://atc.digitellinc.com/p/s/abo-incompatible-adult-living-donor-liver-transplantation-in-high-meld-score-recipients-34201
https://atc.digitellinc.com/p/s/risk-factors-of-early-allograft-dysfunction-ead-after-liver-transplant-lt-with-portable-normothermic-machine-perfusion-nmp-34202
https://atc.digitellinc.com/p/s/modernizing-the-concept-of-donor-risk-index-dri-dbd-dri-and-dcd-dri-scores-to-predict-liver-graft-survival-34203
https://atc.digitellinc.com/p/s/long-term-mortality-prediction-in-patients-with-cirrhosis-with-laboratory-data-comparisons-of-multiple-machine-learning-methods-34204
https://atc.digitellinc.com/p/s/survival-of-adult-recipients-of-a-right-lobe-from-split-livers-in-the-united-states-34205
https://atc.digitellinc.com/p/s/machine-perfusion-protects-against-mortality-and-graft-failure-in-donation-after-cardiac-death-dcd-liver-transplant-recipients-in-the-united-states-34206
https://atc.digitellinc.com/p/s/early-experience-of-normothermic-liver-perfusion-pump-in-liver-transplantation-34207
https://atc.digitellinc.com/p/s/prognostic-factors-affecting-outcomes-of-liver-transplant-graft-with-hyperbilirubinemia-at-the-time-of-organ-recovery-34208
https://atc.digitellinc.com/p/s/utilization-of-and-outcomes-following-living-donor-liver-transplantation-for-recipients-with-high-model-for-end-stage-liver-disease-meld-score-in-the-united-states-34209
https://atc.digitellinc.com/p/s/outcomes-of-liver-transplant-recipients-from-donation-after-circulatory-death-grafts-procured-using-normothermic-regional-perfusion-34210
https://atc.digitellinc.com/p/s/impact-of-donor-allograft-hepatocyte-necrosis-on-liver-transplant-outcomes-34211
https://atc.digitellinc.com/p/s/initial-experience-with-thoracoabdominal-normothermic-regional-perfusion-controlled-donation-after-cardiac-death-liver-transplants-34212
https://atc.digitellinc.com/p/s/normothermic-machine-perfusion-nmp-could-prevent-discarding-livers-from-older-60yo-dbd-donors-34213
https://atc.digitellinc.com/p/s/normothermic-machine-perfusion-reducing-preoperative-admissions-and-increasing-organ-offers-34214
https://atc.digitellinc.com/p/s/liver-transplantation-in-septuagenarians-outcomes-and-potential-impact-of-use-of-organs-from-donors-50-years-34215
https://atc.digitellinc.com/p/s/late-allocation-liver-transplant-outcomes-34216
https://atc.digitellinc.com/p/s/use-of-hepatitis-c-plus-livers-to-combat-national-organ-shortages-perspectives-from-a-quaternary-care-center-34217
https://atc.digitellinc.com/p/s/utilization-of-normothermic-machine-perfusion-to-salvage-liver-allografts-in-unallocated-unstable-donors-34218
https://atc.digitellinc.com/p/s/liver-dcd-using-normothermic-regional-perfusion-a-single-center-review-34219
https://atc.digitellinc.com/p/s/outcomes-of-sexagenarian-living-liver-donors-in-korea-a-multicenter-study-34220
https://atc.digitellinc.com/p/s/clinical-outcomes-and-cost-analysis-following-normothermic-machine-perfusion-versus-static-cold-storage-for-liver-transplantation-a-single-center-analysis-34221
https://atc.digitellinc.com/p/s/salvaging-dcd-visceral-donation-in-the-setting-of-a-hostile-abdomen-a-heretofore-unrecognized-benefit-of-normothermic-regional-perfusion-34222
https://atc.digitellinc.com/p/s/outcomes-of-transplantation-of-hepatitis-b-nat-positive-organs-for-hepatitis-b-seronegative-recipients-of-liver-transplants-34223
https://atc.digitellinc.com/p/s/national-and-regional-trends-in-liver-transplant-after-allocation-change-with-a-focus-in-exception-points-34224
https://atc.digitellinc.com/p/s/procedure-costs-associated-with-management-of-biliary-strictures-in-pediatric-liver-transplant-recipients-in-the-society-of-pediatric-liver-transplant-split-registry-34225
https://atc.digitellinc.com/p/s/state-medicaid-expansion-is-associated-with-improved-survival-after-pediatric-liver-transplantation-34226
https://atc.digitellinc.com/p/s/serostatus-following-live-attenuated-vaccination-for-children-after-living-donor-liver-transplantation-34227
https://atc.digitellinc.com/p/s/assessing-adequacy-of-immunosuppression-late-after-pediatric-liver-transplantation-lt-with-t-cell-alloreactivity-34228
https://atc.digitellinc.com/p/s/donor-characteristics-predict-long-term-survival-outcomes-for-pediatric-liver-transplant-recipients-34229
https://atc.digitellinc.com/p/s/a-retrospective-outcome-analysis-of-deceased-donor-pediatric-split-vs-whole-liver-transplantation-an-institutional-review-of-20-year-experience-34230
https://atc.digitellinc.com/p/s/impact-of-induction-therapy-on-rejection-in-pediatric-transplantation-a-multicenter-study-in-the-united-states-34231
https://atc.digitellinc.com/p/s/pediatric-liver-transplant-for-alagilles-syndrome-as-bad-as-we-think-34232
https://atc.digitellinc.com/p/s/dsa-and-autoantibodies-are-associated-with-acute-rejection-in-pediatric-liver-transplant-recipients-34233
https://atc.digitellinc.com/p/s/an-update-on-biliary-atresia-liver-transplant-candidate-and-recipient-outcomes-in-the-united-states-34234
https://atc.digitellinc.com/p/s/angiotensin-ii-type-1-receptor-expression-in-pediatric-hepatic-vasculature-34235
https://atc.digitellinc.com/p/s/effects-of-acuity-circle-allocation-policy-on-pediatric-split-and-living-donor-liver-transplants-at-low-versus-high-volume-centers-34236
https://atc.digitellinc.com/p/s/pre-liver-transplant-biliary-diversion-provides-relief-for-intractable-pruritis-for-progressive-familial-intrahepatic-cholangitis-patients-but-relief-is-short-lived-34237
https://atc.digitellinc.com/p/s/the-impact-of-health-disparities-on-survival-over-time-for-pediatric-patients-receiving-liver-transplantation-34238
https://atc.digitellinc.com/p/s/the-landscape-of-pediatric-travel-for-liver-transplantation-in-the-united-states-34239
https://atc.digitellinc.com/p/s/hepatocellular-carcinoma-in-children-34240
https://atc.digitellinc.com/p/s/older-donor-age-associated-with-poorer-pediatric-liver-transplant-recipient-graft-and-overall-survival-34241
https://atc.digitellinc.com/p/s/ambient-air-pollution-and-pediatric-liver-transplant-outcomes-34242
https://atc.digitellinc.com/p/s/abo-incompatible-grafts-are-associated-with-excellent-outcomes-in-pediatric-liver-transplant-recipients-an-important-resource-to-reduce-waitlist-mortality-34243
https://atc.digitellinc.com/p/s/outcomes-of-pediatric-liver-transplant-recipients-after-transfer-from-pediatric-to-adult-healthcare-a-report-from-the-starzl-network-34244
https://atc.digitellinc.com/p/s/ultrasonography-of-rectus-femoris-muscle-is-a-feasible-tool-to-assess-sarcopenia-in-children-34245
https://atc.digitellinc.com/p/s/pediatric-acute-liver-failure-palf-score-accurately-predicts-survival-with-native-liver-34246
https://atc.digitellinc.com/p/s/biliary-complications-for-histidine-tryptophan-ketoglutarate-htk-and-university-of-wisconsin-uw-preserved-deceased-donor-liver-grafts-34247
https://atc.digitellinc.com/p/s/creation-of-machine-learning-based-models-predicting-donation-after-circulatory-death-liver-transplantation-survival-and-length-of-stay-34248
https://atc.digitellinc.com/p/s/development-of-a-liver-atlas-using-over-1000-consecutive-deceased-donor-livers-to-identify-hepatic-steatosis-prior-to-retrieval-34249
https://atc.digitellinc.com/p/s/a-multi-class-neural-network-machine-learning-algorithm-to-diagnose-graft-pathology-in-liver-transplant-recipients-34250
https://atc.digitellinc.com/p/s/liver-transplantation-from-marginal-donors-long-term-outcomes-over-the-years-in-the-usa-34251
https://atc.digitellinc.com/p/s/the-impact-of-normothermic-machine-perfusion-nmp-in-deceased-donor-liver-transplantation-in-the-usa-34252
https://atc.digitellinc.com/p/s/liver-transplantation-from-donation-after-circulatory-death-donors-in-acute-liver-failure-outcomes-in-the-usa-34253
https://atc.digitellinc.com/p/s/de-novo-cancer-after-living-donor-liver-transplantation-ldlt-patients-different-pattern-in-a-taiwan-institution-34254
https://atc.digitellinc.com/p/s/predicting-post-liver-transplant-lt-outcomes-in-acute-on-chronic-liver-failure-aclf-patients-using-expert-augmented-machine-learning-eaml-34255
https://atc.digitellinc.com/p/s/mmdx-r-rejection-and-injury-scores-in-pediatric-endomyocardial-biopsies-lack-of-concordance-with-results-of-the-interheart-study-34256
https://atc.digitellinc.com/p/s/where-there-is-smoke-there-is-not-always-fire-cell-free-dna-elevations-without-rejection-34257
https://atc.digitellinc.com/p/s/association-of-high-priority-exceptions-with-waitlist-mortality-among-heart-transplant-candidates-34258
https://atc.digitellinc.com/p/s/the-giant-is-not-sleeping-implications-in-heart-transplantation-34259
https://atc.digitellinc.com/p/s/cant-we-all-just-get-along-comparison-of-cell-free-dna-technologies-34260
https://atc.digitellinc.com/p/s/the-role-of-durable-lvad-placement-in-reversing-pulmonary-hypertension-in-patients-awaiting-heart-transplantation-how-long-does-it-take-34261
https://atc.digitellinc.com/p/s/risk-stratification-of-cardiac-allograft-injury-using-cell-free-dna-testing-real-world-effectiveness-34262
https://atc.digitellinc.com/p/s/differences-in-estimation-of-glomerular-filtration-rate-in-heart-transplant-patients-using-creatinine-versus-cystatin-c-34263
https://atc.digitellinc.com/p/s/never-underestimate-sex-ed-34264
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-dd-cf-dna-and-cardiac-allograft-vasculopathy-cav-34265
https://atc.digitellinc.com/p/s/not-all-machines-anger-the-immunologic-gods-prospective-analysis-of-the-impact-of-impella-55-devices-on-hla-development-in-transplant-recipients-34266
https://atc.digitellinc.com/p/s/correlation-between-molecular-microscope-diagnostic-system-histopathology-and-clinical-judgement-following-heart-transplantation-34267
https://atc.digitellinc.com/p/s/validation-of-the-clinical-utility-of-microrna-as-non-invasive-biomarkers-of-cardiac-allograft-rejection-monitoring-a-prospective-longitudinal-multicenter-study-34268
https://atc.digitellinc.com/p/s/successful-use-of-tocilizumab-for-post-heart-transplant-patients-with-refractory-complement-binding-donor-specific-antibodies-34269
https://atc.digitellinc.com/p/s/association-between-gene-expression-profiling-scores-and-malignancy-in-adult-heart-transplant-recipients-34270
https://atc.digitellinc.com/p/s/transplants-from-donors-with-a-history-of-cancer-an-analysis-of-the-organ-procurement-and-transplantation-network-database-34271
https://atc.digitellinc.com/p/s/improved-graft-function-following-desensitization-of-anti-at1r-and-non-hla-antibodies-in-a-dsa-negative-heart-transplant-recipient-with-amr-34272
https://atc.digitellinc.com/p/s/it-is-not-just-temperature-rising-the-impact-of-active-viruses-on-donor-derived-cell-free-dna-testing-34273
https://atc.digitellinc.com/p/s/bridge-to-transplant-temporary-mechanical-circulatory-support-and-risk-of-allosensitization-34274
https://atc.digitellinc.com/p/s/indeterminate-donor-derived-cell-free-dna-levels-are-not-associated-with-subsequent-adverse-events-in-heart-transplant-recipients-34275
https://atc.digitellinc.com/p/s/changes-in-fontan-associated-liver-disease-following-heart-transplantation-34276
https://atc.digitellinc.com/p/s/efficacy-and-safety-of-early-aceiarb-use-in-heart-transplant-recipients-34277
https://atc.digitellinc.com/p/s/impact-of-persistently-elevated-donor-derived-cell-free-dna-levels-on-clinical-outcomes-after-heart-transplant-34278
https://atc.digitellinc.com/p/s/custodiol-n-versus-custodiol-results-from-a-prospective-randomised-single-blind-multicenter-phase-iii-trial-in-patients-undergoing-heart-transplantation-34279
https://atc.digitellinc.com/p/s/comparison-of-patient-characteristics-and-outcomes-of-left-ventricular-assist-devices-implanted-during-early-and-late-week-34280
https://atc.digitellinc.com/p/s/center-practices-for-submitting-adult-status-2-heart-exceptions-vary-widely-34281
https://atc.digitellinc.com/p/s/prospective-survey-outcome-the-impact-of-racial-disparity-with-economic-inequality-on-long-term-clinical-outcomes-in-heart-transplant-patients-34282
https://atc.digitellinc.com/p/s/impact-of-terbutaline-on-hemodynamics-following-heart-transplantation-34283
https://atc.digitellinc.com/p/s/candida-auris-bloodstream-infection-with-left-ventricular-assist-devices-a-retrospective-case-series-34284
https://atc.digitellinc.com/p/s/endothelial-function-inflammation-co-morbidities-and-10-year-outcomes-among-heart-transplant-recipients-with-intravascular-ultrasound-diagnosed-coronary-allograft-vasculopathy-34285
https://atc.digitellinc.com/p/s/longitudinal-changes-in-renal-function-in-after-first-time-and-repeat-heart-transplantation-in-children-and-young-adults-34286
https://atc.digitellinc.com/p/s/the-protek-duo-a-meta-analysis-34287
https://atc.digitellinc.com/p/s/characterizing-adult-heart-status-2-exceptions-with-risk-stratification-data-34288
https://atc.digitellinc.com/p/s/the-effect-of-off-hour-admissions-on-advanced-treatment-options-in-cardiogenic-shock-patients-34289
https://atc.digitellinc.com/p/s/malnutrition-and-mortality-a-different-m-and-m-following-heart-transplantation-34290
https://atc.digitellinc.com/p/s/cytomegalovirus-reactivation-and-clostridioides-difficile-associated-diarrhea-in-heart-transplant-recipients-34291
https://atc.digitellinc.com/p/s/association-between-donor-derived-cell-free-dna-and-donor-specific-antibodies-and-impact-on-graft-management-a-clinical-experience-study-34292
https://atc.digitellinc.com/p/s/belatacept-based-immunosuppression-in-heart-transplant-recipients-a-single-center-experience-34293
https://atc.digitellinc.com/p/s/time-to-eliminate-surveillance-endomyocardial-biopsies-use-of-donor-derived-cell-free-dna-for-heart-transplant-rejection-surveillance-34294
https://atc.digitellinc.com/p/s/a-quick-and-efficient-method-to-deliver-cardioplegia-during-direct-procurement-of-the-heart-from-a-dcd-donor-34295
https://atc.digitellinc.com/p/s/belatacept-use-in-calcineurin-inhibitor-avoidance-or-minimization-in-kidney-pancreas-and-pancreas-alone-transplants-a-long-term-single-center-experience-34296
https://atc.digitellinc.com/p/s/a-10-year-longitudinal-cohort-study-assessing-the-impact-of-type-1-15-and-2-diabetes-on-pancreas-transplant-outcomes-34297
https://atc.digitellinc.com/p/s/neglected-and-underutilized-pancreas-after-deceased-donor-kidney-transplantation-34298
https://atc.digitellinc.com/p/s/pancreas-transplantation-alone-in-the-usa-where-are-we-standing-after-20-years-34299
https://atc.digitellinc.com/p/s/significant-improvement-in-solitary-pancreas-transplantation-34300
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-and-blood-gene-expression-profiles-in-clinically-stable-simultaneous-pancreas-kidney-transplant-recipients-34301
https://atc.digitellinc.com/p/s/radiomic-assessment-of-donor-pancreatic-fat-content-to-drive-utilization-34302
https://atc.digitellinc.com/p/s/comparison-of-long-term-outcomes-in-simultaneous-pancreas-kidney-transplant-versus-simultaneous-deceased-donor-pancreas-and-living-donor-kidney-transplant-34303
https://atc.digitellinc.com/p/s/utilization-and-outcomes-of-pancreas-transplantation-from-donation-after-circulatory-death-dcd-donors-34304
https://atc.digitellinc.com/p/s/correlation-of-reg-gene-expression-with-degree-of-pancreatic-calcification-and-its-impact-on-graft-function-in-total-pancreatectomy-with-islet-autotransplantation-34305
https://atc.digitellinc.com/p/s/little-change-in-pancreas-discard-reasons-after-removal-of-dsa-and-optn-region-from-pancreas-allocation-34306
https://atc.digitellinc.com/p/s/incidence-and-rate-of-surgical-repair-of-incisional-hernia-following-pancreas-transplant-34307
https://atc.digitellinc.com/p/s/risk-factors-for-and-outcomes-of-orthostatic-hypotension-among-simultaneouspancreas-and-kidney-transplant-recipients-34308
https://atc.digitellinc.com/p/s/pancreatic-exocrine-secretion-and-weight-gain-after-pancreas-transplantation-34309
https://atc.digitellinc.com/p/s/factors-leading-to-the-discard-of-deceased-donor-dd-pancreata-in-the-us-34310
https://atc.digitellinc.com/p/s/novel-en-bloc-simultaneous-pancreas-kidney-transplantation-34311
https://atc.digitellinc.com/p/s/diabetic-outcomes-following-simultaneous-pancreas-kidney-transplant-are-spk-patients-going-back-on-antidiabetic-medications-34312
https://atc.digitellinc.com/p/s/the-value-of-donor-risk-index-and-indices-predicting-pancreas-graft-outcome-in-spk-transplantation-34313
https://atc.digitellinc.com/p/s/heterogeneous-pathology-findings-and-outcomes-in-16-patients-with-pancreas-transplant-biopsies-for-hyperglycemia-34314
https://atc.digitellinc.com/p/s/when-pancreas-transplants-recipients-gain-weight-which-grafts-rise-to-the-challenge-34315
https://atc.digitellinc.com/p/s/outcome-hiv-positive-pancreas-and-kidney-pancreas-transplants-an-analysis-of-the-unos-database-34316
https://atc.digitellinc.com/p/s/c-peptide-post-transplant-trajectory-in-simultaneous-pancreas-and-kidney-transplant-recipients-34317
https://atc.digitellinc.com/p/s/role-0f-gastric-peroral-endoscopic-myotomy-gpoem-in-gastroparesis-management-after-pancreas-transplantation-34318
https://atc.digitellinc.com/p/s/use-of-basiliximab-as-adjunct-maintenance-immunosuppressant-in-pancreas-transplant-recipients-34319
https://atc.digitellinc.com/p/s/belatacept-in-pancreas-transplantation-single-center-experience-34320
https://atc.digitellinc.com/p/s/obesity-does-not-appear-to-significantly-impact-surgical-complications-or-long-term-outcomes-in-pancreas-transplant-34321
https://atc.digitellinc.com/p/s/the-use-of-lcp-tacrolimus-versus-immediate-release-tacrolimus-in-simultaneous-pancreas-kidney-transplantation-34322
https://atc.digitellinc.com/p/s/impact-of-diabetes-on-quality-of-life-in-patients-with-or-without-islet-autotransplantation-34323
https://atc.digitellinc.com/p/s/favorable-outcomes-in-hispanic-recipients-receiving-simultaneous-pancreas-kidney-transplantation-34324
https://atc.digitellinc.com/p/s/optimal-condition-of-long-term-culturing-adult-porcine-islets-for-islet-xenotransplantation-34325
https://atc.digitellinc.com/p/s/subclinical-pancreas-rejection-in-simultaneous-kidney-and-pancreas-transplant-34326
https://atc.digitellinc.com/p/s/impact-of-removing-dsa-and-optn-region-from-pancreas-allocation-34327
https://atc.digitellinc.com/p/s/small-molecule-inhibitor-of-toll-like-receptor-4-tak-242-inhibits-activation-of-monocytes-in-an-in-vitro-model-of-allogenic-cellular-transplantation-34328
https://atc.digitellinc.com/p/s/islet-after-kidney-transplantation-restores-insulin-independence-in-patients-with-type-1-diabetes-34329
https://atc.digitellinc.com/p/s/does-splitting-the-liver-impact-pancreas-procurement-34330
https://atc.digitellinc.com/p/s/impact-of-the-university-of-wisconsin-uw-preservation-fluid-shortage-on-the-risk-of-early-graft-loss-after-pancreas-transplantation-34331
https://atc.digitellinc.com/p/s/surface-engineering-of-pancreatic-islets-by-bissulfosuccinimidyl-suberate-to-reduce-post-transplant-inflammation-34332
https://atc.digitellinc.com/p/s/evaluation-of-cd3-and-cd68-acinarseptal-infiltrates-in-pancreas-biopsies-discriminates-rejection-pathology-and-defines-non-rejection-entities-34333
https://atc.digitellinc.com/p/s/predictors-of-native-renal-function-decline-after-primary-pancreas-transplant-alone-in-type-1-dm-recipients-in-the-united-states-34334
https://atc.digitellinc.com/p/s/islet-transplantation-in-five-cases-of-diabetes-mellitus-after-organ-transplantation-34335
https://atc.digitellinc.com/p/s/risk-factors-for-greater-than-10-years-pancreas-graft-survival-in-the-uk-short-term-risk-factors-are-not-always-the-best-guide-for-long-term-survival-34336
https://atc.digitellinc.com/p/s/whole-procedure-ultrasound-guided-human-islet-transplantation-a-technical-feasibility-study-34337
https://atc.digitellinc.com/p/s/health-related-quality-of-life-after-pancreas-transplantation-34338
https://atc.digitellinc.com/p/s/lung-transplant-outcomes-for-american-indiansalaska-natives-34339
https://atc.digitellinc.com/p/s/difference-in-approach-of-treatment-of-osteoporosis-between-lung-and-heart-transplant-and-its-impact-on-the-progression-of-bone-mineral-density-and-fractures-a-five-year-single-center-experience-34340
https://atc.digitellinc.com/p/s/risk-factors-for-fungal-disease-in-lung-transplant-a-systematic-review-and-meta-analysis-34341
https://atc.digitellinc.com/p/s/similarities-and-differences-in-prevalence-and-components-of-frailty-in-lung-transplant-compared-with-heart-transplant-candidates-34342
https://atc.digitellinc.com/p/s/how-to-handle-the-com-plex-ity-of-antibodies-outcomes-of-intra-operative-plasma-exchange-in-heart-and-lung-transplant-34343
https://atc.digitellinc.com/p/s/quantifying-goals-of-care-discussions-in-transplant-surgery-using-natural-language-processing-34344
https://atc.digitellinc.com/p/s/evaluation-of-low-dose-apixaban-for-prevention-of-venous-thromboembolism-after-lung-transplant-34345
https://atc.digitellinc.com/p/s/does-pre-transplant-utilization-of-antifibrotic-therapy-impact-patients-with-idiopathic-pulmonary-fibrosis-undergoing-lung-transplant-34346
https://atc.digitellinc.com/p/s/feasibility-of-a-rigorous-ambulation-intervention-in-lung-transplant-patients-ifrail-study-34347
https://atc.digitellinc.com/p/s/implementation-of-a-multicenter-study-to-evaluate-the-ability-of-chart-based-frailty-review-to-determine-outcomes-after-lung-transplantation-34348
https://atc.digitellinc.com/p/s/impact-of-immunoglobulin-replacement-therapy-on-hypogammaglobulinemia-and-infection-in-lung-transplant-recipients-34349
https://atc.digitellinc.com/p/s/perioperative-neurological-outcomes-in-recipients-of-ecmo-bridge-to-lung-transplant-34350
https://atc.digitellinc.com/p/s/lung-transplantation-in-the-elderly-when-is-old-too-old-34351
https://atc.digitellinc.com/p/s/infectious-complications-in-elderly-lung-transplant-recipients-during-first-year-post-transplant-34352
https://atc.digitellinc.com/p/s/from-fibrosis-to-fibroelastosis-a-new-paradigm-in-lung-transplantation-34353
https://atc.digitellinc.com/p/s/assessment-of-treatment-response-between-donor-specific-antibodies-and-forced-expiratory-volume-in-lung-transplant-recipients-with-donor-specific-antibodies-34354
https://atc.digitellinc.com/p/s/single-vs-bilateral-lung-transplantation-revisited-an-analysis-of-new-optn-registry-pulmonary-function-measuresin-copd-and-interstitial-lung-disease-34355
https://atc.digitellinc.com/p/s/maintenance-belatacept-based-immunosuppression-in-lung-transplant-recipients-34356
https://atc.digitellinc.com/p/s/evaluation-of-invasive-fungal-infections-in-lung-transplant-recipients-receiving-low-dose-fluconazole-34357
https://atc.digitellinc.com/p/s/immunization-with-exosomes-from-lung-transplant-recipients-following-sars-cov-2-infection-or-vaccination-developed-csp-specific-antibodies-and-lesions-in-murine-lungs-34358
https://atc.digitellinc.com/p/s/acute-cellular-rejection-in-elderly-lung-transplant-recipients-during-first-year-post-transplant-34359
https://atc.digitellinc.com/p/s/single-center-results-of-lung-transplantation-for-coal-workers-pneumoconiosis-34360
https://atc.digitellinc.com/p/s/alemtuzumab-for-antibody-mediated-chronic-rejection-in-a-sensitized-lung-transplant-recipient-34361
https://atc.digitellinc.com/p/s/a-rare-case-with-cutaneous-solid-and-liquid-tissue-malignancies-after-lung-transplantation-34362
https://atc.digitellinc.com/p/s/single-strength-sulfamethoxazole-trimethoprim-provides-sufficient-prophylaxis-against-pneumocystis-jirovecii-pneumonia-in-lung-transplant-recipients-34363
https://atc.digitellinc.com/p/s/bronchial-ring-and-respiratory-cultures-in-lung-transplants-recipients-after-ex-vivo-lung-perfusion-34364
https://atc.digitellinc.com/p/s/small-bowel-obstruction-in-a-fresh-lung-transplant-recipient-laparotomy-after-a-sternotomy-34365
https://atc.digitellinc.com/p/s/rehabilitation-outcomes-of-bilateral-lung-transplant-patients-due-to-covid-19-34366
https://atc.digitellinc.com/p/s/epidemiology-of-respiratory-infections-in-lung-transplant-patients-with-endobronchial-stents-34367
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-levels-within-the-first-30-days-post-transplant-in-patients-receiving-intraoperative-cardiopulmonary-support-34368
https://atc.digitellinc.com/p/s/impact-of-belatacept-on-acute-rejection-outcomes-in-lung-transplantation-34369
https://atc.digitellinc.com/p/s/lung-transplantation-readmissions-based-on-underlying-lung-disease-34370
https://atc.digitellinc.com/p/s/protective-effect-of-liver-allograft-delaying-lung-allograft-dysfunction-in-a-case-of-simultaneous-combined-lung-liver-transplantation-34371
https://atc.digitellinc.com/p/s/combined-small-bowel-and-pancreas-transplant-a-case-report-34372
https://atc.digitellinc.com/p/s/management-of-graft-vs-host-disease-following-intestinal-transplantation-34373
https://atc.digitellinc.com/p/s/nutritional-care-of-pre-and-post-intestinal-transplant-patients-with-nitrogen-balance-34374
https://atc.digitellinc.com/p/s/clinical-outcomes-of-intestinal-transplant-recipients-receiving-maintenance-basiliximab-sublingual-tacrolimus-and-prednisone-a-case-series-34375
https://atc.digitellinc.com/p/s/patient-variables-predictive-of-post-intestinal-transplantation-malignancy-34376
https://atc.digitellinc.com/p/s/the-use-of-teduglutide-in-intestinal-transplantation-a-case-series-34377
https://atc.digitellinc.com/p/s/outcomes-after-intestinal-re-transplant-a-detailed-single-center-analysis-of-clinical-and-technical-factors-34378
https://atc.digitellinc.com/p/s/post-transplant-lymphoproliferative-disorder-following-pediatric-intestinal-transplant-an-old-foe-34379
https://atc.digitellinc.com/p/s/comparing-two-devices-for-liver-normothermic-machine-perfusion-at-transplantation-a-pilot-study-34380
https://atc.digitellinc.com/p/s/a-lipoic-acid-and-long-term-outcomes-in-kidney-transplantation-34381
https://atc.digitellinc.com/p/s/first-case-series-report-using-the-liverguard-static-hypothermic-organ-transport-system-for-liver-transplants-at-a-single-center-34382
https://atc.digitellinc.com/p/s/using-normormothermic-machine-perfusion-nmp-to-assess-resuscitate-and-rescue-livers-for-transplantation-initial-success-from-a-us-single-center-34383
https://atc.digitellinc.com/p/s/normothermic-machine-perfusion-of-the-kidney-prior-to-transplantation-implementations-and-early-outcomes-in-australia-34384
https://atc.digitellinc.com/p/s/normothermic-machine-perfusion-in-liver-transplantation-real-world-intraoperative-and-early-postoperative-impacts-34385
https://atc.digitellinc.com/p/s/gender-impact-on-the-outcomes-of-deceased-donor-liver-transplantation-34386
https://atc.digitellinc.com/p/s/address-history-as-a-novel-marker-of-lung-transplant-population-disparities-34387
https://atc.digitellinc.com/p/s/liver-transplantation-for-complex-hepatic-injuries-a-unos-database-analysis-34388
https://atc.digitellinc.com/p/s/modifying-effect-of-recipient-age-on-the-associations-between-common-risks-factors-and-all-cause-mortality-after-kidney-transplantation-34389
https://atc.digitellinc.com/p/s/new-acuity-circles-policy-did-not-worsen-the-baseline-disparities-that-were-present-during-the-pre-ac-era-in-deceased-donor-liver-transplant-patients-34390
https://atc.digitellinc.com/p/s/development-and-validation-of-a-multidimensional-prognostication-system-for-kidney-transplant-patient-survival-the-mortality-mbox-34391
https://atc.digitellinc.com/p/s/impact-of-area-deprivation-index-on-early-stages-in-the-liver-transplantation-process-34392
https://atc.digitellinc.com/p/s/acceptable-allograft-survival-of-kidney-transplants-in-the-patients-from-black-descent-in-the-uk-but-are-the-outcomes-at-par-with-caucasians-receiving-renal-transplant-34393
https://atc.digitellinc.com/p/s/insurance-type-and-gut-microbiome-diversity-of-kidney-transplant-recipients-34394
https://atc.digitellinc.com/p/s/age-disparities-in-access-to-first-and-repeat-kidney-transplantation-34395
https://atc.digitellinc.com/p/s/race-sex-and-neighborhood-deprivation-index-based-disparities-in-access-to-non-local-liver-transplantation-persist-among-patients-with-the-same-insurance-34396
https://atc.digitellinc.com/p/s/social-determinants-of-health-and-solid-organ-transplant-outcomes-among-hiv-positive-recipients-34397
https://atc.digitellinc.com/p/s/the-impact-of-race-in-access-to-liver-transplantation-for-hepatocellular-carcinoma-34398
https://atc.digitellinc.com/p/s/causes-of-death-among-adult-solid-organ-transplant-recipients-in-the-united-states-1999-2019-34399
https://atc.digitellinc.com/p/s/association-of-low-socio-economic-status-with-liver-graft-survival-and-graft-failure-due-to-acute-rejection-34400
https://atc.digitellinc.com/p/s/access-to-liver-transplantation-and-death-from-end-stage-liver-disease-esld-a-district-of-columbia-analysis-34401
https://atc.digitellinc.com/p/s/structural-social-determinants-of-health-as-barriers-to-liver-transplant-waitlisting-34402
https://atc.digitellinc.com/p/s/post-transplant-de-novo-kidney-cancer-in-kidney-transplant-recipients-an-analysis-of-organ-procurement-and-transplantation-network-data-during-2000-2021-34403
https://atc.digitellinc.com/p/s/cancer-prevalence-and-risk-factors-among-korean-solid-organ-transplant-recipients-34404
https://atc.digitellinc.com/p/s/melanoma-specific-mortality-in-patients-with-pre-transplant-melanoma-34405
https://atc.digitellinc.com/p/s/say-yes-to-transplantation-for-pediatric-renal-failure-due-to-malignancy-34406
https://atc.digitellinc.com/p/s/can-hla-mismatching-modify-the-associations-between-lymphoma-and-risk-factors-after-kidney-transplantation-an-observational-analysis-34407
https://atc.digitellinc.com/p/s/the-outcome-of-kidney-transplantation-after-cancer-treatment-in-the-patient-with-high-estimated-cure-rate-34408
https://atc.digitellinc.com/p/s/the-development-of-rejection-is-associated-with-a-more-aggressive-pattern-of-posttransplant-neoplasia-34409
https://atc.digitellinc.com/p/s/renal-cell-carcinoma-the-risk-of-transmission-from-deceased-donors-to-kidney-transplant-recipients-34410
https://atc.digitellinc.com/p/s/current-kidney-cancer-screening-practices-for-patients-with-kidney-disease-34411
https://atc.digitellinc.com/p/s/initial-results-from-an-open-label-multicenter-phase-1b2-study-of-rp1-oncolytic-immunotherapy-in-solid-organ-and-hematopoietic-cell-transplant-recipients-with-advanced-cutaneous-malignancies-artacus-34412
https://atc.digitellinc.com/p/s/machine-learning-techniques-to-improve-predictive-models-for-kidney-offer-acceptance-34413
https://atc.digitellinc.com/p/s/enhanced-reliability-of-artificial-intelligence-survival-models-to-predict-1-year-survival-after-kidney-transplant-using-a-novel-combined-model-34414
https://atc.digitellinc.com/p/s/the-impact-of-death-for-the-prediction-of-long-term-kidney-allograft-failure-a-competing-risk-analysis-study-34415
https://atc.digitellinc.com/p/s/characteristics-of-kidney-transplant-recipients-with-prolonged-pre-transplant-dialysis-duration-as-identified-by-machine-learning-consensus-clustering-34416
https://atc.digitellinc.com/p/s/machine-learning-based-prediction-of-early-post-transplant-bacteremia-with-pre-transplant-crossmatch-and-donor-specific-antibody-in-solid-organ-transplant-recipients-34417
https://atc.digitellinc.com/p/s/impact-of-a-smartphone-application-for-collaboration-with-local-clinics-in-the-treatment-of-sars-cov-2-infected-kidney-transplant-recipients-34418
https://atc.digitellinc.com/p/s/comparison-of-epts-and-pra-with-an-ai-based-model-to-predict-short-term-transplant-survivorship-34419
https://atc.digitellinc.com/p/s/prediction-of-post-nephrectomy-estimated-glomerular-filtration-rate-of-living-kidney-donors-using-auto-segmented-kidney-volumes-and-clinical-variables-34420
https://atc.digitellinc.com/p/s/analysis-of-instagrams-top-transplant-related-content-34421
https://atc.digitellinc.com/p/s/building-a-searchable-digital-repository-for-kidney-transplant-biopsies-34422
https://atc.digitellinc.com/p/s/medical-expertise-versus-survival-analysis-as-artificial-intelligence-categorization-mechanisms-in-kidney-transplantation-environments-through-a-hackathon-methodology-34423
https://atc.digitellinc.com/p/s/functional-data-analysis-as-a-framework-to-identify-kidney-transplant-recipients-with-early-and-slow-post-transplant-graft-function-associated-with-poor-long-term-graft-survival-34424
https://atc.digitellinc.com/p/s/height-related-single-nucleotide-polymorphisms-early-predicting-growth-patterns-after-pediatric-kidney-transplantation-genomics-based-machine-learning-models-34425
https://atc.digitellinc.com/p/s/novel-artificial-intelligence-algorithms-predict-long-term-outcomes-in-kidney-transplant-recipients-from-baseline-electrocardiograms-34426
https://atc.digitellinc.com/p/s/natural-language-processing-using-donor-narratives-to-predict-donors-at-high-risk-for-delayed-graft-function-34427
https://atc.digitellinc.com/p/s/a-machine-learning-based-model-for-identification-of-prognostic-factors-and-prediction-of-graft-survival-in-kidney-transplant-patients-34428
https://atc.digitellinc.com/p/s/tiktok-and-transplant-building-a-supportive-community-34429
https://atc.digitellinc.com/p/s/machine-learning-model-using-pre-transplant-blood-rna-seq-identifies-small-gene-set-that-predicts-rejection-at-6-months-post-transplant-34430
https://atc.digitellinc.com/p/s/trends-in-marginal-donor-utilization-in-the-united-states-across-solid-organ-transplant-34431
https://atc.digitellinc.com/p/s/expanding-donor-cause-of-death-designations-reflects-changing-donor-population-and-utilization-practices-34432
https://atc.digitellinc.com/p/s/maximal-medical-and-surgical-therapy-to-optimize-the-potential-organ-donor-a-case-report-34433
https://atc.digitellinc.com/p/s/development-of-the-hospital-organ-donation-performance-score-hops-preliminary-results-based-on-a-human-and-artificial-intelligencemachine-learning-collaborative-34434
https://atc.digitellinc.com/p/s/development-of-a-donor-quality-score-applicable-across-solid-organ-transplant-34435
https://atc.digitellinc.com/p/s/rapid-portable-digital-spectrophotometry-to-assess-macrovesicular-steatosis-in-the-liver-34436
https://atc.digitellinc.com/p/s/development-and-implementation-of-an-abdominal-normothermic-regional-perfusion-donation-after-circulatory-death-protocol-34437
https://atc.digitellinc.com/p/s/predictive-value-of-withdrawal-related-variables-on-graft-function-after-donation-after-circulatory-death-34438
https://atc.digitellinc.com/p/s/improving-quality-of-care-in-post-renal-transplant-patients-by-utilizing-a-pharmacist-run-telehealth-blood-pressure-clinic-34439
https://atc.digitellinc.com/p/s/cost-saving-initiatives-for-antithymocyte-globulin-rabbit-at-a-large-transplant-center-34440
https://atc.digitellinc.com/p/s/tailored-multidisciplinary-post-kidney-transplant-diabetes-education-positively-impacts-outcomes-in-a-predominantly-hispanic-and-american-indian-recipient-population-34441
https://atc.digitellinc.com/p/s/increasing-transplant-medication-knowledge-retention-through-implementation-of-a-health-literacymedication-education-intervention-algorithm-34442
https://atc.digitellinc.com/p/s/the-state-of-global-transplant-research-10-year-trends-34443
https://atc.digitellinc.com/p/s/overview-of-transplant-research-collaboration-in-the-us-a-network-analysis-34444
https://atc.digitellinc.com/p/s/developing-a-patient-centered-schematic-map-of-the-transplant-system-34445
https://atc.digitellinc.com/p/s/educational-needs-assessment-of-us-healthcare-practitioners-managing-cytomegalovirus-infection-in-solid-organ-transplant-recipients-results-from-a-survey-using-a-simulated-case-scenario-34446
https://atc.digitellinc.com/p/s/have-we-met-the-mark-a-quantitative-study-looking-at-the-learning-needs-of-post-kidney-transplant-recipients-34447
https://atc.digitellinc.com/p/s/post-kidney-transplant-hypertension-in-native-americans-a-single-center-experience-34448
https://atc.digitellinc.com/p/s/sodium-polystyrene-sulfonate-vs-sodium-zirconium-cyclosilicate-for-hyperkalemia-in-abdominal-transplant-recipients-34449
https://atc.digitellinc.com/p/s/augmenting-the-us-transplant-registry-with-external-mortality-data-impact-of-enhanced-verification-process-34450
https://atc.digitellinc.com/p/s/a-possible-association-of-spontaneous-coronary-artery-dissection-in-a-liver-transplant-patient-34451
https://atc.digitellinc.com/p/s/hemophagocytic-lymphohistiocytosis-in-an-immunocompromised-transplant-recipients-34452
https://atc.digitellinc.com/p/s/activity-measure-for-post-acute-care-6-clicks-short-forms-am-pac-and-model-for-end-stage-liver-disease-score-meld-a-retrospective-correlational-study-in-patients-with-end-stage-liver-disease-in-pre-tr-34453
https://atc.digitellinc.com/p/s/outcomes-for-high-risk-post-kidney-transplant-patients-admitted-to-the-intensive-care-unit-34454
https://atc.digitellinc.com/p/s/mucormycosis-management-in-solid-organ-transplantation-patients-34455
https://atc.digitellinc.com/p/s/light-touch-frailty-phenotype-34456
https://atc.digitellinc.com/p/s/aggressive-de-novo-hepatocellular-carcinoma-and-cholangiocarcinoma-in-post-kidney-transplant-glecaprevirpibrentasvir-treated-hepatitis-c-infection-34457
https://atc.digitellinc.com/p/s/pre-recovery-huddles-for-success-on-the-donation-after-cardiac-death-donor-with-thoracoabdominal-normothermic-regional-perfusion-34458
https://atc.digitellinc.com/p/s/medical-adherence-and-technical-user-behavior-in-patients-after-kidney-transplantation-and-with-and-without-telemedicine-support-a-cross-sectional-survey-34459
https://atc.digitellinc.com/p/s/disseminated-mycobacterium-avium-complex-infection-with-bone-marrow-involvement-in-a-renal-transplant-recipient-34460
https://atc.digitellinc.com/p/s/virtual-crossmatch-as-a-tool-to-increase-transplant-volume-while-maintaining-safety-34461
https://atc.digitellinc.com/p/s/chimerism-analysis-post-hematopoietic-stem-cell-transplantation-by-next-generation-sequencing-a-case-report-34462
https://atc.digitellinc.com/p/s/behavioral-resources-and-intervention-through-digital-group-education-bridge-an-embedded-group-telehealth-program-builds-self-efficacy-in-liver-transplant-lt-recipients-34463
https://atc.digitellinc.com/p/s/bacteriophage-therapy-for-antibiotic-resistant-nontuberculous-mycobacterium-34464
https://atc.digitellinc.com/p/s/is-there-a-risk-of-subtherapeutic-drug-dosing-for-fresh-functioning-kidney-transplant-ktx-recipients-a-prospective-comparison-of-measured-creatinine-clearance-mcrcl-with-estimated-glomerular-filtratio-34465
https://atc.digitellinc.com/p/s/length-of-stay-adversely-affects-patient-survival-34466
https://atc.digitellinc.com/p/s/accelerated-sars-cov-2-elimination-by-nirmatrelvirritonavir-treatment-above-5-days-after-covid-19-onset-in-kidney-transplant-recipients-34467
https://atc.digitellinc.com/p/s/the-impact-of-preoperative-body-composition-and-fat-to-muscle-ratio-on-graft-and-patient-survival-in-human-kidney-transplantation-34468
https://atc.digitellinc.com/p/s/the-potential-benefit-of-rapid-virus-clearance-in-hospitalized-renal-transplant-patients-with-prolonged-covid-19-infection-a-multi-center-clinical-experience-34469
https://atc.digitellinc.com/p/s/a-mixed-methods-study-investigating-the-perception-of-telehealth-by-solid-organ-transplant-recipients-34470
https://atc.digitellinc.com/p/s/importance-of-malnutrition-and-frailty-in-kidney-transplant-waiting-list-34471
https://atc.digitellinc.com/p/s/novel-acoustofluidic-apheresis-device-for-antibody-removal-in-a-rodent-model-34472
https://atc.digitellinc.com/p/s/a-subset-of-effector-tfh-cell-promotes-b-cell-alloimmunity-in-lymph-nodes-and-kidney-grafts-34473
https://atc.digitellinc.com/p/s/indirect-evidence-for-circulating-factors-in-focal-segmental-glomerulosclerosis-via-molecular-analysis-of-podocyte-injury-in-kidney-organoids-34474
https://atc.digitellinc.com/p/s/manufacturing-and-functional-characterization-of-bioengineered-liver-grafts-for-extracorporeal-liver-assistance-in-acute-liver-failure-34475
https://atc.digitellinc.com/p/s/artificial-pancreatic-islets-produced-by-3d-bioprinting-inkjet-technology-with-extracellular-matrix-as-an-environment-for-stem-cell-derived-beta-cells-34476
https://atc.digitellinc.com/p/s/perfusion-decellularized-massive-bone-allografts-the-next-step-to-improve-bone-tissue-transplantation-34477
https://atc.digitellinc.com/p/s/regional-outcomes-of-paediatric-renal-transplantation-in-the-uk-a-machine-learning-analysis-34478
https://atc.digitellinc.com/p/s/proteomics-analysis-reveals-specific-biological-changes-induced-by-the-normothermic-machine-perfusion-of-donor-kidneys-with-latexin-being-the-top-up-regulated-protein-post-treatment-34479
https://atc.digitellinc.com/p/s/aav9-mediated-gene-delivery-to-liver-grafts-during-static-cold-storage-in-a-rat-liver-transplant-model-34480
https://atc.digitellinc.com/p/s/current-practices-and-perceptions-of-ex-vivo-liver-machine-perfusion-in-the-united-states-34481
https://atc.digitellinc.com/p/s/one-opos-experience-with-normothermic-regional-perfusion-34482
https://atc.digitellinc.com/p/s/normothermic-ex-vivo-perfusion-of-liver-grafts-results-in-reduced-expression-of-genes-related-to-ischemia-reperfusion-injury-34483
https://atc.digitellinc.com/p/s/ex-situ-reperfusion-injuryinflammation-immuno-molecular-profiling-of-human-livers-during-normothermic-machine-perfusion-34484
https://atc.digitellinc.com/p/s/utilization-of-cept-polypharmacological-cocktail-in-machine-perfusion-promotes-whole-organ-resuscitation-from-warm-ischemic-damage-34485
https://atc.digitellinc.com/p/s/artery-preparation-of-donor-liver-with-replacement-right-hepatic-artery-for-normothermic-machine-perfusion-34486
https://atc.digitellinc.com/p/s/prevalence-and-potential-impact-of-human-leukocyte-antigen-alleles-unrepresented-on-single-antigen-bead-assays-34487
https://atc.digitellinc.com/p/s/assessment-of-chimerism-by-next-generation-sequencing-a-comparison-to-str-pcr-method-34488
https://atc.digitellinc.com/p/s/hla-a-can-be-potentially-regulated-by-hla-j-pseudogene-microrna-decoy-34489
https://atc.digitellinc.com/p/s/crispr-engineered-cell-culture-model-to-investigate-the-drug-drug-gene-interactions-of-cyp3a5-genetic-variants-and-ritonavir-on-tacrolimus-metabolism-34490
https://atc.digitellinc.com/p/s/iguratimod-attenuates-macrophage-polarization-and-antibody-mediated-rejection-after-renal-transplant-by-regulating-klf4-34491
https://atc.digitellinc.com/p/s/immunosuppressants-regulate-immunity-by-altering-lymph-node-structure-and-intestinal-regulatory-t-cells-34492
https://atc.digitellinc.com/p/s/selenium-protects-against-tacrolimus-induced-nephrotoxicity-in-llc-pk-1-cell-via-anti-oxidative-and-anti-apoptotic-properties-34493
https://atc.digitellinc.com/p/s/ginsenoside-rg3-attenuates-ischemia-reperfusion-induced-renal-injury-in-mice-via-induction-of-autophagy-flux-34494
https://atc.digitellinc.com/p/s/effect-of-cold-storage-on-hepatocytes-and-hepatic-non-parenchymal-cells-34495
https://atc.digitellinc.com/p/s/short-term-hypercaloric-sucrose-rich-drink-improves-resistance-to-ischemia-reperfusion-by-inducing-fgf21-34496
https://atc.digitellinc.com/p/s/frequency-of-blood-pressure-measurements-in-renal-allograft-recipients-under-regular-telemedicine-surveillance-34497
https://atc.digitellinc.com/p/s/patient-survival-outcome-with-dcd-donor-over-90-minutes-34498
https://atc.digitellinc.com/p/s/combined-impact-of-the-inter-and-intra-patient-variability-of-tacrolimus-blood-level-on-allograft-outcomes-in-kidney-transplantation-34499
https://atc.digitellinc.com/p/s/age-dependent-blood-pressure-measurements-in-renal-transplanted-patients-using-home-monitored-telemedicine-surveillance-34500
https://atc.digitellinc.com/p/s/application-of-targeted-next-generation-sequencing-for-early-diagnosis-of-donor-derived-toxoplasma-gondii-in-a-heart-transplant-patient-34501
https://atc.digitellinc.com/p/s/evaluation-of-current-prophylaxis-strategies-for-cytomegalovirus-disease-at-a-large-academic-medical-center-34502
https://atc.digitellinc.com/p/s/early-infections-in-lung-transplant-recipients-34503
https://atc.digitellinc.com/p/s/brain-abscess-in-solid-organ-transplant-recipients-34504
https://atc.digitellinc.com/p/s/the-yield-of-pre-recovery-liver-biopsy-in-allocation-optimization-in-deceased-brain-death-donors-34505
https://atc.digitellinc.com/p/s/graft-livers-can-be-safely-transplanted-even-after-a-certain-amount-of-time-and-distance-34506
https://atc.digitellinc.com/p/s/successful-liver-transplantation-using-an-abnormal-appearance-deceased-donor-liver-with-glycogenic-hepatopathy-34507
https://atc.digitellinc.com/p/s/the-hispanic-experience-in-living-donor-liver-transplantation-outcomes-from-a-single-us-center-34508
https://atc.digitellinc.com/p/s/single-dose-eculizumab-as-desensitization-protocol-for-abo-incompatible-living-donor-34509
https://atc.digitellinc.com/p/s/immunologic-donor-and-recipient-safety-profile-of-altruistic-living-liver-donation-34510
https://atc.digitellinc.com/p/s/bioelectrical-impedance-analysis-for-preoperative-volume-assessment-in-living-donor-hepatectomy-34511
https://atc.digitellinc.com/p/s/challenging-vascular-situations-in-living-donor-liver-transplantation-34512
https://atc.digitellinc.com/p/s/serum-procalcitonin-levels-immediately-after-living-donor-liver-transplantation-the-potential-predictor-of-short-term-positive-blood-cultures-and-graft-loss-34513
https://atc.digitellinc.com/p/s/ethics-and-equity-in-uterine-transplantation-eligibility-a-scoping-review-34514
https://atc.digitellinc.com/p/s/impact-of-medicaid-expansion-on-liver-transplantation-in-the-state-of-oklahoma-34515
https://atc.digitellinc.com/p/s/increasing-access-to-transplantation-for-hispanic-patients-through-an-integrative-pilot-spanish-speaking-liver-transplant-program-34516
https://atc.digitellinc.com/p/s/polyclonal-treg-therapy-for-renal-allograft-inflammation-results-of-ctot-21-a-randomized-controlled-clinical-trial-34517
https://atc.digitellinc.com/p/s/daratumumab-desensitization-before-kidney-transplantation-a-pilot-study-34518
https://atc.digitellinc.com/p/s/results-of-a-multicenter-cluster-randomized-controlled-clinical-trial-testing-the-effectiveness-of-a-bioinformatics-enabled-pharmacist-intervention-in-transplant-recipients-at-the-veterans-affairs-hea-34519
https://atc.digitellinc.com/p/s/normothermic-kidney-perfusion-phase-1-a-clinical-trial-of-up-to-24-hour-normothermic-machine-perfusion-prior-to-transplantation-34520
https://atc.digitellinc.com/p/s/outcomes-of-invasive-fungal-infections-ifis-in-solid-organ-transplant-sot-recipients-treated-with-olorofim-in-an-open-label-salvage-study-34521
https://atc.digitellinc.com/p/s/phase-12-donor-antigen-specific-treg-based-suppressor-t-cells-therapy-clinical-trial-to-induce-operational-tolerance-in-living-donor-liver-transplant-patients-34522
https://atc.digitellinc.com/p/s/continuous-glucose-monitor-use-improves-immediate-post-transplant-glycemic-control-34523
https://atc.digitellinc.com/p/s/ast-lifetime-achievement-and-transplant-advocacy-awards-34531
https://atc.digitellinc.com/p/s/ajt-awards-and-update-34532
https://atc.digitellinc.com/p/s/atcs-peoples-choice-award-34533
https://atc.digitellinc.com/p/s/ast-research-grants-recognition-34534
https://atc.digitellinc.com/p/s/asts-research-grants-recognition-34535
https://atc.digitellinc.com/p/s/asts-pioneer-award-34536
https://atc.digitellinc.com/p/s/just-not-allocation-but-equity-in-organ-transplantation-34537
https://atc.digitellinc.com/p/s/the-science-of-fire-and-ice-machine-perfusion-vs-cryopreservation-34538
https://atc.digitellinc.com/p/s/revisiting-the-barrier-imposed-by-memory-and-effector-t-cells-34539
https://atc.digitellinc.com/p/s/utilizing-ai-and-deep-based-learning-approaches-in-transplantation-34540
https://atc.digitellinc.com/p/s/liver-transplantation-for-acute-alcoholic-hepatitis-lessons-recently-learned-34541
https://atc.digitellinc.com/p/s/proceedings-from-the-3rd-international-ptdm-consensus-meeting-latest-guidelines-updated-recommendations-and-future-directions-34542
https://atc.digitellinc.com/p/s/artificial-intelligence-and-data-driven-decision-making-in-transplantation-34543
https://atc.digitellinc.com/p/s/hospital-based-donor-recovery-centers-34544
https://atc.digitellinc.com/p/s/palliative-care-in-transplant-a-continuum-of-care-34545
https://atc.digitellinc.com/p/s/emerging-omic-and-machine-learning-techniques-the-next-frontier-in-transplant-research-34546
https://atc.digitellinc.com/p/s/emerging-concepts-in-senescence-and-immune-aging-34547
https://atc.digitellinc.com/p/s/pregnancy-and-tolerance-34548
https://atc.digitellinc.com/p/s/environmental-modifiers-of-alloimmune-response-34549
https://atc.digitellinc.com/p/s/transplant-immunology-and-vascularized-composite-allografts-34550
https://atc.digitellinc.com/p/s/beyond-the-genome-epigenetic-biomarkers-in-solid-organ-transplant-34551
https://atc.digitellinc.com/p/s/engineered-regulatory-cells-in-transplantation-34552
https://atc.digitellinc.com/p/s/social-support-and-culturally-relevant-facilitators-of-access-to-transplantation-34553
https://atc.digitellinc.com/p/s/emerging-tools-to-improve-defining-and-managing-t-cell-mediated-rejection-34554
https://atc.digitellinc.com/p/s/expanding-the-liver-donor-pool-living-or-dcd-donors-what-is-the-best-strategy-34555
https://atc.digitellinc.com/p/s/from-identification-to-action-developing-interventions-to-narrow-racial-and-socioeconomic-disparities-in-liver-transplantation-34556
https://atc.digitellinc.com/p/s/every-child-should-have-access-to-ldlt-in-the-usa-34557
https://atc.digitellinc.com/p/s/dangerous-liaisons-pulmonary-hypertension-in-heart-lung-and-liver-transplantation-34558
https://atc.digitellinc.com/p/s/hepatocellular-carcinoma-in-patients-with-fontan-associated-liver-disease-and-congenital-heart-disease-34559
https://atc.digitellinc.com/p/s/post-transplant-glomerulonephritis-gn-what-we-know-and-what-we-must-know-34560
https://atc.digitellinc.com/p/s/could-frailty-assessment-widen-the-sex-gap-in-access-to-transplantation-34561
https://atc.digitellinc.com/p/s/reproductive-rights-legislature-and-impact-on-pre-and-post-transplant-patients-34562
https://atc.digitellinc.com/p/s/fueling-the-fire-or-quelling-the-flames-using-immunotherapy-for-hepatocellular-carcinoma-in-the-setting-of-liver-transplantation-34563
https://atc.digitellinc.com/p/s/ethical-concerns-in-pig-to-human-xenotransplantation-34564
https://atc.digitellinc.com/p/s/dead-or-alive-how-to-define-death-in-the-machine-preservation-era-with-normothermic-regional-perfusion-34565
https://atc.digitellinc.com/p/s/challenges-in-management-of-critically-ill-patient-with-liver-disease-34566
https://atc.digitellinc.com/p/s/approaches-for-biomaterial-based-immunosuppression-systems-34567
https://atc.digitellinc.com/p/s/long-term-successes-of-pancreas-transplantation-34568
https://atc.digitellinc.com/p/s/using-immunologically-active-agents-in-the-setting-of-immunosuppression-34569
https://atc.digitellinc.com/p/s/an-update-from-tpac-transplant-pharmacy-adherence-consortium-on-transplant-adherence-sharing-published-experiences-and-lessons-learned-34570
https://atc.digitellinc.com/p/s/new-tools-to-tame-the-troll-of-transplant-cmv-in-2023-34571
https://atc.digitellinc.com/p/s/best-practices-for-patient-education-bridging-the-equity-gap-and-leveraging-technology-34572
https://atc.digitellinc.com/p/s/teeing-up-for-success-the-pharmacist-impact-on-waitlist-management-34573
https://atc.digitellinc.com/p/s/immune-compatibility-and-equity-in-access-under-kidney-continuous-distribution-34574
https://atc.digitellinc.com/p/s/leveling-the-field-in-health-disparities-in-thoracic-transplantation-equality-vs-equity-vs-justice-34575
https://atc.digitellinc.com/p/s/organ-allocation-in-pediatric-transplantation-joint-symposium-of-the-international-pediatric-transplant-association-ipta-and-atc-34576
https://atc.digitellinc.com/p/s/10-year-update-on-the-role-of-the-transplant-pharmacist-34577
https://atc.digitellinc.com/p/s/kidney-transplant-in-elderly-34578
https://atc.digitellinc.com/p/s/a-bridge-to-nowhere-what-destination-therapies-are-reasonable-options-for-our-transplant-ineligible-patients-34579
https://atc.digitellinc.com/p/s/the-next-frontier-proactively-addressing-potential-disparities-in-access-to-living-donor-liver-transplantation-34580
https://atc.digitellinc.com/p/s/pancreas-capturing-the-benefita-euro-how-to-rejuvenate-your-pancreas-transplant-program-34581
https://atc.digitellinc.com/p/s/utility-and-beneficence-consideration-in-organ-allocation-for-simultaneous-heart-kidney-and-lung-kidney-transplant-34582
https://atc.digitellinc.com/p/s/pitfalls-complexities-and-inapparent-consequences-of-the-use-of-the-egfr-metric-in-transplant-studies-34583
https://atc.digitellinc.com/p/s/understanding-and-communicating-risk-who-to-test-and-how-to-incorporate-apol1-results-in-the-care-of-living-kidney-donors-34584
https://atc.digitellinc.com/p/s/no-more-secrets-addressing-mental-health-and-risky-behaviors-in-adolescent-transplant-recipients-34585
https://atc.digitellinc.com/p/s/liver-transplantation-in-critically-ill-patients-with-cirrhosis-aclf-34586
https://atc.digitellinc.com/p/s/pursuing-healthy-weight-for-life-integrating-long-term-weight-management-to-promote-wellness-and-sustained-weight-loss-among-overweight-andor-obese-living-donor-candidates-34587
https://atc.digitellinc.com/p/s/let-food-be-thy-medicine-a-euro-nutrition-in-kidney-transplantation-34588
https://atc.digitellinc.com/p/s/manufacturing-organs-from-patients-own-cells-where-are-we-and-what-it-will-take-to-get-where-we-want-34589
https://atc.digitellinc.com/p/s/new-fields-in-liver-transplant-oncology-34590
https://atc.digitellinc.com/p/s/creating-a-sustainable-transplant-workforce-moving-beyond-the-individual-to-redesigning-the-system-34591
https://atc.digitellinc.com/p/s/does-rejection-surveillance-still-need-to-be-a-pain-in-the-neck-34592
https://atc.digitellinc.com/p/s/optimizing-use-of-organ-understanding-rates-of-non-utilization-and-opportunities-for-change-34593
https://atc.digitellinc.com/p/s/buy-one-get-one-free-assessing-renal-function-in-heart-failure-to-define-thresholds-for-combined-heart-kidney-transplant-34594
https://atc.digitellinc.com/p/s/screening-and-therapeutic-options-for-graft-versus-host-disease-in-solid-organ-transplant-34595
https://atc.digitellinc.com/p/s/strategies-for-leading-a-transplant-program-34596
https://atc.digitellinc.com/p/s/complement-system-in-organ-transplantation-34597
https://atc.digitellinc.com/p/s/looking-to-the-future-overview-of-new-consensus-guidelines-for-defining-bk-viral-disease-in-renal-transplant-recipients-and-review-of-potential-new-therapies-on-the-horizon-34598
https://atc.digitellinc.com/p/s/implementation-of-human-clinical-trials-for-xenotransplantation-34599
https://atc.digitellinc.com/p/s/engaging-liver-transplant-recipients-in-alcohol-treatment-34600
https://atc.digitellinc.com/p/s/target-testing-to-ensure-successful-desensitization-and-post-transplant-monitoring-34601
https://atc.digitellinc.com/p/s/role-of-virus-specific-t-cells-in-sot-too-many-unknowns-34602
https://atc.digitellinc.com/p/s/monitoring-rejection-and-tolerance-through-high-throughput-tcr-sequencing-34603
https://atc.digitellinc.com/p/s/utility-of-non-traditional-donors-in-pediatric-kidney-transplantation-34604
https://atc.digitellinc.com/p/s/applied-machine-learning-in-immunogenetics-and-transplant-outcomes-34605
https://atc.digitellinc.com/p/s/the-art-and-science-of-kidney-offer-decision-making-34606
https://atc.digitellinc.com/p/s/how-do-you-build-an-abdominal-normothermic-regional-perfusion-dcd-program-34607
https://atc.digitellinc.com/p/s/uterus-transplantation-where-are-we-now-and-how-did-we-get-there-34608
https://atc.digitellinc.com/p/s/progress-in-the-application-of-hla-epitope-data-to-improve-post-transplant-risk-assessment-34609
https://atc.digitellinc.com/p/s/caring-for-gender-diverse-patients-34610
https://atc.digitellinc.com/p/s/machine-perfusion-in-liver-transplantation-current-usage-and-future-directions-34611
https://atc.digitellinc.com/p/s/promoting-equity-in-kidney-and-liver-transplantation-for-minoritized-populations-34612
https://atc.digitellinc.com/p/s/facilitating-the-growth-of-dcd-liver-transplant-34613
https://atc.digitellinc.com/p/s/disparities-in-intestinal-failure-and-transplant-where-are-we-and-how-do-we-improve-34614
https://atc.digitellinc.com/p/s/anthropometrics-sarcopenia-evaluation-in-the-intestinal-rehabilitation-and-transplant-population-34615
https://atc.digitellinc.com/p/s/does-length-really-matter-the-story-of-telomere-length-and-thoracic-organs-34616
https://atc.digitellinc.com/p/s/building-a-sustainable-pediatric-transplant-workforce-34617
https://atc.digitellinc.com/p/s/immunologic-concerns-in-intestine-transplantation-34618
https://atc.digitellinc.com/p/s/innovations-in-transplant-id-medical-education-34619
https://atc.digitellinc.com/p/s/histocompatibility-challenges-in-xenotransplantation-a-euro-gaps-between-clinical-histocompatibility-testing-and-xenotransplantation-34620
https://atc.digitellinc.com/p/s/hope-for-hiv-to-hiv-transplants-34621
https://atc.digitellinc.com/p/s/is-shorter-better-when-is-less-actually-more-for-antibiotics-in-transplant-34622
https://atc.digitellinc.com/p/s/long-term-living-donor-follow-up-in-the-us-a-pipedream-or-an-imminent-reality-34623
https://atc.digitellinc.com/p/s/the-challenge-of-climate-change-and-its-impact-on-transplant-infections-34624
https://atc.digitellinc.com/p/s/allocating-end-of-chain-kidneys-in-paired-exchange-where-should-the-kidney-go-34625
https://atc.digitellinc.com/p/s/updates-in-covid-19-and-monkeypox-34626
https://atc.digitellinc.com/p/s/challenges-posed-by-donor-recipient-size-mismatch-in-pediatric-abdominal-organ-transplantation-34627
https://atc.digitellinc.com/p/s/the-quest-for-solutions-for-the-major-vca-transplant-complications-34628
https://atc.digitellinc.com/p/s/liver-transplantation-as-a-new-treatment-for-unresectable-colorectal-cancer-metastasis-34629
https://atc.digitellinc.com/p/s/expansion-of-the-use-of-car-t-therapy-in-transplantation-34630
https://atc.digitellinc.com/p/s/managing-comorbidities-pre-and-post-transplant-34631
https://atc.digitellinc.com/p/s/measuring-success-in-transitioning-youth-to-adult-transplant-providers-34632
https://atc.digitellinc.com/p/s/id-challenges-for-the-app-34633
https://atc.digitellinc.com/p/s/the-road-to-equity-developing-health-system-interventions-to-narrow-disparities-in-solid-organ-transplantation-34634
https://atc.digitellinc.com/p/s/late-breaking-impact-transplantation-nanomedicine-the-new-frontier-34635
https://atc.digitellinc.com/p/s/pediatric-combined-heart-liver-and-heart-kidney-transplant-34636
https://atc.digitellinc.com/p/s/a-globetrotters-guide-evaluation-for-genetic-kidney-disease-in-transplantation-and-living-donation-practical-genetics-for-the-transplant-nephrologist-34637
https://atc.digitellinc.com/p/s/dont-stop-me-now-low-volume-high-risk-dual-organ-transplantation-opportunities-and-challenges-34638
https://atc.digitellinc.com/p/s/transplant-pharmacy-blueprint-in-2023-how-when-and-where-to-optimize-our-services-34639
https://atc.digitellinc.com/p/s/steering-the-ship-diagnostic-and-antimicrobial-stewardship-in-transplant-id-34640
https://atc.digitellinc.com/p/s/bringing-living-donor-liver-transplantation-to-a-program-near-you-34641
https://atc.digitellinc.com/p/s/a-new-paradigm-enabled-by-portable-non-ischemic-organ-perfusion-with-standardized-national-procurement-and-clinical-management-for-heart-lung-and-liver-transplants-34642
https://atc.digitellinc.com/p/s/applying-polygenic-risk-scores-in-transplantation-34643
https://atc.digitellinc.com/p/s/controversial-living-liver-donors-best-approaches-to-unique-scenarios-34644
https://atc.digitellinc.com/p/s/innovations-in-transplantation-abo-incompatible-organ-transplantation-34645
https://atc.digitellinc.com/p/s/plenary-oral-abstract-session-1-34646
https://atc.digitellinc.com/p/s/plenary-oral-abstract-session-4-34647
https://atc.digitellinc.com/p/s/plenary-oral-abstract-session-3-34648
https://atc.digitellinc.com/p/s/plenary-oral-abstract-session-2-34649
https://atc.digitellinc.com/p/s/ast-presidential-introduction-and-address-34650
https://atc.digitellinc.com/p/s/asts-presidential-introduction-and-address-34651
https://atc.digitellinc.com/p/s/late-breaking-clinical-trials-abstract-session-34652
https://atc.digitellinc.com/p/s/quality-assurance-process-improvement-and-regulatory-issues-34653
https://atc.digitellinc.com/p/s/acute-rejection-34654
https://atc.digitellinc.com/p/s/b-cell-antibody-autoimmunity-34655
https://atc.digitellinc.com/p/s/tissue-engineering-cellular-and-regenerative-medicine-34656
https://atc.digitellinc.com/p/s/vascular-lymphatic-stromal-and-parenchymal-cell-biology-34657
https://atc.digitellinc.com/p/s/innate-immunity-chemokines-cytokines-complement-34658
https://atc.digitellinc.com/p/s/signaling-and-metabolism-34659
https://atc.digitellinc.com/p/s/treg-other-regulatory-cell-tolerance-34660
https://atc.digitellinc.com/p/s/histocompatibility-and-immunogenetics-34661
https://atc.digitellinc.com/p/s/immunosuppression-and-tolerance-preclinical-and-translational-studies-34662
https://atc.digitellinc.com/p/s/xenotransplantation-34663
https://atc.digitellinc.com/p/s/ischemia-reperfusion-34664
https://atc.digitellinc.com/p/s/machine-perfusion-and-organ-rehabilitation-basic-34665
https://atc.digitellinc.com/p/s/biomarkers-omics-and-systems-biology-34666
https://atc.digitellinc.com/p/s/infection-and-immunity-basic-34667
https://atc.digitellinc.com/p/s/biomarkers-liver-34668
https://atc.digitellinc.com/p/s/biomarkers-34669
https://atc.digitellinc.com/p/s/chronic-organ-rejection-34670
https://atc.digitellinc.com/p/s/vca-34671
https://atc.digitellinc.com/p/s/non-organ-specific-public-policy-and-allocation-34672
https://atc.digitellinc.com/p/s/psychosocial-economics-and-ethics-34673
https://atc.digitellinc.com/p/s/polyoma-virus-infection-34674
https://atc.digitellinc.com/p/s/infections-in-liver-transplantation-and-viral-hepatitis-34675
https://atc.digitellinc.com/p/s/covid-19-vaccination-34676
https://atc.digitellinc.com/p/s/donor-issues-in-transplant-id-34677
https://atc.digitellinc.com/p/s/pharmacokineticspharmacogenomicsdrug-interactions-34678
https://atc.digitellinc.com/p/s/clinical-pharmacytransplant-pharmacotherapy-34679
https://atc.digitellinc.com/p/s/kidney-deceased-donor-allocation-34680
https://atc.digitellinc.com/p/s/kidney-deceased-donor-selection-34681
https://atc.digitellinc.com/p/s/kidney-psychosocial-34682
https://atc.digitellinc.com/p/s/kidney-acute-rejection-34683
https://atc.digitellinc.com/p/s/kidney-cardiovascular-and-metabolic-complications-1-34684
https://atc.digitellinc.com/p/s/kidney-immunosuppression-desensitization-34685
https://atc.digitellinc.com/p/s/kidney-immunosuppression-novel-regimens-and-drug-minimization-34686
https://atc.digitellinc.com/p/s/kidney-living-donor-long-term-outcomes-34687
https://atc.digitellinc.com/p/s/kidney-living-donation-34688
https://atc.digitellinc.com/p/s/pediatrics-34689
https://atc.digitellinc.com/p/s/kidney-acute-antibody-mediated-rejection-34690
https://atc.digitellinc.com/p/s/kidney-chronic-antibody-mediated-rejection-34691
https://atc.digitellinc.com/p/s/kidney-complications-non-immune-mediated-late-graft-failure-34692
https://atc.digitellinc.com/p/s/kidney-complications-immune-mediated-late-graft-failure-34693
https://atc.digitellinc.com/p/s/recurrent-kidney-disease-and-genetics-34694
https://atc.digitellinc.com/p/s/health-equity-and-access-1-34695
https://atc.digitellinc.com/p/s/kidney-biomarkers-1-34696
https://atc.digitellinc.com/p/s/liver-kidney-issues-in-liver-transplantation-34697
https://atc.digitellinc.com/p/s/liver-cirrhosis-portal-hypertension-and-other-complications-34698
https://atc.digitellinc.com/p/s/liver-immunosuppression-and-rejection-34699
https://atc.digitellinc.com/p/s/hepatic-malignancy-34700
https://atc.digitellinc.com/p/s/liver-surgery-innovative-techniques-34701
https://atc.digitellinc.com/p/s/liver-living-donor-liver-transplant-and-partial-grafts-34702
https://atc.digitellinc.com/p/s/liver-expanding-the-donor-pool-liver-meld-allocation-donor-issues-34703
https://atc.digitellinc.com/p/s/liver-meld-allocation-and-recipient-selection-and-nbsp-34704
https://atc.digitellinc.com/p/s/liver-pediatrics-34705
https://atc.digitellinc.com/p/s/liver-retransplantation-and-other-complications-34706
https://atc.digitellinc.com/p/s/optimizing-heart-transplant-outcomes-34707
https://atc.digitellinc.com/p/s/optimizing-lung-transplant-outcomes-34708
https://atc.digitellinc.com/p/s/pancreas-and-islet-all-topics-34709
https://atc.digitellinc.com/p/s/intestinal-transplantation-and-rehabilitation-34710
https://atc.digitellinc.com/p/s/non-organ-specific-organ-preservationischemia-reperfusion-injury-34711
https://atc.digitellinc.com/p/s/non-organ-specific-disparities-to-outcome-and-access-to-healthcare-34712
https://atc.digitellinc.com/p/s/machine-learning-artificial-intelligence-and-social-media-in-transplantation-34713
https://atc.digitellinc.com/p/s/research-qi-34714
https://atc.digitellinc.com/p/s/clinical-practice-34715
https://atc.digitellinc.com/p/s/cmv-and-ptld-34716
https://atc.digitellinc.com/p/s/covid-19-miscellaneous-34717
https://atc.digitellinc.com/p/s/covid-19-prevention-and-outcomes-34718
https://atc.digitellinc.com/p/s/fungal-and-misc-infections-in-sotr-34719
https://atc.digitellinc.com/p/s/kidney-cardiovascular-and-metabolic-complications-2-34720
https://atc.digitellinc.com/p/s/health-equity-and-access-2-34721
https://atc.digitellinc.com/p/s/kidney-biomarkers-2-34722
https://atc.digitellinc.com/p/s/heart-transplant-donor-and-allocation-management-34723
https://atc.digitellinc.com/p/s/complications-in-lung-transplantation-34724
https://atc.digitellinc.com/p/s/biomarkers-in-cardiothoracic-transplantation-34725
https://atc.digitellinc.com/p/s/transplant-id-miscellaneous-34726
https://atc.digitellinc.com/p/s/late-breaking-abstracts-clinical-34727
https://atc.digitellinc.com/p/s/late-breaking-basic-and-translational-34728
https://atc.digitellinc.com/p/s/biomarker-for-earlier-kidney-rejection-assessment-and-nbspsupported-by-natera-34729
https://atc.digitellinc.com/p/s/whats-new-and-whats-next-customizing-covid-19-prevention-approaches-in-transplant-patients-to-increase-uptake-access-and-efficacy-supported-by-an-independent-educational-grand-from-astrazeneca-lp-34730
https://atc.digitellinc.com/p/s/an-evolving-standard-of-care-artificial-intelligence-and-molecular-diagnostics-supported-by-caredx-34731
https://atc.digitellinc.com/p/s/making-the-case-for-novel-assays-balancing-the-risk-of-infection-and-rejection-supported-by-eurofins-transplant-diagnostics-34732
https://atc.digitellinc.com/p/s/national-ocs-program-nop-and-ndash-transforming-the-standard-of-care-supported-by-transmedics-34734
https://atc.digitellinc.com/p/s/stronger-for-longer-managing-chronic-active-abmr-in-renal-allograft-recipients-and-nbspsupported-by-an-independent-educational-grant-from-csl-behring-34735
https://atc.digitellinc.com/p/s/incorporating-new-therapies-to-hone-the-treatment-of-resistant-or-refractory-cmv-in-the-post-sot-setting-and-nbsp-supported-by-an-independent-educational-grant-from-takeda-34736
https://atc.digitellinc.com/p/s/thomas-e-starzl-state-of-the-art-lecture-and-nbspinfection-in-transplantation-what-have-we-learned-from-pigs-34738
https://atc.digitellinc.com/p/s/paul-i-terasaki-state-of-the-art-lecture-and-nbspgrowing-organs-in-vivo-ips-cell-derived-xeno-created-organs-for-transplantation-34739
https://atc.digitellinc.com/p/s/whats-hot-whats-new-34740
https://atc.digitellinc.com/p/s/top-papers-in-transplant-id-34741
https://atc.digitellinc.com/p/s/introduction-34742
https://atc.digitellinc.com/p/s/award-acceptance-34743
https://atc.digitellinc.com/p/s/ajt-awards-and-update-34744
https://atc.digitellinc.com/p/s/plenary-session-1-34745
https://atc.digitellinc.com/p/s/plenary-session-2-34746
https://atc.digitellinc.com/p/s/plenary-session-3-34747
https://atc.digitellinc.com/p/s/plenary-session-4-34748
https://atc.digitellinc.com/p/s/q-and-a-voting-34749
https://atc.digitellinc.com/p/s/ast-research-grants-recognition-34750
https://atc.digitellinc.com/p/s/asts-research-grants-recognition-34751
https://atc.digitellinc.com/p/s/introduction-34752
https://atc.digitellinc.com/p/s/award-acceptance-34753
https://atc.digitellinc.com/p/s/what-is-equity-in-organ-transplantation-34754
https://atc.digitellinc.com/p/s/nasem-report-optimizing-quality-and-quantity-of-donated-organs-34755
https://atc.digitellinc.com/p/s/unos-rebuttal-to-nasem-report-34756
https://atc.digitellinc.com/p/s/nasem-rebuttal-34757
https://atc.digitellinc.com/p/s/unos-rebuttal-34758
https://atc.digitellinc.com/p/s/q-and-a-34759
https://atc.digitellinc.com/p/s/the-science-of-pumping-why-machine-perfusion-is-here-to-stay-34760
https://atc.digitellinc.com/p/s/cryopreservation-is-the-future-34761
https://atc.digitellinc.com/p/s/pro-rebuttal-34762
https://atc.digitellinc.com/p/s/con-rebuttal-34763
https://atc.digitellinc.com/p/s/q-and-a-34764
https://atc.digitellinc.com/p/s/t-cell-exhaustion-in-transplant-survival-34765
https://atc.digitellinc.com/p/s/innate-allorecognition-and-memory-in-transplantation-34766
https://atc.digitellinc.com/p/s/q-and-a-34767
https://atc.digitellinc.com/p/s/break-34768
https://atc.digitellinc.com/p/s/the-effects-of-interferon-beta-on-t-cells-in-transplant-34769
https://atc.digitellinc.com/p/s/t-cell-memory-and-transplant-survival-34770
https://atc.digitellinc.com/p/s/implications-of-tigit-plus-human-memory-b-cells-in-immune-regulation-34771
https://atc.digitellinc.com/p/s/q-and-a-34772
https://atc.digitellinc.com/p/s/deep-learning-applications-in-solid-organ-transplantation-and-related-complications-34773
https://atc.digitellinc.com/p/s/ai-in-pathology-what-can-go-rightor-wrong-34774
https://atc.digitellinc.com/p/s/spatial-resolution-of-expression-analysis-in-kidney-transplant-biopsies-34775
https://atc.digitellinc.com/p/s/q-and-a-34776
https://atc.digitellinc.com/p/s/break-34777
https://atc.digitellinc.com/p/s/mass-spectrometry-metabolomics-and-big-data-in-kidney-health-and-disease-34778
https://atc.digitellinc.com/p/s/application-of-deep-learning-in-liver-transplant-histology-34779
https://atc.digitellinc.com/p/s/improving-prediction-of-heart-transplantation-outcome-using-deep-learning-techniques-34780
https://atc.digitellinc.com/p/s/q-and-a-34781
https://atc.digitellinc.com/p/s/financial-and-psychosocial-issues-pre-and-post-transplant-34782
https://atc.digitellinc.com/p/s/are-there-disparities-in-patient-selection-34783
https://atc.digitellinc.com/p/s/do-delays-to-decision-making-impact-outcome-34784
https://atc.digitellinc.com/p/s/q-and-a-34785
https://atc.digitellinc.com/p/s/ptdm-epidemiology-updated-risks-pathophysiology-and-outcome-data-34786
https://atc.digitellinc.com/p/s/future-direction-for-ptdm-knowledge-gaps-controversies-and-research-in-progress-34787
https://atc.digitellinc.com/p/s/proposed-algorithm-for-treatment-hierarchy-for-ptdm-management-using-novel-anti-diabetic-agents-34788
https://atc.digitellinc.com/p/s/q-and-a-34789
https://atc.digitellinc.com/p/s/artificial-intelligence-for-classification-in-transplantation-34790
https://atc.digitellinc.com/p/s/development-validation-and-application-of-decision-aids-in-transplantation-34791
https://atc.digitellinc.com/p/s/strengths-and-weakness-of-machine-learning-in-clinical-transplantation-34792
https://atc.digitellinc.com/p/s/q-and-a-34793
https://atc.digitellinc.com/p/s/implementation-of-a-transplant-hospital-based-donor-recovery-center-34794
https://atc.digitellinc.com/p/s/the-role-of-the-intensivist-and-clinical-donor-management-protocols-34795
https://atc.digitellinc.com/p/s/unique-research-opportunities-facilitated-by-a-drc-34796
https://atc.digitellinc.com/p/s/q-and-a-34797
https://atc.digitellinc.com/p/s/dcd-basics-for-apps-34798
https://atc.digitellinc.com/p/s/q-and-a-34799
https://atc.digitellinc.com/p/s/defining-the-rejectome-using-multi-omic-analysis-and-machine-learning-predictive-models-in-liver-transplantation-34800
https://atc.digitellinc.com/p/s/multi-omic-assessment-of-frailty-in-liver-transplantation-34801
https://atc.digitellinc.com/p/s/q-and-a-34802
https://atc.digitellinc.com/p/s/impact-of-aging-on-the-immune-system-and-its-relevance-to-transplantation-34803
https://atc.digitellinc.com/p/s/cellular-senescence-34804
https://atc.digitellinc.com/p/s/q-and-a-34805
https://atc.digitellinc.com/p/s/pregnancy-induced-humoral-sensitization-and-t-cell-tolerance-34806
https://atc.digitellinc.com/p/s/cd8-t-cell-exhaustion-34807
https://atc.digitellinc.com/p/s/the-unique-immunological-and-microbial-aspects-of-pregnancy-34808
https://atc.digitellinc.com/p/s/q-and-a-34809
https://atc.digitellinc.com/p/s/impact-of-pollutants-34810
https://atc.digitellinc.com/p/s/the-impact-of-the-gut-microbiota-on-the-metabolism-of-immunosuppressive-medications-34811
https://atc.digitellinc.com/p/s/q-and-a-34812
https://atc.digitellinc.com/p/s/immunoregulatory-and-lipid-presentation-pathways-are-upregulated-in-human-face-transplant-rejection-34813
https://atc.digitellinc.com/p/s/single-cell-analysis-of-vca-alloresponses-in-a-mouse-model-of-limb-transplantation-34814
https://atc.digitellinc.com/p/s/targeted-immunosuppression-to-prevent-vca-rejection-34815
https://atc.digitellinc.com/p/s/q-and-a-34816
https://atc.digitellinc.com/p/s/epigenetic-consequences-of-ischemia-reperfusion-injury-34817
https://atc.digitellinc.com/p/s/epigentic-profiling-of-immune-aging-in-infection-and-rejection-34818
https://atc.digitellinc.com/p/s/q-and-a-34819
https://atc.digitellinc.com/p/s/regulatory-t-cells-engineered-with-tcr-signaling-responsive-il-2-nanogels-suppress-alloimmunity-34820
https://atc.digitellinc.com/p/s/regulatory-t-cell-homeostasis-34821
https://atc.digitellinc.com/p/s/sponsor-networking-34822
https://atc.digitellinc.com/p/s/q-and-a-34823
https://atc.digitellinc.com/p/s/development-of-a-validated-culturally-relevant-measure-for-identifying-barriers-in-access-to-kidney-transplantation-34824
https://atc.digitellinc.com/p/s/are-social-support-evaluations-fair-how-to-improve-current-practices-34825
https://atc.digitellinc.com/p/s/a-culturally-tailored-program-for-african-americans-34826
https://atc.digitellinc.com/p/s/how-best-to-assess-the-reversibility-of-tcmr-34827
https://atc.digitellinc.com/p/s/emerging-diagnostic-technologies-playing-a-role-on-rejection-resolution-assessment-34828
https://atc.digitellinc.com/p/s/q-and-a-34829
https://atc.digitellinc.com/p/s/living-liver-donation-is-the-way-to-go-34830
https://atc.digitellinc.com/p/s/q-and-a-34831
https://atc.digitellinc.com/p/s/q-and-a-34832
https://atc.digitellinc.com/p/s/policy-and-heath-system-barriers-to-pediatric-ldlt-in-usa-34833
https://atc.digitellinc.com/p/s/heart-and-vads-all-topics-34834
https://atc.digitellinc.com/p/s/lung-all-topics-34835
https://atc.digitellinc.com/p/s/rebuttal-pro-34836
https://atc.digitellinc.com/p/s/rebuttal-con-34837
https://atc.digitellinc.com/p/s/q-and-a-34838
https://atc.digitellinc.com/p/s/the-devil-you-know-pulmonary-hypertension-in-heart-transplantation-diagnosis-implications-and-management-34839
https://atc.digitellinc.com/p/s/under-pressure-ph-in-interstitial-lung-disease-and-implications-for-lung-transplantation-34840
https://atc.digitellinc.com/p/s/i-cant-get-no-transplantation-portopulmonary-hypertension-screening-diagnosis-treatment-options-and-outcomes-34841
https://atc.digitellinc.com/p/s/q-and-a-34842
https://atc.digitellinc.com/p/s/incidence-and-diagnosis-of-hcc-in-patients-with-congenital-heart-disease-and-fontan-associated-liver-disease-34843
https://atc.digitellinc.com/p/s/challenges-of-intraoperative-planning-and-management-34844
https://atc.digitellinc.com/p/s/combined-heart-liver-transplantation-in-patients-with-hcc-and-congenital-heart-disease-34845
https://atc.digitellinc.com/p/s/q-and-a-34846
https://atc.digitellinc.com/p/s/post-transplant-fsgs-why-it-recurs-and-what-we-can-do-to-prevent-and-treat-it-34847
https://atc.digitellinc.com/p/s/post-transplant-iga-nephropathy-recurrence-and-management-34848
https://atc.digitellinc.com/p/s/post-transplant-membranoproliferative-glomerulonephritis-mpgn-recurrence-and-management-the-pathophysiology-pathology-and-treatment-34849
https://atc.digitellinc.com/p/s/q-and-a-34850
https://atc.digitellinc.com/p/s/setting-the-stage-sex-disparities-and-frailty-in-transplantation-34851
https://atc.digitellinc.com/p/s/pro-could-frailty-assessment-widen-the-sex-gap-in-access-to-transplantation-34852
https://atc.digitellinc.com/p/s/cons-could-frailty-assessment-widen-the-sex-gap-in-access-to-transplantation-34853
https://atc.digitellinc.com/p/s/pro-rebuttal-34854
https://atc.digitellinc.com/p/s/con-rebuttal-34855
https://atc.digitellinc.com/p/s/q-and-a-34856
https://atc.digitellinc.com/p/s/incidence-prevalence-and-challenges-of-pregnancies-on-women-with-end-stage-organ-failure-and-following-transplantation-liver-and-other-organs-34857
https://atc.digitellinc.com/p/s/ethical-issues-surrounding-the-supreme-courts-roe-vs-wade-decision-and-impact-on-transplant-patients-34858
https://atc.digitellinc.com/p/s/legal-background-on-roe-vs-wade-repercussions-for-transplant-professionals-providing-a-framework-for-reproductive-right-discussion-34859
https://atc.digitellinc.com/p/s/q-and-a-34860
https://atc.digitellinc.com/p/s/review-of-the-utility-of-immunotherapy-in-liver-transplant-candidates-34861
https://atc.digitellinc.com/p/s/pro-immunotherapy-can-be-used-safely-in-the-waitlisted-liver-transplant-candidates-34862
https://atc.digitellinc.com/p/s/con-risk-of-allograft-rejection-is-too-high-to-justify-use-in-the-waitlisted-patients-or-post-transplant-population-34863
https://atc.digitellinc.com/p/s/pro-rebuttal-34864
https://atc.digitellinc.com/p/s/con-rebuttal-34865
https://atc.digitellinc.com/p/s/q-and-a-34866
https://atc.digitellinc.com/p/s/patient-focused-potential-infectious-disease-complications-of-xenotransplantation-34867
https://atc.digitellinc.com/p/s/impact-of-xenotransplantation-beyond-the-recipient-the-community-and-the-public-34868
https://atc.digitellinc.com/p/s/ethical-arguments-in-favor-of-continued-and-expanded-xenotransplantation-research-34869
https://atc.digitellinc.com/p/s/ethical-concerns-with-continued-xenotransplantation-research-and-some-ethical-preferable-alternatives-34870
https://atc.digitellinc.com/p/s/scientists-perspective-what-are-the-limits-of-death-34871
https://atc.digitellinc.com/p/s/surgeons-perspective-when-is-it-too-late-for-an-organ-34872
https://atc.digitellinc.com/p/s/ethicists-perspective-when-is-it-ok-to-procure-34873
https://atc.digitellinc.com/p/s/q-and-a-34874
https://atc.digitellinc.com/p/s/which-extra-corporeal-liver-support-for-my-patient-rrt-mars-or-plasma-exchange-34875
https://atc.digitellinc.com/p/s/assessment-of-volume-status-in-the-fluid-overload-critically-ill-patient-with-liver-disease-34876
https://atc.digitellinc.com/p/s/the-alphabet-soup-of-assessment-of-kidney-function-34877
https://atc.digitellinc.com/p/s/q-and-a-34878
https://atc.digitellinc.com/p/s/targeted-delivery-of-immunosuppressive-agents-to-the-graft-endothelium-for-the-prevention-of-rejection-in-lung-transplantation-34879
https://atc.digitellinc.com/p/s/multiphase-assembly-of-small-molecule-microcrystalline-peptide-hydrogel-allows-immunomodulatory-combination-therapy-for-long-term-heart-transplant-survival-34880
https://atc.digitellinc.com/p/s/subcutaneous-nanoparticle-delivery-of-rapamycin-to-antigen-presenting-cells-34881
https://atc.digitellinc.com/p/s/q-and-a-34882
https://atc.digitellinc.com/p/s/lets-remember-in-pancreas-transplantation-the-long-term-benefits-are-there-for-the-taking-34883
https://atc.digitellinc.com/p/s/the-rules-of-the-game-current-unos-policy-requirements-for-spk-listing-34884
https://atc.digitellinc.com/p/s/liberal-criteria-for-spkt-will-increase-adoption-and-benefit-more-patients-optimizing-utilization-of-pancreas-for-all-insulin-dependent-diabetes-patients-34885
https://atc.digitellinc.com/p/s/q-and-a-34886
https://atc.digitellinc.com/p/s/you-better-check-yourself-before-you-wreck-yourself-checkpoint-inhibitors-in-solid-organ-transplant-patients-34887
https://atc.digitellinc.com/p/s/lenalidomide-pomalidomide-and-transplant-consequences-newly-identified-34888
https://atc.digitellinc.com/p/s/giving-regards-to-dmards-and-how-to-manage-concomitant-immunosuppression-34889
https://atc.digitellinc.com/p/s/q-and-a-34890
https://atc.digitellinc.com/p/s/describe-current-center-practice-and-perceptions-regarding-transplant-medication-nonadherence-results-of-a-survey-34891
https://atc.digitellinc.com/p/s/is-pre-transplant-home-based-video-education-effective-results-from-a-multicenter-rct-funded-by-tirn-grant-34892
https://atc.digitellinc.com/p/s/does-non-adherence-to-laboratory-and-clinical-follow-up-impact-medication-nonadherence-34893
https://atc.digitellinc.com/p/s/q-and-a-34894
https://atc.digitellinc.com/p/s/clinical-pearls-letermovir-34895
https://atc.digitellinc.com/p/s/management-of-refractory-cmv-34896
https://atc.digitellinc.com/p/s/personalizing-cmv-treatment-pros-and-pitfalls-of-immune-assays-34897
https://atc.digitellinc.com/p/s/cmv-stewardship-strategies-34898
https://atc.digitellinc.com/p/s/organizational-health-literacy-in-solid-organ-transplant-patient-education-34899
https://atc.digitellinc.com/p/s/patient-centered-education-using-video-and-digital-platform-34900
https://atc.digitellinc.com/p/s/technology-supported-patient-friendly-medication-schedule-and-adherence-tools-34901
https://atc.digitellinc.com/p/s/q-and-a-34902
https://atc.digitellinc.com/p/s/leverage-your-resources-tapping-into-the-ehr-for-pre-transplant-outcomes-monitoring-34903
https://atc.digitellinc.com/p/s/cruisin-for-an-oozin-avoiding-anticoagulation-anguish-in-the-or-34904
https://atc.digitellinc.com/p/s/dont-be-a-pain-planning-ahead-for-surgical-pain-management-in-opioid-tolerant-transplant-candidates-34905
https://atc.digitellinc.com/p/s/q-and-a-34906
https://atc.digitellinc.com/p/s/allocation-modeling-and-equity-in-kidney-continuous-distribution-34907
https://atc.digitellinc.com/p/s/improving-the-metric-for-candidate-hla-sensitization-cpra-34908
https://atc.digitellinc.com/p/s/novel-approaches-for-addressing-disparities-in-access-among-abo-blood-groups-34909
https://atc.digitellinc.com/p/s/q-and-a-34910
https://atc.digitellinc.com/p/s/disparities-in-allocation-of-advanced-heart-failure-therapies-leaving-no-one-behind-34911
https://atc.digitellinc.com/p/s/disparities-in-lung-transplantation-outcomes-how-can-we-do-better-34912
https://atc.digitellinc.com/p/s/measuring-disparities-in-practice-how-can-i-be-a-part-of-the-solution-34913
https://atc.digitellinc.com/p/s/q-and-a-34914
https://atc.digitellinc.com/p/s/equity-vs-utility-in-pediatric-organ-transplantation-34915
https://atc.digitellinc.com/p/s/differences-in-pediatric-prioritization-worldwide-34916
https://atc.digitellinc.com/p/s/the-ipta-position-statement-supporting-prioritizing-pediatric-recipients-for-deceased-donor-allocation-34917
https://atc.digitellinc.com/p/s/q-and-a-34918
https://atc.digitellinc.com/p/s/transplant-pharmacy-10-years-ago-34919
https://atc.digitellinc.com/p/s/how-transplant-pharmacy-has-evolved-34920
https://atc.digitellinc.com/p/s/where-is-transplant-pharmacy-headed-34921
https://atc.digitellinc.com/p/s/q-and-a-34922
https://atc.digitellinc.com/p/s/frailtyis-there-more-than-one-kind-34923
https://atc.digitellinc.com/p/s/challenges-in-listing-and-maintaining-waitlisted-elderly-patients-34924
https://atc.digitellinc.com/p/s/redefining-success-34925
https://atc.digitellinc.com/p/s/q-and-a-34926
https://atc.digitellinc.com/p/s/destination-vad-when-is-the-right-time-for-ventricular-assist-devices-in-congestive-heart-failure-34927
https://atc.digitellinc.com/p/s/destination-dialysis-the-esrd-patient-ineligible-for-kidney-transplant-home-dialysis-therapies-are-the-next-best-option-34928
https://atc.digitellinc.com/p/s/destination-hcc-treatment-ablation-vs-radioembolization-in-the-non-transplantable-hcc-patient-34929
https://atc.digitellinc.com/p/s/q-and-a-34930
https://atc.digitellinc.com/p/s/gender-disparities-in-ldlt-redistributing-the-disproportionate-burden-off-of-women-34931
https://atc.digitellinc.com/p/s/racial-and-ethnic-disparities-what-we-know-dont-know-and-what-we-can-do-about-it-34932
https://atc.digitellinc.com/p/s/financial-and-geographical-barriers-to-ldlt-achieving-equipoise-in-the-sea-of-unseen-minefields-34933
https://atc.digitellinc.com/p/s/q-and-a-34934
https://atc.digitellinc.com/p/s/optimizing-surgical-approach-and-immunosuppression-for-my-pancreas-recipient-34935
https://atc.digitellinc.com/p/s/recipient-selection-does-advancing-age-bmi-and-insulin-dose-really-impact-outcomes-for-pancreas-transplantation-34936
https://atc.digitellinc.com/p/s/donor-selection-how-your-program-can-start-growingincreasing-procurement-confidence-in-the-procuring-surgeon-and-the-recovering-opo-34937
https://atc.digitellinc.com/p/s/q-and-a-34938
https://atc.digitellinc.com/p/s/kidney-function-and-non-renal-solid-organ-transplantation-34939
https://atc.digitellinc.com/p/s/impact-of-pre-heartlung-transplant-egfr-on-post-transplant-renal-function-34940
https://atc.digitellinc.com/p/s/the-pathway-ahead-34941
https://atc.digitellinc.com/p/s/q-and-a-34942
https://atc.digitellinc.com/p/s/how-egfrs-obscure-outcomes-in-transplant-studies-34943
https://atc.digitellinc.com/p/s/how-are-egfrs-derived-and-what-are-they-for-34944
https://atc.digitellinc.com/p/s/the-many-legitimate-uses-of-egfrs-in-transplant-studies-34945
https://atc.digitellinc.com/p/s/q-and-a-34946
https://atc.digitellinc.com/p/s/an-overview-of-ersd-and-transplantation-rates-in-blacks-and-the-status-of-apol1-testing-34947
https://atc.digitellinc.com/p/s/should-potential-african-american-kidney-donors-be-routinely-tested-for-the-apol1-gene-34948
https://atc.digitellinc.com/p/s/is-increased-esrd-risk-in-black-kidney-donors-an-ethical-problem-potential-solutions-34949
https://atc.digitellinc.com/p/s/q-and-a-34950
https://atc.digitellinc.com/p/s/the-ongoing-mental-health-crisis-how-do-we-screen-for-mental-health-disorders-in-adolescent-sot-recipients-34951
https://atc.digitellinc.com/p/s/a-practical-approach-to-screening-for-and-counseling-about-tobacco-marijuana-and-alcohol-use-in-adolescent-solid-organ-transplant-recipients-34952
https://atc.digitellinc.com/p/s/treatment-options-for-sot-recipients-with-mental-health-and-substance-use-disorders-34953
https://atc.digitellinc.com/p/s/q-and-a-34954
https://atc.digitellinc.com/p/s/aclf-vs-decomp-cirrhosis-definitions-and-differences-34955
https://atc.digitellinc.com/p/s/aclf-current-management-and-beyond-34956
https://atc.digitellinc.com/p/s/aclf-in-lt-who-when-and-where-is-the-point-of-futility-34957
https://atc.digitellinc.com/p/s/q-and-a-34958
https://atc.digitellinc.com/p/s/the-obesity-barrier-to-transplant-are-we-shutting-out-too-many-donors-and-recipients-34959
https://atc.digitellinc.com/p/s/pitfalls-and-practices-of-managing-the-obese-transplant-patient-what-should-i-expect-34960
https://atc.digitellinc.com/p/s/effectiveness-of-the-existing-strategies-to-address-obesity-in-living-donors-nutrition-management-noninvasive-medical-therapies-ie-glp1-agonist-orlistat-etc-and-metabolic-surgery-34961
https://atc.digitellinc.com/p/s/q-and-a-34962
https://atc.digitellinc.com/p/s/eating-to-live-nutrition-in-ckd-34963
https://atc.digitellinc.com/p/s/the-meat-of-the-matter-translating-nutritional-science-into-practice-34964
https://atc.digitellinc.com/p/s/pound-for-pound-transplant-bariatrics-and-weight-loss-management-pre-and-post-transplant-34965
https://atc.digitellinc.com/p/s/q-and-a-34966
https://atc.digitellinc.com/p/s/bioengineering-hearts-for-transplant-purposes-34967
https://atc.digitellinc.com/p/s/beta-cells-replacement-via-stem-cell-engineering-34968
https://atc.digitellinc.com/p/s/bioengineering-livers-for-transplant-purposes-34969
https://atc.digitellinc.com/p/s/kidney-bioengineering-regeneration-and-repair-34970
https://atc.digitellinc.com/p/s/pre-and-post-operative-management-adjuvant-therapy-and-immunosuppression-34971
https://atc.digitellinc.com/p/s/how-to-create-a-multidisciplinary-transplant-oncology-program-34972
https://atc.digitellinc.com/p/s/the-need-for-a-national-registry-of-liver-transplantation-for-non-standard-oncological-indications-34973
https://atc.digitellinc.com/p/s/q-and-a-34974
https://atc.digitellinc.com/p/s/creating-supportive-professional-cultures-strategies-for-effective-leadership-34975
https://atc.digitellinc.com/p/s/work-system-redesign-in-the-real-world-center-level-initiatives-to-create-sustainable-workflows-34976
https://atc.digitellinc.com/p/s/policy-advocacy-and-payers-a-paradigm-shift-to-include-clinician-outcomes-34977
https://atc.digitellinc.com/p/s/q-and-a-34978
https://atc.digitellinc.com/p/s/true-blood-rejection-surveillance-modalities-an-overview-34979
https://atc.digitellinc.com/p/s/pro-shine-the-light-on-dracula-34980
https://atc.digitellinc.com/p/s/con-we-vampires-never-die-34981
https://atc.digitellinc.com/p/s/rebuttal-pro-34982
https://atc.digitellinc.com/p/s/rebuttal-con-34983
https://atc.digitellinc.com/p/s/q-and-a-34984
https://atc.digitellinc.com/p/s/why-have-kidney-non-utilization-rates-sharply-increased-since-2021-34985
https://atc.digitellinc.com/p/s/lung-utilization-current-status-and-opportunities-to-reduce-non-use-34986
https://atc.digitellinc.com/p/s/novel-strategies-to-minimize-liver-non-use-34987
https://atc.digitellinc.com/p/s/q-and-a-34988
https://atc.digitellinc.com/p/s/oldie-but-a-goodie-creatinine-based-gfr-in-advanced-hf-34989
https://atc.digitellinc.com/p/s/new-kids-on-the-block-cystatin-c-and-nuclear-gfr-role-in-fine-tuning-renal-function-assessment-34990
https://atc.digitellinc.com/p/s/it-takes-two-to-feel-safe-when-will-we-need-a-kidney-with-the-heart-34991
https://atc.digitellinc.com/p/s/q-and-a-34992
https://atc.digitellinc.com/p/s/monitoring-for-graft-versus-host-disease-in-solid-organ-transplant-make-it-a-routine-34993
https://atc.digitellinc.com/p/s/utility-of-blood-chimerism-for-monitoring-and-detection-of-graft-versus-host-disease-in-sot-34994
https://atc.digitellinc.com/p/s/hsct-as-salvage-therapy-in-sot-recipients-34995
https://atc.digitellinc.com/p/s/q-and-a-34996
https://atc.digitellinc.com/p/s/managing-regulatory-aspects-of-transplantation-34997
https://atc.digitellinc.com/p/s/managing-critical-financial-issues-in-transplantation-the-medicare-cost-report-34998
https://atc.digitellinc.com/p/s/managing-a-transplant-team-through-a-crisis-34999
https://atc.digitellinc.com/p/s/q-and-a-35000
https://atc.digitellinc.com/p/s/complement-regulation-in-the-immune-system-and-organ-transplantation-35001
https://atc.digitellinc.com/p/s/multiple-roles-of-complement-system-in-transplantation-35002
https://atc.digitellinc.com/p/s/a-novel-injury-site-directed-complement-inhibitor-in-lung-transplantation-35003
https://atc.digitellinc.com/p/s/q-and-a-35004
https://atc.digitellinc.com/p/s/impact-of-bk-virus-on-renal-transplant-recipients-35005
https://atc.digitellinc.com/p/s/update-on-international-bkv-guidelines-by-the-tts-consensus-group-35006
https://atc.digitellinc.com/p/s/overview-of-therapies-in-development-for-the-treatment-of-bk-viremia-in-renal-transplant-patients-35007
https://atc.digitellinc.com/p/s/q-and-a-35008
https://atc.digitellinc.com/p/s/designing-and-implementing-human-clinical-trials-in-xenotransplantation-35009
https://atc.digitellinc.com/p/s/infectious-diseases-surveillance-in-human-clinical-trials-in-xenotransplantation-35010
https://atc.digitellinc.com/p/s/regulatory-and-scientific-preparation-for-human-clinical-trials-in-xenotransplantation-35011
https://atc.digitellinc.com/p/s/q-and-a-35012
https://atc.digitellinc.com/p/s/the-impact-of-tobacco-alcohol-and-other-substance-use-on-transplant-eligibility-and-outcomes-35013
https://atc.digitellinc.com/p/s/treatment-options-for-alcohol-use-disorders-prior-to-and-following-liver-transplantation-and-challenges-engaging-patients-in-care-35014
https://atc.digitellinc.com/p/s/evolving-practices-in-engaging-patients-in-alcohol-treatment-following-liver-transplantation-35015
https://atc.digitellinc.com/p/s/q-and-a-35016
https://atc.digitellinc.com/p/s/identification-of-acceptable-risk-in-hla-incompatible-transplantation-surgical-viewpoint-35017
https://atc.digitellinc.com/p/s/identification-of-acceptable-risk-in-hla-incompatible-transplantation-clinical-viewpoint-35018
https://atc.digitellinc.com/p/s/histocompatibility-tools-to-define-risk-in-hla-incompatible-transplantation-35019
https://atc.digitellinc.com/p/s/q-and-a-35020
https://atc.digitellinc.com/p/s/setting-the-stage-35021
https://atc.digitellinc.com/p/s/role-of-virus-specific-t-cells-in-sot-knowns-pro-35022
https://atc.digitellinc.com/p/s/role-of-virus-specific-t-cells-in-sot-unknowns-con-35023
https://atc.digitellinc.com/p/s/rebuttal-pro-35024
https://atc.digitellinc.com/p/s/rebuttal-con-35025
https://atc.digitellinc.com/p/s/q-and-a-35026
https://atc.digitellinc.com/p/s/tcr-sequencing-of-biopsies-for-diagnosing-rejection-35027
https://atc.digitellinc.com/p/s/non-invasive-diagnosis-of-rejections-in-blood-and-urine-by-monitoring-donor-reactive-t-cell-clones-35028
https://atc.digitellinc.com/p/s/monitoring-tolerance-through-high-throughput-tcr-sequencing-35029
https://atc.digitellinc.com/p/s/q-and-a-35030
https://atc.digitellinc.com/p/s/deceased-after-cardiac-death-donors-and-pediatric-candidates-an-opportunity-to-expand-the-donor-pool-35031
https://atc.digitellinc.com/p/s/pediatric-donors-for-pediatric-recipients-time-for-a-reassessment-35032
https://atc.digitellinc.com/p/s/whats-the-risk-of-increased-risk-use-of-phs-increased-risk-donors-in-pediatric-transplantation-35033
https://atc.digitellinc.com/p/s/q-and-a-35034
https://atc.digitellinc.com/p/s/best-practices-in-applying-machine-learning-in-human-immunogenetics-and-complex-immunogenomic-data-mining-35035
https://atc.digitellinc.com/p/s/hla-amino-acid-mismatch-based-risk-stratification-of-kidney-graft-failure-using-a-novel-machine-learning-approach-35036
https://atc.digitellinc.com/p/s/predicting-transplant-outcome-with-machine-learning-35037
https://atc.digitellinc.com/p/s/q-and-a-35038
https://atc.digitellinc.com/p/s/predictive-analytics-tools-and-calculators-for-evidence-based-decision-making-35039
https://atc.digitellinc.com/p/s/what-role-should-procurement-biopsies-have-in-kidney-utilization-decisions-35040
https://atc.digitellinc.com/p/s/patient-specific-mortality-and-time-to-next-offer-predictions-to-aid-decision-making-the-optns-donornet-predictive-analytics-project-35041
https://atc.digitellinc.com/p/s/q-and-a-35042
https://atc.digitellinc.com/p/s/establishing-an-argument-for-abdominal-nrp-dcd-transplant-a-review-of-the-ethics-costs-outcomes-35043
https://atc.digitellinc.com/p/s/assembling-the-abdominal-nrp-dcd-team-and-gaining-institutional-buy-in-35044
https://atc.digitellinc.com/p/s/the-opo-perspective-on-abdominal-nrp-dcd-logistics-outreach-and-hospital-standardization-35045
https://atc.digitellinc.com/p/s/q-and-a-35046
https://atc.digitellinc.com/p/s/five-years-of-uterus-transplantation-in-the-us-how-did-we-get-from-a-research-endeavor-to-a-clinical-option-35047
https://atc.digitellinc.com/p/s/the-practical-ethics-of-uterus-transplantation-cost-utilization-of-resources-inherent-bias-35048
https://atc.digitellinc.com/p/s/how-do-you-start-a-uterus-transplant-program-logistics-barriers-and-pitfalls-35049
https://atc.digitellinc.com/p/s/q-and-a-35050
https://atc.digitellinc.com/p/s/a-path-to-building-a-national-hla-epitope-matching-strategy-35051
https://atc.digitellinc.com/p/s/a-comparison-of-the-different-tools-used-for-modern-calculation-of-hla-mismatches-35052
https://atc.digitellinc.com/p/s/down-to-the-details-potential-pitfalls-and-limitations-of-hla-epitope-matching-35053
https://atc.digitellinc.com/p/s/q-and-a-35054
https://atc.digitellinc.com/p/s/introduction-definitions-terms-pronouns-35055
https://atc.digitellinc.com/p/s/approach-to-care-of-transgender-patient-35056
https://atc.digitellinc.com/p/s/potential-challenges-in-transplant-medication-management-and-implications-of-sex-on-drug-dosing-in-this-population-35057
https://atc.digitellinc.com/p/s/q-and-a-35058
https://atc.digitellinc.com/p/s/increasing-the-donor-pool-utilizing-normothermic-regional-perfusion-in-donation-after-cardiac-death-35059
https://atc.digitellinc.com/p/s/current-status-and-future-directions-of-hypothermic-oxygenated-machine-perfusion-35060
https://atc.digitellinc.com/p/s/can-we-decrease-ischemic-cholangiopathy-in-dcd-with-normothermic-machine-perfusion-35061
https://atc.digitellinc.com/p/s/q-and-a-35062
https://atc.digitellinc.com/p/s/health-disparities-in-transplant-among-latinxhispanic-populations-35063
https://atc.digitellinc.com/p/s/trends-in-gender-disparities-in-transplant-access-and-outcomes-35064
https://atc.digitellinc.com/p/s/the-multi-level-perspective-of-disparities-in-liver-transplantation-35065
https://atc.digitellinc.com/p/s/q-and-a-35066
https://atc.digitellinc.com/p/s/why-should-we-pursue-dcd-liver-transplant-how-do-you-get-buy-in-from-the-surgeons-the-hepatologists-and-the-patients-35067
https://atc.digitellinc.com/p/s/opos-role-in-dcd-procurement-35068
https://atc.digitellinc.com/p/s/improving-program-efficiency-by-removing-logistic-barriers-and-lowering-costs-for-dcd-livers-35069
https://atc.digitellinc.com/p/s/q-and-a-35070
https://atc.digitellinc.com/p/s/disparity-in-access-to-intestinal-rehabilitation-centers-35071
https://atc.digitellinc.com/p/s/disparity-in-access-to-tpn-35072
https://atc.digitellinc.com/p/s/disparity-and-best-practice-of-intestine-transplant-35073
https://atc.digitellinc.com/p/s/q-and-a-35074
https://atc.digitellinc.com/p/s/sarcopenia-and-anthropometrics-definitions-and-measurements-35075
https://atc.digitellinc.com/p/s/anthropometrics-use-in-the-intestinal-failure-population-35076
https://atc.digitellinc.com/p/s/anthropometrics-in-the-intestinal-transplant-population-35077
https://atc.digitellinc.com/p/s/q-and-a-35078
https://atc.digitellinc.com/p/s/the-impact-of-telomere-length-in-thoracic-transplantation-35079
https://atc.digitellinc.com/p/s/the-shortest-path-may-not-be-the-right-one-the-comprehensive-management-of-a-lung-transplant-patient-with-short-telomere-syndrome-35080
https://atc.digitellinc.com/p/s/infectious-complications-in-the-patient-with-short-telomeres-35081
https://atc.digitellinc.com/p/s/q-and-a-35082
https://atc.digitellinc.com/p/s/systemic-factors-contributing-to-workforce-decline-35083
https://atc.digitellinc.com/p/s/changing-the-face-of-mental-health-in-health-care-providers-35084
https://atc.digitellinc.com/p/s/recognizing-and-preventing-burnout-35085
https://atc.digitellinc.com/p/s/q-and-a-35086
https://atc.digitellinc.com/p/s/management-of-the-high-dsa-patient-35087
https://atc.digitellinc.com/p/s/balancing-rejection-and-infection-risk-35088
https://atc.digitellinc.com/p/s/how-to-apply-biomarkers-in-itmvt-going-forward-35089
https://atc.digitellinc.com/p/s/q-and-a-35090
https://atc.digitellinc.com/p/s/creating-online-educational-resources-for-transplant-id-35091
https://atc.digitellinc.com/p/s/using-podcasts-as-a-teaching-tool-35092
https://atc.digitellinc.com/p/s/developing-a-curriculum-for-a-transplant-id-fellowship-program-35093
https://atc.digitellinc.com/p/s/q-and-a-35094
https://atc.digitellinc.com/p/s/gaps-in-histocompatibility-testing-between-human-allotransplantation-and-xenotransplantation-35095
https://atc.digitellinc.com/p/s/an-overview-of-human-allo-immune-effector-mechanisms-with-potential-for-xeno-immune-reactivity-35096
https://atc.digitellinc.com/p/s/the-role-hla-lab-in-clinical-xenotransplantation-35097
https://atc.digitellinc.com/p/s/q-and-a-35098
https://atc.digitellinc.com/p/s/update-on-hiv-to-hiv-liver-and-kidney-transplantation-35099
https://atc.digitellinc.com/p/s/update-on-hiv-to-hiv-thoracic-organ-transplantation-35100
https://atc.digitellinc.com/p/s/the-future-of-hiv-to-hiv-transplantation-living-donors-and-regulatory-issues-35101
https://atc.digitellinc.com/p/s/q-and-a-35102
https://atc.digitellinc.com/p/s/setting-the-stage-common-infections-in-sot-recipients-35103
https://atc.digitellinc.com/p/s/pro-why-shorter-is-better-35104
https://atc.digitellinc.com/p/s/con-is-it-better-to-safe-than-sorry-35105
https://atc.digitellinc.com/p/s/rebuttal-pro-35106
https://atc.digitellinc.com/p/s/rebuttal-con-35107
https://atc.digitellinc.com/p/s/q-and-a-35108
https://atc.digitellinc.com/p/s/overview-of-living-donor-follow-up-in-the-us-35109
https://atc.digitellinc.com/p/s/pro-changing-the-follow-up-paradigm-building-a-collaboration-centers-donors-and-the-srtr-though-the-living-donor-collective-35110
https://atc.digitellinc.com/p/s/con-great-expectations-lead-to-great-disappointments-need-donors-engagement-as-key-stakeholders-35111
https://atc.digitellinc.com/p/s/rebuttal-pro-35112
https://atc.digitellinc.com/p/s/rebuttal-con-35113
https://atc.digitellinc.com/p/s/q-and-a-35114
https://atc.digitellinc.com/p/s/santa-ana-winds-valley-fever-and-beyond-35115
https://atc.digitellinc.com/p/s/the-plague-is-coming-changing-patters-of-vector-borne-illness-in-transplantation-35116
https://atc.digitellinc.com/p/s/seasons-change-is-viral-seasonality-changing-too-35117
https://atc.digitellinc.com/p/s/q-and-a-35118
https://atc.digitellinc.com/p/s/the-best-use-of-end-of-chain-kidneys-is-to-remain-with-the-exchange-35119
https://atc.digitellinc.com/p/s/the-best-use-of-end-of-chain-kidneys-is-to-be-allocated-through-unos-35120
https://atc.digitellinc.com/p/s/end-of-chain-kidneys-should-stay-with-the-donors-center-of-record-35121
https://atc.digitellinc.com/p/s/q-and-a-35122
https://atc.digitellinc.com/p/s/covid-19-treatments-in-transplant-recipients-35123
https://atc.digitellinc.com/p/s/covid-19-vaccination-and-preventative-strategies-35124
https://atc.digitellinc.com/p/s/monkeypox-and-sot-recipients-35125
https://atc.digitellinc.com/p/s/q-and-a-35126
https://atc.digitellinc.com/p/s/organ-size-matching-in-pediatric-liver-transplantation-size-matched-donors-vs-split-liver-transplantation-35127
https://atc.digitellinc.com/p/s/organ-size-matching-in-pediatric-kidney-transplantation-time-to-reconsider-utilizing-pediatric-kidneys-35128
https://atc.digitellinc.com/p/s/allocation-challenges-in-pediatric-kidney-transplantation-changes-that-can-help-prioritize-patients-35129
https://atc.digitellinc.com/p/s/q-and-a-35130
https://atc.digitellinc.com/p/s/limiting-immunosuppression-related-side-effects-what-is-the-current-state-of-tolerance-protocols-for-vca-recipients-35131
https://atc.digitellinc.com/p/s/avoiding-chronic-rejection-the-status-of-cell-based-therapies-engineered-scaffolds-and-3-d-bioprinting-in-vca-transplant-35132
https://atc.digitellinc.com/p/s/dealing-with-graft-loss-in-vca-transplant-what-the-alternative-treatment-options-and-what-are-the-reconstruction-contingency-plans-35133
https://atc.digitellinc.com/p/s/q-and-a-35134
https://atc.digitellinc.com/p/s/selection-and-outcomes-35135
https://atc.digitellinc.com/p/s/balancing-chemotherapy-and-immunosuppression-35136
https://atc.digitellinc.com/p/s/lessons-learned-in-a-high-volume-center-35137
https://atc.digitellinc.com/p/s/q-and-a-35138
https://atc.digitellinc.com/p/s/use-of-car-t-therapy-in-solid-organ-transplant-recipients-with-refractory-posttransplant-lymphoproliferative-disorder-35139
https://atc.digitellinc.com/p/s/tregs-to-treat-gvhd-35140
https://atc.digitellinc.com/p/s/use-of-polyfunctional-car-t-cells-targeting-glypican-3-to-eliminate-hepatocellular-carcinoma-35141
https://atc.digitellinc.com/p/s/q-and-a-35142
https://atc.digitellinc.com/p/s/a-large-problem-in-transplant-the-obesity-epidemic-35143
https://atc.digitellinc.com/p/s/not-so-sweet-diabetes-in-transplant-patients-35144
https://atc.digitellinc.com/p/s/the-heart-of-the-matter-cardiovascular-disease-in-transplant-35145
https://atc.digitellinc.com/p/s/q-and-a-35146
https://atc.digitellinc.com/p/s/optimizing-readiness-interventions-to-support-self-management-skills-in-transition-to-adult-transplant-care-35147
https://atc.digitellinc.com/p/s/from-here-to-there-outcome-parameters-to-monitor-successful-transition-in-transplant-35148
https://atc.digitellinc.com/p/s/does-transition-end-at-transfer-strategies-to-promote-a-collaborative-partnership-between-the-young-adult-and-the-adult-provider-35149
https://atc.digitellinc.com/p/s/q-and-a-35150
https://atc.digitellinc.com/p/s/looking-for-zebras-assessing-for-atypical-infections-after-transplant-35151
https://atc.digitellinc.com/p/s/tough-bugs-multi-drug-resistant-organisms-and-treatment-strategies-35152
https://atc.digitellinc.com/p/s/barriers-strategies-and-interventions-to-address-underimmunization-in-transplant-recipients-35153
https://atc.digitellinc.com/p/s/q-and-a-35154
https://atc.digitellinc.com/p/s/prima-facie-the-role-of-opo-transplant-center-donor-hospital-partnerships-in-maximizing-opportunities-in-donor-intervention-research-and-maintaining-public-trust-35155
https://atc.digitellinc.com/p/s/justice-and-autonomy-implications-and-strategies-for-informed-consent-for-donor-intervention-research-in-the-current-organ-allocation-system-35156
https://atc.digitellinc.com/p/s/beneficence-and-nonmaleficence-establishing-a-scientific-base-for-improving-recipient-outcomes-through-donor-intervention-research-and-navigating-the-current-regulatory-landscape-35157
https://atc.digitellinc.com/p/s/q-and-a-35158
https://atc.digitellinc.com/p/s/advanced-nanocarriers-for-ischemia-mitigation-and-prolonged-ex-vivo-organ-transplant-preservation-35159
https://atc.digitellinc.com/p/s/advances-in-transplant-targeted-immunosuppression-using-nanotechnology-strategies-35160
https://atc.digitellinc.com/p/s/nanobiomaterials-for-transplant-immunomodulation-potential-and-promise-35161
https://atc.digitellinc.com/p/s/q-and-a-35162
https://atc.digitellinc.com/p/s/q-and-a-35163
https://atc.digitellinc.com/p/s/break-35164
https://atc.digitellinc.com/p/s/the-case-for-simultaneous-heartkidney-transplant-pros-vs-safety-netsequential-transplant-35165
https://atc.digitellinc.com/p/s/the-case-for-safety-netsequential-heart-and-kidney-transplant-35166
https://atc.digitellinc.com/p/s/multi-disciplinary-care-of-pediatric-multiple-sot-recipients-35167
https://atc.digitellinc.com/p/s/q-and-a-35168
https://atc.digitellinc.com/p/s/role-of-genetic-testing-in-kidney-transplantation-predicting-recurrence-tailoring-therapy-35169
https://atc.digitellinc.com/p/s/evaluation-of-genetic-kidney-diseases-in-living-donor-candidates-when-related-recipient-diagnosis-is-known-eg-adpkd-col4-nephropathies-fabry-disease-35170
https://atc.digitellinc.com/p/s/assessment-of-genetic-disease-in-living-donor-candidates-without-an-established-diagnosis-in-their-related-recipients-35171
https://atc.digitellinc.com/p/s/interpreting-genetic-test-reports-and-counseling-transplant-recipients-and-living-donors-35172
https://atc.digitellinc.com/p/s/q-and-a-35173
https://atc.digitellinc.com/p/s/break-35174
https://atc.digitellinc.com/p/s/how-to-use-or-not-information-on-apol1-biallelic-variants-35175
https://atc.digitellinc.com/p/s/the-renal-genetics-clinic-promoting-genomics-education-in-nephrology-and-transplantation-35176
https://atc.digitellinc.com/p/s/polygenic-risk-scores-for-kidney-transplant-outcomes-are-they-ready-for-prime-time-35177
https://atc.digitellinc.com/p/s/transplant-genetics-ethical-legal-and-social-implications-35178
https://atc.digitellinc.com/p/s/q-and-a-35179
https://atc.digitellinc.com/p/s/come-together-right-now-heart-liver-transplantation-medical-perspective-35180
https://atc.digitellinc.com/p/s/come-together-right-now-heart-liver-transplantation-surgical-perspective-35181
https://atc.digitellinc.com/p/s/with-a-little-help-from-my-friends-lung-liver-transplantation-medical-perspective-35182
https://atc.digitellinc.com/p/s/with-a-little-help-from-my-friends-lung-liver-transplantation-surgical-perspective-35183
https://atc.digitellinc.com/p/s/q-and-a-35184
https://atc.digitellinc.com/p/s/break-35185
https://atc.digitellinc.com/p/s/stand-by-me-lung-kidney-transplantation-medical-perspective-35186
https://atc.digitellinc.com/p/s/stand-by-me-lung-kidney-transplantation-surgical-perspective-35187
https://atc.digitellinc.com/p/s/take-a-chance-on-me-immunologic-considerations-and-immunosuppression-strategies-in-dual-organ-transplantation-35188
https://atc.digitellinc.com/p/s/in-all-fairness-ethical-considerations-in-high-risk-dual-organ-transplantation-35189
https://atc.digitellinc.com/p/s/q-and-a-35190
https://atc.digitellinc.com/p/s/essential-building-blocks-of-transplant-pharmacy-models-35191
https://atc.digitellinc.com/p/s/strategic-growth-of-a-transplant-pharmacy-team-making-a-compelling-case-to-the-c-suite-35192
https://atc.digitellinc.com/p/s/dont-take-on-more-than-you-can-prescribe-balancing-wellness-with-expansion-35193
https://atc.digitellinc.com/p/s/pre-transplant-pharmacy-adherence-clinic-impact-on-listing-and-transplantation-35194
https://atc.digitellinc.com/p/s/q-and-a-35195
https://atc.digitellinc.com/p/s/break-35196
https://atc.digitellinc.com/p/s/utilization-of-a-transplant-pharmacy-collaborative-agreement-cpa-to-optimize-care-for-patients-and-financial-success-for-the-institution-35197
https://atc.digitellinc.com/p/s/growing-up-how-to-successfully-transition-pediatric-transplant-recipients-to-the-adult-transplant-world-35198
https://atc.digitellinc.com/p/s/we-can-do-it-pharmacists-take-on-post-transplant-diabetes-mellitus-35199
https://atc.digitellinc.com/p/s/transplant-pharmacy-triumphs-in-the-covid-era-vaccines-antivirals-and-antibodies-35200
https://atc.digitellinc.com/p/s/q-and-a-35201
https://atc.digitellinc.com/p/s/transplant-id-ready-for-prime-time-35202
https://atc.digitellinc.com/p/s/fungal-biomarkers-are-they-reliable-35203
https://atc.digitellinc.com/p/s/multiple-multiplex-pcrs-how-much-is-too-much-35204
https://atc.digitellinc.com/p/s/therapeutic-drug-monitoring-in-antifungals-when-is-it-needed-35205
https://atc.digitellinc.com/p/s/q-and-a-35206
https://atc.digitellinc.com/p/s/break-35207
https://atc.digitellinc.com/p/s/are-there-unintended-impacts-of-broad-spectrum-antibiotics-pre-liver-transplant-35208
https://atc.digitellinc.com/p/s/do-antibiotics-in-mcsvad-patients-impact-heart-transplant-outcomes-35209
https://atc.digitellinc.com/p/s/antifungal-prophylaxis-and-lung-transplant-together-forever-35210
https://atc.digitellinc.com/p/s/candida-and-mold-prophylaxis-in-liver-transplant-how-long-is-long-enough-35211
https://atc.digitellinc.com/p/s/q-and-a-35212
https://atc.digitellinc.com/p/s/do-we-need-a-ldlt-program-at-our-institution-35213
https://atc.digitellinc.com/p/s/searching-for-a-donor-donor-champion-donor-ambassador-outreach-and-marketing-35214
https://atc.digitellinc.com/p/s/non-directed-donors-special-considerations-and-practices-35215
https://atc.digitellinc.com/p/s/strategies-to-meet-unos-regulations-for-donor-follow-up-35216
https://atc.digitellinc.com/p/s/q-and-a-35217
https://atc.digitellinc.com/p/s/break-35218
https://atc.digitellinc.com/p/s/advanced-practice-providers-in-living-donation-models-for-pre-donation-care-35219
https://atc.digitellinc.com/p/s/advanced-practice-providers-in-living-donation-models-for-perioperative-care-35220
https://atc.digitellinc.com/p/s/advanced-practice-providers-in-living-donation-models-for-post-donation-and-long-term-care-35221
https://atc.digitellinc.com/p/s/q-and-a-35222
https://atc.digitellinc.com/p/s/ta-nrp-current-clinical-evidence-and-recent-advances-35223
https://atc.digitellinc.com/p/s/ethics-of-nrp-35224
https://atc.digitellinc.com/p/s/expanding-access-to-donor-livers-with-machine-perfusion-services-overcoming-challenges-and-developing-solutions-35225
https://atc.digitellinc.com/p/s/q-and-a-35226
https://atc.digitellinc.com/p/s/break-35227
https://atc.digitellinc.com/p/s/expanding-access-to-donor-hearts-with-machine-perfusion-overcoming-challenges-and-developing-solutions-35228
https://atc.digitellinc.com/p/s/expanding-access-to-donor-lungs-with-machine-perfusion-services-overcoming-challenges-and-developing-solutions-35229
https://atc.digitellinc.com/p/s/machine-perfusion-lessons-learned-from-european-practices-35230
https://atc.digitellinc.com/p/s/experience-of-more-than-1000-livers-on-the-ocs-what-has-been-achieved-so-far-and-the-next-steps-35231
https://atc.digitellinc.com/p/s/q-and-a-35232
https://atc.digitellinc.com/p/s/utilizing-genome-wide-datasets-for-stratification-of-allograft-rejection-risk-using-prs-35233
https://atc.digitellinc.com/p/s/primary-kidney-disease-and-post-transplant-recurrence-risk-assessment-using-prs-35234
https://atc.digitellinc.com/p/s/polygenic-eplet-mismatch-scoring-in-post-transplant-outcomes-35235
https://atc.digitellinc.com/p/s/eplet-matching-as-a-tool-for-risk-stratification-in-donor-organ-acceptance-35236
https://atc.digitellinc.com/p/s/q-and-a-35237
https://atc.digitellinc.com/p/s/break-35238
https://atc.digitellinc.com/p/s/combining-hla-and-non-hla-prs-for-assessing-allograft-survival-35239
https://atc.digitellinc.com/p/s/risk-stratification-for-post-transplant-diabetes-using-donor-and-recipient-type-2-diabetes-prs-35240
https://atc.digitellinc.com/p/s/advancing-polygenic-risk-scores-in-kidney-transplantation-donors-and-recipients-towards-the-individual-patient-35241
https://atc.digitellinc.com/p/s/engineering-functional-polymorphisms-into-human-cells-using-crispr-cas9-35242
https://atc.digitellinc.com/p/s/q-and-a-35243
https://atc.digitellinc.com/p/s/approach-to-the-living-liver-donor-with-steatosis-35244
https://atc.digitellinc.com/p/s/approach-to-the-donor-with-complex-vasculature-duplicate-portal-veins-and-multiple-arteries-35245
https://atc.digitellinc.com/p/s/approach-to-the-living-donor-with-psychosocial-and-socioeconomic-challenges-what-is-acceptable-and-safe-35246
https://atc.digitellinc.com/p/s/q-and-a-35247
https://atc.digitellinc.com/p/s/break-35248
https://atc.digitellinc.com/p/s/considering-a-previous-kidney-donor-as-a-living-liver-donor-35249
https://atc.digitellinc.com/p/s/approach-to-non-directed-living-liver-donors-individually-and-as-a-program-35250
https://atc.digitellinc.com/p/s/the-donor-with-multiple-bile-ducts-best-to-abort-or-clinical-opportunity-35251
https://atc.digitellinc.com/p/s/q-and-a-35252
https://atc.digitellinc.com/p/s/deliberate-crossing-of-blood-group-compatibility-35253
https://atc.digitellinc.com/p/s/universal-blood-type-lungs-35254
https://atc.digitellinc.com/p/s/blood-group-conversions-donor-kidneys-35255
https://atc.digitellinc.com/p/s/panel-discussion-35256
https://atc.digitellinc.com/p/s/welcome-35257
https://atc.digitellinc.com/p/s/welcome-35258
https://atc.digitellinc.com/p/s/long-term-nationwide-outcomes-of-solid-organ-transplantation-from-covid-positive-donors-in-the-united-states-35259
https://atc.digitellinc.com/p/s/single-cell-transcriptomic-analysis-of-renal-allograft-rejection-reveals-novel-insights-into-intra-graft-tcr-clonality-35260
https://atc.digitellinc.com/p/s/race-free-egfr-equation-in-kidney-recipients-a-development-and-validation-study-nct05229939-35261
https://atc.digitellinc.com/p/s/perturbation-of-the-immunomodulatory-properties-of-lymphatic-vessels-is-a-feature-of-chronic-rejection-in-human-kidney-transplants-35262
https://atc.digitellinc.com/p/s/impact-of-different-assumptions-to-address-the-impact-of-covid-19-on-transplant-center-measured-performance-35263
https://atc.digitellinc.com/p/s/relevance-of-the-banff-human-organ-transplant-consensus-gene-panel-for-detecting-antibody-and-t-cell-mediated-rejection-of-kidney-allografts-35264
https://atc.digitellinc.com/p/s/enzymatic-conversion-of-human-blood-group-a-kidneys-to-universal-blood-group-o-35265
https://atc.digitellinc.com/p/s/regulatory-dendritic-cell-therapy-in-humans-safely-modulates-peripheral-and-allograft-immune-reactivity-after-liver-transplantation-35266
https://atc.digitellinc.com/p/s/infections-after-kidney-transplantation-from-donors-with-hiv-to-recipients-with-hiv-results-from-the-multicenter-hope-in-action-study-35267
https://atc.digitellinc.com/p/s/multiscale-genetic-architecture-of-donor-recipient-differences-reveals-intronic-lims1-locus-mismatches-associated-with-long-term-renal-transplant-survival-35268
https://atc.digitellinc.com/p/s/pilot-open-randomized-multicenter-trial-for-the-comparison-of-hypothermic-versus-normothermic-ex-situ-liver-preservation-in-dcd-liver-transplantation-with-extended-ischemia-time-dcdnet-trial-35269
https://atc.digitellinc.com/p/s/experimental-evidence-of-the-essential-role-of-pulmonary-lymphatics-and-their-expression-of-ltbr-in-protection-against-development-of-chronic-lung-allograft-dysfunction-clad-35270
https://atc.digitellinc.com/p/s/pd1-plus-t-cells-are-potential-mediators-andor-markers-of-survival-with-native-liver-in-pediatric-acute-liver-failure-35271
https://atc.digitellinc.com/p/s/graft-derived-interleukin-33-drives-recipient-t-lymphocyte-recovery-after-antibody-mediated-lymphoablation-35272
https://atc.digitellinc.com/p/s/renal-failure-and-mortality-after-heart-alone-transplant-in-recipients-with-egfr-and-6040mlmin-or-on-dialysis-in-the-united-states-35273
https://atc.digitellinc.com/p/s/mthfd2-ablation-in-t-cells-protects-against-heart-transplant-rejection-by-perturbing-irf4-expression-through-an-epigenetic-mechanism-involving-histone-methylation-35274
https://atc.digitellinc.com/p/s/introduction-35275
https://atc.digitellinc.com/p/s/presidential-address-35276
https://atc.digitellinc.com/p/s/introduction-35277
https://atc.digitellinc.com/p/s/presidential-address-35278
https://atc.digitellinc.com/p/s/a-pilot-study-evaluating-dual-co-stimulation-blockade-with-dazodalibep-hzn4920-and-belatacept-for-prophylaxis-of-kidney-allograft-rejection-35279
https://atc.digitellinc.com/p/s/treg-modulation-with-cd28-and-il-6-receptor-antagonists-in-kidney-transplant-recipients-results-of-ctot-24-a-prospective-clinical-trial-35280
https://atc.digitellinc.com/p/s/a-phase-2-randomized-controlled-trial-of-anti-cmv-monoclonal-antibody-fiztasovimab-to-prevent-cmv-infection-in-kidney-transplant-recipients-the-lionheart21-study-35281
https://atc.digitellinc.com/p/s/double-lung-transplant-registry-aimed-for-lung-limited-malignancies-dream-a-prospective-registry-study-for-double-lung-transplantation-for-medically-refractory-cancers-limited-to-the-lungs-35282
https://atc.digitellinc.com/p/s/impact-of-sodium-glucose-cotransporter-2-inhibitor-sglt2i-use-in-kidney-transplant-recipients-35283
https://atc.digitellinc.com/p/s/multistep-algorithm-to-achieve-weight-loss-goal-in-advanced-stage-obesity-kidney-transplant-candidates-a-single-center-interval-report-35284
https://atc.digitellinc.com/p/s/cell-type-specific-expression-of-the-common-rejection-module-revealed-by-single-cell-transcriptomics-in-small-airway-brushes-of-lung-transplant-recipients-35285
https://atc.digitellinc.com/p/s/discrepancies-in-reported-outcomes-between-national-kidney-transplant-data-registries-in-the-united-states-35286
https://atc.digitellinc.com/p/s/understanding-kidney-transplant-wait-list-mortality-risk-35287
https://atc.digitellinc.com/p/s/improving-kidney-transplantation-outcomes-through-implementation-of-a-comprehensive-protocol-for-early-recovery-after-surgery-eras-in-kidney-transplant-recipients-35288
https://atc.digitellinc.com/p/s/stability-of-new-cms-metrics-for-organ-procurement-organizations-comparison-of-2-consecutive-years-35289
https://atc.digitellinc.com/p/s/a-single-center-cross-sectional-analysis-of-vitamin-d-management-in-kidney-transplant-recipients-are-we-sufficiently-addressing-deficiency-35290
https://atc.digitellinc.com/p/s/hla-epitope-electrostatics-a-novel-methodology-to-compare-hla-surface-electrostatic-potential-35291
https://atc.digitellinc.com/p/s/impact-of-the-microbiota-on-the-risk-of-acute-cellular-rejection-in-belatacept-treated-kidney-transplant-recipients-35292
https://atc.digitellinc.com/p/s/immune-regulation-of-the-liver-via-the-pcsk9-cd36-pathway-during-heart-transplant-rejection-35293
https://atc.digitellinc.com/p/s/graft-specific-cd8-plus-t-cells-weakly-proliferate-and-differentiate-into-potent-cd43-plus-effector-populations-during-acute-rejection-35294
https://atc.digitellinc.com/p/s/hypoxia-driven-proinflammatory-responses-in-pretransplant-peripheral-blood-leads-to-a-high-risk-of-early-acute-rejection-in-kidney-transplant-35295
https://atc.digitellinc.com/p/s/donor-specific-antibody-promotes-nk-cell-activation-through-induction-of-allograft-expression-of-rae-1-to-mediate-acute-antibody-mediated-kidney-allograft-rejection-35296
https://atc.digitellinc.com/p/s/gene-expression-profile-of-bronchoalveolar-lavage-cd4-plus-cd57-plus-pd1-plus-t-cells-suggests-a-functional-role-in-the-pathogenesis-of-lung-allograft-dysfunction-35297
https://atc.digitellinc.com/p/s/single-nucleus-rna-sequencing-of-human-kidney-transplant-biopsies-identifies-a-novel-role-of-pericytes-and-endothelium-in-cellular-rejection-35298
https://atc.digitellinc.com/p/s/cd56dim-natural-killer-cells-are-associated-with-belatacept-resistant-rejection-35299
https://atc.digitellinc.com/p/s/graft-dendritic-cells-respond-to-p40-homodimers-and-produce-il-15-driving-endogenous-donor-reactive-memory-cd8-t-cell-activation-within-high-risk-cardiac-allografts-35300
https://atc.digitellinc.com/p/s/lymph-node-fibroblastic-reticular-cells-regulate-alloantibody-through-laminin-and-9454-35301
https://atc.digitellinc.com/p/s/graft-infiltrating-plasma-cells-in-human-cardiac-allograft-vasculopathy-target-bilirubin-accumulating-in-the-rejected-heart-35302
https://atc.digitellinc.com/p/s/peritoneal-cavity-b-cells-exhibit-suppressive-properties-in-indirect-pathway-t-cell-responses-35303
https://atc.digitellinc.com/p/s/influence-of-tnf-and-945-on-in-vitro-induced-regulatory-b-cells-35304
https://atc.digitellinc.com/p/s/notch2-plus-marginal-zone-b-cell-depletion-decreases-antigen-shuttle-to-follicular-dendritic-cells-and-reduces-alloantibody-production-35305
https://atc.digitellinc.com/p/s/complement-5-regulation-ameliorates-antibody-mediated-rejection-after-liver-transplantation-in-rats-35306
https://atc.digitellinc.com/p/s/impact-of-desensitization-therapy-with-isatuximab-on-circulating-hla-specific-memory-b-cells-in-highly-sensitized-patients-waitlisted-for-kidney-transplantation-35307
https://atc.digitellinc.com/p/s/impact-of-covid-19-on-belatacept-and-tacrolimus-treated-kidney-transplant-recipients-from-a-prospective-randomized-multicenter-trial-35308
https://atc.digitellinc.com/p/s/immune-response-of-human-kidney-organoid-based-tissues-in-a-humanized-mouse-model-35309
https://atc.digitellinc.com/p/s/transplantation-of-cryopreserved-kidneys-a-new-paradigm-in-organ-transplantation-35310
https://atc.digitellinc.com/p/s/allogeneic-pancreatic-islets-transplanted-to-a-bioengineered-omentum-achieves-euglycemic-control-in-a-diabetic-non-human-primate-model-35311
https://atc.digitellinc.com/p/s/rxfp1-signaling-regulates-satm-via-ceacam1notch1-axis-and-attenuates-liver-fibrosis-35312
https://atc.digitellinc.com/p/s/chimeric-hla-antibody-receptor-t-cells-for-targeted-therapy-of-antibody-mediated-rejection-in-transplantation-35313
https://atc.digitellinc.com/p/s/engineering-donor-lymphocytes-with-fas-ligand-as-an-effective-approach-to-prevent-acute-graft-versus-host-disease-35314
https://atc.digitellinc.com/p/s/lymph-node-fibroblastic-reticular-cells-sustain-conduits-by-producing-laminins-35315
https://atc.digitellinc.com/p/s/expansion-of-centrilobular-hepatocytes-in-progressive-liver-fibrosis-contributes-to-the-upregulation-of-immune-and-metabolic-dysfunction-35316
https://atc.digitellinc.com/p/s/the-transcriptional-repressor-bcl6-controls-ifn-and-947-induced-endothelial-antigen-presentation-35317
https://atc.digitellinc.com/p/s/bcl6-is-involved-in-tgf-and-946-induced-endothelial-cell-proliferation-and-migration-35318
https://atc.digitellinc.com/p/s/cold-stress-induced-ferroptosis-in-liver-sinusoidal-endothelial-cells-regulates-liver-transplant-injury-via-non-canonical-nrf2-mediated-pathway-35319
https://atc.digitellinc.com/p/s/in-depth-characterization-and-functional-assessment-of-donor-and-recipient-tissue-resident-lymphocytes-in-kidney-transplants-35320
https://atc.digitellinc.com/p/s/liver-derived-mesenchymal-stromal-cells-are-more-effective-than-those-from-adipose-tissue-or-bone-marrow-in-reducing-inflammation-in-vivo-35321
https://atc.digitellinc.com/p/s/iguratimod-alleviates-endothelial-to-mesenchymal-transition-by-influencing-dynamic-changes-of-mitophagy-during-renal-allograft-interstitial-fibrosis-35322
https://atc.digitellinc.com/p/s/genomic-mismatch-at-the-sirpa-locus-and-long-term-kidney-allograft-outcomes-35323
https://atc.digitellinc.com/p/s/understanding-the-heterogeneity-of-alloreactive-natural-killer-cell-function-in-kidney-transplantation-35324
https://atc.digitellinc.com/p/s/negative-impact-of-liver-fibrosis-on-the-antitumor-activity-of-liver-natural-killer-cells-35325
https://atc.digitellinc.com/p/s/axl-inhibition-suppresses-monocyte-to-macrophage-differentiation-and-prolongs-allograft-survival-35326
https://atc.digitellinc.com/p/s/the-epigenetic-and-transcriptional-landscape-of-monocyte-memory-formation-in-response-to-allogeneic-non-self-35327
https://atc.digitellinc.com/p/s/neutrophil-ceacam1-determines-the-susceptibility-to-autophagy-driven-netosis-by-regulating-s1pr2s1pr3-axis-in-liver-transplantation-35328
https://atc.digitellinc.com/p/s/regulation-of-the-development-of-cd4-plus-cd57-plus-pd1-cells-by-il-7il-15mtor-pathway-35329
https://atc.digitellinc.com/p/s/mitochondrial-dysfunction-and-alloimmunity-in-chronic-lung-transplant-rejection-35330
https://atc.digitellinc.com/p/s/human-antigen-r-hur-dictates-ceacam1-cytoprotection-in-liver-injury-in-mouse-and-humans-35331
https://atc.digitellinc.com/p/s/il-10-direct-signaling-in-t-cells-is-essential-for-transplant-tolerance-induction-via-cd40cd154-pathway-blockade-35332
https://atc.digitellinc.com/p/s/water-channel-aquaporin-4-is-required-for-t-cell-activation-35333
https://atc.digitellinc.com/p/s/rifaximin-treatment-improves-liver-transplant-outcomes-by-promoting-hepatocellular-regeneration-35334
https://atc.digitellinc.com/p/s/hypoxia-inducible-factor-alpha-hif-2-and-945-is-a-global-regulator-of-alternative-splicing-following-hepatic-ischemic-stress-35335
https://atc.digitellinc.com/p/s/q-and-a-35336
https://atc.digitellinc.com/p/s/a-role-for-iga-in-gzmb-plus-regulatory-b-cells-in-tolerance-35337
https://atc.digitellinc.com/p/s/donor-pd-l1-is-required-for-organ-transplant-tolerance-in-mhc-mismatched-mixed-chimeras-35338
https://atc.digitellinc.com/p/s/multiple-infusions-of-ex-vivo-expanded-polyclonal-treg-delay-rejection-and-promote-systemic-and-intragraft-cd163-plus-myeloid-cells-in-kidney-allograft-recipient-monkeys-35339
https://atc.digitellinc.com/p/s/maintenance-of-lung-graft-tolerance-is-dependent-on-continuous-recruitment-of-foxp3-plus-cells-to-allografts-35340
https://atc.digitellinc.com/p/s/selective-regulatory-t-cell-expansion-by-a-novel-il-2-mutein-in-murine-transplant-and-humanized-nsg-models-35341
https://atc.digitellinc.com/p/s/treg-poorly-migrate-to-inflamed-allografts-in-absence-of-effector-t-cells-35342
https://atc.digitellinc.com/p/s/stabilization-of-deptor-expression-in-cd4-plus-t-cells-using-mln4924-to-augment-immunoregulation-post-transplantation-35343
https://atc.digitellinc.com/p/s/successful-induction-of-mixed-chimerism-by-bcl-2-inhibition-and-tolerogenic-rapamycin-encapsulating-nanoparticles-immtor-without-chemotherapy-or-total-body-irradiation-in-nonhuman-primates-35344
https://atc.digitellinc.com/p/s/genome-wide-survival-study-identifies-two-novel-associations-between-non-hla-donor-recipient-mismatches-and-kidney-graft-failure-35345
https://atc.digitellinc.com/p/s/dynamic-expression-of-hla-class-ii-molecules-on-human-glomerular-endothelial-cells-35346
https://atc.digitellinc.com/p/s/hla-epitope-electrostatics-a-novel-methodology-to-compare-hla-surface-electrostatic-potential-35347
https://atc.digitellinc.com/p/s/toward-a-combined-dr-plus-dq-human-leukocyte-antigen-molecular-mismatch-score-for-risk-stratification-of-pediatric-heart-transplant-patients-35348
https://atc.digitellinc.com/p/s/single-cell-rna-seq-reveals-similarities-and-differences-of-biological-characteristics-among-bk-virus-associated-nephropathy-antibody-mediated-rejection-and-renal-clear-cell-carcinoma-35349
https://atc.digitellinc.com/p/s/hla-eplets-are-common-in-the-world-population-and-do-not-impact-equity-35350
https://atc.digitellinc.com/p/s/sex-hormone-specific-dc-and-t-cell-interactions-in-alloimmunity-a-single-cell-analysis-35351
https://atc.digitellinc.com/p/s/q-and-a-35352
https://atc.digitellinc.com/p/s/anti-cd40l-based-desensitization-and-immunosuppression-promotes-long-term-graft-survival-in-allosensitized-nonhuman-primate-kidney-transplantation-35353
https://atc.digitellinc.com/p/s/use-of-anti-il-6-or-anti-il-6r-mab-therapy-in-a-mixed-chimerism-protocol-to-achieve-heart-allograft-tolerance-in-non-human-primates-35354
https://atc.digitellinc.com/p/s/impact-of-immunossupression-withdrawal-in-donorhla-specific-memory-b-cell-responses-in-pediatric-liver-transplant-recipients-35355
https://atc.digitellinc.com/p/s/single-cell-analysis-reveals-distinct-t-cell-receptor-repertoire-of-ex-vivo-expanded-human-antigen-specific-t-regulatory-cell-enriched-line-astrl-35356
https://atc.digitellinc.com/p/s/fc-modified-anti-cd154-mab-induced-long-term-renal-allograft-survival-without-thromboembolic-complications-35357
https://atc.digitellinc.com/p/s/an-exome-wide-study-of-renal-operational-tolerance-35358
https://atc.digitellinc.com/p/s/a-novel-bi-specific-fusion-protein-with-ctla4-igpd-l2-as-a-novel-immunosuppressant-molecule-modulating-alloimmune-responses-35359
https://atc.digitellinc.com/p/s/anti-sla-igg-xenoantibodies-contribute-to-graft-rejection-in-highly-sensitized-non-human-primate-xenotransplantation-35360
https://atc.digitellinc.com/p/s/contribution-of-anti-sla-antibodies-to-rejection-in-nonhuman-primate-model-of-kidney-xenotransplantation-35361
https://atc.digitellinc.com/p/s/pre-and-post-transplant-donor-specific-anti-porcine-antibodies-in-transplantation-of-kidney-xenografts-with-triple-knock-out-with-or-without-multiple-human-transgenes-in-nonhuman-primates-35362
https://atc.digitellinc.com/p/s/human-immunoglobulin-preparations-contain-significant-anti-pig-antibodies-35363
https://atc.digitellinc.com/p/s/genetically-modified-porcine-kidneys-expressing-human-transgenes-support-and-622-year-survival-in-pig-to-cynomolgus-macaque-xenotransplantation-35364
https://atc.digitellinc.com/p/s/xenorecognition-and-costimulation-of-porcine-endothelium-derived-extracellular-vesicles-in-initiating-human-porcine-specific-t-cell-immune-responses-35365
https://atc.digitellinc.com/p/s/routine-cold-storage-5-hours-leads-to-hyperacute-graft-loss-in-pig-to-primate-kidney-xenotransplantation-static-cold-storage-versus-hypothermic-machine-perfusion-35366
https://atc.digitellinc.com/p/s/multimodality-deep-phenotyping-of-genetically-modified-pig-kidney-xenografts-transplanted-to-human-recipients-reveals-antibody-mediated-rejection-35367
https://atc.digitellinc.com/p/s/impact-of-tocilizumab-based-desensitization-on-access-to-kidney-transplantation-and-outcomes-after-transplantation-35368
https://atc.digitellinc.com/p/s/disulfide-hmgb1-increases-graft-injury-and-pro-inflammatory-macrophage-activation-via-tlr4-and-tlr9-following-liver-transplantation-35369
https://atc.digitellinc.com/p/s/circulating-cd4-plus-tfh-and-b-cells-with-antibody-secreting-phenotypes-are-detectable-in-adult-liver-transplant-recipients-with-ischemia-reperfusion-injury-35370
https://atc.digitellinc.com/p/s/preservation-of-human-kidneys-with-oxygenated-perfusion-at-room-temperature-35371
https://atc.digitellinc.com/p/s/visualization-of-ischemia-reperfusion-injury-of-kidney-and-prediction-of-early-allograft-dysfunction-after-kidney-transplantation-using-cysteine-probe-35372
https://atc.digitellinc.com/p/s/hypoxia-inducible-factor-1-and-945-controls-the-alternative-splicing-of-ceacam1-and-enhances-hepatic-ischemia-tolerance-in-mice-and-humans-35373
https://atc.digitellinc.com/p/s/hepatocyte-notch1-switches-pyroptosis-to-apoptosis-via-chop-dependent-mechanism-against-oxidative-stress-in-liver-transplantation-35374
https://atc.digitellinc.com/p/s/protective-effect-of-extracellular-vesicles-derived-from-mesenchymal-stromal-cells-on-kidney-ischemia-reperfusion-injury-by-complement-inhbition-and-induction-of-a-t-regulatory-phenotype-35375
https://atc.digitellinc.com/p/s/beneficial-effects-of-c1q-in-resolving-ischemia-reperfusion-in-kidney-transplants-35376
https://atc.digitellinc.com/p/s/role-of-reperfusion-after-cold-preservation-for-liver-transplant-at-single-cell-resolution-35377
https://atc.digitellinc.com/p/s/removal-of-circulating-nucleosomesneutrophil-extracellular-traps-nets-reduces-ex-situ-reperfusion-injury-in-porcine-dcd-livers-preserved-with-normothermic-machine-perfusion-nmp-35378
https://atc.digitellinc.com/p/s/break-35379
https://atc.digitellinc.com/p/s/pulsatile-perfusion-characteristics-of-en-bloc-kidneys-transplanted-from-small-pediatric-donors-may-predict-early-allograft-failure-35380
https://atc.digitellinc.com/p/s/reliable-continuous-oxygen-monitoring-during-ex-vivo-machine-perfusion-35381
https://atc.digitellinc.com/p/s/impact-of-liver-graft-preservation-method-and-liver-failure-etiology-on-the-gut-microbiome-35382
https://atc.digitellinc.com/p/s/cryopreservation-of-rat-hearts-by-vitrification-and-nanowarming-35383
https://atc.digitellinc.com/p/s/repurposed-drug-induces-novel-hibernating-like-alterations-in-metabolism-and-cardiac-function-during-prolonged-heart-preservation-35384
https://atc.digitellinc.com/p/s/evaluation-of-liver-maximum-capacity-limax-measurements-to-monitor-hepatocellular-function-during-extended-normothermic-machine-perfusion-35385
https://atc.digitellinc.com/p/s/bac-transgenic-mice-show-a-novel-t-cell-intrinsic-excitatory-role-for-apol1-risk-alleles-35386
https://atc.digitellinc.com/p/s/differential-gene-expression-changes-due-to-altered-dna-methylation-results-in-hepatic-ischemia-reperfusion-injury-in-deceased-donor-liver-transplant-recipients-35387
https://atc.digitellinc.com/p/s/ex-vivo-perfusion-based-genetic-modification-of-vascularized-composite-allografts-35388
https://atc.digitellinc.com/p/s/systematic-comparison-of-murine-models-of-chronic-lung-allograft-dysfunction-35389
https://atc.digitellinc.com/p/s/tolerogenic-dna-methylation-signature-of-human-dcregs-35390
https://atc.digitellinc.com/p/s/risk-assessment-of-donor-livers-for-transplantation-through-quantification-of-mitochondrial-dysfunction-surrogates-in-flushing-solutions-35391
https://atc.digitellinc.com/p/s/differential-gene-expression-changes-due-to-altered-dna-methylation-results-in-hepatic-ischemia-reperfusion-injury-in-deceased-donor-liver-transplant-recipients-35392
https://atc.digitellinc.com/p/s/alterations-of-the-gut-microbiota-and-associated-metabolome-in-renal-transplant-acute-rejection-35393
https://atc.digitellinc.com/p/s/gaining-consensus-around-patient-risk-groups-and-prognostic-profiles-to-guide-cmv-management-among-patients-with-allogeneic-hematopoietic-stem-cell-transplant-hsct-insights-from-a-delphi-panel-with-hs-35394
https://atc.digitellinc.com/p/s/cross-pathogen-proteomic-signatures-of-acute-and-convalescent-infection-identify-pan-infection-signatures-with-post-transplant-cmv-and-bkv-infection-35395
https://atc.digitellinc.com/p/s/cytomegalovirus-cmv-specific-t-cell-and-humoral-immune-responses-in-a-randomized-trial-of-preemptive-antiviral-therapy-pet-vs-antiviral-prophylaxis-pro-after-high-risk-cmv-d-plus-r-liver-transplant-lt-35396
https://atc.digitellinc.com/p/s/neutralizing-and-cellular-responses-against-sars-cov-2-omicron-ba5-in-vaccinated-andor-infected-pediatric-solid-organ-transplant-recipients-35397
https://atc.digitellinc.com/p/s/detectable-spike-antigen-following-third-mrna-sars-cov-2-vaccination-is-not-associated-with-antibody-development-in-kidney-transplant-recipients-35398
https://atc.digitellinc.com/p/s/optimising-adjuvant-effect-of-rapamycin-to-improve-the-immunogenicity-of-covid-19-vaccines-35399
https://atc.digitellinc.com/p/s/pertubations-in-the-urine-proteome-to-distinguish-covid19-and-acute-rejection-in-renal-transplantation-35400
https://atc.digitellinc.com/p/s/the-septic-spleen-continuously-releases-neutrophils-with-distinct-functional-andtranscriptomic-signatures-into-the-blood-35401
https://atc.digitellinc.com/p/s/transplantation-increases-cd8-t-cell-senescence-impacting-risk-for-infection-and-rejection-after-kidney-transplantation-35402
https://atc.digitellinc.com/p/s/association-of-epigenetic-age-with-clinical-frailty-and-outcomes-in-a-pilot-study-of-patients-undergoing-liver-transplantation-35403
https://atc.digitellinc.com/p/s/immunometabolic-shifts-are-associated-with-development-of-severe-pre-liver-transplant-immune-dysfunction-35404
https://atc.digitellinc.com/p/s/differential-components-of-donor-versus-recipient-insulin-pathways-affect-development-of-post-liver-transplant-diabetes-mellitus-35405
https://atc.digitellinc.com/p/s/metabolic-flexibility-predictor-of-weight-gain-among-liver-transplant-recipients-35406
https://atc.digitellinc.com/p/s/development-of-immune-related-gene-polymorphism-sets-for-predicting-characteristic-complications-after-liver-transplantation-35407
https://atc.digitellinc.com/p/s/the-impact-of-donor-and-recipient-polygenic-risk-score-interactions-on-the-development-of-post-transplant-diabetes-mellitus-35408
https://atc.digitellinc.com/p/s/banff-human-organ-transplant-consensus-gene-panel-for-detecting-antibody-mediated-rejection-in-heart-allograft-biopsies-35409
https://atc.digitellinc.com/p/s/molecular-diagnostic-classification-of-heart-allograft-rejection-based-on-the-targeted-banff-human-organ-transplant-gene-expression-panel-35410
https://atc.digitellinc.com/p/s/heartcare-across-the-age-spectrum-35411
https://atc.digitellinc.com/p/s/effect-of-covid-19-infection-on-heartcare-updated-data-from-the-shore-multicenter-registry-35412
https://atc.digitellinc.com/p/s/the-diagnosis-and-preemptive-prediction-of-kidney-antibody-mediated-rejection-based-on-allograft-transcriptome-profiling-35413
https://atc.digitellinc.com/p/s/validation-of-a-urinary-exosome-mrna-signature-for-the-diagnosis-of-human-kidney-transplant-rejection-35414
https://atc.digitellinc.com/p/s/computational-analysis-of-multiplex-immunofluorescence-imaging-identifies-endothelial-cell-macrophage-interaction-as-a-potential-novel-spatial-biomarker-in-antibody-mediated-kidney-rejection-35415
https://atc.digitellinc.com/p/s/q-and-a-35416
https://atc.digitellinc.com/p/s/cd40-induces-pir-a-to-promote-chronic-rejection-of-cardiac-transplantation-35417
https://atc.digitellinc.com/p/s/transglutaminase-2-in-chronic-lung-allograft-dysfunction-35418
https://atc.digitellinc.com/p/s/cell-type-specific-expression-of-the-common-rejection-module-revealed-by-single-cell-transcriptomics-in-small-airway-brushes-of-lung-transplant-recipients-35419
https://atc.digitellinc.com/p/s/discerning-cell-subtypes-and-cell-specific-molecular-pathways-balancing-injury-and-repair-in-normal-allografts-35420
https://atc.digitellinc.com/p/s/absence-of-recipient-neutrophil-cathepsin-g-alters-donor-specific-antibody-mediated-rejection-from-acute-to-chronic-kidney-allograft-injury-35421
https://atc.digitellinc.com/p/s/natural-killer-cell-functions-in-chronic-antibody-mediated-rejection-in-kidney-allografts-35422
https://atc.digitellinc.com/p/s/immunoregulatory-pathways-are-upregulated-in-t-cell-mediated-rejection-of-human-face-transplants-35423
https://atc.digitellinc.com/p/s/prolonged-subzero-preservation-of-vascularized-composite-allografts-with-nature-inspired-cryoprotectants-35424
https://atc.digitellinc.com/p/s/vca-graft-outcomes-have-improved-over-time-35425
https://atc.digitellinc.com/p/s/insights-from-immunoproteomic-profiling-of-a-rejected-full-face-allotransplant-35426
https://atc.digitellinc.com/p/s/24-hour-supercooling-preservation-of-vascularized-composite-allografts-in-rodents-35427
https://atc.digitellinc.com/p/s/24h-acellular-subnormothermic-machine-perfusion-for-vca-preservation-35428
https://atc.digitellinc.com/p/s/endometrial-immune-reconstitution-associates-with-post-transplant-hormonal-synchronization-in-uterus-transplant-recipients-35429
https://atc.digitellinc.com/p/s/clinically-translatable-multispectral-nanoimaging-for-non-invasive-surveillance-of-rejection-in-vca-35430
https://atc.digitellinc.com/p/s/impact-of-area-deprivation-index-on-organ-procurement-organization-performance-metrics-35431
https://atc.digitellinc.com/p/s/impact-of-transitioning-to-lung-continuous-distribution-35432
https://atc.digitellinc.com/p/s/provisional-acceptance-decline-rates-35433
https://atc.digitellinc.com/p/s/why-is-the-optn-hope-kidney-waiting-list-shrinking-despite-shorter-wait-times-35434
https://atc.digitellinc.com/p/s/merit-points-system-and-the-change-of-willingness-to-donate-35435
https://atc.digitellinc.com/p/s/determinants-of-liver-transplant-center-phenotype-35436
https://atc.digitellinc.com/p/s/expanding-hope-act-experience-criteria-for-transplantation-from-donors-with-hiv-to-recipients-with-hiv-35437
https://atc.digitellinc.com/p/s/powerful-new-methods-and-tools-for-designing-allocation-policy-for-deceased-donor-organs-35438
https://atc.digitellinc.com/p/s/pre-transplant-multidisciplinary-assessment-on-medication-adherence-and-transplant-outcomes-35439
https://atc.digitellinc.com/p/s/cost-effectiveness-analysis-of-adult-living-donor-liver-transplantation-in-japan-35440
https://atc.digitellinc.com/p/s/the-development-of-psychological-services-for-lung-transplant-patients-35441
https://atc.digitellinc.com/p/s/associated-factors-to-nonadherence-to-routine-health-care-appointments-after-kidney-transplantation-the-adhere-brazil-multicenter-study-35442
https://atc.digitellinc.com/p/s/a-patient-facing-tool-for-multiorgan-transplant-outcomes-35443
https://atc.digitellinc.com/p/s/a-multicomponent-medication-adherence-promotion-system-decreases-late-t-cell-mediated-rejection-35444
https://atc.digitellinc.com/p/s/psychiatric-disease-is-common-after-adult-liver-transplantation-and-associated-with-significant-financial-burden-in-a-large-us-national-cohort-35445
https://atc.digitellinc.com/p/s/a-single-center-cross-sectional-analysis-of-vitamin-d-management-in-kidney-transplant-recipients-are-we-sufficiently-addressing-deficiency-35446
https://atc.digitellinc.com/p/s/underserved-communities-receiving-kidney-transplant-have-optimal-graft-and-patient-survival-and-is-cost-effective-35447
https://atc.digitellinc.com/p/s/a-randomized-phase-2-study-of-mau868-vs-placebo-for-bk-viremia-in-kidney-transplant-recipients-bk-viral-kinetics-and-outcomes-in-two-dosing-cohorts-35448
https://atc.digitellinc.com/p/s/identifying-the-hub-genes-driving-cells-from-bk-polyomavirus-uninfected-to-infected-state-at-single-cell-resolution-in-vivo-35449
https://atc.digitellinc.com/p/s/outcomes-of-kidney-retransplant-after-bk-nephropathy-graft-loss-by-induction-type-in-the-united-states-35450
https://atc.digitellinc.com/p/s/bk-polyomavirus-integration-increases-both-host-and-viral-oncogene-expression-35451
https://atc.digitellinc.com/p/s/allogeneic-immunity-helps-sustain-effective-bk-virus-immune-responses-and-prevents-bk-virus-associated-nephropathy-35452
https://atc.digitellinc.com/p/s/concurrent-jc-viremia-is-associated-with-poor-graft-outcome-in-kidney-transplant-recipients-with-polyomavirus-associated-nephropathy-35453
https://atc.digitellinc.com/p/s/outcomes-of-bk-viremia-in-simultaneous-heart-and-kidney-transplants-35454
https://atc.digitellinc.com/p/s/the-significance-of-tubular-basement-membrane-c4d-deposition-in-polyomavirus-associated-nephropathy-of-renal-allograft-and-native-kidney-35455
https://atc.digitellinc.com/p/s/urinary-single-cell-rna-sequencing-captures-immunosuppression-of-regulatory-t-cells-in-bk-virus-associated-nephropathy-35456
https://atc.digitellinc.com/p/s/trends-and-outcomes-of-liver-transplantation-in-human-immunodeficiency-virus-hiv-recipients-35457
https://atc.digitellinc.com/p/s/glecaprevirpibrentasvir-compared-to-sofosbuvirvelpatasvir-for-the-treatment-of-hcv-in-hcv-negative-recipients-who-received-hcv-nat-positive-kidneys-35458
https://atc.digitellinc.com/p/s/active-hcv-infection-at-the-time-of-liver-transplant-results-in-decreased-graft-failure-and-increased-incidence-of-complications-after-liver-transplant-35459
https://atc.digitellinc.com/p/s/hepatitis-c-viremia-after-liver-transplant-from-antibody-positive-and-nucleic-acid-testing-negative-donors-to-nonviremic-recipients-35460
https://atc.digitellinc.com/p/s/standard-versus-reduced-dose-valganciclovir-cmv-prophylaxis-in-high-risk-liver-transplant-recipients-35461
https://atc.digitellinc.com/p/s/pre-emptive-therapy-for-cmv-in-high-risk-liver-transplant-recipients-a-real-world-application-35462
https://atc.digitellinc.com/p/s/efficacy-and-safety-of-accelerated-versus-standard-hepatitis-b-vaccine-schedule-among-kidney-transplant-candidate-a-randomized-controlled-trial-35463
https://atc.digitellinc.com/p/s/abdominal-transplantation-from-hcv-viremic-and-hcvhiv-co-infected-donors-to-recipients-with-hiv-under-the-hope-act-35464
https://atc.digitellinc.com/p/s/sars-cov-2-vaccination-rates-and-uptake-of-tixagevimab-cilgavimab-among-a-cohort-of-pediatric-solid-organ-transplant-recipients-35465
https://atc.digitellinc.com/p/s/multi-center-study-of-omicron-ba45-neutralizing-antibody-and-t-cell-responses-in-transplant-recipients-after-three-and-four-doses-of-covid-vaccine-35466
https://atc.digitellinc.com/p/s/advances-in-transplant-targeted-immunosuppression-using-nanotechnology-strategies-35467
https://atc.digitellinc.com/p/s/sars-cov-2-specific-immunological-memory-predicts-successful-booster-immunization-and-severe-covid-19-in-solid-organ-transplant-patients-35468
https://atc.digitellinc.com/p/s/re-emerging-covid-vaccine-hesitancy-and-health-locus-of-control-in-inner-city-kidney-transplant-recipients-35469
https://atc.digitellinc.com/p/s/immunosupressive-treatment-and-cd4cd8-t-cell-exhaustion-impact-sars-cov-2-specific-adaptive-responses-after-mrna-vaccination-in-solid-organ-transplant-patients-35470
https://atc.digitellinc.com/p/s/risk-factors-for-poor-t-cell-responses-to-three-doses-of-sars-cov-2-mrna-vaccination-in-kidney-transplant-recipients-35471
https://atc.digitellinc.com/p/s/bivalent-sars-cov-2-mrna-booster-vaccines-in-transplant-recipients-improve-neutralization-of-omicron-sublineages-35472
https://atc.digitellinc.com/p/s/donor-derived-transmissions-2021-analysis-of-the-optn-ad-hoc-disease-transmission-advisory-committee-dtac-35473
https://atc.digitellinc.com/p/s/opo-donor-testing-minimizing-donor-derived-infections-and-optimizing-post-transplant-management-35474
https://atc.digitellinc.com/p/s/surveillance-and-treatment-of-donor-derived-human-herpesvirus-8-infection-in-transplant-recipients-a-strict-protocol-to-impact-on-mortality-35475
https://atc.digitellinc.com/p/s/quantifying-the-potential-pool-of-cardiothoracic-organs-from-donors-with-hiv-35476
https://atc.digitellinc.com/p/s/regional-differences-in-the-utilization-of-hcv-nat-positive-donors-in-kidney-transplantation-35477
https://atc.digitellinc.com/p/s/ureaplasma-and-mycoplasma-species-transmission-through-solid-organ-transplantation-in-the-united-states-a-report-from-the-ad-hoc-disease-transmission-advisory-committee-35478
https://atc.digitellinc.com/p/s/age-influence-on-p-glycoprotein-function-in-peripheral-blood-mononuclear-cells-in-stable-kidney-transplant-recipients-35479
https://atc.digitellinc.com/p/s/managing-the-significant-drug-drug-interaction-between-tacrolimus-and-isavuconazole-in-solid-organ-transplant-recipients-35480
https://atc.digitellinc.com/p/s/pharmacokinetic-evaluation-of-tacrolimus-extended-release-and-tacrolimus-immediate-release-combined-with-early-steroid-withdrawal-in-de-novo-kidney-transplant-recipients-35481
https://atc.digitellinc.com/p/s/possible-regulatory-variant-in-the-cyp3a-gene-association-with-tacrolimus-tac-troughs-in-african-american-kidney-transplant-recipients-35482
https://atc.digitellinc.com/p/s/introduction-35483
https://atc.digitellinc.com/p/s/mycophenolic-acid-exposure-in-belatacept-or-tacrolimus-when-combined-with-early-steroid-withdrawal-in-kidney-transplant-recipients-35484
https://atc.digitellinc.com/p/s/neutropenialeukopenia-and-viral-resistance-with-letermovir-let-vs-valganciclovir-vgcv-as-cytomegalovirus-cmv-prophylaxis-in-adult-kidney-transplant-recipients-ktrs-results-of-a-pivotal-randomized-phas-35485
https://atc.digitellinc.com/p/s/efficacy-of-cd154-blockade-with-tnx-1500-to-prevent-heart-allograft-immune-injury-35486
https://atc.digitellinc.com/p/s/implementation-of-a-multi-disciplinary-post-transplant-diabetes-clinic-leads-to-more-frequent-prescribing-of-antihyperglycemic-agents-with-cardiovascular-and-renal-benefit-35487
https://atc.digitellinc.com/p/s/renal-transplantation-can-be-performed-safely-without-pre-operative-apixaban-reversal-35488
https://atc.digitellinc.com/p/s/impaired-seroconversion-rates-after-adjuvanted-hepatitis-b-vaccination-in-organ-transplant-candidates-and-recipients-35489
https://atc.digitellinc.com/p/s/pharmacist-driven-cytomegalovirus-viremia-treatment-in-liver-transplant-recipients-35490
https://atc.digitellinc.com/p/s/evaluating-the-use-of-sodium-glucose-cotransporter-2-inhibitors-sglt2i-in-a-matched-cohort-of-kidney-and-liver-transplant-recipients-35491
https://atc.digitellinc.com/p/s/impact-of-glucagon-like-peptide-1-receptor-agonists-on-tacrolimus-dose-to-concentration-ratios-in-solid-organ-transplant-recipients-35492
https://atc.digitellinc.com/p/s/conversion-of-tacrolimus-immediate-release-to-lcp-tacrolimus-in-non-kidney-transplant-recipients-35493
https://atc.digitellinc.com/p/s/unintended-consequences-of-a-change-in-deceased-donor-kidney-allocation-35494
https://atc.digitellinc.com/p/s/time-to-next-transplantable-deceased-donor-kidney-offer-35495
https://atc.digitellinc.com/p/s/patient-level-social-determinants-of-health-are-associated-with-kidney-waitlist-outcomes-in-the-united-states-35496
https://atc.digitellinc.com/p/s/association-of-race-and-ethnicity-with-priority-for-transplantation-with-high-guality-deceased-donor-kidneys-in-the-us-35497
https://atc.digitellinc.com/p/s/disparity-and-best-practice-of-intestine-transplant-35498
https://atc.digitellinc.com/p/s/racialethnic-fairness-in-eplet-based-kidney-allocation-35499
https://atc.digitellinc.com/p/s/list-diving-to-allocate-kidneys-to-lower-waitlist-priority-candidates-35500
https://atc.digitellinc.com/p/s/resolving-the-use-of-race-in-kidney-donor-profile-index-kdpi-35501
https://atc.digitellinc.com/p/s/increasing-use-of-kidneys-in-multi-organ-transplants-35502
https://atc.digitellinc.com/p/s/systemic-factors-contributing-to-workforce-decline-35503
https://atc.digitellinc.com/p/s/a-glomerulosclerosis-informed-kdpi-to-better-predict-long-term-kidney-graft-survival-and-8239-35504
https://atc.digitellinc.com/p/s/offer-decision-making-with-predictive-analytics-in-donornet-mobile-pilot-project-35505
https://atc.digitellinc.com/p/s/deceased-donor-system-performance-in-a-jurisdiction-with-early-communication-between-transplant-and-opo-professionals-35506
https://atc.digitellinc.com/p/s/wait-time-advantage-for-transplant-candidates-with-hiv-who-accept-kidneys-from-donors-with-hiv-35507
https://atc.digitellinc.com/p/s/transplanting-kidneys-from-hcv-rna-ab-plus-donors-opt-in-patterns-and-post-transplant-outcomes-35508
https://atc.digitellinc.com/p/s/outcomes-of-active-and-resolved-covid-19-positive-deceased-donor-kidney-transplants-35509
https://atc.digitellinc.com/p/s/outcomes-from-donation-after-circulatory-death-kidneys-with-prolonged-warm-ischemia-times-are-comparable-to-all-deceased-donor-kidney-transplants-35510
https://atc.digitellinc.com/p/s/improved-early-outcome-of-kidney-transplantation-with-the-use-of-normothermic-regional-perfusion-in-donation-after-circulatory-death-35511
https://atc.digitellinc.com/p/s/unplanned-pregnancy-after-kidney-transplant-is-associated-with-acute-graft-rejection-35512
https://atc.digitellinc.com/p/s/racial-differences-in-reactivation-on-the-kidney-transplant-waitlist-among-individuals-made-inactive-due-to-insurance-issues-35513
https://atc.digitellinc.com/p/s/race-and-psychosocial-reasons-for-exclusion-from-kidney-transplantation-in-each-phase-of-the-process-35514
https://atc.digitellinc.com/p/s/postoperative-delirium-and-incident-dementia-among-older-kidney-transplant-recipients-35515
https://atc.digitellinc.com/p/s/pre-donation-hypertension-and-post-donation-kidney-function-in-living-kidney-donors-35516
https://atc.digitellinc.com/p/s/treatment-burden-as-a-novel-risk-factor-for-rehospitalizations-after-kidney-transplantation-35517
https://atc.digitellinc.com/p/s/multistep-algorithm-to-achieve-weight-loss-goal-in-advanced-stage-obesity-kidney-transplant-candidates-a-single-center-interval-report-35518
https://atc.digitellinc.com/p/s/q-and-a-35519
https://atc.digitellinc.com/p/s/clinical-and-molecular-spectrum-of-v-lesion-35520
https://atc.digitellinc.com/p/s/the-spectrum-of-molecular-rejection-in-the-prevalent-kidney-transplant-population-a-new-analysis-of-5087-biopsies-35521
https://atc.digitellinc.com/p/s/decoding-the-fate-of-early-acute-tcmr-after-renal-transplantation-35522
https://atc.digitellinc.com/p/s/accurate-histologic-diagnoses-of-antibody-mediated-rejection-can-be-made-using-lesions-but-without-dsa-or-c4d-35523
https://atc.digitellinc.com/p/s/transcriptional-heterogeneity-of-t-cell-mediated-rejection-in-human-kidney-transplantation-35524
https://atc.digitellinc.com/p/s/the-role-of-the-molecular-microscope-and-donor-derived-cell-free-dna-to-guide-therapy-for-t-cell-mediated-rejection-in-kidney-transplants-35525
https://atc.digitellinc.com/p/s/bystander-activation-but-not-heterologous-immunity-drives-susceptibility-to-allograft-rejection-in-patients-with-high-frequencies-of-preformed-donor-reactive-memory-t-cells-35526
https://atc.digitellinc.com/p/s/landscape-of-t-cell-mediated-rejection-response-to-treatment-after-kidney-transplantation-35527
https://atc.digitellinc.com/p/s/clinical-impact-of-early-blood-transfusion-after-kidney-transplantation-35528
https://atc.digitellinc.com/p/s/aldosterone-secreting-adrenal-adenomas-in-the-kidney-transplant-population-underdiagnosed-and-important-35529
https://atc.digitellinc.com/p/s/the-association-between-the-uremic-solute-asymmetric-dimethylarginine-and-regression-of-myocardial-fibrosis-post-kidney-transplantation-35530
https://atc.digitellinc.com/p/s/impact-of-arterial-calcification-and-vascular-stiffness-on-cardiovascular-outcomes-in-kidney-transplant-recipients-results-from-the-know-kt-study-35531
https://atc.digitellinc.com/p/s/utility-of-pre-transplant-cardiac-catheterization-in-high-cardiovascular-risk-kidney-transplant-candidates-35532
https://atc.digitellinc.com/p/s/a-nomogram-for-predicting-major-adverse-cardiovascular-events-after-kidney-transplantation-35533
https://atc.digitellinc.com/p/s/multimodal-late-fusion-model-for-predicting-risk-of-post-kidney-transplant-major-adverse-cardiac-events-35534
https://atc.digitellinc.com/p/s/kidney-transplantation-improves-survival-in-patients-with-treated-severe-pulmonary-hypertension-compared-to-dialysis-a-single-center-approach-35535
https://atc.digitellinc.com/p/s/effectiveness-of-metformin-in-kidney-transplant-recipients-with-post-transplantation-diabetes-mellitus-35536
https://atc.digitellinc.com/p/s/early-results-of-the-adapt-desensitization-trial-in-kidney-transplant-tx-candidates-with-100-percent-cpra-impact-of-carfilzomib-and-belatacept-35537
https://atc.digitellinc.com/p/s/comparison-of-preemptive-therapy-using-high-dose-ivig-and-rituximab-versus-rituximab-alone-in-kidney-transplant-patients-with-subclinical-de-novo-donor-specific-antibodies-a-randomized-clinical-trial-35538
https://atc.digitellinc.com/p/s/impaired-seroconversion-rates-after-adjuvanted-hepatitis-b-vaccination-in-organ-transplant-candidates-and-recipients-35539
https://atc.digitellinc.com/p/s/impact-of-tocilizumab-based-desensitization-on-access-to-kidney-transplantation-and-outcomes-after-transplantation-35540
https://atc.digitellinc.com/p/s/individualized-approach-to-hla-incompatible-kidney-transplantation-based-solely-on-virtual-crossmatch-results-a-single-center-experience-35541
https://atc.digitellinc.com/p/s/daratumumab-anti-cd38-for-desensitization-des-of-treatment-resistant-highly-hla-sensitized-esrd-patients-35542
https://atc.digitellinc.com/p/s/impact-of-anti-cd38-mab-daratumumab-plus-belatacept-on-hla-antibodies-and-bone-marrow-plasma-cells-in-kidney-transplant-candidates-with-100-percent-cpra-early-results-of-attain-itn090st-35543
https://atc.digitellinc.com/p/s/20-year-outcomes-following-hla-incompatible-living-donor-kidney-transplantation-35544
https://atc.digitellinc.com/p/s/addition-of-a-single-low-dose-of-total-body-irradiation-tbi-to-a-total-lymphoid-irradiation-tli-and-anti-thymocyte-globulin-atg-conditioning-regimen-improves-mixed-hematopoietic-engraftment-in-a-toler-35545
https://atc.digitellinc.com/p/s/evaluation-of-extended-release-and-immediate-release-tacrolimus-with-early-steroid-withdrawal-in-kidney-transplants-utilizing-novel-endpoints-35546
https://atc.digitellinc.com/p/s/five-years-results-of-de-novo-kidney-transplant-recipients-treated-with-the-combination-of-low-dose-tacrolimus-and-everolimus-a-prospective-randomized-clinical-trial-35547
https://atc.digitellinc.com/p/s/assessing-the-safety-and-38-efficacy-of-renal-artery-infusions-of-c1-esterase-inhibitor-c1inh-in-kidney-transplant-recipients-at-risk-for-iridgf-35548
https://atc.digitellinc.com/p/s/cytomegalovirus-infection-in-renal-transplant-recipients-converted-to-belatacept-following-alemtuzumab-induction-35549
https://atc.digitellinc.com/p/s/conversion-of-belatacept-dosing-to-two-monthly-interval-in-kidney-transplant-patients-deemed-at-high-risk-of-infections-a-single-center-study-35550
https://atc.digitellinc.com/p/s/registry-based-external-controls-for-benefit-study-demonstration-of-rwe-for-long-term-survival-comparisons-35551
https://atc.digitellinc.com/p/s/multimodality-induction-with-eculizumab-and-obinutuzumab-in-highly-sensitized-deceased-donor-kidney-transplant-recipients-a-pilot-study-35552
https://atc.digitellinc.com/p/s/are-normal-kidneys-histologically-normal-prevalence-of-abnormal-implantation-biopsy-findings-in-living-donor-kidneys-35553
https://atc.digitellinc.com/p/s/kidney-transplantation-improves-survival-in-patients-with-treated-severe-pulmonary-hypertension-compared-to-dialysis-a-single-center-approach-35554
https://atc.digitellinc.com/p/s/multimodal-late-fusion-model-for-predicting-risk-of-post-kidney-transplant-major-adverse-cardiac-events-35555
https://atc.digitellinc.com/p/s/pre-donation-hypertension-and-post-donation-kidney-function-in-living-kidney-donors-35556
https://atc.digitellinc.com/p/s/mkidney-system-a-randomized-control-trial-of-a-mobile-health-platform-for-collecting-living-donor-follow-up-data-35557
https://atc.digitellinc.com/p/s/all-cause-hospitalization-among-live-kidney-donors-after-nephrectomy-35558
https://atc.digitellinc.com/p/s/living-donor-champion-program-innovation-leads-to-lives-saved-35559
https://atc.digitellinc.com/p/s/utility-of-urinary-epidermal-growth-factor-in-predicting-post-donation-kidney-function-35560
https://atc.digitellinc.com/p/s/impact-of-area-social-deprivation-index-on-long-term-living-kidney-donor-outcomes-35561
https://atc.digitellinc.com/p/s/support-needs-for-living-kidney-donor-candidates-results-from-a-multicenter-qualitative-study-35562
https://atc.digitellinc.com/p/s/the-first-58-global-kidney-exchange-transplants-overcoming-multiple-barriers-to-transplantation-35563
https://atc.digitellinc.com/p/s/q-and-a-35564
https://atc.digitellinc.com/p/s/prediction-of-graft-survival-among-living-donor-kidney-transplant-an-artificial-intellegence-approach-35565
https://atc.digitellinc.com/p/s/converting-interested-into-actual-non-directed-living-donors-opportunities-to-increase-donor-conversion-rates-within-paired-donation-programs-35566
https://atc.digitellinc.com/p/s/consequences-of-low-estimated-glomerular-filtration-rate-egfr-either-pre-or-early-post-kidney-donation-35567
https://atc.digitellinc.com/p/s/kidney-paired-donation-in-the-latin-america-and-caribbean-35568
https://atc.digitellinc.com/p/s/q-and-a-35569
https://atc.digitellinc.com/p/s/combining-peripheral-blood-gene-expression-profiling-and-donor-derived-cell-free-dna-to-identify-the-absence-of-subclinical-rejection-in-pediatric-kidney-transplantation-35570
https://atc.digitellinc.com/p/s/belatacept-outcomes-in-pediatric-kidney-transplantation-an-international-multicenter-study-35571
https://atc.digitellinc.com/p/s/validation-of-a-dynamic-prediction-model-of-kidney-allograft-survival-in-pediatric-kidney-transplant-recipients-35572
https://atc.digitellinc.com/p/s/utility-of-a-blood-gene-expression-profiling-score-allomap-to-predict-rejection-events-in-pediatric-kidney-transplant-recipients-35573
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-testing-in-children-indications-and-utility-35574
https://atc.digitellinc.com/p/s/prognostic-value-of-normal-surveillance-biopsies-in-pediatric-kidney-transplant-recipients-35575
https://atc.digitellinc.com/p/s/kidney-graft-outcomes-following-pediatric-blood-group-incompatible-transplantation-a-comparative-study-using-unos-database-analysis-35576
https://atc.digitellinc.com/p/s/multicenter-experience-using-donor-derived-cell-free-dna-in-pediatric-patients-less-than-20-kg-35577
https://atc.digitellinc.com/p/s/circulating-and-allograft-infiltrating-cd56dimcd16bright-nk-cells-in-kidney-allograft-antibody-mediated-rejection-display-transcriptomic-and-epigenetic-changes-conferring-their-increased-il-21-respons-35578
https://atc.digitellinc.com/p/s/atn-like-abmr-transcriptome-is-similar-to-acute-active-abmr-in-early-post-transplant-period-35579
https://atc.digitellinc.com/p/s/evaluation-of-histomap-molecular-model-for-renal-allograft-rejection-diagnosis-in-biopsies-with-suspicious-histologic-findings-for-antibody-mediated-rejection-35580
https://atc.digitellinc.com/p/s/real-word-evidence-of-the-effectiveness-of-the-treatment-of-antibody-mediated-rejection-in-kidney-transplant-recipients-35581
https://atc.digitellinc.com/p/s/assessment-of-nk-cell-alloreactivity-in-hla-sensitized-patients-association-with-risk-for-antibody-mediated-rejection-35582
https://atc.digitellinc.com/p/s/spatially-resolved-transcriptomics-in-biopsies-from-angiotensin-ii-type-1-receptor-antibody-positive-kidney-transplant-recipients-with-and-without-concurrent-human-leukocyte-antigen-donor-specific-ant-35583
https://atc.digitellinc.com/p/s/ibox-prognostication-in-kidney-transplant-recipients-who-undergo-belatacept-conversion-for-chronic-active-antibody-mediated-rejection-35584
https://atc.digitellinc.com/p/s/tocilizumab-use-in-chronic-active-antibody-mediated-rejection-caamr-mitigating-risks-with-surveillance-donor-derived-cell-free-dna-and-low-dose-strategy-35585
https://atc.digitellinc.com/p/s/clazakizumab-anti-il6-monoclonal-to-reduce-donor-specific-hla-antibodies-dsa-and-improve-outcomes-in-post-kidney-transplant-patients-with-chronic-active-antibody-mediated-rejection-nct03380377-35586
https://atc.digitellinc.com/p/s/association-of-cxcr5-polymorphisms-with-detection-of-de-novo-donor-specific-antibodies-in-kidney-transplant-recipients-35587
https://atc.digitellinc.com/p/s/spatial-genomics-analysis-of-nk-cells-and-glomerular-endothelium-in-chronic-antibody-mediated-rejection-camr-35588
https://atc.digitellinc.com/p/s/protein-and-micro-rna-expression-distinguish-donor-specific-antibody-plus-kidney-transplant-recipients-with-and-without-antibody-mediated-rejection-35589
https://atc.digitellinc.com/p/s/higher-levels-of-mesangial-expansion-predict-death-censored-graft-loss-35590
https://atc.digitellinc.com/p/s/serum-creatinine-elevation-following-initiation-of-raas-inhibitors-identifies-kidney-transplant-recipients-at-risk-of-hyperfiltration-injury-35591
https://atc.digitellinc.com/p/s/delayed-graft-function-among-kidney-transplant-recipients-is-associated-with-increased-risk-of-infections-35592
https://atc.digitellinc.com/p/s/delayed-kidney-graft-function-in-re-transplantation-and-the-effect-on-graft-and-patient-survival-a-unos-database-analysis-35593
https://atc.digitellinc.com/p/s/impact-of-body-mass-index-on-long-term-outcomes-post-renal-transplantation-35594
https://atc.digitellinc.com/p/s/prediction-of-graft-survival-among-living-donor-kidney-transplant-an-artificial-intellegence-approach-35595
https://atc.digitellinc.com/p/s/outcomes-following-graft-loss-among-patients-who-experience-premature-renal-allograft-failure-35596
https://atc.digitellinc.com/p/s/hyperparathyroidism-during-1st-year-of-renal-transplant-is-associated-with-long-term-graft-loss-35597
https://atc.digitellinc.com/p/s/repeat-hla-class-ii-mismatches-are-associated-with-increased-graft-loss-of-the-second-kidney-transplant-a-contemporary-collaborative-transplant-study-cts-registry-analysis-35598
https://atc.digitellinc.com/p/s/the-age-dependent-difference-in-graft-failure-is-preceded-by-age-dependent-differences-in-de-novo-donor-specific-antibody-development-and-rejection-35599
https://atc.digitellinc.com/p/s/ibox-prognostication-in-kidney-transplant-recipients-who-undergo-belatacept-conversion-for-chronic-active-antibody-mediated-rejection-35600
https://atc.digitellinc.com/p/s/offspring-living-donor-transplant-outcomes-is-the-risk-of-transplant-failure-immune-mediated-35601
https://atc.digitellinc.com/p/s/an-artificial-intelligence-approach-for-prediction-of-worsening-renal-allograft-function-35602
https://atc.digitellinc.com/p/s/eplet-mismatch-predicts-sensitization-in-transplant-failure-patients-35603
https://atc.digitellinc.com/p/s/changes-in-endothelial-and-proximal-tubule-cells-in-focal-segmental-glomerulosclerosis-single-cell-resolution-of-human-renal-allografts-with-recurrent-disease-35604
https://atc.digitellinc.com/p/s/identification-of-apol1-genotype-with-probe-independent-pcr-method-novel-classification-with-haplotypes-35605
https://atc.digitellinc.com/p/s/a-crispr-cas-based-assay-to-genotype-high-risk-variants-in-kidney-transplantation-35606
https://atc.digitellinc.com/p/s/recipient-polygenic-risk-scores-as-a-predictor-of-graft-function-35607
https://atc.digitellinc.com/p/s/a-single-center-experience-of-the-first-100-next-generation-sequencing-renal-gene-panel-testing-during-kidney-transplant-evaluation-35608
https://atc.digitellinc.com/p/s/employing-the-evolving-knowledge-in-gentetic-testing-in-evaluating-kidney-transplant-candidates-35609
https://atc.digitellinc.com/p/s/the-costs-of-pretransplant-services-in-kidney-transplantation-in-the-united-states-implications-for-increasing-transplant-referrals-35610
https://atc.digitellinc.com/p/s/estimating-advance-care-planning-and-palliative-care-consultation-prevalence-and-racial-disparities-among-kidney-transplant-candidates-and-recipients-35611
https://atc.digitellinc.com/p/s/safety-and-efficacy-of-kidney-transplantation-from-donors-with-hiv-to-recipients-with-hiv-results-of-the-multicenter-hope-in-action-study-35612
https://atc.digitellinc.com/p/s/gender-dynamics-among-south-asian-living-kidney-donors-and-kidney-transplant-recipients-35613
https://atc.digitellinc.com/p/s/it-and-8217s-time-to-measure-gfr-before-and-after-living-kidney-donation-35614
https://atc.digitellinc.com/p/s/how-do-social-determinants-affect-the-relationship-between-county-level-ckd-burden-and-the-number-of-kidney-candidates-ever-waiting-35615
https://atc.digitellinc.com/p/s/increases-in-donor-derived-cell-free-dna-prior-to-biopsy-proven-rejection-in-kidney-transplant-35616
https://atc.digitellinc.com/p/s/development-of-prognostic-biomarkers-for-alloimmune-risk-stratification-to-guide-personalised-recipient-care-is-an-unmet-need-in-kidney-transplantation-35617
https://atc.digitellinc.com/p/s/validation-of-the-optimal-torque-teno-virus-range-for-risk-stratification-of-graft-rejection-and-infection-in-kidney-transplant-recipients-by-a-commercial-pcr-35618
https://atc.digitellinc.com/p/s/use-of-polyfunctional-car-t-cells-targeting-glypican-3-to-eliminate-hepatocellular-carcinoma-35619
https://atc.digitellinc.com/p/s/improving-single-cell-rna-sequencing-bioinformatics-of-bk-polyomavirus-bkpyv-infected-human-renal-proximal-tubular-epithelial-cells-reveals-novel-stress-pattern-with-potential-utility-for-renal-biopsy-35620
https://atc.digitellinc.com/p/s/optimizing-urinary-cell-mrna-profiling-of-kidney-allograft-recipients-development-of-a-home-processing-protocol-for-noninvasive-diagnosis-of-t-cell-mediated-rejection-and-bk-virus-nephropathy-35621
https://atc.digitellinc.com/p/s/impact-of-omnigraf-results-on-renal-function-changes-over-a-year-an-interim-report-of-the-trulo-study-35622
https://atc.digitellinc.com/p/s/development-and-validation-of-an-integrative-dd-cfdna-system-to-predict-allograft-rejection-an-international-population-based-study-35623
https://atc.digitellinc.com/p/s/rejection-and-survival-outcomes-in-simultaneous-liver-kidney-transplant-versus-kidney-after-liver-35624
https://atc.digitellinc.com/p/s/comparing-immediate-versus-delayed-calcineurin-inhibitor-use-after-liver-transplant-35625
https://atc.digitellinc.com/p/s/reduction-in-rate-of-post-operative-acute-kidney-injury-with-single-intra-operative-dose-of-steroids-in-transplantation-of-donation-after-cardiac-death-liver-grafts-35626
https://atc.digitellinc.com/p/s/treatment-burden-as-a-novel-risk-factor-for-rehospitalizations-after-kidney-transplantation-35627
https://atc.digitellinc.com/p/s/a-nationwide-analysis-of-utilization-of-hemodialysis-for-hepatorenal-syndrome-in-alcoholic-hepatitis-and-outcomes-with-liver-transplant-35628
https://atc.digitellinc.com/p/s/terlipressin-improves-clinical-outcomes-in-patients-with-hepatorenal-syndrome-type-1-and-systemic-inflammatory-response-syndrome-a-pooled-analysis-of-the-phase-iii-reverse-and-confirm-studies-35629
https://atc.digitellinc.com/p/s/liver-transplant-rates-and-clinical-outcomes-in-patients-with-hepatorenal-syndrome-type-1-and-aclf-grade-0-and-87222-and-serum-creatinine-scr-and-605mgdl-at-baseline-35630
https://atc.digitellinc.com/p/s/prolonged-recipient-warm-ischemia-time-increases-the-occurrence-of-postreperfusion-syndrome-in-deceased-donor-liver-transplantation-with-extended-criteria-donors-35631
https://atc.digitellinc.com/p/s/non-selective-beta-blockers-are-associated-with-increased-risk-of-stage-2-acute-kidney-injury-and-waitlist-mortality-among-liver-transplant-candidates-35632
https://atc.digitellinc.com/p/s/liver-transplantation-restores-a-circulating-environment-that-supports-healthy-platelet-aggregation-within-two-hours-of-reperfusion-35633
https://atc.digitellinc.com/p/s/understanding-the-relationship-between-depression-and-hepatic-encephalopathy-in-decompensated-cirrhosis-35634
https://atc.digitellinc.com/p/s/distinguishing-an-antibody-mediated-rejection-like-state-in-liver-transplants-with-high-expression-of-nk-cell-transcripts-and-ifng-induced-transcripts-35635
https://atc.digitellinc.com/p/s/operational-tolerance-tol-is-associated-with-missense-mutations-in-immune-deficiency-genes-that-regulate-b-cell-function-35636
https://atc.digitellinc.com/p/s/interplay-between-intrahepatic-macrophages-and-alloreactive-and-regulatory-t-cells-mediates-the-complex-alloimmune-microenvironment-during-acute-rejection-in-clinical-liver-transplantation-35637
https://atc.digitellinc.com/p/s/plasma-cell-rich-rejection-occurring-in-autoimmune-hepatitis-liver-transplant-recipients-an-entity-adding-to-the-conundrum-of-antibody-mediated-rejection-35638
https://atc.digitellinc.com/p/s/phenotypic-personalized-medicine-to-guide-immunosuppression-management-in-liver-transplantation-35639
https://atc.digitellinc.com/p/s/desensitization-of-highly-sensitized-patients-undergoing-living-donor-liver-transplant-to-improve-post-transplant-outcomes-35640
https://atc.digitellinc.com/p/s/risk-factors-for-antibody-mediated-rejection-in-abo-blood-type-incompatible-and-donor-specific-antibody-positive-liver-transplantation-35641
https://atc.digitellinc.com/p/s/q-and-a-35642
https://atc.digitellinc.com/p/s/dynamic-changes-during-the-6-month-waiting-period-predict-waitlist-outcome-in-liver-transplant-candidates-with-hepatocellular-carcinoma-35643
https://atc.digitellinc.com/p/s/phase-i-study-of-adjuvant-immunotherapy-using-donor-liver-natural-killer-cells-for-liver-transplant-recipients-with-hepatocellular-carcinoma-35644
https://atc.digitellinc.com/p/s/a-prospective-multicenter-validation-of-retreat-for-post-transplant-hepatocellular-carcinoma-recurrence-prediction-35645
https://atc.digitellinc.com/p/s/prognostic-gene-signature-present-within-background-liver-parenchyma-of-transplant-recipients-with-hepatocellular-carcinoma-35646
https://atc.digitellinc.com/p/s/dendritic-cell-based-immunotherapy-for-recurrent-hepatocellular-carcinoma-after-liver-transplantation-35647
https://atc.digitellinc.com/p/s/impact-of-immune-checkpoint-inhibitors-pre-transplantation-intention-to-treat-outcomes-from-a-multi-center-study-35648
https://atc.digitellinc.com/p/s/unaccounted-tumor-deposits-in-pathologic-specimens-of-patients-with-colorectal-liver-metastases-treated-with-liver-transplantation-35649
https://atc.digitellinc.com/p/s/living-donor-liver-transplantation-for-colorectal-cancer-liver-metastases-midterm-outcomes-at-a-single-center-in-north-america-35650
https://atc.digitellinc.com/p/s/liver-transplantation-with-neoadjuvant-therapy-or-resection-in-localized-intrahepatic-cholangiocarcinoma-a-national-cancer-database-analysis-35651
https://atc.digitellinc.com/p/s/effect-of-ischemia-free-liver-transplantation-vs-conventional-liver-transplantation-on-complications-relatedto-ischemia-reperfusion-injury-in-patients-with-end-stage-liver-disease-35652
https://atc.digitellinc.com/p/s/multi-center-liver-allograft-and-patient-outcomes-after-thoracoabdominal-normothermic-regional-perfusion-for-donation-after-circulatory-death-donors-35653
https://atc.digitellinc.com/p/s/early-outcomes-and-hospital-resource-utilization-after-liver-transplantation-impact-of-normothermic-mechanical-perfusion-in-a-high-volume-us-dcd-liver-transplant-center-35654
https://atc.digitellinc.com/p/s/ex-situ-end-ischemic-hypothermic-oxygenated-perfusion-hope-versus-static-cold-storage-prior-to-liver-transplantation-positive-interim-results-of-the-bridge-to-hope-pivotal-multicenter-randomized-contr-35655
https://atc.digitellinc.com/p/s/classified-analysis-and-proposal-of-surgical-indications-for-ex-vivo-liver-resection-and-autotransplantation-35656
https://atc.digitellinc.com/p/s/comparison-of-pure-laparoscopic-donor-right-posterior-sectionectomy-versus-right-hemihepatectomy-for-living-donor-liver-transplantation-35657
https://atc.digitellinc.com/p/s/living-liver-donor-exclusion-rate-at-university-of-pittsburgh-medical-center-35658
https://atc.digitellinc.com/p/s/risk-factors-associated-with-surgical-morbidities-of-laparoscopic-living-liver-donors-35659
https://atc.digitellinc.com/p/s/an-intention-to-treat-analysis-of-live-donor-liver-transplantation-vs-deceased-donor-liver-transplantation-for-patients-with-autoimmune-liver-diseases-35660
https://atc.digitellinc.com/p/s/role-of-splenic-volume-in-predicting-early-allograft-dysfunction-following-adult-live-donor-liver-transplantation-35661
https://atc.digitellinc.com/p/s/a-safe-strategy-for-sequential-living-donor-liver-donation-following-living-donor-kidney-donation-35662
https://atc.digitellinc.com/p/s/geographic-disparities-in-utilization-of-living-donor-liver-transplants-for-racial-and-ethnic-minorities-in-the-united-states-35663
https://atc.digitellinc.com/p/s/who-donates-to-whom-in-living-donor-liver-transplantation-exploring-the-intersection-of-race-and-gender-35664
https://atc.digitellinc.com/p/s/future-liver-remnant-less-than-30-percent-is-not-contraindication-to-living-donor-right-hepatectomy-35665
https://atc.digitellinc.com/p/s/improved-waitlist-outcomes-in-liver-transplant-patients-with-mid-meld-scores-listed-in-aggressive-centers-toward-donation-after-cardiac-death-35666
https://atc.digitellinc.com/p/s/the-paradox-of-splitting-the-liver-doubling-the-impact-yet-moving-in-the-wrong-direction-35667
https://atc.digitellinc.com/p/s/expansion-of-the-liver-donor-pool-by-portable-normothermic-machine-perfusion-nmp-single-center-experience-of-108-donor-livers-preserved-with-nmp-35668
https://atc.digitellinc.com/p/s/living-donor-wellness-program-for-overweightobese-and-steatotic-living-donor-liver-transplantation-donors-35669
https://atc.digitellinc.com/p/s/normothermic-mechanical-perfusion-nmp-significantly-reduces-the-risk-of-ischemic-cholangiopathy-in-recipients-of-donation-after-cardiac-death-dcd-liver-transplants-35670
https://atc.digitellinc.com/p/s/first-report-of-the-organ-care-system-liver-perfusion-registry-organ-utilization-and-transplant-outcomes-35671
https://atc.digitellinc.com/p/s/recovery-of-warm-ischemic-rat-livers-through-machine-perfusion-mediated-apoptosis-inhibition-35672
https://atc.digitellinc.com/p/s/a-comparison-of-living-donor-liver-transplant-ldlt-and-donor-after-cardiac-death-dcd-is-there-a-superior-option-35673
https://atc.digitellinc.com/p/s/impact-of-acuity-circles-model-for-liver-allocation-on-liver-transplantation-for-patients-with-alcohol-associated-liver-disease-35674
https://atc.digitellinc.com/p/s/meld-is-a-poor-predictor-of-liver-transplant-futility-compared-with-biomarkers-of-severe-pre-transplant-immune-dysfunction-35675
https://atc.digitellinc.com/p/s/local-liver-procurement-post-adoption-of-acuity-circles-does-not-impact-graft-survival-35676
https://atc.digitellinc.com/p/s/mmat-3-policy-implementation-is-associated-with-decreased-access-to-transplant-and-increased-use-of-higher-risk-allografts-for-hepatocellular-carcinoma-patients-35677
https://atc.digitellinc.com/p/s/must-peth-a-multicenter-study-of-social-determinants-of-health-and-biochemical-alcohol-relapse-in-patients-transplanted-for-alcohol-associated-liver-disease-35678
https://atc.digitellinc.com/p/s/use-of-the-claims-based-frailty-index-for-pre-transplant-mortality-in-cirrhosis-patients-with-low-meld-na-35679
https://atc.digitellinc.com/p/s/predicting-of-success-in-combined-cardiac-surgery-and-liver-transplant-the-lt-plus-cs-risk-score-35680
https://atc.digitellinc.com/p/s/racial-and-ethnic-disparities-in-liver-transplantation-for-alcohol-associated-liver-diseases-in-the-united-states-35681
https://atc.digitellinc.com/p/s/where-you-live-matters-patients-with-cirrhosis-living-in-more-deprived-neighborhoods-are-associated-with-lower-survival-and-transplant-wait-listing-35682
https://atc.digitellinc.com/p/s/asymmetry-in-non-standard-graft-use-by-centers-and-the-impact-on-low-meld-score-liver-transplant-rates-35683
https://atc.digitellinc.com/p/s/immediate-extubation-after-pediatric-liver-transplantation-update-on-a-single-center-experience-35684
https://atc.digitellinc.com/p/s/regional-transcriptomes-reveal-differential-enrichment-of-mechanisms-and-novel-drug-targets-in-liver-allografts-with-acute-cellular-rejection-acr-35685
https://atc.digitellinc.com/p/s/auxiliary-partial-orthotopic-liver-transplant-in-children-with-acute-liver-failure-the-gold-standard-35686
https://atc.digitellinc.com/p/s/immediate-revascularization-of-early-hepatic-artery-thrombosis-after-pediatric-liver-transplant-is-it-worth-it-35687
https://atc.digitellinc.com/p/s/utilization-of-normothermic-machine-perfusion-in-pediatric-donor-livers-35688
https://atc.digitellinc.com/p/s/liver-acuity-circles-allocation-impact-on-children-on-the-waitlist-35689
https://atc.digitellinc.com/p/s/the-accuracy-of-non-standardized-meldpeld-score-exceptions-in-the-pediatric-liver-allocation-system-35690
https://atc.digitellinc.com/p/s/q-and-a-35691
https://atc.digitellinc.com/p/s/identifying-predictors-of-post-liver-transplant-alcohol-relapse-a-1200-patient-single-center-analysis-35692
https://atc.digitellinc.com/p/s/must-peth-low-rates-of-biochemical-alcohol-relapse-after-liver-transplantation-for-alcohol-associated-liver-disease-in-a-multicenter-cohort-35693
https://atc.digitellinc.com/p/s/choledochoplasty-is-associated-with-increased-risk-of-early-biliary-complications-in-liver-transplantation-35694
https://atc.digitellinc.com/p/s/srtr-outcomes-of-liver-retransplantation-in-children-strategies-are-needed-to-avoid-waitlist-mortality-35695
https://atc.digitellinc.com/p/s/disparity-in-access-to-tpn-35696
https://atc.digitellinc.com/p/s/assessment-of-genetic-disease-in-living-donor-candidates-without-an-established-diagnosis-in-their-related-recipients-35697
https://atc.digitellinc.com/p/s/reclassifying-rejection-in-3258-heart-transplant-biopsies-using-optimized-algorithms-35698
https://atc.digitellinc.com/p/s/landscape-and-outcomes-of-heart-transplantation-in-recipients-with-hiv-35699
https://atc.digitellinc.com/p/s/impact-of-continuously-elevated-donor-derived-cell-free-dna-levels-on-clinical-outcomes-in-heart-transplant-patients-35700
https://atc.digitellinc.com/p/s/roadmap-to-improved-outcomes-after-heart-transplantation-look-east-35701
https://atc.digitellinc.com/p/s/elastography-does-not-predict-cirrhosis-in-patients-referred-for-advanced-heart-failure-therapies-35702
https://atc.digitellinc.com/p/s/post-transplantation-outcome-of-sensitized-heart-failure-patients-in-korea-35703
https://atc.digitellinc.com/p/s/development-of-a-machine-learning-model-to-predict-textbook-outcomes-in-lung-transplant-patients-35704
https://atc.digitellinc.com/p/s/proximal-esophageal-reflux-important-predictor-of-mortality-post-lung-transplantation-35705
https://atc.digitellinc.com/p/s/waitlist-and-post-transplant-outcomes-among-lung-transplant-patients-with-covid-19-associated-pulmonary-diagnoses-in-the-united-states-35706
https://atc.digitellinc.com/p/s/assessment-of-antimetabolite-intolerance-in-older-lung-transplant-recipients-35707
https://atc.digitellinc.com/p/s/human-antigen-r-hur-dictates-ceacam1-cytoprotection-in-liver-injury-in-mouse-and-humans-35708
https://atc.digitellinc.com/p/s/staying-on-beat-use-of-beta-blockers-and-rate-of-atrial-fibrillation-in-post-operative-lung-transplant-35709
https://atc.digitellinc.com/p/s/landscape-and-outcomes-of-lung-transplantation-in-recipients-with-hiv-35710
https://atc.digitellinc.com/p/s/immune-outcomes-of-lung-transplant-recipients-with-different-cytochrome-p450-cyp-3a5-phenotypes-after-discontinuation-of-voriconazole-antifungal-prophylaxis-35711
https://atc.digitellinc.com/p/s/changes-to-kidney-pancreas-waiting-time-criteria-improved-equity-without-adverse-impact-on-post-transplant-outcomes-35712
https://atc.digitellinc.com/p/s/the-pancreas-graft-response-to-oral-glucose-challenge-in-type-1-vs-type-2-diabetes-35713
https://atc.digitellinc.com/p/s/understanding-barriers-and-potential-strategies-to-increase-pancreas-transplantation-in-the-united-states-a-delphi-survey-of-us-transplant-professionals-35714
https://atc.digitellinc.com/p/s/covid-19-caused-higher-mortality-in-simultaneous-pancreaskidney-transplants-in-patients-with-dm-type-2-35715
https://atc.digitellinc.com/p/s/expansion-and-differentiation-of-adult-human-islet-cell-precursors-for-islet-cell-transplantation-35716
https://atc.digitellinc.com/p/s/pancreas-after-kidney-transplantation-outcomes-over-the-past-20-years-in-the-usa-35717
https://atc.digitellinc.com/p/s/the-utility-of-robotic-assisted-pancreas-transplants-a-single-center-retrospective-study-35718
https://atc.digitellinc.com/p/s/utilization-of-non-insulin-antidiabetic-agents-following-pancreas-transplantation-35719
https://atc.digitellinc.com/p/s/the-first-collective-examination-of-immunosuppressive-practices-among-american-intestinal-transplant-centers-35720
https://atc.digitellinc.com/p/s/reduced-access-to-multivisceral-transplantation-after-liver-acuity-circles-implementation-35721
https://atc.digitellinc.com/p/s/first-report-with-medium-term-follow-up-of-intestinal-transplantation-for-advanced-and-recurrent-non-resectable-pseudomyxoma-peritonei-35722
https://atc.digitellinc.com/p/s/outcomes-of-small-intestinalmulti-visceral-transplant-recipients-infected-with-sars-cov-2-35723
https://atc.digitellinc.com/p/s/a-risk-factor-analysis-of-donor-specific-factors-on-one-and-three-year-post-transplant-mortality-after-multi-visceral-transplantation-35724
https://atc.digitellinc.com/p/s/single-cell-analysis-reveals-distinct-t-cell-receptor-repertoire-of-ex-vivo-expanded-human-antigen-specific-t-regulatory-cell-enriched-line-astrl-35725
https://atc.digitellinc.com/p/s/long-term-nationwide-outcomes-of-solid-organ-transplantation-from-covid-positive-donors-in-the-united-states-35726
https://atc.digitellinc.com/p/s/impact-of-ocs-liver-perfusion-time-on-post-transplant-survival-real-world-clinical-experience-from-the-ocs-liver-perfusion-olp-post-approval-us-registry-35727
https://atc.digitellinc.com/p/s/transplant-rates-and-outcomes-of-organs-recovered-from-the-national-cohort-of-normothermic-regional-perfusion-nrp-donors-35728
https://atc.digitellinc.com/p/s/hypothermic-oxygenated-machine-perfusion-hmp-o2-in-liver-transplantation-the-pilottm-experience-35729
https://atc.digitellinc.com/p/s/single-center-experience-utilizing-thoracoabdominal-normothermic-regional-perfusion-for-cardiac-and-liver-recovery-in-donation-after-circulatory-death-donors-35730
https://atc.digitellinc.com/p/s/6-month-outcomes-of-liver-and-kidney-transplantation-from-donation-after-circulatory-death-heart-donors-in-the-us-35731
https://atc.digitellinc.com/p/s/extended-subzero-kidney-preservation-with-peptoid-based-cryoprotectants-35732
https://atc.digitellinc.com/p/s/sensitivity-and-specificity-of-biomarkers-in-perfusate-and-bile-during-orphan-liver-normothermic-machine-perfusion-to-predict-post-transplant-outcomes-35733
https://atc.digitellinc.com/p/s/financial-burden-after-liver-transplantation-in-a-large-us-national-patient-cohort-35734
https://atc.digitellinc.com/p/s/acuity-circle-policy-associated-with-persistent-racial-and-ethnic-disparities-in-waitlist-outcomes-and-access-to-liver-transplant-35735
https://atc.digitellinc.com/p/s/racial-and-socioeconomic-disparities-in-patients-receiving-heart-or-lung-transplantation-35736
https://atc.digitellinc.com/p/s/how-big-is-our-blind-spot-estimating-the-burden-of-organ-failure-unmet-by-transplantation-an-analysis-by-the-ast-setting-the-tent-work-group-35737
https://atc.digitellinc.com/p/s/identifying-and-understanding-variation-in-population-based-access-to-liver-transplantation-in-the-united-states-35738
https://atc.digitellinc.com/p/s/racial-disparities-in-access-to-liver-transplantation-in-the-united-states-35739
https://atc.digitellinc.com/p/s/patient-disparities-in-consent-for-hcv-nat-plus-solid-organ-transplant-35740
https://atc.digitellinc.com/p/s/hidden-hla-antibodies-in-non-european-transplant-candidates-35741
https://atc.digitellinc.com/p/s/anthropometrics-in-the-intestinal-transplant-population-35742
https://atc.digitellinc.com/p/s/dynamic-expression-of-hla-class-ii-molecules-on-human-glomerular-endothelial-cells-35743
https://atc.digitellinc.com/p/s/the-effect-of-social-issues-and-the-impact-of-mass-media-expressed-in-portal-on-organ-donation-in-korea-35744
https://atc.digitellinc.com/p/s/multi-institutional-validation-of-automated-ai-banff-lesion-score-predictions-from-renal-allograft-biopsies-35745
https://atc.digitellinc.com/p/s/a-visualization-model-for-health-related-big-data-personalized-patient-contextualization-after-kidney-transplantation-35746
https://atc.digitellinc.com/p/s/community-level-social-vulnerability-and-liver-waitlisting-and-transplantation-of-cirrhosis-patients-35747
https://atc.digitellinc.com/p/s/kidney-graft-outcomes-following-pediatric-blood-group-incompatible-transplantation-a-comparative-study-using-unos-database-analysis-35748
https://atc.digitellinc.com/p/s/identification-of-novel-liver-transplant-biopsies-phenotypes-associated-with-distinct-biological-profiles-and-allograft-survival-35749
https://atc.digitellinc.com/p/s/global-trends-in-gender-authorship-in-high-impact-transplant-journals-a-10-year-analysis-35750
https://atc.digitellinc.com/p/s/impact-of-liver-transplant-lt-advanced-practice-providers-apps-a-single-center-study-35751
https://atc.digitellinc.com/p/s/effect-of-a-multidisciplinary-team-to-reduce-post-heart-transplant-dialysis-and-length-of-stay-35752
https://atc.digitellinc.com/p/s/a-novel-intra-operative-score-to-predict-delayed-graft-function-in-renal-transplantation-35753
https://atc.digitellinc.com/p/s/patient-characteristics-of-30-and-90-day-readmissions-after-liver-transplantation-35754
https://atc.digitellinc.com/p/s/a-propensity-score-matched-analysis-of-liver-transplantation-outcomes-in-the-setting-of-preservation-solution-shortage-35755
https://atc.digitellinc.com/p/s/heart-liver-kidney-transplantation-for-al-amyloidosis-using-normothermic-recovery-and-storage-from-a-donor-following-circulatory-death-short-term-outcome-in-a-first-in-world-experience-35756
https://atc.digitellinc.com/p/s/pregnancy-after-kidney-transplantation-impact-of-functional-renal-reserve-on-allograft-outcome-and-maternal-health-35757
https://atc.digitellinc.com/p/s/screening-pattern-and-rate-of-return-to-alcohol-use-in-patients-following-liver-transplantation-35758
https://atc.digitellinc.com/p/s/practice-and-challenges-of-pancreas-allograft-biopsies-a-survey-of-us-transplant-centers-35759
https://atc.digitellinc.com/p/s/a-provider-survey-on-preparedness-planning-discussions-in-transplantation-35760
https://atc.digitellinc.com/p/s/outcomes-of-a-structured-transition-program-in-liver-transplant-extending-transition-into-adult-care-for-the-emerging-adult-35761
https://atc.digitellinc.com/p/s/cmv-in-association-with-important-outcomes-in-kidney-transplantation-35762
https://atc.digitellinc.com/p/s/real-world-experience-with-cmv-insight-t-cell-immunity-testing-in-kidney-and-pancreas-transplant-recipients-35763
https://atc.digitellinc.com/p/s/renal-transplantation-can-be-performed-safely-without-pre-operative-apixaban-reversal-35764
https://atc.digitellinc.com/p/s/real-life-clinical-implementation-and-validation-of-a-strategy-based-on-cmv-specific-cell-mediated-immunity-to-guide-cmv-preventive-therapy-in-kidney-transplantation-35765
https://atc.digitellinc.com/p/s/assessing-viral-kinetics-in-sot-recipients-receiving-maribavir-for-resistantrefractory-cmv-infection-andor-disease-35766
https://atc.digitellinc.com/p/s/outcome-characteristics-by-organ-involvement-or-non-destructive-type-in-a-large-3-center-cohort-of-post-transplant-lymphoproliferative-disorders-ptld-35767
https://atc.digitellinc.com/p/s/tabelecleucel-for-epstein-barr-virus-positive-post-transplant-lymphoproliferative-disease-after-failure-of-rituximab-and-177-chemotherapy-following-solid-organ-or-allogeneic-hematopoietic-cell-transpl-35768
https://atc.digitellinc.com/p/s/optimizing-epstein-barr-virus-surveillance-in-thoracic-transplantation-for-early-diagnosis-of-post-transplant-lymphoproliferative-disorder-35769
https://atc.digitellinc.com/p/s/epstein-barr-virus-associated-post-transplant-lymphoproliferative-disorders-in-pediatric-transplantation-a-prospective-multicenter-study-in-the-united-states-35770
https://atc.digitellinc.com/p/s/deceased-donor-kidney-transplantation-in-sars-cov-2-positive-recipients-35771
https://atc.digitellinc.com/p/s/clinical-characteristics-and-clinical-outcomes-of-solid-organ-transplant-recipients-with-secondary-invasive-fungal-infections-after-covid-19-35772
https://atc.digitellinc.com/p/s/impact-of-covid-19-on-belatacept-and-tacrolimus-treated-kidney-transplant-recipients-from-a-prospective-randomized-multicenter-trial-35773
https://atc.digitellinc.com/p/s/effectiveness-and-feasibility-of-using-nirmatrelvirritonavir-in-solid-organ-transplant-recipients-with-mild-covid-19-35774
https://atc.digitellinc.com/p/s/t-cell-repertoire-profiling-in-allografts-and-native-tissues-in-recipients-with-covid-19-after-solid-organ-transplantation-insight-into-t-cell-mediated-allograft-protection-from-viral-infection-35775
https://atc.digitellinc.com/p/s/implementation-of-clinical-work-flow-for-management-of-covid-positive-solid-organ-transplant-recipients-sotrs-with-nirmatrelvirritonavir-paxlovid-across-a-wide-geography-35776
https://atc.digitellinc.com/p/s/pre-exposure-tixagevimabcilgavimab-monoclonal-antibodies-reduces-severe-covid-19-infection-in-lung-transplant-recipients-35777
https://atc.digitellinc.com/p/s/variant-specific-neutralization-activity-against-ba45-with-tixagevimabcilgavimab-in-transplant-recipients-35778
https://atc.digitellinc.com/p/s/increased-mortality-in-kidney-transplant-recipients-during-the-covid-19-era-35779
https://atc.digitellinc.com/p/s/clinical-outcomes-of-sars-cov2-infection-in-kidney-transplant-recipients-receiving-belatacept-a-single-center-experience-35780
https://atc.digitellinc.com/p/s/effectiveness-of-tixagevimabcilgavimab-during-the-ba5-omicron-period-35781
https://atc.digitellinc.com/p/s/longitudinal-outcomes-of-covid-19-in-a-large-cohort-of-transplant-recipients-2020-2022-35782
https://atc.digitellinc.com/p/s/trends-in-kidney-transplant-outcomes-in-older-adults-before-and-after-covid-19-pandemic-onset-35783
https://atc.digitellinc.com/p/s/heartcare-across-the-age-spectrum-35784
https://atc.digitellinc.com/p/s/coccidioidomycosis-testing-and-infection-among-solid-organ-transplant-recipients-in-california-1990-2022-35785
https://atc.digitellinc.com/p/s/incidence-of-invasive-fungal-infections-in-abdominal-solid-organ-transplant-recipients-using-a-high-risk-aspergillus-prophylaxis-protocol-35786
https://atc.digitellinc.com/p/s/infectious-complications-of-lung-transplant-for-covid-associated-lung-injury-cali-a-single-center-case-control-cohort-study-35787
https://atc.digitellinc.com/p/s/duration-of-anti-fungal-therapy-in-patients-with-cryptococcosis-following-solid-organ-transplantation-35788
https://atc.digitellinc.com/p/s/covid-19-associated-pulmonary-aspergillosis-among-solid-organ-transplant-recipients-in-the-icu-an-international-case-control-study-35789
https://atc.digitellinc.com/p/s/a-multicenter-case-series-of-mpox-in-transplant-recipients-35790
https://atc.digitellinc.com/p/s/deciphering-the-true-immunologic-risk-in-renal-transplantation-in-patients-with-hiv-35791
https://atc.digitellinc.com/p/s/list-diving-to-allocate-kidneys-to-lower-waitlist-priority-candidates-35792
https://atc.digitellinc.com/p/s/effect-of-mtors-vs-cni-on-lipid-levels-in-renal-transplant-recipients-and-the-role-of-the-pcsk-9-inhibitors-in-lipid-management-35793
https://atc.digitellinc.com/p/s/clinical-effect-of-early-statin-uses-in-kidney-transplant-recipients-results-from-the-know-kt-study-35794
https://atc.digitellinc.com/p/s/long-term-nodat-outcomes-from-a-prospective-randomized-trial-of-belatacept-based-versus-tacrolimus-based-early-corticosteroid-withdrawal-regimens-35795
https://atc.digitellinc.com/p/s/remission-of-diabetes-mellitus-in-kidney-transplant-recipients-with-pre-transplant-diabetes-a-multicenter-1-year-prospective-study-35796
https://atc.digitellinc.com/p/s/efficacy-and-safety-of-glucose-like-peptide-1-receptor-agonist-glp1-ra-in-patients-with-diabetes-who-underwent-kidney-transplantation-kt-a-potential-approach-to-improve-post-transplant-metabolic-outco-35797
https://atc.digitellinc.com/p/s/renal-benefits-of-glucagon-like-peptide-1-receptor-agonists-after-kidney-transplantation-35798
https://atc.digitellinc.com/p/s/are-sodium-glucose-co-transporter-2-inhibitors-sglt2i-safe-to-use-in-kidney-transplant-recipients-with-diabetes-35799
https://atc.digitellinc.com/p/s/thrombotic-risk-in-kidney-transplant-recipients-treated-with-sglt2-inhibitors-35800
https://atc.digitellinc.com/p/s/association-of-variabilities-in-body-mass-index-and-metabolic-parameters-with-kidney-outcomes-after-kidney-transplantation-35801
https://atc.digitellinc.com/p/s/disparate-impact-of-inactive-status-on-the-kidney-transplant-waitlist-results-in-worsening-racial-disparities-in-transplant-access-35802
https://atc.digitellinc.com/p/s/black-donor-race-and-deceased-donor-kidney-utilization-35803
https://atc.digitellinc.com/p/s/long-term-impact-of-immigration-status-on-outcomes-in-undocumented-pediatric-kidney-transplant-recipients-35804
https://atc.digitellinc.com/p/s/transition-of-care-of-stable-kidney-transplant-patients-to-referring-nephrologists-a-national-survey-of-transplant-centers-in-the-united-states-35805
https://atc.digitellinc.com/p/s/persistent-racial-disparities-in-delayed-graft-function-and-implications-for-kidney-transplantation-35806
https://atc.digitellinc.com/p/s/will-transplant-rate-increase-for-candidates-with-lower-socioeconomic-status-if-only-candidates-on-dialysis-earned-waiting-time-35807
https://atc.digitellinc.com/p/s/belatacept-modifies-the-immune-event-risk-associated-with-predicted-indirectly-recognizable-hla-epitopes-pirche-ii-35808
https://atc.digitellinc.com/p/s/hypoxia-driven-proinflammatory-responses-in-pretransplant-peripheral-blood-leads-to-a-high-risk-of-early-acute-rejection-in-kidney-transplant-35809
https://atc.digitellinc.com/p/s/pre-transplant-mitochondrial-respiration-in-human-kidney-allografts-predicts-clinical-outcome-upon-transplantation-35810
https://atc.digitellinc.com/p/s/high-performing-and-multicenter-validated-dynamic-prediction-models-with-longitudinal-measurements-of-serum-creatinine-and-proteinuria-for-death-censored-kidney-graft-failure-35811
https://atc.digitellinc.com/p/s/subclinical-rejection-free-diagnostic-after-kidney-transplantation-using-blood-gene-expression-35812
https://atc.digitellinc.com/p/s/association-between-abdominal-ct-measurements-of-body-composition-and-waitlist-mortality-in-kidney-transplant-candidates-35813
https://atc.digitellinc.com/p/s/anthropometrics-use-in-the-intestinal-failure-population-35814
https://atc.digitellinc.com/p/s/adapting-imaging-mass-cytometry-to-explore-renal-allograft-inflammation-and-develop-a-tissue-based-classifier-35815
https://atc.digitellinc.com/p/s/is-it-time-to-extend-donor-ischemic-time-beyond-4-hours-in-heart-transplant-35816
https://atc.digitellinc.com/p/s/utilization-of-heart-machine-perfusion-for-donation-after-cardiac-death-transplantation-does-not-compromise-liver-transplant-outcomes-35817
https://atc.digitellinc.com/p/s/clinical-application-and-outcomes-with-use-of-the-heart-organ-care-system-35818
https://atc.digitellinc.com/p/s/waiting-list-mortality-under-the-new-adult-heart-system-suggests-potential-status-changes-35819
https://atc.digitellinc.com/p/s/impact-of-removing-optn-region-from-heart-transplant-allocation-35820
https://atc.digitellinc.com/p/s/a-novel-heart-allocation-score-predicts-waitlist-survival-better-than-the-current-6-status-heart-allocation-system-35821
https://atc.digitellinc.com/p/s/a-dynamic-calculator-of-waitlist-outcomes-for-adult-heart-transplant-candidates-35822
https://atc.digitellinc.com/p/s/outcomes-of-hepatitis-b-virus-infected-donors-in-heart-transplantation-35823
https://atc.digitellinc.com/p/s/circulating-exosomes-with-liver-kinase-b1-as-a-potential-predictor-for-chronic-lung-allograft-dysfunction-development-in-lung-transplanted-recipients-for-cystic-fibrosis-35824
https://atc.digitellinc.com/p/s/lymphocyte-count-recovery-after-anti-thymocyte-globulin-in-lung-transplant-recipients-35825
https://atc.digitellinc.com/p/s/the-emergence-of-a-survival-advantage-for-bilateral-vs-single-lung-transplant-within-one-year-35826
https://atc.digitellinc.com/p/s/predicting-kidney-injury-in-lung-transplant-recipients-a-multicenter-cohort-study-35827
https://atc.digitellinc.com/p/s/evaluation-of-risk-factors-for-early-post-operative-acute-kidney-injury-after-lung-transplantation-35828
https://atc.digitellinc.com/p/s/complications-of-anticoagulation-in-lung-transplant-recipients-on-concurrent-azole-antifungal-therapy-35829
https://atc.digitellinc.com/p/s/correlation-of-plasma-cell-free-dna-with-molecular-rejection-in-heart-transplant-biopsies-35830
https://atc.digitellinc.com/p/s/a-modern-heart-transplant-rejection-surveillance-protocol-utilizing-cell-free-dna-testing-a-single-center-experience-35831
https://atc.digitellinc.com/p/s/stratification-of-biopsy-confirmed-rejection-severity-using-donor-derived-cell-free-dna-and-gene-expression-profiling-35832
https://atc.digitellinc.com/p/s/impact-of-primary-graft-dysfunction-on-exosomal-liver-kinase-b1-expression-following-lung-transplantation-35833
https://atc.digitellinc.com/p/s/plasma-inflammatory-markers-associated-with-lung-allograft-injury-35834
https://atc.digitellinc.com/p/s/phenotypes-of-chronic-lung-allograft-dysfunction-with-donor-specific-antibodies-after-lung-transplantation-35835
https://atc.digitellinc.com/p/s/validation-of-a-blood-gene-signature-to-predict-chronic-allograft-dysfunction-in-lung-transplantation-35836
https://atc.digitellinc.com/p/s/q-and-a-35837
https://atc.digitellinc.com/p/s/next-generation-sequencing-of-the-microvirome-in-a-cohort-of-renal-transplant-recipients-with-unexplained-viral-syndromes-35838
https://atc.digitellinc.com/p/s/defining-the-landscape-of-educational-experiences-in-transplant-infectious-diseases-a-national-survey-of-id-fellows-35839
https://atc.digitellinc.com/p/s/quantifying-the-relationship-between-tacrolimus-dose-and-post-transplant-relative-abundance-of-clostridioides-difficile-in-kidney-transplant-recipients-with-similar-metabolism-based-on-identical-cyp3a-35840
https://atc.digitellinc.com/p/s/gut-microbiota-dysbiosis-with-differential-abundance-of-ruminococcaceae-is-a-feature-of-vancomycin-resistant-enterococcus-colonization-in-kidney-transplant-recipients-35841
https://atc.digitellinc.com/p/s/the-antimicrobial-stewardship-predicament-while-treating-asymptomatic-bacteriuria-in-kidney-transplant-recipients-a-standpoint-from-all-clinical-trials-35842
https://atc.digitellinc.com/p/s/effect-of-single-strength-trimethoprim-sulfamethoxazole-on-early-post-kidney-transplant-urinary-tract-infections-35843
https://atc.digitellinc.com/p/s/evaluation-of-oral-beta-lactam-step-down-therapy-for-enterobacterales-bacteremia-in-solid-organ-transplant-recipients-35844
https://atc.digitellinc.com/p/s/q-and-a-35845
https://atc.digitellinc.com/p/s/posoleucel-for-bkv-infection-in-kidney-transplant-patients-final-results-from-randomized-placebo-controlled-phase-2-trial-35846
https://atc.digitellinc.com/p/s/pilot-study-of-a-prophylactic-2-week-direct-acting-antiviral-course-for-recipients-of-hepatitis-c-viremic-kidneys-35847
https://atc.digitellinc.com/p/s/would-you-accept-the-same-offer-twice-35848
https://atc.digitellinc.com/p/s/increasing-access-to-living-donor-transplants-by-overcoming-barriers-to-recipients-identifying-a-living-donor-35849
https://atc.digitellinc.com/p/s/10-year-follow-up-cohort-of-the-everolimus-versus-azathioprine-multi-national-prospective-study-focusing-on-intravascular-ultrasound-finding-35850
https://atc.digitellinc.com/p/s/immunomodulatory-microporous-annealed-particle-map-gel-improves-whole-or-dissociated-islet-transplantation-35851
https://atc.digitellinc.com/p/s/prior-viral-infection-primes-cross-reactive-cd8-plus-t-cells-that-respond-to-mouse-heart-allografts-35852
https://atc.digitellinc.com/p/s/3d-bioprinting-of-a-bionic-pancreas-with-a-vascular-system-as-a-macro-device-for-stem-cell-derived-beta-cells-or-knocked-out-xeno-derived-islets-results-of-transplantation-in-large-animals-35853
https://atc.digitellinc.com/p/s/activated-frozen-thawed-mesenchymal-stem-cells-in-humanized-mice-after-induction-of-acute-liver-injury-through-alcohol-binging-response-at-various-doses-35854
https://atc.digitellinc.com/p/s/insulin-independence-of-diabetic-pigs-after-autotransplantation-of-3d-bioprinted-bionic-pancreatic-tissue-petals-35855
https://atc.digitellinc.com/p/s/single-cell-rna-sequencing-reveals-the-pivotal-role-of-irf1-in-macrophages-in-renal-allograft-rejection-35856
https://atc.digitellinc.com/p/s/induction-of-and-8220spontaneous-and-8221-allograft-tolerance-by-pluripotent-stem-cells-35857
https://atc.digitellinc.com/p/s/deciphering-hla-dq-immunogenicity-a-small-step-forward-35858
https://atc.digitellinc.com/p/s/auxiliary-liver-xenotransplantation-technique-in-a-transgenic-pig-to-non-human-primate-model-a-surgical-approach-to-prolong-survival-and-better-understand-graft-rejection-35859
https://atc.digitellinc.com/p/s/supported-by-natera-35860
https://atc.digitellinc.com/p/s/supported-by-an-independent-educational-grant-by-astrazeneca-lp-35861
https://atc.digitellinc.com/p/s/supported-by-caredx-35862
https://atc.digitellinc.com/p/s/supported-by-eurofins-transplant-diagnostics-35863
https://atc.digitellinc.com/p/s/supported-by-and-independent-educations-grant-from-mallinckrodt-35864
https://atc.digitellinc.com/p/s/supported-by-transmedics-35865
https://atc.digitellinc.com/p/s/supported-by-an-independent-educational-grant-from-csl-behring-35866
https://atc.digitellinc.com/p/s/supported-by-an-independent-educational-grant-from-takeda-35867
https://atc.digitellinc.com/p/s/supported-by-and-independent-educational-grant-from-veloxis-35868
https://atc.digitellinc.com/p/s/introduction-35869
https://atc.digitellinc.com/p/s/infection-in-transplantation-what-have-we-learned-from-pigs-35870
https://atc.digitellinc.com/p/s/introduction-35871
https://atc.digitellinc.com/p/s/growing-organs-in-vivo-ips-cell-derived-xeno-created-organs-for-transplantation-35872
https://atc.digitellinc.com/p/s/clinical-35873
https://atc.digitellinc.com/p/s/basic-35874
https://atc.digitellinc.com/p/s/top-bacterial-papers-in-transplant-id-35875
https://atc.digitellinc.com/p/s/top-fungal-papers-in-transplant-id-35876
https://atc.digitellinc.com/p/s/top-viral-papers-in-transplant-id-35877
https://atc.digitellinc.com/p/s/manufacturing-organs-from-patients-own-cells-where-are-we-and-what-it-will-take-to-get-where-we-want-35878
https://atc.digitellinc.com/p/s/strategies-for-leading-a-transplant-program-35879
https://atc.digitellinc.com/p/s/uterus-transplantation-where-are-we-now-and-how-did-we-get-there-35880
https://atc.digitellinc.com/p/s/disparities-in-intestinal-failure-and-transplant-where-are-we-and-how-do-we-improve-35881
https://atc.digitellinc.com/p/s/long-term-living-donor-follow-up-in-the-us-a-pipedream-or-an-imminent-reality-35882
https://atc.digitellinc.com/p/s/late-breaking-impact-perspectives-on-donor-research-victories-and-failures-obstacles-and-opportunities-the-imperative-for-continued-progress-35883
https://atc.digitellinc.com/p/s/b-cell-antibody-autoimmunity-35884
https://atc.digitellinc.com/p/s/machine-perfusion-and-organ-rehabilitation-basic-35885
https://atc.digitellinc.com/p/s/infection-and-immunity-basic-35886
https://atc.digitellinc.com/p/s/biomarkers-35887
https://atc.digitellinc.com/p/s/kidney-chronic-antibody-mediated-rejection-35888
https://atc.digitellinc.com/p/s/kidney-complications-immune-mediated-late-graft-failure-35889
https://atc.digitellinc.com/p/s/hepatic-malignancy-35890
https://atc.digitellinc.com/p/s/liver-meld-allocation-and-recipient-selection-35891
https://atc.digitellinc.com/p/s/pancreas-and-islet-all-topics-35892
https://atc.digitellinc.com/p/s/kidney-biomarkers-2-35893
https://atc.digitellinc.com/p/s/complications-in-lung-transplantation-35894
https://atc.digitellinc.com/p/s/and-8220medical-noncompliance-and-8221-labeling-of-racial-minority-esrd-patients-is-impacting-access-to-renal-transplantation-35895
https://atc.digitellinc.com/p/s/and-8220what-i-desire-from-my-family-physician-and-8221-the-living-kidney-donor-perspective-35896
https://atc.digitellinc.com/p/s/10-year-trends-and-patters-of-kidney-transplantation-according-to-kdpi-score-and-factos-associated-with-allocation-of-higher-kdpi-score-35897
https://atc.digitellinc.com/p/s/18-and-946-glycyrrhetinic-acid-alleviates-ischemia-reperfusion-injury-induced-kidney-fibrosis-by-skewing-macrophage-polarization-towards-m2-phenotype-via-inhibiting-the-nlrirf7-signaling-pathway-35898
https://atc.digitellinc.com/p/s/30-and-365-readmissions-in-patients-with-orthotopic-liver-transplantation-in-a-large-volume-single-center-35899
https://atc.digitellinc.com/p/s/3-day-preservation-of-human-livers-through-supercooling-35900
https://atc.digitellinc.com/p/s/52-months-follow-up-of-a-cohort-in-the-transplant-continuum-after-using-a-new-electronic-medical-record-tool-to-document-transplant-option-discussions-among-patients-with-egfr-and-6020-mlmin173m2-35901
https://atc.digitellinc.com/p/s/a-behavioral-study-on-the-effect-of-incorporating-glomerulosclerosis-into-the-kdpi-on-kidney-offer-acceptance-decisions-35902
https://atc.digitellinc.com/p/s/a-biomarker-of-frailty-and-aging-in-liver-transplant-recipients-35903
https://atc.digitellinc.com/p/s/a-case-of-monkeypox-in-a-kidney-transplant-recipient-living-with-hiv-35904
https://atc.digitellinc.com/p/s/a-comparative-analysis-of-envarsus-once-daily-to-tacrolimus-twice-daily-formulation-in-hispanic-kidney-transplant-recipients-35905
https://atc.digitellinc.com/p/s/a-comprehensive-analysis-of-an-intensive-in-patient-post-transplant-physical-therapy-program-is-it-worth-the-effort-35906
https://atc.digitellinc.com/p/s/a-curious-case-of-subcutaneous-immunoglobulin-and-hla-interaction-35907
https://atc.digitellinc.com/p/s/a-direct-oral-factor-xa-inhibitor-edoxaban-ameriorates-hepatic-ischemia-reperfusion-injury-35908
https://atc.digitellinc.com/p/s/a-grounded-theory-approach-to-understanding-dialysis-providers-and-8217-transplant-referral-decisions-for-patients-with-past-non-adherence-35909
https://atc.digitellinc.com/p/s/a-machine-learning-based-model-for-identification-of-prognostic-factors-and-prediction-of-graft-survival-in-kidney-transplant-patients-35910
https://atc.digitellinc.com/p/s/a-mixed-methods-study-investigating-the-perception-of-telehealth-by-solid-organ-transplant-recipients-35911
https://atc.digitellinc.com/p/s/a-more-informative-model-of-cardiovascular-disease-burden-in-kidney-transplantation-a-new-risk-adjustment-measure-35912
https://atc.digitellinc.com/p/s/a-multi-centre-non-interventional-study-to-assess-the-tolerability-and-effectiveness-of-extended-release-tacrolimus-lcpt-in-de-novo-liver-transplant-patients-35913
https://atc.digitellinc.com/p/s/a-multi-class-neural-network-machine-learning-algorithm-to-diagnose-graft-pathology-in-liver-transplant-recipients-35914
https://atc.digitellinc.com/p/s/a-multidisciplinary-approach-optimizes-access-to-extended-release-tacrolimus-tablets-after-living-donor-kidney-transplantation-35915
https://atc.digitellinc.com/p/s/a-novel-animal-model-for-utilizing-fatty-liver-grafts-and-8212orthotopic-fatty-liver-transplantation-in-mice-35916
https://atc.digitellinc.com/p/s/a-novel-il-2-mutein-induces-regulatory-t-cell-rich-microenvironment-and-leads-to-alloantigen-specific-graft-acceptance-35917
https://atc.digitellinc.com/p/s/a-novel-il-2-mutein-induces-regulatory-t-cell-rich-microenvironment-and-leads-to-alloantigen-specific-graft-acceptance-35918
https://atc.digitellinc.com/p/s/a-novel-mathematical-simulation-to-predict-liver-hemodynamic-alterations-for-living-donor-livertransplantation-and-partial-liver-resections-35919
https://atc.digitellinc.com/p/s/a-novel-ror-and-947t-inverse-agonist-to-target-th17-in-sensitized-skin-allograft-mouse-model-35920
https://atc.digitellinc.com/p/s/a-novel-source-of-vertebral-bone-adherent-mesenchymal-stem-cells-with-potent-immunoregulatory-function-35921
https://atc.digitellinc.com/p/s/a-nuanced-look-of-diastolic-dysfunction-and-liver-transplant-outcomes-in-acute-alcohol-associated-hepatitis-35922
https://atc.digitellinc.com/p/s/a-pharmacist-survey-of-utilization-of-sodium-glucose-cotransporter-2-inhibitors-in-solid-organ-transplant-recipients-35923
https://atc.digitellinc.com/p/s/a-possible-association-of-spontaneous-coronary-artery-dissection-in-a-liver-transplant-patient-35924
https://atc.digitellinc.com/p/s/a-pragmatic-tool-to-screen-for-moderate-to-severe-cognitive-impairment-among-candidates-for-liver-transplant-35925
https://atc.digitellinc.com/p/s/a-preliminary-clinical-study-on-safety-and-efficacy-of-ischemia-free-kidney-transplantation-35926
https://atc.digitellinc.com/p/s/a-pro-inflammatory-immune-state-is-influenced-by-perturbations-of-microbial-metabolites-in-renal-transplantation-35927
https://atc.digitellinc.com/p/s/a-quick-and-efficient-method-to-deliver-cardioplegia-during-direct-procurement-of-the-heart-from-a-dcd-donor-35928
https://atc.digitellinc.com/p/s/a-retrospective-outcome-analysis-of-deceased-donor-pediatric-split-vs-whole-liver-transplantation-an-institutional-review-of-20-year-experience-35929
https://atc.digitellinc.com/p/s/a-scoping-review-of-pediatric-transplant-education-35930
https://atc.digitellinc.com/p/s/a-single-center-experience-with-sglt2-inhibitors-treatment-in-renal-transplant-recipients-35931
https://atc.digitellinc.com/p/s/a-stone-left-unturned-a-case-of-primary-hyperoxaluria-in-a-transplant-kidney-35932
https://atc.digitellinc.com/p/s/a-subset-of-effector-tfh-cell-promotes-b-cell-alloimmunity-in-lymph-nodes-and-kidney-grafts-35933
https://atc.digitellinc.com/p/s/a-successful-double-lung-and-kidney-transplant-despite-strongly-positive-t-and-b-cell-cross-match-35934
https://atc.digitellinc.com/p/s/aav9-mediated-gene-delivery-to-liver-grafts-during-static-cold-storage-in-a-rat-liver-transplant-model-35935
https://atc.digitellinc.com/p/s/abo-incompatible-grafts-are-associated-with-excellent-outcomes-in-pediatric-liver-transplant-recipients-an-important-resource-to-reduce-waitlist-mortality-35936
https://atc.digitellinc.com/p/s/abo-incompatible-adult-living-donor-liver-transplantation-in-high-meld-score-recipients-35937
https://atc.digitellinc.com/p/s/abo-incompatible-kidney-transplantation-reduces-the-incidence-of-de-novo-donor-specific-antibodies-independent-from-the-hla-epitope-mismatch-load-35938
https://atc.digitellinc.com/p/s/absolute-copies-is-better-than-percentage-of-donor-and-8208derived-cell-and-8208free-dna-as-a-marker-of-rejection-and-graft-injury-in-pediatric-kidney-transplantation-35939
https://atc.digitellinc.com/p/s/access-to-liver-transplantation-and-death-from-end-stage-liver-disease-esld-a-district-of-columbia-analysis-35940
https://atc.digitellinc.com/p/s/acellular-ex-vivo-lung-perfusion-silences-pro-inflammatory-pathways-in-human-lung-endothelial-and-epithelial-cells-35941
https://atc.digitellinc.com/p/s/acquired-cystinuria-with-kidney-transplantation-35942
https://atc.digitellinc.com/p/s/activity-measure-for-post-acute-care-and-82166-clicks-and-8217-short-forms-am-pac-and-model-for-end-stage-liver-disease-score-meld-a-retrospective-correlational-study-in-patients-with-end-stage-liver--35943
https://atc.digitellinc.com/p/s/acute-cellular-rejection-after-liver-transplant-is-associated-with-altered-gut-microbiome-composition-35944
https://atc.digitellinc.com/p/s/acute-cellular-rejection-following-liver-transplantation-is-associated-with-fibrinolysis-changes-during-the-perioperative-period-35945
https://atc.digitellinc.com/p/s/acute-cellular-rejection-in-elderly-lung-transplant-recipients-during-first-year-post-transplant-35946
https://atc.digitellinc.com/p/s/addition-of-an-oxygen-carrier-hemo2life-in-preservation-solution-for-preventing-ischemia-reperfusion-injuries-35947
https://atc.digitellinc.com/p/s/addition-of-donor-critical-care-data-improves-performance-of-the-srtr-expected-heart-yield-model-35948
https://atc.digitellinc.com/p/s/address-history-as-a-novel-marker-of-lung-transplant-population-disparities-35949
https://atc.digitellinc.com/p/s/adjusting-for-race-in-metrics-of-organ-procurement-organization-performance-35950
https://atc.digitellinc.com/p/s/advantage-and-feasibility-of-extended-left-lobe-graft-for-adult-to-adult-living-donor-liver-transplantation-35951
https://atc.digitellinc.com/p/s/advantages-of-pcr-blood-testing-vs-default-ab-typing-35952
https://atc.digitellinc.com/p/s/adverse-childhood-experiences-and-pediatric-solid-organ-transplant-long-term-outcomes-single-center-study-35953
https://atc.digitellinc.com/p/s/adverse-effects-of-new-onset-diabetes-after-liver-transplantation-35954
https://atc.digitellinc.com/p/s/advyser-solid-organs-software-35955
https://atc.digitellinc.com/p/s/african-american-transplant-candidates-benefit-from-hla-matching-algorithms-tailored-to-race-35956
https://atc.digitellinc.com/p/s/age-dependent-blood-pressure-measurements-in-renal-transplanted-patients-using-home-monitored-telemedicine-surveillance-35957
https://atc.digitellinc.com/p/s/age-disparities-in-access-to-first-and-repeat-kidney-transplantation-35958
https://atc.digitellinc.com/p/s/aggressive-de-novo-hepatocellular-carcinoma-and-38-cholangiocarcinoma-in-post-kidney-transplant-glecaprevirpibrentasvir-treated-hepatitis-c-infection-35959
https://atc.digitellinc.com/p/s/ai-enabled-digital-support-to-increase-placement-of-hard-to-place-deceased-donor-kidneys-35960
https://atc.digitellinc.com/p/s/alemtuzumab-for-antibody-mediated-chronic-rejection-in-a-sensitized-lung-transplant-recipient-35961
https://atc.digitellinc.com/p/s/alemtuzumab-vs-anti-thymocyte-globulin-in-kidney-transplant-recipients-receiving-a-steroid-free-maintenance-regimen-35962
https://atc.digitellinc.com/p/s/a-lipoic-acid-and-long-term-outcomes-in-kidney-transplantation-35963
https://atc.digitellinc.com/p/s/ambient-air-pollution-and-pediatric-liver-transplant-outcomes-35964
https://atc.digitellinc.com/p/s/ambulance-utilization-by-kidney-transplant-recipients-35965
https://atc.digitellinc.com/p/s/an-intention-to-treat-analysis-of-live-donor-liver-transplantation-vs-deceased-donor-liver-transplantation-for-patients-with-alcoholic-liver-disease-35966
https://atc.digitellinc.com/p/s/an-unexpected-cause-of-kidney-injury-in-a-heart-transplant-patient-unmasking-bk-nephropathy-35967
https://atc.digitellinc.com/p/s/an-update-on-biliary-atresia-liver-transplant-candidate-and-recipient-outcomes-in-the-united-states-35968
https://atc.digitellinc.com/p/s/analysis-of-antithymocyte-globulin-induction-dose-and-incidence-of-post-transplant-lymphoproliferative-disorder-in-ebstein-barr-virus-high-risk-renal-transplant-recipients-35969
https://atc.digitellinc.com/p/s/analysis-of-donor-and-recipient-characteristics-in-donation-after-circulatory-death-kidney-transplants-resulting-in-primary-non-function-35970
https://atc.digitellinc.com/p/s/analysis-of-donor-derived-cell-free-dna-dd-cfdna-in-en-bloc-and-single-kidney-transplants-from-small-pediatric-donors-35971
https://atc.digitellinc.com/p/s/analysis-of-hemodynamic-state-and-oxygen-utilization-of-a-right-lobe-graft-during-living-donor-hepatectomy-35972
https://atc.digitellinc.com/p/s/analysis-of-induction-therapy-in-patients-receiving-a-kidney-after-lung-transplant-35973
https://atc.digitellinc.com/p/s/analysis-of-instagrams-top-transplant-related-content-35974
https://atc.digitellinc.com/p/s/analysis-of-virtual-hla-crossmatch-strategy-for-deceased-donor-kidney-transplantation-35975
https://atc.digitellinc.com/p/s/angiotensin-ii-type-1-receptor-expression-in-pediatric-hepatic-vasculature-35976
https://atc.digitellinc.com/p/s/antibacterial-prophylaxis-regimens-in-adult-orthotopic-liver-transplantation-and-incidence-of-post-operative-bacterial-infections-35977
https://atc.digitellinc.com/p/s/antigen-specific-alloreactive-cd8-plus-t-cells-maintain-clonal-diversity-during-acute-rejection-35978
https://atc.digitellinc.com/p/s/anti-hla-i-igg-fc-agalactosylation-drives-direct-endothelial-cell-activation-via-interferon-alpha-pathway-35979
https://atc.digitellinc.com/p/s/anti-spike-antibody-durability-after-sars-cov-2-vaccination-in-adolescent-solid-organ-transplant-recipients-35980
https://atc.digitellinc.com/p/s/apixaban-levels-in-liver-and-lung-transplant-recipients-receiving-tacrolimus-based-immunosuppression-a-prospective-real-world-pharmacokinetic-study-35981
https://atc.digitellinc.com/p/s/apol1-genetic-risk-factors-eliminates-potential-living-kidney-donors-35982
https://atc.digitellinc.com/p/s/application-of-gene-sequencing-in-pediatric-kidney-transplant-recipients-and-clinical-value-of-accurate-diagnosis-of-primary-nephropathy-35983
https://atc.digitellinc.com/p/s/application-of-spatial-clustering-methods-to-identify-fine-scale-geographic-disparities-in-deceased-donor-kidney-discards-35984
https://atc.digitellinc.com/p/s/application-of-targeted-next-generation-sequencing-for-early-diagnosis-of-donor-derived-toxoplasma-gondii-in-a-heart-transplant-patient-35985
https://atc.digitellinc.com/p/s/applying-hibernation-biochemistry-to-reduce-ischemia-reperfusion-injury-in-solid-organ-transplantation-35986
https://atc.digitellinc.com/p/s/approach-to-improve-microsite-utilization-to-increase-living-donor-referrals-for-potential-kidney-transplant-candidates-35987
https://atc.digitellinc.com/p/s/appropriate-dosing-of-gut-microbial-metabolite-phenylacetylglycine-alleviates-renal-ischemia-reperfusion-injury-35988
https://atc.digitellinc.com/p/s/are-transplant-centers-where-we-need-them-a-geospatial-analysis-of-supply-and-demand-35989
https://atc.digitellinc.com/p/s/artery-preparation-of-donor-liver-with-replacement-right-hepatic-artery-for-normothermic-machine-perfusion-35990
https://atc.digitellinc.com/p/s/artificial-pancreatic-islets-produced-by-3d-bioprinting-inkjet-technology-with-extracellular-matrix-as-an-environment-for-stem-cell-derived-beta-cells-35991
https://atc.digitellinc.com/p/s/assessing-adequacy-of-immunosuppression-late-after-pediatric-liver-transplantation-lt-with-t-cell-alloreactivity-35992
https://atc.digitellinc.com/p/s/assessing-long-term-complications-of-kidney-transplantation-without-intraoperative-ureteral-dj-stent-a-single-center-experience-35993
https://atc.digitellinc.com/p/s/assessing-public-dialogue-about-living-donation-from-anonymous-reddit-users-who-and-8217s-in-the-room-and-what-do-they-share-35994
https://atc.digitellinc.com/p/s/assessing-the-efficacy-of-evusheld-for-prevention-of-sars-cov-2-and-38-omicron-infections-in-solid-organ-transplant-recipients-35995
https://atc.digitellinc.com/p/s/assessing-the-feasibility-of-the-banff-human-organ-transplant-panel-in-diagnosing-antibody-mediated-rejection-in-lung-transplant-biopsies-35996
https://atc.digitellinc.com/p/s/assessing-the-impact-of-calcineurin-versus-mtor-inhibitors-on-homeostatic-repopulation-when-used-with-belatacept-in-a-nonhuman-primate-model-of-kidney-transplantation-35997
https://atc.digitellinc.com/p/s/assessing-the-need-for-cytomegalovirus-antiviral-stewardship-in-high-risk-cardiothoracic-transplant-recipients-35998
https://atc.digitellinc.com/p/s/assessing-the-utility-of-activated-partial-thromboplastin-time-aptt-testing-in-unselected-prospective-living-kidney-donors-35999
https://atc.digitellinc.com/p/s/assessment-of-biofire-and-174-pneumonia-panel-utility-in-lung-transplant-recipients-with-concern-for-respiratory-infection-36000
https://atc.digitellinc.com/p/s/assessment-of-chimerism-by-next-generation-sequencing-a-comparison-to-str-pcr-method-36001
https://atc.digitellinc.com/p/s/assessment-of-induction-antithymocyte-globulin-dose-reduction-on-outcomes-of-de-novo-belatacept-immunosuppression-in-kidney-transplant-recipients-at-risk-for-delayed-graft-function-36002
https://atc.digitellinc.com/p/s/assessment-of-post-transplant-bacteremias-caused-by-extended-spectrum-beta-lactamase-producing-bacteria-among-kidney-transplant-recipients-36003
https://atc.digitellinc.com/p/s/assessment-of-regional-outcomes-of-paediatric-renal-transplantation-in-the-uk-36004
https://atc.digitellinc.com/p/s/assessment-of-treatment-response-between-donor-specific-antibodies-and-forced-expiratory-volume-in-lung-transplant-recipients-with-donor-specific-antibodies-36005
https://atc.digitellinc.com/p/s/association-between-dipstick-proteinuria-and-allograft-outcomes-in-living-donor-kidney-transplant-recipients-36006
https://atc.digitellinc.com/p/s/association-between-donor-derived-cell-free-dna-and-donor-specific-antibodies-and-impact-on-graft-management-a-clinical-experience-study-36007
https://atc.digitellinc.com/p/s/association-between-early-allograft-dysfunction-and-requirement-of-renal-replacement-therapy-in-liver-transplant-recipients-36008
https://atc.digitellinc.com/p/s/association-between-gene-expression-profiling-scores-and-malignancy-in-adult-heart-transplant-recipients-36009
https://atc.digitellinc.com/p/s/association-between-hla-molecular-mismatch-and-histological-rejection-in-kidney-allograft-36010
https://atc.digitellinc.com/p/s/association-between-induction-immunosuppression-and-de-novo-donor-specific-hla-antibody-production-in-combined-kidney-and-pancreas-transplant-recipients-a-single-center-experience-36011
https://atc.digitellinc.com/p/s/association-between-induction-immunosuppression-and-donor-specific-hla-antibodies-in-combined-kidney-and-liver-transplant-recipients-a-single-center-experience-36012
https://atc.digitellinc.com/p/s/association-between-severe-sars-cov-2-infection-and-de-novo-hla-donor-specific-antibody-production-in-lung-transplant-recipients-single-center-study-36013
https://atc.digitellinc.com/p/s/association-of-body-mass-index-with-post-transplant-outcomes-in-liver-transplant-recipients-36014
https://atc.digitellinc.com/p/s/association-of-donor-derived-cell-free-dna-and-histology-in-kidney-transplant-recipients-with-bkpyv-viremia-36015
https://atc.digitellinc.com/p/s/association-of-early-steroid-withdrawal-with-kidney-transplant-outcomes-by-dialysis-vintage-36016
https://atc.digitellinc.com/p/s/association-of-exhausted-t-cell-with-adverse-graft-outcome-in-kidney-transplant-patients-36017
https://atc.digitellinc.com/p/s/association-of-high-priority-exceptions-with-waitlist-mortality-among-heart-transplant-candidates-36018
https://atc.digitellinc.com/p/s/association-of-hla-eplet-mismatch-with-positive-gene-expression-and-dd-cfdna-biomarkers-in-kidney-transplant-recipients-36019
https://atc.digitellinc.com/p/s/association-of-hla-molecular-mismatch-with-risk-and-severity-of-rejection-in-kidney-transplant-recipients-36020
https://atc.digitellinc.com/p/s/association-of-low-socio-economic-status-with-liver-graft-survival-and-graft-failure-due-to-acute-rejection-36021
https://atc.digitellinc.com/p/s/association-of-post-transplant-lymphoproliferative-disorder-with-cumulative-rabbit-anti-thymocyte-globulin-exposure-in-pediatric-renal-transplant-recipients-36022
https://atc.digitellinc.com/p/s/association-of-pre-transplant-dialysis-modality-with-incident-atrial-fibrillation-following-kidney-transplantation-36023
https://atc.digitellinc.com/p/s/association-of-pre-transplant-dialysis-modality-with-incident-atrial-fibrillation-following-kidney-transplantation-36024
https://atc.digitellinc.com/p/s/association-of-serum-activin-level-with-progression-of-chronic-kidney-disease-in-patients-with-kidney-transplantation-results-from-the-know-kt-36025
https://atc.digitellinc.com/p/s/associations-between-slow-graft-function-and-long-term-kidney-transplant-outcomes-36026
https://atc.digitellinc.com/p/s/attitudes-of-patients-with-renal-disease-on-xenotransplantation-a-systematic-review-36027
https://atc.digitellinc.com/p/s/atypical-anti-glomerular-basement-membrane-nephritis-in-the-transplant-36028
https://atc.digitellinc.com/p/s/augmenting-the-us-transplant-registry-with-external-mortality-data-impact-of-enhanced-verification-process-36029
https://atc.digitellinc.com/p/s/away-with-the-ana-does-routine-ana-screening-reduce-high-value-care-in-liver-transplant-evaluation-36030
https://atc.digitellinc.com/p/s/baby-steps-early-outcomes-at-a-pediatric-to-young-adult-transition-program-36031
https://atc.digitellinc.com/p/s/bacteriophage-therapy-for-antibiotic-resistant-nontuberculous-mycobacterium-36032
https://atc.digitellinc.com/p/s/barriers-in-access-to-transplantation-in-central-texas-in-the-setting-of-a-new-transplant-program-36033
https://atc.digitellinc.com/p/s/basiliximab-induction-with-reduced-dose-mycophenolate-in-simultaneous-liver-kidney-transplant-recipients-36034
https://atc.digitellinc.com/p/s/behavioral-resources-and-38-intervention-through-digital-group-education-bridge-an-embedded-group-telehealth-program-builds-self-efficacy-in-liver-transplant-lt-recipients-36035
https://atc.digitellinc.com/p/s/belatacept-conversion-for-refractory-bk-polyoma-virus-nephropathy-in-kidney-transplant-patients-36036
https://atc.digitellinc.com/p/s/belatacept-conversion-in-kidney-transplant-with-or-without-calcineurin-inhibitor-taper-36037
https://atc.digitellinc.com/p/s/belatacept-discontinuation-in-stable-recipients-of-elevated-risk-kidney-transplants-36038
https://atc.digitellinc.com/p/s/belatacept-in-pancreas-transplantation-single-center-experience-36039
https://atc.digitellinc.com/p/s/belatacept-use-in-calcineurin-inhibitor-avoidance-or-minimization-in-kidney-pancreas-and-pancreas-alone-transplants-a-long-term-single-center-experience-36040
https://atc.digitellinc.com/p/s/belatacept-based-immunosuppression-in-heart-transplant-recipients-a-single-center-experience-36041
https://atc.digitellinc.com/p/s/better-hla-matching-improved-kidney-allograft-survival-in-african-american-patients-with-race-adjusted-immunogenicity-thresholds-36042
https://atc.digitellinc.com/p/s/biliary-complications-for-histidine-tryptophan-ketoglutarate-htk-and-university-of-wisconsin-uw-preserved-deceased-donor-liver-grafts-36043
https://atc.digitellinc.com/p/s/biliary-reconstruction-for-multiple-graft-bile-ducts-does-not-impact-posttransplant-outcomes-compared-with-single-graft-bile-duct-during-living-donor-liver-transplantation-36044
https://atc.digitellinc.com/p/s/bioelectrical-impedance-analysis-for-preoperative-volume-assessment-in-living-donor-hepatectomy-36045
https://atc.digitellinc.com/p/s/biomarker-discovery-through-transcriptional-spatial-profiling-of-allograft-biopsy-in-acute-t-cell-mediated-rejection-36046
https://atc.digitellinc.com/p/s/biomarkers-of-cellular-senescence-and-decreased-physical-performance-in-patients-undergoing-kidney-transplantation-36047
https://atc.digitellinc.com/p/s/biomarkers-of-pre-transplant-immune-dysfunction-improve-risk-assessment-of-post-transplant-mortality-compared-with-conventional-clinical-risk-scores-36048
https://atc.digitellinc.com/p/s/bk-polyomavirus-bkpyv-infection-incidence-in-an-elderly-population-following-changes-to-immunosuppression-induction-and-management-36049
https://atc.digitellinc.com/p/s/bk-viremia-after-kidney-transplantation-efficacy-of-stepwise-treatments-36050
https://atc.digitellinc.com/p/s/bk-virus-high-threshold-results-correlation-between-urine-and-blood-samples-36051
https://atc.digitellinc.com/p/s/bk-virus-infection-in-the-current-era-risk-factors-and-outcomes-of-large-kidney-transplant-cohort-36052
https://atc.digitellinc.com/p/s/blinded-after-belatacept-a-case-report-36053
https://atc.digitellinc.com/p/s/blood-based-transcriptomic-changes-during-two-cases-of-pig-to-human-kidney-xenotransplantation-36054
https://atc.digitellinc.com/p/s/bnt162b2-vs-mrna1273-in-solid-organ-transplant-recipients-propensity-score-analysis-of-japanese-national-cohort-study-36055
https://atc.digitellinc.com/p/s/body-surface-area-valganciclovir-prophylactic-dosing-is-associated-with-higher-toxicities-compared-to-body-weight-dosing-in-pediatric-solid-organ-transplant-recipients-36056
https://atc.digitellinc.com/p/s/bone-marrow-from-focal-segmental-glomerulosclerosis-displays-activation-of-inflammatory-pathways-36057
https://atc.digitellinc.com/p/s/brain-abscess-in-solid-organ-transplant-recipients-36058
https://atc.digitellinc.com/p/s/breakdown-of-liver-donor-and-recipient-relationships-at-university-of-pittsburgh-medical-center-36059
https://atc.digitellinc.com/p/s/breakthrough-invasive-fungal-infections-in-lung-transplant-recipients-receiving-universal-prophylaxis-a-single-center-retrospective-study-36060
https://atc.digitellinc.com/p/s/bridge-to-transplant-temporary-mechanical-circulatory-support-and-risk-of-allosensitization-36061
https://atc.digitellinc.com/p/s/bronchial-ring-and-respiratory-cultures-in-lung-transplants-recipients-after-ex-vivo-lung-perfusion-36062
https://atc.digitellinc.com/p/s/building-a-searchable-digital-repository-for-kidney-transplant-biopsies-36063
https://atc.digitellinc.com/p/s/bulk-and-spatial-transcriptomic-analysis-of-preimplantation-kidney-biopsy-identified-interstitial-fibrosis-and-tubular-abnormalities-before-transplantation-36064
https://atc.digitellinc.com/p/s/burden-of-cmv-infections-after-simultaneous-pancreas-kidney-transplantation-a-nationwide-cohort-study-36065
https://atc.digitellinc.com/p/s/can-hla-mismatching-modify-the-associations-between-lymphoma-and-risk-factors-after-kidney-transplantation-an-observational-analysis-36066
https://atc.digitellinc.com/p/s/can-we-turn-back-time-using-non-race-based-egfr-formulas-for-waitlisted-patients-36067
https://atc.digitellinc.com/p/s/can-and-8217t-we-all-just-get-along-comparison-of-cell-free-dna-technologies-36068
https://atc.digitellinc.com/p/s/cancer-prevalence-and-risk-factors-among-korean-solid-organ-transplant-recipients-36069
https://atc.digitellinc.com/p/s/candida-auris-bloodstream-infection-with-left-ventricular-assist-devices-a-retrospective-case-series-36070
https://atc.digitellinc.com/p/s/canonical-gpx4-mediated-ferroptosis-pathway-regulates-ischemia-reperfusion-injury-in-liver-transplantation-36071
https://atc.digitellinc.com/p/s/cardiovascular-decompensation-modifies-the-effect-of-delayed-graft-function-dgf-on-renal-transplant-outcomes-36072
https://atc.digitellinc.com/p/s/cautious-optimism-needed-in-using-dcd-livers-for-retransplantation-36073
https://atc.digitellinc.com/p/s/cd4-plus-t-cell-specific-hif1a-signaling-is-essential-for-th17treg-regulatory-axis-in-liver-transplantation-from-mouse-to-human-36074
https://atc.digitellinc.com/p/s/cd9-a-new-marker-for-regulatory-b-cells-36075
https://atc.digitellinc.com/p/s/cefiderocol-utilization-in-lung-transplant-recipients-at-a-single-center-36076
https://atc.digitellinc.com/p/s/cell-based-assays-for-the-detection-of-class-i-sla-antibodies-36077
https://atc.digitellinc.com/p/s/cell-free-dna-derived-temporal-dynamics-and-trends-of-torque-teno-virus-in-kidney-transplant-36078
https://atc.digitellinc.com/p/s/cellular-and-humoral-immune-response-after-sars-cov-2-vaccination-in-pediatric-kidney-recipients-36079
https://atc.digitellinc.com/p/s/cellular-immunotherapy-with-qa1hla-e-specific-cd8-treg-for-alloimmune-response-modulation-36080
https://atc.digitellinc.com/p/s/center-practices-for-submitting-adult-status-2-heart-exceptions-vary-widely-36081
https://atc.digitellinc.com/p/s/challenging-vascular-situations-in-living-donor-liver-transplantation-36082
https://atc.digitellinc.com/p/s/change-in-organ-offer-volume-and-bypass-filter-settings-under-new-kidney-allocation-system-36083
https://atc.digitellinc.com/p/s/changes-in-cfdna-associated-with-bk-viremia-in-kidney-transplant-recipients-36084
https://atc.digitellinc.com/p/s/changes-in-fontan-associated-liver-disease-following-heart-transplantation-36085
https://atc.digitellinc.com/p/s/changes-in-the-landscape-of-infectious-risk-donor-ird-organs-under-the-new-definition-of-ird-36086
https://atc.digitellinc.com/p/s/changes-of-calculated-panel-reactive-antibody-in-waitlisted-kidney-transplant-candidates-utilizing-the-transplantation-toolbox-36087
https://atc.digitellinc.com/p/s/characterisation-of-deceased-donor-kidney-offers-combining-clinical-expert-knowledge-and-statistical-methods-to-select-relevant-donor-features-for-early-transplant-outcome-36088
https://atc.digitellinc.com/p/s/characteristics-and-outcomes-of-kidney-transplant-recipients-with-rejection-and-marked-elevations-in-donor-derived-cell-free-dna-dd-cfdna-36089
https://atc.digitellinc.com/p/s/characteristics-of-kidney-candidates-with-hla-dpb1-unacceptable-antigen-assignment-36090
https://atc.digitellinc.com/p/s/characteristics-of-kidney-transplant-recipients-with-prolonged-pre-transplant-dialysis-duration-as-identified-by-machine-learning-consensus-clustering-36091
https://atc.digitellinc.com/p/s/characteristics-of-multiple-listed-kidney-candidates-36092
https://atc.digitellinc.com/p/s/characterization-of-antifungal-prophylaxis-in-high-meld-liver-transplant-candidates-36093
https://atc.digitellinc.com/p/s/characterization-of-maribavir-for-management-of-resistant-or-refractory-cytomegalovirus-in-solid-organ-transplant-recipients-36094
https://atc.digitellinc.com/p/s/characterization-of-the-directly-alloreactive-repertoire-of-graft-antigen-specific-cd4-plus-t-cells-in-peripheral-blood-36095
https://atc.digitellinc.com/p/s/characterizing-adult-heart-status-2-exceptions-with-risk-stratification-data-36096
https://atc.digitellinc.com/p/s/characterizing-gene-expression-with-deferoxamine-along-the-ferroptosis-signaling-pathway-using-a-novel-perfusion-regulated-organ-therapeutics-with-enhanced-controlled-testing-system-36097
https://atc.digitellinc.com/p/s/chimerism-analysis-post-hematopoietic-stem-cell-transplantation-by-next-generation-sequencing-a-case-report-36098
https://atc.digitellinc.com/p/s/chronic-active-t-cell-mediated-rejection-a-common-finding-on-renal-allograft-biopsies-36099
https://atc.digitellinc.com/p/s/circulating-tfh-cells-from-dsa-plus-antibody-mediated-rejection-kidney-transplant-recipients-display-stem-like-features-and-decreased-mtorc1-dependency-36100
https://atc.digitellinc.com/p/s/clinical-characteristics-of-talaromyces-marneffei-infection-in-renal-transplant-recipients-36101
https://atc.digitellinc.com/p/s/clinical-experience-with-use-of-budesonide-post-kidney-transplant-in-patients-with-iga-nephropathy-36102
https://atc.digitellinc.com/p/s/clinical-impact-of-incorporating-omnigraf-on-renal-function-36103
https://atc.digitellinc.com/p/s/clinical-management-of-pregnant-transplant-recipients-utilization-of-fetal-fraction-and-dd-cfdna-36104
https://atc.digitellinc.com/p/s/clinical-outcomes-and-cost-analysis-following-normothermic-machine-perfusion-versus-static-cold-storage-for-liver-transplantation-a-single-center-analysis-36105
https://atc.digitellinc.com/p/s/clinical-outcomes-and-histologic-features-of-end-stage-kidney-disease-associated-noncirrhotic-portal-hypertension-36106
https://atc.digitellinc.com/p/s/clinical-outcomes-in-kidney-transplant-recipients-with-nafld-vs-non-nafld-36107
https://atc.digitellinc.com/p/s/clinical-outcomes-of-baloxavir-vs-oseltamivir-in-transplant-and-other-immunocompromised-patients-36108
https://atc.digitellinc.com/p/s/clinical-outcomes-of-lung-transplant-recipients-with-pre-transplant-mycobacterium-avium-complex-infection-36109
https://atc.digitellinc.com/p/s/clinical-relevance-and-characteristics-of-pre-transplant-donor-specific-anti-hla-dq-antibodies-in-kidney-transplantation-36110
https://atc.digitellinc.com/p/s/clinical-relevance-of-preformed-donor-specific-anti-hla-antibody-in-kidney-transplant-recipients-transplanted-in-a-program-based-on-abdr-unacceptable-mismatches-36111
https://atc.digitellinc.com/p/s/clinical-significance-and-risk-factors-of-developing-slow-graft-function-in-immunological-low-risk-deceased-donor-kidney-transplantation-a-single-center-retrospective-study-36112
https://atc.digitellinc.com/p/s/clinical-utility-of-dd-cfdna-in-assessing-incomplete-recovery-of-kidney-function-after-transplantation-36113
https://atc.digitellinc.com/p/s/clinical-utility-of-donor-derived-cell-free-dna-during-the-period-of-recovery-of-renal-function-after-kidney-transplantation-36114
https://atc.digitellinc.com/p/s/clinical-utility-of-hiv-confirmatory-testing-in-the-deceased-donor-organ-transplant-setting-36115
https://atc.digitellinc.com/p/s/clinical-utility-of-oncoguard-liver-test-to-further-classify-indeterminate-liver-lesions-in-a-high-risk-cirrhotic-population-at-risk-for-hcc-36116
https://atc.digitellinc.com/p/s/clinical-utility-of-trugraf-gene-expression-profile-and-trac-dd-cfdna-in-immunosuppressant-adjustments-an-interim-report-of-the-trulo-study-36117
https://atc.digitellinc.com/p/s/clinical-workflow-automation-in-organ-transplantation-36118
https://atc.digitellinc.com/p/s/clinically-significant-cytomegalovirus-infection-is-associated-with-allograft-loss-and-mortality-after-pancreas-transplantation-36119
https://atc.digitellinc.com/p/s/clinically-significant-cytomegalovirus-infection-is-associated-with-increased-mortality-after-heart-transplantation-36120
https://atc.digitellinc.com/p/s/clinicopathological-analyses-of-chronic-renal-allograft-arteriopathy-after-kidney-transplantation-36121
https://atc.digitellinc.com/p/s/cms-final-rule-for-organ-donation-unintended-consequences-of-the-pancreas-research-loophole-36122
https://atc.digitellinc.com/p/s/cmv-t-cell-assays-may-be-useful-in-detecting-mtor-induced-immunity-36123
https://atc.digitellinc.com/p/s/cmv-seropositive-donor-status-in-cmv-seronegative-lung-transplant-recipients-is-associated-with-increased-mortality-across-the-age-span-data-from-the-srtr-36124
https://atc.digitellinc.com/p/s/cognition-and-patient-reported-outcomes-among-liver-transplant-recipients-36125
https://atc.digitellinc.com/p/s/cognitive-outcomes-and-quality-of-life-in-stable-renal-transplant-patients-switched-from-twice-daily-immediate-release-tacrolimus-to-once-daily-extended-release-tacrolimus-envarsus-xr-and-8482-36126
https://atc.digitellinc.com/p/s/combination-of-blood-gene-expression-allomap-and-donor-derived-cell-free-dna-allosure-to-diagnose-allograft-rejection-in-kidney-transplant-recipients-36127
https://atc.digitellinc.com/p/s/combination-of-blood-gene-expression-allomap-and-donor-derived-cell-free-dna-allosure-to-diagnose-allograft-rejection-in-kidney-transplant-recipients-36128
https://atc.digitellinc.com/p/s/combined-genetic-signature-biomarkers-in-the-diagnosis-of-subclinical-rejection-of-transplanted-kidneys-36129
https://atc.digitellinc.com/p/s/combined-impact-of-the-inter-and-intra-patient-variability-of-tacrolimus-blood-level-on-allograft-outcomes-in-kidney-transplantation-36130
https://atc.digitellinc.com/p/s/combined-small-bowel-and-pancreas-transplant-a-case-report-36131
https://atc.digitellinc.com/p/s/comparative-one-year-allograft-outcomes-for-recipients-of-kidneys-from-sars-cov-2-nat-plus-donors-36132
https://atc.digitellinc.com/p/s/comparing-efficacy-of-itraconazole-solution-versus-posaconazole-for-antifungal-prophylaxis-after-heart-transplant-36133
https://atc.digitellinc.com/p/s/comparing-two-devices-for-liver-normothermic-machine-perfusion-at-transplantation-a-pilot-study-36134
https://atc.digitellinc.com/p/s/comparison-of-12-month-outcomes-of-sglt2-inhibitors-between-african-american-and-caucasian-diabetic-kidney-transplant-recipients-36135
https://atc.digitellinc.com/p/s/comparison-of-epts-and-pra-with-an-ai-based-model-to-predict-short-term-transplant-survivorship-36136
https://atc.digitellinc.com/p/s/comparison-of-hemodynamic-and-echocardiographic-findings-in-two-brain-dead-decedent-xenoheart-transplant-recipients-36137
https://atc.digitellinc.com/p/s/comparison-of-high-versus-low-revised-cardiac-risk-index-rcri-score-for-prediction-of-major-cardiovascular-events-mace-in-kidney-transplant-ktxr-36138
https://atc.digitellinc.com/p/s/comparison-of-liver-transplantation-outcomes-by-socioeconomic-factors-in-the-acuity-circles-era-36139
https://atc.digitellinc.com/p/s/comparison-of-long-term-outcomes-in-simultaneous-pancreas-kidney-transplant-versus-simultaneous-deceased-donor-pancreas-and-living-donor-kidney-transplant-36140
https://atc.digitellinc.com/p/s/comparison-of-outcomes-in-unvaccinated-versus-vaccinated-covid-19-kidney-transplant-recipients-is-the-taboo-justified-36141
https://atc.digitellinc.com/p/s/comparison-of-patient-characteristics-and-outcomes-of-left-ventricular-assist-devices-implanted-during-early-and-late-week-36142
https://atc.digitellinc.com/p/s/comparison-of-safety-outcomes-between-weight-based-and-fixed-dose-prednisone-taper-dosing-strategies-after-kidney-transplant-36143
https://atc.digitellinc.com/p/s/comparison-of-the-different-drugs-used-for-covid-19-omicron-in-patients-with-a-kidney-transplant-36144
https://atc.digitellinc.com/p/s/comprehensive-program-to-improve-equity-in-kidney-transplantation-36145
https://atc.digitellinc.com/p/s/confirming-regulatory-function-of-ex-vivo-expanded-human-bregs-tlr-36146
https://atc.digitellinc.com/p/s/content-analysis-of-us-transplant-centers-and-8217-online-covid-19-related-resources-36147
https://atc.digitellinc.com/p/s/continuous-glucose-monitor-use-improves-immediate-post-transplant-glycemic-control-36148
https://atc.digitellinc.com/p/s/continuous-vs-intermittent-subnomothermic-machine-perfusion-of-fasciocutaneous-flaps-in-swine-36149
https://atc.digitellinc.com/p/s/contrast-enhanced-magnetic-resonance-angiography-in-the-early-period-after-renal-transplantation-36150
https://atc.digitellinc.com/p/s/correlation-of-reg-gene-expression-with-degree-of-pancreatic-calcification-and-its-impact-on-graft-function-in-total-pancreatectomy-with-islet-autotransplantation-36151
https://atc.digitellinc.com/p/s/cost-analysis-of-once-daily-extended-release-tacrolimus-and-38-twice-daily-immediate-release-tacrolimus-for-kidney-transplant-recipients-36152
https://atc.digitellinc.com/p/s/cost-saving-initiatives-for-antithymocyte-globulin-rabbit-at-a-large-transplant-center-36153
https://atc.digitellinc.com/p/s/covid-19-and-deceased-donor-organ-donation-36154
https://atc.digitellinc.com/p/s/covid-19-and-kidney-transplantation-in-older-adults-in-the-united-states-36155
https://atc.digitellinc.com/p/s/covid-19-breakthrough-infections-in-vaccinated-solid-organ-transplant-recipients-who-received-tixagevimabcilgavimab-evusheldtm-for-pre-exposure-prophylaxis-36156
https://atc.digitellinc.com/p/s/covid-19-hospitalization-rates-for-renal-transplant-recipients-on-belatacept-bela-a-retrospective-study-36157
https://atc.digitellinc.com/p/s/covid-19-incidence-in-a-national-solid-organ-transplant-cohort-mirrors-population-viral-circulation-36158
https://atc.digitellinc.com/p/s/covid-19-mortality-among-solid-organ-transplant-recipients-in-the-united-states-during-june-to-december-2020-36159
https://atc.digitellinc.com/p/s/covid-19-outcomes-in-lung-transplant-recipients-receiving-tixagevimabcilgavimab-pre-exposure-prophylaxis-a-single-center-experience-36160
https://atc.digitellinc.com/p/s/covid-19-severity-of-patients-with-solid-organ-transplants-through-the-covid-19-variant-waves-36161
https://atc.digitellinc.com/p/s/covid-19-vaccination-strategies-and-seroconversion-in-solid-organ-transplant-recipients-a-living-systematic-review-and-network-meta-analysis-of-observational-studies-36162
https://atc.digitellinc.com/p/s/covid-19-vaccine-stimulation-of-dsa-and-dd-cfdna-in-heart-transplant-patients-36163
https://atc.digitellinc.com/p/s/c-peptide-post-transplant-trajectory-in-simultaneous-pancreas-and-kidney-transplant-recipients-36164
https://atc.digitellinc.com/p/s/creation-of-a-multidisciplinary-high-risk-committee-for-review-of-liver-transplant-candidates-with-significant-cardiopulmonary-risk-factors-36165
https://atc.digitellinc.com/p/s/creation-of-machine-learning-based-models-predicting-donation-after-circulatory-death-liver-transplantation-survival-and-length-of-stay-36166
https://atc.digitellinc.com/p/s/crispr-engineered-cell-culture-model-to-investigate-the-drug-drug-gene-interactions-of-cyp3a5-genetic-variants-and-ritonavir-on-tacrolimus-metabolism-36167
https://atc.digitellinc.com/p/s/critical-role-of-accelerated-senescence-in-driving-chronic-allograft-dysfunction-36168
https://atc.digitellinc.com/p/s/crosstalk-between-recipient-adipose-tissue-tim4-plus-macrophages-and-donor-hepatocytes-is-critical-for-hepatocellular-protection-in-liver-transplantation-36169
https://atc.digitellinc.com/p/s/current-kidney-cancer-screening-practices-for-patients-with-kidney-disease-36170
https://atc.digitellinc.com/p/s/current-landscape-of-transplant-nephrology-fellowship-application-36171
https://atc.digitellinc.com/p/s/current-practice-in-psychosocial-evaluation-and-follow-up-of-living-kidney-donors-36172
https://atc.digitellinc.com/p/s/current-practices-and-perceptions-of-ex-vivo-liver-machine-perfusion-in-the-united-states-36173
https://atc.digitellinc.com/p/s/current-safety-and-outcomes-of-kidney-allograft-biopsy-36174
https://atc.digitellinc.com/p/s/cytomegalovirus-cmv-infection-incidence-in-an-elderly-population-following-changes-to-immunosuppression-induction-and-management-36175
https://atc.digitellinc.com/p/s/cytomegalovirus-reactivation-and-clostridioides-difficile-associated-diarrhea-in-heart-transplant-recipients-36176
https://atc.digitellinc.com/p/s/cytomegalovirus-viral-load-at-initiating-antiviral-pre-emptive-therapy-may-predict-longer-duration-of-dnaemia-and-antiviral-therapy-in-pediatric-allogeneic-hematopoietic-cell-transplantation-recipient-36177
https://atc.digitellinc.com/p/s/dapsone-induced-anemia-in-solid-organ-transplant-recipients-with-normal-g6pd-activity-36178
https://atc.digitellinc.com/p/s/daratumumab-desensitization-before-kidney-transplantation-a-pilot-study-36179
https://atc.digitellinc.com/p/s/darbepoetin-utilization-in-renal-transplant-recipients-36180
https://atc.digitellinc.com/p/s/ddcf-dna-and-allograft-injury-single-center-experience-36181
https://atc.digitellinc.com/p/s/de-novo-cancer-after-living-donor-liver-transplantation-ldlt-patients-different-pattern-in-a-taiwan-institution-36182
https://atc.digitellinc.com/p/s/de-novo-inflammatory-bowel-disease-after-solid-organ-transplantation-a-case-series-36183
https://atc.digitellinc.com/p/s/death-and-overall-kidney-graft-survival-in-older-transplant-recipients-by-induction-type-in-the-united-states-36184
https://atc.digitellinc.com/p/s/decreased-immunogenicity-after-sars-cov-2-vaccination-in-liver-and-kidney-transplant-recipients-36185
https://atc.digitellinc.com/p/s/deep-venous-thrombosis-prophylaxis-post-liver-transplantation-in-the-setting-of-thrombocytopenia-and-coagulopathy-36186
https://atc.digitellinc.com/p/s/defining-the-minimal-clinically-important-differences-in-physical-frailty-using-the-liver-frailty-index-in-patients-with-cirrhosis-awaiting-liver-transplantation-36187
https://atc.digitellinc.com/p/s/delayed-belatacept-initiation-in-kidney-transplant-and-kidney-pancreas-transplant-in-steroid-sparing-regimens-early-experience-36188
https://atc.digitellinc.com/p/s/delays-despite-priority-qualitative-interviews-of-living-kidney-donors-with-esrd-36189
https://atc.digitellinc.com/p/s/dermatologic-manifestations-and-outcomes-of-patients-with-graft-vs-host-disease-following-liver-transplant-in-a-real-world-setting-36190
https://atc.digitellinc.com/p/s/desensitization-and-immunomodulation-in-sensitized-kidney-transplant-recipients-a-delphi-method-consensus-from-the-european-guidelines-for-the-management-of-graft-recipients-engage-working-group-of-th-36191
https://atc.digitellinc.com/p/s/detect-direct-allo-reactivity-via-quasi-public-allo-associated-cd8-plus-t-cell-clones-36192
https://atc.digitellinc.com/p/s/detecting-hepatic-arterial-complications-and-acute-bleeding-after-liver-transplantation-contrast-enhanced-ultrasound-as-an-add-on-test-with-doppler-ultrasound-36193
https://atc.digitellinc.com/p/s/determinants-of-optimal-outcomes-in-high-meld-living-donor-liver-transplantation-a-north-american-experience-36194
https://atc.digitellinc.com/p/s/developing-a-patient-centered-schematic-map-of-the-transplant-system-36195
https://atc.digitellinc.com/p/s/developing-regulatory-and-operational-oversight-structures-for-clinical-xenotransplantation-36196
https://atc.digitellinc.com/p/s/development-and-implementation-of-an-abdominal-normothermic-regional-perfusion-donation-after-circulatory-death-protocol-36197
https://atc.digitellinc.com/p/s/development-and-validation-of-a-multidimensional-prognostication-system-for-kidney-transplant-patient-survival-the-mortality-mbox-36198
https://atc.digitellinc.com/p/s/development-and-validation-of-a-multidimensional-prognostication-system-for-kidney-transplant-patient-survival-the-mortality-mbox-36199
https://atc.digitellinc.com/p/s/development-of-a-biovascular-pancreas-to-improve-efficacy-of-islet-transplant-in-type-1-diabetes-36200
https://atc.digitellinc.com/p/s/development-of-a-donor-quality-score-applicable-across-solid-organ-transplant-36201
https://atc.digitellinc.com/p/s/development-of-a-novel-multiplex-digital-pcr-assay-for-same-day-measurement-of-donor-derived-cell-free-dna-36202
https://atc.digitellinc.com/p/s/development-of-an-extended-normothermic-machine-liver-perfusion-protocol-36203
https://atc.digitellinc.com/p/s/development-of-anti-hla-antibodies-after-severe-bacterial-infection-requiring-immunosuppression-reduction-in-kidney-transplant-recipients-36204
https://atc.digitellinc.com/p/s/development-of-the-hospital-organ-donation-performance-score-hops-preliminary-results-based-on-a-human-and-artificial-intelligencemachine-learning-collaborative-36205
https://atc.digitellinc.com/p/s/deviating-from-the-match-run-to-save-a-kidney-36206
https://atc.digitellinc.com/p/s/diabetic-outcomes-following-simultaneous-pancreas-kidney-transplant-are-spk-patients-going-back-on-antidiabetic-medications-36207
https://atc.digitellinc.com/p/s/diagnosis-of-acute-graft-rejection-after-kidney-transplantation-using-metabolomic-profiling-of-biofluids-36208
https://atc.digitellinc.com/p/s/diagnostic-performance-of-preimplantation-biopsy-for-assessing-quality-of-deceased-donor-kidneys-36209
https://atc.digitellinc.com/p/s/dialysis-modality-and-access-among-kidney-transplant-recipients-with-graft-failure-36210
https://atc.digitellinc.com/p/s/dialysis-providers-and-8217-role-expectations-in-transplant-referral-decision-making-a-qualitative-study-36211
https://atc.digitellinc.com/p/s/dietary-fiber-provides-protection-against-kidney-ischemia-reperfusion-injury-through-modulation-of-the-gut-microbiota-36212
https://atc.digitellinc.com/p/s/differences-in-estimation-of-glomerular-filtration-rate-in-heart-transplant-patients-using-creatinine-versus-cystatin-c-36213
https://atc.digitellinc.com/p/s/differential-effects-of-delayed-graft-function-in-pediatric-kidney-transplantation-by-age-group-36214
https://atc.digitellinc.com/p/s/differing-humoral-and-cellular-response-against-sars-cov-2-variants-by-vaccine-platform-in-solid-organ-transplant-recipients-36215
https://atc.digitellinc.com/p/s/dihydroartemisinin-attenuates-acute-antibody-mediated-rejection-in-heart-transplantation-by-inhibiting-tfh-to-reduce-b-cells-activation-and-antibody-production-36216
https://atc.digitellinc.com/p/s/directing-tryptophan-immunometabolism-to-ameliorate-ischemia-reperfusion-injury-36217
https://atc.digitellinc.com/p/s/discordance-of-diastolic-dysfunction-by-echocardiography-for-cirrhotic-cardiomyopathy-36218
https://atc.digitellinc.com/p/s/discordant-acute-rejection-in-combined-heart-and-kidney-transplant-recipient-patients-36219
https://atc.digitellinc.com/p/s/discordant-humoral-and-cellular-immune-responses-following-bnt162b-vaccination-in-pediatric-solid-organ-transplant-recipients-36220
https://atc.digitellinc.com/p/s/discrepancy-analysis-between-histology-and-molecular-diagnoses-in-kidney-allograft-biopsies-a-single-center-experience-36221
https://atc.digitellinc.com/p/s/disparities-in-access-to-kidney-transplantation-for-patients-of-asian-and-hispanic-ancestry-36222
https://atc.digitellinc.com/p/s/disparities-in-access-to-preemptive-referral-for-kidney-transplant-evaluation-among-patients-in-the-southeastern-united-states-36223
https://atc.digitellinc.com/p/s/disseminated-monkeypox-infection-in-a-kidney-transplant-recipient-36224
https://atc.digitellinc.com/p/s/disseminated-mycobacterium-avium-complex-infection-with-bone-marrow-involvement-in-a-renal-transplant-recipient-36225
https://atc.digitellinc.com/p/s/do-hispanic-patients-complete-kidney-transplant-evaluation-as-fast-as-non-hispanic-white-patients-36226
https://atc.digitellinc.com/p/s/does-donor-dialysis-duration-influence-kidney-transplant-outcomes-36227
https://atc.digitellinc.com/p/s/does-living-donor-kidney-volume-or-measured-gfr-affect-recipient-allograft-function-36228
https://atc.digitellinc.com/p/s/does-post-procurement-allocation-of-donation-after-circulatory-death-kidneys-affect-kidney-use-rates-36229
https://atc.digitellinc.com/p/s/does-pre-transplant-utilization-of-antifibrotic-therapy-impact-patients-with-idiopathic-pulmonary-fibrosis-undergoing-lung-transplant-36230
https://atc.digitellinc.com/p/s/does-splitting-the-liver-impact-pancreas-procurement-36231
https://atc.digitellinc.com/p/s/donor-characteristics-predict-long-term-survival-outcomes-for-pediatric-liver-transplant-recipients-36232
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-dd-cf-dna-and-cardiac-allograft-vasculopathy-cav-36233
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-testing-in-a-kidney-transplant-recipient-with-fsgs-recurrence-36234
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-levels-within-the-first-30-days-post-transplant-in-patients-receiving-intraoperative-cardiopulmonary-support-36235
https://atc.digitellinc.com/p/s/donor-derived-cfdna-fraction-levels-in-stable-kidney-transplant-recipients-in-the-first-year-after-transplant-36236
https://atc.digitellinc.com/p/s/donor-graft-tolerance-induced-by-alloantigen-specific-regulatory-t-cell-based-therapy-in-mouse-cardiac-transplantation-model-36237
https://atc.digitellinc.com/p/s/donor-hepatitis-c-positivity-does-not-increase-risk-of-rejection-in-renal-transplant-recipients-36238
https://atc.digitellinc.com/p/s/donor-hla-discrepancies-have-decreased-with-time-36239
https://atc.digitellinc.com/p/s/donor-lims1-genotype-as-an-important-determinant-of-allograft-kidney-response-to-ischemia-and-reperfusion-36240
https://atc.digitellinc.com/p/s/donor-specific-antibody-development-in-kidney-transplant-recipients-with-or-without-delayed-graft-function-receiving-alemtuzumab-induction-36241
https://atc.digitellinc.com/p/s/donor-splenic-vein-graft-to-improve-the-patency-of-portal-vein-in-pediatric-liver-transplantation-with-the-consideration-of-long-periods-of-postoperative-course-36242
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-dd-cfdna-accurately-correlates-with-and-predicts-microvascular-inflammation-mvi-in-kidney-transplant-recipients-36243
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-dd-cfdna-in-100-kidney-transplant-recipients-with-indication-biopsy-results-of-a-prospective-single-center-trial-36244
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-dd-cfdna-in-patients-with-antibody-mediated-rejection-abmr-and-non-hla-donor-specific-antibodies-dsa-36245
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-dd-cfdna-results-and-clinical-outcomes-in-antibody-mediated-rejection-abmr-36246
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-accurately-identifies-allograft-injury-in-kidney-transplant-recipients-36247
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-analysis-is-capable-of-detecting-antibody-mediated-rejection-in-one-year-biopsy-of-living-kidney-transplantation-36248
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-and-blood-gene-expression-profiles-in-clinically-stable-simultaneous-pancreas-kidney-transplant-recipients-36249
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-is-not-confounded-by-cytomegalovirus-viremia-in-kidney-transplant-recipients-36250
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-kinetics-in-hcv-positive-donor-organ-kidney-transplant-recipients-36251
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-surveillance-in-kidney-transplant-recipients-receiving-belatacept-based-maintenance-immunosuppression-36252
https://atc.digitellinc.com/p/s/donor-derived-cell-free-dna-utility-in-differentiating-acute-versus-chronic-active-antibody-mediated-rejection-36253
https://atc.digitellinc.com/p/s/donor-derived-disease-transmission-events-in-germany-2016-2021-36254
https://atc.digitellinc.com/p/s/donor-drived-cell-free-dna-levels-are-predictive-of-rejection-in-a-prospective-trial-of-hiv-positive-kidney-transplant-recipients-36255
https://atc.digitellinc.com/p/s/donor-transmitted-malignancy-in-organ-donation-and-solid-organ-transplantation-in-germany-2016-2021-36256
https://atc.digitellinc.com/p/s/double-strength-versus-single-strength-bactrim-for-prophylaxis-of-urinary-tract-infections-in-kidney-transplant-recipients-36257
https://atc.digitellinc.com/p/s/downregulation-of-senescent-pathways-with-upregulation-of-cytolytic-effectors-are-the-predominant-signatures-of-covid-19-disease-in-children-with-solid-organ-transplants-36258
https://atc.digitellinc.com/p/s/dsa-and-autoantibodies-are-associated-with-acute-rejection-in-pediatric-liver-transplant-recipients-36259
https://atc.digitellinc.com/p/s/dsa-negative-microvascular-inflammation-in-kidney-transplant-biopsies-gene-expression-comparison-with-native-and-transplant-kidney-controls-36260
https://atc.digitellinc.com/p/s/dsba-l-deficiency-attenuates-lps-induced-acute-kidney-injury-via-nf-and-954bap-1-regulation-of-macrophage-polarization-36261
https://atc.digitellinc.com/p/s/duration-of-the-agonal-phase-does-not-impact-delayed-graft-function-nor-one-year-renal-function-in-donation-after-circulatory-death-kidney-transplantation-36262
https://atc.digitellinc.com/p/s/dyslipidemia-and-statin-use-following-adult-liver-transplantation-a-retrospective-review-36263
https://atc.digitellinc.com/p/s/early-conversion-to-everolimus-following-living-donor-liver-transplantation-36264
https://atc.digitellinc.com/p/s/early-experience-of-normothermic-liver-perfusion-pump-in-liver-transplantation-36265
https://atc.digitellinc.com/p/s/early-experience-using-donor-derived-cell-free-dna-for-the-surveillance-of-alloimmune-injury-in-kidney-transplantation-36266
https://atc.digitellinc.com/p/s/early-experience-with-maribavir-in-solid-organ-transplant-recipients-36267
https://atc.digitellinc.com/p/s/early-hcc-recurrence-following-liver-resection-an-oncological-indicator-for-subsequent-salvage-liver-transplant-36268
https://atc.digitellinc.com/p/s/early-infections-in-lung-transplant-recipients-36269
https://atc.digitellinc.com/p/s/early-liver-transplant-for-alcohol-associated-liver-disease-outcomes-after-more-than-a-decade-of-experience-36270
https://atc.digitellinc.com/p/s/early-outcomes-from-liver-transplantation-in-patients-with-high-risk-alcohol-use-a-novel-clinical-pathway-with-expanded-criteria-36271
https://atc.digitellinc.com/p/s/early-removal-of-ureteric-stent-is-associated-with-lower-incidence-of-urinary-tract-infection-in-the-first-month-following-kidney-transplantation-36272
https://atc.digitellinc.com/p/s/ebv-mirnas-bhrf1-1-and-bart2-5p-aggravate-post-transplant-lymphoproliferative-disorder-via-lzts2-pi3k-akt-axis-36273
https://atc.digitellinc.com/p/s/ecdi-treated-donor-b-cell-infusions-prolong-allograft-survival-in-a-nonhuman-primate-kidney-transplantation-model-36274
https://atc.digitellinc.com/p/s/economic-evaluation-of-accepting-a-preemptive-kidney-transplant-from-a-high-kdpi-donor-in-older-adults-36275
https://atc.digitellinc.com/p/s/educational-needs-assessment-of-us-healthcare-practitioners-managing-cytomegalovirus-infection-in-solid-organ-transplant-recipients-results-from-a-survey-using-a-simulated-case-scenario-36276
https://atc.digitellinc.com/p/s/effect-of-aging-donors-on-metabolic-signature-and-cellular-senescence-of-ipsc-derived-hepatocyte-like-cells-36277
https://atc.digitellinc.com/p/s/effect-of-antiproliferative-dose-on-clinical-outcomes-in-adult-kidney-transplant-recipients-converted-to-belatacept-36278
https://atc.digitellinc.com/p/s/effect-of-cold-storage-on-hepatocytes-and-hepatic-non-parenchymal-cells-36279
https://atc.digitellinc.com/p/s/effect-of-donor-and-recipient-characteristics-on-donor-derived-cell-free-dna-levels-upto-one-year-post-kidney-transplant-36280
https://atc.digitellinc.com/p/s/effect-of-donor-type-on-graft-and-patient-survival-in-paediatric-recipients-of-kidney-and-liver-transplantation-36281
https://atc.digitellinc.com/p/s/effect-of-kidney-allocation-policy-and-organ-donor-hospital-location-on-kidney-discard-36282
https://atc.digitellinc.com/p/s/effect-of-mammalian-target-of-rapamycin-inhibition-on-activated-regulatory-t-cell-expansion-in-kidney-transplantation-36283
https://atc.digitellinc.com/p/s/effect-of-recipient-donor-weight-mismatch-on-graft-survival-in-high-kidney-donor-profile-index-deceased-donor-kidney-transplants-36284
https://atc.digitellinc.com/p/s/effect-of-reconstruction-type-of-dual-arteries-on-long-term-outcome-in-living-donor-kidney-transplantation-36285
https://atc.digitellinc.com/p/s/effect-of-tacrolimus-metabolism-rate-on-renal-function-among-hispanic-kidney-transplant-recipients-36286
https://atc.digitellinc.com/p/s/effectiveness-of-low-versus-standard-dose-of-rabbit-anti-thymocyte-globulin-induction-in-kidney-transplant-recipients-36287
https://atc.digitellinc.com/p/s/effectiveness-of-norepinephrine-infusion-protocol-in-achieving-the-resolution-of-hepatorenal-syndrome-36288
https://atc.digitellinc.com/p/s/effects-of-acuity-circle-allocation-policy-on-pediatric-split-and-living-donor-liver-transplants-at-low-versus-high-volume-centers-36289
https://atc.digitellinc.com/p/s/efficacy-and-safety-of-12-month-daprodustat-administration-in-post-renal-transplant-patients-36290
https://atc.digitellinc.com/p/s/efficacy-and-safety-of-early-aceiarb-use-in-heart-transplant-recipients-36291
https://atc.digitellinc.com/p/s/efficacy-and-safety-of-early-aceiarb-use-in-heart-transplant-recipients-36292
https://atc.digitellinc.com/p/s/efficacy-of-a-de-novo-tacrolimus-extended-release-envarsus-xr-and-174-dosing-algorithm-36293
https://atc.digitellinc.com/p/s/efficacy-of-basiliximab-in-delayed-tacrolimus-initiation-post-liver-transplantation-36294
https://atc.digitellinc.com/p/s/efficacy-of-fidaxomicin-versus-oral-vancomycin-for-clostridium-difficile-infection-in-solid-organ-transplant-recipients-36295
https://atc.digitellinc.com/p/s/efficacy-of-linezolid-combination-against-gram-positive-bacteria-in-preservation-fluid-36296
https://atc.digitellinc.com/p/s/elderly-living-kidney-transplant-donors-and-their-renal-prognosis-36297
https://atc.digitellinc.com/p/s/elevation-in-fraction-or-quantity-of-donor-derived-cell-free-dna-at-1-and-3-month-after-kidney-transplant-is-associated-with-early-development-of-de-novo-donor-specific-antibody-36298
https://atc.digitellinc.com/p/s/emphysematous-pyelonephritis-in-a-kidney-transplant-recipient-a-rare-complication-36299
https://atc.digitellinc.com/p/s/end-of-treatment-positron-emission-tomography-response-and-outcomes-in-post-transplant-lymphoproliferative-disorder-ptld-36300
https://atc.digitellinc.com/p/s/endomyocardial-biopsy-technique-in-brain-dead-decedent-porcine-xenoheart-transplant-recipients-36301
https://atc.digitellinc.com/p/s/endothelial-connexin-43-gap-junctions-in-ischemia-reperfusion-injury-role-and-therapeutic-implications-for-solid-organ-transplantation-36302
https://atc.digitellinc.com/p/s/engaging-dialysis-teams-in-shared-decision-making-conversations-with-patients-to-improve-rates-of-kidney-transplantation-36303
https://atc.digitellinc.com/p/s/enhanced-reliability-of-artificial-intelligence-survival-models-to-predict-1-year-survival-after-kidney-transplant-using-a-novel-combined-model-36304
https://atc.digitellinc.com/p/s/enhanced-retention-and-knowledge-transfer-using-digital-sop-approaches-36305
https://atc.digitellinc.com/p/s/enhancing-anti-fibrotic-properties-of-mesenchymal-stem-cells-for-the-treatment-of-liver-fibrosis-36306
https://atc.digitellinc.com/p/s/environmental-performance-of-renal-replacement-therapy-comparative-lifecycle-assessments-of-dialysis-and-kidney-transplantation-36307
https://atc.digitellinc.com/p/s/enzymatic-conversion-of-blood-group-a-to-h-antigen-in-a-mouse-model-to-facilitate-abo-incompatible-transplantation-aboi-tx-kinetics-of-a-antigen-re-expression-36308
https://atc.digitellinc.com/p/s/epidemiology-of-respiratory-infections-in-lung-transplant-patients-with-endobronchial-stents-36309
https://atc.digitellinc.com/p/s/era-specific-improvements-in-age-disparate-outcomes-after-liver-transplantation-for-acute-liver-failure-a-population-based-analysis-of-the-united-kingdom-and-ireland-36310
https://atc.digitellinc.com/p/s/estimating-life-years-from-transplant-in-older-candidates-36311
https://atc.digitellinc.com/p/s/ethics-and-equity-in-uterine-transplantation-eligibility-a-scoping-review-36312
https://atc.digitellinc.com/p/s/european-society-for-organ-transplantationesot-tlj-30-consensus-on-histopathological-analysis-of-pre-implantation-donor-kidney-biopsy-redefining-the-role-in-the-process-of-graft-assessment-36313
https://atc.digitellinc.com/p/s/evaluating-the-use-of-glucagon-like-peptide-1-receptor-agonists-glp1-ra-in-a-matched-cohort-of-kidney-and-liver-transplant-recipients-36314
https://atc.digitellinc.com/p/s/evaluation-of-a-belatacept-based-immunosuppression-regimen-in-kidney-transplant-recipients-36315
https://atc.digitellinc.com/p/s/evaluation-of-a-ureteral-stent-removal-antibiotic-prophylaxis-protocol-in-kidney-transplant-recipients-36316
https://atc.digitellinc.com/p/s/evaluation-of-cd3-and-cd68-acinarseptal-infiltrates-in-pancreas-biopsies-discriminates-rejection-pathology-and-defines-non-rejection-entities-36317
https://atc.digitellinc.com/p/s/evaluation-of-clinical-outcomes-among-renal-transplant-recipients-obtaining-immunosuppression-prescriptions-from-insurance-mandated-specialty-pharmacies-36318
https://atc.digitellinc.com/p/s/evaluation-of-current-prophylaxis-strategies-for-cytomegalovirus-disease-at-a-large-academic-medical-center-36319
https://atc.digitellinc.com/p/s/evaluation-of-dd-cfdna-measures-in-kidney-transplant-recipients-more-than-two-years-post-transplantation-36320
https://atc.digitellinc.com/p/s/evaluation-of-invasive-fungal-infections-in-lung-transplant-recipients-receiving-low-dose-fluconazole-36321
https://atc.digitellinc.com/p/s/evaluation-of-low-dose-apixaban-for-prevention-of-venous-thromboembolism-after-lung-transplant-36322
https://atc.digitellinc.com/p/s/evaluation-of-nmr-based-gfr-estimating-for-kidney-transplant-recipients-in-a-clinical-routine-setting-36323
https://atc.digitellinc.com/p/s/evaluation-of-oral-potassium-binders-in-decreasing-delayed-graft-function-in-renal-transplant-recipients-36324
https://atc.digitellinc.com/p/s/evaluation-of-oral-vs-intravenous-phosphate-replacement-in-liver-donors-36325
https://atc.digitellinc.com/p/s/evaluation-of-safety-and-efficacy-outcomes-with-regards-to-anti-xa-versus-activated-partial-thromboplastin-time-aptt-in-patients-with-liver-disease-being-managed-on-intravenous-heparin-infusion-36326
https://atc.digitellinc.com/p/s/evaluation-of-the-effect-of-potassium-binders-on-extended-release-tacrolimus-36327
https://atc.digitellinc.com/p/s/evaluation-of-the-incidence-of-nocardia-infection-in-solid-organ-transplant-recipients-on-opportunistic-infection-prophylaxis-36328
https://atc.digitellinc.com/p/s/evaluation-of-the-prognostic-and-diagnostic-capacity-of-continuous-glucose-monitoring-cgm-regarding-post-transplantation-diabetes-mellitus-ptdm-early-after-kidney-transplantation-36329
https://atc.digitellinc.com/p/s/evaluation-of-the-safety-and-benefits-of-peripherally-administered-anti-thymocyte-globulin-p-ratg-in-kidney-transplant-kt-recipients-36330
https://atc.digitellinc.com/p/s/evaluation-of-twice-daily-tacrolimus-switched-to-once-daily-tacrolimus-in-kidney-transplant-recipients-36331
https://atc.digitellinc.com/p/s/evidence-of-field-cancerization-within-background-liver-parenchyma-of-transplant-recipients-with-hepatocellular-carcinoma-36332
https://atc.digitellinc.com/p/s/evolving-experience-with-aboi-transplantation-36333
https://atc.digitellinc.com/p/s/ex-vivo-preconditioning-of-human-kidney-with-phd-inhibitor-upregulates-hif-target-genes-with-a-goal-to-mitigate-ischemia-reperfusion-injury-prior-to-transplant-36334
https://atc.digitellinc.com/p/s/examining-racial-equity-in-access-to-kidney-transplant-in-each-phase-of-the-process-36335
https://atc.digitellinc.com/p/s/exosomal-small-rna-signatures-from-donor-liver-preservation-fluid-associate-with-transplant-outcomes-36336
https://atc.digitellinc.com/p/s/expanding-donor-cause-of-death-designations-reflects-changing-donor-population-and-utilization-practices-36337
https://atc.digitellinc.com/p/s/expanding-minimum-acceptance-criteria-benefits-lower-volume-kidney-transplant-centers-36338
https://atc.digitellinc.com/p/s/exploration-of-normothermic-machine-perfusion-strategies-in-rat-kidney-36339
https://atc.digitellinc.com/p/s/expression-of-rejection-associated-transcripts-in-early-protocol-renal-transplant-biopsies-are-modulated-by-tacrolimus-exposure-and-hla-class-i-eplet-donor-recipient-mismatch-36340
https://atc.digitellinc.com/p/s/ex-situ-reperfusion-injuryinflammation-immuno-molecular-profiling-of-human-livers-during-normothermic-machine-perfusion-36341
https://atc.digitellinc.com/p/s/extended-corticosteroid-induction-impact-on-outcomes-in-orthotopic-liver-transplant-36342
https://atc.digitellinc.com/p/s/extended-duration-venous-thromboembolism-prophylaxis-in-kidney-transplant-recipients-after-hospital-discharge-is-not-associated-with-bleeding-36343
https://atc.digitellinc.com/p/s/external-validation-of-toulouse-rangueil-egfr12-prediction-model-after-living-donor-nephrectomy-36344
https://atc.digitellinc.com/p/s/extracellular-vesicles-released-by-donor-macrophages-semi-directly-stimulate-allogeneic-t-cells-36345
https://atc.digitellinc.com/p/s/facilitators-and-barriers-to-the-implementation-of-the-live-donor-champion-program-36346
https://atc.digitellinc.com/p/s/factors-leading-to-the-discard-of-deceased-donor-dd-pancreata-in-the-us-36347
https://atc.digitellinc.com/p/s/fasting-mimicking-diet-prolongs-heart-transplant-survival-in-mice-36348
https://atc.digitellinc.com/p/s/favorable-outcomes-in-hispanic-recipients-receiving-simultaneous-pancreas-kidney-transplantation-36349
https://atc.digitellinc.com/p/s/feasibility-and-impact-of-the-implementation-of-remote-patient-monitoring-combined-with-enhanced-education-and-monitoring-of-transplant-recipients-36350
https://atc.digitellinc.com/p/s/feasibility-of-a-rigorous-ambulation-intervention-in-lung-transplant-patients-ifrail-study-36351
https://atc.digitellinc.com/p/s/feasibility-pilot-study-on-lifestyle-interventions-for-weight-loss-in-obese-post-transplant-patients-36352
https://atc.digitellinc.com/p/s/fetal-and-donor-derived-cell-free-dna-may-assist-in-differentiating-pregnancy-related-changes-from-allograft-rejection-in-kidney-transplant-recipients-36353
https://atc.digitellinc.com/p/s/first-case-series-report-using-the-liverguard-static-hypothermic-organ-transport-system-for-liver-transplants-at-a-single-center-36354
https://atc.digitellinc.com/p/s/first-experiences-with-organ-transplantation-of-sars-cov-2-positive-organ-donors-in-germany-36355
https://atc.digitellinc.com/p/s/first-routine-clinical-application-of-molecular-microscope-diagnosis-mmdx-in-europe-36356
https://atc.digitellinc.com/p/s/frequency-and-outcomes-of-bk-viremia-after-simultaneous-heart-kidney-transplant-a-single-center-experience-36357
https://atc.digitellinc.com/p/s/frequency-of-blood-pressure-measurements-in-renal-allograft-recipients-under-regular-telemedicine-surveillance-36358
https://atc.digitellinc.com/p/s/from-fibrosis-to-fibroelastosis-a-new-paradigm-in-lung-transplantation-36359
https://atc.digitellinc.com/p/s/from-one-million-to-two-the-growth-of-transplantation-in-the-united-states-36360
https://atc.digitellinc.com/p/s/functional-data-analysis-as-a-framework-to-identify-kidney-transplant-recipients-with-early-and-slow-post-transplant-graft-function-associated-with-poor-long-term-graft-survival-36361
https://atc.digitellinc.com/p/s/functional-warm-ischemic-time-impacts-short-term-graft-function-in-donation-after-circulatory-death-renal-transplant-recipients-36362
https://atc.digitellinc.com/p/s/fungal-infections-confer-worse-outcomes-relative-to-bacterial-counterparts-in-the-multi-disciplinary-medical-intensive-liver-unit-36363
https://atc.digitellinc.com/p/s/fungemia-in-thoracic-organ-transplant-recipients-36364
https://atc.digitellinc.com/p/s/gaining-consensus-around-patient-risk-groups-and-prognostic-profiles-to-guide-cmv-management-among-patients-with-solid-organ-transplant-sot-insights-from-a-delphi-panel-with-sot-experts-36365
https://atc.digitellinc.com/p/s/gasdermin-d-mutation-is-protective-against-renal-ischemia-reperfusion-injury-36366
https://atc.digitellinc.com/p/s/gastrointestinal-side-effects-in-de-novo-kidney-transplant-recipients-using-immediate-release-tacrolimus-versus-envarsus-xr-results-from-a-randomized-controlled-trial-36367
https://atc.digitellinc.com/p/s/gclc-enzymatic-activity-as-a-measure-of-t-cell-activation-capacity-36368
https://atc.digitellinc.com/p/s/gender-and-leadership-in-liver-transplantation-defining-the-gap-36369
https://atc.digitellinc.com/p/s/gender-impact-on-the-outcomes-of-deceased-donor-liver-transplantation-36370
https://atc.digitellinc.com/p/s/generation-of-cd141-plus-cd163-plus-regulatory-dendritic-cells-from-living-donor-liver-transplant-perfusate-36371
https://atc.digitellinc.com/p/s/genetic-variations-in-a-sestrin2sestrin3mtor-axis-and-development-of-new-onset-diabetes-after-renal-transplantation-36372
https://atc.digitellinc.com/p/s/geographic-inequity-in-access-to-donors-persists-under-ring-based-kidney-allocation-36373
https://atc.digitellinc.com/p/s/geographic-variation-in-access-to-kidney-donors-under-continuous-distribution-framework-36374
https://atc.digitellinc.com/p/s/ginsenoside-rg3-attenuates-ischemia-reperfusion-induced-renal-injury-in-mice-via-induction-of-autophagy-flux-36375
https://atc.digitellinc.com/p/s/graft-and-patient-survival-in-hyperimmunized-liver-kidney-and-kidney-transplant-recipients-36376
https://atc.digitellinc.com/p/s/graft-function-in-kidney-transplant-patients-with-iga-nephropathy-is-influenced-by-mannose-binding-lectin-levels-36377
https://atc.digitellinc.com/p/s/graft-livers-can-be-safely-transplanted-even-after-a-certain-amount-of-time-and-distance-36378
https://atc.digitellinc.com/p/s/graft-survival-is-reduced-in-cmv-high-risk-kidney-transplant-recipients-with-early-neutropenia-36379
https://atc.digitellinc.com/p/s/graft-versus-host-disease-gvhd-in-adult-liver-transplant-recipients-a-single-center-experience-36380
https://atc.digitellinc.com/p/s/growth-trajectories-in-pediatric-kidney-transplant-recipients-36381
https://atc.digitellinc.com/p/s/have-we-met-the-mark-a-quantitative-study-looking-at-the-learning-needs-of-post-kidney-transplant-recipients-36382
https://atc.digitellinc.com/p/s/health-disparity-in-pre-emptive-transplant-and-dialysis-vintage-based-on-social-vulnerability-index-36383
https://atc.digitellinc.com/p/s/health-related-quality-of-life-after-pancreas-transplantation-36384
https://atc.digitellinc.com/p/s/height-related-single-nucleotide-polymorphisms-early-predicting-growth-patterns-after-pediatric-kidney-transplantation-genomics-based-machine-learning-models-36385
https://atc.digitellinc.com/p/s/hematological-and-immunologic-factors-associated-with-the-development-of-chronic-rhinosinusitis-in-transplant-patients-36386
https://atc.digitellinc.com/p/s/hemophagocytic-lymphohistiocytosis-in-an-immunocompromised-transplant-recipients-36387
https://atc.digitellinc.com/p/s/hepatocellular-carcinoma-exacerbates-adverse-outcomes-of-long-cold-ischemia-time-in-liver-transplantation-36388
https://atc.digitellinc.com/p/s/hepatocellular-carcinoma-in-children-36389
https://atc.digitellinc.com/p/s/heterogeneous-pathology-findings-and-outcomes-in-16-patients-with-pancreas-transplant-biopsies-for-hyperglycemia-36390
https://atc.digitellinc.com/p/s/heterotopic-hemifacial-transplantation-in-mice-36391
https://atc.digitellinc.com/p/s/high-class-ii-eplets-mismatch-with-variability-low-of-tacrolimus-level-are-associated-with-the-development-of-dn-dsa-and-poor-graft-outcomes-36392
https://atc.digitellinc.com/p/s/high-levels-of-donor-derived-cell-free-dna-in-the-early-post-transplant-phase-indicates-injury-independent-of-renal-function-status-36393
https://atc.digitellinc.com/p/s/high-pretransplant-fgf-23-level-is-associated-with-poor-graft-survival-and-persistent-vitamin-d-insufficiency-in-kidney-transplant-patients-36394
https://atc.digitellinc.com/p/s/high-throughput-drug-screening-identifies-novel-compounds-with-potential-to-enhance-immunoregulation-following-transplantation-36395
https://atc.digitellinc.com/p/s/high-throughput-serologic-screening-demonstrates-influenza-vaccination-elicits-broadly-protective-serologic-responses-in-kidney-transplant-recipients-36396
https://atc.digitellinc.com/p/s/higher-density-of-interstitial-fibrosis-foci-predicts-death-censored-graft-loss-36397
https://atc.digitellinc.com/p/s/higher-frequency-of-host-cd8-plus-memory-t-cells-correlates-with-failure-to-achieve-heart-allograft-tolerance-via-mixed-chimerism-and-il-6-signaling-blockade-in-multiparous-female-non-human-primates-36398
https://atc.digitellinc.com/p/s/higher-portal-vein-flow-per-gram-of-liver-tissue-is-associated-with-fewer-total-late-transplant-complications-in-adult-living-donor-liver-transplant-recipients-36399
https://atc.digitellinc.com/p/s/high-resolution-hla-genotyping-informs-assessment-of-hla-t-cell-epitope-mismatches-associated-with-early-dsa-and-tcmr-in-kidney-transplant-recipients-36400
https://atc.digitellinc.com/p/s/histological-and-serological-evaluations-of-antibody-mediated-rejection-in-protocol-and-for-cause-renal-graft-biopsies-in-single-center-study-36401
https://atc.digitellinc.com/p/s/hla-desensitization-in-36-renal-transplant-recipients-single-centre-experience-36402
https://atc.digitellinc.com/p/s/hla-molecular-mismatches-and-induced-donor-specific-tolerance-in-kidney-transplantation-36403
https://atc.digitellinc.com/p/s/hla-a-can-be-potentially-regulated-by-hla-j-pseudogene-microrna-decoy-36404
https://atc.digitellinc.com/p/s/hla-incompatible-living-donor-kidney-transplantation-follow-up-results-of-a-monocentric-french-cohort-36405
https://atc.digitellinc.com/p/s/homoharringtonine-promotes-mouse-heart-allograft-acceptance-by-expanding-regulatory-t-cells-and-enhancing-il-10-expression-36406
https://atc.digitellinc.com/p/s/how-do-irb-members-and-ethicists-assess-the-risk-of-zoonotic-disease-transmission-in-xenotransplant-pig-kidney-clinical-trials-36407
https://atc.digitellinc.com/p/s/how-does-hla-dr-frequency-impact-time-to-deceased-donor-kidney-transplant-in-the-current-kidney-allocation-system-36408
https://atc.digitellinc.com/p/s/how-far-left-can-we-go-high-risk-living-donor-liver-transplantation-using-left-lobe-graft-in-a-single-us-center-36409
https://atc.digitellinc.com/p/s/how-to-handle-the-com-plex-ity-of-antibodies-outcomes-of-intra-operative-plasma-exchange-in-heart-and-lung-transplant-36410
https://atc.digitellinc.com/p/s/human-dermis-as-a-new-substitute-for-middle-hepatic-vein-reconstruction-during-living-donor-liver-transplantation-outcome-of-clinical-trial-36411
https://atc.digitellinc.com/p/s/human-leucocyte-antigen-a-forgotten-criterion-for-decellularization-success-36412
https://atc.digitellinc.com/p/s/human-regulatory-b-cells-prevent-effector-cd4-plus-cd25-t-cell-proliferation-though-a-mechanism-dependent-from-granzyme-b-and-lymphotoxin-alpha-36413
https://atc.digitellinc.com/p/s/identification-of-microbial-signatures-and-compounds-that-associate-with-peritransplant-liver-damage-in-mouse-and-human-recipients-36414
https://atc.digitellinc.com/p/s/identification-of-molecular-determinants-that-govern-the-self-renewal-and-effector-differentiation-potential-of-stem-like-cd4-plus-effector-precursors-36415
https://atc.digitellinc.com/p/s/identification-of-novel-genes-for-defatting-of-fatty-liver-via-crispr-inhibition-screening-36416
https://atc.digitellinc.com/p/s/identification-of-unique-dq4-allo-reactivity-36417
https://atc.digitellinc.com/p/s/identifying-ideal-liver-candidates-for-donor-after-cardiac-death-transplants-36418
https://atc.digitellinc.com/p/s/identifying-risks-for-new-onset-diabetes-post-transplantation-in-kidney-transplant-recipients-using-perioperative-continuous-glucose-monitoring-device-36419
https://atc.digitellinc.com/p/s/ifitm1-regulates-mitophagy-and-immunosuppressive-function-of-double-negative-t-cells-36420
https://atc.digitellinc.com/p/s/iguratimod-attenuates-macrophage-polarization-and-antibody-mediated-rejection-after-renal-transplant-by-regulating-klf4-36421
https://atc.digitellinc.com/p/s/iguratimod-upregulated-ptpn22-inhibited-b-cells-activation-then-attenuated-acute-antibody-mediated-rejection-and-prolonged-renal-graft-survival-in-mouse-kidney-transplant-model-36422
https://atc.digitellinc.com/p/s/il-6-is-critical-in-mitotherapy-dependent-improvement-in-oxidative-capacity-and-energy-homeostasis-in-nih3t3-l1-adipocytes-36423
https://atc.digitellinc.com/p/s/il-6-receptor-blockade-attenuates-effector-t-cell-function-and-significantly-prolongs-kidney-allograft-survival-in-ctla4ig-treated-rhesus-monkeys-36424
https://atc.digitellinc.com/p/s/ilc2s-constrain-alloreactive-cd4-plus-t-cells-through-mhcii-mediated-allo-antigen-presentation-in-mouse-heart-transplant-36425
https://atc.digitellinc.com/p/s/ilc2s-constrain-alloreactive-cd4-plus-t-cells-through-mhcii-mediated-allo-antigen-presentation-in-mouse-heart-transplant-36426
https://atc.digitellinc.com/p/s/immediate-post-transplant-intravenous-iron-supplementation-and-risk-of-bacterial-infections-in-renal-transplant-recipients-36427
https://atc.digitellinc.com/p/s/immediate-rewarming-of-the-kidney-with-the-use-of-the-ice-blanket-technique-is-associated-with-worse-short-term-graft-function-36428
https://atc.digitellinc.com/p/s/immune-checkpoint-inhibitor-induced-acute-cellular-rejection-of-a-living-donor-kidney-transplant-36429
https://atc.digitellinc.com/p/s/immune-checkpoint-inhibitors-for-cancer-recurrence-or-de-novo-cancer-after-liver-transplantation-36430
https://atc.digitellinc.com/p/s/immune-effects-of-extracellular-vesicles-generated-during-normothermic-ex-vivo-liver-perfusion-36431
https://atc.digitellinc.com/p/s/immune-profiling-by-single-nuclei-rna-sequencing-reveals-a-signature-specific-to-the-onset-of-non-alcoholic-fatty-liver-disease-36432
https://atc.digitellinc.com/p/s/immunization-with-exosomes-from-lung-transplant-recipients-following-sars-cov-2-infection-or-vaccination-developed-csp-specific-antibodies-and-lesions-in-murine-lungs-36433
https://atc.digitellinc.com/p/s/immunofluorescence-linear-igg-of-glomerular-capillaries-correlates-with-early-proteinuria-in-kidney-allografts-36434
https://atc.digitellinc.com/p/s/immunoprotective-effect-of-liver-allograft-on-patients-with-combined-liver-and-kidney-transplantation-36435
https://atc.digitellinc.com/p/s/immunosuppressants-regulate-immunity-by-altering-lymph-node-structure-and-intestinal-regulatory-t-cells-36436
https://atc.digitellinc.com/p/s/immunosuppression-and-iga-recurrence-after-kidney-transplant-a-unos-database-analysis-36437
https://atc.digitellinc.com/p/s/immunosuppression-minimization-in-belatacept-treated-kidney-transplant-recipients-guided-by-combined-allosure-and-trugraf-monitoring-36438
https://atc.digitellinc.com/p/s/immunosuppression-minimization-in-renal-transplant-recipients-with-transplant-excellence-based-on-the-trugraf-test-36439
https://atc.digitellinc.com/p/s/immunosuppression-protocol-change-from-immediate-release-to-extended-release-tacrolimus-in-kidney-transplant-recipients-impact-on-patient-and-provider-36440
https://atc.digitellinc.com/p/s/impact-of-a-dosing-change-for-cmv-prophylaxis-on-rates-of-leukopenia-in-liver-transplant-recipients-36441
https://atc.digitellinc.com/p/s/impact-of-a-smartphone-application-for-collaboration-with-local-clinics-in-the-treatment-of-sars-cov-2-infected-kidney-transplant-recipients-36442
https://atc.digitellinc.com/p/s/impact-of-acute-kidney-injury-on-outcomes-of-deceased-kidney-transplantation-a-korean-nationwide-study-36443
https://atc.digitellinc.com/p/s/impact-of-age-on-hepatitis-b-virus-immunity-post-transplant-36444
https://atc.digitellinc.com/p/s/impact-of-area-deprivation-index-on-early-stages-in-the-liver-transplantation-process-36445
https://atc.digitellinc.com/p/s/impact-of-banff-score-in-protocol-biopsy-7-years-after-kidney-transplantation-to-the-prognosis-of-kidney-transplantation-36446
https://atc.digitellinc.com/p/s/impact-of-belatacept-on-acute-rejection-outcomes-in-lung-transplantation-36447
https://atc.digitellinc.com/p/s/impact-of-bk-polyomavirus-plasma-viral-load-in-kidney-transplant-outcomes-36448
https://atc.digitellinc.com/p/s/impact-of-blood-pressure-on-kidney-outcomes-after-kidney-transplantation-36449
https://atc.digitellinc.com/p/s/impact-of-c1q-binding-on-rejection-rates-post-kidney-or-simultaneous-pancreas-kidney-transplantation-in-a-high-immunologic-risk-population-at-an-urban-transplant-center-36450
https://atc.digitellinc.com/p/s/impact-of-calcineurin-inhibitor-use-after-graft-failure-on-sensitization-in-repeat-kidney-transplant-recipients-36451
https://atc.digitellinc.com/p/s/impact-of-culturally-competent-care-in-post-transplant-clinical-outcomes-among-hispanic-kidney-transplant-recipients-36452
https://atc.digitellinc.com/p/s/impact-of-current-desensitization-protocols-and-surgical-outcomes-in-abo-incompatible-kidney-transplant-recipients-a-japanese-single-center-experience-36453
https://atc.digitellinc.com/p/s/impact-of-diabetes-on-quality-of-life-in-patients-with-or-without-islet-autotransplantation-36454
https://atc.digitellinc.com/p/s/impact-of-donor-allograft-hepatocyte-necrosis-on-liver-transplant-outcomes-36455
https://atc.digitellinc.com/p/s/impact-of-donor-specific-antibodies-on-deceased-donor-kidney-transplants-after-kas-implementation-36456
https://atc.digitellinc.com/p/s/impact-of-early-vs-late-bebtelovimab-administration-in-a-nurse-driven-program-for-solid-organ-transplant-recipients-with-mild-to-moderate-covid-19-a-propensity-score-analysis-36457
https://atc.digitellinc.com/p/s/impact-of-hla-evolutionary-divergence-and-eplet-mismatches-on-kidney-allograft-rejection-and-outcome-a-population-based-study-36458
https://atc.digitellinc.com/p/s/impact-of-immunoglobulin-replacement-therapy-on-hypogammaglobulinemia-and-infection-in-lung-transplant-recipients-36459
https://atc.digitellinc.com/p/s/impact-of-induction-selection-on-incidence-and-severity-of-sars-cov-2-infection-in-kidney-transplant-recipients-36460
https://atc.digitellinc.com/p/s/impact-of-induction-therapy-on-rejection-in-pediatric-transplantation-a-multicenter-study-in-the-united-states-36461
https://atc.digitellinc.com/p/s/impact-of-isolated-hla-dp-donor-specific-antibodies-on-graft-outcomes-after-kidney-transplantation-36462
https://atc.digitellinc.com/p/s/impact-of-ivig-on-the-treatment-of-bkv-in-kidney-transplant-recipients-36463
https://atc.digitellinc.com/p/s/impact-of-kidney-allocation-system-changes-on-the-cost-of-post-transplant-medical-care-36464
https://atc.digitellinc.com/p/s/impact-of-medicaid-expansion-on-liver-transplantation-in-the-state-of-oklahoma-36465
https://atc.digitellinc.com/p/s/impact-of-multi-drug-resistant-infections-in-the-medical-liver-intensive-unit-on-transplant-outcomes-36466
https://atc.digitellinc.com/p/s/impact-of-offer-filters-after-6-months-36467
https://atc.digitellinc.com/p/s/impact-of-persistently-elevated-donor-derived-cell-free-dna-levels-on-clinical-outcomes-after-heart-transplant-36468
https://atc.digitellinc.com/p/s/impact-of-pre-transplant-pharmacist-evaluations-on-hepatitis-b-and-herpes-zoster-vaccination-rates-in-solid-organ-transplant-recipients-36469
https://atc.digitellinc.com/p/s/impact-of-rejection-treatment-in-kidney-transplant-patients-on-infection-development-36470
https://atc.digitellinc.com/p/s/impact-of-removing-dsa-and-optn-region-from-pancreas-allocation-36471
https://atc.digitellinc.com/p/s/impact-of-removing-optn-region-from-vca-allocation-36472
https://atc.digitellinc.com/p/s/impact-of-sars-cov2-mrna-vaccination-on-human-leukocyte-antigen-antibody-responses-in-kidney-transplant-36473
https://atc.digitellinc.com/p/s/impact-of-subclinical-hfpef-for-recipients-of-kidney-transplantation-36474
https://atc.digitellinc.com/p/s/impact-of-terbutaline-on-hemodynamics-following-heart-transplantation-36475
https://atc.digitellinc.com/p/s/impact-of-the-new-glomerular-filtration-rate-formulas-on-kidney-function-assessment-in-living-kidney-donors-and-candidates-36476
https://atc.digitellinc.com/p/s/impact-of-the-university-of-wisconsin-uw-preservation-fluid-shortage-on-the-risk-of-early-graft-loss-after-pancreas-transplantation-36477
https://atc.digitellinc.com/p/s/impact-of-using-pediatric-en-bloc-donors-with-low-glomerular-filtration-rate-gfr-in-adult-renal-transplants-36478
https://atc.digitellinc.com/p/s/implementation-of-a-multicenter-study-to-evaluate-the-ability-of-chart-based-frailty-review-to-determine-outcomes-after-lung-transplantation-36479
https://atc.digitellinc.com/p/s/implementation-of-an-enhanced-recovery-after-surgery-pathway-for-deceased-donor-kidney-transplants-36480
https://atc.digitellinc.com/p/s/implementation-of-providing-web-based-information-to-patients-prior-to-kidney-transplant-evaluation-36481
https://atc.digitellinc.com/p/s/importance-of-malnutrition-and-frailty-in-kidney-transplant-waiting-list-36482
https://atc.digitellinc.com/p/s/importance-of-spirituality-as-a-social-determinant-of-health-in-a-population-of-foreign-born-inner-city-kidney-transplant-recipients-36483
https://atc.digitellinc.com/p/s/improved-graft-function-following-desensitization-of-anti-at1r-and-non-hla-antibodies-in-a-dsa-negative-heart-transplant-recipient-with-amr-36484
https://atc.digitellinc.com/p/s/improved-renal-outcomes-in-kidney-transplant-recipients-with-early-denovo-dsas-on-belatacept-versus-calcineurin-inhibitor-based-immunosuppression-36485
https://atc.digitellinc.com/p/s/improved-transplant-time-study-billing-and-compliance-using-communication-data-36486
https://atc.digitellinc.com/p/s/improving-access-to-transplant-non-a1non-a1b-to-blood-group-b-deceased-donor-kidney-transplants-36487
https://atc.digitellinc.com/p/s/improving-informed-consent-for-living-liver-donors-what-information-do-donors-want-about-their-recipient-36488
https://atc.digitellinc.com/p/s/improving-living-donors-selection-in-a-multiple-direct-donors-and-kidney-paired-exchange-settings-36489
https://atc.digitellinc.com/p/s/improving-post-kidney-transplant-related-outcomes-through-video-based-educational-platforms-36490
https://atc.digitellinc.com/p/s/improving-quality-of-care-in-post-renal-transplant-patients-by-utilizing-a-pharmacist-run-telehealth-blood-pressure-clinic-36491
https://atc.digitellinc.com/p/s/in-search-of-reasons-for-death-with-a-functioning-kidney-graft-and-reasons-for-overall-graft-failure-36492
https://atc.digitellinc.com/p/s/in-the-era-of-computed-tomography-volumetry-is-isotope-renography-still-routinely-required-in-the-preparation-and-selection-of-living-kidney-donors-36493
https://atc.digitellinc.com/p/s/in-vitro-differentiation-of-hematopoietic-stem-cells-into-immunoregulatory-t-and-myeloid-cells-following-allogeneic-stimulation-36494
https://atc.digitellinc.com/p/s/inadequate-iodine-intake-and-long-term-outcomes-after-kidney-transplantation-36495
https://atc.digitellinc.com/p/s/incidence-and-impact-of-bk-viremia-in-simultaneous-liver-kidney-transplant-recipients-36496
https://atc.digitellinc.com/p/s/incidence-and-rate-of-surgical-repair-of-incisional-hernia-following-pancreas-transplant-36497
https://atc.digitellinc.com/p/s/incidence-of-bk-polyoma-virus-infection-in-kidney-transplant-recipients-treated-with-belatacept-based-immunosuppression-36498
https://atc.digitellinc.com/p/s/incidence-of-bk-polyomavirus-in-us-vs-foreign-born-kidney-transplant-recipients-36499
https://atc.digitellinc.com/p/s/incidence-of-chronic-kidney-disease-in-renal-transplant-patients-after-sars-cov2-infection-36500
https://atc.digitellinc.com/p/s/incidence-of-covid-in-vaccinated-patients-receiving-evusheld-36501
https://atc.digitellinc.com/p/s/incidence-of-invasive-fungal-diseases-in-solid-organ-transplant-recipients-on-belatacept-for-organ-rejection-prophylaxis-a-single-center-retrospective-cohort-study-36502
https://atc.digitellinc.com/p/s/incidence-of-opportunistic-infection-in-kidney-transplant-recipients-receiving-belatacept-versus-tacrolimus-early-post-transplant-36503
https://atc.digitellinc.com/p/s/incidence-of-oral-or-esophageal-candidiasis-with-and-without-topical-antifungal-prophylaxis-following-lung-transplant-36504
https://atc.digitellinc.com/p/s/increased-deposition-of-complement-in-renal-mitochondria-following-cold-storage-and-transplantation-36505
https://atc.digitellinc.com/p/s/increases-from-baseline-dd-cfdna-fraction-are-associated-with-acute-allograft-rejection-in-kidney-transplant-recipients-36506
https://atc.digitellinc.com/p/s/increasing-access-to-transplantation-for-hispanic-patients-through-an-integrative-pilot-spanish-speaking-liver-transplant-program-36507
https://atc.digitellinc.com/p/s/increasing-the-accuracy-of-molecular-diagnosis-mdx-of-cardiac-tcmr-by-substituting-heart-specific-genes-for-kidney-specific-genes-in-archetype-analysis-36508
https://atc.digitellinc.com/p/s/increasing-transplant-medication-knowledge-retention-through-implementation-of-a-health-literacymedication-education-intervention-algorithm-36509
https://atc.digitellinc.com/p/s/increasing-use-of-covid-19-donors-in-solid-organ-transplantation-36510
https://atc.digitellinc.com/p/s/indeterminate-donor-derived-cell-free-dna-levels-are-not-associated-with-subsequent-adverse-events-in-heart-transplant-recipients-36511
https://atc.digitellinc.com/p/s/indirect-evidence-for-circulating-factors-in-focal-segmental-glomerulosclerosis-via-molecular-analysis-of-podocyte-injury-in-kidney-organoids-36512
https://atc.digitellinc.com/p/s/individual-difference-in-the-frequency-of-alloreactive-memory-b-cells-in-sensitized-transplant-patients-36513
https://atc.digitellinc.com/p/s/induction-comparison-of-antithymocyte-globulin-with-basiliximab-versus-antithymocyte-globulin-alone-in-renal-transplant-recipients-36514
https://atc.digitellinc.com/p/s/induction-immunosuppression-in-low-risk-pediatric-kidney-transplant-recipients-from-pediatric-deceased-donors-36515
https://atc.digitellinc.com/p/s/induction-of-delayed-immune-tolerance-after-reconstructive-transplantation-by-combining-donor-bone-marrow-transplantation-and-high-dose-cyclophosphamide-treatment-36516
https://atc.digitellinc.com/p/s/infection-in-patients-on-belatacept-based-regimen-after-kidney-transplantation-36517
https://atc.digitellinc.com/p/s/infections-in-renal-transplant-treated-with-belatacept-36518
https://atc.digitellinc.com/p/s/infectious-complications-in-elderly-lung-transplant-recipients-during-first-year-post-transplant-36519
https://atc.digitellinc.com/p/s/infiltrating-cytotoxic-cd8-t-cells-are-reprogramed-to-an-exhaustedregulatory-phenotype-in-spontaneously-accepted-kidney-allografts-in-mice-36520
https://atc.digitellinc.com/p/s/influence-of-dialysis-duration-on-transplant-outcomes-with-high-kidney-donor-profile-index-kdpi-kidneys-less-is-more-36521
https://atc.digitellinc.com/p/s/influence-of-intraoperative-hemodynamics-and-pressor-use-on-delayed-graft-function-36522
https://atc.digitellinc.com/p/s/inhibition-of-cd154cd11b-interaction-using-a-novel-nanotherapeutic-improves-allograft-survival-36523
https://atc.digitellinc.com/p/s/initial-experience-with-thoracoabdominal-normothermic-regional-perfusion-controlled-donation-after-cardiac-death-liver-transplants-36524
https://atc.digitellinc.com/p/s/initial-preclinical-evaluation-of-a-bioengineered-kidney-36525
https://atc.digitellinc.com/p/s/insurance-type-and-gut-microbiome-diversity-of-kidney-transplant-recipients-36526
https://atc.digitellinc.com/p/s/integrating-data-from-early-kinetic-ddcfdna-after-transplantation-and-ibox-to-predict-long-term-renal-graft-outcomes-36527
https://atc.digitellinc.com/p/s/interaction-between-donor-and-recipient-raceethnicity-in-living-donor-liver-transplantation-36528
https://atc.digitellinc.com/p/s/interferon-beta-pretreatment-alleviates-allogeneic-renal-tubular-epithelial-cell-induced-nk-and-cd8-plus-t-cell-responses-via-the-irf7haenkg2a-axis-36529
https://atc.digitellinc.com/p/s/intermediate-term-outcomes-of-recipient-and-kidney-graft-utilizing-false-and-true-positive-human-immunodeficiency-virus-deceased-donors-in-the-united-states-36530
https://atc.digitellinc.com/p/s/intermittent-dosing-of-rabbit-anti-thymocyte-globulin-induction-is-effective-for-rejection-prevention-in-high-risk-kidney-transplant-recipients-36531
https://atc.digitellinc.com/p/s/internal-biliary-stent-in-adult-liver-transplantation-a-systematic-review-and-meta-analysis-36532
https://atc.digitellinc.com/p/s/interventional-radiology-guided-splenic-artery-embolism-in-liver-transplant-patients-a-10-year-experience-36533
https://atc.digitellinc.com/p/s/intragraft-induction-of-regulatory-t-cells-and-the-emergence-ff-thymic-like-characteristics-in-accepted-kidney-allografts-36534
https://atc.digitellinc.com/p/s/intraoperative-fluid-management-for-pediatric-kidney-recipients-less-than-15kg-body-weight-with-retroperitoneal-surgical-approach-36535
https://atc.digitellinc.com/p/s/invasive-aspergillosis-in-liver-transplant-recipients-in-the-current-era-36536
https://atc.digitellinc.com/p/s/investigating-rna-interference-mediated-knockdown-of-fas-on-ischemia-reperfusion-injury-during-the-liver-transplantation-process-36537
https://atc.digitellinc.com/p/s/involvement-of-hla-epitope-mismatch-and-tacrolimus-trough-levels-in-de-novo-dsa-production-in-long-term-kidney-transplant-patients-36538
https://atc.digitellinc.com/p/s/irf1znf350gpx4-mediated-ferroptosis-of-renal-tubular-epithelial-cells-promote-chronic-renal-allograft-interstitial-fibrosis-36539
https://atc.digitellinc.com/p/s/is-alkaline-phosphatase-a-predictor-of-mortality-in-liver-transplant-patients-36540
https://atc.digitellinc.com/p/s/is-it-better-to-wait-for-paired-exchange-or-undergo-abo-incompatible-living-donor-kidney-transplantation-a-single-center-retrospective-review-36541
https://atc.digitellinc.com/p/s/ischemia-reperfusion-upregulates-mir-23a-5p-in-kidney-cells-to-induce-fibrosis-36542
https://atc.digitellinc.com/p/s/ischemia-free-liver-transplantation-as-a-novel-approach-to-optimize-transplant-outcomein-the-acute-on-chronic-liver-failure-scenario-36543
https://atc.digitellinc.com/p/s/islet-after-kidney-transplantation-restores-insulin-independence-in-patients-with-type-1-diabetes-36544
https://atc.digitellinc.com/p/s/islet-transplantation-in-five-cases-of-diabetes-mellitus-after-organ-transplantation-36545
https://atc.digitellinc.com/p/s/isolated-glomerulitis-is-associated-with-the-absence-of-antibody-mediated-rejection-by-molecular-diagnostics-36546
https://atc.digitellinc.com/p/s/it-is-not-just-temperature-rising-the-impact-of-active-viruses-on-donor-derived-cell-free-dna-testing-36547
https://atc.digitellinc.com/p/s/itraq-and-mrm-based-proteomic-analysis-remarks-early-injury-index-associated-with-primary-dysfunction-after-liver-transplantation-36548
https://atc.digitellinc.com/p/s/kdpiepts-matching-for-high-creatinine-donors-goldilocks-redux-36549
https://atc.digitellinc.com/p/s/kidney-allograft-outcomes-in-diagnostic-and-suspicious-amr-with-peritubular-capillaritis-without-glomerulitis-36550
https://atc.digitellinc.com/p/s/kidney-allografts-at-risk-for-graft-failure-following-covid-19-36551
https://atc.digitellinc.com/p/s/kidney-donor-profile-index-in-hepatitis-c-positive-kidney-transplantation-36552
https://atc.digitellinc.com/p/s/kidney-donors-older-than-50-years-have-an-increased-risk-for-calcineurin-inhibitor-induced-nephrotoxicity-36553
https://atc.digitellinc.com/p/s/kidney-parenchymal-cells-in-acute-rejection-of-human-kidney-transplants-and-8212lest-we-forget-36554
https://atc.digitellinc.com/p/s/kidney-stone-incidence-in-living-kidney-donor-candidates-with-increased-metabolic-risk-36555
https://atc.digitellinc.com/p/s/kidney-transplant-kt-recipients-with-high-body-mass-index-bmi-shows-better-survival-when-estimated-predicted-survival-epts-score-is-more-than-forty-36556
https://atc.digitellinc.com/p/s/kidney-transplant-from-donor-with-alport-and-8217s-syndrome-36557
https://atc.digitellinc.com/p/s/kidney-transplant-of-the-future-advanced-robotic-surgery-for-graft-implantation-36558
https://atc.digitellinc.com/p/s/kidney-transplant-outcomes-in-an-elderly-veteran-population-36559
https://atc.digitellinc.com/p/s/kidney-transplant-patients-should-be-immunized-with-moderna-moderna-1273-rather-than-pfizer-biontech-bnt162b2-vaccines-36560
https://atc.digitellinc.com/p/s/kidney-transplant-recipients-with-enteric-risk-factors-for-hyperoxaluria-are-at-high-risk-for-transplant-nephrolithiasis-36561
https://atc.digitellinc.com/p/s/kidney-transplantation-in-class-3-severely-obese-recipients-is-safeuk-renal-transplant-registry-data-analysis-since-year-2000-36562
https://atc.digitellinc.com/p/s/kidney-transplantation-in-extremely-old-deceased-donors-to-extremely-old-recipients-36563
https://atc.digitellinc.com/p/s/kidney-transplantation-in-medically-complex-patients-is-it-a-risk-worth-taking-experience-of-a-high-volume-center-36564
https://atc.digitellinc.com/p/s/killer-ig-like-receptor-kir-expressing-regulatory-cd8-t-cells-inhibit-inflammatory-cd4-t-cells-in-a-peptide-specific-manner-36565
https://atc.digitellinc.com/p/s/lack-of-association-between-vitamin-d-levels-and-mortality-in-kidney-transplant-recipients-with-covid-19-36566
https://atc.digitellinc.com/p/s/lack-of-concordance-between-trugraf-gene-expression-profile-and-trac-dd-cfdna-results-an-interim-report-of-the-trulo-study-36567
https://atc.digitellinc.com/p/s/laparoscopic-donor-nephrectomy-training-in-the-uk-national-re-audit-of-the-trainee-experience-36568
https://atc.digitellinc.com/p/s/laparoscopic-kidney-transplantation-following-vaginal-insertion-of-kidney-graft-a-new-trick-for-an-old-dog-36569
https://atc.digitellinc.com/p/s/late-allocation-liver-transplant-outcomes-36570
https://atc.digitellinc.com/p/s/left-lateral-section-liver-volumetry-with-a-light-detection-and-ranging-system-for-split-liver-transplantation-preliminary-results-in-a-cadaveric-model-36571
https://atc.digitellinc.com/p/s/length-of-stay-adversely-affects-patient-survival-36572
https://atc.digitellinc.com/p/s/letermovir-as-a-rescue-therapy-in-kidney-transplant-recipients-with-valganciclovirganciclovir-refractoryresistant-cmv-disease-36573
https://atc.digitellinc.com/p/s/letermovir-as-step-down-antiviral-treatment-for-solid-organ-transplant-recipients-with-cytomegalovirus-infection-36574
https://atc.digitellinc.com/p/s/leveling-up-a-literature-review-on-the-gamification-of-healthcare-36575
https://atc.digitellinc.com/p/s/lifelong-polyuria-continues-post-kidney-transplant-in-teenagers-with-end-stage-kidney-disease-lessons-learned-and-need-for-newer-strategies-beyond-native-nephrectomies-36576
https://atc.digitellinc.com/p/s/light-touch-frailty-phenotype-36577
https://atc.digitellinc.com/p/s/little-change-in-pancreas-discard-reasons-after-removal-of-dsa-and-optn-region-from-pancreas-allocation-36578
https://atc.digitellinc.com/p/s/live-kidney-donor-communication-beyond-the-optn-mandated-two-year-follow-up-and-8239-36579
https://atc.digitellinc.com/p/s/liver-dcd-using-normothermic-regional-perfusion-a-single-center-review-36580
https://atc.digitellinc.com/p/s/liver-or-thyroid-cancer-in-living-liver-donors-should-be-monitored-after-donor-hepatectomy-36581
https://atc.digitellinc.com/p/s/liver-transplantation-for-acute-alcohol-induced-hepatitis-a-multidisciplinary-approach-leads-to-excellent-outcomes-36582
https://atc.digitellinc.com/p/s/liver-transplantation-for-complex-hepatic-injuries-a-unos-database-analysis-36583
https://atc.digitellinc.com/p/s/liver-transplantation-for-post-covid-cholangiopathy-a-case-series-36584
https://atc.digitellinc.com/p/s/liver-transplantation-from-donation-after-circulatory-death-donors-in-acute-liver-failure-outcomes-in-the-usa-36585
https://atc.digitellinc.com/p/s/liver-transplantation-from-marginal-donors-long-term-outcomes-over-the-years-in-the-usa-36586
https://atc.digitellinc.com/p/s/liver-transplantation-in-septuagenarians-outcomes-and-potential-impact-of-use-of-organs-from-donors-and-8805-50-years-36587
https://atc.digitellinc.com/p/s/liver-related-frailty-biomarkers-are-associated-with-the-likelihood-of-undergoing-liver-transplantation-36588
https://atc.digitellinc.com/p/s/living-donor-liver-transplant-trends-in-the-era-of-acuity-circle-allocation-36589
https://atc.digitellinc.com/p/s/living-kidney-donors-and-8217-willingness-and-preferences-for-post-donation-follow-up-with-the-living-donor-collective-36590
https://atc.digitellinc.com/p/s/long-term-benefit-to-add-belatacept-in-kidney-receptors-with-de-novo-dsa-36591
https://atc.digitellinc.com/p/s/long-term-outcomes-and-risk-factors-for-graft-failure-following-second-liver-transplantation-36592
https://atc.digitellinc.com/p/s/long-term-use-of-belatacept-in-two-liver-transplant-recipients-with-successful-stabilization-of-chronic-kidney-disease-36593
https://atc.digitellinc.com/p/s/long-covid-in-kidney-transplant-recipients-in-the-omicron-predominance-a-longitudinal-cohort-study-36594
https://atc.digitellinc.com/p/s/longitudinal-changes-in-renal-function-in-after-first-time-and-repeat-heart-transplantation-in-children-and-young-adults-36595
https://atc.digitellinc.com/p/s/longitudinal-evaluation-of-immune-single-cell-transcriptome-of-living-donor-kidney-transplant-recipients-tolerized-with-allogeneic-stem-cell-therapy-36596
https://atc.digitellinc.com/p/s/longitudinal-monitoring-of-donor-cell-free-dna-in-porcine-kidney-xenotransplantations-36597
https://atc.digitellinc.com/p/s/long-term-acute-rejection-and-graft-loss-incidences-in-prevalent-kidney-transplant-recipients-after-critical-care-survival-36598
https://atc.digitellinc.com/p/s/long-term-consequences-of-delayed-graft-function-in-pediatric-kidney-transplantation-36599
https://atc.digitellinc.com/p/s/long-term-efficacy-and-safety-of-everolimus-compared-to-mycophenolate-in-a-steroid-free-regimen-36600
https://atc.digitellinc.com/p/s/long-term-mortality-of-living-liver-donors-a-systematic-review-and-meta-analysis-36601
https://atc.digitellinc.com/p/s/long-term-mortality-prediction-in-patients-with-cirrhosis-with-laboratory-data-comparisons-of-multiple-machine-learning-methods-36602
https://atc.digitellinc.com/p/s/long-term-outcome-in-patients-undergoing-abo-incompatible-living-donor-liver-transplantation-retrospective-analysis-of-116-patients-reduced-rituximab-and-prophylactic-antibiotics-after-surgery-decreas-36603
https://atc.digitellinc.com/p/s/long-term-outcome-of-liver-transplantation-versus-resection-for-hepatocellular-carcinoma-a-single-center-experience-36604
https://atc.digitellinc.com/p/s/long-term-outcomes-of-alemtuzumab-induction-in-pediatric-kidney-transplantation-36605
https://atc.digitellinc.com/p/s/long-term-outcomes-of-conversion-from-tacrolimus-to-sirolimus-in-kidney-transplant-recipients-an-8-year-follow-up-study-36606
https://atc.digitellinc.com/p/s/long-term-outcomes-of-primary-living-donor-kidney-transplants-in-the-united-statescomparing-hla-vs-eplet-mismatches-using-a-novel-weighted-imputation-method-36607
https://atc.digitellinc.com/p/s/loss-of-potential-living-kidney-donors-prior-to-donation-identifying-targeted-opportunities-for-greater-donor-support-36608
https://atc.digitellinc.com/p/s/loss-of-wait-time-advantage-for-hcv-positive-kidneys-in-hcv-negative-recipients-36609
https://atc.digitellinc.com/p/s/low-dose-aspirin-does-not-reduce-the-incidence-of-bk-and-jc-polyomavirus-infections-in-renal-transplant-recipients-36610
https://atc.digitellinc.com/p/s/low-dose-aspirin-prophylaxis-of-transplant-renal-artery-stenosis-across-ages-categories-36611
https://atc.digitellinc.com/p/s/lower-dose-anti-thymocyte-globulin-induction-in-kidney-transplant-recipients-with-slow-or-delayed-graft-function-is-not-associated-with-higher-risk-of-rejection-or-de-novo-donor-specific-antibodies-36612
https://atc.digitellinc.com/p/s/low-level-asymptomatic-cytomegalovirus-viremia-after-prophylaxis-can-be-safely-monitored-in-kidney-transplant-recipients-36613
https://atc.digitellinc.com/p/s/lung-transplant-outcomes-for-american-indiansalaska-natives-36614
https://atc.digitellinc.com/p/s/lung-transplant-recipients-and-8217-perspectives-on-integration-of-pharmacogenomic-testing-to-transplant-care-36615
https://atc.digitellinc.com/p/s/lung-transplantation-in-the-elderly-when-is-old-too-old-36616
https://atc.digitellinc.com/p/s/lung-transplantation-readmissions-based-on-underlying-lung-disease-36617
https://atc.digitellinc.com/p/s/machine-learning-model-using-pre-transplant-blood-rna-seq-identifies-small-gene-set-that-predicts-rejection-at-6-months-post-transplant-36618
https://atc.digitellinc.com/p/s/machine-learning-techniques-to-improve-predictive-models-for-kidney-offer-acceptance-36619
https://atc.digitellinc.com/p/s/machine-learning-based-prediction-of-early-post-transplant-bacteremia-with-pre-transplant-crossmatch-and-donor-specific-antibody-in-solid-organ-transplant-recipients-36620
https://atc.digitellinc.com/p/s/machine-perfusion-protects-against-mortality-and-graft-failure-in-donation-after-cardiac-death-dcd-liver-transplant-recipients-in-the-united-states-36621
https://atc.digitellinc.com/p/s/machine-perfusion-protects-against-mortality-and-graft-failure-in-donation-after-cardiac-death-dcd-liver-transplant-recipients-in-the-united-states-36622
https://atc.digitellinc.com/p/s/macrophage-polarization-induces-endothelium-to-myofibroblast-transition-in-chronic-allograft-dysfunction-36623
https://atc.digitellinc.com/p/s/macrophage-polarization-induces-endothelium-to-myofibroblast-transition-in-chronic-allograft-dysfunction-36624
https://atc.digitellinc.com/p/s/maintenance-belatacept-based-immunosuppression-in-lung-transplant-recipients-36625
https://atc.digitellinc.com/p/s/malnutrition-and-mortality-a-different-m-and-38m-following-heart-transplantation-36626
https://atc.digitellinc.com/p/s/management-and-outcome-of-severe-multifactorial-anemia-in-jehovah-and-8217s-witness-deceased-donor-kidney-transplant-recipient-a-case-report-36627
https://atc.digitellinc.com/p/s/management-and-outcomes-of-patients-requiring-tracheostomy-post-liver-transplant-36628
https://atc.digitellinc.com/p/s/management-of-atrial-fibrillation-after-kidney-transplant-do-we-need-a-new-metric-36629
https://atc.digitellinc.com/p/s/management-of-graft-vs-host-disease-following-intestinal-transplantation-36630
https://atc.digitellinc.com/p/s/management-of-recurrence-of-c3-glomerulopathy-post-kidney-transplant-36631
https://atc.digitellinc.com/p/s/management-of-recurrent-focal-segmental-glomerulosclerosis-post-transplant-using-low-density-lipoprotein-apheresis-ldla-36632
https://atc.digitellinc.com/p/s/manufacturing-and-functional-characterization-of-bioengineered-liver-grafts-for-extracorporeal-liver-assistance-in-acute-liver-failure-36633
https://atc.digitellinc.com/p/s/mapping-the-cellular-and-molecular-landscape-of-adaptive-immune-responses-in-kidney-allograft-rejection-36634
https://atc.digitellinc.com/p/s/marginal-zone-b-cells-play-both-effector-and-regulatory-roles-in-allogeneic-sensitization-36635
https://atc.digitellinc.com/p/s/maximal-medical-and-surgical-therapy-to-optimize-the-potential-organ-donor-a-case-report-36636
https://atc.digitellinc.com/p/s/medical-adherence-and-technical-user-behavior-in-patients-after-kidney-transplantation-and-with-and-without-telemedicine-support-a-cross-sectional-survey-36637
https://atc.digitellinc.com/p/s/medical-expertise-versus-survival-analysis-as-artificial-intelligence-categorization-mechanisms-in-kidney-transplantation-environments-through-a-hackathon-methodology-36638
https://atc.digitellinc.com/p/s/melanoma-specific-mortality-in-patients-with-pre-transplant-melanoma-36639
https://atc.digitellinc.com/p/s/mercedes-vs-reverse-lexus-in-liver-transplantation-who-has-the-better-incisional-warranty-36640
https://atc.digitellinc.com/p/s/metabolic-outcomes-in-overweight-obese-robotic-assisted-kidney-transplant-recipients-single-center-experience-36641
https://atc.digitellinc.com/p/s/metabolic-reprogramming-during-dcd-heart-perfusion-36642
https://atc.digitellinc.com/p/s/mhc-matchmaker-for-mamu-and-sla-evaluating-epitope-mismatches-for-xenotransplantation-36643
https://atc.digitellinc.com/p/s/mir-1-3p-centric-lncrna-mirna-mrna-network-controls-hepatic-iri-in-human-orthotopic-liver-transplantation-36644
https://atc.digitellinc.com/p/s/missing-the-match-a-national-survey-investigating-surgery-fellowship-education-in-renal-donor-recipient-matching-36645
https://atc.digitellinc.com/p/s/mitigating-bias-in-machine-learning-improving-minority-specific-graft-failure-survival-prediction-with-synthetic-minority-oversampling-36646
https://atc.digitellinc.com/p/s/mitochondrial-markers-measured-during-normothermic-liver-perfusion-predict-early-posttransplant-outcomes-36647
https://atc.digitellinc.com/p/s/mitsugumin-53-mitigation-of-ischemia-reperfusion-injury-in-vitro-and-in-vivo-hepatocytes-36648
https://atc.digitellinc.com/p/s/mixed-rejection-after-kidney-transplantation-and-its-relationship-with-dsa-timing-36649
https://atc.digitellinc.com/p/s/mmdx-and-174-rejection-and-injury-scores-in-pediatric-endomyocardial-biopsies-lack-of-concordance-with-results-of-the-interheart-study-36650
https://atc.digitellinc.com/p/s/modeling-of-non-alcoholic-steatohepatitis-ex-vivo-using-hepatocyte-like-cells-differentiated-from-human-induced-pluripotent-stem-cells-36651
https://atc.digitellinc.com/p/s/modelling-changes-in-the-pharmacokinetics-of-tacrolimus-during-pregnancy-after-kidney-transplantation-a-retrospective-cohort-study-36652
https://atc.digitellinc.com/p/s/models-of-islet-and-lung-xenotransplantation-in-human-immune-system-mice-36653
https://atc.digitellinc.com/p/s/modernizing-the-concept-of-donor-risk-index-dri-dbd-dri-and-dcd-dri-scores-to-predict-liver-graft-survival-36654
https://atc.digitellinc.com/p/s/modifying-effect-of-recipient-age-on-the-associations-between-common-risks-factors-and-all-cause-mortality-after-kidney-transplantation-36655
https://atc.digitellinc.com/p/s/molecular-and-cellular-mechanisms-of-lipocalin-2-mediated-renoprotection-in-kidney-transplantation-36656
https://atc.digitellinc.com/p/s/molecular-calls-of-minimal-histological-inflammation-is-it-safe-not-to-treat-36657
https://atc.digitellinc.com/p/s/molecular-mapping-of-nk-like-cd8-t-cell-atlas-in-kidney-transplantation-36658
https://atc.digitellinc.com/p/s/molecular-mapping-of-nk-like-cd8-t-cell-atlas-in-kidney-transplantation-36659
https://atc.digitellinc.com/p/s/molecular-signature-of-biopsies-with-thrombotic-microangiopathy-36660
https://atc.digitellinc.com/p/s/monitoring-recovery-of-kidney-allograft-function-after-transplantation-using-a-multi-analyte-urine-based-test-qsant-36661
https://atc.digitellinc.com/p/s/monosodium-urate-crystal-depletion-in-renal-transplant-recipients-treated-with-pegloticase-protect-serial-dual-energy-computed-tomography-findings-36662
https://atc.digitellinc.com/p/s/mortality-and-graft-failure-after-coronary-angiogram-among-kidney-transplant-recipients-a-population-based-study-36663
https://atc.digitellinc.com/p/s/mtor-inhibitor-nanoimmunotherapy-prolongs-cardiac-and-lung-allograft-survival-in-non-human-primates-nhps-36664
https://atc.digitellinc.com/p/s/mucormycosis-management-in-solid-organ-transplantation-patients-36665
https://atc.digitellinc.com/p/s/multiple-listing-in-kidney-transplantation-following-implementation-of-the-concentric-circle-kidney-allocation-policy-36666
https://atc.digitellinc.com/p/s/multiple-mycophenolic-acid-enterohepatic-recirculation-peaks-after-oral-mmf-in-kidney-transplant-recipients-36667
https://atc.digitellinc.com/p/s/mycophenolate-mofetil-mmf-pharmacokinetic-profiles-and-dosage-modification-in-pediatric-kidney-transplant-patients-36668
https://atc.digitellinc.com/p/s/mycophenolate-tolerability-in-liver-transplant-recipients-36669
https://atc.digitellinc.com/p/s/n-acetylcysteine-successfully-meliorates-methaemoglobin-accumulation-during-extended-normothermic-machine-liver-perfusion-36670
https://atc.digitellinc.com/p/s/nanostructured-mass-exchangers-as-liver-assist-devices-36671
https://atc.digitellinc.com/p/s/national-and-regional-trends-in-liver-transplant-after-allocation-change-with-a-focus-in-exception-points-36672
https://atc.digitellinc.com/p/s/national-attitudes-towards-living-kidney-donation-in-the-united-states-results-of-a-public-opinion-survey-36673
https://atc.digitellinc.com/p/s/national-discard-trends-of-livers-from-donation-after-circulatory-death-dcd-donors-an-11-year-analysis-36674
https://atc.digitellinc.com/p/s/nationwide-variation-in-practices-surrounding-the-eligibility-and-disclosure-of-deceased-kidney-offers-amidst-planned-living-kidney-donation-36675
https://atc.digitellinc.com/p/s/native-american-disparities-in-access-to-kidney-transplantation-36676
https://atc.digitellinc.com/p/s/natural-language-processing-using-donor-narratives-to-predict-donors-at-high-risk-for-delayed-graft-function-36677
https://atc.digitellinc.com/p/s/necessity-of-induction-agent-modification-for-elderly-kidney-transplant-recipients-36678
https://atc.digitellinc.com/p/s/neglected-and-underutilized-pancreas-after-deceased-donor-kidney-transplantation-36679
https://atc.digitellinc.com/p/s/neonatal-kidney-donation-a-solution-for-organ-shortage-36680
https://atc.digitellinc.com/p/s/neutrophil-extracellular-traps-in-xeno-islet-transplantation-and-cd46-gene-expression-36681
https://atc.digitellinc.com/p/s/never-underestimate-sex-ed-36682
https://atc.digitellinc.com/p/s/new-acuity-circles-policy-did-not-worsen-the-baseline-disparities-that-were-present-during-the-pre-ac-era-in-deceased-donor-liver-transplant-patients-36683
https://atc.digitellinc.com/p/s/ninjurin-1-mediated-plasma-membrane-rupture-contributes-to-hepatic-ischemia-reperfusion-injury-36684
https://atc.digitellinc.com/p/s/nirmatrelvirritonavir-for-mild-covid-19-in-abdominal-organ-transplant-recipients-36685
https://atc.digitellinc.com/p/s/nk-cells-are-implicated-in-early-rejection-in-pig-to-nonhuman-primate-renal-xenotransplantation-36686
https://atc.digitellinc.com/p/s/no-antibody-induction-in-non-high-risk-kidney-transplant-recipients-is-effective-for-rejection-prevention-36687
https://atc.digitellinc.com/p/s/nocardiosis-in-solid-organ-transplant-recipients-10-year-single-center-experience-36688
https://atc.digitellinc.com/p/s/non-antigen-specific-immunoadsorption-is-a-risk-factor-for-severe-postoperative-infections-and-increased-mortality-in-abo-incompatible-kidney-transplant-recipients-36689
https://atc.digitellinc.com/p/s/non-hla-antibodies-in-kidney-transplant-recipients-with-indication-and-follow-up-graft-biopsies-at-one-and-three-years-36690
https://atc.digitellinc.com/p/s/non-hla-antibody-profiles-associated-with-antibody-mediated-rejection-and-graft-survival-in-kidney-transplantation-36691
https://atc.digitellinc.com/p/s/non-hla-panel-reactive-antibodies-pra-determined-by-a-novel-multiplex-luminex-assay-correlates-with-kidney-transplant-outcomes-36692
https://atc.digitellinc.com/p/s/non-invasive-multimodality-testing-with-allosure-and-allomap-predicts-microvascular-inflammation-mvi-and-rejection-after-kidney-transplant-36693
https://atc.digitellinc.com/p/s/noninvasive-quantification-of-granzyme-b-in-cardiac-allografts-using-targeted-ultrasound-imaging-36694
https://atc.digitellinc.com/p/s/non-tuberculous-mycobacteria-in-lung-transplant-patients-treat-or-wait-36695
https://atc.digitellinc.com/p/s/non-uremic-calciphylaxis-in-a-kidney-transplant-recipient-36696
https://atc.digitellinc.com/p/s/normalizing-the-percent-donor-derived-cell-free-dna-percent-dd-cfdna-to-recipient-body-surface-area-bsa-or-to-donor-to-recipient-bsa-ratio-effects-on-the-diagnostic-performance-in-detecting-acute-tran-36697
https://atc.digitellinc.com/p/s/normothermic-ex-vivo-perfusion-of-liver-grafts-results-in-reduced-expression-of-genes-related-to-ischemia-reperfusion-injury-36698
https://atc.digitellinc.com/p/s/normothermic-kidney-perfusion-phase-1-a-clinical-trial-of-up-to-24-hour-normothermic-machine-perfusion-prior-to-transplantation-36699
https://atc.digitellinc.com/p/s/normothermic-machine-perfusion-nmp-could-prevent-discarding-livers-from-older-and-6260yo-dbd-donors-36700
https://atc.digitellinc.com/p/s/normothermic-machine-perfusion-and-apol1-inflammation-and-hypoxia-axis-in-donor-kidney-36701
https://atc.digitellinc.com/p/s/normothermic-machine-perfusion-in-liver-transplantation-real-world-intraoperative-and-early-postoperative-impacts-36702
https://atc.digitellinc.com/p/s/normothermic-machine-perfusion-of-the-kidney-prior-to-transplantation-implementations-and-early-outcomes-in-australia-36703
https://atc.digitellinc.com/p/s/normothermic-machine-perfusion-reducing-preoperative-admissions-and-increasing-organ-offers-36704
https://atc.digitellinc.com/p/s/not-all-machines-anger-the-immunologic-gods-prospective-analysis-of-the-impact-of-impella-55-devices-on-hla-development-in-transplant-recipients-36705
https://atc.digitellinc.com/p/s/novel-acoustofluidic-apheresis-device-for-antibody-removal-in-a-rodent-model-36706
https://atc.digitellinc.com/p/s/novel-artificial-intelligence-algorithms-predict-long-term-outcomes-in-kidney-transplant-recipients-from-baseline-electrocardiograms-36707
https://atc.digitellinc.com/p/s/novel-coronavirus-pneumonia-after-kidney-transplantation-analysis-of-risk-factors-36708
https://atc.digitellinc.com/p/s/novel-en-bloc-simultaneous-pancreas-kidney-transplantation-36709
https://atc.digitellinc.com/p/s/novel-non-hla-antibodies-targeted-against-cardiolipin-are-associated-with-higher-risk-of-rejection-in-kidney-transplant-recipients-36710
https://atc.digitellinc.com/p/s/novel-prediction-model-based-on-machine-learning-for-post-donation-renal-adaptation-in-living-kidney-donors-36711
https://atc.digitellinc.com/p/s/novel-protein-biomarkers-as-predictors-of-autoimmune-type-1-diabetes-development-36712
https://atc.digitellinc.com/p/s/novel-role-of-mif-cd74-signaling-in-immune-regulation-36713
https://atc.digitellinc.com/p/s/number-of-covid-19-vaccine-doses-and-clinical-outcomes-in-solid-organ-transplant-recipients-a-living-systematic-review-and-network-meta-analysis-of-observational-studies-36714
https://atc.digitellinc.com/p/s/nutritional-care-of-pre-and-post-intestinal-transplant-patients-with-nitrogen-balance-36715
https://atc.digitellinc.com/p/s/obesity-does-not-appear-to-significantly-impact-surgical-complications-or-long-term-outcomes-in-pancreas-transplant-36716
https://atc.digitellinc.com/p/s/occurrence-of-hernias-in-the-post-living-donor-nephrectomy-population-a-single-center-review-36717
https://atc.digitellinc.com/p/s/octreotide-in-recurrent-iga-nephropathy-case-series-36718
https://atc.digitellinc.com/p/s/older-donor-age-associated-with-poorer-pediatric-liver-transplant-recipient-graft-and-overall-survival-36719
https://atc.digitellinc.com/p/s/oncology-screening-in-post-renal-transplant-patients-a-retrospective-review-of-adherence-to-screening-guidelines-in-a-canadian-health-region-36720
https://atc.digitellinc.com/p/s/one-opos-experience-with-normothermic-regional-perfusion-36721
https://atc.digitellinc.com/p/s/one-size-does-not-fit-all-differential-benefits-of-simultaneous-liver-kidney-transplantation-by-kidney-eligibility-criteria-36722
https://atc.digitellinc.com/p/s/one-year-post-kidney-transplant-urinary-tract-infection-and-the-impact-on-kidney-transplant-outcomes-36723
https://atc.digitellinc.com/p/s/open-simultaneous-offers-for-high-kdri-kidneys-may-significantly-reduce-discards-36724
https://atc.digitellinc.com/p/s/opioid-avoidance-protocol-following-liver-transplantation-36725
https://atc.digitellinc.com/p/s/opo-measured-donation-rate-is-highly-volatile-year-to-year-and-not-a-stable-quality-indicator-36726
https://atc.digitellinc.com/p/s/opportunistic-viral-infections-in-transplant-recipients-of-hepatitis-c-viremic-donor-organs-36727
https://atc.digitellinc.com/p/s/opportunity-to-detect-allograft-rejection-in-the-first-week-after-kidney-transplantation-using-a-non-invasive-multi-analyte-qsant-assay-36728
https://atc.digitellinc.com/p/s/optimal-condition-of-long-term-culturing-adult-porcine-islets-for-islet-xenotransplantation-36729
https://atc.digitellinc.com/p/s/optimal-dose-of-anti-tymocyte-globulin-as-induction-regimen-after-kidney-transplantation-analysis-of-the-nationwide-korean-organ-transplantation-registry-database-36730
https://atc.digitellinc.com/p/s/optimal-dose-of-rituximab-in-abo-incompatible-kidney-transplantation-in-patients-with-low-anti-ab-antibody-titers-a-single-center-retrospective-cohort-study-36731
https://atc.digitellinc.com/p/s/optimal-matched-comparison-of-short-term-outcomes-in-kidney-recipients-from-covid-infected-versus-non-infected-deceased-donors-36732
https://atc.digitellinc.com/p/s/optimizing-a-race-free-kidney-donor-risk-index-36733
https://atc.digitellinc.com/p/s/organ-donation-and-transplantation-recovery-during-the-first-two-years-of-the-covid-19-pandemic-a-comparison-of-canada-and-the-united-states-36734
https://atc.digitellinc.com/p/s/organ-survival-prediction-of-high-risk-recipients-based-on-reverse-survival-model-36735
https://atc.digitellinc.com/p/s/osteoprotegerin-reduces-antitumor-activity-of-liver-natural-killer-cells-and-increases-the-risk-of-hepatocellular-carcinoma-recurrence-36736
https://atc.digitellinc.com/p/s/outcome-hiv-positive-pancreas-and-kidney-pancreas-transplants-an-analysis-of-the-unos-database-36737
https://atc.digitellinc.com/p/s/outcomes-after-intestinal-re-transplant-a-detailed-single-center-analysis-of-clinical-and-technical-factors-36738
https://atc.digitellinc.com/p/s/outcomes-following-donation-after-circulatory-death-liver-transplantation-for-hepatocellular-carcinoma-and-impact-of-direct-acting-anti-viral-therapy-36739
https://atc.digitellinc.com/p/s/outcomes-for-high-risk-post-kidney-transplant-patients-admitted-to-the-intensive-care-unit-36740
https://atc.digitellinc.com/p/s/outcomes-for-waitlisted-kidney-transplant-candidates-with-declined-kidney-donor-offers-a-retrospective-single-centre-uk-analysis-36741
https://atc.digitellinc.com/p/s/outcomes-in-kidney-transplant-recipients-hospitalized-with-covid-19-insights-from-a-nationally-representative-sample-36742
https://atc.digitellinc.com/p/s/outcomes-in-kidney-transplant-recipients-with-pretransplant-uncontrolled-diabetes-on-belatacept-versus-tacrolimus-based-immunosuppression-36743
https://atc.digitellinc.com/p/s/outcomes-of-a-kidney-transplantation-exchange-program-in-very-highly-sensitized-patients-based-on-virtual-crossmatch-36744
https://atc.digitellinc.com/p/s/outcomes-of-a2-to-b-deceased-donor-kidney-transplantation-36745
https://atc.digitellinc.com/p/s/outcomes-of-invasive-fungal-infections-ifis-in-solid-organ-transplant-sot-recipients-treated-with-olorofim-in-an-open-label-salvage-study-36746
https://atc.digitellinc.com/p/s/outcomes-of-kidney-transplantation-in-patients-with-pre-transplant-malignancy-36747
https://atc.digitellinc.com/p/s/outcomes-of-kidney-transplantation-recipients-with-covid-19-infection-282-cases-of-a-single-center-experience-36748
https://atc.digitellinc.com/p/s/outcomes-of-kidney-transplants-from-pediatric-donors-with-acute-kidney-injury-36749
https://atc.digitellinc.com/p/s/outcomes-of-liver-transplant-recipients-from-donation-after-circulatory-death-grafts-procured-using-normothermic-regional-perfusion-36750
https://atc.digitellinc.com/p/s/outcomes-of-liver-transplantation-with-the-use-of-organs-from-donation-after-circulatory-death-and-hepatitis-c-positive-donors-36751
https://atc.digitellinc.com/p/s/outcomes-of-oral-antiviral-therapy-compared-to-monoclonal-antibody-against-sars-cov-2-and-vaccination-in-kidney-transplant-recipients-with-covid-19-36752
https://atc.digitellinc.com/p/s/outcomes-of-pediatric-liver-transplant-recipients-after-transfer-from-pediatric-to-adult-healthcare-a-report-from-the-starzl-network-36753
https://atc.digitellinc.com/p/s/outcomes-of-sexagenarian-living-liver-donors-in-korea-a-multicenter-study-36754
https://atc.digitellinc.com/p/s/outcomes-of-transplantation-of-hepatitis-b-nat-positive-organs-for-hepatitis-b-seronegative-recipients-of-liver-transplants-36755
https://atc.digitellinc.com/p/s/outcomes-of-transplantation-of-single-kidneys-from-splitting-en-bloc-pediatric-donor-kidneys-into-adult-recipients-a-single-center-experience-36756
https://atc.digitellinc.com/p/s/outcomes-of-transplanted-expedited-allocation-deceased-donor-kidneys-36757
https://atc.digitellinc.com/p/s/overview-of-transplant-research-collaboration-in-the-us-a-network-analysis-36758
https://atc.digitellinc.com/p/s/p2x7r-inhibition-impairs-training-of-macrophages-in-vitro-and-rescind-the-effect-of-training-in-allo-skin-graft-model-36759
https://atc.digitellinc.com/p/s/pancreatic-exocrine-secretion-and-weight-gain-after-pancreas-transplantation-36760
https://atc.digitellinc.com/p/s/parathyroid-allotransplantation-report-of-outcomes-in-3-patients-36761
https://atc.digitellinc.com/p/s/patient-and-graft-survival-after-a2a2b-to-b-deceased-donor-kidney-transplantation-36762
https://atc.digitellinc.com/p/s/patient-perspectives-on-the-bioethical-considerations-of-using-frailty-and-cognition-in-kt-decision-making-factors-36763
https://atc.digitellinc.com/p/s/patient-perspectives-on-weight-management-and-wellness-after-liver-transplantation-36764
https://atc.digitellinc.com/p/s/patient-recorded-outcomes-pros-after-kidney-transplantation-envarsus-vs-tacrolimus-multicenter-transplant-alliance-cohort-36765
https://atc.digitellinc.com/p/s/patient-survival-outcome-with-dcd-donor-over-90-minutes-36766
https://atc.digitellinc.com/p/s/patient-survival-outcome-with-dcd-donor-over-90-minutes-36767
https://atc.digitellinc.com/p/s/patient-variables-predictive-of-post-intestinal-transplantation-malignancy-36768
https://atc.digitellinc.com/p/s/pd-1-inhibitor-prior-to-liver-transplantation-for-hepatocellular-carcinoma-is-not-associated-with-increased-graft-loss-36769
https://atc.digitellinc.com/p/s/peak-creatinine-improves-ability-to-predict-reduced-glomerular-filtration-rate-in-deceased-donors-with-diabetes-insipidus-36770
https://atc.digitellinc.com/p/s/pediatric-acute-liver-failure-palf-score-accurately-predicts-survival-with-native-liver-36771
https://atc.digitellinc.com/p/s/pediatric-liver-transplant-for-alagille-and-8217s-syndrome-as-bad-as-we-think-36772
https://atc.digitellinc.com/p/s/pediatric-priority-after-age-18-years-kids-gaming-the-system-36773
https://atc.digitellinc.com/p/s/pediatric-recipients-of-deceased-donor-kidney-transplants-from-donors-after-cardiac-death-a-single-center-study-36774
https://atc.digitellinc.com/p/s/perceived-systemic-racism-and-discrimination-among-indigenous-kidney-transplant-recipients-and-donors-in-canada-36775
https://atc.digitellinc.com/p/s/perceptions-and-potential-barriers-of-personnel-involved-in-xenotransplant-research-36776
https://atc.digitellinc.com/p/s/perceptions-of-reproductive-health-in-adolescents-and-young-adults-with-kidney-transplants-36777
https://atc.digitellinc.com/p/s/performance-of-combine-gene-profiling-and-donor-derived-cell-free-dna-dd-cf-dna-test-in-the-setttings-of-worsening-renal-allograft-function-36778
https://atc.digitellinc.com/p/s/performance-of-donor-derived-cell-free-dna-in-detecting-antibody-mediated-rejection-when-coupled-with-donor-specific-antibodies-36779
https://atc.digitellinc.com/p/s/performance-of-donor-derived-cell-free-dna-in-repeat-kidney-transplant-recipients-36780
https://atc.digitellinc.com/p/s/performance-of-the-kidney-solid-organ-response-test-ksort-for-prediction-of-rejection-in-kidney-transplant-recipients-36781
https://atc.digitellinc.com/p/s/perfusion-decellularized-massive-bone-allografts-the-next-step-to-improve-bone-tissue-transplantation-36782
https://atc.digitellinc.com/p/s/perioperative-desensitization-with-intravenous-immunoglobulin-vs-bortezomib-in-positive-crossmatch-deceased-donor-kidney-transplants-24-months-outcomes-analysis-36783
https://atc.digitellinc.com/p/s/perioperative-neurological-outcomes-in-recipients-of-ecmo-bridge-to-lung-transplant-36784
https://atc.digitellinc.com/p/s/peripheral-clonal-deletion-of-the-t-cell-repertoire-induces-allograft-tolerance-by-targeting-programmed-death-1-36785
https://atc.digitellinc.com/p/s/phase-12-donor-antigen-specific-treg-based-suppressor-t-cells-therapy-clinical-trial-to-induce-operational-tolerance-in-living-donor-liver-transplant-patients-36786
https://atc.digitellinc.com/p/s/pig-organs-with-10-gene-edits-support-post-transplant-survival-in-non-human-primates-and-humans-36787
https://atc.digitellinc.com/p/s/pig-xenogeneic-stimulation-of-human-t-cells-induces-unique-transcriptional-changes-associated-with-pro-coagulant-and-pro-inflammatory-responses-36788
https://atc.digitellinc.com/p/s/pilot-evaluation-of-a-clinical-xeno-heart-transplant-regimen-in-a-preclinical-model-36789
https://atc.digitellinc.com/p/s/pneumocystis-pneumonia-outbreaks-among-transplant-recipients-unraveling-the-mystery-36790
https://atc.digitellinc.com/p/s/podocyte-differentiation-of-primary-human-glomerular-outgrowth-cells-36791
https://atc.digitellinc.com/p/s/post-kidney-transplant-hospitalizations-and-long-term-graft-outcomes-36792
https://atc.digitellinc.com/p/s/post-donation-remote-patient-monitoring-offers-the-opportunity-to-more-closely-follow-kidney-living-donors-36793
https://atc.digitellinc.com/p/s/post-kidney-transplant-hypertension-in-native-americans-a-single-center-experience-36794
https://atc.digitellinc.com/p/s/post-transplant-acute-intra-graft-sickle-cell-vaso-occlusive-crisis-in-patient-with-sickle-cell-trait-36795
https://atc.digitellinc.com/p/s/post-transplant-de-novo-kidney-cancer-in-kidney-transplant-recipients-an-analysis-of-organ-procurement-and-transplantation-network-data-during-2000-2021-36796
https://atc.digitellinc.com/p/s/post-transplant-lymphoproliferative-disorder-following-pediatric-intestinal-transplant-an-old-foe-36797
https://atc.digitellinc.com/p/s/post-transplant-nephrocalcinosis-a-single-center-case-series-36798
https://atc.digitellinc.com/p/s/post-transplant-outcomes-in-covid-19-vaccinated-vs-unvaccinated-liver-transplant-recipients-is-there-a-price-to-pay-36799
https://atc.digitellinc.com/p/s/potential-living-kidney-donors-and-8217-concerns-about-opting-out-and-preferences-for-an-alibi-results-from-a-multicenter-study-36800
https://atc.digitellinc.com/p/s/potential-tacrolimus-sparing-role-of-bisphosphonate-in-kidney-transplant-recipients-36801
https://atc.digitellinc.com/p/s/practices-and-perceptions-of-the-use-of-covid-19-positive-organs-in-solid-organ-transplant-an-international-survey-36802
https://atc.digitellinc.com/p/s/preconditioning-using-rituximab-in-kidney-transplantation-reduces-incidence-of-acute-t-cell-mediated-rejection-and-prevents-development-of-anti-hla-antibody-36803
https://atc.digitellinc.com/p/s/predicting-evaluation-completion-and-donation-by-relationship-type-identifying-opportunities-for-more-donors-36804
https://atc.digitellinc.com/p/s/predicting-patient-outcomes-in-kidney-transplant-recipients-plasma-versus-whole-blood-tacrolimus-36805
https://atc.digitellinc.com/p/s/predicting-patient-outcomes-in-kidney-transplant-recipients-plasma-versus-whole-blood-tacrolimus-36806
https://atc.digitellinc.com/p/s/predicting-post-liver-transplant-lt-outcomes-in-acute-on-chronic-liver-failure-aclf-patients-using-expert-augmented-machine-learning-eaml-36807
https://atc.digitellinc.com/p/s/predicting-recipient-and-graft-survival-in-living-donor-kidney-transplant-can-the-risk-tools-be-helpful-in-pretransplant-counseling-36808
https://atc.digitellinc.com/p/s/prediction-models-for-ideal-graft-function-after-living-donor-kidney-transplantation-are-useful-to-predict-graft-survival-36809
https://atc.digitellinc.com/p/s/prediction-of-6-month-post-donation-serum-creatinine-in-living-kidney-donors-36810
https://atc.digitellinc.com/p/s/prediction-of-early-acute-rejection-after-kidney-transplantation-by-gut-microbiome-36811
https://atc.digitellinc.com/p/s/prediction-of-kidney-failure-in-potential-donors-prior-to-donation-36812
https://atc.digitellinc.com/p/s/prediction-of-post-nephrectomy-estimated-glomerular-filtration-rate-of-living-kidney-donors-using-auto-segmented-kidney-volumes-and-clinical-variables-36813
https://atc.digitellinc.com/p/s/predictive-ability-of-epts-in-pediatric-renal-recipients-36814
https://atc.digitellinc.com/p/s/predictive-value-of-withdrawal-related-variables-on-graft-function-after-donation-after-circulatory-death-36815
https://atc.digitellinc.com/p/s/predictors-of-native-renal-function-decline-after-primary-pancreas-transplant-alone-in-type-1-dm-recipients-in-the-united-states-36816
https://atc.digitellinc.com/p/s/pre-donation-medication-patterns-among-living-kidney-donors-36817
https://atc.digitellinc.com/p/s/pre-exposure-tixagevimabcilgavimab-monoclonal-antibodies-reduces-covid-19-infection-in-heart-transplant-recipients-36818
https://atc.digitellinc.com/p/s/pre-liver-transplantation-locoregional-therapy-in-patients-with-hepatocellular-carcinoma-36819
https://atc.digitellinc.com/p/s/pre-op-use-of-midodrine-a-risk-factor-for-poor-graft-outcomes-in-kidney-transplant-36820
https://atc.digitellinc.com/p/s/pre-recovery-huddles-for-success-on-the-donation-after-cardiac-death-donor-with-thoracoabdominal-normothermic-regional-perfusion-36821
https://atc.digitellinc.com/p/s/presence-of-retained-renal-cysts-does-not-impact-kidney-function-recovery-after-living-kidney-donation-36822
https://atc.digitellinc.com/p/s/preservation-of-dcd-kidney-grafts-using-subnormothermic-oxygenated-machine-perfusion-in-a-porcine-auto-transplant-model-36823
https://atc.digitellinc.com/p/s/pre-transplant-cognitive-function-does-not-adversely-affect-post-transplant-outcomes-36824
https://atc.digitellinc.com/p/s/prevalence-and-potential-impact-of-human-leukocyte-antigen-alleles-unrepresented-on-single-antigen-bead-assays-36825
https://atc.digitellinc.com/p/s/prevalence-of-medical-distrust-among-kidney-transplant-candidates-36826
https://atc.digitellinc.com/p/s/primary-care-utilization-by-kidney-transplant-recipients-36827
https://atc.digitellinc.com/p/s/primary-hepatic-neuoendocrine-neoplasms-graded-as-net-g3-treated-with-liver-transplantation-36828
https://atc.digitellinc.com/p/s/pro-active-genetic-testing-in-kidney-transplant-recipients-36829
https://atc.digitellinc.com/p/s/procedure-costs-associated-with-management-of-biliary-strictures-in-pediatric-liver-transplant-recipients-in-the-society-of-pediatric-liver-transplant-split-registry-36830
https://atc.digitellinc.com/p/s/prognostic-biomarkers-in-kidney-transplantation-a-meta-epidemiological-study-36831
https://atc.digitellinc.com/p/s/prognostic-factors-affecting-outcomes-of-liver-transplant-graft-with-hyperbilirubinemia-at-the-time-of-organ-recovery-36832
https://atc.digitellinc.com/p/s/prognostic-value-of-quantitative-real-time-pcr-forpneumocystis-jiroveciipneumonia-pjp-in-solid-organ-transplant-recipients-36833
https://atc.digitellinc.com/p/s/prolonged-donated-human-hearts-preservation-using-the-vps-encore-and-8482-portable-oxygenated-machine-perfusion-device-36834
https://atc.digitellinc.com/p/s/prolonged-warm-ischemia-injury-enhances-cellular-immune-responses-to-mouse-renal-allografts-36835
https://atc.digitellinc.com/p/s/prophylaxis-and-risk-factors-for-nocardiosis-in-solid-organ-transplant-recipients-36836
https://atc.digitellinc.com/p/s/prospective-assessment-of-the-need-for-and-added-value-of-molecular-diagnostics-of-kidney-allograft-biopsies-an-evaluation-in-clinical-practice-36837
https://atc.digitellinc.com/p/s/prospective-evaluation-of-sars-cov-2-spike-s-anti-receptor-binding-domain-rbd-igg-titers-after-administration-of-tixagevimab-cilgavimab-tc-pre-exposure-prophylaxis-prep-in-solid-organ-transplant-recip-36838
https://atc.digitellinc.com/p/s/prospective-study-of-donors-with-nephrolithiasis-at-the-time-of-transplant-evaluation-donate-36839
https://atc.digitellinc.com/p/s/prospective-survey-outcome-the-impact-of-racial-disparity-with-economic-inequality-on-long-term-clinical-outcomes-in-heart-transplant-patients-36840
https://atc.digitellinc.com/p/s/proteasome-dysfunction-a-potential-contributor-of-kidney-dysfunction-during-cold-storage-and-transplantation-36841
https://atc.digitellinc.com/p/s/protective-effect-of-liver-allograft-delaying-lung-allograft-dysfunction-in-a-case-of-simultaneous-combined-lung-liver-transplantation-36842
https://atc.digitellinc.com/p/s/proteomic-effluent-analysis-reveals-down-regulation-of-novel-inflammatory-and-transcriptional-biomarkers-following-hypothermic-oxygenated-machine-perfusion-of-liver-allografts-36843
https://atc.digitellinc.com/p/s/proteomics-analysis-reveals-specific-biological-changes-induced-by-the-normothermic-machine-perfusion-of-donor-kidneys-with-latexin-being-the-top-up-regulated-protein-post-treatment-36844
https://atc.digitellinc.com/p/s/pro-tolerogenic-gut-microbiota-induce-distinct-metabolic-activities-after-cardiac-allografting-36845
https://atc.digitellinc.com/p/s/pulmonary-complications-of-everolimus-in-liver-transplant-patients-a-10-year-experience-36846
https://atc.digitellinc.com/p/s/pyelovesicostomy-as-a-urinary-reconstruction-alternative-in-renal-transplantation-a-case-series-36847
https://atc.digitellinc.com/p/s/quality-of-life-changes-after-kidney-transplant-in-people-living-with-hiv-36848
https://atc.digitellinc.com/p/s/quantifying-goals-of-care-discussions-in-transplant-surgery-using-natural-language-processing-36849
https://atc.digitellinc.com/p/s/quantifying-informed-consent-kidney-transplant-candidates-that-list-for-high-kdpi-donors-and-the-estimated-benefit-36850
https://atc.digitellinc.com/p/s/r-for-hla-data-a-suite-of-tools-for-managing-and-analyzing-data-from-clinical-hla-laboratory-information-systems-36851
https://atc.digitellinc.com/p/s/r-for-hla-data-a-suite-of-tools-for-managing-and-analyzing-data-from-clinical-hla-laboratory-information-systems-36852
https://atc.digitellinc.com/p/s/racial-disparities-among-liver-transplant-waitlist-candidates-before-and-after-acuity-circles-36853
https://atc.digitellinc.com/p/s/racial-disparities-in-reactivation-on-the-kidney-transplant-waitlist-among-individuals-that-are-inactivated-for-being-temporarily-too-sick-36854
https://atc.digitellinc.com/p/s/racially-disparate-disease-progression-rates-in-early-stage-hepatocellular-carcinoma-patients-36855
https://atc.digitellinc.com/p/s/radiomic-assessment-of-donor-pancreatic-fat-content-to-drive-utilization-36856
https://atc.digitellinc.com/p/s/randomized-controlled-trial-testing-a-new-tool-that-helps-patients-find-transplant-centers-that-transplant-patients-like-them-36857
https://atc.digitellinc.com/p/s/range-of-donor-derived-cell-free-dna-in-liver-transplant-recipients-an-exploratory-analysis-36858
https://atc.digitellinc.com/p/s/rapid-portable-digital-spectrophotometry-to-assess-macrovesicular-steatosis-in-the-liver-36859
https://atc.digitellinc.com/p/s/rapid-portable-digital-spectrophotometry-to-assess-macrovesicular-steatosis-in-the-liver-36860
https://atc.digitellinc.com/p/s/real-world-experience-with-maribavir-for-the-treatment-of-cytomegalovirus-in-solid-organ-transplant-recipients-36861
https://atc.digitellinc.com/p/s/real-time-measurements-of-urinary-biomarkers-for-deceased-donor-kidney-quality-assessment-36862
https://atc.digitellinc.com/p/s/real-world-adherence-to-belatacept-bela-maintenance-immunosuppression-is-guidelines-36863
https://atc.digitellinc.com/p/s/real-world-experience-with-molnupiravir-in-a-heterogeneous-population-of-solid-organ-transplant-recipients-36864
https://atc.digitellinc.com/p/s/real-world-healthcare-resource-utilization-hcru-and-costs-among-patients-with-hematopoietic-stem-cell-transplant-hsct-or-solid-organ-transplant-sot-with-covid-19-in-a-commercially-insured-or-medicare--36865
https://atc.digitellinc.com/p/s/reasons-for-referral-closure-among-patients-with-kidney-failure-referred-for-kidney-transplantation-in-the-southeastern-united-states-36866
https://atc.digitellinc.com/p/s/recent-intravenous-immunoglobulin-ivig-lots-contains-neutralizing-igg-to-sars-cov-2-omicron-variant-36867
https://atc.digitellinc.com/p/s/recipient-macrophage-derived-xbp1-mitigates-ischemia-and-reperfusion-injury-mediated-via-regulating-tgf-and-9461klf4-pathways-response-following-kidney-transplantation-36868
https://atc.digitellinc.com/p/s/recombinant-sars-cov-2-antibodies-in-kidney-transplant-recipients-without-neutralizing-antibodies-following-full-vaccination-rescue-tx-36869
https://atc.digitellinc.com/p/s/recovery-of-physical-function-pf-after-kidney-kt-versus-liver-lt-transplantation-36870
https://atc.digitellinc.com/p/s/recurrence-of-focal-segmental-glomerulosclerosis-and-hla-genotypes-after-kidney-transplantation-in-adults-36871
https://atc.digitellinc.com/p/s/recycling-transplanted-kidneys-36872
https://atc.digitellinc.com/p/s/redefining-warm-ischemia-time-to-focus-on-temperature-36873
https://atc.digitellinc.com/p/s/reduced-severe-neutropenia-with-steroid-avoidant-immunosuppression-in-pediatric-kidney-transplant-recipients-36874
https://atc.digitellinc.com/p/s/regional-outcomes-of-paediatric-renal-transplantation-in-the-uk-a-machine-learning-analysis-36875
https://atc.digitellinc.com/p/s/regulatory-b-cells-as-a-useful-biomarker-of-improved-graft-outcome-and-rejection-risk-in-kidney-transplant-patients-36876
https://atc.digitellinc.com/p/s/regulatory-t-cells-in-chronically-rejected-human-lung-allografts-exhibit-a-gene-expression-program-suggesting-dysfunction-36877
https://atc.digitellinc.com/p/s/rehabilitation-outcomes-of-bilateral-lung-transplant-patients-due-to-covid-19-36878
https://atc.digitellinc.com/p/s/re-infections-with-sars-cov-2-and-severity-in-solid-organ-transplant-recipients-a-matched-case-control-study-36879
https://atc.digitellinc.com/p/s/rejection-and-infection-risk-after-basiliximab-induction-in-low-immunologic-risk-kidney-transplant-recipients-at-a-high-volume-transplant-center-36880
https://atc.digitellinc.com/p/s/rejection-in-liver-transplant-recipients-at-high-risk-for-invasive-fungal-infection-36881
https://atc.digitellinc.com/p/s/relapse-of-fsgs-in-native-kidneys-post-kidney-transplantation-36882
https://atc.digitellinc.com/p/s/renal-allograft-outcomes-in-recipients-with-new-onset-diabetes-after-transplantation-36883
https://atc.digitellinc.com/p/s/renal-allograft-pathology-in-methylmalonic-aciduria-a-comparative-study-36884
https://atc.digitellinc.com/p/s/renal-cell-carcinoma-the-risk-of-transmission-from-deceased-donors-to-kidney-transplant-recipients-36885
https://atc.digitellinc.com/p/s/renal-outcomes-of-high-risk-kidney-transplant-recipients-after-conversion-to-belatacept-based-immunosuppression-36886
https://atc.digitellinc.com/p/s/repeat-transplantation-outcomes-in-patients-with-iga-nephropathy-36887
https://atc.digitellinc.com/p/s/research-for-novel-mechanism-of-immunosuppression-through-pd-1pd-l1-pathway-36888
https://atc.digitellinc.com/p/s/results-of-a-multicenter-cluster-randomized-controlled-clinical-trial-testing-the-effectiveness-of-a-bioinformatics-enabled-pharmacist-intervention-in-transplant-recipients-at-the-veterans-affairs-hea-36889
https://atc.digitellinc.com/p/s/results-of-the-multimodal-aftercare-program-ktx360-and-176-indicate-an-improved-outcome-in-kidney-transplant-recipients-36890
https://atc.digitellinc.com/p/s/retooling-epts-in-era-of-continuous-distribution-36891
https://atc.digitellinc.com/p/s/re-transplant-as-an-effect-modifier-of-early-steroid-withdrawal-in-deceased-donor-kidney-transplant-recipients-36892
https://atc.digitellinc.com/p/s/risk-and-outcomes-after-living-donor-nephrectomy-in-korea-15-year-single-center-outcome-36893
https://atc.digitellinc.com/p/s/risk-factors-and-outcomes-of-mucorales-infection-in-solid-organ-and-hematopoietic-stem-cell-transplant-recipients-36894
https://atc.digitellinc.com/p/s/risk-factors-and-outcomes-of-recurrent-cytomegalovirus-infections-in-heart-transplant-recipients-36895
https://atc.digitellinc.com/p/s/risk-factors-associated-with-vancomycin-resistant-enterococcus-bacteremia-in-liver-transplant-recipients-a-single-center-study-36896
https://atc.digitellinc.com/p/s/risk-factors-for-and-outcomes-of-orthostatic-hypotension-among-simultaneouspancreas-and-kidney-transplant-recipients-36897
https://atc.digitellinc.com/p/s/risk-factors-for-breakthrough-covid-19-infections-in-solid-organ-transplant-recipients-receiving-tixagevimabcilgavimab-for-pre-exposure-prophylaxis-36898
https://atc.digitellinc.com/p/s/risk-factors-for-breakthrough-cytomegalovirus-infection-while-on-prophylaxis-in-kidney-and-pancreas-transplant-recipients-36899
https://atc.digitellinc.com/p/s/risk-factors-for-death-censored-graft-loss-and-death-in-kidney-transplant-recipients-with-delayed-graft-function-36900
https://atc.digitellinc.com/p/s/risk-factors-for-developing-low-estimated-glomerular-filtration-rate-and-albuminuria-in-living-kidney-donors-36901
https://atc.digitellinc.com/p/s/risk-factors-for-early-post-solid-organ-transplant-fungal-disease-a-systematic-review-and-meta-analysis-36902
https://atc.digitellinc.com/p/s/risk-factors-for-fungal-disease-in-lung-transplant-a-systematic-review-and-meta-analysis-36903
https://atc.digitellinc.com/p/s/risk-factors-for-greater-than-10-years-pancreas-graft-survival-in-the-uk-short-term-risk-factors-are-not-always-the-best-guide-for-long-term-survival-36904
https://atc.digitellinc.com/p/s/risk-factors-for-invasive-fungal-infection-in-lung-transplant-recipients-on-universal-prophylaxis-with-inhaled-amphotericin-b-lipid-complex-36905
https://atc.digitellinc.com/p/s/risk-factors-for-late-onset-pneumocystis-jirovecii-pneumonia-in-liver-transplant-recipients-36906
https://atc.digitellinc.com/p/s/risk-factors-for-pneumocystis-jirovecii-pneumonia-in-renal-transplant-recipients-a-case-control-study-from-the-usrds-database-36907
https://atc.digitellinc.com/p/s/risk-factors-for-rejection-at-1-year-in-kidney-transplant-recipients-with-delayed-graft-function-36908
https://atc.digitellinc.com/p/s/risk-factors-of-early-allograft-dysfunction-ead-after-liver-transplant-lt-with-portable-normothermic-machine-perfusion-nmp-36909
https://atc.digitellinc.com/p/s/risk-of-hyperuricemia-and-chronic-kidney-disease-in-living-kidney-donors-a-nationwide-population-based-cohort-study-with-propensity-score-matching-analysis-36910
https://atc.digitellinc.com/p/s/risk-of-opportunistic-infection-in-adult-kidney-transplant-recipients-treated-with-belatacept-a-retrospective-cohort-study-36911
https://atc.digitellinc.com/p/s/risk-of-skin-cancer-after-liver-transplantation-in-a-large-us-national-cohort-36912
https://atc.digitellinc.com/p/s/risk-stratification-of-cardiac-allograft-injury-using-cell-free-dna-testing-real-world-effectiveness-36913
https://atc.digitellinc.com/p/s/robot-assisted-deceased-donors-kidney-transplants-in-obese-recipients-outcomes-and-challenges-36914
https://atc.digitellinc.com/p/s/robotic-kidney-transplantation-vs-traditional-open-kidney-transplant-in-setting-of-deceased-donation-a-single-center-experience-36915
https://atc.digitellinc.com/p/s/robotic-versus-laparoscopic-living-donor-nephrectomy-techniques-a-retrospective-review-of-a-single-center-experience-36916
https://atc.digitellinc.com/p/s/robotic-assisted-transplant-ureteral-reimplantation-for-the-management-of-post-transplant-ureteral-complications-a-case-series-36917
https://atc.digitellinc.com/p/s/roboticincisional-hernia-repair-after-solid-abdominal-organ-transplantation-36918
https://atc.digitellinc.com/p/s/role-0f-gastric-peroral-endoscopic-myotomy-gpoem-in-gastroparesis-management-after-pancreas-transplantation-36919
https://atc.digitellinc.com/p/s/safety-and-efficacy-of-belatacept-conversion-following-kidney-transplant-36920
https://atc.digitellinc.com/p/s/safety-and-efficacy-of-condensed-induction-dosing-of-rabbit-antithymocyte-globulin-in-kidney-transplant-recipients-36921
https://atc.digitellinc.com/p/s/safety-and-efficacy-of-early-metformin-initiation-post-kidney-transplant-36922
https://atc.digitellinc.com/p/s/safety-and-efficacy-of-hypoxia-inducible-factor-prolyl-hydroxylase-inhibitor-in-kidney-transplant-patients-with-post-transplant-anemia-36923
https://atc.digitellinc.com/p/s/safety-and-efficacy-of-retroperitoneoscopic-native-nephrectomy-in-renal-transplant-recipients-with-autosomal-dominant-polycystic-kidney-disease-36924
https://atc.digitellinc.com/p/s/safety-and-efficacy-of-secondary-prophylaxis-with-valganciclovir-for-recurrent-cytomegalovirus-in-kidney-transplant-36925
https://atc.digitellinc.com/p/s/safety-and-immunogenicity-of-the-live-attenuated-varicella-vaccine-in-solid-organ-transplant-recipients-a-systematic-review-and-meta-analysis-36926
https://atc.digitellinc.com/p/s/safety-of-early-transition-to-belatacept-based-immunosuppression-in-kidney-transplant-patients-36927
https://atc.digitellinc.com/p/s/salvaging-dcd-visceral-donation-in-the-setting-of-a-hostile-abdomen-a-heretofore-unrecognized-benefit-of-normothermic-regional-perfusion-36928
https://atc.digitellinc.com/p/s/sars-cov-2-antibody-kinetics-after-vaccination-in-solid-organ-transplant-recipients-multicenter-study-36929
https://atc.digitellinc.com/p/s/sars-cov-2-infection-and-disease-in-pediatric-kidney-transplant-recipients-results-from-the-brazilian-multicenter-study-36930
https://atc.digitellinc.com/p/s/sars-cov-2-vaccination-is-associated-with-dsa-development-in-kidney-transplant-recipients-36931
https://atc.digitellinc.com/p/s/sars-cov-2-variant-dependent-mortality-in-abdominal-solid-organ-transplant-recipients-36932
https://atc.digitellinc.com/p/s/sars-cov-2-variants-and-anti-spike-igg-levels-associated-with-covid-19-c19-in-solid-organ-transplant-recipients-sotr-with-and-without-tixagevimab-cilgavimab-tc-pre-exposure-prophylaxis-prep-36933
https://atc.digitellinc.com/p/s/say-yes-to-transplantation-for-pediatric-renal-failure-due-to-malignancy-36934
https://atc.digitellinc.com/p/s/selenium-protects-against-tacrolimus-induced-nephrotoxicity-in-llc-pk-1-cell-via-anti-oxidative-and-anti-apoptotic-properties-36935
https://atc.digitellinc.com/p/s/sensitivity-of-anti-nucleocapsid-antibody-to-detect-prior-covid-19-in-vaccinated-solid-organ-transplant-recipients-36936
https://atc.digitellinc.com/p/s/serial-donor-derived-cell-free-dna-monitoring-during-belatacept-conversion-in-kidney-transplant-recipients-36937
https://atc.digitellinc.com/p/s/serostatus-following-live-attenuated-vaccination-for-children-after-living-donor-liver-transplantation-36938
https://atc.digitellinc.com/p/s/serum-procalcitonin-levels-immediately-after-living-donor-liver-transplantation-and-8212the-potential-predictor-of-short-term-positive-blood-cultures-and-graft-loss-36939
https://atc.digitellinc.com/p/s/sex-and-gender-disparities-in-living-kidney-donation-a-scoping-review-36940
https://atc.digitellinc.com/p/s/sex-differences-in-trauma-history-in-liver-transplant-candidates-an-underrecognized-barrier-to-care-36941
https://atc.digitellinc.com/p/s/sex-based-differences-of-circulatory-galectin-3-in-cirrhotic-patients-36942
https://atc.digitellinc.com/p/s/shifting-anti-thymocyte-globulin-induction-administration-to-outpatient-setting-increases-inpatient-cost-savings-and-transplant-reimbursement-36943
https://atc.digitellinc.com/p/s/short-course-outcome-of-mycobacterium-abscessus-infections-in-fresh-lung-transplant-recipients-a-case-series-36944
https://atc.digitellinc.com/p/s/short-term-alcohol-abstinence-prior-to-liver-transplantation-and-impact-on-rejection-36945
https://atc.digitellinc.com/p/s/should-kidney-transplant-candidates-with-epts-of-20-percent-or-less-wait-for-a-donor-with-a-kdpi-of-20-percent-or-less-36946
https://atc.digitellinc.com/p/s/should-we-hesitate-to-do-re-transplants-for-hepatocellular-carcinoma-patients-with-high-malignancy-in-explant-pathology-after-initial-transplants-36947
https://atc.digitellinc.com/p/s/should-zero-hla-mismatched-donors-be-avoided-in-young-adults-with-iga-nephropathy-36948
https://atc.digitellinc.com/p/s/significance-of-pre-transplant-donor-specific-antibodies-detected-by-luminex-impact-on-renal-allograft-rejection-and-short-term-graft-survival-36949
https://atc.digitellinc.com/p/s/significance-of-surveillance-biopsy-in-detecting-subclinical-borderline-rejection-and-predicting-outcomes-in-high-risk-renal-transplant-recipients-36950
https://atc.digitellinc.com/p/s/significant-discrepancies-to-evaluate-organ-procurement-organization-performance-based-on-exclusion-criteria-36951
https://atc.digitellinc.com/p/s/significant-improvement-in-solitary-pancreas-transplantation-36952
https://atc.digitellinc.com/p/s/similarities-and-differences-in-prevalence-and-components-of-frailty-in-lung-transplant-compared-with-heart-transplant-candidates-36953
https://atc.digitellinc.com/p/s/simplified-questionnaire-for-assessing-immunosuppression-adherence-in-kidney-transplant-recipients-36954
https://atc.digitellinc.com/p/s/simulation-of-anoxic-cold-storage-and-oxygenated-ischemia-reperfusion-injury-models-to-study-drug-repositioning-in-donor-kidney-preservation-at-22-and-176c-36955
https://atc.digitellinc.com/p/s/simultaneous-liver-kidney-transplant-organ-allocation-and-outcomes-36956
https://atc.digitellinc.com/p/s/simultaneous-robotic-bilateral-nephrectomy-and-robotic-kidney-transplant-in-patients-with-symptomatic-polycystic-kidneys-a-case-series-36957
https://atc.digitellinc.com/p/s/single-cell-rna-sequencing-identifies-peripheral-blood-mononuclear-cells-landscape-associated-with-operational-tolerance-in-kidney-transplant-recipient-36958
https://atc.digitellinc.com/p/s/single-center-experience-with-autotransplantation-of-patients-with-nutcracker-syndrome-36959
https://atc.digitellinc.com/p/s/single-center-results-of-lung-transplantation-for-coal-worker-and-8217s-pneumoconiosis-36960
https://atc.digitellinc.com/p/s/single-dose-eculizumab-as-desensitization-protocol-for-abo-incompatible-living-donor-36961
https://atc.digitellinc.com/p/s/single-lymphocyte-profiling-with-isoplexis-for-immune-stratification-a-pilot-study-36962
https://atc.digitellinc.com/p/s/single-nucleus-endothelial-multi-omics-reveals-myeloid-and-vascular-microheterogeneity-in-acute-rejection-of-human-cardiac-transplants-36963
https://atc.digitellinc.com/p/s/single-nucleus-sequencing-reveals-hippo-signaling-as-a-key-driver-of-human-liver-regeneration-36964
https://atc.digitellinc.com/p/s/single-strength-sulfamethoxazole-trimethoprim-provides-sufficient-prophylaxis-against-pneumocystis-jirovecii-pneumonia-in-lung-transplant-recipients-36965
https://atc.digitellinc.com/p/s/single-cell-atlas-of-immune-cell-chimerism-resolution-in-ischaemia-free-versus-conventional-liver-transplantation-36966
https://atc.digitellinc.com/p/s/single-cell-rna-sequencing-provides-insight-into-early-ischemiareperfusion-of-transplanted-kidney-36967
https://atc.digitellinc.com/p/s/single-center-experience-with-maribavir-for-the-treatment-of-cmv-infection-in-solid-organ-transplant-recipients-36968
https://atc.digitellinc.com/p/s/single-center-outcomes-of-first-cycle-yttrium-90-for-bridge-to-liver-transplantation-in-hepatocellular-carcinoma-patients-36969
https://atc.digitellinc.com/p/s/single-center-review-of-tixagevimab-cilgavimab-use-in-solid-organ-transplant-recipients-36970
https://atc.digitellinc.com/p/s/single-dose-thymoglobulin-achieves-higher-efficacy-than-basiliximab-induction-without-compromisingsafety-in-pediatric-kidney-transplant-recipients-36971
https://atc.digitellinc.com/p/s/single-port-robot-assisted-kidney-transplantation-learning-curve-from-a-single-institution-experience-36972
https://atc.digitellinc.com/p/s/single-port-robot-assisted-kidney-transplantation-learning-curve-from-a-single-institution-experience-36973
https://atc.digitellinc.com/p/s/six-month-graft-function-in-recipients-of-kidneys-from-therapeutic-donors-36974
https://atc.digitellinc.com/p/s/skin-grafts-from-genetically-engineered-pigs-in-squirrel-monkeys-survive-longer-than-allografts-36975
https://atc.digitellinc.com/p/s/slow-graft-function-following-pure-laparoscopic-vs-hand-assisted-laparoscopic-living-donor-nephrectomy-in-kidney-transplantation-36976
https://atc.digitellinc.com/p/s/small-bowel-obstruction-in-a-fresh-lung-transplant-recipient-laparotomy-after-a-sternotomy-36977
https://atc.digitellinc.com/p/s/social-determinants-of-health-and-access-to-living-donor-liver-transplantation-from-2005-2021-36978
https://atc.digitellinc.com/p/s/social-determinants-of-health-and-solid-organ-transplant-outcomes-among-hiv-positive-recipients-36979
https://atc.digitellinc.com/p/s/social-determinants-of-health-help-explain-disparities-in-access-to-multiple-listing-among-kidney-transplant-candidates-in-the-united-states-36980
https://atc.digitellinc.com/p/s/social-participation-in-kidney-transplant-recipients-kt-compared-to-patients-on-hemodialysis-hd-36981
https://atc.digitellinc.com/p/s/sodium-polystyrene-sulfonate-vs-sodium-zirconium-cyclosilicate-for-hyperkalemia-in-abdominal-transplant-recipients-36982
https://atc.digitellinc.com/p/s/sodium-zirconium-cyclosilicate-to-prevent-hyperkalemia-associated-complications-in-kidney-transplant-recipients-is-associated-with-less-fludrocortisone-use-36983
https://atc.digitellinc.com/p/s/solid-organ-and-vascularize-composite-allotransplantation-have-distinct-requirements-for-localized-delivery-of-enhanced-costimulation-blockade-to-control-rejection-36984
https://atc.digitellinc.com/p/s/soluble-dna-a-proposed-biomarker-for-post-transplant-renal-function-in-hypothermic-perfused-kidney-allografts-36985
https://atc.digitellinc.com/p/s/sotrovimab-as-pre-exposition-prophylaxis-in-kidney-transplant-recipients-neutralization-of-omicron-ba1-and-ba2-variants-36986
https://atc.digitellinc.com/p/s/spanish-language-as-a-predictor-of-longer-kidney-transplant-evaluation-times-36987
https://atc.digitellinc.com/p/s/spatial-patterns-in-eskd-prevalence-and-referral-in-the-first-year-of-a-new-transplant-center-opportunities-to-improve-access-36988
https://atc.digitellinc.com/p/s/st2-plus-reparative-regulatory-t-cell-therapy-for-inflammation-reduction-and-tissue-repair-36989
https://atc.digitellinc.com/p/s/starting-successfully-steps-in-establishing-robotic-kidney-transplantation-program-with-early-outcomes-36990
https://atc.digitellinc.com/p/s/state-medicaid-expansion-is-associated-with-improved-survival-after-pediatric-liver-transplantation-36991
https://atc.digitellinc.com/p/s/steroid-free-immunosuppression-and-the-risk-of-rejection-in-elderly-renal-transplant-recipients-36992
https://atc.digitellinc.com/p/s/steroid-based-vs-steroid-free-immunosuppression-in-paediatric-kidney-transplants-a-systematic-review-and-meta-analysis-36993
https://atc.digitellinc.com/p/s/steroid-free-immunosuppression-does-not-increase-the-risk-of-one-year-rejection-in-elderly-liver-transplant-recipients-36994
https://atc.digitellinc.com/p/s/strategies-for-development-of-interleukin-2-therapy-in-transplant-recipients-what-works-and-what-doesn-and-8217t-36995
https://atc.digitellinc.com/p/s/strategies-to-decrease-incidence-of-cdc-defined-central-line-associated-bloodstream-infections-in-the-liver-icu-36996
https://atc.digitellinc.com/p/s/stress-perception-among-pre-kidney-transplant-patients-36997
https://atc.digitellinc.com/p/s/structural-social-determinants-of-health-as-barriers-to-liver-transplant-waitlisting-36998
https://atc.digitellinc.com/p/s/study-design-of-a-prospective-clinical-data-registry-and-biorepository-on-post-transplant-glomerular-diseases-a-tango-initiative-36999
https://atc.digitellinc.com/p/s/study-of-the-repair-potentials-of-nephron-progenitor-cell-transplantation-in-kidney-injury-37000
https://atc.digitellinc.com/p/s/subclinical-antibody-mediated-rejection-detected-by-early-protocol-two-weeks-biopsies-in-highly-immunized-transplant-recipients-37001
https://atc.digitellinc.com/p/s/subclinical-pancreas-rejection-in-simultaneous-kidney-and-pancreas-transplant-37002
https://atc.digitellinc.com/p/s/successful-kidney-transplantation-improves-atrophic-bladder-capacity-and-function-within-3-months-after-transplantation-in-patients-with-end-stage-renal-disease-37003
https://atc.digitellinc.com/p/s/successful-liver-transplantation-using-an-abnormal-appearance-deceased-donor-liver-with-glycogenic-hepatopathy-37004
https://atc.digitellinc.com/p/s/successful-lung-transplantation-for-covid-19-pcr-positive-recipients-37005
https://atc.digitellinc.com/p/s/successful-opioid-minimization-following-kidney-transplant-37006
https://atc.digitellinc.com/p/s/successful-treatment-of-acute-antibody-mediated-rejection-of-liver-allograft-with-imlifidase-37007
https://atc.digitellinc.com/p/s/successful-use-of-phenytoin-fosphenytoin-in-a-pediatric-transplant-recipient-with-nimatrelvir-ritonavir-induced-tacrolimus-toxicity-37008
https://atc.digitellinc.com/p/s/successful-use-of-tocilizumab-for-post-heart-transplant-patients-with-refractory-complement-binding-donor-specific-antibodies-37009
https://atc.digitellinc.com/p/s/supercooling-to-extend-the-preservation-of-vca-in-a-pig-hindlimb-model-37010
https://atc.digitellinc.com/p/s/supratherapeutic-tacrolimus-levels-in-a-kidney-transplant-recipient-after-laparoscopic-sleeve-gastrectomy-37011
https://atc.digitellinc.com/p/s/surface-engineering-of-pancreatic-islets-by-bissulfosuccinimidyl-suberate-to-reduce-post-transplant-inflammation-37012
https://atc.digitellinc.com/p/s/surgical-results-of-urinary-tract-reconstruction-for-transplanted-kidney-vesicoureteral-reflux-37013
https://atc.digitellinc.com/p/s/survey-of-prior-non-directed-donors-actionable-items-to-increase-non-directed-live-organ-donors-37014
https://atc.digitellinc.com/p/s/survival-of-adult-recipients-of-a-right-lobe-from-split-livers-in-the-united-states-37015
https://atc.digitellinc.com/p/s/t-cell-ceacam1-tim-3-crosstalk-alleviates-hepatocellular-injury-in-mouse-and-human-liver-transplantation-37016
https://atc.digitellinc.com/p/s/tacrolimus-immunosuppression-maintains-greater-kidney-function-at-discharge-when-compared-to-belatacept-regimen-37017
https://atc.digitellinc.com/p/s/tacrolimus-induced-thrombotic-microangiopathy-tma-complicated-by-anamnestic-donor-specific-antibodies-post-kidney-transplantation-37018
https://atc.digitellinc.com/p/s/tailored-multidisciplinary-post-kidney-transplant-diabetes-education-positively-impacts-outcomes-in-a-predominantly-hispanic-and-american-indian-recipient-population-37019
https://atc.digitellinc.com/p/s/targeting-brd4-achieves-transplant-tolerance-by-abrogating-the-generation-of-effector-and-memory-t-cells-37020
https://atc.digitellinc.com/p/s/tcl1a-involvement-in-b-cells-in-long-term-kidney-transplantation-37021
https://atc.digitellinc.com/p/s/temporal-changes-in-the-utilization-of-kidneys-from-hepatitis-c-virus-infected-donors-in-the-united-states-37022
https://atc.digitellinc.com/p/s/tertiary-lymphoid-organs-promote-allograft-rejection-37023
https://atc.digitellinc.com/p/s/th1-cd4-plus-t-cells-enhance-the-development-and-expansion-of-alloprimed-antibody-suppressor-cxcr5-plus-cd8-plus-t-cells-37024
https://atc.digitellinc.com/p/s/the-24-hour-normothermic-machine-perfusion-of-discarded-human-liver-grafts-37025
https://atc.digitellinc.com/p/s/the-alteration-of-monocyte-subsets-and-the-early-acute-rejection-after-kidney-transplantation-37026
https://atc.digitellinc.com/p/s/the-association-between-self-reported-health-and-frailty-in-patients-undergoing-kidney-transplantation-37027
https://atc.digitellinc.com/p/s/the-benefit-of-measuring-and-modulating-hepatic-artery-and-portal-vein-flows-in-deceased-donor-liver-transplantation-37028
https://atc.digitellinc.com/p/s/the-canadian-anatomic-kidney-score-caks-assessment-of-reproducibility-among-surgeons-and-trainees-across-canada-37029
https://atc.digitellinc.com/p/s/the-covid-19-pandemic-from-the-perspective-of-kidney-transplant-recipients-37030
https://atc.digitellinc.com/p/s/the-critical-care-nursing-experience-with-xenotransplant-research-37031
https://atc.digitellinc.com/p/s/the-current-20-percent-kdpi-for-20-percent-epts-decreases-equity-of-access-to-deceased-donor-kidney-transplant-for-candidates-with-epts-greater-than-20-percent-due-to-double-dipping-37032
https://atc.digitellinc.com/p/s/the-development-of-rejection-is-associated-with-a-more-aggressive-pattern-of-posttransplant-neoplasia-37033
https://atc.digitellinc.com/p/s/the-difference-of-outcomes-according-to-the-duration-of-delayed-graft-function-for-kidney-transplantation-15-years-experience-of-single-institution-37034
https://atc.digitellinc.com/p/s/the-difference-of-outcomes-against-covid-19-between-variants-of-concern-in-solid-organ-transplant-recipients-japanese-national-registry-study-37035
https://atc.digitellinc.com/p/s/the-effect-of-a-booster-dosemrnavaccine-on-covid-19-infection-in-kidney-transplant-recipients-after-inactivated-or-viral-vector-vaccine-immunization-37036
https://atc.digitellinc.com/p/s/the-effect-of-change-in-the-kidney-allocation-policy-on-outcomes-of-a-sole-transplant-center-in-a-single-donor-service-area-dsa-37037
https://atc.digitellinc.com/p/s/the-effect-of-continuation-of-angiotensin-converting-enzyme-inhibitor-and-angiotensin-receptor-blocker-before-kidney-transplantation-37038
https://atc.digitellinc.com/p/s/the-effect-of-depletional-induction-strategies-on-non-human-primate-islet-xenotransplant-outcomes-37039
https://atc.digitellinc.com/p/s/the-effect-of-induction-therapy-in-kidney-transplantation-a-network-meta-analysis-using-recent-data-37040
https://atc.digitellinc.com/p/s/the-effect-of-loupe-magnification-on-occurrence-of-biliary-complication-after-liver-transplantation-37041
https://atc.digitellinc.com/p/s/the-effect-of-off-hour-admissions-on-advanced-treatment-options-in-cardiogenic-shock-patients-37042
https://atc.digitellinc.com/p/s/the-effectiveness-of-device-associated-healthcare-infections-prevention-measures-in-the-incidence-of-infections-and-mortality-in-prevalent-kidney-transplant-recipients-admitted-to-an-intensive-care-un-37043
https://atc.digitellinc.com/p/s/the-effectiveness-of-tixagevimabcilgavimab-evusheld-in-preventing-severe-sars-cov-2-covid-infection-after-kidney-transplantation-37044
https://atc.digitellinc.com/p/s/the-efficacy-of-everolimus-in-liver-transplant-patients-37045
https://atc.digitellinc.com/p/s/the-estimated-effect-of-broader-sharing-on-slk-transplants-37046
https://atc.digitellinc.com/p/s/the-first-decade-of-renal-transplantation-in-a-single-center-in-nepal-37047
https://atc.digitellinc.com/p/s/the-function-of-small-non-coding-rnas-during-hepatic-iri-in-human-orthotopic-liver-transplantation-37048
https://atc.digitellinc.com/p/s/the-future-of-training-impact-of-normothermic-machine-perfusion-on-abdominal-transplant-fellowship-training-37049
https://atc.digitellinc.com/p/s/the-giant-is-not-sleeping-implications-in-heart-transplantation-37050
https://atc.digitellinc.com/p/s/the-hispanic-experience-in-living-donor-liver-transplantation-outcomes-from-a-single-us-center-37051
https://atc.digitellinc.com/p/s/the-impact-of-allograft-portal-flow-in-split-liver-transplantation-is-portal-hyper-perfusion-harmful-like-living-donor-liver-transplantation-37052
https://atc.digitellinc.com/p/s/the-impact-of-death-for-the-prediction-of-long-term-kidney-allograft-failure-a-competing-risk-analysis-study-37053
https://atc.digitellinc.com/p/s/the-impact-of-enhanced-recovery-after-surgery-eras-protocol-in-living-liver-donors-37054
https://atc.digitellinc.com/p/s/the-impact-of-health-disparities-on-survival-over-time-for-pediatric-patients-receiving-liver-transplantation-37055
https://atc.digitellinc.com/p/s/the-impact-of-hormone-replacement-therapy-on-covid-19-outcomes-in-solid-organ-transplant-recipients-37056
https://atc.digitellinc.com/p/s/the-impact-of-kidney-allocation-policy-change-on-center-waiting-times-and-volume-37057
https://atc.digitellinc.com/p/s/the-impact-of-monoclonal-antibody-against-sars-cov2-and-vaccination-on-outcomes-in-kidney-transplant-recipients-with-covid-19-37058
https://atc.digitellinc.com/p/s/the-impact-of-new-kidney-allocation-policy-on-transplant-practice-in-the-united-states-37059
https://atc.digitellinc.com/p/s/the-impact-of-normothermic-machine-perfusion-nmp-in-deceased-donor-liver-transplantation-in-the-usa-37060
https://atc.digitellinc.com/p/s/the-impact-of-post-transplant-opportunistic-infection-on-autoimmune-liver-disease-post-liver-transplantation-37061
https://atc.digitellinc.com/p/s/the-impact-of-preoperative-body-composition-and-fat-to-muscle-ratio-on-graft-and-patient-survival-in-human-kidney-transplantation-37062
https://atc.digitellinc.com/p/s/the-impact-of-prioritization-of-multi-organ-kidney-allocation-for-liver-transplants-on-deaths-and-delisting-on-the-kidney-transplant-waiting-list-in-the-united-states-37063
https://atc.digitellinc.com/p/s/the-impact-of-race-in-access-to-liver-transplantation-for-hepatocellular-carcinoma-37064
https://atc.digitellinc.com/p/s/the-impact-of-sodium-zirconium-cyclosilicate-zs-9-use-on-the-incidence-of-delayed-graft-function-dgf-in-deceased-donor-kidney-transplant-recipients-ktrs-37065
https://atc.digitellinc.com/p/s/the-impact-of-splenectomy-based-on-spleen-volume-in-living-donor-liver-transplantation-in-a-us-cohort-37066
https://atc.digitellinc.com/p/s/the-impact-of-the-clarifying-multiple-organ-transplant-policy-on-simultaneous-heart-kidney-transplants-37067
https://atc.digitellinc.com/p/s/the-impact-of-the-pd1-pdl1-pathway-in-breg-induced-transplantation-tolerance-37068
https://atc.digitellinc.com/p/s/the-impact-of-time-on-dialysis-before-transplantation-on-clinical-outcomes-for-hla-identical-siblings-kidney-transplant-recipients-37069
https://atc.digitellinc.com/p/s/the-implementation-process-for-an-electronic-pre-visit-planning-tool-a-pediatric-kidney-transplant-quality-improvement-project-37070
https://atc.digitellinc.com/p/s/the-important-role-of-treg-in-the-ex-vivo-expanded-breg-induced-tolerance-37071
https://atc.digitellinc.com/p/s/the-induction-of-regulatory-t-cells-by-once-daily-prolonged-release-tacrolimus-in-renal-transplant-recipients-37072
https://atc.digitellinc.com/p/s/the-influence-of-kidney-transplant-on-kidney-disease-patient-reported-outcomes-37073
https://atc.digitellinc.com/p/s/the-influence-of-metformin-on-natural-killer-cells-37074
https://atc.digitellinc.com/p/s/the-landscape-of-pediatric-travel-for-liver-transplantation-in-the-united-states-37075
https://atc.digitellinc.com/p/s/the-learning-curve-of-covid-19-and-organ-donation-potential-missed-opportunities-in-the-covid-era-37076
https://atc.digitellinc.com/p/s/the-learning-curve-of-covid-19-and-organ-donation-potential-missed-opportunities-in-the-covid-era-37077
https://atc.digitellinc.com/p/s/the-level-of-anti-hla-sensitization-is-not-associated-with-an-increased-risk-of-acute-rejection-among-kidney-transplant-recipients-without-donor-specific-antibodies-37078
https://atc.digitellinc.com/p/s/the-longest-survival-in-case-of-abo-incompatible-renal-transplant-since-1989-37079
https://atc.digitellinc.com/p/s/the-long-term-impact-of-sars-cov-2-infection-on-kidney-transplant-outcomes-37080
https://atc.digitellinc.com/p/s/the-long-term-renal-outcome-and-pregnancy-complications-with-kidney-transplantation-of-iga-nephropathy-37081
https://atc.digitellinc.com/p/s/the-maintenance-immunosuppressive-regimen-is-associated-with-survival-probability-after-post-transplant-lymphoproliferative-disease-with-a-positive-ebv-viremia-37082
https://atc.digitellinc.com/p/s/the-molecular-microscope-mmdx-and-174-does-not-recognize-t-cell-mediated-rejection-tcmr-in-biopsies-with-mixed-tcmr-antibody-mediated-rejection-abmr-37083
https://atc.digitellinc.com/p/s/the-new-normal-of-wait-list-mortality-in-kidney-transplantation-post-pandemic-37084
https://atc.digitellinc.com/p/s/the-outcome-and-risk-factor-of-refractory-t-cell-mediated-rejection-on-renal-allograft-transplantation-37085
https://atc.digitellinc.com/p/s/the-outcome-of-kidney-transplantation-after-cancer-treatment-in-the-patient-with-high-estimated-cure-rate-37086
https://atc.digitellinc.com/p/s/the-outcomes-of-living-donors-aged-70-years-and-older-37087
https://atc.digitellinc.com/p/s/the-paradoxical-impact-of-calcineurin-inhibitor-cni-therapy-following-transplantation-37088
https://atc.digitellinc.com/p/s/the-performance-of-bronchoalveolar-lavage-aspergillus-pcr-in-solid-organ-transplant-recipients-a-single-center-experience-37089
https://atc.digitellinc.com/p/s/the-pro-resolution-mechanism-of-glycogen-synthase-kinase-3-beta-inactivation-in-liver-ischemia-reperfusion-injury-37090
https://atc.digitellinc.com/p/s/the-protek-duo-a-meta-analysis-37091
https://atc.digitellinc.com/p/s/the-relevance-of-non-aspergillus-fumigatus-mold-infections-in-lung-transplant-recipients-multicentric-comparison-with-aspergillus-fumigatus-37092
https://atc.digitellinc.com/p/s/the-role-and-mechanism-of-interleukin-34-il-34-in-acute-t-cell-mediated-rejection-of-renal-transplantation-37093
https://atc.digitellinc.com/p/s/the-role-of-bob1-in-chronic-lung-allograft-dysfunction-37094
https://atc.digitellinc.com/p/s/the-role-of-durable-lvad-placement-in-reversing-pulmonary-hypertension-in-patients-awaiting-heart-transplantation-how-long-does-it-take-37095
https://atc.digitellinc.com/p/s/the-role-of-ly49-plus-cd8-plus-regulatory-t-cell-in-mouse-cardiac-allograft-transplant-tolerance-37096
https://atc.digitellinc.com/p/s/the-role-of-non-hla-antibodies-in-solid-organ-renal-transplantation-37097
https://atc.digitellinc.com/p/s/the-safety-and-efficacy-of-concomitant-sodium-zirconium-cyclosilicate-and-tacrolimus-use-in-heart-transplant-recipients-37098
https://atc.digitellinc.com/p/s/the-safety-of-severe-acute-respiratory-syndrome-coronavirus-2-vaccine-in-solid-organ-transplant-recipients-37099
https://atc.digitellinc.com/p/s/the-state-of-global-transplant-research-10-year-trends-37100
https://atc.digitellinc.com/p/s/the-use-of-lcp-tacrolimus-versus-immediate-release-tacrolimus-in-simultaneous-pancreas-kidney-transplantation-37101
https://atc.digitellinc.com/p/s/the-use-of-teduglutide-in-intestinal-transplantation-a-case-series-37102
https://atc.digitellinc.com/p/s/the-utility-of-the-pirche-ii-score-in-risk-stratifying-simultaneous-liver-kidney-transplant-recipients-with-preformed-donor-specific-anti-hla-antibodies-37103
https://atc.digitellinc.com/p/s/the-utilization-of-pre-albumin-in-liver-transplantation-37104
https://atc.digitellinc.com/p/s/the-value-of-donor-risk-index-and-indices-predicting-pancreas-graft-outcome-in-spk-transplantation-37105
https://atc.digitellinc.com/p/s/the-xbp1s-agonist-ixa4-regulates-bile-acids-in-the-abcb4-knockout-model-of-primary-sclerosing-cholangitis-37106
https://atc.digitellinc.com/p/s/the-yield-of-pre-recovery-liver-biopsy-in-allocation-optimization-in-deceased-brain-death-donors-37107
https://atc.digitellinc.com/p/s/therapeutic-low-density-lipoprotein-apheresis-for-treatment-of-focal-segmental-glomerular-sclerosis-post-kidney-transplantation-37108
https://atc.digitellinc.com/p/s/therapeutic-role-of-cd38-on-liver-ischemia-reperfusion-injury-37109
https://atc.digitellinc.com/p/s/thymic-irradiation-and-donor-mesenchymal-stem-cell-infusions-to-alter-homeostatic-repopulation-in-a-nonhuman-primate-model-of-kidney-transplantation-37110
https://atc.digitellinc.com/p/s/tiktok-and-transplant-building-a-supportive-community-37111
https://atc.digitellinc.com/p/s/time-to-change-the-time-zero-biopsy-a-retrospective-analysis-of-kidney-graft-outcomes-37112
https://atc.digitellinc.com/p/s/time-to-eliminate-surveillance-endomyocardial-biopsies-use-of-donor-derived-cell-free-dna-for-heart-transplant-rejection-surveillance-37113
https://atc.digitellinc.com/p/s/tissue-transcriptomics-and-histology-influence-on-clinical-management-for-kidney-transplant-biopsy-results-37114
https://atc.digitellinc.com/p/s/tixagevimabcilgavimab-for-prevention-of-covid-19-in-newly-transplanted-kidney-recipients-37115
https://atc.digitellinc.com/p/s/to-biopsy-or-not-to-biopsy-kdpi-begs-the-question-37116
https://atc.digitellinc.com/p/s/tolerogenic-potential-of-foxp3-plus-exosomes-derived-from-alloantigen-specifically-expanded-regulatory-t-cells-37117
https://atc.digitellinc.com/p/s/total-bilirubin-as-a-predictor-of-autoimmune-liver-disease-recurrence-after-liver-transplantation-37118
https://atc.digitellinc.com/p/s/toxoplasmosis-prophylaxis-practices-survey-of-international-pediatric-solid-organ-transplant-centers-37119
https://atc.digitellinc.com/p/s/training-in-robotic-transplant-surgery-37120
https://atc.digitellinc.com/p/s/transcription-factor-nfatc4-gene-polymorphism-determines-susceptibility-bk-virus-infection-after-kidney-transplant-37121
https://atc.digitellinc.com/p/s/transcriptomic-exploration-of-chronic-antibody-mediated-rejection-in-kidney-transplantation-37122
https://atc.digitellinc.com/p/s/transition-from-open-to-robot-assisted-donor-right-hepatectomy-program-for-adult-to-adult-living-liver-donation-early-outcomes-and-lessons-learned-37123
https://atc.digitellinc.com/p/s/transition-of-care-of-successful-kidney-transplant-patients-from-the-transplant-center-a-national-survey-of-referring-nephrologists-37124
https://atc.digitellinc.com/p/s/transplant-centers-kidney-acceptance-rates-vary-even-after-risk-adjusting-for-donor-and-kidney-characteristics-as-well-as-cold-time-at-offer-37125
https://atc.digitellinc.com/p/s/transplant-immunosuppressants-differentially-alter-intestinal-metabolic-activities-37126
https://atc.digitellinc.com/p/s/transplant-pharmacist-service-stewardship-a-service-line-pilot-37127
https://atc.digitellinc.com/p/s/transplantation-amid-a-pandemic-the-fall-and-rise-of-kidney-transplantation-in-the-united-states-37128
https://atc.digitellinc.com/p/s/transplantation-of-contaminated-kidneys-the-utility-of-perioperative-donor-perfusate-cultures-37129
https://atc.digitellinc.com/p/s/transplantation-of-kidneys-from-deceased-donors-receiving-dialysis-are-not-associated-with-adverse-long-term-allograft-outcomes-37130
https://atc.digitellinc.com/p/s/transplanting-old-organs-accelerates-aging-in-young-recipients-37131
https://atc.digitellinc.com/p/s/transplants-from-donors-with-a-history-of-cancer-an-analysis-of-the-organ-procurement-and-transplantation-network-database-37132
https://atc.digitellinc.com/p/s/transverse-abdominis-plane-and-rectus-sheath-block-after-hand-assisted-laparoscopic-live-donor-nephrectomy-37133
https://atc.digitellinc.com/p/s/trends-in-discard-of-kidneys-from-covid-positive-donors-in-the-united-states-37134
https://atc.digitellinc.com/p/s/trends-in-marginal-donor-utilization-in-the-united-states-across-solid-organ-transplant-37135
https://atc.digitellinc.com/p/s/trial-of-a-cardiac-xenotransplantation-regimen-in-a-preclinical-heterotopic-model-37136
https://atc.digitellinc.com/p/s/tributyrin-as-a-metabolic-treatment-to-modulate-rejection-immune-responses-37137
https://atc.digitellinc.com/p/s/two-to-tango-kidney-transplantation-anastomotic-time-is-influenced-by-both-resident-and-attending-experience-37138
https://atc.digitellinc.com/p/s/type-1-innate-lymphoid-cellsnk-cells-protect-liver-orthotopic-transplants-from-ischemiareperfusion-injury-via-interferon-and-947-mediated-pathway-37139
https://atc.digitellinc.com/p/s/ultra-short-direct-acting-antiviral-prophylaxis-in-hepatitis-c-virus-antibody-positive-donors-to-hepatitis-c-virus-na-and-239ve-liver-transplant-recipients-37140
https://atc.digitellinc.com/p/s/ultrasonography-of-rectus-femoris-muscle-is-a-feasible-tool-to-assess-sarcopenia-in-children-37141
https://atc.digitellinc.com/p/s/uncovering-the-memory-response-in-sensitised-renal-patients-37142
https://atc.digitellinc.com/p/s/undergoing-an-organizational-level-intervention-reduces-perceived-discrimination-and-medical-mistrust-among-kidney-transplant-candidates-37143
https://atc.digitellinc.com/p/s/understanding-humanistic-motivations-of-potential-living-donors-who-are-friends-and-acquaintances-compared-to-family-members-37144
https://atc.digitellinc.com/p/s/understanding-public-perceptions-of-deemed-consent-legislation-for-organ-donation-in-canada-37145
https://atc.digitellinc.com/p/s/urinary-progenitor-cells-derived-from-kidney-mesenchyme-alleviate-acute-kidney-injury-in-mice-37146
https://atc.digitellinc.com/p/s/urinary-tract-infections-in-renal-transplant-recipients-with-sulfamethoxazole-trimethoprim-versus-alternative-prophylactic-agents-for-pneumocystis-jirovecii-pneumonia-prophylaxis-37147
https://atc.digitellinc.com/p/s/urine-gene-expression-profiling-score-uromap-for-rejection-surveillance-in-pediatric-kidney-transplantation-37148
https://atc.digitellinc.com/p/s/urine-microbiome-profiling-in-kidney-transplant-recipients-37149
https://atc.digitellinc.com/p/s/urine-derived-stem-cell-attenuated-renal-fibrosis-via-klotho-activation-37150
https://atc.digitellinc.com/p/s/ursodiol-prophylaxis-for-liver-transplantation-from-donation-after-cardiac-death-donors-37151
https://atc.digitellinc.com/p/s/usage-of-offer-filters-after-6-months-37152
https://atc.digitellinc.com/p/s/use-of-a-cmv-specific-t-cell-immunity-panel-tcip-to-guide-secondary-prophylaxis-after-cmv-infection-37153
https://atc.digitellinc.com/p/s/use-of-basiliximab-as-adjunct-maintenance-immunosuppressant-in-pancreas-transplant-recipients-37154
https://atc.digitellinc.com/p/s/use-of-hepatitis-c-plus-livers-to-combat-national-organ-shortages-perspectives-from-a-quaternary-care-center-37155
https://atc.digitellinc.com/p/s/use-of-intravenous-hydroxocobalamin-for-vasoplegia-in-liver-transplant-recipients-37156
https://atc.digitellinc.com/p/s/use-of-pcsk9-inhibitors-in-liver-transplant-recipients-a-single-center-review-37157
https://atc.digitellinc.com/p/s/use-of-remdesivir-in-solid-organ-transplant-recipients-with-covid-19-37158
https://atc.digitellinc.com/p/s/using-cognitive-interviews-to-gather-public-views-and-for-health-literary-37159
https://atc.digitellinc.com/p/s/using-donor-derived-cell-free-dna-dd-cfdna-to-diagnose-subclinical-rejection-an-analysis-of-256-patients-at-a-single-institutions-and-8217-3-year-study-37160
https://atc.digitellinc.com/p/s/usp25-deficiency-promotes-t-cell-dysfunction-and-transplant-acceptance-via-mitochondrial-dynamics-37161
https://atc.digitellinc.com/p/s/utility-of-donor-derived-cell-free-dna-and-tacrolimus-variability-in-monitoring-early-post-kidney-transplant-outcomes-37162
https://atc.digitellinc.com/p/s/utility-of-immune-function-monitoring-for-infectious-complications-in-liver-transplant-recipients-37163
https://atc.digitellinc.com/p/s/utility-of-ramp-test-time-in-patients-undergoing-assessment-for-renal-transplantation-37164
https://atc.digitellinc.com/p/s/utilization-and-outcomes-of-pancreas-transplantation-from-donation-after-circulatory-death-dcd-donors-37165
https://atc.digitellinc.com/p/s/utilization-of-a-cmv-t-cell-immunity-panel-in-directing-duration-of-valganciclovir-prophylaxis-in-cmv-high-risk-kidney-transplant-recipients-37166
https://atc.digitellinc.com/p/s/utilization-of-and-outcomes-following-living-donor-liver-transplantation-for-recipients-with-high-model-for-end-stage-liver-disease-meld-score-in-the-united-states-37167
https://atc.digitellinc.com/p/s/utilization-of-cept-polypharmacological-cocktail-in-machine-perfusion-promotes-whole-organ-resuscitation-from-warm-ischemic-damage-37168
https://atc.digitellinc.com/p/s/utilization-of-normothermic-machine-perfusion-to-salvage-liver-allografts-in-unallocated-unstable-donors-37169
https://atc.digitellinc.com/p/s/utilization-of-oral-step-down-antiviral-therapy-may-decrease-length-of-hospital-admission-for-resistant-cytomegalovirus-after-solid-organ-transplant-a-real-world-case-series-37170
https://atc.digitellinc.com/p/s/valacyclovir-for-prevention-of-cytomegalovirus-infection-after-kidney-transplantation-37171
https://atc.digitellinc.com/p/s/validation-of-histomap-molecular-model-for-renal-allograft-rejection-diagnosis-in-a-multi-center-cohort-study-37172
https://atc.digitellinc.com/p/s/validation-of-kidney-donor-profile-index-kdpi-for-long-term-outcomes-in-brazilian-kidney-transplant-recipients-37173
https://atc.digitellinc.com/p/s/validation-of-original-and-modified-donor-kidney-pathological-scoring-systems-for-prognostic-value-in-core-biopsy-specimens-37174
https://atc.digitellinc.com/p/s/validation-of-the-clinical-utility-of-microrna-as-non-invasive-biomarkers-of-cardiac-allograft-rejection-monitoring-a-prospective-longitudinal-multicenter-study-37175
https://atc.digitellinc.com/p/s/variability-in-mycophenolate-mofetil-mmf-pharmacokinetics-and-dose-requirements-across-transplant-tx-types-37176
https://atc.digitellinc.com/p/s/variant-hepatic-artery-anatomy-and-cannulation-solutions-expanding-applications-of-normothermic-machine-perfusion-in-liver-transplantation-37177
https://atc.digitellinc.com/p/s/variation-in-quality-of-life-in-elderly-patients-before-and-after-kidney-transplantation-implications-for-transplant-practice-37178
https://atc.digitellinc.com/p/s/vascularized-composite-allograft-vca-trends-and-challenges-in-the-us-through-the-covid-era-37179
https://atc.digitellinc.com/p/s/venous-thromboembolism-in-kidney-transplant-recipients-a-case-control-study-37180
https://atc.digitellinc.com/p/s/virtual-crossmatch-as-a-tool-to-increase-transplant-volume-while-maintaining-safety-37181
https://atc.digitellinc.com/p/s/virus-specific-t-cells-therapy-promising-but-not-magical-37182
https://atc.digitellinc.com/p/s/what-are-the-top-organ-refusal-reasons-under-the-2021-updated-refusal-codes-37183
https://atc.digitellinc.com/p/s/what-factors-are-associated-with-re-transplantation-following-allograft-nephrectomy-37184
https://atc.digitellinc.com/p/s/what-information-do-kidney-transplant-candidates-need-to-make-informed-treatment-decisions-about-participating-in-a-first-in-human-pig-xenotransplant-clinical-trial-37185
https://atc.digitellinc.com/p/s/what-matters-now-did-not-always-matter-how-recipient-demographics-have-changed-risk-factors-in-deceased-kidney-transplantation-in-the-uk-37186
https://atc.digitellinc.com/p/s/when-pancreas-transplants-recipients-gain-weight-which-grafts-rise-to-the-challenge-37187
https://atc.digitellinc.com/p/s/when-you-need-to-dive-in-the-deep-end-transplanting-sars-cov-2-pcr-plus-recipients-37188
https://atc.digitellinc.com/p/s/when-you-need-to-dive-in-the-deep-end-transplanting-sars-cov-2-pcr-plus-recipients-37189
https://atc.digitellinc.com/p/s/where-do-ethnic-disparities-arise-in-the-living-kidney-donor-evaluation-process-37190
https://atc.digitellinc.com/p/s/who-should-participate-in-first-in-human-pig-xenotransplant-clinical-trials-37191
https://atc.digitellinc.com/p/s/whole-body-phase-angle-in-the-assessment-of-frailty-in-kidney-transplant-recipients-relationship-to-hand-grip-and-physical-strength-37192
https://atc.digitellinc.com/p/s/whole-procedure-ultrasound-guided-human-islet-transplantation-a-technical-feasibility-study-37193
https://atc.digitellinc.com/p/s/women-have-reduced-access-at-all-steps-of-the-complex-kidney-transplant-process-evidence-from-a-multi-regional-cohort-study-37194
https://atc.digitellinc.com/p/s/women-and-8217s-access-to-waiting-list-and-renal-transplantation-argentinian-reality-37195
https://atc.digitellinc.com/p/s/womens-health-history-an-important-and-under-addressed-topic-in-transplant-clinic-37196
https://atc.digitellinc.com/p/s/would-kidney-transplant-candidates-participate-in-a-first-in-human-pig-xenotransplant-clinical-trial-37197
https://atc.digitellinc.com/p/s/xanthogranulomatous-pyelonephritis-a-rare-post-transplant-complication-37198
https://atc.digitellinc.com/p/cf/atc-2024-37216
https://atc.digitellinc.com/p/s/challenges-and-strategies-for-keeping-elderly-patients-on-the-kidney-transplant-waitlist-and-getting-transplanted-37217
https://atc.digitellinc.com/p/s/advances-in-pediatric-kidney-transplantation-a-tribute-to-richard-fine-37218
https://atc.digitellinc.com/p/s/climbing-the-ladder-of-success-as-a-transplant-professional-defining-building-and-sustaining-a-career-in-academics-37219
https://atc.digitellinc.com/p/s/heart-transplantation-in-adult-congenital-heart-disease-achd-challenges-and-opportunities-37221
https://atc.digitellinc.com/p/s/navigating-the-barriers-empowering-women-with-careers-in-transplantation-37223
https://atc.digitellinc.com/p/s/new-and-controversial-topics-in-precision-pharmacotherapy-for-immunosuppression-37224
https://atc.digitellinc.com/p/s/new-perspectives-on-innate-immunity-in-transplantation-37225
https://atc.digitellinc.com/p/s/respiratory-viruses-in-transplantation-what-every-transplant-provider-needs-to-know-37226
https://atc.digitellinc.com/p/s/sex-drugs-and-pop-culture-liver-transplant-and-young-adulthood-37227
https://atc.digitellinc.com/p/s/alloislet-cell-transplant-where-do-we-go-from-here-37228
https://atc.digitellinc.com/p/s/cells-on-a-diet-the-impact-of-diet-on-the-alloimmune-response-37229
https://atc.digitellinc.com/p/s/examining-the-role-of-nk-cells-in-antibody-mediated-rejection-abmr-and-microvascular-inflammation-mvi-from-a-clinical-perspective-37230
https://atc.digitellinc.com/p/s/facilitating-kpd-education-as-part-of-every-living-donor-and-recipient-evaluation-37231
https://atc.digitellinc.com/p/s/glp1-agonists-a-formidable-tool-in-the-wild-goose-chase-of-ideal-bmi-in-potential-living-donor-candidates-37232
https://atc.digitellinc.com/p/s/how-do-you-handle-infection-in-the-immunocompromised-transplant-patient-who-becomes-even-more-immunocompromised-37234
https://atc.digitellinc.com/p/s/is-it-time-to-allow-financial-incentives-for-living-organ-donation-37236
https://atc.digitellinc.com/p/s/nihil-de-nobis-sine-nobis-nothing-about-us-without-us-should-the-transplant-candidate-participate-in-the-selection-committee-meeting-37237
https://atc.digitellinc.com/p/s/accepting-the-unacceptable-transplanting-across-selected-hla-antibodies-37239
https://atc.digitellinc.com/p/s/generative-ai-in-transplantation-37242
https://atc.digitellinc.com/p/s/leveraging-the-nasem-report-on-transplant-equity-to-improve-opo-performance-by-applying-healthcare-quality-improvement-measurement-and-strategies-37243
https://atc.digitellinc.com/p/s/liver-transplant-oncology-recent-advances-and-indications-for-transplantation-37244
https://atc.digitellinc.com/p/s/maximizing-efficiency-and-collaboration-the-integral-role-of-advanced-practice-providers-in-organ-procurement-and-transplant-surgery-37245
https://atc.digitellinc.com/p/s/organ-offers-acceptancerefusal-practices-in-kidney-and-pancreas-transplantation-37246
https://atc.digitellinc.com/p/s/overcoming-roadblocks-to-health-equity-in-pediatric-transplant-37247
https://atc.digitellinc.com/p/s/shedding-light-on-glp-1-agonists-and-sglt2-inhibitors-in-transplant-practice-37249
https://atc.digitellinc.com/p/s/controversial-living-liver-donors-best-approaches-to-unique-scenarios-37250
https://atc.digitellinc.com/p/s/state-of-the-art-lecture-dr-peter-friend-37251
https://atc.digitellinc.com/p/s/implementation-barriers-to-addressing-medication-non-adherence-in-kidney-transplantation-taking-the-next-step-37252
https://atc.digitellinc.com/p/s/public-policy-advocacy-101-the-what-why-and-how-to-influence-change-in-transplantation-37253
https://atc.digitellinc.com/p/s/pulmonary-amr-consensus-2024-a-novel-strategy-and-a-new-path-forward-37254
https://atc.digitellinc.com/p/s/resource-utilization-and-programmatic-considerations-in-the-era-of-machine-perfusion-37255
https://atc.digitellinc.com/p/s/scalpel-or-pills-options-for-living-donor-candidates-with-obesity-and-metabolic-syndrome-37256
https://atc.digitellinc.com/p/s/to-tid-infinity-and-beyond-transplant-id-as-a-metric-of-excellence-in-your-transplant-center-37259
https://atc.digitellinc.com/p/s/when-it-rains-look-for-rainbows-how-to-build-inclusive-solid-organ-transplant-programs-and-systems-for-lgbtq-plus-donors-and-recipients-37260
https://atc.digitellinc.com/p/s/why-are-so-many-donor-pancreata-non-utilized-37261
https://atc.digitellinc.com/p/s/your-transplant-was-a-success-now-what-navigating-long-term-functional-challenges-after-pediatric-organ-transplantation-37262
https://atc.digitellinc.com/p/s/are-we-improving-management-of-immunological-issues-in-intestinal-transplantation-37264
https://atc.digitellinc.com/p/s/expanding-virtual-hla-crossmatch-for-deceased-donor-kidney-transplantation-is-it-time-37265
https://atc.digitellinc.com/p/s/fungal-infections-and-novel-antifungals-in-transplantation-37266
https://atc.digitellinc.com/p/s/moving-the-needle-actionable-steps-towards-transplant-equity-37268
https://atc.digitellinc.com/p/s/multiorgan-transplant-does-my-patient-actually-need-a-liver-with-their-kidney-heart-or-lung-transplant-37269
https://atc.digitellinc.com/p/s/transcriptomic-approach-to-rejection-and-immune-quiescence-37272
https://atc.digitellinc.com/p/s/your-story-isnt-over-yet-recurrent-disease-in-pediatric-transplantation-37273
https://atc.digitellinc.com/p/s/navigating-the-complexities-and-challenges-in-recurrent-fsgs-through-a-collaborative-effort-for-risk-assessment-and-management-37274
https://atc.digitellinc.com/p/s/to-b-or-not-to-b-transplanting-organs-from-hepatitis-b-nat-positive-donors-37275
https://atc.digitellinc.com/p/s/an-update-from-tpac-transplant-pharmacy-adherence-consortium-on-transplant-adherence-sharing-published-experiences-lessons-learned-and-an-update-from-the-ast-controversy-conference-37276
https://atc.digitellinc.com/p/s/for-the-health-of-it-donor-screening-for-seasonal-and-geographically-limited-infectious-diseases-37278
https://atc.digitellinc.com/p/s/give-me-a-break-evaluation-and-treatment-of-post-transplant-osteoporosis-37279
https://atc.digitellinc.com/p/s/health-psychology-consultative-assessment-therapeutic-intervention-and-treatment-pre-and-post-transplant-37280
https://atc.digitellinc.com/p/s/integration-of-big-data-from-transplant-registries-and-histocompatibility-laboratories-for-multicenter-studies-37281
https://atc.digitellinc.com/p/s/moving-beyond-the-waiting-list-capturing-the-true-gaps-in-access-for-transplantation-an-integrative-approach-37283
https://atc.digitellinc.com/p/s/pushing-the-boundaries-of-liver-transplantation-transplantation-after-systemic-and-immunotherapy-for-hcc-37287
https://atc.digitellinc.com/p/s/developing-and-testing-health-system-interventions-to-improve-transplant-outcomes-37289
https://atc.digitellinc.com/p/s/getting-off-the-gold-standard-in-lung-transplantation-37290
https://atc.digitellinc.com/p/s/hal9000-how-ai-is-changing-transplant-diagnostics-37291
https://atc.digitellinc.com/p/s/how-can-we-close-the-gap-for-gender-and-race-disparities-in-solid-organ-transplantation-37293
https://atc.digitellinc.com/p/s/immunosuppression-minimization-in-transplant-thinking-beyond-rejection-risk-37294
https://atc.digitellinc.com/p/s/out-of-sequence-allocation-time-for-policy-change-37295
https://atc.digitellinc.com/p/s/should-we-do-protocol-biopsies-after-intestinal-transplantation-37296
https://atc.digitellinc.com/p/s/top-papers-in-transplant-infectious-diseases-37297
https://atc.digitellinc.com/p/s/getting-techy-the-use-of-advanced-technology-and-machine-learning-in-post-transplant-care-37298
https://atc.digitellinc.com/p/s/optimizing-dcd-liver-transplant-nrpmachine-perfusion-v-conventional-approach-37299
https://atc.digitellinc.com/p/s/are-robotic-living-donor-nephroctomy-and-hepatectomy-the-future-37300
https://atc.digitellinc.com/p/s/artificial-intelligence-in-transplant-infectious-disease-the-wave-of-the-future-37301
https://atc.digitellinc.com/p/s/expanding-horizons-reassessing-living-kidney-donor-acceptance-criteria-to-bridge-the-shortage-gap-37302
https://atc.digitellinc.com/p/s/improving-access-for-simultaneous-pancreas-kidney-transplantation-whos-in-who-needs-work-37303
https://atc.digitellinc.com/p/s/navigating-alcohol-use-disorder-in-liver-transplantation-contemporary-challenges-and-approaches-37304
https://atc.digitellinc.com/p/s/navigating-necessity-the-battle-for-medication-access-in-solid-organ-transplantation-37305
https://atc.digitellinc.com/p/s/newer-techniques-for-improving-clinical-outcomes-after-islet-cell-auto-transplantation-37306
https://atc.digitellinc.com/p/s/policies-bylaws-and-cops-oh-my-keeping-up-with-ever-changing-regulations-in-donation-and-transplantation-37308
https://atc.digitellinc.com/p/s/whatever-happened-to-pediatric-intestine-transplantation-37310
https://atc.digitellinc.com/p/s/a-nephrology-focused-transplant-inclusive-end-to-end-value-based-care-payment-model-challenges-and-opportunities-37311
https://atc.digitellinc.com/p/s/advances-in-transplant-oncology-from-immune-checkpoint-blockade-to-car-t-therapies-37312
https://atc.digitellinc.com/p/s/artificial-intelligence-and-machine-learning-applications-in-transplant-pathology-37313
https://atc.digitellinc.com/p/s/emerging-landscape-of-covid-19-in-pediatric-transplant-recipients-37314
https://atc.digitellinc.com/p/s/expanding-the-reach-of-living-donor-liver-transplant-current-and-future-innovations-37315
https://atc.digitellinc.com/p/s/godzilla-vs-kong-the-epic-battle-between-heart-transplant-and-lvad-37316
https://atc.digitellinc.com/p/s/i-once-was-lost-but-now-am-profound-philosophy-for-big-questions-in-transplant-37317
https://atc.digitellinc.com/p/s/updates-in-management-of-hepatorenal-syndrome-37320
https://atc.digitellinc.com/p/s/the-courage-to-succeed-lessons-from-70-years-of-living-donor-transplants-37322
https://atc.digitellinc.com/p/s/state-of-the-art-lecture-sec-alex-azar-37323
https://atc.digitellinc.com/p/s/optn-modernization-effort-37324
https://atc.digitellinc.com/p/s/whats-hot-whats-new-37325
https://atc.digitellinc.com/p/s/townhall-37326
https://atc.digitellinc.com/p/s/test-purchase-37327
https://atc.digitellinc.com/packages/159/view